PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Allen, CDC; Okada, T; Tang, HL; Cyster, JG				Allen, Christopher D. C.; Okada, Takaharu; Tang, H. Lucy; Cyster, Jason G.			Imaging of germinal center selection events during affinity maturation	SCIENCE			English	Article							FOLLICULAR DENDRITIC CELLS; PROLIFERATION; OPINION; MEMORY; ZONE	The germinal center ( GC) is an important site for the generation and selection of B cells bearing high-affinity antibodies, yet GC cell migration and interaction dynamics have not been directly observed. Using two-photon microscopy of mouse lymph nodes, we revealed that GC B cells are highly motile and extend long cell processes. They transited between GC dark and light zones and divided in both regions, although these B cells resided for only several hours in the light zone where antigen is displayed. GC B cells formed few stable contacts with GC T cells despite frequent encounters, and T cells were seen to carry dead B cell blebs. On the basis of these observations, we propose a model in which competition for T cell help plays a more dominant role in the selection of GC B cells than previously appreciated.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Okada, T (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	Takaharu.Okada@ucsf.edu; Jason.Cyster@ucsf.edu	Okada, Takaharu/N-7931-2015	Allen, Christopher/0000-0002-1879-9047				Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; Meyer-Hermann ME, 2006, MATH MED BIOL, V23, P255, DOI 10.1093/imammb/dql012; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Ryser JE, 1999, NUCL MED BIOL, V26, P673, DOI 10.1016/S0969-8051(99)00042-6; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Wang Y, 2005, IMMUNITY, V22, P749, DOI 10.1016/j.immuni.2005.04.012	17	569	579	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					528	531		10.1126/science.1136736	http://dx.doi.org/10.1126/science.1136736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17185562				2022-12-28	WOS:000243726600051
J	Zegerman, P; Diffley, JFX				Zegerman, Philip; Diffley, John F. X.			Phosphorylation of Sld2 and Sld3 by cyclin-dependent kinases promotes DNA replication in budding yeast	NATURE			English	Article							B-TYPE CYCLINS; SACCHAROMYCES-CEREVISIAE; S-PHASE; CHROMOSOMAL DNA; POLYMERASE-ALPHA; CELL-CYCLE; PROTEIN; COMPLEX; G1; ORIGINS	Cyclin-dependent kinases (CDKs) drive major cell cycle events including the initiation of chromosomal DNA replication. We identified two S phase CDK (S-CDK) phosphorylation sites in the budding yeast Sld3 protein that, together, are essential for DNA replication. Here we show that, when phosphorylated, these sites bind to the amino-terminal BRCT repeats of Dpb11. An Sld3 - Dpb11 fusion construct bypasses the requirement for both Sld3 phosphorylation and the N-terminal BRCT repeats of Dpb11. Co-expression of this fusion with a phospho-mimicking mutant in a second essential CDK substrate, Sld2, promotes DNA replication in the absence of S-CDK. Therefore, Sld2 and Sld3 are the minimal set of S-CDK targets required for DNA replication. DNA replication in cells lacking G1 phase CDK (G1-CDK) required expression of the Cdc7 kinase regulatory subunit, Dbf4, as well as Sld2 and Sld3 bypass. Our results help to explain how G1- and S-CDKs promote DNA replication in yeast.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	John.Diffley@cancer.org.uk		Diffley, John/0000-0001-5184-7680; Zegerman, Philip/0000-0002-5707-1083				Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Cheng LA, 1999, MOL CELL BIOL, V19, P4270; Desdouets C, 1998, EMBO J, V17, P4139, DOI 10.1093/emboj/17.14.4139; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; HARLOW E, 1998, USING ANTIBODIES LAB; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; KUHNE C, 1993, EMBO J, V12, P3437, DOI 10.1002/j.1460-2075.1993.tb06018.x; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Noguchi E, 2002, CURR BIOL, V12, P599, DOI 10.1016/S0960-9822(02)00739-X; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Oshiro G, 1999, MOL CELL BIOL, V19, P4888; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tyers M, 1996, P NATL ACAD SCI USA, V93, P7772, DOI 10.1073/pnas.93.15.7772; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304; Yamamoto RR, 2000, GENETICS, V156, P711; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	40	358	361	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					281	285		10.1038/nature05432	http://dx.doi.org/10.1038/nature05432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17167417				2022-12-28	WOS:000243504700037
J	Sari, ABA; Sheldon, TA; Cracknell, A; Turnbull, A				Sari, Ali Baba-Akbari; Sheldon, Trevor A.; Cracknell, Alison; Turnbull, Alastair			Sensitivity of routine system for reporting patient safety incidents in an NHS hospital: retrospective patient case note review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ADVERSE EVENTS; BARRIERS; ERROR	Objective To evaluate the performance of a routine incident reporting system in identifying patient safety incidents. Design Two stage retrospective review of patients' case notes and analysis of data submitted to the routine incident reporting system on the same patients. Setting A large NHS hospital in England. Population 1006 hospital admissions between January and May 2004: surgery (n=311), general medicine (n=251), elderly care (n=184), orthopaedics (n=131), urology (n=61), and three other specialties (n=68). Main outcome measures Proportion of admissions with at least one patient safety incident; proportion and type of patient safety incidents missed by routine incident reporting and case note review methods. Results 324 patient safety incidents were identified in 230/1006 admissions (22.9%; 95% confidence interval 20.3% to 25.5%). 270 (83%) patient safety incidents were identified by case note review only, 21 (7%) by the routine reporting system only, and 33 (100%) by both methods. 110 admissions (10.9%; 9.0% to 12.8%) had at least one patient safety incident resulting in patient harm, all of which were detected by the case note review and six (5%) by the reporting system. Conclusion The routine incident reporting system may be poor at identifying patient safety incidents, particularly those resulting in harm. Structured case note review may have a useful role in surveillance of routine incident reporting and associated quality improvement programmes.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; York Hosp, York YO31 8HE, N Yorkshire, England	University of York - UK; Leeds General Infirmary	Sheldon, TA (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	tas5@york.ac.uk	Sheldon, Trevor/AAK-7088-2021	Sheldon, Trevor/0000-0002-7479-5913				Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Campbell M.J., 1999, MED STAT SUMMARY APP, V3rd; Davis Peter, 2002, N Z Med J, V115, pU271; Evans SM, 2006, QUAL SAF HEALTH CARE, V15, P39, DOI 10.1136/qshc.2004.012559; Firth-Cozens J, 2002, QUAL SAF HEALTH CARE, V11, P7, DOI 10.1136/qhc.11.1.7; Kilbridge PM, 2006, QUAL SAF HEALTH CARE, V15, P148, DOI 10.1136/qshc.2006.018218; Kingston MJ, 2004, MED J AUSTRALIA, V181, P36, DOI 10.5694/j.1326-5377.2004.tb06158.x; National Patient Safety Agency, 2005, BUILD MEM PREV HARM; Thomas EJ, 2003, J GEN INTERN MED, V18, P61, DOI 10.1046/j.1525-1497.2003.20147.x; Uribe CL, 2002, J HEALTHC MANAG, V47, P263, DOI 10.1097/00115514-200207000-00009; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; VINCENT C, 2001, CLIN RISK MANAGEMENT; Vincent C., 2006, PATIENT SAFETY; Walsh T, 2002, PHYSIOL MEAS, V23, pR111, DOI 10.1088/0967-3334/23/3/201; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	16	252	255	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2007	334	7584					79	81		10.1136/bmj.39031.507153.AE	http://dx.doi.org/10.1136/bmj.39031.507153.AE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	127DZ	17175566	Green Published, Bronze			2022-12-28	WOS:000243566800030
J	Chadwick, WW				Chadwick, William W., Jr.			A submarine volcano is caught in the act	SCIENCE			English	Editorial Material							MIDOCEAN RIDGE; ERUPTION		Oregon State Univ, Hatfield Marine Sci Ctr, NOAA, Newport, OR 97365 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University	Chadwick, WW (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, NOAA, Newport, OR 97365 USA.	william.w.chadwick@noaa.gov	Chadwick, William W./R-7623-2019	Chadwick, William W./0000-0002-5129-4569				Cowen JP, 2004, GEOPH MONOG SERIES, V144, P227, DOI 10.1029/144GM15; Dziak R. P, 2006, EOS T AGU, V87, DOI [10.1029/2006EO040001, DOI 10.1029/2006EO040001]; Fox CG, 2001, NATURE, V412, P727, DOI 10.1038/35089066; HAYMON RM, 1993, EARTH PLANET SC LETT, V119, P85, DOI 10.1016/0012-821X(93)90008-W; McNutt S., 2000, ENCY VOLCANOES, P1095; Tolstoy M, 2006, SCIENCE, V314, P1920, DOI 10.1126/science.1133950	6	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1887	1888		10.1126/science.1137082	http://dx.doi.org/10.1126/science.1137082			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185591				2022-12-28	WOS:000242996800035
J	Heyland, D; Cook, D; Dodek, P; Muscedere, J; Day, A				Heyland, Daren; Cook, Deborah; Dodek, Peter; Muscedere, John; Day, Andrew		Canadian Critical Care Trials	A randomized trial of diagnostic techniques for ventilator-associated pneumonia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; NOSOCOMIAL INFECTION; ANTIBIOTIC-TREATMENT; RISK-FACTORS; GRAM STAIN; IMPACT; MORTALITY; MANAGEMENT; SEVERITY	BACKGROUND: Critically ill patients who require mechanical ventilation are at risk for ventilator-associated pneumonia. Current data are conflicting as to the optimal diagnostic approach in patients who have suspected ventilator-associated pneumonia. Methods: In a multicenter trial, we randomly assigned immunocompetent adults who were receiving mechanical ventilation and who had suspected ventilator-associated pneumonia after 4 days in the intensive care unit (ICU) to undergo either bronchoalveolar lavage with quantitative culture of the bronchoalveolar-lavage fluid or endotracheal aspiration with nonquantitative culture of the aspirate. Patients known to be colonized or infected with pseudomonas species or methicillin-resistant Staphylococcus aureus were excluded. Empirical antibiotic therapy was initiated in all patients until culture results were available, at which point a protocol of targeted therapy was used for discontinuing or reducing the dose or number of antibiotics, or for resuming antibiotic therapy to treat a preenrollment condition if the culture was negative. RESULTS: We enrolled 740 patients in 28 ICUs in Canada and the United States. There was no significant difference in the primary outcome (28-day mortality rate) between the bronchoalveolar-lavage group and the endotracheal-aspiration group (18.9% and 18.4%, respectively; P=0.94). The bronchoalveolar-lavage group and the endotracheal-aspiration group also had similar rates of targeted therapy (74.2% and 74.6%, respectively; P=0.90), days alive without antibiotics (10.4+/-7.5 and 10.6+/-7.9, P=0.86), and maximum organ-dysfunction scores (mean [+/-SD], 8.3+/-3.6 and 8.6+/-4.0; P=0.26). The two groups did not differ significantly in the length of stay in the ICU or hospital. CONCLUSIONS: Two diagnostic strategies for ventilator-associated pneumonia -bronchoalveolar lavage with quantitative culture of the bronchoalveolar-lavage fluid and endotracheal aspiration with nonquantitative culture of the aspirate - are associated with similar clinical outcomes and similar overall use of antibiotics.	Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada; Queens Univ, Kingston, ON, Canada; St Josephs Hosp, Hamilton, ON, Canada; McMaster Univ, Hamilton, ON, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada; Ottawa Civic Hosp, Ottawa, ON K1Y 4E9, Canada; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Walter C Mackenzie Hlth Sci Ctr, Edmonton, AB, Canada; Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; London Hlth Sci Ctr, London, ON, Canada; Hop Charles Lemoyne, Longueuil, France; Royal Columbian Hosp, New Westminster, BC, Canada; Royal Univ Hosp, Saskatoon, SK S7N 0W8, Canada; Hosp St Luc, Montreal, PQ, Canada; Hamilton Hlth Sci, Hamilton, ON, Canada; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Sunnybrook & Womens Coll, Toronto, ON, Canada; Sudbury Reg Hosp, Sudbury, ON, Canada; Grey Nuns Community Hosp, Edmonton, AB, Canada; Foothills Med Ctr, Calgary, AB, Canada; Peter Lougheed Hosp, Calgary, AB, Canada; Rockyview Hosp, Calgary, AB, Canada; Vancouver Hosp, Vancouver, BC, Canada; Hop Sacre Coeur, Montreal, PQ H4J 1C5, Canada; Royal Alexandra Hosp, Glasgow, Lanark, Scotland; Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; St Josephs Hlth Care, London, ON, Canada; Hlth Sci Ctr St Johns, St John, NF, Canada	Queens University - Canada; Queens University - Canada; McGill University; McMaster University; McMaster University; University of British Columbia; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Oregon Health & Science University; University of Alberta; Universite de Montreal; St. Paul's Hospital; University of Saskatchewan; London Health Sciences Centre; University of Saskatchewan; Universite de Montreal; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Health Sciences North; University of Calgary; University of British Columbia; Universite de Montreal; Queen Elizabeth II Health Sciences Centre; Western University (University of Western Ontario)	Heyland, D (corresponding author), Kingston Gen Hosp, Angada 4, Kingston, ON K7L 2V7, Canada.	dkh2@post.queensu.ca	Mehta, Sangeeta/C-4623-2015; Muscedere, John/AAH-9291-2021; Zuege, Danny J./L-5368-2017	Zuege, Danny J./0000-0003-2033-5847; Dale, Craig/0000-0002-5042-0332				AlvarezLerma F, 1996, INTENS CARE MED, V22, P387, DOI 10.1007/BF01712153; ANDREWS CP, 1981, CHEST, V80, P254, DOI 10.1378/chest.80.3.254; Blot F, 2000, AM J RESP CRIT CARE, V162, P1731, DOI 10.1164/ajrccm.162.5.9908088; BUENOCAVANILLAS A, 1994, CRIT CARE MED, V22, P55, DOI 10.1097/00003246-199401000-00013; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Duflo F, 2001, ANESTH ANALG, V92, P442, DOI 10.1213/00000539-200102000-00031; Dupont H, 2001, INTENS CARE MED, V27, P355, DOI 10.1007/s001340000640; Fagon JY, 2000, ANN INTERN MED, V132, P621, DOI 10.7326/0003-4819-132-8-200004180-00004; FAGON JY, 1988, AM REV RESPIR DIS, V138, P110, DOI 10.1164/ajrccm/138.1.110; Girou E, 1998, AM J RESP CRIT CARE, V157, P1151, DOI 10.1164/ajrccm.157.4.9701129; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; Heyland DK, 1999, CHEST, V115, P1076, DOI 10.1378/chest.115.4.1076; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Luna CM, 1997, CHEST, V111, P676, DOI 10.1378/chest.111.3.676; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MEDURI GU, 1992, CHEST, V102, pS557, DOI 10.1378/chest.102.5_Supplement_1.557S; Micek S, 2004, CHEST, V125, P1791, DOI 10.1378/chest.125.5.1791; Namias N, 1998, J TRAUMA, V44, P102, DOI 10.1097/00005373-199801000-00012; Pittet D, 2000, LANCET, V356, P874, DOI 10.1016/S0140-6736(00)02675-1; Rello J, 1997, CRIT CARE MED, V25, P1862, DOI 10.1097/00003246-199711000-00026; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; Ruiz M, 2000, AM J RESP CRIT CARE, V162, P119, DOI 10.1164/ajrccm.162.1.9907090; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Sanchez-Nieto JM, 1998, AM J RESP CRIT CARE, V157, P371, DOI 10.1164/ajrccm.157.2.97-02039; Shorr AF, 2005, CRIT CARE MED, V33, P46, DOI 10.1097/01.CCM.0000149852.32599.31; Stokes ME, 2000, CATEGORICAL DATA ANA; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Violan JS, 2000, CRIT CARE MED, V28, P2737, DOI 10.1097/00003246-200008000-00009	31	339	350	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2619	2630		10.1056/NEJMoa052904	http://dx.doi.org/10.1056/NEJMoa052904			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182987	Bronze			2022-12-28	WOS:000242956200003
J	Kantarjian, HM; Talpaz, M; Giles, F; O'Brien, S; Cortes, J				Kantarjian, Hagop M.; Talpaz, Moshe; Giles, Francis; O'Brien, Susan; Cortes, Jorge			New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE KINASE INHIBITOR; FOCAL ADHESION KINASE; SRC FAMILY KINASES; IN-VITRO ACTIVITY; BCR-ABL; CHRONIC-PHASE; BLAST CRISIS; CYTOGENETIC RESPONSES	Chronic myeloid leukemia (CML) was the first human malignant disease to be linked to a single, acquired genetic abnormality. Identification of the BCR-ABL kinase fusion protein and its central role in the pathogenesis of CAAL provided new opportunities to develop rational molecular targeted therapies. This review provides an update on the underlying pathophysiologies of disease progression and imatinib mesylate resistance, leading to the development of new targeted tyrosine kinase inhibitors for managing CML. Imatinib, a selective inhibitor of BCR-ABL, represents a major success in the era of target-directed cancer chemotherapy. However, patients with advanced CML have been less sensitive to therapy and responses have been short. In addition, treatment resistance is an emerging problem at all disease stages. Insight into factors involved in imatinib resistance and disease progression has highlighted a role for such BCR-ABL-dependent factors as amplification and overexpression of the BCR-ABL gene and the emergence of mutant isoforms of BCR-ABL. However, BCR-ABL-independent factors, including leukemogenic pathways involving kinases other than BCRABL, also play a part. In light of the limitations of imatinib against these factors, newer tyrosine kinase inhibitors, including dasatinib (a multitargeted kinase inhibitor of BCR-ABL and Src family kinases) and nilotinib (AMN107, a selective BCR-ABL inhibitor), may provide promising treatment options for patients with CML.	Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Texas System; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan	Kantarjian, HM (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Box 428, Houston, TX 77030 USA.	hkantarj@mdanderson.org		Talpaz, Moshe/0000-0003-3361-3981				Al-Ali HK, 2004, HEMATOL J, V5, P55, DOI 10.1038/sj.thj.6200319; Apperley JF, 2002, NEW ENGL J MED, V347, P481, DOI 10.1056/NEJMoa020150; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Bartholomeusz GA, 2005, BLOOD, V106, p802A; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Branford S, 2004, BLOOD, V104, P2926, DOI 10.1182/blood-2004-03-1134; Branford S, 2003, LEUKEMIA, V17, P2401, DOI 10.1038/sj.leu.2403158; Branford S, 2006, METH MOLEC MED, V125, P93; Burgess MR, 2005, P NATL ACAD SCI USA, V102, P3395, DOI 10.1073/pnas.0409770102; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chai SK, 1997, J IMMUNOL, V159, P4720; Chandra J, 2003, BLOOD, V102, P4512, DOI 10.1182/blood-2003-02-0562; Cheng KD, 2002, CANCER, V95, P440, DOI 10.1002/cncr.10670; Corbin AS, 2003, BLOOD, V101, P4611, DOI 10.1182/blood-2002-12-3659; Cortes JE, 2006, J CLIN ONCOL, V24, p344S; Coutre S, 2006, J CLIN ONCOL, V24, p344S; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Deininger MWN, 2003, J CLIN ONCOL, V21, P1637, DOI 10.1200/JCO.2003.11.143; Deutsch E, 2001, BLOOD, V97, P2084, DOI 10.1182/blood.V97.7.2084; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dorsey JF, 2000, CANCER RES, V60, P3127; Druker BJ, 2006, J CLIN ONCOL, V24, p338S; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Faderl S, 1999, ANN INTERN MED, V131, P207, DOI 10.7326/0003-4819-131-3-199908030-00008; Faderl S, 2000, LEUKEMIA LYMPHOMA, V36, P263, DOI 10.3109/10428190009148847; Gambacorti-Passerini C, 2000, JNCI-J NATL CANCER I, V92, P1641, DOI 10.1093/jnci/92.20.1641; Giles FJ, 2006, J CLIN ONCOL, V24, p346S; Golas JM, 2003, CANCER RES, V63, P375; Golemovic M, 2005, CLIN CANCER RES, V11, P4941, DOI 10.1158/1078-0432.CCR-04-2601; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; GOTOH A, 1995, EXP HEMATOL, V23, P1153; Guilhot F, 1997, NEW ENGL J MED, V337, P223, DOI 10.1056/NEJM199707243370402; Gumireddy K, 2005, P NATL ACAD SCI USA, V102, P1992, DOI 10.1073/pnas.0408283102; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; Hochhaus A, 2006, J CLIN ONCOL, V24, p339S; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hofmann WK, 2002, BLOOD, V99, P1860, DOI 10.1182/blood.V99.5.1860; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Huron DR, 2003, CLIN CANCER RES, V9, P1267; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Illmer T, 2004, LEUKEMIA, V18, P401, DOI 10.1038/sj.leu.2403257; Jiang XY, 1999, P NATL ACAD SCI USA, V96, P12804, DOI 10.1073/pnas.96.22.12804; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian HM, 2006, J CLIN ONCOL, V24, p345S; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; KANTARJIAN HM, 1991, CANCER-AM CANCER SOC, V68, P1201, DOI 10.1002/1097-0142(19910915)68:6<1201::AID-CNCR2820680604>3.0.CO;2-1; KANTARJIAN HM, 1995, ANN INTERN MED, V122, P254, DOI 10.7326/0003-4819-122-4-199502150-00003; La Rosee P, 2002, CANCER RES, V62, P7149; Le Coutre P, 2004, BLOOD, V104, p218A, DOI 10.1182/blood.V104.11.762.762; Le Coutre PD, 2006, J CLIN ONCOL, V24, p344S; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; MAHON FX, 1994, BLOOD, V84, P3592; Mauro MJ, 2006, HAEMATOL-HEMATOL J, V91, P152; Mestan J, 2004, BLOOD, V104, p546A, DOI 10.1182/blood.V104.11.1978.1978; Mow BMF, 2002, BLOOD, V99, P664, DOI 10.1182/blood.V99.2.664; Muller MC, 2003, LEUKEMIA, V17, P2392, DOI 10.1038/sj.leu.2403157; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; Ottmann OG, 2002, BLOOD, V100, P1965, DOI 10.1182/blood-2001-12-0181; Peggs K, 2003, NEW ENGL J MED, V348, P1048, DOI 10.1056/NEJMe030009; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Reyes M, 2005, BLOOD, V106, P3646, DOI 10.1182/blood-2004-12-4603; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Roginskaya V, 1999, LEUKEMIA, V13, P855, DOI 10.1038/sj.leu.2401429; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sacchi S, 1999, CANCER-AM CANCER SOC, V86, P2632, DOI 10.1002/(SICI)1097-0142(19991215)86:12<2632::AID-CNCR7>3.0.CO;2-A; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Silver RT, 1999, BLOOD, V94, P1517; Silver RT, 2004, BLOOD, V104, p11A; SKORSKI T, 1995, BLOOD, V86, P726, DOI 10.1182/blood.V86.2.726.bloodjournal862726; Slupianek A, 2001, MOL CELL, V8, P795, DOI 10.1016/S1097-2765(01)00357-4; Talpaz M, 2003, BLOOD, V102, p905A; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Talpaz M, 2006, J CLIN ONCOL, V24, p343S; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tauchi T, 1998, INT J ONCOL, V12, P1269; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; Tipping AJ, 2004, LEUKEMIA, V18, P1352, DOI 10.1038/sj.leu.2403416; Tokarski JS, 2004, BLOOD, V104, p160A, DOI 10.1182/blood.V104.11.553.553; Verstovsek S, 2005, CANCER-AM CANCER SOC, V104, P1230, DOI 10.1002/cncr.21299; von Bubnoff N, 2002, LANCET, V359, P487, DOI 10.1016/S0140-6736(02)07679-1; VONCKEN JW, 1995, BLOOD, V86, P4603, DOI 10.1182/blood.V86.12.4603.bloodjournal86124603; Warmuth M, 2003, CURR PHARM DESIGN, V9, P2043, DOI 10.2174/1381612033454126; Warmuth M, 2003, BLOOD, V101, P664, DOI 10.1182/blood-2002-01-0288; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Wolff NC, 2005, BLOOD, V105, P3995, DOI 10.1182/blood-2004-09-3534	103	198	221	1	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2006	145	12					913	923		10.7326/0003-4819-145-12-200612190-00008	http://dx.doi.org/10.7326/0003-4819-145-12-200612190-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120BB	17179059				2022-12-28	WOS:000243057400006
J	Eisenstein, M				Eisenstein, Michael			Protein arrays - Growing pains	NATURE			English	Article																			0	33	37	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					959	964		10.1038/444959a	http://dx.doi.org/10.1038/444959a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167490	Green Published, Bronze			2022-12-28	WOS:000242805400063
J	Chen, IA				Chen, Irene A.			The emergence of cells during the origin of life	SCIENCE			English	Editorial Material							FATTY-ACID VESICLES; GROWTH; RNA		Harvard Univ, Sch Med, Div Hlth Sci & Technol, Boston, MA 02115 USA; MIT, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Chen, IA (corresponding author), Harvard Univ, Sch Med, Div Hlth Sci & Technol, Boston, MA 02115 USA.	ichen@post.harvard.edu		Chen, Irene/0000-0001-6040-7927				ALLEN WILLIAM V., 1967, CURR MOD BIOL, V1, P24; Chen IA, 2005, J AM CHEM SOC, V127, P13213, DOI 10.1021/ja051784p; Chen IA, 2004, BIOPHYS J, V87, P988, DOI 10.1529/biophysj.104.039875; Chen IA, 2004, SCIENCE, V305, P1474, DOI 10.1126/science.1100757; Chen IA, 2004, P NATL ACAD SCI USA, V101, P7965, DOI 10.1073/pnas.0308045101; Chen IA, 2006, COLD SPRING HARB MON, V43, P57; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Knoll AH, 2003, LIFE YOUNG PLANET 1; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Rushdi AI, 2001, ORIGINS LIFE EVOL B, V31, P103, DOI 10.1023/A:1006702503954; Steitz TA, 2003, TRENDS BIOCHEM SCI, V28, P411, DOI 10.1016/S0968-0004(03)00169-5; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; YUEN GU, 1973, NATURE, V246, P301, DOI 10.1038/246303a0	16	31	32	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1558	1559		10.1126/science.1137541	http://dx.doi.org/10.1126/science.1137541			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158315				2022-12-28	WOS:000242624600029
J	Kopec, C; Malinow, R				Kopec, Charles; Malinow, Roberto			Matters of size	SCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; DENDRITIC SPINES; AMPA RECEPTORS; ACTIN; PLASTICITY; HIPPOCAMPUS; LTP; SYNAPSES		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Kopec, C (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org						Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Kim CH, 1999, J NEUROSCI, V19, P4314; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lin B, 2005, J NEUROSCI, V25, P2062, DOI 10.1523/JNEUROSCI.4283-04.2005; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; ZADOR A, 1990, P NATL ACAD SCI USA, V87, P6718, DOI 10.1073/pnas.87.17.6718	19	19	19	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1554	1555		10.1126/science.1137595	http://dx.doi.org/10.1126/science.1137595			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158312				2022-12-28	WOS:000242624600026
J	Walker, J; Cliff, RA; Latham, AG				Walker, Joanne; Cliff, Robert A.; Latham, Alfred G.			U-Pb isotopic age of the StW 573 hominid from Sterkfontein, South Africa	SCIENCE			English	Article							COSMOGENIC AL-26; FOOT BONES; REAPPRAISAL; INFORMATION; BE-10; DECAY; RIVER	Sterkfontein cave, South Africa, has yielded an australopith skeleton, StW 573, whose completeness has excited great interest in paleoanthropology. StW 573, or "Little Foot," was found 25 meters below the surface in the Silberberg Grotto. U-238-Pb-206 measurements on speleothems immediately above and below the fossil remains, corrected for initial U-234 disequilibrium, yield ages of 2.17 +/- 0.17 million years ago (Ma) and 2.24(-0.07)(+0.09) Ma, respectively, indicating an age for StW 573 of close to 2.2 Ma. This age is in contrast to an age of similar to 3.3 Ma suggested by magnetochronology and ages of similar to 4 Ma based on Be-10 and Al-26, but it is compatible with a faunal age range of 4 to 2 Ma.	Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; Univ Liverpool, Sch Archaeol Class & Egyptol, Liverpool L69 3GS, Merseyside, England	University of Leeds; University of Liverpool	Cliff, RA (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	bob@earth.leeds.ac.uk						Berger LR, 2002, AM J PHYS ANTHROPOL, V119, P192, DOI 10.1002/ajpa.10156; BRAIN CK, 1958, TRANSVAAL MUS MEM, V111; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; CLARKE RJ, 1995, SCIENCE, V269, P521, DOI 10.1126/science.7624772; Clarke RJ, 2002, S AFR J SCI, V98, P523; Clarke RJ, 2002, S AFR J SCI, V98, P415; Clarke RJ, 1998, S AFR J SCI, V94, P460; de Lumley MA, 1982, P 1 INT C HUM PAL, P707; Delson E., 1988, P317; Gibbons A, 2003, SCIENCE, V300, P562, DOI 10.1126/science.300.5619.562; Granger DE, 1997, GEOLOGY, V25, P107, DOI 10.1130/0091-7613(1997)025<0107:QDROTN>2.3.CO;2; Granger DE, 2001, GEOL SOC AM BULL, V113, P825, DOI 10.1130/0016-7606(2001)113<0825:PPIOTG>2.0.CO;2; KENDALL AC, 1978, J SEDIMENT PETROL, V48, P519; KRONFELD J, 1994, EARTH PLANET SC LETT, V123, P81, DOI 10.1016/0012-821X(94)90259-3; Lanphere MA, 2002, GEOL SOC AM BULL, V114, P559, DOI 10.1130/0016-7606(2002)114<0559:RAFTOT>2.0.CO;2; Latham AG, 1993, APPL PALEOMAGNETISM, P150; LUDWIG KR, 1977, J RES US GEOL SURV, V5, P663; MCDOUGALL I, 1992, GEOPHYS RES LETT, V19, P2349, DOI 10.1029/92GL02714; McKee JK, 1996, SCIENCE, V272, P339; Muzikar P, 2006, EARTH PLANET SC LETT, V243, P400, DOI 10.1016/j.epsl.2005.12.020; Partridge T. C., 2005, Transactions of the Royal Society of South Africa, V60, P107; PARTRIDGE TC, 1978, NATURE, V275, P282, DOI 10.1038/275282a0; Partridge TC, 2003, SCIENCE, V300, P607, DOI 10.1126/science.1081651; Partridge TC, 1999, J QUATERNARY SCI, V14, P293, DOI 10.1002/(SICI)1099-1417(199907)14:4<293::AID-JQS471>3.0.CO;2-X; Richards DA, 1998, GEOCHIM COSMOCHIM AC, V62, P3683, DOI 10.1016/S0016-7037(98)00256-7; SCHWARCZ HP, 1994, J HUM EVOL, V26, P175, DOI 10.1006/jhev.1994.1010; Turner A., 1997, Palaeontologia Africana, V34, P115; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385	28	73	83	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1592	1594		10.1126/science.1132916	http://dx.doi.org/10.1126/science.1132916			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158326				2022-12-28	WOS:000242624600040
J	Gomendio, M; Malo, AF; Soler, AJ; Fernandez-Santos, MR; Esteso, MC; Garcia, AJ; Roldan, ERS; Garde, J				Gomendio, Montserrat; Malo, Aurelio F.; Soler, Ana J.; Fernandez-Santos, Maria R.; Esteso, Milagros C.; Garcia, Andres J.; Roldan, Eduardo R. S.; Garde, Julian			Male fertility and sex ratio at birth in red deer	SCIENCE			English	Article							SPERM; QUALITY; CHROMOSOME; DAUGHTERS; BEARING; SUCCESS; MOUSE; SONS	Efforts to test sex ratio theory have focused mostly on females. However, when males possess traits that could enhance the reproductive success of sons, males would also benefit from the manipulation of the offspring sex ratio. We tested the prediction that more-fertile red deer males produce more sons. Our findings reveal that male fertility is positively related to the proportion of male offspring. We also show that there is a positive correlation between the percentage of morphologically normal spermatozoa ( a main determinant of male fertility) and the proportion of male offspring. Thus, males may contribute significantly to biases in sex ratio at birth among mammals, creating the potential for conflicts of interest between males and females.	CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Grp, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain; Univ Castilla La Mancha, CSIC, Inst Invest Recursos Cineget, Junta Communidades Castilla La Mancha, Albacete 02071, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Gomendio, M (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Grp, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	montseg@mncn.csic.es; roldane@mncn.csic.es	Fernández-Santos, Maria Rocío/H-1522-2018; López-Brea, José Julián Garde/AAE-5894-2019; Malo, Aurelio F/D-3973-2011; Soler, Ana Josefa/M-8209-2013; Malo, Aurelio F/X-8865-2019; Roldan, Eduardo R.S./M-7947-2014; Soler, Ana Josefa/AAB-1024-2020; Garde, Julian J/O-5607-2015; Esteso, Milagros C/K-7895-2014; Garcia Diaz, Andres Jose/A-9162-2012	Fernández-Santos, Maria Rocío/0000-0002-3359-1623; López-Brea, José Julián Garde/0000-0002-3667-6518; Malo, Aurelio F/0000-0002-0846-2096; Soler, Ana Josefa/0000-0002-6429-5157; Malo, Aurelio F/0000-0002-0846-2096; Roldan, Eduardo R.S./0000-0002-7545-4248; Soler, Ana Josefa/0000-0002-6429-5157; Garde, Julian J/0000-0002-3667-6518; Esteso, Milagros C/0000-0002-8963-5736; Garcia Diaz, Andres Jose/0000-0002-4662-2185				Carranza J, 1996, ETHOLOGY, V102, P793; Chandler JE, 2002, THERIOGENOLOGY, V57, P1327, DOI 10.1016/S0093-691X(01)00721-X; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; GOMENDIO M, 1990, NATURE, V343, P261, DOI 10.1038/343261a0; Gomendio M., 1998, SPERM COMPETITION SE; Henter HJ, 2004, J EVOLUTION BIOL, V17, P886, DOI 10.1111/j.1420-9101.2004.00746.x; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Kilgallon SJ, 2005, BIOL LETTERS, V1, P253, DOI 10.1098/rsbl.2005.0324; LaMunyon CW, 1997, P NATL ACAD SCI USA, V94, P185, DOI 10.1073/pnas.94.1.185; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Malo AF, 2005, P ROY SOC B-BIOL SCI, V272, P149, DOI 10.1098/rspb.2004.2933; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; Smital J, 2005, ANIM REPROD SCI, V86, P119, DOI 10.1016/j.anireprosci.2004.05.023; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Ward MA, 2006, BIOL REPROD, V74, P652, DOI 10.1095/biolreprod.105.048090	17	74	75	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1445	1447		10.1126/science.1133064	http://dx.doi.org/10.1126/science.1133064			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138900	Green Submitted			2022-12-28	WOS:000242406100039
J	Gavin, AL; Hoebe, K; Duong, B; Ota, T; Martin, C; Beutler, B; Nemazee, D				Gavin, Amanda L.; Hoebe, Kasper; Duong, Bao; Ota, Takayuki; Martin, Christopher; Beutler, Bruce; Nemazee, David			Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling	SCIENCE			English	Article							ACTIVATE B-CELLS; INTERFERON-GAMMA; HOST-RESISTANCE; ENGAGEMENT; IMMUNITY; PATHWAY; MICE	Innate immune signals mediated by Toll-like receptors (TLRs) have been thought to contribute considerably to the antibody-enhancing effects of vaccine adjuvants. However, we report here that mice deficient in the critical signaling components for TLR mount robust antibody responses to T cell-dependent antigen given in four typical adjuvants: alum, Freund's complete adjuvant, Freund's incomplete adjuvant, and monophosphoryl-lipid A/trehalose dicorynomycolate adjuvant. We conclude that TLR signaling does not account for the action of classical adjuvants and does not fully explain the action of a strong adjuvant containing a TLR ligand. This may have important implications in the use and development of vaccine adjuvants.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Kellogg Sch Sci & Technol, Doctoral Program Chem & Biol Sci, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Nemazee, D (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nemazee@scripps.edu	Ota, Takayuki/Q-5528-2017	Ota, Takayuki/0000-0001-6249-0664; Hoebe, Kasper/0000-0002-3626-8098	NIAID NIH HHS [AI050241, T32AI07606] Funding Source: Medline; NIGMS NIH HHS [R01GM44809, R01 GM044809] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007606, R01AI050241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044809] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON J, 1972, TRANSPLANT REV-DENMA, V11, P131; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; FINKELMAN FD, 1991, J EXP MED, V174, P1179, DOI 10.1084/jem.174.5.1179; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Pasare C, 2003, CURR OPIN IMMUNOL, V15, P677, DOI 10.1016/j.coi.2003.09.002; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1992, J EXP MED, V175, P1367, DOI 10.1084/jem.175.5.1367; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	17	452	467	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1936	1938		10.1126/science.1135299	http://dx.doi.org/10.1126/science.1135299			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185603	Green Accepted			2022-12-28	WOS:000242996800052
J	Abgrall, S				Abgrall, Sophie			Initial strategy for antiretroviral-naive patients	LANCET			English	Editorial Material							SEQUENTIAL 3-DRUG REGIMENS; RANDOMIZED-TRIAL; HIV-1 INFECTION; THERAPY; EFFICACY		Avicenne Hosp, Dept Infect & Trop Dis, F-93000 Bobigny, France; Univ Paris 13, Bobigny, France; Univ Paris 06, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; UDICE-French Research Universities; Sorbonne Universite	Abgrall, S (corresponding author), Avicenne Hosp, Dept Infect & Trop Dis, F-93000 Bobigny, France.	sophie.abgrall@avc.aphp.fr						Arasteh K, 2005, AIDS, V19, P943, DOI 10.1097/01.aids.0000171408.38490.01; Flandre P, 2002, AIDS, V16, P561, DOI 10.1097/00002030-200203080-00007; Kirk O, 1999, AIDS, V13, pF9, DOI 10.1097/00002030-199901140-00002; MacArthur RD, 2006, LANCET, V368, P2125, DOI 10.1016/S0140-6736(06)69861-9; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Phillips AN, 2004, AIDS, V18, P1795, DOI 10.1097/00002030-200409030-00008; Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Shafer RW, 2003, NEW ENGL J MED, V349, P2304, DOI 10.1056/NEJMoa030265; WILLIAMS I, 2004, 11 C RETR OPP INF CR; Yeni P, 2006, LANCET, V368, P287, DOI 10.1016/S0140-6736(06)69074-0	11	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 16	2006	368	9553					2107	2109		10.1016/S0140-6736(06)69842-5	http://dx.doi.org/10.1016/S0140-6736(06)69842-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174691				2022-12-28	WOS:000242856900004
J	Ahmed, MF; Ahuja, S; Alauddin, M; Hug, SJ; Lloyd, JR; Pfaff, A; Pichler, T; Saltikov, C; Stute, M; van Geen, A				Ahmed, M. F.; Ahuja, S.; Alauddin, M.; Hug, S. J.; Lloyd, J. R.; Pfaff, A.; Pichler, T.; Saltikov, C.; Stute, M.; van Geen, A.			Epidemiology - Ensuring safe drinking water in Bangladesh	SCIENCE			English	Editorial Material							CHILDRENS INTELLECTUAL FUNCTION; GROUNDWATER DYNAMICS; WEST-BENGAL; ARAIHAZAR; EXPOSURE; RELIABILITY; AQUIFERS; RELEASE; SHALLOW		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Bangladesh Univ Engn & Technol, Dhaka 1000, Bangladesh; Ahuja Consulting, Calabash, NC 28467 USA; Wagner Coll, Dept Chem, Staten Isl, NY 10301 USA; Swiss Fed Inst Aquat Sci & Technol, Dept Water Resources & Drinking Water, CH-8600 Dubendorf, Switzerland; Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; Columbia Univ, Earth Inst, New York, NY 10027 USA; Univ S Florida, Dept Geol, Tampa, FL 33620 USA; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Columbia Univ Barnard Coll, Dept Environm Sci, New York, NY 10027 USA	Columbia University; Bangladesh University of Engineering & Technology (BUET); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Manchester; Columbia University; State University System of Florida; University of South Florida; University of California System; University of California Santa Cruz; Columbia University	van Geen, A (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	avangeen@ldeo.columbia.edu		Thomas, Pichler/0000-0003-3327-2451; Lloyd, Jonathan/0000-0002-0719-0498	Engineering and Physical Sciences Research Council [GR/S30207/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Ahmed M.F., 2005, RISK ASSESSMENT ARSE; CHAKRABORTY AK, 1987, INDIAN J MED RES, V85, P326; Charlet L, 2006, ELEMENTS, V2, P91, DOI 10.2113/gselements.2.2.91; Dhar RK, 1997, CURR SCI INDIA, V73, P48; Gelman A, 2004, RISK ANAL, V24, P1597, DOI 10.1111/j.0272-4332.2004.00553.x; Harvey CF, 2006, CHEM GEOL, V228, P112, DOI 10.1016/j.chemgeo.2005.11.025; Hossain MA, 2005, ENVIRON SCI TECHNOL, V39, P4300, DOI 10.1021/es048703u; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; Kinniburgh D. G., 2001, WC0019 BGS; Klump S, 2006, ENVIRON SCI TECHNOL, V40, P243, DOI 10.1021/es051284w; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Opar A, 2007, HEALTH PLACE, V13, P164, DOI 10.1016/j.healthplace.2005.11.004; Polizzotto ML, 2005, P NATL ACAD SCI USA, V102, P18819, DOI 10.1073/pnas.0509539103; Ravenscroft P, 2005, HYDROGEOL J, V13, P727, DOI 10.1007/s10040-003-0314-0; Sarker M. M. H, 2005, REPORT DEV ARSENIC D; SCHOENFELD A, 2006, THESIS COLUMBIA U NE; van Geen A, 2006, SCI TOTAL ENVIRON, V367, P769, DOI 10.1016/j.scitotenv.2006.01.030; Van Geen A, 2005, ENVIRON SCI TECHNOL, V39, P299, DOI 10.1021/es0491073; Wasserman GA, 2006, ENVIRON HEALTH PERSP, V114, P124, DOI 10.1289/ehp.8030; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Williams PN, 2005, ENVIRON SCI TECHNOL, V39, P5531, DOI 10.1021/es0502324; Zheng Y, 2005, GEOCHIM COSMOCHIM AC, V69, P5203, DOI 10.1016/j.gca.2005.06.001	22	205	207	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1687	1688		10.1126/science.1133146	http://dx.doi.org/10.1126/science.1133146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	116WD	17170279				2022-12-28	WOS:000242833600030
J	Petruk, S; Sedkov, Y; Riley, KM; Hodgson, J; Schweisguth, F; Hirose, S; Jaynes, JB; Brock, HW; Mazo, A				Petruk, Svetlana; Sedkov, Yurii; Riley, Kristen M.; Hodgson, Jacob; Schweisguth, Francois; Hirose, Susumu; Jaynes, James B.; Brock, Hugh W.; Mazo, Alexander			Transcription of bxd noncoding RNAs promoted by trithorax represses Ubx in cis by transcriptional interference	CELL			English	Article							DROSOPHILA BITHORAX COMPLEX; HISTONE METHYLTRANSFERASE COMPLEX; GROUP RESPONSE ELEMENTS; HOX GENE-EXPRESSION; POLYCOMB-GROUP; HOMEOTIC GENE; INTERGENIC TRANSCRIPTION; ULTRABITHORAX; MAINTENANCE; PROTEINS	Much of the genome is transcribed into long noncoding RNAs (ncRNAs). Previous data suggested that bithoraxoid (bxd) ncRNAs of the Drosophila bithorax complex (BX-C) prevent silencing of Ultrabithorax (Ubx) and recruit activating proteins of the trithorax group (trxG) to their maintenance elements (MEs). We found that, surprisingly, Ubx and several bxd ncRNAs are expressed in nonoverlapping patterns in both embryos and imaginal discs, suggesting that transcription of these ncRNAs is associated with repression, not activation, of Ubx. Our data rule out siRNA or miRNA-based mechanisms for repression by bxd ncRNAs. Rather, ncRNA transcription itself, acting in cis, represses Ubx. The Trithorax complex TAC1 binds the Ubx coding region in nuclei expressing Ubx, and the bxd region in nuclei not expressing Ubx. We propose that TAC1 promotes the mosaic pattern of Ubx expression by facilitating transcriptional elongation of bxd ncRNAs, which represses Ubx transcription.	Thomas Jefferson Univ, Dept Biochem, Philadelphia, PA 19107 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Ecole Normale Super, CNRS, UMR 8542, Paris, France; Natl Inst Genet, Dept Dev Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Mishima, Shizuoka 4118540, Japan	Jefferson University; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Mazo, A (corresponding author), Thomas Jefferson Univ, Dept Biochem, Philadelphia, PA 19107 USA.	mazo@mail.tju.edu	Hirose, Susumu/I-8865-2019	Jaynes, James/0000-0001-7943-794X	NATIONAL CANCER INSTITUTE [P01CA050507] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075141, R01GM050231] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA050507, 5P01CA50507] Funding Source: Medline; NHLBI NIH HHS [T32 HL007780, T32-HL07780] Funding Source: Medline; NIGMS NIH HHS [R01 GM075141, 2R01GM50231, R01 GM050231-09A2, R01 GM050231, 1R01GM075141] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bender W, 2002, DEVELOPMENT, V129, P4923; BROWER DL, 1987, DEVELOPMENT, V101, P83; CARROLL SB, 1988, GENE DEV, V2, P350, DOI 10.1101/gad.2.3.350; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; CUMBERLEDGE S, 1990, P NATL ACAD SCI USA, V87, P3259, DOI 10.1073/pnas.87.9.3259; Dzitoyeva S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-33; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; GOODRICH JA, 1991, TRENDS BIOCHEM SCI, V16, P394, DOI 10.1016/0968-0004(91)90162-O; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hodgson JW, 2001, MOL CELL BIOL, V21, P4528, DOI 10.1128/MCB.21.14.4528-4543.2001; Hogga I, 2002, DEVELOPMENT, V129, P4915; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; IRISH VF, 1989, EMBO J, V8, P1527, DOI 10.1002/j.1460-2075.1989.tb03537.x; IRVINE KD, 1991, DEVELOPMENT, V111, P407; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; KUZIN B, 1994, GENE DEV, V8, P2478, DOI 10.1101/gad.8.20.2478; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Massirer KB, 2006, BIOESSAYS, V28, P449, DOI 10.1002/bies.20406; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; MULLER J, 1991, EMBO J, V10, P3147, DOI 10.1002/j.1460-2075.1991.tb04876.x; Pallavi SK, 2003, DEVELOPMENT, V130, P4931, DOI 10.1242/dev.00719; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; PIRROTTA V, 1995, GENETICS, V141, P1439; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; SANCHEZHERRERO E, 1989, DEVELOPMENT, V107, P321; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Sen GL, 2006, FASEB J, V20, P1293, DOI 10.1096/fj.06-6014rev; Shimojima T, 2003, GENE DEV, V17, P1605, DOI 10.1101/gad.1086803; SIMON J, 1993, DEV BIOL, V158, P131, DOI 10.1006/dbio.1993.1174; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; SOTO MC, 1995, GENETICS, V140, P231; STRUHL G, 1985, EMBO J, V4, P3259, DOI 10.1002/j.1460-2075.1985.tb04075.x; Tillib S, 1999, MOL CELL BIOL, V19, P5189; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	48	220	231	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1209	1221		10.1016/j.cell.2006.10.039	http://dx.doi.org/10.1016/j.cell.2006.10.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174895	Green Accepted, Bronze			2022-12-28	WOS:000242991000018
J	Zolensky, ME; Zega, TJ; Yano, H; Wirick, S; Westphal, AJ; Weisberg, MK; Weber, I; Warren, JL; Velbel, MA; Tsuchiyama, A; Tsou, P; Toppani, A; Tomioka, N; Tomeoka, K; Teslich, N; Taheri, M; Susini, J; Stroud, R; Stephan, T; Stadermann, FJ; Snead, CJ; Simon, SB; Simionovici, A; See, TH; Robert, F; Rietmeijer, FJM; Rao, W; Perronnet, MC; Papanastassiou, DA; Okudaira, K; Ohsumi, K; Ohnishi, I; Nakamura-Messenger, K; Nakamura, T; Mostefaoui, S; Mikouchi, T; Meibom, A; Matrajt, G; Marcus, MA; Leroux, H; Lemelle, L; Le, L; Lanzirotti, A; Langenhorst, F; Krot, AN; Keller, LP; Kearsley, AT; Joswiak, D; Jacob, D; Ishii, H; Harvey, R; Hagiya, K; Grossman, L; Grossman, JN; Graham, GA; Gounelle, M; Gillet, P; Genge, MJ; Flynn, G; Ferroir, T; Fallon, S; Ebel, DS; Dai, ZR; Cordier, P; Clark, B; Chi, MF; Butterworth, AL; Brownlee, DE; Bridges, JC; Brennan, S; Brearley, A; Bradley, JP; Bleuet, P; Bland, PA; Bastien, R				Zolensky, Michael E.; Zega, Thomas J.; Yano, Hajime; Wirick, Sue; Westphal, Andrew J.; Weisberg, Mike K.; Weber, Iris; Warren, Jack L.; Velbel, Michael A.; Tsuchiyama, Akira; Tsou, Peter; Toppani, Alice; Tomioka, Naotaka; Tomeoka, Kazushige; Teslich, Nick; Taheri, Mitra; Susini, Jean; Stroud, Rhonda; Stephan, Thomas; Stadermann, Frank J.; Snead, Christopher J.; Simon, Steven B.; Simionovici, Alexandre; See, Thomas H.; Robert, Francois; Rietmeijer, Frans J. M.; Rao, William; Perronnet, Murielle C.; Papanastassiou, Dimitri A.; Okudaira, Kyoko; Ohsumi, Kazumasa; Ohnishi, Ichiro; Nakamura-Messenger, Keiko; Nakamura, Tomoki; Mostefaoui, Smail; Mikouchi, Takashi; Meibom, Anders; Matrajt, Graciela; Marcus, Matthew A.; Leroux, Hugues; Lemelle, Laurence; Le, Loan; Lanzirotti, Antonio; Langenhorst, Falko; Krot, Alexander N.; Keller, Lindsay P.; Kearsley, Anton T.; Joswiak, David; Jacob, Damien; Ishii, Hope; Harvey, Ralph; Hagiya, Kenji; Grossman, Lawrence; Grossman, Jeffrey N.; Graham, Giles A.; Gounelle, Matthieu; Gillet, Philippe; Genge, Matthew J.; Flynn, George; Ferroir, Tristan; Fallon, Stewart; Ebel, Denton S.; Dai, Zu Rong; Cordier, Patrick; Clark, Benton; Chi, Miaofang; Butterworth, Anna L.; Brownlee, Donald E.; Bridges, John C.; Brennan, Sean; Brearley, Adrian; Bradley, John P.; Bleuet, Pierre; Bland, Phil A.; Bastien, Ron			Report - Mineralogy and petrology of comet 81P/Wild 2 nucleus samples	SCIENCE			English	Article							INTERPLANETARY DUST; SOLAR-SYSTEM; CHONDRITE; MATRIX; GRAINS; IRON	The bulk of the comet 81P/Wild 2 ( hereafter Wild 2) samples returned to Earth by the Stardust spacecraft appear to be weakly constructed mixtures of nanometer-scale grains, with occasional much larger ( over 1 micrometer) ferromagnesian silicates, Fe-Ni sulfides, Fe-Ni metal, and accessory phases. The very wide range of olivine and low-Ca pyroxene compositions in comet Wild 2 requires a wide range of formation conditions, probably reflecting very different formation locations in the protoplanetary disk. The restricted compositional ranges of Fe-Ni sulfides, the wide range for silicates, and the absence of hydrous phases indicate that comet Wild 2 experienced little or no aqueous alteration. Less abundant Wild 2 materials include a refractory particle, whose presence appears to require radial transport in the early protoplanetary disk.	NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; USN, Res Lab, Washington, DC 20375 USA; JAXA ISAS, Kanagawa 2298510, Japan; Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; CUNY, Kingsborough Community Coll, Dept Phys Sci, Brooklyn, NY 11235 USA; Univ Munster, Inst Planetol, D-48149 Munster, Germany; JAcobs Scerdrup, Engn Sci Contract Grp, Houston, TX 77058 USA; Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA; Osaka Univ, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Ctr Spectrometrie Nucl & Spectrometrie Masse, F-91405 Orsay, France; Kobe Univ, Fac Sci, Dept Earth & Planetary Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; European Synchrotron Radiat Facil, F-38043 Grenoble, France; Washington Univ, Dept Phys, St Louis, MO 63130 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Ecole Normale Super Lyon, Lab Sci Terre, F-69007 Lyon, France; ARES JSC, Engn Sci Contract Barrios Technol, Houston, TX 77258 USA; Museum Natl Hist Nat, Lab Etude Mat Extraterr, LEME, F-75005 Paris, France; Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; Savannah River Ecol Lab, Aiken, SC 29801 USA; CALTECH, Jet Prop Lab, Div Sci, Pasadena, CA 91109 USA; Inst Mat Struct Sci, Tsukuba, Ibaraki 305, Japan; Kyushu Univ, Fac Sci, Dept Earth & Planetary Sci, Fukuoka 8128581, Japan; Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Univ Sci & Tech Lille, Lab Struct & Proprietes Etat Solide, F-59655 Villeneuve Dascq, France; Univ Chicago, Consortium Adv Radiat Source, Chicago, IL 60637 USA; Univ Jena, Inst Geosci, D-07749 Jena, Germany; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Nat Hist Museum, Impact & Astromat Res Ctr, Dept Mineral, London SW7 5BD, England; Case Western Reserve Univ, Dept Geol, Cleveland, OH 44106 USA; Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; Univ Jena, Inst Geosci, D-07749 Jena, Germany; Nat Hist Museum, Impact & Astromat Res Ctr, Dept Mineral, London SW7 5BD, England; Case Western Reserve Univ, Dept Geol, Cleveland, OH 44106 USA; Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; US Geol Survey, Reston, VA 20192 USA; Univ London Imperial Coll Sci Technol & Med, Impact & Astromat Res Ctr, Dept Earth Sci & Engn, London SW7 2AZ, England; SUNY Coll Plattsburgh, Dept Phys, Plattsburgh, NY 12901 USA; Amer Museum Nat Hist, Dept Earth & Planetary Sci, New York, NY 10024 USA; Lockheed Martin Astronaut, Denver, CO 80201 USA; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; Stanford Linear Accelerator Ctr, Menlo Pk, CA 94025 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; United States Department of Defense; United States Navy; Naval Research Laboratory; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; University of California System; University of California Berkeley; City University of New York (CUNY) System; University of Munster; Michigan State University; Osaka University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; UDICE-French Research Universities; Universite Paris Saclay; Kobe University; European Synchrotron Radiation Facility (ESRF); Washington University (WUSTL); University of Chicago; Ecole Normale Superieure de Lyon (ENS de LYON); Museum National d'Histoire Naturelle (MNHN); University of New Mexico; United States Department of Energy (DOE); Savannah River Ecology Laboratory; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); High Energy Accelerator Research Organization (KEK); Kyushu University; University of Tokyo; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Universite de Lille - ISITE; Universite de Lille; University of Chicago; Friedrich Schiller University of Jena; University of Hawaii System; Natural History Museum London; Case Western Reserve University; University of Hyogo; Friedrich Schiller University of Jena; Natural History Museum London; Case Western Reserve University; University of Hyogo; University of Chicago; United States Department of the Interior; United States Geological Survey; Imperial College London; State University of New York (SUNY) System; SUNY Plattsburgh; American Museum of Natural History (AMNH); Lockheed Martin; Open University - UK; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Zolensky, ME (corresponding author), NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA.	michael.e.zolensky@nasa.gov	Stephan, Thomas/C-1023-2008; Stroud, Rhonda/GQZ-0151-2022; Tomioka, Naotaka/AID-3472-2022; Stroud, Rhonda M./C-5503-2008; Fallon, Stewart J/G-6645-2011; Cordier, Patrick/D-2357-2012; Simionovici, Alexandre S/E-5867-2018; Dai, Zurong/E-6732-2010; Leroux, Hugues/S-4570-2017; Taheri, Mitra/F-1321-2011; marcus, matthew/P-8023-2019; Stroud, Rhonda M/S-4584-2018; Tomioka, Naotaka/B-1888-2011; Chi, Miaofang/Y-3603-2019; Matrajt, Graciela/A-4812-2017; Mikouchi, Takashi/AAY-7355-2021; Bland, Phil/M-9392-2018; Jacob, Damien/N-8419-2013	Stephan, Thomas/0000-0001-6377-8731; Stroud, Rhonda/0000-0001-5242-8015; Stroud, Rhonda M./0000-0001-5242-8015; Fallon, Stewart J/0000-0002-8064-5903; Cordier, Patrick/0000-0002-1883-2994; Simionovici, Alexandre S/0000-0001-5349-6482; Leroux, Hugues/0000-0002-8806-8434; Stroud, Rhonda M/0000-0001-5242-8015; Tomioka, Naotaka/0000-0001-5725-9513; Chi, Miaofang/0000-0003-0764-1567; Bland, Phil/0000-0002-4681-7898; Jacob, Damien/0000-0001-7931-7171; Langenhorst, Falko/0000-0003-4892-7713; Ishii, Hope/0000-0002-7976-5078; Zolensky, Michael/0000-0002-3181-1303; Meibom, Anders/0000-0002-4542-2819; Dai, Zurong/0000-0002-4209-8718; Brearley, Adrian/0000-0002-7364-8815; Mikouchi, Takashi/0000-0002-9998-8754; Lanzirotti, Antonio/0000-0002-7597-5924; Butterworth, Anna/0000-0002-6439-1472				Akai J, 1990, P NIPR S ANTARCTIC M, V3, P55; ANDERS E, 1982, GEOCHIM COSMOCHIM AC, V46, P2363, DOI 10.1016/0016-7037(82)90208-3; BARRETT RA, 1992, P LUNAR PLANET SCI, V22, P203; BRADLEY JP, 1994, SCIENCE, V265, P925, DOI 10.1126/science.265.5174.925; BREARLEY AJ, 1993, GEOCHIM COSMOCHIM AC, V57, P1521, DOI 10.1016/0016-7037(93)90011-K; Burchell MJ, 2006, ANNU REV EARTH PL SC, V34, P385, DOI 10.1146/annurev.earth.34.031405.124939; Cuzzi JN, 2003, ICARUS, V166, P385, DOI 10.1016/j.icarus.2003.08.016; Deer W. A., 1978, ROCK FORMING MINER A, V2; Ebel D. S, 2006, METEORITES EARLY SOL, V1, P253, DOI [10.2307/j.ctv1v7zdmm.18, DOI 10.2307/J.CTV1V7ZDMM.18]; Flynn GJ, 2006, SCIENCE, V314, P1731, DOI 10.1126/science.1136141; GANGULY J, 1994, AM MINERAL, V79, P930; Gounelle M, 2002, METEORIT PLANET SCI, V37, pA55; Greshake A, 1997, GEOCHIM COSMOCHIM AC, V61, P437, DOI 10.1016/S0016-7037(96)00332-8; Horz F, 2006, SCIENCE, V314, P1716, DOI 10.1126/science.1135705; HUTCHISON MN, 1983, GEOCHIM COSMOCHIM AC, V47, P101, DOI 10.1016/0016-7037(83)90094-7; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; KLOCK W, 1989, NATURE, V339, P126, DOI 10.1038/339126a0; KROT AN, 1994, METEORITICS, V29, P707, DOI 10.1111/j.1945-5100.1994.tb00788.x; LAWLER ME, 1989, ICARUS, V80, P225, DOI 10.1016/0019-1035(89)90135-8; Li AG, 1998, ASTROPHYS J, V498, pL83, DOI 10.1086/311308; Lisse CM, 2006, SCIENCE, V313, P635, DOI 10.1126/science.1124694; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Messenger S, 2003, SCIENCE, V300, P105, DOI 10.1126/science.1080576; NIER AO, 1993, METEORITICS, V28, P675, DOI 10.1111/j.1945-5100.1993.tb00639.x; RIETMEIJER FJM, 1998, PLANETARY MAT; Shu FH, 1997, SCIENCE, V277, P1475, DOI 10.1126/science.277.5331.1475; Simon SB, 2003, METEORIT PLANET SCI, V38, P813, DOI 10.1111/j.1945-5100.2003.tb00044.x; TSOU P, 1990, LUNAR PLANET SCI, V21, P1264; TSUCHIYAMA A, 2006, LUNAR PLANET SCI C, V37, P2001; Vaughan DJ., 1978, MINERAL CHEM METAL S; Weisberg MK, 2004, METEORIT PLANET SCI, V39, P1741, DOI 10.1111/j.1945-5100.2004.tb00070.x; Zolensky M, 2003, METEORIT PLANET SCI, V38, P305, DOI 10.1111/j.1945-5100.2003.tb00266.x; ZOLENSKY ME, 1994, METEORITICS, V29, P616, DOI 10.1111/j.1945-5100.1994.tb00774.x; ZOLENSKY ME, 1993, ADV SPACE RES-SERIES, V13, P75, DOI 10.1016/0273-1177(93)90571-R; ZOLENSKY ME, 1995, GEOCHIM COSMOCHIM AC, V59, P4707, DOI 10.1016/0016-7037(95)00329-0	35	563	565	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1735	1739		10.1126/science.1135842	http://dx.doi.org/10.1126/science.1135842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170295	Green Submitted			2022-12-28	WOS:000242833600047
J	Cox, JJ; Reimann, F; Nicholas, AK; Thornton, G; Roberts, E; Springell, K; Karbani, G; Jafri, H; Mannan, J; Raashid, Y; Al-Gazali, L; Hamamy, H; Valente, EM; Gorman, S; Williams, R; McHale, DP; Wood, JN; Gribble, FM; Woods, CG				Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey			An SCN9A channelopathy causes congenital inability to experience pain	NATURE			English	Article							CLOSED-STATE INACTIVATION; NA(V)1.7 SODIUM-CHANNELS; OF-FUNCTION MUTATION; ALPHA-SUBUNIT; INDIFFERENCE; INSENSITIVITY; EXPRESSION; CURRENTS; PN1	The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype. In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3. This region contains the gene SCN9A, encoding the alpha-subunit of the voltage-gated sodium channel, Na(v)1.7, which is strongly expressed in nociceptive neurons. Sequence analysis of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X). We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Na(v)1.7 with sodium channel beta(1) and beta(2) subunits in HEK293 cells. In cells expressing mutant Nav1.7, the currents were no greater than background. Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans. These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.	Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 OXY, England; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 OXY, England; St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Gene Tech Lab 146 1, Lahore, Pakistan; Fatima Jinah Med Coll, Dept Paediat, Lahore, Pakistan; King Edward Med Univ, Dept Obstet & Gynaecol, Lahore, Pakistan; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates; Natl Ctr Diabet Endocrinol & Genet, Amman, Jordan; CSS Mendel, I-00168 Rome, Italy; IRCCS CSS, San Giovanni Rotondo, Italy; St Lukes Hosp, Dept Paediat, Bradford BD5 0NA, W Yorkshire, England; Pfizer Ltd, Global Res & Dev, Sandwich Labs, Sandwich CT13 9NJ, Kent, England; UCL, Dept Biol, Mol Nocicept Grp, London WC1E 6BT, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; United Arab Emirates University; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Pfizer; University of London; University College London	Woods, CG (corresponding author), Addenbrookes Hosp, Dept Med Genet, Wellcome MRC Bldg, Cambridge CB2 OXY, England.	cw347@cam.ac.uk	Valente, Enza Maria/G-2942-2017; woods, christopher g/A-1361-2010; Cox, James/R-1910-2016	Valente, Enza Maria/0000-0002-0600-6820; Gribble, Fiona/0000-0002-4232-2898; Reimann, Frank/0000-0001-9399-6377; Nicholas, Adeline/0000-0002-7124-629X	Medical Research Council [G9717869] Funding Source: Medline; Wellcome Trust [057964, 071187] Funding Source: Medline; MRC [G9717869] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akopian AN, 1996, TRENDS NEUROSCI, V19, P240, DOI 10.1016/0166-2236(96)10030-8; Amir R, 2006, J PAIN, V7, pS1, DOI 10.1016/j.jpain.2006.01.444; Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; Blair NT, 2002, J NEUROSCI, V22, P10277; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dearborn GV, 1932, J NERV MENT DIS, V75, P612; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; DYCK PJ, 1983, BRAIN, V106, P373, DOI 10.1093/brain/106.2.373; Han CY, 2006, ANN NEUROL, V59, P553, DOI 10.1002/ana.20776; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Klein CJ, 2003, ANN NEUROL, V53, P417, DOI 10.1002/ana.10469; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; LANDRIEU P, 1990, ANN NEUROL, V27, P574, DOI 10.1002/ana.410270520; Nagasako EM, 2003, PAIN, V101, P213, DOI 10.1016/S0304-3959(02)00482-7; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nassar MA, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-24; Raymond CK, 2004, J BIOL CHEM, V279, P46234, DOI 10.1074/jbc.M406387200; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	28	1042	1171	5	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					894	898		10.1038/nature05413	http://dx.doi.org/10.1038/nature05413			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167479	Green Accepted			2022-12-28	WOS:000242805400048
J	Marris, E				Marris, Emma			Drink the best and drive the rest	NATURE			English	News Item																		De Oliveira MED, 2005, BIOSCIENCE, V55, P593, DOI 10.1641/0006-3568(2005)055[0593:EAFECD]2.0.CO;2; MACEDO IDC, 2004, ASSESSMENT GREENHOUS	2	48	51	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					670	672		10.1038/444670a	http://dx.doi.org/10.1038/444670a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151627				2022-12-28	WOS:000242581100014
J	Hellmann, DB; Imboden, JB				Hellmann, David B.; Imboden, John B.			Update in rheumatology	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Johns Hopkins Bayview Med Ctr, Dept Med, Baltimore, MD 21224 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Francisco	Hellmann, DB (corresponding author), Johns Hopkins Bayview Med Ctr, Dept Med, Room 109,4940 Eastern Ave,B-1 N, Baltimore, MD 21224 USA.	hellmann@jhmi.edu						Lustberg ME, 2006, NEW ENGL J MED, V354, P1532	1	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2006	145	11					834	838		10.7326/0003-4819-145-11-200612050-00008	http://dx.doi.org/10.7326/0003-4819-145-11-200612050-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114PE	17146068				2022-12-28	WOS:000242677300005
J	Bayer, R; Oppenheimer, GM				Bayer, Ronald; Oppenheimer, Gerald M.			Pioneers in AIDS care - Reflections on the epidemic's early year	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA; CUNY, Dept Hlth & Nutr Sci, Brooklyn Coll, New York, NY 10021 USA; CUNY, Grad Ctr, New York, NY 10021 USA	Columbia University; City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System	Bayer, R (corresponding author), Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA.							Bayer R., 2000, AIDS DOCTORS VOICES, V163, P1486	1	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2273	2275		10.1056/NEJMp068202	http://dx.doi.org/10.1056/NEJMp068202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	110CG	17135580	Green Submitted, Bronze			2022-12-28	WOS:000242355300001
J	Herzberg, C				Herzberg, Claude			Petrology and thermal structure of the Hawaiian plume from Mauna Kea volcano	NATURE			English	Article							PHASE-RELATIONS; MANTLE PLUME; OCEANIC-CRUST; BASALTS; OLIVINE; LITHOSPHERE; PERIDOTITE; ECLOGITE; MAGMAS; LAVAS	There is uncertainty about whether the abundant tholeiitic lavas on Hawaii are the product of melt from peridotite or pyroxenite/ eclogite rocks(1,2). Using a parameterization of melting experiments on peridotite(3) with glass analyses from the Hawaii Scientific Deep Project 2 on Mauna Kea volcano(1), I show here that a small population of the core samples had fractionated from a peridotite-source primary magma. Most lavas, however, differentiated from magmas that were too deficient in CaO and enriched in NiO ( ref. 2) to have formed from a peridotite source. For these, experiments indicate that they were produced by the melting of garnet pyroxenite, a lithology that had formed in a second stage by reaction of peridotite with partial melts of subducted oceanic crust(2). Samples in the Hawaiian core are therefore consistent with previous suggestions that pyroxenite occurs in a host peridotite, and both contribute to melt production(2,4). Primary magma compositions vary down the drill core, and these reveal evidence for temperature variations within the underlying mantle plume. Mauna Kea magmatism is represented in other Hawaiian volcanoes, and provides a key for a general understanding of melt production in lithologically heterogeneous mantle.	Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Herzberg, C (corresponding author), Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA.	herzberg@rci.rutgers.edu						Abouchami W, 2005, NATURE, V434, P851, DOI 10.1038/nature03402; Arndt NT, 1997, EARTH PLANET SC LETT, V146, P289, DOI 10.1016/S0012-821X(96)00219-1; BEATTIE P, 1993, CONTRIB MINERAL PETR, V115, P103, DOI 10.1007/BF00712982; Blichert-Toft J, 1999, SCIENCE, V285, P879, DOI 10.1126/science.285.5429.879; Blichert-Toft J, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000340; FREY FA, 1991, J GEOPHYS RES-SOLID, V96, P14347, DOI 10.1029/91JB00940; Hauri EH, 1996, NATURE, V382, P415, DOI 10.1038/382415a0; Herzberg C, 2002, J PETROL, V43, P1857, DOI 10.1093/petrology/43.10.1857; Herzberg C, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000089; Hirschmann MM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000070; Huang SC, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC001012; ITO K, 1968, CONTRIB MINERAL PETR, V19, P177; Kogiso T, 2004, GEOCHIM COSMOCHIM AC, V68, P345, DOI 10.1016/S0016-7037(03)00419-8; Kogiso T, 2004, J PETROL, V45, P2407, DOI 10.1093/petrology/egh057; Korzhinskii D. S., 1970, THEORY METASOMATIC Z; Lassiter JC, 1998, EARTH PLANET SC LETT, V164, P483, DOI 10.1016/S0012-821X(98)00240-4; Maaloe S, 2004, CONTRIB MINERAL PETR, V148, P236, DOI 10.1007/s00410-004-0601-3; Milholland CS, 1998, J PETROL, V39, P3, DOI 10.1093/petrology/39.1.3; O'Hara MJ., 1967, SCOT J GEOL, V3, P67, DOI 10.1144/sjg03010067; Pertermann M, 2003, J PETROL, V44, P2173, DOI 10.1093/petrology/egg074; Ren ZY, 2005, NATURE, V436, P837, DOI 10.1038/nature03907; Rhodes JM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2002GC000434; Sobolev AV, 2005, NATURE, V434, P590, DOI 10.1038/nature03411; Sobolev AV, 2000, NATURE, V404, P986, DOI 10.1038/35010098; Sobolev AV., 1994, PETROLOGY+, V2, P111; Stolper E, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000553; Takahashi E, 2002, GEOPH MONOG SERIES, V128, P403; Toplis MJ, 2005, CONTRIB MINERAL PETR, V149, P22, DOI 10.1007/s00410-004-0629-4; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29; Yaxley GM, 1998, SCHWEIZ MINER PETROG, V78, P243	30	206	223	6	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2006	444	7119					605	609		10.1038/nature05254	http://dx.doi.org/10.1038/nature05254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136091				2022-12-28	WOS:000242377600045
J	Hilborn, R; Arcese, P; Borner, M; Hando, J; Hopcraft, G; Loibooki, M; Mduma, S; Sinclair, ARE				Hilborn, Ray; Arcese, Peter; Borner, Markus; Hando, Justin; Hopcraft, Grant; Loibooki, Martin; Mduma, Simon; Sinclair, Anthony R. E.			Effective enforcement in a conservation area	SCIENCE			English	Article									Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; Univ British Columbia, Ctr Appl Conservat Res, Vancouver, BC VLT 1Z4, Canada; Frankfurt Zool Soc, Arusha, Tanzania; Tanzania Natl Pks, Arusha, Tanzania; Tanzanian Wildlife Res Inst, Arusha, Tanzania; Univ British Columbia, Ctr Biodivers Res, Vancouver, BC VLT 1Z4, Canada; Univ Groningen, NL-9750 AA Haren, Netherlands	University of Washington; University of Washington Seattle; University of British Columbia; University of British Columbia; University of Groningen	Hilborn, R (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	rayh@u.washington.edu	Hilborn, Ray W/D-6332-2013					DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; Hofer H., 1995, SERENGETI, P332, DOI DOI 10.1186/1471-2148-9-253; MUPHREE MW, 2004, PARKS TRANSITION, P217; Newmark WD, 2000, BIOSCIENCE, V50, P585, DOI 10.1641/0006-3568(2000)050[0585:CWIAIC]2.0.CO;2; THIRGOOD S, IN PRESS SERENGETI, V3; [No title captured]	6	229	233	2	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2006	314	5803					1266	1266		10.1126/science.1132780	http://dx.doi.org/10.1126/science.1132780			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124316				2022-12-28	WOS:000242215800033
J	Wang, LF; Baade, D; Patat, F				Wang, Lifan; Baade, Dietrich; Patat, Ferdinando			Spectropolarimetric diagnostics of thermonuclear supernova explosions	SCIENCE			English	Article							DELAYED-DETONATION MODEL; IA SUPERNOVAE; LIGHT CURVES; SN 1999BY; ASPHERICITY; POLARIMETRY; 2001EL	Even at extragalactic distances, the shape of supernova ejecta can be effectively diagnosed by spectropolarimetry. We present results for 17 type Ia supernovae that allow a statistical study of the correlation among the geometric structures and other observable parameters of type Ia supernovae. These observations suggest that type Ia supernova ejecta typically consist of a smooth, central, iron-rich core and an outer layer with chemical asymmetries. The degree of this peripheral asphericity is correlated with the light-curve decline rate of type Ia supernovae. These results lend strong support to delayed-detonation models of type Ia supernovae.	Texas A&M Univ, Dept Phys, College Stn, TX 77843 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; European So Univ, D-85748 Garching, Germany	Texas A&M University System; Texas A&M University College Station; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wang, LF (corresponding author), Texas A&M Univ, Dept Phys, College Stn, TX 77843 USA.	wang@physics.tamu.edu		Baade, Dietrich/0000-0003-1637-9679; Patat, Ferdinando/0000-0002-0537-3573				ARNETT WD, 1969, ASTROPHYS SPACE SCI, V5, P180, DOI 10.1007/BF00650291; Benetti S, 2004, MON NOT R ASTRON SOC, V348, P261, DOI 10.1111/j.1365-2966.2004.07357.x; CHANDARSEKHA S, 1960, RAD TRANSFER, P22; Gamezo VN, 2005, ASTROPHYS J, V623, P337, DOI 10.1086/428767; Garnavich PM, 2004, ASTROPHYS J, V613, P1120, DOI 10.1086/422986; HOFLICH P, 1991, ASTRON ASTROPHYS, V246, P481; Howell DA, 2001, ASTROPHYS J, V556, P302, DOI 10.1086/321584; Jha S, 2006, ASTRON J, V131, P527, DOI 10.1086/497989; Kasen D, 2003, ASTROPHYS J, V593, P788, DOI 10.1086/376601; KHOKHLOV AM, 1991, ASTRON ASTROPHYS, V245, P114; Krisciunas K, 2003, ASTRON J, V125, P166, DOI 10.1086/345571; Leonard DC, 2005, ASTROPHYS J, V632, P450, DOI 10.1086/432866; Li WD, 1999, ASTRON J, V117, P2709, DOI 10.1086/300895; NOMOTO K, 1976, ASTROPHYS SPACE SCI, V39, pL37, DOI 10.1007/BF00648354; NUGENT P, 1995, ASTROPHYS J, V455, pL147, DOI 10.1086/309846; PASTORELLO A, COMMUNICATION; Plewa T, 2004, ASTROPHYS J, V612, pL37, DOI 10.1086/424036; Reinecke M, 2002, ASTRON ASTROPHYS, V391, P1167, DOI 10.1051/0004-6361:20020885; Riess AG, 1999, ASTRON J, V117, P707, DOI 10.1086/300738; Vinko J, 2003, ASTRON ASTROPHYS, V397, P115, DOI 10.1051/0004-6361:20021469; WANG L, ASTROPHYS J; Wang LF, 2003, ASTROPHYS J, V591, P1110, DOI 10.1086/375444; Wang LF, 2001, ASTROPHYS J, V550, P1030, DOI 10.1086/319822; Wang LF, 1996, ASTROPHYS J, V467, P435, DOI 10.1086/177617; Wang LF, 2006, ASTROPHYS J, V641, P50, DOI 10.1086/500422; Wang LF, 1997, ASTROPHYS J, V476, pL27, DOI 10.1086/310495; WHELAN J, 1973, ASTROPHYS J, V186, P1007, DOI 10.1086/152565	28	64	65	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2007	315	5809					212	214		10.1126/science.1121656	http://dx.doi.org/10.1126/science.1121656			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17138869				2022-12-28	WOS:000243407400038
J	Acquisti, C; Kleffe, J; Collins, S				Acquisti, Claudia; Kleffe, Juergen; Collins, Sinead			Oxygen content of transmembrane proteins over macroevolutionary time scales	NATURE			English	Article							AMINO-ACID-COMPOSITION; MEMBRANE-PROTEINS; EVOLUTION; GENOMES; ORGANISMS; EUKARYOTES; PROTEOMES; TOPOLOGY; MODEL; LIFE	We observe that the time of appearance of cellular compartmentalization correlates with atmospheric oxygen concentration. To explore this correlation, we predict and characterize the topology of all transmembrane proteins in 19 taxa and correlate differences in topology with historical atmospheric oxygen concentrations. Here we show that transmembrane proteins, individually and as a group, were probably selectively excluding oxygen in ancient ancestral taxa, and that this constraint decreased over time when atmospheric oxygen levels rose. As this constraint decreased, the size and number of communication-related transmembrane proteins increased. We suggest the hypothesis that atmospheric oxygen concentrations affected the timing of the evolution of cellular compartmentalization by constraining the size of domains necessary for communication across membranes.	Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; Inst Mol Biol & Biochem, D-14195 Berlin, Germany	Max Planck Society	Acquisti, C (corresponding author), Arizona State Univ, Ctr Evolutionary Funct Genom, Biodesign Inst, Tempe, AZ 85287 USA.	Claudia.Acquisti.1@asu.edu	Collins, Sinead/F-3788-2010	Collins, Sinead/0000-0003-3856-4285				AITCHISON J, 1986, STAT ANAL COMPOSITIO, P154; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; ANDERSON JS, IN PRESS MAJOR TRANS; Baudouin-Cornu P, 2004, J BIOL CHEM, V279, P5421, DOI 10.1074/jbc.M306415200; Baudouin-Cornu P, 2001, SCIENCE, V293, P297, DOI 10.1126/science.1061052; Berner RA, 1999, P NATL ACAD SCI USA, V96, P10955, DOI 10.1073/pnas.96.20.10955; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Elser JJ, 2006, MOL BIOL EVOL, V23, P1946, DOI 10.1093/molbev/msl068; Elser JJ, 2006, ECOL LETT, V9, P292, DOI 10.1111/j.1461-0248.2005.00873.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; Hasenfuss I, 2002, J ZOOL SYST EVOL RES, V40, P65, DOI 10.1046/j.1439-0469.2002.00180.x; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Kay AD, 2005, OIKOS, V109, P6, DOI 10.1111/j.0030-1299.2005.14048.x; KNOLL AH, 1994, P NATL ACAD SCI USA, V91, P6743, DOI 10.1073/pnas.91.15.6743; Knoll AH, 2003, LIFE YOUNG PLANET 1; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lio P, 2003, GENE, V317, P29, DOI 10.1016/S0378-1119(03)00666-8; Liu JF, 2001, PROTEIN SCI, V10, P1970, DOI 10.1110/ps.10101; Martin W, 2003, IUBMB LIFE, V55, P193, DOI 10.1080/1521654031000141231; MAZEL D, 1989, NATURE, V341, P245, DOI 10.1038/341245a0; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Ren QH, 2005, PLOS COMPUT BIOL, V1, P190, DOI 10.1371/journal.pcbi.0010027; SCHOPF J.W., 1992, PROTEROZOIC BIOSPHER; Sheridan PP, 2003, GEOMICROBIOL J, V20, P1, DOI 10.1080/01490450303891; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Tamames J, 1996, FEBS LETT, V389, P96, DOI 10.1016/0014-5793(96)00527-3; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1986, J MOL BIOL, V192, P287, DOI 10.1016/0022-2836(86)90365-7; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420	34	52	55	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					47	52		10.1038/nature05450	http://dx.doi.org/10.1038/nature05450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17183269	Green Published			2022-12-28	WOS:000243225100032
J	Gilsdorf, JR				Gilsdorf, Janet R.			A long time ago	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												gilsdorf@umich.edu							0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2777	2778		10.1001/jama.296.23.2777	http://dx.doi.org/10.1001/jama.296.23.2777			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179446				2022-12-28	WOS:000242826400001
J	Lean, M; Gruer, L; Alberti, G; Sattar, N				Lean, Mike; Gruer, Laurence; Alberti, George; Sattar, Naveed			ABC of obesity - Obesity - can we turn the tide?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; NHS Hlth Scotland, Edinburgh, Midlothian, Scotland; Univ Newcastle, Sch Med, Newcastle, NSW 2308, Australia	University of Glasgow; University of Newcastle	Lean, M (corresponding author), Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland.	nsattar@clinmed.gla.ac.uk		Gruer, Laurence/0000-0002-1089-2896				World Health Organization and Food and Agriculture Organization, 2002, DIET NUTR PREV CHRON	1	20	20	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 16	2006	333	7581					1261	1264		10.1136/bmj.39049.626076.68	http://dx.doi.org/10.1136/bmj.39049.626076.68			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122AB	17170418	Green Published			2022-12-28	WOS:000243197000023
J	Olivieri, A; Achilli, A; Pala, M; Battaglia, V; Fornarino, S; Al-Zahery, N; Scozzari, R; Cruciani, F; Behar, DM; Dugoujon, JM; Coudray, C; Santachiara-Benerecetti, AS; Semino, O; Bandelt, HJ; Torroni, A				Olivieri, Anna; Achilli, Alessandro; Pala, Maria; Battaglia, Vincenza; Fornarino, Simona; Al-Zahery, Nadia; Scozzari, Rosaria; Cruciani, Fulvio; Behar, Doron M.; Dugoujon, Jean-Michel; Coudray, Clotilde; Santachiara-Benerecetti, A. Silvana; Semino, Ornella; Bandelt, Hans-Juergen; Torroni, Antonio			The mtDNA legacy of the Levantine early Upper Palaeolithic in Africa	SCIENCE			English	Article							SUB-SAHARAN AFRICA; NEAR-EASTERN; GENE FLOW; MITOCHONDRIAL; ASIA; HUMANS; NORTH	Sequencing of 81 entire human mitochondrial DNAs (mtDNAs) belonging to haplogroups M1 and U6 reveals that these predominantly North African clades arose in southwestern Asia and moved together to Africa about 40,000 to 45,000 years ago. Their arrival temporally overlaps with the event(s) that led to the peopling of Europe by modern humans and was most likely the result of the same change in climate conditions that allowed humans to enter the Levant, opening the way to the colonization of both Europe and North Africa. Thus, the early Upper Palaeolithic population( s) carrying M1 and U6 did not return to Africa along the southern coastal route of the "out of Africa" exit, but from the Mediterranean area; and the North African Dabban and European Aurignacian industries derived from a common Levantine source.	Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; Univ Baghdad, Coll Sci, Dept Biotechnol, Baghdad, Iraq; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Mol Med Lab, IL-31096 Haifa, Israel; Univ Toulouse 3, Ctr Anthropol, FRE 2960, CNRS, F-31073 Toulouse, France; Univ Hamburg, Dept Math, D-20146 Hamburg, Germany	University of Pavia; University of Baghdad; Sapienza University Rome; Rambam Health Care Campus; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Hamburg	Torroni, A (corresponding author), Univ Pavia, Dept Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	torroni@ipvgen.unipv.it	OLIVIERI, ANNA/I-9235-2012; Al-Zahery, Nadia/AAV-5878-2020; Battaglia, Vincenza/F-6950-2017; Cruciani, Fulvio/G-6105-2012; Torroni, Antonio/E-1557-2011; Achilli, Alessandro/I-9236-2012	OLIVIERI, ANNA/0000-0002-3941-8098; Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; Pala, Maria/0000-0001-9202-8331; Cruciani, Fulvio/0000-0002-6900-024X; SEMINO, Ornella/0000-0002-9675-9403				Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Burroughs W.J., 2005, CLIMATE CHANGE PREHI, DOI [10.1017/CBO9780511535826, DOI 10.1017/CBO9780511535826]; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Richards M, 2006, NUCL ACID M, V18, P225; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Shackleton NJ, 2004, QUATERNARY SCI REV, V23, P1513, DOI 10.1016/j.quascirev.2004.03.006; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Van Peer P., 1990, EMERGENCE MODERN HUM, P139; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5	29	190	191	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1767	1770		10.1126/science.1135566	http://dx.doi.org/10.1126/science.1135566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170302				2022-12-28	WOS:000242833600056
J	Ruby, JG; Jan, C; Player, C; Axtell, MJ; Lee, W; Nusbaum, C; Ge, H; Bartel, DP				Ruby, J. Graham; Jan, Calvin; Player, Christopher; Axtell, Michael J.; Lee, William; Nusbaum, Chad; Ge, Hui; Bartel, David P.			Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C-elegans	CELL			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; GERM-LINE; INTERFERENCE; POLYMERASE; GENES; IDENTIFICATION; MECHANISMS; PROTEIN; DSRNA	We sequenced 400,000 small RNAs from Caenorhabditis elegans. Another 18 microRNA (miRNA) genes were identified, thereby extending to 112 our tally of confidently identified miRNA genes in C. elegans. Also observed were thousands of endogenous siRNAs generated by RNA-directed RNA polymerases acting preferentially on transcripts associated with spermatogenesis and transposons. In addition, a third class of nematode small RNAs, called 21 U-RNAs, was discovered. 21 U-RNAs are precisely 21 nucleotides long, begin with a uridine 5'-monophosphate but are diverse in their remaining 20 nucleotides, and appear modified at their 3'-terminal ribose. 21 U-RNAs originate from more than 5700 genomic loci dispersed in two broad regions of chromosome IV-primarily between protein-coding genes or within their introns. These loci share a large upstream motif that enables accurate prediction of additional 21 U-RNAs. The motif is conserved in other nematodes, presumably because of its importance for producing these diverse, autonomously expressed, small RNAs (dasRNAs).	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; KEMPER B, 1976, NATURE, V262, P321, DOI 10.1038/262321a0; Kent WJ, 2000, NUCLEIC ACIDS RES, V28, P91, DOI 10.1093/nar/28.1.91; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARTIN CT, 1989, BIOCHEMISTRY-US, V28, P2760, DOI 10.1021/bi00433a002; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; PAK J, 2006, IN PRESS SCIENCE; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; WILLIAMS KP, 1995, NUCLEIC ACIDS RES, V23, P4220, DOI 10.1093/nar/23.20.4220; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	58	704	870	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1193	1207		10.1016/j.cell.2006.10.040	http://dx.doi.org/10.1016/j.cell.2006.10.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174894	Bronze, Green Submitted			2022-12-28	WOS:000242991000017
J	Wurthner, F				Wuerthner, Frank			Generating a photocurrent on the nanometer scale	SCIENCE			English	Editorial Material							CHARGE		Univ Wurzburg, Inst Organ Chem, D-97074 Wurzburg, Germany; Univ Wurzburg, Wilhelm Conrad Rontgen Res Ctr Complex Mat Syst, D-97074 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Wurthner, F (corresponding author), Univ Wurzburg, Inst Organ Chem, D-97074 Wurzburg, Germany.	wuerthner@chemie.uni-wuerzburg.de	Würthner, Frank/K-5181-2015	Würthner, Frank/0000-0001-7245-0471				ADAM D, 1994, NATURE, V371, P141, DOI 10.1038/371141a0; Balaban TS, 2005, TOP CURR CHEM, V258, P1, DOI 10.1007/b137480; LOUTFY RO, 1988, PURE APPL CHEM, V60, P1047, DOI 10.1351/pac198860071047; Percec V, 2002, NATURE, V419, P384, DOI 10.1038/nature01072; Pullerits T, 1996, ACCOUNTS CHEM RES, V29, P381, DOI 10.1021/ar950110o; Schenning APHJ, 2005, CHEM COMMUN, P3245, DOI 10.1039/b501804h; van de Craats AM, 1999, ADV MATER, V11, P1469, DOI 10.1002/(SICI)1521-4095(199912)11:17<1469::AID-ADMA1469>3.0.CO;2-K; Wasielewski MR, 2006, J ORG CHEM, V71, P5051, DOI 10.1021/jo060225d; Wurthner F, 2004, J AM CHEM SOC, V126, P10611, DOI 10.1021/ja0475353; Yamamoto Y, 2006, SCIENCE, V314, P1761, DOI 10.1126/science.1134441	10	5	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1693	1694		10.1126/science.1136984	http://dx.doi.org/10.1126/science.1136984			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170284				2022-12-28	WOS:000242833600035
J	Kahn, SE; Hull, RL; Utzschneider, KM				Kahn, Steven E.; Hull, Rebecca L.; Utzschneider, Kristina M.			Mechanisms linking obesity to insulin resistance and type 2 diabetes	NATURE			English	Article							BETA-CELL FUNCTION; IMPAIRED GLUCOSE-TOLERANCE; FREE FATTY-ACIDS; SECRETORY CAPACITY; ADIPOSE-TISSUE; HIGH-RISK; SENSITIVITY; ADAPTATION; DYSFUNCTION; HYPERINSULINEMIA	Obesity is associated with an increased risk of developing insulin resistance and type 2 diabetes. In obese individuals, adipose tissue releases increased amounts of non-esterified fatty acids, glycerol, hormones, proinflammatory cytokines and other factors that are involved in the development of insulin resistance. When insulin resistance is accompanied by dysfunction of pancreatic islet beta-cells - the cells that release insulin failure to control blood glucose levels results. Abnormalities in beta-cell function are therefore critical in defining the risk and development of type 2 diabetes. This knowledge is fostering exploration of the molecular and genetic basis of the disease and new approaches to its treatment and prevention.	VA Puget Sound Hlth Care Syst, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98108 USA; Univ Washington, Seattle, WA 98108 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Kahn, SE (corresponding author), VA Puget Sound Hlth Care Syst, Dept Med, Div Metab Endocrinol & Nutr, 1660 S Columbian Way, Seattle, WA 98108 USA.	skahn@u.washington.edu	Tuluc, Petronel/C-2527-2011; Hull-Meichle, Rebecca L./CAG-5879-2022	Kahn, Steven/0000-0001-7307-9002; Utzschneider, Kristina/0000-0002-4924-196X; Hull, Rebecca/0000-0001-9690-4087				AHREN B, 1986, DIABETOLOGIA, V29, P827, DOI 10.1007/BF00870137; Andrulionyte L, 2004, DIABETOLOGIA, V47, P2176, DOI 10.1007/s00125-004-1577-2; Barroso I, 2005, DIABETIC MED, V22, P517, DOI 10.1111/j.1464-5491.2005.01550.x; Bergeman CS, 2006, N D SER QUANT METHOD, V1, P19; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; BERTHOUD HR, 1979, ENDOCRINOLOGY, V105, P146, DOI 10.1210/endo-105-1-146; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; BUCHANAN TA, 1990, AM J OBSTET GYNECOL, V162, P1008, DOI 10.1016/0002-9378(90)91306-W; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633; Carpentier A, 1999, AM J PHYSIOL-ENDOC M, V276, pE1055, DOI 10.1152/ajpendo.1999.276.6.E1055; Cavaghan MK, 1997, J CLIN INVEST, V100, P530, DOI 10.1172/JCI119562; CHEN C, 1994, J CLIN INVEST, V94, P399, DOI 10.1172/JCI117335; CHEN M, 1988, J CLIN ENDOCR METAB, V67, P951, DOI 10.1210/jcem-67-5-951; Cnop M, 2002, DIABETES, V51, P1005, DOI 10.2337/diabetes.51.4.1005; DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095; Dobbins RL, 1998, J CLIN INVEST, V101, P2370, DOI 10.1172/JCI1813; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; EHRMANN DA, 1995, J CLIN INVEST, V96, P520, DOI 10.1172/JCI118064; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Festa A, 2006, DIABETES, V55, P1114, DOI 10.2337/diabetes.55.04.06.db05-1100; Fujimoto WY, 2000, BRIT J NUTR, V84, pS173, DOI 10.1079/096582197388635; GARVEY WT, 1985, DIABETES, V34, P222, DOI 10.2337/diabetes.34.3.222; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jensen CC, 2002, DIABETES, V51, P2170, DOI 10.2337/diabetes.51.7.2170; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; KAHN SE, 1992, J CLIN ENDOCR METAB, V74, P1336, DOI 10.1210/jc.74.6.1336; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; KAHN SE, 1989, DIABETES, V38, P562, DOI 10.2337/diabetes.38.5.562; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; KAHN SE, 1990, AM J PHYSIOL, V258, pE937, DOI 10.1152/ajpendo.1990.258.6.E937; KAHN SE, 1992, AM J PHYSIOL, V262, pE518, DOI 10.1152/ajpendo.1992.262.4.E518; Kaiyala KJ, 1999, AM J PHYSIOL-ENDOC M, V277, pE659, DOI 10.1152/ajpendo.1999.277.4.E659; Kiba T, 1996, GASTROENTEROLOGY, V110, P885, DOI 10.1053/gast.1996.v110.pm8608899; Kim SP, 2003, DIABETES, V52, P2453, DOI 10.2337/diabetes.52.10.2453; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Knowles NG, 2002, DIABETES CARE, V25, P292, DOI 10.2337/diacare.25.2.292; Leung N, 2004, DIABETOLOGIA, V47, P204, DOI 10.1007/s00125-003-1301-7; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Maeda K, 1997, GENE, V190, P227, DOI 10.1016/S0378-1119(96)00730-5; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039; Motoshima H, 2002, J CLIN ENDOCR METAB, V87, P5662, DOI 10.1210/JC.2002-020635; O'Rahilly S, 2006, PHILOS T R SOC B, V361, P1095, DOI 10.1098/rstb.2006.1850; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; PERLEY M, 1966, DIABETES, V15, P867, DOI 10.2337/diab.15.12.867; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; POLONSKY KS, 1988, J CLIN INVEST, V81, P442, DOI 10.1172/JCI113339; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; RANDLE PJ, 1963, LANCET, V1, P785; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Reynisdottir S, 1997, J CLIN ENDOCR METAB, V82, P4162, DOI 10.1210/jc.82.12.4162; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Roder ME, 1998, J CLIN ENDOCR METAB, V83, P604, DOI 10.1210/jc.83.2.604; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580; Santomauro ATMG, 1999, DIABETES, V48, P1836, DOI 10.2337/diabetes.48.9.1836; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Steil GM, 2001, AM J PHYSIOL-ENDOC M, V280, pE788, DOI 10.1152/ajpendo.2001.280.5.E788; Utzschneider KM, 2006, DIABETES CARE, V29, P356, DOI 10.2337/diacare.29.02.06.dc05-1963; Verdich C, 2001, INT J OBESITY, V25, P1206, DOI 10.1038/sj.ijo.0801655; WARD WK, 1985, DIABETES, V34, P861, DOI 10.2337/diabetes.34.9.861; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2000, WHO EUR SER, V91; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	83	3189	3324	14	747	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					840	846		10.1038/nature05482	http://dx.doi.org/10.1038/nature05482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167471				2022-12-28	WOS:000242805400040
J	Fathalla, MF; Sinding, SW; Rosenfield, A; Fathalla, MMF				Fathalla, Mahmoud F.; Sinding, Steven W.; Rosenfield, Allan; Fathalla, Mohammed M. F.			Sexual and reproductive health 6 - Sexual and reproductive health for all: a call for action	LANCET			English	Article							GOALS	At the United Nations International Conference on Population and Development in Cairo in 1994, the international community agreed to make reproductive health care universally available no later than 2015. After a 5-year review of progress towards implementation of the Cairo programme of action, that commitment was extended to include sexual, as well as reproductive, health and rights. Although progress has been made towards this commitment, it has fallen a long way short of the original goal. We argue that sexual and reproductive health for all is an achievable goal-if cost-effective interventions are properly scaled up; political commitment is revitalised; and financial resources are mobilised, rationally allocated, and more effectively used. National action will need to be backed up by international action. Sustained effort is needed by governments in developing countries and in the donor community, by inter-governmental organisations, non-governmental. organisations, civil society groups, the women's health movement, philanthropic foundations, the private for-profit sector, the health profession, and the research community.	Assiut Univ, Dept Obstet & Gynaecol, Assiut, Egypt; Int Planned Parenthood Federat, London, England; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Egyptian Knowledge Bank (EKB); Assiut University; Columbia University	Fathalla, MF (corresponding author), Assiut Univ, Dept Obstet & Gynaecol, POB 30, Assiut, Egypt.	mfathall@intouch.com		Fathalla, Mahmoud/0000-0001-6955-1933				Bernstein S., 2006, PUBLIC CHOICES PRIVA; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cleland J, 2005, LANCET, V366, P1899, DOI 10.1016/S0140-6736(05)67603-9; CLELAND J, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69480-4; Fathalla MF., 2002, AGENDA PEOPLE UNFPA, P24; GLASIER A, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69478-6; Grimes DA, 2004, OBSTET GYNECOL, V104, P220, DOI 10.1097/01.AOG.0000135804.89369.59; GRIMES DA, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69481-6; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; LANGER A, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69486-5; LOW N, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69482-8; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Rosenfield A, 2005, NEW ENGL J MED, V352, P647, DOI 10.1056/NEJMp048281; Simmons R., 2006, SCALING HLTH SERVICE; Singh S, 2003, ADDING BENEFITS INVE; *UN, 1994, INT C POP DEV 1994 S; *UN COMM POP DEV, 2006, INT C POP DEV NEW YO; *UN FUND POP ACT, 2004, SEC SUPPL PEOPL REL; UN Millennium Project, 2005, INV DEV PRACT PLAN A; *UN POP DIV DEP EC, 2004, STESASERA215 UN POP; VLASSOFF M, RESOURCE REQUIREMENT; WELLINGS K, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69479-8; *WHO DEP REPR HLTH, 2004, WHORHR048; *WHO DEP REPR HLTH, 2006, WHORHR063; *WHO UNFPA UNAIDS, 2005, SEX REPR HLTH HIV AI; [No title captured]	26	55	55	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 9	2006	368	9552					2095	2100		10.1016/S0140-6736(06)69483-X	http://dx.doi.org/10.1016/S0140-6736(06)69483-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114JY	17161731				2022-12-28	WOS:000242663700024
J	Richmond, C				Richmond, Caroline			Shark cartilage in the water - Ignorance based cancer treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Letter												c@roline.demon.co.uk						Waxman J, 2006, BRIT MED J, V333, P1129, DOI 10.1136/bmj.39037.692743.59	1	1	1	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2006	333	7580					1222	1222		10.1136/bmj.39051.727350.3A	http://dx.doi.org/10.1136/bmj.39051.727350.3A			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	119JW	17158402	Green Published			2022-12-28	WOS:000243009600032
J	Tonkin, SL; Vogel, SA; Bennet, L; Gunn, AJ				Tonkin, Shirley L.; Vogel, Sall A.; Bennet, Laura; Gunn, Alistair Jan			Apparently life threatening events in infant car safety seats	BRITISH MEDICAL JOURNAL			English	Article							NEWBORN-INFANTS; LAMBS; SLEEP; TERM		Univ Auckland, Dept Physiol, Auckland 1, New Zealand; Univ Auckland, Dept Paediat, Auckland 1, New Zealand; New Zealand Cot Death Assoc, Auckland, New Zealand; Starship Childrens Hosp, Auckland, New Zealand	University of Auckland; University of Auckland; Starship Children's Hospital	Gunn, AJ (corresponding author), Univ Auckland, Dept Physiol, Auckland 1, New Zealand.	aj.gunn@auckland.ac.nz		Gunn, Alistair/0000-0003-0656-7035; Bennet, Laura/0000-0002-4336-7596				Bass JL, 2002, PEDIATRICS, V110, P401, DOI 10.1542/peds.110.2.401; Cohen G, 2005, P NATL ACAD SCI USA, V102, P3817, DOI 10.1073/pnas.0409782102; Davis P., 2001, ALL WALES PERINATAL; Gunn TR, 2000, ACTA PAEDIATR, V89, P82, DOI 10.1080/080352500750029121; Johnston RV, 1998, J PHYSIOL-LONDON, V510, P651, DOI 10.1111/j.1469-7793.1998.651bk.x; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; Kianicka I, 1997, PEDIATR RES, V41, P862, DOI 10.1203/00006450-199706000-00011; Kinane TB, 2006, PEDIATRICS, V118, P522, DOI 10.1542/peds.2005-2712; Merchant JR, 2001, PEDIATRICS, V108, P647, DOI 10.1542/peds.108.3.647; Nagase H, 2002, PEDIATR INT, V44, P60, DOI 10.1046/j.1442-200X.2002.01507.x; STARK AR, 1976, J PEDIATR-US, V89, P982, DOI 10.1016/S0022-3476(76)80615-4; Tonkin SL, 2003, PEDIATRICS, V112, P907, DOI 10.1542/peds.112.4.907; Webber K., 2000, UMTRI RES REV, V31, P1; WIDOME MD, 1991, PEDIATRICS, V87, P120	14	18	18	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 9	2006	333	7580					1205	1206		10.1136/bmj.39021.657083.47	http://dx.doi.org/10.1136/bmj.39021.657083.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	119JW	17158387	Green Published			2022-12-28	WOS:000243009600017
J	Wroe, SJ; Pal, S; Siddique, D; Hyare, H; Macfarlane, R; Joiner, S; Linehan, JM; Brandner, S; Wadsworth, JDF; Hewitt, P; Collinge, J				Wroe, Stephen J.; Pal, Suvankar; Siddique, Durrenajaf; Hyare, Harpreet; Macfarlane, Rebecca; Joiner, Susan; Linehan, Jacqueline M.; Brandner, Sebastian; Wadsworth, Jonathan D. F.; Hewitt, Patricia; Collinge, John			Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report	LANCET			English	Article							HUMAN PRION PROTEIN; PULVINAR SIGN; TONSIL BIOPSY; TRANSMISSION; VCJD; CJD; UK; ACCUMULATION; PHENOTYPE; SAMPLES	Background Concerns have been raised that variant Creutzfeldt-jakob disease (vCJD) might be transmissible by blood transfusion. Two cases of prion infection in a group of known recipients of transfusion from donors who subsequently developed vCJD were identified post-mortem and reported in 2004. Another patient from this at-risk group developed neurological signs and was referred to the National Prion Clinic. Methods The patient was admitted for investigation and details of blood transfusion history were obtained from the National Blood Service and Health Protection Agency; after diagnosis of vCJD, the patient was enrolled into the MRC PRION-1 trial. When the patient died, brain and tonsil tissue were obtained at autopsy and assessed for the presence of disease-related PrP by immunoblotting and immunohistochemistry. Findings A clinical diagnosis of probable vCJD was made; tonsil biopsy was not done. The patient received experimental therapy with quinacrine, but deteriorated and died after a clinical course typical of vCJD. Autopsy confirmed the diagnosis and showed prion infection of the tonsils. Interpretation This case of transfusion-associated vCJD infection, identified ante-mortem, is the third instance from a group of 23 known recipients who survived at least 5 years after receiving a transfusion from donors who subsequently developed vCJD. The risk to the remaining recipients of such tranfusions is probably high, and these patients should be offered specialist follow-up and investigation. Tonsil biopsy will allow early and pre-symptomatic diagnosis in other iatrogenically exposed individuals at high risk, as in those with primary infection with bovine spongiform encephalopathy prions.	Natl Hosp Neurol & Neurosurg, Natl Prion Clin, London WC1N 3BG, England; UCL, MRC Prion Unit, London, England; UCL, Dept Neurodegenerat Dis, Inst Neurol, London, England; Natl Blood Serv, London, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Collinge, J (corresponding author), Natl Hosp Neurol & Neurosurg, Natl Prion Clin, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342; Wadsworth, Jonathan/0000-0002-4797-2259; Macfarlane, Rebecca/0000-0003-1121-4808	MRC [MC_U123160657, MC_U123160655] Funding Source: UKRI; Medical Research Council [MC_U123160657, MC_U123192748, MC_U123160655] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Asante EA, 2006, P NATL ACAD SCI USA, V103, P10759, DOI 10.1073/pnas.0604292103; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Chazot G, 1996, LANCET, V347, P1181, DOI 10.1016/S0140-6736(96)90638-8; Collie DA, 2003, AM J NEURORADIOL, V24, P1560; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Cordery RJ, 2006, EUR RADIOL, V16, P1692, DOI 10.1007/s00330-005-0090-4; CUSMAI R, 1994, NEUROPEDIATRICS, V25, P44, DOI 10.1055/s-2008-1071582; Frosh A, 2004, LANCET, V364, P1260, DOI 10.1016/S0140-6736(04)17143-2; HAHN JS, 1994, PEDIATR NEUROL, V10, P255, DOI 10.1016/0887-8994(94)90035-3; HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill AF, 2003, TRENDS MICROBIOL, V11, P578, DOI 10.1016/j.tim.2003.10.007; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Mallucci G, 2005, NAT REV NEUROSCI, V6, P23, DOI 10.1038/nrn1584; Mihara M, 2005, J NEUROL NEUROSUR PS, V76, P882, DOI 10.1136/jnnp.2004.049783; *MRC CLIN TRIALS U, PRION1 RAND TRIAL QU; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Rossetti AO, 2004, ARCH NEUROL-CHICAGO, V61, P445, DOI 10.1001/archneur.61.3.445; Siddique D, 2005, J NEUROL SCI, V238, pS52; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yoshimura N, 1992, Rinsho Shinkeigaku, V32, P327; Zeidler M, 2000, LANCET, V355, P1412, DOI 10.1016/S0140-6736(00)02140-1	38	292	305	1	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2006	368	9552					2061	2067		10.1016/S0140-6736(06)69835-8	http://dx.doi.org/10.1016/S0140-6736(06)69835-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114JY	17161728	Bronze			2022-12-28	WOS:000242663700021
J	Shin, D; Lee, J; Huang, H; Groisman, EA				Shin, Dongwoo; Lee, Eun-Jin; Huang, Henry; Groisman, Eduardo A.			A positive feedback loop promotes transcription surge that jump-starts Salmonella virulence circuit	SCIENCE			English	Article							2-COMPONENT REGULATORY SYSTEM; ANTIMICROBIAL PEPTIDE RESISTANCE; SIGNAL-TRANSDUCTION SYSTEM; ESCHERICHIA-COLI; PHOP-PHOQ; STREPTOCOCCUS-PNEUMONIAE; TYPHIMURIUM VIRULENCE; ENTERICA; EXPRESSION; GENE	The PhoP/ PhoQ two-component system is a master regulator of Salmonella pathogenicity. Here we report that induction of the PhoP/ PhoQ system results in an initial surge of PhoP phosphorylation; the occupancy of target promoters by the PhoP protein; and the transcription of PhoP-activated genes, which then subsides to reach new steady-state levels. This surge in PhoP activity is due to PhoP positively activating its own transcription, because a strain constitutively expressing the PhoP protein attained steady-state levels of activation asymptotically, without the surge. The strain constitutively expressing the PhoP protein was attenuated for virulence in mice, demonstrating that the surge conferred by PhoP's positive feedback loop is necessary to jump-start Salmonella's virulence program.	Washington Univ, Sch Med, Dept Mol Microbiol, Howard Hughes Med Inst, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Groisman, EA (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Howard Hughes Med Inst, Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	groisman@borcim.wustl.edu			NIAID NIH HHS [AI49561] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049561] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Guiral S, 2006, MICROBIOL-SGM, V152, P323, DOI 10.1099/mic.0.28425-0; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Hutchings MI, 2006, MOL MICROBIOL, V59, P923, DOI 10.1111/j.1365-2958.2005.04953.x; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Montagne M, 2001, J BACTERIOL, V183, P1787, DOI 10.1128/JB.183.5.1787-1791.2001; Mouslim C, 2004, MOL MICROBIOL, V54, P386, DOI 10.1111/j.1365-2958.2004.04293.x; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Shin D, 2005, J BIOL CHEM, V280, P4089, DOI 10.1074/jbc.M412741200; Soncini FC, 1996, J BACTERIOL, V178, P6796, DOI 10.1128/jb.178.23.6796-6801.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Valdivia RH, 2000, INFECT IMMUN, V68, P7126, DOI 10.1128/IAI.68.12.7126-7131.2000; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	29	105	107	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1607	1609		10.1126/science.1134930	http://dx.doi.org/10.1126/science.1134930			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158330				2022-12-28	WOS:000242624600045
J	Piccirillo, SGM; Reynolds, BA; Zanetti, N; Lamorte, G; Binda, E; Broggi, G; Brem, H; Olivi, A; Dimeco, F; Vescovi, AL				Piccirillo, S. G. M.; Reynolds, B. A.; Zanetti, N.; Lamorte, G.; Binda, E.; Broggi, G.; Brem, H.; Olivi, A.; Dimeco, F.; Vescovi, A. L.			Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells	NATURE			English	Article							NEURAL STEM-CELLS; TGF-BETA; CNS; CANCER; DIFFERENTIATION; IDENTIFICATION; PRECURSORS; APOPTOSIS; SMAD; BMPS	Transformed, oncogenic precursors, possessing both defining neural-stem-cell properties and the ability to initiate intracerebral tumours, have been identified in human brain cancers(1). Here we report that bone morphogenetic proteins (BMPs), amongst which BMP4 elicits the strongest effect, trigger a significant reduction in the stem-like, tumour-initiating precursors of human glioblastomas (GBMs). Transient in vitro exposure to BMP4 abolishes the capacity of transplanted GBM cells to establish intracerebral GBMs. Most importantly, in vivo delivery of BMP4 effectively blocks the tumour growth and associated mortality that occur in 100% of mice after intracerebral grafting of human GBM cells. We demonstrate that BMPs activate their cognate receptors (BMPRs) and trigger the Smad signalling cascade in cells isolated from human glioblastomas ( GBMs). This is followed by a reduction in proliferation, and increased expression of markers of neural differentiation, with no effect on cell viability. The concomitant reduction in clonogenic ability, in the size of the CD133(+) population and in the growth kinetics of GBM cells indicates that BMP4 reduces the tumour-initiating cell pool of GBMs. These findings show that the BMP - BMPR signalling system - which controls the activity of normal brain stem cells(2,3) - may also act as a key inhibitory regulator of tumour-initiating, stem-like cells from GBMs and the results also identify BMP4 as a novel, non-cytotoxic therapeutic effector, which may be used to prevent growth and recurrence of GBMs in humans.	Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; Univ Milano Bicocca, StemGen Spa, Unit Canc Stem Cell Biol, I-20126 Milan, Italy; Univ Queensland, Queensland Brain Inst, Lab Neural Stem Cell Biol, Brisbane, Qld, Australia; Hosp San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy; Natl Neurol Inst C Besta, I-20133 Milan, Italy; Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21287 USA	University of Milano-Bicocca; University of Milano-Bicocca; University of Queensland; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Istituto Neurologico Besta; Johns Hopkins University	Vescovi, AL (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy.	vescovi@tin.it	Olivi, Alessandro/K-6531-2016; Vescovi, Angelo Luigi/A-4919-2015; Binda, Elena/B-2650-2017; Zanetti, Nadia/AAK-4682-2021; DiMeco, Francesco/Z-5431-2019; DiMeco, Francesco/Q-3785-2016	Olivi, Alessandro/0000-0002-4489-7564; Vescovi, Angelo Luigi/0000-0002-1742-4112; Binda, Elena/0000-0002-8750-2905; Zanetti, Nadia/0000-0003-1485-8983; Lamorte, Giuseppe/0000-0001-9377-7537; Piccirillo, Sara Grazia Maria/0000-0003-4109-1992; DiMeco, Francesco/0000-0001-6213-5793				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker FG, 1998, NEUROSURGERY, V42, P709, DOI 10.1097/00006123-199804000-00013; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Golestaneh N, 2005, ONCOGENE, V24, P5722, DOI 10.1038/sj.onc.1208925; Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Iantosca MR, 1999, J NEUROSCI RES, V56, P248; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Kjellman C, 2000, INT J CANCER, V89, P251, DOI 10.1002/1097-0215(20000520)89:3<251::AID-IJC7>3.0.CO;2-5; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li WW, 1998, J NEUROSCI, V18, P8853; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Weiss S, 1996, J NEUROSCI, V16, P7599	30	907	954	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					761	765		10.1038/nature05349	http://dx.doi.org/10.1038/nature05349			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151667				2022-12-28	WOS:000242581100061
J	Brouwer, JLP; Veeger, NJGM; Kluin-Nelemans, HC; van der Meer, J				Brouwer, Jan-Leendert P.; Veeger, Nic J. G. M.; Kluin-Nelemans, Hanneke C.; van der Meer, Jan			The pathogenesis of venous thromboembolism: Evidence for multiple interrelated causes	ANNALS OF INTERNAL MEDICINE			English	Article							PROTEIN-S DEFICIENCY; DEEP-VEIN THROMBOSIS; FACTOR-V-LEIDEN; PROSPECTIVE COHORT; RISK-FACTOR; INHERITED THROMBOPHILIA; ANTITHROMBIN-III; FAMILIES; PROTHROMBIN; RESISTANCE	Background: Venous thromboembolism (VTE) is thought to result from interactions between multiple genetic and environmental risk factors. Objective: To assess the contribution of multiple thrombophilic defects and exogenous risk factors to the absolute risk for VTE. Design: Retrospective family cohort study. Setting: Single university hospital. Participants: 468 relatives of 91 probands with a symptomatic hereditary deficiency of protein S, protein C, or antithrombin. Measurements: All relatives were tested for 10 thrombophilic deficiencies and defects in addition to the index deficiency and were assessed for exogenous risk factors (surgery, trauma, immobilization, use of oral contraceptives, and pregnancy). The authors compared annual incidences and relative risks for VTE in deficient and nondeficient relatives. Results: Annual incidences of VTE in relatives with 0, 1, and 2 or more additional thrombophilic deficiencies or defects were 1.16 (95% Cl, 0.60 to 2.03), 1.75 (Cl, 1.17 to 2.53), and 2.64 (Cl, 1.67 to 3.96) per 100 person-years, respectively, compared with 0.06 (CI, 0.002 to 0.33) per 100 person-years in nondeficient relatives without additional deficiencies or defects. Adjusted relative risks were 16.3 (CI, 2.0 to 131.0), 50.3 (6.5 to 389.7), and 102.8 (12.5 to 843.4). Of deficient relatives, 38% with no additional defect, 57% with 1 additional defect, and 81 % with 2 or more additional defects had VTE at age 65 years compared with 5% of nondeficient relatives (P < 0.001). In deficient relatives with additional deficiencies or defects, exogenous risk factors increased the risk for VTE from 1.20% to 2.51% per year (relative risk, 2.1 [CI, 1.1 to 4.2]). Limitations: This was a retrospective study without the ability to distinguish interactions between specific thrombophilic deficiencies and defects. Conclusion: Additional thrombophilic defects and exogenous risk factors increase the risk for VTE in persons with hereditary deficiencies of protein S, protein C, or antithrombin and provide evidence that multiple genetic and environmental risk factors contribute to VTE.	Univ Groningen, Med Ctr, Dept Hematol, Div Hameostasis Thrombosis & Rheol, NL-9713 GZ Groningen, Netherlands	University of Groningen	van der Meer, J (corresponding author), Univ Groningen, Med Ctr, Dept Hematol, Div Hameostasis Thrombosis & Rheol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	j.van.der.meer@int.umcg.nl	Veeger, Nic JGM/F-2966-2013; Kluin-Nelemans, Johanna C/F-8658-2018	Veeger, Nic JGM/0000-0002-1492-7937; Kluin-Nelemans, Johanna C/0000-0003-2617-9427				ALLAART CF, 1995, BRIT MED J, V311, P910; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Brouwer JLP, 2005, BRIT J HAEMATOL, V128, P703, DOI 10.1111/j.1365-2141.2005.05371.x; Caprini JA, 2004, CIRCULATION, V109, pI4, DOI 10.1161/01.CIR.0000122869.59485.36; Castaman G, 2000, BLOOD COAGUL FIBRIN, V11, P321, DOI 10.1097/00001721-200006000-00002; Danneberg J, 1998, CLIN CHEM, V44, P349; denHeijer M, 1996, NEW ENGL J MED, V334, P759, DOI 10.1056/NEJM199603213341203; DESTEFANO V, 1994, THROMB HAEMOSTASIS, V72, P352; EXNER T, 1991, THROMB HAEMOSTASIS, V65, P320; Frezzato M, 1996, AM J EPIDEMIOL, V143, P1257; KOELEMAN BPC, 1994, BLOOD, V84, P1031; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; PABINGER I, 1994, THROMB HAEMOSTASIS, V71, P441; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; ROSENDAAL FR, 1991, LANCET, V337, P260, DOI 10.1016/0140-6736(91)90867-O; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Rosendaal FR, 1998, THROMB HAEMOSTASIS, V79, P706; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P247; Sanson BJ, 1999, BLOOD, V94, P3702; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; Tirado I, 2001, HAEMATOLOGICA, V86, P1200; vanBoven HH, 1996, THROMB HAEMOSTASIS, V75, P417; vandenBelt AGM, 1996, CLIN APPL THROMB-HEM, V2, P227, DOI 10.1177/107602969600200402; Vossen CY, 2005, J THROMB HAEMOST, V3, P459, DOI 10.1111/j.1538-7836.2005.01197.x; ZOLLER B, 1995, BLOOD, V85, P3518, DOI 10.1182/blood.V85.12.3518.bloodjournal85123518	27	61	63	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2006	145	11					807	815		10.7326/0003-4819-145-11-200612050-00005	http://dx.doi.org/10.7326/0003-4819-145-11-200612050-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114PE	17146065				2022-12-28	WOS:000242677300002
J	Cardon, LR				Cardon, Lon R.			Delivering new disease genes	SCIENCE			English	Editorial Material							GENOME-WIDE ASSOCIATION; MACULAR DEGENERATION; CROHNS-DISEASE; SUSCEPTIBILITY; POLYMORPHISM; VARIANT; CFH		Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Oxford; Wellcome Centre for Human Genetics; Fred Hutchinson Cancer Center	Cardon, LR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	lon.cardon@well.ox.ac.uk						Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	13	27	29	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1403	+		10.1126/science.1136668	http://dx.doi.org/10.1126/science.1136668			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	110UF	17138888				2022-12-28	WOS:000242406100024
J	Hime, T; Reichardt, PA; Plourde, BLT; Robertson, TL; Wu, CE; Ustinov, AV; Clarke, J				Hime, T.; Reichardt, P. A.; Plourde, B. L. T.; Robertson, T. L.; Wu, C. -E.; Ustinov, A. V.; Clarke, John			Solid-state qubits with current-controlled coupling	SCIENCE			English	Article							MACROSCOPIC QUANTUM STATES; CHARGE QUBITS; SUPERPOSITION	The ability to switch the coupling between quantum bits (qubits) on and off is essential for implementing many quantum-computing algorithms. We demonstrated such control with two flux qubits coupled together through their mutual inductances and through the dc superconducting quantum interference device ( SQUID) that reads out their magnetic flux states. A bias current applied to the SQUID in the zero-voltage state induced a change in the dynamic inductance, reducing the coupling energy controllably to zero and reversing its sign.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Syracuse Univ, Dept Phys, Syracuse, NY 13244 USA; Natl Tsing Hua Univ, Dept Phys, Hsinchu 300, Taiwan; Univ Erlangen Nurnberg, Inst Phys 3, D-91058 Erlangen, Germany	University of California System; University of California Berkeley; Syracuse University; National Tsing Hua University; University of Erlangen Nuremberg	Clarke, J (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	jclarke@berkeley.edu	Ustinov, Alexey/J-4663-2015	Ustinov, Alexey/0000-0002-1202-1787				Abragam A., 1961, PRINCIPLES NUCL MAGN; Averin DV, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.057003; Berkley AJ, 2003, SCIENCE, V300, P1548, DOI 10.1126/science.1084528; Bertet P, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.064512; Bertet P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257002; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; Grajcar M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.047006; Izmalkov A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.037003; KAMON M, 1994, IEEE T MICROW THEORY, V42, P1750, DOI 10.1109/22.310584; Majer JB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.090501; McDermott R, 2005, SCIENCE, V307, P1299, DOI 10.1126/science.1107572; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Niskanen AO, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094506; Pashkin YA, 2003, NATURE, V421, P823, DOI 10.1038/nature01365; Plourde BLT, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.060506; Plourde BLT, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.140501; Robertson TL, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174526; Storcz MJ, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.042319; van der Wal CH, 2000, SCIENCE, V290, P773, DOI 10.1126/science.290.5492.773; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; von Neumann J, 1929, PHYS Z, V30, P467; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015; You JQ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.197902	25	170	173	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1427	1429		10.1126/science.1134388	http://dx.doi.org/10.1126/science.1134388			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138895				2022-12-28	WOS:000242406100033
J	Mulligan, CJ; Kitchen, A; Miyamoto, MM				Mulligan, Connie J.; Kitchen, Andrew; Miyamoto, Michael M.			Comment on "Population size does not influence mitochondrial genetic diversity in animals"	SCIENCE			English	Editorial Material							DNA; CHIMPANZEES; EVOLUTION		Univ Florida, Dept Anthropol, Gainesville, FL 32610 USA; Univ Florida, Dept Zool, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mulligan, CJ (corresponding author), Univ Florida, Dept Anthropol, Box 103610, Gainesville, FL 32610 USA.	mulligan@anthro.ufl.edu						Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Eyre-Walker A, 2006, SCIENCE, V312, P537, DOI 10.1126/science.1127182; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Nevo E., 1984, Lecture Notes in Biomathematics, V53, P13; Yu N, 2003, GENETICS, V164, P1511	7	47	47	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804								10.1126/science.1132585	http://dx.doi.org/10.1126/science.1132585			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138883				2022-12-28	WOS:000242406100016
J	van Hameren, R; Schon, P; van Buul, AM; Hoogboom, J; Lazarenko, SV; Gerritsen, JW; Engelkamp, H; Christianen, PCM; Heus, HA; Maan, JC; Rasing, T; Speller, S; Rowan, AE; Elemans, JAAW; Nolte, RJM				van Hameren, Richard; Schoen, Peter; van Buul, Arend M.; Hoogboom, Johan; Lazarenko, Sergiy V.; Gerritsen, Jan W.; Engelkamp, Hans; Christianen, Peter C. M.; Heus, Hans A.; Maan, Jan C.; Rasing, Theo; Speller, Sylvia; Rowan, Alan E.; Elemans, Johannes A. A. W.; Nolte, Roeland J. M.			Macroscopic hierarchical surface patterning of porphyrin trimers via self-assembly and dewetting	SCIENCE			English	Article							THIN LIQUID-FILMS; COMPLEX; NANOSTRUCTURES; ARCHITECTURES; DENDRIMERS; FORCES; DROPS	The use of bottom-up approaches to construct patterned surfaces for technological applications is appealing, but to date is applicable to only relatively small areas (similar to 10 square micrometers). We constructed highly periodic patterns at macroscopic length scales, in the range of square millimeters, by combining self-assembly of disk-like porphyrin dyes with physical dewetting phenomena. The patterns consisted of equidistant 5-nanometer-wide lines spaced 0.5 to 1 micrometers apart, forming single porphyrin stacks containing millions of molecules, and were formed spontaneously upon drop-casting a solution of the molecules onto a mica surface. On glass, thicker lines are formed, which can be used to align liquid crystals in large domains of square millimeter size.	Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands; MIT, Dept Chem, Cambridge, MA 02139 USA	Radboud University Nijmegen; Massachusetts Institute of Technology (MIT)	Elemans, JAAW (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	j.elemans@science.ru.nl	Heus, Hans/F-9696-2015; Hoogboom, Johan/AAE-6954-2019; Christianen, Peter CM/E-1627-2012; Rowan, Alan E/F-9702-2015; Maan, Jan Cornelis/D-4952-2012; Elemans, Johannes/D-4334-2012; Speller, Sylvia/C-2596-2009; Nolte, Roeland/C-9930-2013; Engelkamp, Hans/A-8933-2012; Rasing, Theo/D-5207-2012	Heus, Hans/0000-0001-7256-4241; Hoogboom, Johan/0000-0002-2615-3131; Rowan, Alan E/0000-0003-0728-3851; Nolte, Roeland/0000-0002-5612-7815; Engelkamp, Hans/0000-0001-9920-0536; Rasing, Theo/0000-0002-6656-5528; Elemans, Johannes/0000-0003-3825-7218				Barth JV, 2000, ANGEW CHEM INT EDIT, V39, P1230, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1230::AID-ANIE1230>3.0.CO;2-I; Behdani M, 2002, APPL PHYS LETT, V80, P4635, DOI 10.1063/1.1484556; Bushey ML, 2004, ANGEW CHEM INT EDIT, V43, P5446, DOI 10.1002/anie.200301678; Deegan RD, 2000, PHYS REV E, V61, P475, DOI 10.1103/PhysRevE.61.475; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Higgins AM, 2000, NATURE, V404, P476, DOI 10.1038/35006597; Huang JX, 2005, NAT MATER, V4, P896, DOI 10.1038/nmat1517; Hudson SD, 1997, SCIENCE, V278, P449, DOI 10.1126/science.278.5337.449; Jacobs HO, 2002, SCIENCE, V296, P323, DOI 10.1126/science.1069153; Jeukens CRLPN, 2004, NANO LETT, V4, P1401, DOI 10.1021/nl049363d; Lensen MC, 2004, CHEM-EUR J, V10, P831, DOI 10.1002/chem.200305436; Lightfoot MP, 1999, CHEM COMMUN, P1945, DOI 10.1039/a905245c; Lin ZQ, 2005, J AM CHEM SOC, V127, P2816, DOI 10.1021/ja044792z; Mougin K, 2002, LANGMUIR, V18, P9566, DOI 10.1021/la020491w; Percec V, 2004, NATURE, V430, P764, DOI 10.1038/nature02770; Percec V, 2002, NATURE, V419, P384, DOI 10.1038/nature01072; Ranganathan S, 2001, CHEM COMMUN, P2544, DOI 10.1039/b109465n; Rasing T., 2004, SURF INTERFACES; Ray MA, 2005, LANGMUIR, V21, P4786, DOI 10.1021/la050165r; Reiter G, 1998, SCIENCE, V282, P888, DOI 10.1126/science.282.5390.888; Sharma A, 1999, J CHEM PHYS, V110, P4929, DOI 10.1063/1.478378; Sharma A, 2002, LANGMUIR, V18, P10213, DOI 10.1021/la025958h; Sharma A, 1998, PHYS REV LETT, V81, P3463, DOI 10.1103/PhysRevLett.81.3463; Smalyukh II, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.177801; Stenzel MH, 2006, J POLYM SCI POL CHEM, V44, P2363, DOI 10.1002/pola.21334; Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384; Verbiest T, 1998, SCIENCE, V282, P913, DOI 10.1126/science.282.5390.913; Vyawahare S, 2006, NANO LETT, V6, P271, DOI 10.1021/nl0522678; Wilson AJ, 2005, ANGEW CHEM INT EDIT, V44, P2275, DOI 10.1002/anie.200462347; Yabu H, 2005, ADV FUNCT MATER, V15, P575, DOI 10.1002/adfm.200400315	30	277	277	4	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1433	1436		10.1126/science.1133004	http://dx.doi.org/10.1126/science.1133004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138897				2022-12-28	WOS:000242406100035
J	Zarrin, AA; Del Vecchio, C; Tseng, E; Gleason, M; Zarin, P; Tian, M; Alt, FW				Zarrin, Ali A.; Del Vecchio, Catherine; Tseng, Eva; Gleason, Megan; Zarin, Payam; Tian, Ming; Alt, Frederick W.			Antibody class switching mediated by yeast endonuclease-generated DNA breaks	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; S-MU REGION; SOMATIC HYPERMUTATION; GENE CONVERSION; B-CELLS; RECOMBINATION; AID; MECHANISM; TRANSLOCATIONS; DELETION	Antibody class switching in activated B cells uses class switch recombination (CSR), which joins activation-induced cytidine deaminase (AID)-dependent double-strand breaks (DSBs) within two large immunoglobulin heavy chain (IgH) locus switch (S) regions that lie up to 200 kilobases apart. To test postulated roles of S regions and AID in CSR, we generated mutant B cells in which donor S mu and accepter S gamma 1 regions were replaced with yeast 1-SceI endonuclease sites. We found that site-specific 1-SceI DSBs mediate recombinational IgH locus class switching from IgM to IgG(2) without S regions or AID. We propose that CSR evolved to exploit a general DNA repair process that promotes joining of widely separated DSBs within a chromosome.	Harvard Univ, Sch Med, Childrens Hosp, CBR Inst Biomed Res,Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Texas, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Texas System; University of Texas Austin	Alt, FW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, CBR Inst Biomed Res,Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu		Del Vecchio Fitz, Catherine/0000-0002-9554-411X	NCI NIH HHS [P01CA092625-05] Funding Source: Medline; NIAID NIH HHS [2P01AI031541-15] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI031541] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; Elliott B, 2005, MOL CELL, V17, P885, DOI 10.1016/j.molcel.2005.02.028; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Khamlichi AA, 2004, BLOOD, V103, P3828, DOI 10.1182/blood-2003-10-3470; Larson ED, 2005, CURR BIOL, V15, P470, DOI 10.1016/j.cub.2004.12.077; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rush JS, 2004, INT IMMUNOL, V16, P549, DOI 10.1093/intimm/dxh057; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Schrader CE, 2003, EMBO J, V22, P5893, DOI 10.1093/emboj/cdg550; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Toffolatti L, 2002, GENOMICS, V80, P523, DOI 10.1006/geno.2002.6861; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; Zarrin AA, 2005, P NATL ACAD SCI USA, V102, P2466, DOI 10.1073/pnas.0409847102; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137	30	78	84	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					377	381		10.1126/science.1136386	http://dx.doi.org/10.1126/science.1136386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17170253				2022-12-28	WOS:000243535400042
J	Bailey, JV; Joye, SB; Kalanetra, KM; Flood, BE; Corsetti, FA				Bailey, Jake V.; Joye, Samantha B.; Kalanetra, Karen M.; Flood, Beverly E.; Corsetti, Frank A.			Evidence of giant sulphur bacteria in Neoproterozoic phosphorites	NATURE			English	Article							PRECAMBRIAN ANIMAL LIFE; DOUSHANTUO FORMATION; EMBRYOS; PRESERVATION; CONSTRAINTS; TAPHONOMY; GUIZHOU; FOSSILS; ALGAE	In situ phosphatization(1) and reductive cell division(2) have recently been discovered within the vacuolate sulphur-oxidizing bacteria. Here we show that certain Neoproterozoic Doushantuo Formation ( about 600 million years BP) microfossils, including structures previously interpreted as the oldest known metazoan eggs and embryos(3-10), can be interpreted as giant vacuolate sulphur bacteria. Sulphur bacteria of the genus Thiomargarita have sizes and morphologies similar to those of many Doushantuo microfossils, including symmetrical cell clusters that result from multiple stages of reductive division in three planes. We also propose that Doushantuo phosphorite precipitation was mediated by these bacteria, as shown in modern Thiomargarita-associated phosphogenic sites, thus providing the taphonomic conditions that preserved other fossils known from the Doushantuo Formation.	Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA	University of Southern California; University of Southern California; University System of Georgia; University of Georgia	Bailey, JV (corresponding author), Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.	jvbailey@usc.edu	Kalanetra, Karen/AAP-3669-2021	Bailey, Jake/0000-0002-7655-5200; Joye, Samantha/0000-0003-1610-451X				AWRAMIK SM, 1985, NATURE, V315, P655, DOI 10.1038/315655a0; Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Bengtson S, 2004, SCIENCE, V306; CHEN J. Y., 2004, DAWN ANIMAL WORLD; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JY, 2006, SCIENCE, V312, P1644, DOI 10.1126/science.1125964; Chen JY, 2004, SCIENCE, V305, P218, DOI 10.1126/science.1099213; Chen JY, 2002, DEV BIOL, V248, P182, DOI 10.1006/dbio.2002.0714; Costello DP, 1971, METHODS OBTAINING HA; Dornbos SQ, 2005, LETHAIA, V38, P101, DOI 10.1080/00241160510013187; Goldberg T, 2005, PRECAMBRIAN RES, V137, P223, DOI 10.1016/j.precamres.2005.03.003; Hagadorn JW, 2006, SCIENCE, V314, P291, DOI 10.1126/science.1133129; Jorgensen B.B., 2004, GEOL S AM, V379, P63, DOI DOI 10.1130/0-8137-2379-5.63; Kalanetra KM, 2005, ENVIRON MICROBIOL, V7, P1451, DOI 10.1111/j.1462-2920.2005.00832.x; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; Martin D, 2005, PALAIOS, V20, P562, DOI 10.2110/palo.2004.p04-67; Raff EC, 2006, P NATL ACAD SCI USA, V103, P5846, DOI 10.1073/pnas.0601536103; Schulz HN, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P1156, DOI 10.1007/0-387-30746-x_47; Schulz HN, 2005, SCIENCE, V307, P416, DOI 10.1126/science.1103096; Schulz HN, 1999, SCIENCE, V284, P493, DOI 10.1126/science.284.5413.493; Xiao SH, 1999, LETHAIA, V32, P219, DOI 10.1111/j.1502-3931.1999.tb00541.x; Xiao SH, 2000, J PALEONTOL, V74, P767, DOI 10.1666/0022-3360(2000)074<0767:PAEFTN>2.0.CO;2; Xiao SH, 2000, P NATL ACAD SCI USA, V97, P13684, DOI 10.1073/pnas.250491697; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2002, PALEOBIOLOGY, V28, P244, DOI 10.1666/0094-8373(2002)028<0244:MTAMON>2.0.CO;2; Xiao Shu-hai, 1999, Acta Micropalaeontologica Sinica, V16, P313; Xue Yao-song, 1995, Acta Palaeontologica Sinica, V34, P688; Xue Yao-song, 1999, Acta Micropalaeontologica Sinica, V16, P1; ZHANG Y, 1998, PALEONTOL SOC MEM, V50, P1; Zhou CM, 2001, PALAEONTOLOGY, V44, P1157	30	142	165	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					198	201		10.1038/nature05457	http://dx.doi.org/10.1038/nature05457			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17183268				2022-12-28	WOS:000243384300049
J	Flynn, GJ; Bleuet, P; Borg, J; Bradley, JP; Brenker, FE; Brennan, S; Bridges, J; Brownlee, DE; Bullock, ES; Burghammer, M; Clark, BC; Dai, ZR; Daghlian, CP; Djouadi, Z; Fakra, S; Ferroir, T; Floss, C; Franchi, IA; Gainsforth, Z; Gallien, JP; Gillet, P; Grant, PG; Graham, GA; Green, SF; Grossemy, F; Heck, PR; Herzog, GF; Hoppe, P; Horz, F; Huth, J; Ignatyev, K; Ishii, HA; Janssens, K; Joswiak, D; Kearsley, AT; Khodja, H; Lanzirotti, A; Leitner, J; Lemelle, L; Leroux, H; Luening, K; MacPherson, GJ; Marhas, KK; Marcus, MA; Matrajt, G; Nakamura, T; Nakamura-Messenger, K; Nakano, T; Newville, M; Papanastassiou, DA; Pianetta, P; Rao, W; Riekel, C; Rietmeijer, FJM; Rost, D; Schwandt, CS; See, TH; Sheffield-Parker, J; Simionovici, A; Sitnitsky, I; Snead, CJ; Stadermann, FJ; Stephan, T; Stroud, RM; Susini, J; Suzuki, Y; Sutton, SR; Taylor, S; Teslich, N; Troadec, D; Tsou, P; Tsuchiyama, A; Uesugi, K; Vekemans, B; Vicenzi, EP; Vincze, L; Westphal, AJ; Wozniakiewicz, P; Zinner, E; Zolensky, ME				Flynn, George J.; Bleuet, Pierre; Borg, Janet; Bradley, John P.; Brenker, Frank E.; Brennan, Sean; Bridges, John; Brownlee, Don E.; Bullock, Emma S.; Burghammer, Manfred; Clark, Benton C.; Dai, Zu Rong; Daghlian, Charles P.; Djouadi, Zahia; Fakra, Sirine; Ferroir, Tristan; Floss, Christine; Franchi, Ian A.; Gainsforth, Zack; Gallien, Jean-Paul; Gillet, Philippe; Grant, Patrick G.; Graham, Giles A.; Green, Simon F.; Grossemy, Faustine; Heck, Philipp R.; Herzog, Gregory F.; Hoppe, Peter; Hoerz, Friedrich; Huth, Joachim; Ignatyev, Konstantin; Ishii, Hope A.; Janssens, Koen; Joswiak, David; Kearsley, Anton T.; Khodja, Hicham; Lanzirotti, Antonio; Leitner, Jan; Lemelle, Laurence; Leroux, Hugues; Luening, Katharina; MacPherson, Glenn J.; Marhas, Kuljeet K.; Marcus, Matthew A.; Matrajt, Graciela; Nakamura, Tomoki; Nakamura-Messenger, Keiko; Nakano, Tsukasa; Newville, Matthew; Papanastassiou, Dimitri A.; Pianetta, Piero; Rao, William; Riekel, Christian; Rietmeijer, Frans J. M.; Rost, Detlef; Schwandt, Craig S.; See, Thomas H.; Sheffield-Parker, Julie; Simionovici, Alexandre; Sitnitsky, Ilona; Snead, Christopher J.; Stadermann, Frank J.; Stephan, Thomas; Stroud, Rhonda M.; Susini, Jean; Suzuki, Yoshio; Sutton, Stephen R.; Taylor, Susan; Teslich, Nick; Troadec, D.; Tsou, Peter; Tsuchiyama, Akira; Uesugi, Kentaro; Vekemans, Bart; Vicenzi, Edward P.; Vincze, Laszlo; Westphal, Andrew J.; Wozniakiewicz, Penelope; Zinner, Ernst; Zolensky, Michael E.			Elemental compositions of comet 81P/Wild 2 samples collected by Stardust	SCIENCE			English	Article							SPACECRAFT; ABUNDANCES; SOLAR; DUST	We measured the elemental compositions of material from 23 particles in aerogel and from residue in seven craters in aluminum foil that was collected during passage of the Stardust spacecraft through the coma of comet 81P/Wild 2. These particles are chemically heterogeneous at the largest size scale analyzed (similar to 180 ng). The mean elemental composition of this Wild 2 material is consistent with the CI meteorite composition, which is thought to represent the bulk composition of the solar system, for the elements Mg, Si, Mn, Fe, and Ni to 35%, and for Ca and Ti to 60%. The elements Cu, Zn, and Ga appear enriched in this Wild 2 material, which suggests that the CI meteorites may not represent the solar system composition for these moderately volatile minor elements.	SUNY Coll Plattsburgh, Dept Phys, Plattsburgh, NY 12901 USA; European Synchrotron Radiat Facil, F-38043 Grenoble, France; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Inst Astrophys Spatiale, Orsay, France; Goethe Univ Frankfurt, Inst Mineral, D-6000 Frankfurt, Germany; Stanford Linear Accelerator Ctr, Menlo Pk, CA 94025 USA; Open Univ, Milton Keynes MK7 6AA, Bucks, England; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Smithsonian Inst, Dept Mineral Sci, Washington, DC 20560 USA; Lockheed Martin, Denver, CO 80201 USA; Dartmouth Coll, Hanover, NH 03755 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Ecole Normale Super Lyon, F-69364 Lyon, France; Washington Univ, St Louis, MO 63130 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; CNRS, CEA, Lab Pierre Sue, Saclay, France; Max Planck Inst Chem, D-55128 Mainz, Germany; Rutgers State Univ, Dept Chem & Biol Chem, Piscataway, NJ 08854 USA; NASA, Lyndon B Johnson Space Ctr, Engn & Sci Contract Grp Jacobs Sverdrup, Houston, TX 77058 USA; Univ Antwerp, Dept Chem, B-2020 Antwerp, Belgium; Nat Hist Museum, Dept Mineral, London SW7 5BD, England; Univ Chicago, Chicago, IL 60637 USA; Univ Munster, Inst Planetol, D-48149 Munster, Germany; Univ Lille, Lille, France; Kyushu Univ, Fukuoka 812, Japan; Geol Survey Japan, Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 305, Japan; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Georgia, Athens, GA 30602 USA; Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; XRT Ltd, Port Melbourne, Vic, Australia; USN, Res Lab, Washington, DC 20375 USA; Japan Synchrotron Radiat Res Inst SPring8, Hyogo, Japan; Cold Reg Res & Engn Lab, Engn Res & Dev Ctr, Hanover, NH 03755 USA; Univ Ghent, B-9000 Ghent, Belgium; Osaka Univ, Toyonaka, Osaka 560, Japan	State University of New York (SUNY) System; SUNY Plattsburgh; European Synchrotron Radiation Facility (ESRF); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Goethe University Frankfurt; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Open University - UK; University of Washington; University of Washington Seattle; Smithsonian Institution; Smithsonian National Museum of Natural History; Lockheed Martin; Dartmouth College; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Ecole Normale Superieure de Lyon (ENS de LYON); Washington University (WUSTL); University of California System; University of California Berkeley; CEA; Centre National de la Recherche Scientifique (CNRS); Max Planck Society; Rutgers State University New Brunswick; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Antwerp; Natural History Museum London; University of Chicago; University of Munster; Universite de Lille - ISITE; Universite de Lille; Kyushu University; National Institute of Advanced Industrial Science & Technology (AIST); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University System of Georgia; University of Georgia; University of New Mexico; United States Department of Defense; United States Navy; Naval Research Laboratory; Japan Synchrotron Radiation Research Institute; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); Ghent University; Osaka University	Flynn, GJ (corresponding author), SUNY Coll Plattsburgh, Dept Phys, 101 Broad St, Plattsburgh, NY 12901 USA.	george.flynn@plattsburgh.edu	marcus, matthew/P-8023-2019; Newville, Matthew G/B-3372-2009; Stroud, Rhonda M./C-5503-2008; Newville, Matthew/GNP-3282-2022; Stephan, Thomas/C-1023-2008; Heck, Philipp R/AAU-1433-2021; Stroud, Rhonda/GQZ-0151-2022; Janssens, Koen Henri/B-8049-2011; Green, Simon F/C-7408-2009; Leroux, Hugues/S-4570-2017; Pianetta, Piero/GLS-9094-2022; Vincze, Laszlo/AAP-3914-2020; Stroud, Rhonda M/S-4584-2018; Bullock, Emma/A-3870-2016; Heck, Philipp/C-6092-2012; Vicenzi, Edward P/T-9430-2017; Simionovici, Alexandre S/E-5867-2018; Khodja, Hicham/A-1869-2016; Janssens, Koen/ABG-7298-2020; Leitner, Jan/A-7391-2015; Matrajt, Graciela/A-4812-2017; Dai, Zurong/E-6732-2010; Hoppe, Peter/B-3032-2015	Newville, Matthew G/0000-0001-6938-1014; Stroud, Rhonda M./0000-0001-5242-8015; Stephan, Thomas/0000-0001-6377-8731; Heck, Philipp R/0000-0002-6319-2594; Stroud, Rhonda/0000-0001-5242-8015; Janssens, Koen Henri/0000-0002-6752-6408; Green, Simon F/0000-0002-9153-9786; Leroux, Hugues/0000-0002-8806-8434; Pianetta, Piero/0000-0002-4834-6014; Stroud, Rhonda M/0000-0001-5242-8015; Bullock, Emma/0000-0002-5678-3695; Vicenzi, Edward P/0000-0003-2085-6546; Simionovici, Alexandre S/0000-0001-5349-6482; Khodja, Hicham/0000-0001-8374-4539; Leitner, Jan/0000-0003-3655-6273; Hoppe, Peter/0000-0003-3681-050X; Ignatyev, Konstantin/0000-0002-8937-5655; Zolensky, Michael/0000-0002-3181-1303; Lanzirotti, Antonio/0000-0002-7597-5924; Ishii, Hope/0000-0002-7976-5078; Dai, Zurong/0000-0002-4209-8718; Marhas, Kuljeet/0000-0002-3375-3047; Brenker, Frank Erich/0000-0002-9735-8206				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Brownlee D. E., 1993, 24 LUN PLAN SCI C, P205; FLYNN GJ, 1990, P LUNAR PLANET SCI, P335; Flynn GJ, 1996, ASTR SOC P, V104, P291; FLYNN GJ, 1996, LUNAR PLANET SCI, V27, P369; Horz F, 2006, SCIENCE, V314, P1716, DOI 10.1126/science.1135705; Jessberger EK, 1999, SPACE SCI REV, V90, P91, DOI 10.1023/A:1005233727874; Kearsley AT, 2006, METEORIT PLANET SCI, V41, P167, DOI 10.1111/j.1945-5100.2006.tb00201.x; KEARSLEY AT, IN PRESS METEORIT PL; KISSEL J, 1986, ADV MASS SPECTROM, P175; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; SCHRAMM LS, 1989, METEORITICS, V24, P99, DOI 10.1111/j.1945-5100.1989.tb00950.x; Tsou P, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002317; Westphal AJ, 2004, METEORIT PLANET SCI, V39, P1375, DOI 10.1111/j.1945-5100.2004.tb00952.x; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842; [No title captured]	17	187	187	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1731	1735		10.1126/science.1136141	http://dx.doi.org/10.1126/science.1136141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170294	Green Submitted			2022-12-28	WOS:000242833600046
J	Taylor, S; Barragan, A; Su, C; Fux, B; Fentress, SJ; Tang, K; Beatty, WL; El Hajj, H; Jerome, M; Behnke, MS; White, M; Wootton, JC; Sibley, LD				Taylor, S.; Barragan, A.; Su, C.; Fux, B.; Fentress, S. J.; Tang, K.; Beatty, W. L.; El Hajj, H.; Jerome, M.; Behnke, M. S.; White, M.; Wootton, J. C.; Sibley, L. D.			A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii	SCIENCE			English	Article							PARASITOPHOROUS VACUOLE; INTRACELLULAR PARASITE; STRAINS; INFECTION; REVEALS; OVERPRODUCTION; RECOMBINATION; TRANSMISSION; APOPTOSIS; LINEAGES	Toxoplasma gondii strains differ dramatically in virulence despite being genetically very similar. Genetic mapping revealed two closely adjacent quantitative trait loci on parasite chromosome VIIa that control the extreme virulence of the type I lineage. Positional cloning identified the candidate virulence gene ROP18, a highly polymorphic serine-threonine kinase that was secreted into the host cell during parasite invasion. Transfection of the virulent ROP18 allele into a nonpathogenic type III strain increased growth and enhanced mortality by 4 to 5 logs. These attributes of ROP18 required kinase activity, which revealed that secretion of effectors is a major component of parasite virulence.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA; Karolinska Inst, Swedish Inst Infect Dis Control, Dept Med, S-14186 Stockholm, Sweden; Karolinska Inst, Ctr Infect Med, Dept Med, S-14186 Stockholm, Sweden; Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; Univ Montpellier 2, UMR 5539, CNRS, F-34095 Montpellier 5, France; Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA	Washington University (WUSTL); Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; University of Tennessee System; University of Tennessee Knoxville; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Montana State University System; Montana State University Bozeman; National Institutes of Health (NIH) - USA	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA.	sibley@borcim.wustl.edu	White, Michael/A-4978-2012; Barragan, Antonio/P-6278-2015; Sibley, L. David/C-4616-2008; Behnke, Michael S/R-8839-2016; Barragan, Antonio/AAL-8618-2020; Fux, Blima/AAO-2941-2020; Su, Chunlei/M-1892-2013	Barragan, Antonio/0000-0001-7746-9964; Behnke, Michael S/0000-0002-4668-8109; Barragan, Antonio/0000-0001-7746-9964; Su, Chunlei/0000-0001-8392-7108; Fux, Blima/0000-0002-5038-3551	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059176, R01AI036629, R01AI044600] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000026] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCRR NIH HHS [P20 RR-020185] Funding Source: Medline; NIAID NIH HHS [AI059176, AI44600, AI36629] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Denkers EY, 2004, IMMUNOL REV, V201, P191, DOI 10.1111/j.0105-2896.2004.00180.x; Doerig C, 2005, BBA-PROTEINS PROTEOM, V1754, P132, DOI 10.1016/j.bbapap.2005.08.027; El Hajj H, 2007, CELL MICROBIOL, V9, P54, DOI 10.1111/j.1462-5822.2006.00767.x; El Hajj H, 2006, PROTEOMICS, V6, P5773, DOI 10.1002/pmic.200600187; ELHAJJ H, IN PRESS PLOS PATHOG; Fuentes I, 2001, J CLIN MICROBIOL, V39, P1566, DOI 10.1128/JCM.39.4.1566-1570.2001; Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1996, INFECT IMMUN, V64, P5193, DOI 10.1128/IAI.64.12.5193-5198.1996; Joynson DH, 2001, TOXOPLASMOSIS COMPRE; Khan A, 2005, J CLIN MICROBIOL, V43, P5881, DOI 10.1128/JCM.43.12.5881-5887.2005; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Luder CGK, 2005, CURR TOP MICROBIOL, V289, P219; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Su CL, 2002, P NATL ACAD SCI USA, V99, P10753, DOI 10.1073/pnas.172117099	29	394	426	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1776	1780		10.1126/science.1133643	http://dx.doi.org/10.1126/science.1133643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170305				2022-12-28	WOS:000242833600059
J	Guarente, L				Guarente, Leonard			Sirtuins as potential targets for metabolic syndrome	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; LIFE-SPAN EXTENSION; ACETYL-COA SYNTHETASE; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; GLUCOSE-HOMEOSTASIS; COACTIVATOR TORC2; INCREASED DOSAGE; MAMMALIAN SIR2; CELL-SURVIVAL	Metabolic syndrome threatens health gains made during the past century. Physiological processes degraded by this syndrome are often oppositely affected by calorie restriction, which extends lifespan and prevents disease in rodents. Recent research in the field of ageing has begun to identify important mediators of calorie restriction, offering the hope of new drugs to improve healthspan. Moreover, if metabolic syndrome and calorie restriction are opposite extremes of the same metabolic spectrum, calorie restriction mimetics might provide another therapeutic approach to metabolic syndrome. Sirtuins and other important metabolic pathways that affect calorie restriction may serve as entry points for drugs to treat metabolic syndrome.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu						Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Birnbaum MJ, 2005, MOL CELL, V19, P289, DOI 10.1016/j.molcel.2005.07.012; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; BUCKLEY BM, 1977, BIOCHEM J, V166, P539, DOI 10.1042/bj1660539; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; FERNANDES G, 1976, NATURE, V263, P504, DOI 10.1038/263504b0; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; INGRAM DK, 1987, J GERONTOL, V42, P78, DOI 10.1093/geronj/42.1.78; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; LUCHSINGER JA, 2006, SCI AGING KNOWL ENV, V10, pPE19; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; Weindruch R., 1988, RETARDATION AGING DI; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhu HY, 1999, BRAIN RES, V842, P224, DOI 10.1016/S0006-8993(99)01827-2	76	359	373	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					868	874		10.1038/nature05486	http://dx.doi.org/10.1038/nature05486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167475				2022-12-28	WOS:000242805400044
J	Offit, K; Sagi, M; Hurley, K				Offit, Kenneth; Sagi, Michal; Hurley, Karen			Preimplantation genetic diagnosis for cancer syndromes - A new challenge for preventive medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PGD		Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Psychiat, New York, NY 10021 USA; Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Offit, K (corresponding author), Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA.	offitk@mskcc.org						*AM MED ASS, E 2 12 GEN COUNS AMA; BARUCH S, 2006, FERTIL STERIL; Braude P, 2006, NEW ENGL J MED, V355, P541, DOI 10.1056/NEJMp068139; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; *CHURCH ENGL, HUM GEN CONS; de Wert G, 2005, HUM REPROD, V20, P3261, DOI 10.1093/humrep/dei222; Eugster A, 1999, SOC SCI MED, V48, P575, DOI 10.1016/S0277-9536(98)00386-4; Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042; *GEN PUBL POL CTR, 2004, REPR GEN TEST ISS OP; Hamann HA, 2005, PSYCHOSOM MED, V67, P766, DOI 10.1097/01.psy.0000181273.74398.d7; *J HOPK U, ONL MEND INH MAN DAT; Kalfoglou AL, 2005, FERTIL STERIL, V83, P1612, DOI 10.1016/j.fertnstert.2005.01.090; Kalfoglou AL, 2005, REPROD BIOMED ONLINE, V11, P486, DOI 10.1016/S1472-6483(10)61145-5; Kuliev A, 2006, REPROD BIOMED ONLINE, V12, P328, DOI 10.1016/S1472-6483(10)61005-X; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; Offit K, 2004, JAMA-J AM MED ASSOC, V292, P1469, DOI 10.1001/jama.292.12.1469; Offit K, 2006, J CLIN ONCOL, V24, P4775, DOI 10.1200/JCO.2006.06.6100; Ola B, 2006, CURR OPIN OBSTET GYN, V18, P440, DOI 10.1097/01.gco.0000233940.82296.49; President's Council on Bioethics Eugenics and Inequality, REPR RESP REG NEW BI; Smith KR, 2004, CANCER EPIDEM BIOMAR, V13, P733; Thornhill AR, 2005, HUM REPROD, V20, P35, DOI 10.1093/humrep/deh579; van Asperen CJ, 2002, J MED GENET, V39, P410, DOI 10.1136/jmg.39.6.410; Verlinsky Y, 2004, FERTIL STERIL, V82, P292, DOI 10.1016/j.fertnstert.2003.09.082	24	58	58	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2727	2730		10.1001/jama.296.22.2727	http://dx.doi.org/10.1001/jama.296.22.2727			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164459				2022-12-28	WOS:000242765700028
J	Vuttanont, U; Greenhalgh, T; Griffin, M; Boynton, P				Vuttanont, Uraiwan; Greenhalgh, Trisha; Griffin, Mark; Boynton, Petra			"Smart boys" and "sweet girls" - sex education needs in Thai teenagers: a mixed-method study	LANCET			English	Article							HIV PREVENTION; INTERVENTIONS; ADOLESCENTS; PREGNANCY; PROGRAM; RISK	Background In Thailand, rapid increases in economic prosperity have been accompanied by erosion of traditional cultural and religious values and by negative effects on sexual health of young people. We investigated knowledge, attitudes, norms, and values of teenagers, parents, teachers, and policymakers in relation to sex and sex education in Chiang Mai, Thailand, with a view to informing sex education policy. Methods We selected six secondary schools for maximum variation in socioeconomic background, religious background, and location. Methods were: narrative interviews with key stakeholders, and analysis of key policy documents; questionnaire survey of 2301 teenagers; 20 focus groups of teenagers; questionnaire survey of 351 parents; and two focus groups of parents. Qualitative and quantitative data were assessed separately with thematic and respectively then combined. statistical analysis,, Findings We noted five important influences on Thai teenagers' sexual attitudes and behaviour: ambiguous social roles leading to confused identity; heightened sexual awareness and curiosity; key gaps in knowledge and life skills; limited parental input; and impulsivity and risk-taking. Male teenagers aspire to be "smart boys", whose status depends on stories of sexual performance and conquests. Female teenagers, traditionally constrained and protected as "sweet girls", are managing a new concept of dating without their parents' support, and with few life skills to enable them to manage their desires or negotiate in potentially coercive situations. School-based sex education is biologically focused and inconsistently delivered. Interpretation Results of this large exploratory study suggest five approaches that could be developed to improve sex education: targeted training and support for teachers; peer-led sex education by teenagers; story-based scenarios to promote applied learning; local development of educational materials; and use of trained sexual health professionals to address learning needs of pupils, teachers, and parents.	UCL, Dept Primary Care & Populat Sci, London N19 5LW, England	University of London; University College London	Boynton, P (corresponding author), UCL, Dept Primary Care & Populat Sci, 417 Holborn Union Bldg,Highgate Hill, London N19 5LW, England.	p.boynton@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015; Griffin, Mark/C-1827-2008	Greenhalgh, Trisha/0000-0003-2369-8088; Boynton, Petra/0000-0001-6699-2266				Allen DR, 2003, AIDS BEHAV, V7, P9, DOI 10.1023/A:1022553121782; Buckingham D, 2003, YOUNG PEOPLE, SEX AND THE MEDIA:THE FACTS OF LIFE?, P1, DOI 10.1057/9780230508637; Buston K, 2002, HEALTH EDUC RES, V17, P59, DOI 10.1093/her/17.1.59; Campbell C, 2005, AM J PUBLIC HEALTH, V95, P808, DOI 10.2105/AJPH.2003.037499; Campbell C, 2002, SOC SCI MED, V55, P331, DOI 10.1016/S0277-9536(01)00289-1; CHEMNASIRI T, 2004, RELATED BEHAV HIV IN; CLELAND J, 2000, ASKING YOUNG PEOPLE; Cowan FM, 2002, SEX TRANSM INFECT, V78, P315, DOI 10.1136/sti.78.5.315; DASEN PR, 2002, INT J GROUP TENSIONS, V29, P17; DiCenso A, 2002, BMJ-BRIT MED J, V324, P1426, DOI 10.1136/bmj.324.7351.1426; Duffy M., 2004, YOUNG PEOPLE SEXUAL; Fry K., 1996, GENDER ED, V8, P275, DOI DOI 10.1080/09540259621520; Greenhalgh T, 2005, BRIT MED J, V330, P628, DOI 10.1136/bmj.330.7492.628; Greenhalgh T, 1998, BRIT MED J, V316, P978, DOI 10.1136/bmj.316.7136.978; HILTON G, 2001, SEX ED, V1, P35; *INT PLANN PAR FED, 2001, IPPF COUNTR PROF THA; Isarabhakdi P, 1999, Warasan Prachakon Lae Sangkhom, V8, P21; Jejeebhoy SJ, 1998, SOC SCI MED, V46, P1275, DOI 10.1016/S0277-9536(97)10056-9; Johnson BT, 2003, ARCH PEDIAT ADOL MED, V157, P381, DOI 10.1001/archpedi.157.4.381; Kirby D, 2002, J SEX RES, V39, P51, DOI 10.1080/00224490209552120; MOHAMMED EM, 2006, INT FAMILY PLAN PERS, V32, P35; Nicoll A, 1999, Commun Dis Public Health, V2, P85; OAKLEY A, 1995, BRIT MED J, V310, P158, DOI 10.1136/bmj.310.6973.158; Oshi DC, 2005, J BIOSOC SCI, V37, P175, DOI 10.1017/S0021932004006820; Parker I., 1993, DISCOURSE ANAL RES R; Pedlow CT, 2004, ANN BEHAV MED, V27, P172, DOI 10.1207/s15324796abm2703_5; PURI M, 2006, EXTENT SEXUAL COERCI; Ritchie A, 2001, ANAL QUALITATIVE DAT; Robin L, 2004, J ADOLESCENT HEALTH, V34, P3, DOI 10.1016/S1054-139X(03)00244-1; ROSS MW, 2005, AIDS IMP C; Sumartojo E, 2000, AIDS, V14, pS3, DOI 10.1097/00002030-200006001-00002; *UN ED SCI CULT OR, 2001, THAIL PROGR RESP ARS; *UN ED SCI CULT OR, 2001, THAIL DEM CHAR AD; *UNAIDS IATT ED, 2002, HIV PREV ED STRAT AP; Warakamin S, 1998, REPROD HLTH THAILAND; *WHO, 2004, WHO DISC PAP AD; Wight D, 2000, HEALTH EDUC RES, V15, P25, DOI 10.1093/her/15.1.25; 2003, THAILAND RATE HIV IN; 2005, NATION BANGKOK  1114	39	63	66	1	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2006	368	9552					2068	2080		10.1016/S0140-6736(06)69836-X	http://dx.doi.org/10.1016/S0140-6736(06)69836-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114JY	17161729	Green Submitted			2022-12-28	WOS:000242663700022
J	Paltiel, AD; Walensky, RP; Schackman, BR; Seage, GR; Mercincavage, LM; Weinstein, MC; Freedberg, KA				Paltiel, A. David; Walensky, Rochelle P.; Schackman, Bruce R.; Seage, George R., III; Mercincavage, Lauren M.; Weinstein, Milton C.; Freedberg, Kenneth A.			Expanded HIV screening in the United States: Effect on clinical outcomes, HIV transmission, and costs	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COMBINATION ANTIRETROVIRAL THERAPY; RISK BEHAVIORS; VIRAL LOAD; PREVENTION; INFECTION; HEALTH; IMPACT; CARE; SEX	Background: An extensive literature supports expanded HIV screening in the United States. However, the question of whom to test and how frequently remains controversial. Objective: To inform the design of HIV screening programs by identifying combinations of screening frequency and HIV prevalence and incidence at which screening is cost-effective. Design: Cost-effectiveness analysis linking simulation models of HIV screening to published reports of HIV transmission risk, with and without antiretroviral therapy. Data Sources: Published randomized trials, observational cohorts, national cost and service utilization surveys, the Red Book, and previous modeling results. Target Population: U.S. communities with low to moderate HIV prevalence (0.05% to 1.0%) and annual incidence (0.0084% to 0.12%). Time Horizon: Lifetime. Perspective: Societal. Interventions: One-time and increasingly frequent voluntary HIV screening of all adults using a same-day rapid test. Outcome Measures: HIV infections detected, secondary transmissions averted, quality-adjusted survival, lifetime medical costs, and societal cost-effectiveness, reported in discounted 2004 dollars per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: Under moderately favorable assumptions regarding the effect of HIV patient care on secondary transmission, routine HIV screening in a population with HIV prevalence of 1.0% and annual incidence of 0.12% had incremental cost-effectiveness ratios of $30800/QALY (one-time screening), $32300/QALY (screening every 5 years), and $55500/QALY (screening every 3 years). In settings with HIV prevalence of 0.10% and annual incidence of 0.014%, one-time screening produced cost-effectiveness ratios of $60700/QALY. Results of Sensitivity Analysis: The cost-effectiveness of screening policies varied within a narrow range as assumptions about the effect of screening on secondary transmission varied from favorable to unfavorable. Assuming moderately favorable effects of antiretroviral therapy on transmission, cost-effectiveness ratios remained below $50000/QALY in settings with HIV prevalence as low as 0.20% for routine HIV screening on a one-time basis and at prevalences as low as 0.45% and annual incidences as low as 0.0075% for screening every 5 years. Limitations: This analysis does not address the difficulty of determining the prevalence and incidence of undetected HIV infection in a given patient population. Conclusions: Routine, rapid HIV testing is recommended for all adults except in settings where there is evidence that the prevalence of undiagnosed HIV infection is below 0.2%.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Cornell Univ, Weill Med Coll, New York, NY USA	Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Cornell University	Paltiel, AD (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	david.paltiel@yale.edu	Schackman, Bruce R./J-8208-2019	Schackman, Bruce R./0000-0002-1132-2932; Walensky, Rochelle P./0000-0002-8795-379X; Paltiel, A. David/0000-0002-4861-3290	NIAID NIH HHS [K23 AI001794, R01 AI042006, P30AI42851, K23AI01794, K24AI062476, R01AI42006, K24 AI062476, P30 AI042851] Funding Source: Medline; NIDA NIH HHS [R01DA015612, K01DA0717179, R01 DA015612, K01 DA017179] Funding Source: Medline; NIMH NIH HHS [R01MH65869, R01 MH065869] Funding Source: Medline; PHS HHS [S1396-20/21] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI062476, P30AI042851, R01AI042006, K23AI001794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, K01DA017179, R37DA015612] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANDERSON R M, 1991; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1; Barroso PF, 2000, ANN INTERN MED, V133, P280, DOI 10.7326/0003-4819-133-4-200008150-00012; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brawley OW, 1997, CANCER-AM CANCER SOC, V80, P1857, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1857::AID-CNCR26>3.0.CO;2-3; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; *CDCP, 2005, HIV AIDS UPD GLANC H; *CDCP, 2004, HIV AIDS SPEC SURV R; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1051; Chou R, 2005, ANN INTERN MED, V143, P55, DOI 10.7326/0003-4819-143-1-200507050-00010; Cohen C, 2005, CURR MED RES OPIN, V21, P1683, DOI 10.1185/030079905X65439; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; COSTELLO D, 2005, LOS ANGELES TIM 1219, pF1; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Demmer C, 2002, J COMMUN HEALTH, V27, P63, DOI 10.1023/A:1013884310983; DUMON J, 2006, 13 C RETR OPP INF DE; Dybul M, 2002, J INFECT DIS, V185, P1818, DOI 10.1086/340650; EDDY DM, 1988, JAMA-J AM MED ASSOC, V259, P1512, DOI 10.1001/jama.259.10.1512; Ekwueme DU, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00115-6; Farnham PG, 1996, PUBLIC HEALTH REP, V111, P44; Frame P S, 1998, J Am Board Fam Pract, V11, P87; FRASER C, 2006, 13 C RETR OPP INF DE; Freedberg KA, 1999, ARCH INTERN MED, V159, P1994, DOI 10.1001/archinte.159.17.1994; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; GLYNN MK, 2005, 2005 NAT HIV PREV C; Gold MR, 1996, COST EFFECTIVENESS H; GRAHAM S, 2006, 13 C RETR OPP INF DE; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; *I CLIN RES HLTH P, COMPR TAB COST UT RA; JACOBSON LP, 2004, INT C AIDS, V15; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Kelly JA, 1998, AIDS, V12, pF91, DOI 10.1097/00002030-199810000-00001; Kimmel AD, 2005, ANTIVIR THER, V10, P41; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; MCCORMICK A, 2005, ANTIMICROBIAL USE TR; McGowan JP, 2004, CLIN INFECT DIS, V38, P122, DOI 10.1086/380128; *MED AG HLTH RES Q, 2005, MED EXP PAN SURV; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Meltzer D, 2000, MED CARE, V38, P679, DOI 10.1097/00005650-200006000-00009; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; OSTER G, 1987, JAMA-J AM MED ASSOC, V258, P2381, DOI 10.1001/jama.258.17.2381; OTTEN MW, 1993, AM J PUBLIC HEALTH, V83, P529, DOI 10.2105/AJPH.83.4.529; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; PEREZPENA R, 2005, NY TIMES        0606, pB1; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Samet JH, 2001, AIDS, V15, P77, DOI 10.1097/00002030-200101050-00012; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schackman BR, 2002, ARCH INTERN MED, V162, P2478, DOI 10.1001/archinte.162.21.2478; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Scheer S, 2001, LANCET, V357, P432, DOI 10.1016/S0140-6736(00)04007-1; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Stolte G, 2002, Euro Surveill, V7, P19; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; U.S. Preventive Services Task Force, 2002, SCREEN COL CANC REC; US Preventive Serv Task Force, 2005, ANN INTERN MED, V143, P32, DOI 10.7326/0003-4819-143-1-200507050-00008; Valdiserri RO, 2004, AIDS EDUC PREV, V16, P426, DOI 10.1521/aeap.16.5.426.48738; Varghese B, 1999, AIDS, V13, P1745, DOI 10.1097/00002030-199909100-00019; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; VIANI R, 2006, 13 C RETR OPP INF DE; Walensky RP, 2005, MED DECIS MAKING, V25, P321, DOI 10.1177/0272989X05276955; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Webster RD, 2003, JAIDS-J ACQ IMM DEF, V33, P223, DOI 10.1097/00126334-200306010-00018; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008	72	154	161	1	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2006	145	11					797	806		10.7326/0003-4819-145-11-200612050-00004	http://dx.doi.org/10.7326/0003-4819-145-11-200612050-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114PE	17146064				2022-12-28	WOS:000242677300001
J	Cilliers, AM				Cilliers, Antoinette M.			Rheumatic fever and its management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEART-VALVES; CHILDREN; CEPHALOSPORINS; PENICILLINS; RESISTANCE; VACCINE; TISSUE; ERA		CH Baragwanath Hosp, Div Paediat Cardiol, ZA-2115 Johannesburg, South Africa		Cilliers, AM (corresponding author), CH Baragwanath Hosp, Div Paediat Cardiol, POB 2588, ZA-2115 Johannesburg, South Africa.	amcilliers@icon.co.za						BARLOW JB, 1990, S AFR MED J, V78, P181; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Carapetis JR, 2006, DIAGNOSIS MANAGEMENT; Cilliers AM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003176; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; DERRICK CW, 1976, AM J DIS CHILD, V130, P175, DOI 10.1001/archpedi.1976.02120030065012; ESSOP MR, 1993, J AM COLL CARDIOL, V22, P826, DOI 10.1016/0735-1097(93)90197-9; Galvin JE, 2000, J CLIN INVEST, V106, P217, DOI 10.1172/JCI7132; GENTLES TL, 2001, J AM COLL CARDIOL, P201; Guedez Y, 1999, CIRCULATION, V99, P2784, DOI 10.1161/01.CIR.99.21.2784; Herdy G V, 1999, Arq Bras Cardiol, V72, P601; KAPLAN MH, 1964, NEW ENGL J MED, V271, P637, DOI 10.1056/NEJM196409242711301; LENNON DR, 2002, 42 INT C ANT AG CHEM, pG1481; Manyemba J., 2002, COCHRANE DB SYST REV, V2002, pCD002227, DOI [10.1002/14651858.CD002227, DOI 10.1002/14651858.CD002227, 10.1002/14651858.CD00222712137650]; MARTIN DR, 1994, PEDIATR INFECT DIS J, V13, P264, DOI 10.1097/00006454-199404000-00004; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; MORTIMER EA, 1959, NEW ENGL J MED, V260, P101, DOI 10.1056/NEJM195901152600301; Olive C, 2006, J INFECT DIS, V193, P1666, DOI 10.1086/504266; Park HS, 2005, INFECT IMMUN, V73, P7878, DOI 10.1128/IAI.73.12.7878-7886.2005; PICHICHERO ME, 1991, PEDIATR INFECT DIS J, V10, P275, DOI 10.1097/00006454-199104000-00002; Principi N, 1999, J CHEMOTHERAPY, V11, P379, DOI 10.1179/joc.1999.11.5.379; Pruksakorn S, 2000, J CLIN MICROBIOL, V38, P1250, DOI 10.1128/JCM.38.3.1250-1254.2000; RAIZADA V, 1983, AM J MED, V74, P90, DOI 10.1016/0002-9343(83)91124-5; ROBERTSON KA, 2006, S AFR MED J, V96, P242; Robertson Katharine A, 2005, BMC Cardiovasc Disord, V5, P11, DOI 10.1186/1471-2261-5-11; SEPPALA H, 1992, NEW ENGL J MED, V326, P292, DOI 10.1056/NEJM199201303260503; Shulman ST, 2006, CLIN INFECT DIS, V42, P441, DOI 10.1086/499812; Shulman ST, 1996, PEDIATRICS, V97, P955; SKOULARIGIS J, 1994, CIRCULATION, V90, P167; SPINETTO H, 2003, THESIS U AUCKLAND AU; Uziel Y, 2000, J PEDIATR-US, V137, P269, DOI 10.1067/mpd.2000.107158; Vasan RS, 1996, CIRCULATION, V94, P73, DOI 10.1161/01.CIR.94.1.73; Veasy LG, 2004, PEDIATRICS, V113, pE168, DOI 10.1542/peds.113.3.e168; *WHO, 2001, WHO TECH REP SER, V923; WISENBAUGH T, 1994, CIRCULATION, V89, P191, DOI 10.1161/01.CIR.89.1.191; Zwart S, 2003, BRIT MED J, V327, P1324, DOI 10.1136/bmj.327.7427.1324	38	38	38	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2006	333	7579					1153	1156A		10.1136/bmj.39031.420637.BE	http://dx.doi.org/10.1136/bmj.39031.420637.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114LG	17138996	Green Published			2022-12-28	WOS:000242667100017
J	Wilkinson, P; French, R; Kane, R; Lachowycz, K; Stephenson, J; Grundy, C; Jacklin, P; Kingori, P; Stevens, M; Wellings, K				Wilkinson, Paul; French, Rebecca; Kane, Ras; Lachowycz, Kate; Stephenson, Judith; Grundy, Chris; Jacklin, Paul; Kingori, Patricia; Stevens, Maryjane; Wellings, Kaye			Teenage conceptions, abortions, and births in England, 1994-2003, and the national teenage pregnancy strategy	LANCET			English	Article							CHILDBEARING; POVERTY; BRITAIN; TRENDS	Background The aim of this study was to quantify the change in the number of conceptions and abortions among women younger than 18 years in England in relation to the government's national teenage pregnancy strategy. Methods We undertook geographic analysis of data for 148 top-tier local authority areas. The main outcomes were changes in under-18 conceptions, abortions, and births between the 5-year period before implementation of the strategy (1994-98) and the period immediately after implementation (1999-2003). Findings The number of teenage conceptions peaked in 1998, then declined after the implementation in 1999 of the teenage pregnancy strategy. Under-18 conception rates fell by an average of 2.0% (95% CI 1.8 to 2.2) per year between 1998 and 2003, below the rate needed to achieve the target of 50% reduction by 2010. The net change between 1994-98 and 1999-2003 was a fall in conceptions of 3.2% (2.6 to 3.9) or 1.4 per 1000 women aged 15-17 years, a rise in abortions of 7.5% (6.5 to 8.6) or 1.4 per 1000, and a fall in births of 10.6% (9.9 to 11.3) or 2.8 per 1000. The change in the number of conceptions was greater in deprived and more rural areas, and in those with lower educational attainment. The change was greater in areas where services and access to them were poorer, but greater where more strategy-related resources had been targeted. Interpretation The decline in under-18 conception and birth rates since 1998 and evidence that the declines have been greatest in areas receiving higher amounts of strategy-related funding provides limited evidence of the effect of England's national teenage pregnancy strategy. The full effect of local prevention will be clear only with longer observation, and substantial further progress is needed to remedy England's historically poor international position in teenage conceptions.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; UCL, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Wellings, K (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	kaye.wellings@lshtm.ac.uk	Kane, Ros/K-6855-2013	Kane, Ros/0000-0002-6926-2530; Wilkinson, Paul/0000-0001-7456-259X				BABB P, 1993, POPULATION TRENDS, V74, P12; Bonell CP, 2003, J EPIDEMIOL COMMUN H, V57, P871, DOI 10.1136/jech.57.11.871; BOTTING B, 1998, POPULATION TRENDS, V93, P9; da Silva AAM, 2003, PAEDIATR PERINAT EP, V17, P332, DOI 10.1046/j.1365-3016.2003.00515.x; Hamlyn Cathy, 2002, J Fam Health Care, V12, P71; Hobcraft J, 2001, BRIT J SOCIOL, V52, P495; *ISD SCOTL, TEEN PREGN TEEN PREG; KANE R, 1999, REDUCING RATE TEENAG; Loto O M, 2004, J Obstet Gynaecol, V24, P395, DOI 10.1080/01443610410001685529; McCulloch A, 2001, J EPIDEMIOL COMMUN H, V55, P16, DOI 10.1136/jech.55.1.16; McLeod A, 2001, BRIT MED J, V323, P199, DOI 10.1136/bmj.323.7306.199; Nanchahal K, 2005, J EPIDEMIOL COMMUN H, V59, P828, DOI 10.1136/jech.2004.026021; *ODPM NEIGHB REN U, 2001, ENGL IND DEPR 2004 S; *OFF NAT STAT, 2001, POPULATION TRENDS, V103, P84; Paton D, 2002, J HEALTH ECON, V21, P207, DOI 10.1016/S0167-6296(01)00115-1; SHARP S, 1998, STATA TECH B, V7, P148; Singh S, 2000, FAM PLANN PERSPECT, V32, P14, DOI 10.2307/2648144; SMITH T, 1993, BRIT MED J, V306, P1232, DOI 10.1136/bmj.306.6887.1232; *SOC EXCL UN, 1999, TEEN PREGN; *TEEN PREGN UN, RES EV TEEN PREGN ST; Wellings K, 1999, J ROY SOC MED, V92, P277, DOI 10.1177/014107689909200603; Wood R, 1997, Popul Trends, P5	22	38	38	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1879	1886		10.1016/S0140-6736(06)69777-8	http://dx.doi.org/10.1016/S0140-6736(06)69777-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126720				2022-12-28	WOS:000242345900029
J	Lay, T; Hernlund, J; Garnero, EJ; Thorne, MS				Lay, Thorne; Hernlund, John; Garnero, Edward J.; Thorne, Michael S.			A post-perovskite lens and D '' heat flux beneath the central Pacific	SCIENCE			English	Article							CORE-MANTLE BOUNDARY; EARTHS LOWERMOST MANTLE; PHASE-TRANSITION; MGSIO3; VELOCITY; LAYER; DISCONTINUITIES; CONSTRAINTS; DENSITY; AFRICAN	Temperature gradients in a low-shear-velocity province in the lowermost mantle (D" region) beneath the central Pacific Ocean were inferred from the observation of a rapid S-wave velocity increase overlying a rapid decrease. These paired seismic discontinuities are attributed to a phase change from perovskite to post-perovskite and then back to perovskite as the temperature increases with depth. Iron enrichment could explain the occurrence of post-perovskite several hundred kilometers above the core-mantle boundary in this warm, chemically distinct province. The double phase-boundary crossing directly constrains the lowermost mantle temperature gradients. Assuming a standard but unconstrained choice of thermal conductivity, the regional core-mantle boundary heat flux (similar to 85 +/- 25 milliwatts per square meter), comparable to the average at Earth's surface, was estimated, along with a lower bound on global core-mantle boundary heat flow in the range of 13 +/- 4 terawatts. Mapped velocity-contrast variations indicate that the lens of post-perovskite minerals thins and vanishes over 1000 kilometers laterally toward the margin of the chemical distinct region as a result of a similar to 500-kelvin temperature increase.	Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; Inst Phys Globe, F-75252 Paris, France; Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; Univ Alaska, Arctic Reg Supercomp Ctr, Fairbanks, AK 99775 USA	University of California System; University of California Santa Cruz; UDICE-French Research Universities; Universite Paris Cite; Arizona State University; Arizona State University-Tempe; University of Alaska System; University of Alaska Fairbanks	Lay, T (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	thorne@pmc.ucsc.edu	Hernlund, John/A-8931-2014; Lay, Thorne/ABE-6272-2021	Hernlund, John/0000-0003-1008-0182; 				Akber-Knutson S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023192; Avants M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024989; Avants M, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003270; Caracas R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023164; Flores C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024366; Grand SP, 2002, PHILOS T R SOC A, V360, P2475, DOI 10.1098/rsta.2002.1077; Hernlund JW, 2005, NATURE, V434, P882, DOI 10.1038/nature03472; Hirose K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024468; Hirose K, 2005, EARTH PLANET SC LETT, V237, P239, DOI 10.1016/j.epsl.2005.06.035; Hirose K, 2006, REV GEOPHYS, V44, DOI 10.1029/2005RG000186; Hutko AR, 2006, NATURE, V441, P333, DOI 10.1038/nature04757; Iitaka T, 2004, NATURE, V430, P442, DOI 10.1038/nature02702; Ishii M, 1999, SCIENCE, V285, P1231, DOI 10.1126/science.285.5431.1231; Kobayashi Y, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023257; Lay T, 2004, GEOPHYS MONOGR SER, V150, P25, DOI 10.1029/150GM04; Lin JF, 2005, NATURE, V436, P377, DOI 10.1038/nature03825; Lithgow-Bertelloni C, 1998, REV GEOPHYS, V36, P27, DOI 10.1029/97RG02282; Luo SN, 2001, EARTH PLANET SC LETT, V189, P155, DOI 10.1016/S0012-821X(01)00364-8; Mao WL, 2004, P NATL ACAD SCI USA, V101, P15867, DOI 10.1073/pnas.0407135101; McNamara AK, 2005, NATURE, V437, P1136, DOI 10.1038/nature04066; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Ni SD, 2005, GEOPHYS J INT, V161, P283, DOI 10.1111/j.1365-246X.2005.02508.x; Oganov AR, 2005, P NATL ACAD SCI USA, V102, P10828, DOI 10.1073/pnas.0501800102; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Ono S, 2005, EARTH PLANET SC LETT, V236, P914, DOI 10.1016/j.epsl.2005.06.001; POLLACK HN, 1993, REV GEOPHYS, V31, P267, DOI 10.1029/93RG01249; Rost S, 2005, NATURE, V435, P666, DOI 10.1038/nature03620; Russell SA, 2001, GEOPHYS RES LETT, V28, P2281, DOI 10.1029/2000GL012553; Russell SA, 1999, J GEOPHYS RES-SOL EA, V104, P13183, DOI 10.1029/1999JB900114; Sidorin I, 1999, SCIENCE, V286, P1326, DOI 10.1126/science.286.5443.1326; Stacey F. D., 1992, PHYS EARTH; Stackhouse S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL023887; Sun DL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024780; Tateno S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023309; Thomas C, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003013; Thomas C, 2004, EARTH PLANET SC LETT, V225, P105, DOI 10.1016/j.epsl.2004.05.038; Thorne MS, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003010; To A, 2005, EARTH PLANET SC LETT, V233, P137, DOI 10.1016/j.epsl.2005.01.037; Trampert J, 2004, SCIENCE, V306, P853, DOI 10.1126/science.1101996; Tsuchiya T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020278; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; Williams Q, 1998, GEODYNAMICS, V28, P73; Wookey J, 2005, NATURE, V438, P1004, DOI 10.1038/nature04345	43	202	208	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1272	1276		10.1126/science.1133280	http://dx.doi.org/10.1126/science.1133280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124317				2022-12-28	WOS:000242215800035
J	Baier, DB; Gatesy, SM; Jenkins, FA				Baier, David B.; Gatesy, Stephen M.; Jenkins, Farish A., Jr.			A critical ligamentous mechanism in the evolution of avian flight	NATURE			English	Article							PIGEONS COLUMBA-LIVIA; FLAPPING FLIGHT; SPEEDS; RANGE; CHINA; BIRD; KINEMATICS; SHOULDER; ANATOMY; HUMERUS	Despite recent advances in aerodynamic(1,2), neuromuscular(3-5) and kinematic(6,7) aspects of avian flight and dozens of relevant fossil discoveries(8), the origin of aerial locomotion and the transition from limbs to wings continue to be debated(9,10). Interpreting this transition depends on understanding the mechanical interplay of forces in living birds, particularly at the shoulder where most wing motion takes place. Shoulder function depends on a balance of forces from muscles, ligaments and articular cartilages, as well as inertial, gravitational and aerodynamic loads on the wing(11). Here we show that the force balance system of the shoulder evolved from a primarily muscular mechanism to one in which the acrocoracohumeral ligament has a critical role. Features of the shoulder of Mesozoic birds and closely related theropod dinosaurs indicate that the evolution of flight preceded the acquisition of the ligament-based force balance system and that some basal birds are intermediate in shoulder morphology.	Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Brown University; Harvard University; Harvard University	Baier, DB (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	David_Baier@brown.edu						Bannasch R., 1986, Gegenbaurs Morphologisches Jahrbuch, V132, P757; BIEWENER AA, 1995, J MORPHOL, V225, P61, DOI 10.1002/jmor.1052250106; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chiappe LM., 2002, MESOZOIC BIRDS; de Beer G., 1954, CRAFTSMANS HDB; DIAL KP, 1993, J EXP BIOL, V176, P31; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Gatesy SM, 2005, PALEOBIOLOGY, V31, P382, DOI 10.1666/0094-8373(2005)031[0382:TOOTAF]2.0.CO;2; Gatesy S, 2004, J VERTEBR PALEONTOL, V24, p63A; Goslow GE, 2000, BRAIN BEHAV EVOLUT, V55, P85; Gray S.J., 1968, ANIMAL LOCOMOTION; Hedrick TL, 2004, J EXP BIOL, V207, P1689, DOI 10.1242/jeb.00933; JENKINS FA, 1988, SCIENCE, V241, P1495, DOI 10.1126/science.241.4872.1495; JENKINS FA, 1993, AM J SCI, V293A, P253, DOI 10.2475/ajs.293.A.253; JENKINS FA, 1983, J MORPHOL, V175, P195, DOI 10.1002/jmor.1051750207; Norell MA, 2001, NATURE, V409, P181, DOI 10.1038/35051563; Ostrom J.H., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P1; Paul G. S., 2002, DINOSAURS OF THE AIR; PENNYCUICK CJ, 1967, J EXP BIOL, V46, P219; Poore SO, 1997, J EXP BIOL, V200, P2987; Poore SO, 1997, NATURE, V387, P799, DOI 10.1038/42930; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Sy M., 1936, Journal fuer Ornithologie Berlin, V84, P199, DOI 10.1007/BF01906709; Tobalske BW, 1999, J EXP BIOL, V202, P1725; TOBALSKE BW, 1995, J EXP BIOL, V198, P1259; Usherwood JR, 2005, J EXP BIOL, V208, P355, DOI 10.1242/jeb.01359; Woolley JD, 2000, J EXP BIOL, V203, P1767; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930	30	52	54	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					307	310		10.1038/nature05435	http://dx.doi.org/10.1038/nature05435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17173029				2022-12-28	WOS:000243504700043
J	Shima, K; Isoda, M; Mushiake, H; Tanji, J				Shima, Keisetsu; Isoda, Masaki; Mushiake, Hajime; Tanji, Jun			Categorization of behavioural sequences in the prefrontal cortex	NATURE			English	Article							SUPPLEMENTARY MOTOR AREA; TEMPORAL ORGANIZATION; NEURONAL-ACTIVITY; MULTIPLE MOVEMENTS; MONKEY; REPRESENTATION; DAMAGE; CELLS	Although it has long been thought that the prefrontal cortex of primates is involved in the integrative regulation of behaviours(1-4), the neural architecture underlying specific aspects of cognitive behavioural planning has yet to be clarified(5-8). If subjects are required to remember a large number of complex motor sequences and plan to execute each of them individually, categorization of the sequences according to the specific temporal structure inherent in each subset of sequences serves to facilitate higher-order planning based on memory. Here we show, using these requirements, that cells in the lateral prefrontal cortex selectively exhibit activity for a specific category of behavioural sequences, and that categories of behaviours, embodied by different types of movement sequences, are represented in prefrontal cells during the process of planning. This cellular activity implies the generation of neural representations capable of storing structured event complexes at an abstract level, exemplifying the development of macro-structured action knowledge in the lateral prefrontal cortex(9).	Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 9808575, Japan; Tamagawa Univ Res Inst, Brain Sci Res Ctr, Tokyo 1948610, Japan	Tohoku University	Tanji, J (corresponding author), Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 9808575, Japan.	tanji@lab.tamagawa.ac.jp		Mushiake, Hajime/0000-0002-5130-4720				Averbeck BB, 2006, NAT NEUROSCI, V9, P276, DOI 10.1038/nn1634; Averbeck BB, 2003, EXP BRAIN RES, V150, P127, DOI 10.1007/s00221-003-1416-6; BARONE P, 1989, EXP BRAIN RES, V78, P447; Dominey PF, 1998, J COGNITIVE NEUROSCI, V10, P734, DOI 10.1162/089892998563130; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Fuster J.M., 1989, PREFRONTAL CORTEX; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; GREEN DM, 1966, SIGNAL DETECTION THE; Isoda M, 2003, J NEUROPHYSIOL, V90, P3054, DOI 10.1152/jn.00367.2003; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; MUSHIAKE H, 1990, EXP BRAIN RES, V82, P208; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; PASSINGHAM PE, 1993, FRONTAL LOBES VOLUNT; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Saito N, 2005, CEREB CORTEX, V15, P1535, DOI 10.1093/cercor/bhi032; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; SIRIGU A, 1995, CORTEX, V31, P301, DOI 10.1016/S0010-9452(13)80364-4; Sirigu A, 1995, ANN NY ACAD SCI, V769, P277, DOI 10.1111/j.1749-6632.1995.tb38145.x; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Zalla T, 2003, NEUROPSYCHOLOGIA, V41, P1619, DOI 10.1016/S0028-3932(03)00098-8	30	148	150	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2007	445	7125					315	318		10.1038/nature05470	http://dx.doi.org/10.1038/nature05470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17183266				2022-12-28	WOS:000243504700045
J	Palike, H; Norris, RD; Herrle, JO; Wilson, PA; Coxall, HK; Lear, CH; Shackleton, NJ; Tripati, AK; Wade, BS				Paelike, Heiko; Norris, Richard D.; Herrle, Jens O.; Wilson, Paul A.; Coxall, Helen K.; Lear, Caroline H.; Shackleton, Nicholas J.; Tripati, Aradhna K.; Wade, Bridget S.			The heartbeat of the oligocene climate system	SCIENCE			English	Article							SEDIMENTS ODP SITE-1218; INSOLATION QUANTITIES; ANTARCTIC GLACIATION; CALCITE COMPENSATION; MIOCENE BOUNDARY; ATMOSPHERIC CO2; CARBON-DIOXIDE; CALIBRATION; MYR; CONSTRAINTS	A 13-million-year continuous record of Oligocene climate from the equatorial Pacific reveals a pronounced "heartbeat" in the global carbon cycle and periodicity of glaciations. This heartbeat consists of 405,000-, 127,000-, and 96,000- year eccentricity cycles and 1.2-million-year obliquity cycles in periodically recurring glacial and carbon cycle events. That climate system response to intricate orbital variations suggests a fundamental interaction of the carbon cycle, solar forcing, and glacial events. Box modeling shows that the interaction of the carbon cycle and solar forcing modulates deep ocean acidity as well as the production and burial of global biomass. The pronounced 405,000- year eccentricity cycle is amplified by the long residence time of carbon in the oceans.	Southampton Sch Ocean & Earth Sci, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; Cardiff Univ, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3AT, S Glam, Wales; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA	NERC National Oceanography Centre; University of Southampton; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Alberta; Cardiff University; University of Cambridge; Rutgers State University New Brunswick	Palike, H (corresponding author), Southampton Sch Ocean & Earth Sci, Natl Oceanog Ctr, European Way, Southampton SO14 3ZH, Hants, England.	H.Palike@soton.ac.uk	Wade, Bridget S/F-4987-2014; Herrle, Jens O/B-9088-2008; Tripati, Aradhna/C-9419-2011; Lear, Caroline/D-2582-2009; Palike, Heiko/A-6560-2008	Wade, Bridget S/0000-0002-7245-8614; Tripati, Aradhna/0000-0002-1695-1754; Palike, Heiko/0000-0003-3386-0923; Lear, Caroline/0000-0002-7533-4430; Coxall, Helen/0000-0002-2843-2898; Wilson, Paul/0000-0001-6425-8906	Natural Environment Research Council [NE/D000343/1] Funding Source: researchfish; NERC [NE/D000343/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Billups K, 2004, EARTH PLANET SC LETT, V224, P33, DOI 10.1016/j.epsl.2004.05.004; Broecker W.S., 1982, TRACERS SEA; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; GHIL M, 2002, REV GEOPHYS, V40; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; KENNETT JP, 1976, NATURE, V260, P513, DOI 10.1038/260513a0; Lanci L, 2005, EARTH PLANET SC LETT, V237, P617, DOI 10.1016/j.epsl.2005.07.004; Lanci L, 2004, EARTH PLANET SC LETT, V226, P207, DOI 10.1016/j.epsl.2004.07.025; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; Lear CH, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001039; Loutre MF, 2004, EARTH PLANET SC LETT, V221, P1, DOI 10.1016/S0012-821X(04)00108-6; LYLE M, 2002, INIT REP P OCEAN DRI, V199; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; OPDYKE BN, 1992, GEOLOGY, V20, P733, DOI 10.1130/0091-7613(1992)020<0733:ROTCRH>2.3.CO;2; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Palike H, 2004, GEOLOGY, V32, P929, DOI 10.1130/G20750.1; Palike H, 2000, EARTH PLANET SC LETT, V182, P1, DOI 10.1016/S0012-821X(00)00229-6; PALIKE H, 2005, SCI RES P OCEAN DRIL, V199; PALIKE H, IN PRESS QUAT SCI RE; Paul HA, 2000, PALEOCEANOGRAPHY, V15, P471, DOI 10.1029/1999PA000443; Pekar SF, 2002, GEOLOGY, V30, P903, DOI 10.1130/0091-7613(2002)030<0903:CBEEFB>2.0.CO;2; Raffi I, 1999, PHILOS T R SOC A, V357, P1975, DOI 10.1098/rsta.1999.0410; Shackleton N. J., 1973, Quaternary Research, V3, P39, DOI 10.1016/0033-5894(73)90052-5; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Shackleton NJ, 2000, GEOLOGY, V28, P447, DOI 10.1130/0091-7613(2000)028<0447:ACAFTO>2.3.CO;2; TRIPATI A, 2006, SCI RES P OCEAN DRIL, V199; Van Simaeys S, 2005, GEOLOGY, V33, P709, DOI 10.1130/G21634.1; VANANDEL TH, 1975, EARTH PLANET SC LETT, V26, P187, DOI 10.1016/0012-821X(75)90086-2; Wade BS, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001042; WALKER JCG, 1992, GLOBAL PLANET CHANGE, V97, P151, DOI 10.1016/0921-8181(92)90009-Y; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2005, GLOBAL PLANET CHANGE, V47, P51, DOI 10.1016/j.gloplacha.2005.01.001; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571	36	438	474	11	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1894	1898		10.1126/science.1133822	http://dx.doi.org/10.1126/science.1133822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185595	Green Published, Green Accepted			2022-12-28	WOS:000242996800039
J	Munger, KL; Levin, LI; Hollis, BW; Howard, NS; Ascherio, A				Munger, Kassandra L.; Levin, Lynn I.; Hollis, Bruce W.; Howard, Noel S.; Ascherio, Alberto			Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VITAMIN-D DEFICIENCY; AUTOIMMUNE; EXPOSURE; ENCEPHALOMYELITIS; PREVALENCE; PREVENTION; MECHANISMS; SYMPTOMS; SUNLIGHT; DISEASE	Context Epidemiological and experimental evidence suggests that high levels of vitamin D, a potent immunomodulator, may decrease the risk of multiple sclerosis. There are no prospective studies addressing this hypothesis. Objective To examine whether levels of 25-hydroxyvitamin D are associated with risk of multiple sclerosis. Design, Setting, and Participants Prospective, nested case-control study among more than 7 million US military personnel who have serum samples stored in the Department of Defense Serum Repository. Multiple sclerosis cases were identified through Army and Navy physical disability databases for 1992 through 2004, and diagnoses were confirmed by medical record review. Each case (n= 257) was matched to 2 controls by age, sex, race/ethnicity, and dates of blood collection. Vitamin D status was estimated by averaging 25-hydroxyvitamin D levels of 2 or more serum samples collected before the date of initial multiple sclerosis symptoms. Main Outcome Measures Odds ratios of multiple sclerosis associated with continuous or categorical levels (quantiles or a priori - defined categories) of serum 25-hydroxyvitamin D within each racial/ethnic group. Results Among whites ( 148 cases, 296 controls), the risk of multiple sclerosis significantly decreased with increasing levels of 25-hydroxyvitamin D ( odds ratio [ OR] for a 50-nmol/L increase in 25-hydroxyvitamin D, 0.59; 95% confidence interval, 0.36-0.97). In categorical analyses using the lowest quintile ( < 63.3 nmol/L) as the reference, the ORs for each subsequent quintile were 0.57, 0.57, 0.74, and 0.38 (P=. 02 for trend across quintiles). Only the OR for the highest quintile, corresponding to 25-hydroxyvitamin D levels higher than 99.1 nmol/L, was significantly different from 1.00 ( OR, 0.38; 95% confidence interval, 0.19-0.75; P=. 006). The inverse relation with multiple sclerosis risk was particularly strong for 25-hydroxyvitamin D levels measured before age 20 years. Among blacks and Hispanics ( 109 cases, 218 controls), who had lower 25-hydroxyvitamin D levels than whites, no significant associations between vitamin D and multiple sclerosis risk were found. Conclusion The results of our study suggest that high circulating levels of vitamin D are associated with a lower risk of multiple sclerosis.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Walter Reed Army Inst Res, Div Prevent Med, Silver Spring, MD USA; Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Mol Biol, Charleston, SC 29425 USA; Dept Navy, Navy Council Review Boards, Washington, DC USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Ascherio, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 655 Huntington Ave,3rd Floor, Boston, MA 02115 USA.	aascheri@hsph.harvard.edu			NINDS NIH HHS [NS042194, NS46635] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046635, R01NS042194] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x; ANDERSON DW, 1992, ANN NEUROL, V31, P333, DOI 10.1002/ana.410310317; Aubin F, 2003, EUR J DERMATOL, V13, P515; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; BLISS CI, 1958, CONN AGRIC EXPT ST B, P615; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Compston Alastair, 2002, Curr Neurol Neurosci Rep, V2, P259, DOI 10.1007/s11910-002-0085-3; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; [Food and Nutrition Board Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes], 1997, DIET REF INT CALC PH, DOI 10.17226/5776; Freedman DM, 2000, OCCUP ENVIRON MED, V57, P418, DOI 10.1136/oem.57.6.418; Gale CR, 1995, PROG NEUROBIOL, V47, P425, DOI 10.1016/0301-0082(95)00033-X; Giulietti A, 2004, DIABETOLOGIA, V47, P451, DOI 10.1007/s00125-004-1329-3; GOLDBERG P, 1974, INT J ENVIRON STUD, V6, P19, DOI 10.1080/00207237408709630; HAUSER SL, 1984, J IMMUNOL, V132, P1276; Hayes CE, 2003, CELL MOL BIOL, V49, P277; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Hernan MA, 1999, NEUROLOGY, V53, P1711, DOI 10.1212/WNL.53.8.1711; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2004, AM J CLIN NUTR, V79, P362; HOLLIS BW, 1993, CLIN CHEM, V39, P529; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; LEIBOWITZ U, 1967, BRAIN, V90, P871, DOI 10.1093/brain/90.4.871; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Lucas RM, 2006, PROG BIOPHYS MOL BIO, V92, P140, DOI 10.1016/j.pbiomolbio.2006.02.019; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Nashold FE, 2001, J NEUROIMMUNOL, V119, P16, DOI 10.1016/S0165-5728(01)00360-5; *NAT WEATH SERV CL, 2006, UV IND ANN TIM SER; Ozgocmen S, 2005, J BONE MINER METAB, V23, P309, DOI 10.1007/s00774-005-0604-9; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSER CM, 1995, J NEUROL NEUROSUR PS, V58, P253, DOI 10.1136/jnnp.58.2.253-a; RAHMANIYAN M, 2005, VITAMIN D, V1, P769; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; SUTHERLAND JM, 1962, BRAIN, V85, P149, DOI 10.1093/brain/85.1.149; Van Den SK, 2004, NEUROEPIDEMIOLOGY PR, P188; van der Mei IAF, 2003, BRIT MED J, V327, P316, DOI 10.1136/bmj.327.7410.316; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Weiner HL, 2004, ARCH NEUROL-CHICAGO, V61, P1613, DOI 10.1001/archneur.61.10.1613; ZADSHIR A, 2005, ETHN DIS S5, V15, DOI DOI 10.1136/JMG.2004.024083	47	1267	1298	2	100	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2832	2838		10.1001/jama.296.23.2832	http://dx.doi.org/10.1001/jama.296.23.2832			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179460	Bronze			2022-12-28	WOS:000242826400025
J	Kotwaliwale, C; Biggins, S				Kotwaliwale, Chitra; Biggins, Sue			Microtubule capture: A concerted effort	CELL			English	Review							SPINDLE CHECKPOINT; KINETOCHORES; ATTACHMENT; TENSION; BINDING; YEAST; EVENTS; HEC1	Kinetochores direct attachment of chromosomes to microtubules of the mitotic spindle during cell division. Three recent studies in Cell, including one in this issue, reveal important new roles for two kinetochore protein complexes-Ndc80 and INCENP-Survivin-in establishing the correct attachment of chromosomes to spindle microtubules (Cheeseman et al., 2006; DeLuca et al., 2006; Sandall et al., 2006).	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Biggins, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,A2-168, Seattle, WA 98109 USA.	sbiggins@fhcrc.org		Biggins, Susan/0000-0002-4499-6319				Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Kitagawa K, 2003, MOL CELL, V11, P1201, DOI 10.1016/S1097-2765(03)00145-X; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; SORGER PK, 1994, J CELL BIOL, V127, P995, DOI 10.1083/jcb.127.4.995; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208	18	28	31	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1105	1108		10.1016/j.cell.2006.11.032	http://dx.doi.org/10.1016/j.cell.2006.11.032			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174890	Bronze			2022-12-28	WOS:000242991000010
J	Landick, R				Landick, Robert			A long time in the making - The Nobel prize for RNA polymerase	CELL			English	Editorial Material							STRUCTURAL BASIS; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; TRANSCRIPTION; HOLOENZYME; COMPLEX	The 2006 Nobel Prize in Chemistry has been awarded to Roger Kornberg for elucidating the molecular basis of eukaryotic transcription. The prize caps a decades-long quest to unlock one of the central mysteries of molecular biology-how RNA transcripts are assembled.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Landick, R (corresponding author), Univ Wisconsin, Dept Bacteriol, 420 Henry Mall, Madison, WI 53706 USA.	landick@bact.wisc.edu						Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DARST SA, 1989, NATURE, V340, P730, DOI 10.1038/340730a0; DARST SA, 1991, CELL, V66, P121, DOI 10.1016/0092-8674(91)90144-N; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; UZGIRIS EE, 1983, NATURE, V301, P125, DOI 10.1038/301125a0; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; WEISS SB, 1959, J AM CHEM SOC, V81, P4118, DOI 10.1021/ja01524a087; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	18	5	6	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1087	1090		10.1016/j.cell.2006.11.036	http://dx.doi.org/10.1016/j.cell.2006.11.036			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174884	Bronze			2022-12-28	WOS:000242991000004
J	Sibert, J; Hampton, J; Kleiber, P; Maunder, M				Sibert, John; Hampton, John; Kleiber, Pierre; Maunder, Mark			Biomass, size, and trophic status of top predators in the Pacific Ocean	SCIENCE			English	Article								Fisheries have removed at least 50 million tons of tuna and other top-level predators from the Pacific Ocean pelagic ecosystem since 1950, leading to concerns about a catastrophic reduction in population biomass and the collapse of oceanic food chains. We analyzed all available data from Pacific tuna fisheries for 1950-2004 to provide comprehensive estimates of fishery impacts on population biomass and size structure. Current biomass ranges among species from 36 to 91% of the biomass predicted in the absence of fishing, a level consistent with or higher than standard fisheries management targets. Fish larger than 175 centimeters fork length have decreased from 5% to approximately 1% of the total population. The trophic level of the catch has decreased slightly, but there is no detectable decrease in the trophic level of the population. These results indicate substantial, though not catastrophic, impacts of fisheries on these top-level predators and minor impacts on the ecosystem in the Pacific Ocean.	Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; Secretariat Pacific Community, Ocean Fisheries Programme, Noumea 98848, New Caledonia; NOAA, Pacific Isl Fisheries Sci Ctr, Natl Marine Fisheries Serv, Honolulu, HI 96822 USA; Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA	University of Hawaii System; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Sibert, J (corresponding author), Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	sibert@hawaii.edu						Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005	1	174	179	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1773	1776		10.1126/science.1135347	http://dx.doi.org/10.1126/science.1135347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170304				2022-12-28	WOS:000242833600058
J	Xu, YH; Xing, YN; Chen, Y; Chao, Y; Lin, Z; Fan, E; Yu, JW; Strack, S; Jeffrey, PD; Shi, YG				Xu, Yanhui; Xing, Yongna; Chen, Yu; Chao, Yang; Lin, Zheng; Fan, Eugene; Yu, Jong W.; Strack, Stefan; Jeffrey, Philip D.; Shi, Yigong			Structure of the protein phosphatase 2A holoenzyme	CELL			English	Article							B56-GAMMA REGULATORY SUBUNIT; PP2A CATALYTIC SUBUNIT; A-ALPHA SUBUNIT; MOLECULAR-CLONING; TRUNCATED ISOFORM; B-SUBUNITS; CARBOXYL METHYLATION; REDUCED EXPRESSION; TUMOR-ANTIGENS; BETA	Protein Phosphatase 2A (PP2A) plays an essential role in many aspects of cellular physiology. The PP2A holoenzyme consists of a heterodimeric core enzyme, which comprises a scaffolding subunit and a catalytic subunit, and a variable regulatory subunit. Here we report the crystal structure of the heterotrimeric PP2A holoenzyme involving the regulatory subunit B'/B56/PR61. Surprisingly, the B'/PR61 subunit has a HEAT-like (huntingtin-elongation-A subunit-TOR-like) repeat structure, similar to that of the scaffolding subunit. The regulatory B'/B56/ PR61 subunit simultaneously interacts with the catalytic subunit as well as the conserved ridge of the scaffolding subunit. The carboxyterminus of the catalytic subunit recognizes a surface groove at the interface between the B'/B56/ PR61 subunit and the scaffolding subunit. Compared to the scaffolding subunit in the PP2A core enzyme, formation of the holoenzyme forces the scaffolding subunit to undergo pronounced conformational rearrangements. This structure reveals significant ramifications for understanding the function and regulation of PP2A.	Princeton Univ, Lewis Thomas Lab, Dept Biol Mol, Princeton, NJ 08544 USA; Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	Princeton University; University of Iowa	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Biol Mol, Princeton, NJ 08544 USA.	ygshi@princeton.edu	Xu, Yanhui/D-5119-2019	Jeffrey, Philip/0000-0002-4351-5341; Strack, Stefan/0000-0002-6175-7280; Shi, Yigong/0000-0003-2030-168X				ARINO J, 1988, P NATL ACAD SCI USA, V85, P4252, DOI 10.1073/pnas.85.12.4252; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; CHO US, 2006, NATURE; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; GREEN DD, 1987, P NATL ACAD SCI USA, V84, P4880, DOI 10.1073/pnas.84.14.4880; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ito A, 2003, AM J PATHOL, V162, P81, DOI 10.1016/S0002-9440(10)63800-X; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2003, J BIOL CHEM, V278, P10697, DOI 10.1074/jbc.M211717200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMIBAYASHI C, 1994, J BIOL CHEM, V269, P20139; KAMIBAYASHI C, 1992, J BIOL CHEM, V267, P21864; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kloeker S, 1997, BIOCHEM J, V327, P481, DOI 10.1042/bj3270481; Koma YI, 2004, HISTOL HISTOPATHOL, V19, P391, DOI 10.14670/HH-19.391; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Li XH, 2002, EUR J BIOCHEM, V269, P546, DOI 10.1046/j.0014-2956.2001.02680.x; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; STONE SR, 1987, BIOCHEMISTRY-US, V26, P7215, DOI 10.1021/bi00397a003; Suzuki K, 2003, INT J ONCOL, V23, P1263; TAKATA K, 2000, BREED RES, V2, P11; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; WALTER G, 1989, P NATL ACAD SCI USA, V86, P8669, DOI 10.1073/pnas.86.22.8669; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185	50	329	352	1	59	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1239	1251		10.1016/j.cell.2006.11.033	http://dx.doi.org/10.1016/j.cell.2006.11.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174897	Bronze			2022-12-28	WOS:000242991000020
J	King, JC,; Stoddard, JJ; Gaglani, MJ; Moore, KA; Magder, L; McClure, E; Rubin, JD; Englund, JA; Neuzil, K				King, James C., Jr.; Stoddard, Jeffrey J.; Gaglani, Manjusha J.; Moore, Kristine A.; Magder, Laurence; McClure, Elizabeth; Rubin, Judith D.; Englund, Janet A.; Neuzil, Kathleen			Effectiveness of school-based influenza vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS INFECTIONS; CAIV-T; CHILDREN; SCHOOLCHILDREN; SURVEILLANCE; COMMUNITY; TRIVALENT; ILLNESS	BACKGROUND: Vaccination of children in school is one strategy to reduce the spread of influenza in households and communities. METHODS: We identified 11 demographically similar clusters of elementary schools in four states, consisting of one school we assigned to participate in a vaccination program (intervention school) and one or two schools that did not participate (control schools). During a predicted week of peak influenza activity in each state, all households with children in intervention and control schools were surveyed regarding demographic characteristics, influenza vaccination, and outcomes of influenza-like illness during the previous 7 days. RESULTS: In all, 47% of students in intervention schools received live attenuated influenza vaccine. As compared with control-school households, intervention-school households had significantly fewer influenza-like symptoms and outcomes during the recall week. Paradoxically, intervention-school households (both children and adults) had higher rates of hospitalization per 100 persons than did control-school households. However, there was no difference in the overall hospitalization rates for children or adults in households with vaccinated children, as compared with those with unvaccinated children, regardless of study-group assignment. Rates of school absenteeism for any cause (based on school records) were not significantly different between intervention and control schools. CONCLUSIONS: Most outcomes related to influenza-like illness were significantly lower in intervention-school households than in control-school households.	Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; Medimmune Inc, Gaithersburg, MD 20878 USA; Texas A&M Univ, Scott & White Clin, Temple, TX USA; Univ Minnesota, Minneapolis, MN USA; Univ Washington, Seattle, WA 98195 USA	University System of Maryland; University of Maryland Baltimore; AstraZeneca; Medimmune; Scott & White Medical Center; Texas A&M University System; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle	King, JC, (corresponding author), Univ Maryland, Sch Med, Dept Pediat, 737 W Lombard St, Baltimore, MD 21201 USA.	jking@peds.umaryland.edu	Gaglani, Manjusha/AFQ-6802-2022	Gaglani, Manjusha/0000-0002-3952-9230				CLOVER RD, 1986, AM J DIS CHILD, V140, P706, DOI 10.1001/archpedi.1986.02140210104036; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; FOY HM, 1988, J INFECT DIS, V157, P180, DOI 10.1093/infdis/157.1.180; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Halloran ME, 2003, AM J EPIDEMIOL, V158, P305, DOI 10.1093/aje/kwg163; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; King JC, 2005, PEDIATRICS, V116, pE868, DOI 10.1542/peds.2005-1301; Long CE, 1997, ARCH FAM MED, V6, P459, DOI 10.1001/archfami.6.5.459; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; *MEDIMMUNE VACC, 2004, FLUMIST INFL VIR VAC; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; 2005, MMWR MORB MORTAL WKL, V54, P328	18	233	240	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2523	2532		10.1056/NEJMoa055414	http://dx.doi.org/10.1056/NEJMoa055414			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116BZ	17167135				2022-12-28	WOS:000242778800004
J	Bowles, S				Bowles, Samuel			Group competition, reproductive leveling, and the evolution of human altruism	SCIENCE			English	Article							GROUP SELECTION; CHIMPANZEES; BEHAVIORS; EVOLVE	Humans behave altruistically in natural settings and experiments. A possible explanation-that groups with more altruists survive when groups compete-has long been judged untenable on empirical grounds for most species. But there have been no empirical tests of this explanation for humans. My empirical estimates show that genetic differences between early human groups are likely to have been great enough so that lethal intergroup competition could account for the evolution of altruism. Crucial to this process were distinctive human practices such as sharing food beyond the immediate family, monogamy, and other forms of reproductive leveling. These culturally transmitted practices presuppose advanced cognitive and linguistic capacities, possibly accounting for the distinctive forms of altruism found in our species.	Santa Fe Inst, Santa Fe, NM 87501 USA; Univ Siena, I-53100 Siena, Italy	The Santa Fe Institute; University of Siena	Bowles, S (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	bowles@santafe.edu						Alexander R., 1987, BIOL MORAL SYSTEMS; AOKI K, 1983, EVOL INT J ORG EVOL, V36, P832; BOEHM C, 1982, J SOC BIOL STRUCT, V5, P413, DOI 10.1016/S0140-1750(82)92069-3; BOEHM C, 2000, HIERARCHY FOREST; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Bowles S, 2003, J THEOR BIOL, V223, P135, DOI 10.1016/S0022-5193(03)00060-2; BOYD R, 1990, J THEOR BIOL, V145, P331, DOI 10.1016/S0022-5193(05)80113-4; BOYD R, 2003, P NATL ACAD SCI USA, V20, P123; COHEN MN, 1980, BIOSOCIAL MECHANISMS, P275; Darwin Charles, 1998, DESCENT MAN; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; EIBLEIBESFELDT I, 1982, Z TIERPSYCHOL, V60, P177; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Giles BE, 1997, AM NAT, V149, P507, DOI 10.1086/286002; Goldberg TL, 1997, MOL BIOL EVOL, V14, P976, DOI 10.1093/oxfordjournals.molbev.a025841; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; Hassan Fekri A., 1980, BIOSOCIAL MECH POPUL; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Kaplan H., 2005, MORAL SENTIMENTS MAT; Kerr B, 2004, TRENDS ECOL EVOL, V19, P135, DOI 10.1016/j.tree.2003.10.004; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; NOE R, 1995, INT J PRIMATOL, V16, P77, DOI 10.1007/BF02700154; Pandit SA, 2003, BEHAV ECOL SOCIOBIOL, V55, P161, DOI 10.1007/s00265-003-0692-2; PRICE GR, 1972, ANN HUM GENET, V35, P485, DOI 10.1111/j.1469-1809.1957.tb01874.x; RIDLEY M, 1981, ANIM BEHAV, V29, P954, DOI 10.1016/S0003-3472(81)80034-6; ROGERS AR, 1987, ANN HUM GENET, V51, P169, DOI 10.1111/j.1469-1809.1987.tb01059.x; SOLTIS J, 1995, CURR ANTHROPOL, V36, P473, DOI 10.1086/204381; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Watts DP, 2006, AM J PRIMATOL, V68, P161, DOI 10.1002/ajp.20214; Williams G. C., 1966, P307; Wilson DS, 1997, AM NAT, V149, P336, DOI 10.1086/285993; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; WILSON DS, 1997, AM NAT S, V150; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; WRIGHT S, 1950, J CELL COMPAR PHYSL, V35, P187, DOI 10.1002/jcp.1030350414; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	37	334	342	3	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1569	1572		10.1126/science.1134829	http://dx.doi.org/10.1126/science.1134829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158320				2022-12-28	WOS:000242624600033
J	Ottesen, EA; Hong, JW; Quake, SR; Leadbetter, JR				Ottesen, Elizabeth A.; Hong, Jong Wook; Quake, Stephen R.; Leadbetter, Jared R.			Microfluidic digital PCR enables multigene analysis of individual environmental bacteria	SCIENCE			English	Article							TERMITE RETICULITERMES-FLAVIPES; IN-SITU HYBRIDIZATION; RIBOSOMAL-RNA GENES; H-2 PLUS CO2; PHYLOGENETIC DIVERSITY; MICROBIAL COMMUNITIES; ACETATE SYNTHESIS; METABOLISM; HINDGUT; METAGENOMICS	Gene inventory and metagenomic techniques have allowed rapid exploration of bacterial diversity and the potential physiologies present within microbial communities. However, it remains nontrivial to discover the identities of environmental bacteria carrying two or more genes of interest. We have used microfluidic digital polymerase chain reaction (PCR) to amplify and analyze multiple, different genes obtained from single bacterial cells harvested from nature. A gene encoding a key enzyme involved in the mutualistic symbiosis occurring between termites and their gut microbiota was used as an experimental hook to discover the previously unknown ribosomal RNA - based species identity of several symbionts. The ability to systematically identify bacteria carrying a particular gene and to link any two or more genes of interest to single species residing in complex ecosystems opens up new opportunities for research on the environment.	CALTECH, Environm Sci & Engn Program, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Auburn Univ, Samuel Ginn Coll Engn, Mat Res & Educ Ctr, Auburn, AL 36849 USA; Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	California Institute of Technology; California Institute of Technology; Auburn University System; Auburn University; Stanford University; Howard Hughes Medical Institute; Stanford University	Leadbetter, JR (corresponding author), CALTECH, Environm Sci & Engn Program, Pasadena, CA 91125 USA.	jleadbetter@caltech.edu	Baird, Cheryl L/F-6569-2011	Leadbetter, Jared/0000-0002-7033-0844	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; NHGRI NIH HHS [1R01 HG002644-01A1] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07616] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; BRAUMAN A, 1992, SCIENCE, V257, P1384, DOI 10.1126/science.257.5075.1384; BREZNAK JA, 1986, APPL ENVIRON MICROB, V52, P623, DOI 10.1128/AEM.52.4.623-630.1986; BREZNAK JA, 1977, APPL ENVIRON MICROB, V33, P406, DOI 10.1128/AEM.33.2.406-426.1977; Gray ND, 2001, ENVIRON MICROBIOL, V3, P481, DOI 10.1046/j.1462-2920.2001.00214.x; Hong JW, 2003, NAT BIOTECHNOL, V21, P1179, DOI 10.1038/nbt871; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Leadbetter JR, 1996, APPL ENVIRON MICROB, V62, P3620, DOI 10.1128/AEM.62.10.3620-3631.1996; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Lilburn TG, 1999, ENVIRON MICROBIOL, V1, P331; LJUNGDAHL LG, 1986, ANNU REV MICROBIOL, V40, P415, DOI 10.1146/annurev.mi.40.100186.002215; MANEFIELD M, 2002, APPL ENVIRON MICROB, V68, P2002; Nielsen JL, 2003, ENVIRON MICROBIOL, V5, P202, DOI 10.1046/j.1462-2920.2003.00402.x; ODELSON DA, 1983, APPL ENVIRON MICROB, V45, P1602, DOI 10.1128/AEM.45.5.1602-1613.1983; Ohkuma M, 1996, APPL ENVIRON MICROB, V62, P461, DOI 10.1128/AEM.62.2.461-468.1996; PANG HL, 1993, J BACTERIOL, V175, P3893, DOI 10.1128/JB.175.12.3893-3896.1993; Rainey FA, 1996, MICROBIOL-UK, V142, P2087, DOI 10.1099/13500872-142-8-2087; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Salmassi TM, 2003, MICROBIOL-SGM, V149, P2529, DOI 10.1099/mic.0.26351-0; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sogin S J, 1971, J Mol Evol, V1, P173; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tholen A, 2000, ENVIRON MICROBIOL, V2, P436, DOI 10.1046/j.1462-2920.2000.00127.x; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4; Zwirglmaier K, 2004, MOL MICROBIOL, V51, P89, DOI 10.1046/j.1365-2958.2003.03834.x	35	548	621	19	368	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1464	1467		10.1126/science.1131370	http://dx.doi.org/10.1126/science.1131370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138901	Green Submitted			2022-12-28	WOS:000242406100045
J	Zeeman, B				Zeeman, Beth			HIV-AIDS in Tanzania - Realities on the ground	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Med Ctr, Ctr Infect Dis, Boston, MA USA; Metrowest Med Ctr, Natick, MA USA; Metrowest Med Ctr, Framingham, MA USA	Boston Medical Center	Zeeman, B (corresponding author), Boston Med Ctr, Ctr Infect Dis, Boston, MA USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2276	2277		10.1056/NEJMp068243	http://dx.doi.org/10.1056/NEJMp068243			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	110CG	17135581				2022-12-28	WOS:000242355300002
J	Nylenna, M; Horton, R				Nylenna, Magne; Horton, Richard			Research misconduct: learning the lessons	LANCET			English	Editorial Material									Norwegian Knowledge Ctr Hlth Serv, Norwegian Elect Hlth Lib, N-0130 Oslo, Norway; Lancet, London NW1 7BY, England	Norwegian Knowledge Centre for Health Services	Nylenna, M (corresponding author), Norwegian Knowledge Ctr Hlth Serv, Norwegian Elect Hlth Lib, N-0130 Oslo, Norway.	magne.nylenna@helsebiblioteket.no						Barach P, 2000, BMJ-BRIT MED J, V320, P759, DOI 10.1136/bmj.320.7237.759; Horton R, 2006, LANCET, V367, P382, DOI 10.1016/S0140-6736(06)68119-1; *INV COMM RIKSH RA, 2006, REP INV COMM APP R; Lock S, 2001, FRAUD MISCONDUCT BIO; Sudbo J, 2005, LANCET, V366, P1359, DOI 10.1016/S0140-6736(05)67488-0; 2006, LANCET, V367, P1	6	3	3	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1856	1856		10.1016/S0140-6736(06)69757-2	http://dx.doi.org/10.1016/S0140-6736(06)69757-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	109YQ	17126705				2022-12-28	WOS:000242345900011
J	Singh, S				Singh, Susheela			Hospital admissions resulting from unsafe abortion: estimates from 13 developing countries	LANCET			English	Article							SOUTH-AFRICA; EPIDEMIOLOGY; PHILIPPINES; PREGNANCY; HEALTH; LEVEL; AGE	Background Complications from unsafe abortion are believed to account for the largest proportion of hospital admissions for gynaecological services in developing countries. The WHO estimates that one in eight pregnancy-related deaths result from unsafe abortions. The social stigma and legal restrictions associated with abortion in many countries means that data on the magnitude of this problem are scarce; this article estimates the rate and numbers of hospital admissions resulting from unsafe abortions in developing countries to help quantify the problem. Methods National estimates of abortion-related hospital admissions in women aged 15-44 years were compiled for 13 developing countries: Africa (Egypt, Nigeria, and Uganda), Asia (Bangladesh, Pakistan, and the Philippines), and Latin America and the Caribbean (Brazil, Chile, Colombia, Dominican Republic, Guatemala, Mexico, and Peru). These data were combined with supplementary data from five countries in sub-Saharan Africa (Burkina Faso, Ghana, Kenya, Nigeria, and South Africa) to give estimates for the three world regions. Findings The annual hospitalisation rate varies from a low of about 3 per 1000 women in Bangladesh to a high of about 15 per 1000 in Egypt and Uganda. Nigeria, Pakistan, and the Philippines have rates of 4-7 per 1000, and two countries in Latin America with recent data have rates of almost 9 per 1000. In the developing world as a whole, an estimated five million women are admitted to hospital for treatment of complications from induced abortions each year. This equates to an average rate of 5.7 per 1000 women per year in all developing regions, excluding China. By comparison, in developed countries complications from abortion procedures or hospitalisation are rare. Interpretation These results help quantify the magnitude of the adverse health effects of unsafe abortion in developing countries and highlight the need for improved access to post-abortion care. The provision of abortion services is changing to include the drug misoprostol and this could reduce the severity of abortion complications and the number of women who are hospitalised. Researchers will need to monitor these changes to provide countries with up-to-date information on illness and death from unsafe abortion. Improved contraceptive services are necessary to prevent unintended pregnancy. However, increasing access to safe abortion services is the most effective way of preventing the burden of unsafe abortion, and remains a high priority for developing countries.	Alan Guttmacher Inst, New York, NY 10005 USA		Singh, S (corresponding author), Alan Guttmacher Inst, 120 Wall St, New York, NY 10005 USA.	ssingh@guttmacher.org						*A GUTTM I, 1999, SHAR RESP WOM SOC AB; AAHMAN E, 2004, UNSAFE ABORTION GLOB; AbouZahr C, 2000, B WORLD HEALTH ORGAN, V78, P655; Ahiadeke C, 2001, INT FAM PLAN PERSPEC, V27, P96, DOI 10.2307/2673822; [Anonymous], 2003, ADDING IT BENEFITS I; Blanchard K, 2000, J Am Med Womens Assoc (1972), V55, P189; BONGAARTS J, 1983, FERTILITY BIOL BEHAV, P39; *BRAZ MIN HLTH, SIST INF HOSP SUS SI; Carbonell J L, 1997, Eur J Contracept Reprod Health Care, V2, P181; Duggal R, 2002, ABORTION SERVICES IN; FERRANDO D, 2001, UNPUB PREVALENCIA AB; Gebreselassie H, 2005, BJOG-INT J OBSTET GY, V112, P1229, DOI 10.1111/j.1471-0528.2004.00503.x; Harlap S, 1980, HUMAN EMBRYONIC FETA, p[148, 157]; Henshaw SK, 1998, INT FAM PLAN PERSPEC, V24, P156, DOI 10.2307/2991973; HENSHAW SK, 2005, INT UN SCI STUD POP; Huntington D, 1998, INT FAM PLAN PERSPEC, V24, P25, DOI 10.2307/2991916; Jewkes R, 2005, BJOG-INT J OBSTET GY, V112, P355, DOI 10.1111/j.1471-0528.2004.00422.x; Juarez F, 2005, INT FAM PLAN PERSPEC, V31, P140, DOI 10.1363/3114005; Koopersmith TB, 1996, CONTRACEPTION, V53, P237, DOI 10.1016/0010-7824(96)00043-1; Rees H, 1997, S AFR MED J, V87, P432; Rossier C, 2006, SOC SCI MED, V62, P254, DOI 10.1016/j.socscimed.2005.05.024; Rossier C, 2003, STUD FAMILY PLANN, V34, P87, DOI 10.1111/j.1728-4465.2003.00087.x; SATHAR Z, POP ASS AM ANN M MAR; Shah L, 2004, REPROD HEALTH MATTER, V12, P9, DOI 10.1016/S0968-8080(04)24002-2; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Singh S, 1997, INT FAM PLAN PERSPEC, V23, P100, DOI 10.2307/2950765; Singh S, 1997, INT FAM PLAN PERSPEC, V23, P59, DOI 10.2307/2950825; Singh S, 1994, INT FAM PLAN PERSPEC, V20, P4, DOI [10.2307/2133331, DOI 10.2307/2133331]; Singh S, 2006, INT FAM PLAN PERSPEC, V32, P136, DOI 10.1363/3213606; *WHO, 2002, EST DALYS SEX CAUS W; *WHO, 1993, INT CLASS DIS REL HL, P131; World Health Organization, 1992, PREV MAN UNS AB REP	32	189	196	2	33	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1887	1892		10.1016/S0140-6736(06)69778-X	http://dx.doi.org/10.1016/S0140-6736(06)69778-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126721				2022-12-28	WOS:000242345900030
J	Brideau, NJ; Flores, HA; Wang, J; Maheshwari, S; Wang, X; Barbash, DA				Brideau, Nicholas J.; Flores, Heather A.; Wang, Jun; Maheshwari, Shamoni; Wang, Xu; Barbash, Daniel A.			Two Dobzhansky-Muller genes interact to cause hybrid lethality in Drosophila	SCIENCE			English	Article							MALE-STERILITY; RESCUE GENE; SIMULANS; MELANOGASTER; INVIABILITY; HP1; LOCALIZATION; CHROMOSOME; MAURITIANA; EVOLUTION	The Dobzhansky-Muller model proposes that hybrid incompatibilities are caused by the interaction between genes that have functionally diverged in the respective hybridizing species. Here, we show that Lethal hybrid rescue (Lhr) has functionally diverged in Drosophila simulans and interacts with Hybrid male rescue (Hmr), which has functionally diverged in D. melanogaster, to cause lethality in F1 hybrid males. LHR localizes to heterochromatic regions of the genome and has diverged extensively in sequence between these species in a manner consistent with positive selection. Rapidly evolving heterochromatic DNA sequences may be driving the evolution of this incompatibility gene.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Barbash, DA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	dab87@cornell.edu	Wang, Xu/B-4587-2008; Flores, Heather/A-7403-2019; TATSUTA, HARUKI/F-2997-2010	Wang, Xu/0000-0002-7594-5004; Flores, Heather/0000-0001-5003-7547; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074737] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074737-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbash DA, 2000, GENETICS, V154, P1747; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Barbash DA, 2004, PLOS BIOL, V2, P839, DOI 10.1371/journal.pbio.0020142; Bhaskar V, 2002, GENE, V299, P173, DOI 10.1016/S0378-1119(02)01058-2; CABOT EL, 1994, GENETICS, V137, P175; Carvajal AR, 1996, GENETICA, V98, P1, DOI 10.1007/BF00120214; CHRISTIE P, 1984, J HERED, V75, P510, DOI 10.1093/oxfordjournals.jhered.a110004; Coyne J.A., 2004, SPECIATION; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Fanti L, 2003, GENETICA, V117, P135, DOI 10.1023/A:1022971407290; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hutchinson JB, 1932, J GENET, V25, P281, DOI 10.1007/BF02984592; Kazianis S, 1998, GENE CHROMOSOME CANC, V22, P210, DOI 10.1002/(SICI)1098-2264(199807)22:3<210::AID-GCC6>3.0.CO;2-Z; Mallet J, 2006, TRENDS ECOL EVOL, V21, P386, DOI 10.1016/j.tree.2006.05.004; Maside XR, 1998, GENETICS, V150, P745; Orr HA, 2000, GENETICS, V155, P225; ORR HA, COMMUNICATION; Pontecorvo G, 1943, J GENET, V45, P51, DOI 10.1007/BF02982774; POWERS JA, 1993, J CELL BIOL, V120, P291, DOI 10.1083/jcb.120.2.291; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Sweigart AL, 2006, GENETICS, V172, P2465, DOI 10.1534/genetics.105.053686; Tao Y, 2003, GENETICS, V164, P1399; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; WATANABE TK, 1979, JPN J GENET, V54, P325, DOI 10.1266/jjg.54.325; Yamamoto MT, 1997, GENES GENET SYST, V72, P297, DOI 10.1266/ggs.72.297	27	294	298	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1292	1295		10.1126/science.1133953	http://dx.doi.org/10.1126/science.1133953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124320				2022-12-28	WOS:000242215800041
J	Chaudhuri, J; Jasin, M				Chaudhuri, Jayanta; Jasin, Maria			Antibodies get a break	SCIENCE			English	Editorial Material							CLASS-SWITCH RECOMBINATION; DNA DEAMINATION; AID; HYPERMUTATION; DELETION; REPAIR; MODEL; SITE		Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chaudhuri, J (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	chaudhuj@mskcc.org; m-jasin@ski.mskcc.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054668] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054668] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; COLLEAUX L, 1988, P NATL ACAD SCI USA, V85, P6022, DOI 10.1073/pnas.85.16.6022; Franco S, 2006, DNA REPAIR, V5, P1030, DOI 10.1016/j.dnarep.2006.05.024; HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140; Larson ED, 2005, CURR BIOL, V15, P470, DOI 10.1016/j.cub.2004.12.077; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Weinstock DM, 2006, BLOOD, V107, P777, DOI 10.1182/blood-2005-06-2437; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386	12	5	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					335	336		10.1126/science.1138091	http://dx.doi.org/10.1126/science.1138091			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17170256				2022-12-28	WOS:000243535400024
J	Koelle, K; Cobey, S; Grenfell, B; Pascual, M				Koelle, Katia; Cobey, Sarah; Grenfell, Bryan; Pascual, Mercedes			Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans	SCIENCE			English	Article							SEQUENCE SPACE; VIRUS; PROTEIN; DYNAMICS; HEMAGGLUTININ; EMERGENCE; MORTALITY; MODEL; DRIFT; IDENTIFICATION	Human influenza A ( subtype H3N2) is characterized genetically by the limited standing diversity of its hemagglutinin and antigenically by clusters that emerge and replace each other within 2 to 8 years. By introducing an epidemiological model that allows for differences between the genetic and antigenic properties of the virus's hemagglutinin, we show that these patterns can arise from cluster-specific immunity alone. Central to the formulation is a genotype-to-phenotype mapping, based on neutral networks, with antigenic phenotypes, not genotypes, determining the degree of strain cross-immunity. The model parsimoniously explains well-known, as well as previously unremarked, features of interpandemic influenza dynamics and evolution. It captures the observed boom-and-bust pattern of viral evolution, with periods of antigenic stasis during which genetic diversity grows, and with episodic contraction of this diversity during cluster transitions.	Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; Penn State Univ, Dept Biol, Mueller Lab 208, Eberly Coll Sci, University Pk, PA 16802 USA; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Koelle, K (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, 2019 Kraus Nat Sci Bldg,830 N Univ Ave, Ann Arbor, MI 48109 USA.	kkoelle@psu.edu						Babajide A, 2001, J THEOR BIOL, V212, P35, DOI 10.1006/jtbi.2001.2343; Barnett L, 1998, FROM ANIM ANIMAT, P18; Bastolla U, 1999, J THEOR BIOL, V200, P49, DOI 10.1006/jtbi.1999.0975; BornbergBauer E, 1997, BIOPHYS J, V73, P2393, DOI 10.1016/S0006-3495(97)78268-7; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Douglas RG, 1975, INFLUENZA VIRUSES IN, P375; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Fontana W, 1998, J THEOR BIOL, V194, P491, DOI 10.1006/jtbi.1998.0771; GILL PW, 1977, MED J AUSTRALIA, V2, P761, DOI 10.5694/j.1326-5377.1977.tb99276.x; Girvan M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031915; Gog JR, 2003, P NATL ACAD SCI USA, V100, P11143, DOI 10.1073/pnas.1830296100; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; GREENE SK, 2004, P INT C OPT CONTR IN, V5, P795; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Huynen MA, 1996, J MOL EVOL, V43, P165; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; KAUFFMAN SA, 1991, J THEOR BIOL, V149, P467, DOI 10.1016/S0022-5193(05)80094-3; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAU KF, 1990, P NATL ACAD SCI USA, V87, P638, DOI 10.1073/pnas.87.2.638; Li H, 1996, SCIENCE, V273, P666, DOI 10.1126/science.273.5275.666; LIPMAN DJ, 1991, P ROY SOC B-BIOL SCI, V245, P7, DOI 10.1098/rspb.1991.0081; MEIKLEJOHN G, 1978, J INFECT DIS, V138, P618, DOI 10.1093/infdis/138.5.618; Nakajima K, 2005, J VIROL, V79, P6472, DOI 10.1128/JVI.79.10.6472-6477.2005; Nakajima S, 2000, VIROLOGY, V274, P220, DOI 10.1006/viro.2000.0453; Newman MEJ, 1998, P ROY SOC B-BIOL SCI, V265, P1333, DOI 10.1098/rspb.1998.0438; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Sato K, 2004, EPIDEMIOL INFECT, V132, P399, DOI 10.1017/S0950268803001821; Schuster P, 1999, PHYSICA D, V133, P427, DOI 10.1016/S0167-2789(99)00076-7; Smith DJ, 2006, SCIENCE, V312, P392, DOI 10.1126/science.1122665; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; SPICER CC, 1984, J HYG-CAMBRIDGE, V93, P105, DOI 10.1017/S0022172400060988; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; Van Nimwegen E, 2000, B MATH BIOL, V62, P799, DOI 10.1006/bulm.2000.0180; van Nimwegen E, 1999, THEOR COMPUT SCI, V229, P41, DOI 10.1016/S0304-3975(99)00119-X; vanNimwegen E, 1997, PHYS LETT A, V229, P144, DOI 10.1016/S0375-9601(97)00192-8; WAGNER A, 2005, ROBUSTNESS EVOLVABIL, P223; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Xia YC, 2005, J R STAT SOC C-APPL, V54, P659, DOI 10.1111/j.1467-9876.2005.05383.x; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	49	334	345	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1898	1903		10.1126/science.1132745	http://dx.doi.org/10.1126/science.1132745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185596				2022-12-28	WOS:000242996800040
J	Nackley, AG; Shabalina, SA; Tchivileva, IE; Satterfield, K; Korchynskyi, O; Makarov, SS; Maixner, W; Diatchenko, L				Nackley, A. G.; Shabalina, S. A.; Tchivileva, I. E.; Satterfield, K.; Korchynskyi, O.; Makarov, S. S.; Maixner, W.; Diatchenko, L.			Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure	SCIENCE			English	Article							PAIN PATIENTS; GENE; COMT; POLYMORPHISMS; TRANSLATION; PREDICTION; PATTERN	Catechol-O-methyltransferase (COMT) is a key regulator of pain perception, cognitive function, and affective mood. Three common haplotypes of the human COMT gene, divergent in two synonymous and one nonsynonymous position, code for differences in COMT enzymatic activity and are associated with pain sensitivity. Haplotypes divergent in synonymous changes exhibited the largest difference in COMT enzymatic activity, due to a reduced amount of translated protein. The major COMT haplotypes varied with respect to messenger RNA local stem-loop structures, such that the most stable structure was associated with the lowest protein levels and enzymatic activity. Site-directed mutagenesis that eliminated the stable structure restored the amount of translated protein. These data highlight the functional significance of synonymous variations and suggest the importance of haplotypes over single-nucleotide polymorphisms for analysis of genetic variations.	Univ N Carolina, Ctr Neurosensory Disorders, Chapel Hill, NC 27599 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Univ N Carolina, Thurston Arthrit Ctr, Chapel Hill, NC 27599 USA; Attagene Inc, Res Triangle Pk, NC 27560 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; University of North Carolina; University of North Carolina Chapel Hill	Diatchenko, L (corresponding author), Univ N Carolina, Ctr Neurosensory Disorders, Chapel Hill, NC 27599 USA.	lbdiatch@email.unc.edu	Shabalina, Svetlana/N-8939-2013; Korchynskyi, Olexandr/ADA-6398-2022	Shabalina, Svetlana/0000-0003-2272-7473; Korchynskyi, Olexandr/0000-0002-4557-4003	NIDCR NIH HHS [R01 DE016558] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Funke B, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-19; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Mannisto PT, 1999, PHARMACOL REV, V51, P593; MARBACH JJ, 1976, J DENT RES, V55, P711, DOI 10.1177/00220345760550043801; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MITA K, 1988, J MOL BIOL, V203, P917, DOI 10.1016/0022-2836(88)90117-9; Ogurtsov AY, 2006, BIOINFORMATICS, V22, P1317, DOI 10.1093/bioinformatics/btl083; Oroszi G, 2004, PHARMACOGENOMICS, V5, P1037, DOI 10.1517/14622416.5.8.1037; Puga I, 2005, ENDOCRINOLOGY, V146, P2210, DOI 10.1210/en.2004-1366; Rakvag TT, 2005, PAIN, V116, P73, DOI 10.1016/j.pain.2005.03.032; SCHMITTGEN TD, 1994, J BIOL CHEM, V269, P16269; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shalev A, 2002, ENDOCRINOLOGY, V143, P2541, DOI 10.1210/en.143.7.2541; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Winterer G, 2003, BRAIN RES REV, V43, P134, DOI 10.1016/S0165-0173(03)00205-4; Yampolsky LY, 2005, HUM MOL GENET, V14, P3191, DOI 10.1093/hmg/ddi350; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	20	683	784	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1930	1933		10.1126/science.1131262	http://dx.doi.org/10.1126/science.1131262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185601				2022-12-28	WOS:000242996800050
J	Danilczyk, U; Sarao, R; Remy, C; Benabbas, C; Stange, G; Richter, A; Arya, S; Pospisilik, JA; Singer, D; Camargo, SMR; Makrides, V; Ramadan, T; Verrey, F; Wagner, CA; Penninger, JM				Danilczyk, Ursula; Sarao, Renu; Remy, Christine; Benabbas, Chahira; Stange, Gerti; Richter, Andreas; Arya, Sudha; Pospisilik, J. Andrew; Singer, Dustin; Camargo, Simone M. R.; Makrides, Victoria; Ramadan, Tamara; Verrey, Francois; Wagner, Carsten A.; Penninger, Josef M.			Essential role for collectrin in renal amino acid transport	NATURE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; KIDNEY; ACE2	Angiotensin-converting enzyme 2 (ACE2) is a regulator of the renin angiotensin system involved in acute lung failure, cardiovascular functions and severe acute respiratory syndrome (SARS) infections in mammals(1-3). A gene encoding a homologue to ACE2, termed collectrin (Tmem27), has been identified in immediate proximity to the ace2 locus(4). The in vivo function of collectrin was unclear. Here we report that targeted disruption of collectrin in mice results in a severe defect in renal amino acid uptake owing to downregulation of apical amino acid transporters in the kidney. Collectrin associates with multiple apical transporters and defines a novel group of renal amino acid transporters. Expression of collectrin in Xenopus oocytes and Madin-Darby canine kidney (MDCK) cells enhances amino acid transport by the transporter B-0 AT1. These data identify collectrin as a key regulator of renal amino acid uptake.	Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; Univ Vienna, Ctr Ecol, Dept chem Ecol & Ecosyst Res, A-1090 Vienna, Austria; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Vienna; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Penninger, JM (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	wagnerca@access.unizh.ch; josef.penninger@imba.oeaw.ac.at	Richter, Andreas/D-8483-2012; Penninger, Josef M/I-6860-2013; makrides, victoria/GSN-6210-2022	Richter, Andreas/0000-0003-3282-4808; Penninger, Josef M/0000-0002-8194-3777; Camargo, Simone/0000-0003-0091-7380; Verrey, Francois/0000-0003-3250-9824				Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Bauch C, 2003, J BIOL CHEM, V278, P1316, DOI 10.1074/jbc.M210449200; Bergeron A, 2003, M S-MED SCI, V19, P976, DOI 10.1051/medsci/20031910976; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Camargo SMR, 2005, PFLUG ARCH EUR J PHY, V451, P338, DOI 10.1007/s00424-005-1455-x; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Endo F, 2003, J NUTR, V133, p2063S, DOI 10.1093/jn/133.6.2063S; Feliubadalo L, 2003, HUM MOL GENET, V12, P2097, DOI 10.1093/hmg/ddg228; FOMEO E, 2006, AM J PHYSIOL-RENAL, V290, pF376; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; KENNY AJ, 1982, PHYSIOL REV, V62, P91, DOI 10.1152/physrev.1982.62.1.91; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; KOWALCZUK S, 2005, BIOCH J MAR, V15, P417; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; MALATHI P, 1979, BIOCHIM BIOPHYS ACTA, V554, P259, DOI 10.1016/0005-2736(79)90023-3; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Ristic Z, 2006, AM J PHYSIOL-RENAL, V290, pF880, DOI 10.1152/ajprenal.00319.2005; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Verrey F, 2005, ANNU REV PHYSIOL, V67, P557, DOI 10.1146/annurev.physiol.67.031103.153949; Wagner CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1077, DOI 10.1152/ajpcell.2001.281.4.C1077; Zhang H, 2001, J BIOL CHEM, V276, P17132, DOI 10.1074/jbc.M006723200	23	161	165	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1088	1091		10.1038/nature05475	http://dx.doi.org/10.1038/nature05475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17167413				2022-12-28	WOS:000242971100060
J	Kuba, H; Ishii, TM; Ohmori, H				Kuba, Hiroshi; Ishii, Takahiro M.; Ohmori, Harunori			Axonal site of spike initiation enhances auditory coincidence detection	NATURE			English	Article							ACTION-POTENTIAL INITIATION; CEREBELLAR PURKINJE NEURONS; NUCLEUS LAMINARIS; BRAIN-STEM; SYNAPTIC DEPRESSION; PYRAMIDAL NEURONS; TIME DIFFERENCES; BARN OWL; CHICKEN; SOUND	Neurons initiate spikes in the axon initial segment or at the first node in the axon(1-4). However, it is not yet understood how the site of spike initiation affects neuronal activity and function. In nucleus laminaris of birds, neurons behave as coincidence detectors for sound source localization and encode interaural time differences (ITDs) separately at each characteristic frequency (CF)(5-7). Here we show, in nucleus laminaris of the chick, that the site of spike initiation in the axon is arranged at a distance from the soma, so as to achieve the highest ITD sensitivity at each CF. Na+ channels were not found in the soma of high-CF (2.5-3.3 kHz) and middle-CF (1.0-2.5 kHz) neurons but were clustered within a short segment of the axon separated by 20-50 mu m from the soma; in low-CF (0.4-1.0 kHz) neurons they were clustered in a longer stretch of the axon closer to the soma. Thus, neurons initiate spikes at a more remote site as the CF of neurons increases. Consequently, the somatic amplitudes of both orthodromic and antidromic spikes were small in high-CF and middle-CF neurons and were large in low-CF neurons. Computer simulation showed that the geometry of the initiation site was optimized to reduce the threshold of spike generation and to increase the ITD sensitivity at each CF. Especially in high-CF neurons, a distant localization of the spike initiation site improved the ITD sensitivity because of electrical isolation of the initiation site from the soma and dendrites, and because of reduction of Na+-channel inactivation by attenuating the temporal summation of synaptic potentials through the low-pass filtering along the axon.	Kyoto Univ, Fac Med, Dept Physiol, Kyoto 6068501, Japan	Kyoto University	Ohmori, H (corresponding author), Kyoto Univ, Fac Med, Dept Physiol, Kyoto 6068501, Japan.	ohmori@nbiol.med.kyoto-u.ac.jp	Kuba, Hiroshi/I-7519-2014	Ohmori, Harunori/0000-0002-4319-4947				Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; CARR CE, 1993, BRAIN RES, V628, P330, DOI 10.1016/0006-8993(93)90975-S; CARR CE, 1990, J NEUROSCI, V10, P3227; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Funabiki K, 1998, J PHYSIOL-LONDON, V508, P851, DOI 10.1111/j.1469-7793.1998.851bp.x; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Khaliq ZM, 2006, J NEUROSCI, V26, P1935, DOI 10.1523/JNEUROSCI.4664-05.2006; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; Kuba H, 2003, J PHYSIOL-LONDON, V552, P611, DOI 10.1113/jphysiol.2003.041574; Kuba H, 2002, J PHYSIOL-LONDON, V540, P529, DOI 10.1113/jphysiol.2001.013365; Kuba H, 2002, EUR J NEUROSCI, V15, P984, DOI 10.1046/j.1460-9568.2002.01933.x; Kuba H, 2005, J NEUROSCI, V25, P1924, DOI 10.1523/JnEUROSCI.4428-04.2005; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Pena JL, 1996, J NEUROSCI, V16, P7046; Rasband MN, 2000, J PHYSIOL-LONDON, V525, P63, DOI 10.1111/j.1469-7793.2000.00063.x; Rathouz M, 1998, J NEUROPHYSIOL, V80, P2824, DOI 10.1152/jn.1998.80.6.2824; Reyes AD, 1996, J NEUROSCI, V16, P993; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3097, DOI 10.1152/jn.00127.2002; RUBEL EW, 1975, J COMP NEUROL, V164, P411, DOI 10.1002/cne.901640403; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Simon JZ, 1999, NEUROCOMPUTING, V26-7, P263, DOI 10.1016/S0925-2312(99)00020-X; SMITH DJ, 1979, J COMP NEUROL, V186, P213, DOI 10.1002/cne.901860207; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Yamada R, 2005, J NEUROSCI, V25, P8867, DOI 10.1523/JNEUROSCI.2541-05.2005	28	158	158	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1069	1072		10.1038/nature05347	http://dx.doi.org/10.1038/nature05347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17136099				2022-12-28	WOS:000242971100056
J	Brumfiel, G				Brumfiel, Geoff			Aerial ambition	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					804	805		10.1038/444804a	http://dx.doi.org/10.1038/444804a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167446				2022-12-28	WOS:000242805400013
J	Djulbegovic, B; Lyman, GH				Djulbegovic, Benjamin; Lyman, Gary H.			Screening mammography at 40-49 years: regret or no regret?	LANCET			English	Editorial Material							BREAST-CANCER; MORTALITY		Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA; Univ Rochester, Sch Med & Dent Hlth Serv & Outcomes Res, Med Ctr, Strong Mem Hosp,James P Wilmot Canc Ctr, Rochester, NY USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Rochester	Djulbegovic, B (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA.	djulbebm@moffitt.usf.edu	Lyman, Gary H/K-5227-2019; Djulbegovic, Benjamin/I-3661-2012	Lyman, Gary H/0000-0002-0823-8086; Djulbegovic, Benjamin/0000-0003-0671-1447				Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; de Gonzalez AB, 2005, BRIT J CANCER, V93, P590, DOI 10.1038/sj.bjc.6602683; Djulbegovic B, 2000, MedGenMed, V2, pE6; Djulbegovic B, 2005, J CLIN ONCOL, V23, P6822, DOI 10.1200/JCO.2005.06.007; Djulbegovic B, 1999, MED HYPOTHESES, V53, P253, DOI 10.1054/mehy.1998.0020; DJULBEGOVIC B, IN PRESS PLOS MED; Hozo I, 1999, COMPUT BIOMED RES, V32, P168, DOI 10.1006/cbmr.1998.1505; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Law J, 2001, BRIT J RADIOL, V74, P1121, DOI 10.1259/bjr.74.888.741121; Lyman GH, 2005, CANCER TREAT REV, V31, P628, DOI 10.1016/j.ctrv.2005.07.001; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Pisano ED, 2005, RADIOLOGY, V236, P404, DOI 10.1148/radiol.2362050440; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001	16	18	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2006	368	9552					2035	2037		10.1016/S0140-6736(06)69816-4	http://dx.doi.org/10.1016/S0140-6736(06)69816-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114JY	17161713				2022-12-28	WOS:000242663700004
J	Chiorescu, I				Chiorescu, Irinel			Microwave cooling of an artificial atom	SCIENCE			English	Editorial Material							PERSISTENT-CURRENT QUBIT		Florida State Univ, Dept Phys, Tallahassee, FL 32309 USA; Natl High Magnet Field Lab, Tallahassee, FL 32309 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Chiorescu, I (corresponding author), Florida State Univ, Dept Phys, Tallahassee, FL 32309 USA.	ic@magnet.fsu.edu						Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Orlando TP, 1999, PHYS REV B, V60, P15398, DOI 10.1103/PhysRevB.60.15398; Valenzuela SO, 2006, SCIENCE, V314, P1589, DOI 10.1126/science.1134008	4	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1549	1550		10.1126/science.1136100	http://dx.doi.org/10.1126/science.1136100			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158308				2022-12-28	WOS:000242624600022
J	Pagani, M; Caldeira, K; Archer, D; Zachos, JC				Pagani, Mark; Caldeira, Ken; Archer, David; Zachos, James C.			An ancient carbon mystery	SCIENCE			English	Editorial Material							EOCENE THERMAL MAXIMUM; METHANE HYDRATE; PALEOCENE; OCEAN; DISSOCIATION		Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Carnegie Inst, Dept Global Ecol, Stanford, CA 94305 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA	Yale University; Carnegie Institution for Science; University of Chicago; University of California System; University of California Santa Cruz	Pagani, M (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	mark.pagani@yale.edu	Caldeira, Ken/E-7914-2011; Zachos, James C/A-7674-2008; Archer, David/K-7371-2012; Pagani, Mark/B-3233-2008	Caldeira, Ken/0000-0002-4591-643X; Zachos, James C/0000-0001-8439-1886; Archer, David/0000-0002-4523-7912; 				Bowen GJ, 2004, NATURE, V432, P495, DOI 10.1038/nature03115; Buffett B, 2004, EARTH PLANET SC LETT, V227, P185, DOI 10.1016/j.epsl.2004.09.005; Crouch EM, 2003, PALAEOGEOGR PALAEOCL, V194, P387, DOI 10.1016/S0031-0182(03)00334-1; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Higgins JA, 2006, EARTH PLANET SC LETT, V245, P523, DOI 10.1016/j.epsl.2006.03.009; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Thomas DJ, 2002, GEOLOGY, V30, P1067, DOI 10.1130/0091-7613(2002)030<1067:WTFFTF>2.0.CO;2; Thomas E., 1996, SPECIAL PUBLICATION, V101, P401; WING SL, 2003, 369 GEOL SOC AM; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	15	142	144	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1556	1557		10.1126/science.1136110	http://dx.doi.org/10.1126/science.1136110			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158314				2022-12-28	WOS:000242624600028
J	Seelig, G; Soloveichik, D; Zhang, DY; Winfree, E				Seelig, Georg; Soloveichik, David; Zhang, David Yu; Winfree, Erik			Enzyme-free nucleic acid logic circuits	SCIENCE			English	Article							GENE-EXPRESSION; ALLOSTERIC RIBOZYMES; DNA; RIBOREGULATORS; MACHINE	Biological organisms perform complex information processing and control tasks using sophisticated biochemical circuits, yet the engineering of such circuits remains ineffective compared with that of electronic circuits. To systematically create complex yet reliable circuits, electrical engineers use digital logic, wherein gates and subcircuits are composed modularly and signal restoration prevents signal degradation. We report the design and experimental implementation of DNA-based digital logic circuits. We demonstrate AND, OR, and NOT gates, signal restoration, amplification, feedback, and cascading. Gate design and circuit construction is modular. The gates use single-stranded nucleic acids as inputs and outputs, and the mechanism relies exclusively on sequence recognition and strand displacement. Biological nucleic acids such as microRNAs can serve as inputs, suggesting applications in biotechnology and bioengineering.	CALTECH, Dept Computat & Neural Syst, Pasadena, CA 91125 USA; CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; CALTECH, Dept Comp Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Winfree, E (corresponding author), CALTECH, Dept Computat & Neural Syst, Pasadena, CA 91125 USA.	winfree@caltech.edu	Winfree, Erik/L-4002-2013	Winfree, Erik/0000-0002-5899-7523				Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Hagiya M, 2006, NAT COMP SER, P293, DOI 10.1007/3-540-30296-4_18; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; LEE CS, 1970, J MOL BIOL, V48, P1, DOI 10.1016/0022-2836(70)90215-9; Levy M, 2003, P NATL ACAD SCI USA, V100, P6416, DOI 10.1073/pnas.1130145100; MULLER DE, 1963, ASYNCHRONOUS LOGICS, P289; Penchovsky R, 2005, NAT BIOTECHNOL, V23, P1424, DOI 10.1038/nbt1155; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; Seelig G, 2006, J AM CHEM SOC, V128, P12211, DOI 10.1021/ja0635635; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102; Von Neumann J., 1956, ANN MATH STUD, V34, P43; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Yurke B, 1999, BIOSYSTEMS, V52, P165, DOI 10.1016/S0303-2647(99)00043-X	22	1034	1111	29	524	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1585	1588		10.1126/science.1132493	http://dx.doi.org/10.1126/science.1132493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158324				2022-12-28	WOS:000242624600038
J	McHardy, IM; Koerding, E; Knigge, C; Uttley, P; Fender, RP				McHardy, I. M.; Koerding, E.; Knigge, C.; Uttley, P.; Fender, R. P.			Active galactic nuclei as scaled-up Galactic black holes	NATURE			English	Article							X-RAY VARIABILITY; LONG-TERM VARIABILITY; SEYFERT 1 GALAXIES; POWER SPECTRA; CYGNUS X-1; STATES; LUMINOSITY; EVOLUTION; NGC-5506; RXTE	A long-standing question is whether active galactic nuclei (AGN) vary like Galactic black hole systems when appropriately scaled up by mass(1-3). If so, we can then determine how AGN should behave on cosmological timescales by studying the brighter and much faster varying Galactic systems. As X-ray emission is produced very close to the black holes, it provides one of the best diagnostics of their behaviour. A characteristic timescale - which potentially could tell us about the mass of the black hole - is found in the X-ray variations from both AGN and Galactic black holes(1-6), but whether it is physically meaningful to compare the two has been questioned(7). Here we report that, after correcting for variations in the accretion rate, the timescales can be physically linked, revealing that the accretion process is exactly the same for small and large black holes. Strong support for this linkage comes, perhaps surprisingly, from the permitted optical emission lines in AGN whose widths ( in both broad-line AGN and narrow-emission-line Seyfert 1 galaxies) correlate strongly with the characteristic X-ray timescale, exactly as expected from the AGN black hole masses and accretion rates. So AGN really are just scaled-up Galactic black holes.	Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands	University of Southampton; University of Amsterdam	McHardy, IM (corresponding author), Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England.	imh@astro.soton.ac.uk		Knigge, Christian/0000-0002-1116-2553	STFC [PP/D001013/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D001013/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Axelsson M, 2005, ASTRON ASTROPHYS, V438, P999, DOI 10.1051/0004-6361:20042362; Bentz MC, 2006, ASTROPHYS J, V644, P133, DOI 10.1086/503537; BRANDT WN, 1999, MNRAS, V303, P53; Edelson R, 1999, ASTROPHYS J, V514, P682, DOI 10.1086/306980; Falcke H, 2004, ASTRON ASTROPHYS, V414, P895, DOI 10.1051/0004-6361:20031683; HARDY M, 1987, NATURE, V325, P696; Kollatschny W, 2006, ASTRON ASTROPHYS, V454, P459, DOI 10.1051/0004-6361:20054357; LAWRENCE A, 1987, NATURE, V325, P694, DOI 10.1038/325694a0; Leighly KM, 1999, ASTROPHYS J SUPPL S, V125, P297, DOI 10.1086/313277; LIU BF, 1999, APJ, V527, P17; Lyubarskii YE, 1997, MON NOT R ASTRON SOC, V292, P679, DOI 10.1093/mnras/292.3.679; Markowitz A, 2003, ASTROPHYS J, V593, P96, DOI 10.1086/375330; McClintock J. E., 2006, COMPACT STELLAR XRAY, P157, DOI DOI 10.2277/0521826594; McHardy I., 1988, Memorie della Societa Astronomica Italiana, V59, P239; McHardy IM, 2004, MON NOT R ASTRON SOC, V348, P783, DOI 10.1111/j.1365-2966.2004.07376.x; McHardy IM, 2005, MON NOT R ASTRON SOC, V359, P1469, DOI 10.1111/j.1365-2966.2005.08992.x; Merloni A, 2003, MON NOT R ASTRON SOC, V345, P1057, DOI 10.1046/j.1365-2966.2003.07017.x; Migliari S, 2005, MON NOT R ASTRON SOC, V363, P112, DOI 10.1111/j.1365-2966.2005.09412.x; Nagar NM, 2002, ASTRON ASTROPHYS, V391, pL21, DOI 10.1051/0004-6361:20021039; Nowak MA, 2000, MON NOT R ASTRON SOC, V318, P361, DOI 10.1046/j.1365-8711.2000.03668.x; Papadakis IE, 2004, MON NOT R ASTRON SOC, V348, P207, DOI 10.1111/j.1365-2966.2004.07351.x; Peterson BM, 2004, ASTROPHYS J, V613, P682, DOI 10.1086/423269; Peterson BM, 2000, ASTROPHYS J, V542, P161, DOI 10.1086/309518; Potttschmidt K, 2003, ASTRON ASTROPHYS, V407, P1039, DOI 10.1051/0004-6361:20030906; Trudolyubov SP, 2001, ASTROPHYS J, V558, P276, DOI 10.1086/322466; Turner TJ, 1999, ASTROPHYS J, V524, P667, DOI 10.1086/307834; Uttley P, 2005, MON NOT R ASTRON SOC, V363, P586, DOI 10.1111/j.1365-2966.2005.09475.x; Wilms J, 2006, ASTRON ASTROPHYS, V447, P245, DOI 10.1051/0004-6361:20053938	30	468	471	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					730	732		10.1038/nature05389	http://dx.doi.org/10.1038/nature05389			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151661	Green Submitted			2022-12-28	WOS:000242581100053
J	Mehrotra, A; Epstein, AM; Rosenthal, MB				Mehrotra, Ateev; Epstein, Arnold M.; Rosenthal, Meredith B.			Do integrated medical groups provide higher-quality medical care than individual practice associations?	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE; MANAGED CARE; OF-CARE; PHYSICIAN ORGANIZATIONS; UNITED-STATES; CALIFORNIA; PATIENT; OUTCOMES; EXPERIENCE; MORTALITY	Background: The association between the organizational structure of physician groups and health care quality has never been evaluated empirically. Objective: To examine whether integrated medical groups (IMGs) provide higher-quality primary care than individual practice associations (IPAs). Design: Cross-sectional study. Setting: PacifiCare, a large health maintenance organization. Participants: Approximately 1.7 million enrollees of PacifiCare cared for by 119 California physician groups between July 1999 and June 2000. Measurements: The percentage of eligible PacifiCare enrollees who received mammography, Papanicolaou smear screening, chlamydia screening, diabetic eye examination, an asthma controller medication, or a beta-blocker after acute myocardial infarction. Results: Physician groups identified as IMGs, compared with those identified as IPAs, had higher rates of mammography (relative risk, 1.15 [95% CI, 1.01 to 1.33]), Papanicolaou smear screening (relative risk, 2.29 [CI, 1.53 to 3.42]), chlamydia screening (relative risk, 2.17 [CI, 1.04 to 4.55]), and diabetic eye screening (relative risk, 1.55 [CI, 1.28 to 1.88]). Leaders of IMGs were more likely to report using EMRs (37% vs. 2%; P < 0.001) and quality improvement strategies, but these characteristics explained little of the quality differences between IMGs and IPAs. Limitations: Organizational characteristics, including group type, were reported by physician group leaders and not directly assessed. Patient characteristics that could have accounted for some of the observed differences also were not assessed. Conclusions: Patients cared for in IMGs generally received higher-quality primary care than those cared for in IPAs. Having an EMR and implementation of quality improvement strategies did not explain the differences in quality. These findings suggest that physician group type influences health care quality.	RAND Hlth, Pittsburgh, PA 15213 USA	RAND Corporation	Mehrotra, A (corresponding author), RAND Hlth, 4570 5th Ave,Suite 600, Pittsburgh, PA 15213 USA.	mehrotra@rand.org	Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582; Rosenthal, Meredith/0000-0003-3410-0184	PHS HHS [5 T32 HP11001-15).] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1064, DOI 10.1056/NEJM200004063421422; Casalino L, 2003, JAMA-J AM MED ASSOC, V289, P434, DOI 10.1001/jama.289.4.434; Casalino LP, 2003, ARCH INTERN MED, V163, P1958, DOI 10.1001/archinte.163.16.1958; ENTHOVEN AC, 2005, HLTH AFF MILLWO 0907; Franks P, 2003, MED CARE, V41, P842, DOI 10.1097/00005650-200307000-00008; GILLIES RR, 2003, HLTH AFF MILLWOOD S; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Himmelstein DU, 1999, JAMA-J AM MED ASSOC, V282, P159, DOI 10.1001/jama.282.2.159; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Keating NL, 2004, MED CARE, V42, P829, DOI 10.1097/01.mlr.0000135829.73795.a7; Kerr EA, 1996, JAMA-J AM MED ASSOC, V276, P1236, DOI 10.1001/jama.276.15.1236; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; Landon BE, 1998, JAMA-J AM MED ASSOC, V279, P1377, DOI 10.1001/jama.279.17.1377; Malin JL, 2000, CANCER-AM CANCER SOC, V88, P2824, DOI 10.1002/1097-0142(20000615)88:12<2824::AID-CNCR23>3.3.CO;2-J; McBean AM, 2005, AM J MANAG CARE, V11, P213; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; *NAT COMM QUAL ASS, 1998, HLTH PLAN EMPL DAT I; Rittenhouse DR, 2004, HEALTH AFFAIR, V23, P51, DOI 10.1377/hlthaff.23.6.51; Robinson JC, 1996, HEALTH AFFAIR, V15, P7, DOI 10.1377/hlthaff.15.1.7; Robinson JC, 2001, HEALTH AFFAIR, V20, P81, DOI 10.1377/hlthaff.20.4.81; Rosenthal MB, 2001, HEALTH AFFAIR, V20, P109, DOI 10.1377/hlthaff.20.4.109; Schmittdiel J, 2004, PREV MED, V39, P1000, DOI 10.1016/j.ypmed.2004.04.005; Shojania KG, 2005, HEALTH AFFAIR, V24, P138, DOI 10.1377/hlthaff.24.1.138; Solomon LS, 2002, HEALTH CARE FINANC R, V23, P85; Stone EG, 2002, ANN INTERN MED, V136, P641, DOI 10.7326/0003-4819-136-9-200205070-00006; STONE VE, 1992, JAMA-J AM MED ASSOC, V268, P2655, DOI 10.1001/jama.268.19.2655; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Zaslavsky AM, 2005, INT J QUAL HEALTH C, V17, P67, DOI 10.1093/intqhc/mzi005; Zaslavsky AM, 2000, MED CARE, V38, P981, DOI 10.1097/00005650-200010000-00002	31	82	83	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2006	145	11					826	833		10.7326/0003-4819-145-11-200612050-00007	http://dx.doi.org/10.7326/0003-4819-145-11-200612050-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114PE	17146067				2022-12-28	WOS:000242677300004
J	Batty, M				Batty, Michael			Rank clocks	NATURE			English	Article							POWER LAWS; ZIPFS LAW; CITIES; SYSTEMS; GROWTH	Many objects and events, such as cities, firms and internet hubs, scale with size(1-4) in the upper tails of their distributions. Despite intense interest in using power laws to characterize such distributions, most analyses have been concerned with observations at a single instant of time, with little analysis of objects or events that change in size through time ( notwithstanding some significant exceptions(5-7)). It is now clear that the evident macro-stability in such distributions at different times can mask a volatile and often turbulent micro-dynamics, in which objects can change their position or rank-order rapidly while their aggregate distribution appears quite stable. Here I introduce a graphical representation termed the 'rank clock' to examine such dynamics for three distributions: the size of cities in the US from AD 1790, the UK from AD1901 and the world from 430 BC. Our results destroy any notion that rank - size scaling is universal: at the micro-level, these clocks show cities and civilizations rising and falling in size at many times and on many scales. The conventional model explaining such scaling on the basis of growth by proportionate effect cannot replicate these micro-dynamics, suggesting that such models and explanations are considerably less general than has hitherto been assumed.	UCL, Bartlett Sch, Ctr Adv Spatial Anal, London WC1E 6BT, England	University of London; University College London	Batty, M (corresponding author), UCL, Bartlett Sch, Ctr Adv Spatial Anal, 1-19 Torrington Pl, London WC1E 6BT, England.	m.batty@ucl.ac.uk	Batty, Michael/I-5638-2014; Batty, Michael/D-4422-2011	Batty, Michael/0000-0002-9931-1305	Engineering and Physical Sciences Research Council [EP/C513703/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Adamic L.A., 2002, GLOTTOMETRICS, V3, P143; [Anonymous], 2018, HIST DYNAMICS WHY ST, DOI DOI 10.23943/PRINCETON/9780691180779.001.0001; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; BATTY M, 1976, GEOGR ANAL, V8, P1; Blank A, 2000, PHYSICA A, V287, P279, DOI 10.1016/S0378-4371(00)00464-7; *CDU, CENS WEBS; Chandler T, 1987, 4000 YEARS URBAN GRO, DOI [10.5744/bi.2019.1012, DOI 10.5744/BI.2019.1012]; Gabaix X, 1999, Q J ECON, V114, P739, DOI 10.1162/003355399556133; Gabaix X., 2004, HDB REGIONAL URBAN E, P2341, DOI DOI 10.1016/S1574-0080(04)80010-5; Gell-Mann M., 2004, NONEXTENSIVE ENTROPY; Gibrat R., 1931, INEGALITES EC; GIBSON C, 1998, 27 US BUR CENS POP D; GUERINPACE F, 1995, URBAN STUD, V32, P551, DOI 10.1080/00420989550012960; HAVLIN S, 1995, PHYSICA A, V216, P148, DOI 10.1016/0378-4371(95)00069-J; Ioannides YM, 2003, REG SCI URBAN ECON, V33, P127, DOI 10.1016/S0166-0462(02)00006-6; Krapivsky PL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258703; Malcai O, 1999, PHYS REV E, V60, P1299, DOI 10.1103/PhysRevE.60.1299; Pumain D, 2006, METHODS SER, V3, P169; ROBSON BT, 1972, URBAN GROWTH APPROAC; Sornette D, 1997, J PHYS I, V7, P431, DOI 10.1051/jp1:1997169; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; Theil H., 1972, STAT DECOMPOSITION; WHITE DR, 2005, GENERATIVE HIST MODE; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	25	141	154	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2006	444	7119					592	596		10.1038/nature05302	http://dx.doi.org/10.1038/nature05302			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136088				2022-12-28	WOS:000242377600042
J	Jones, WD; Cayirlioglu, P; Kadow, IG; Vosshall, LB				Jones, Walton D.; Cayirlioglu, Pelin; Kadow, Ilona Grunwald; Vosshall, Leslie B.			Two chemosensory receptors together mediate carbon dioxide detection in Drosophila	NATURE			English	Article							ANTENNAL LOBE; MELANOGASTER; RESPONSES; BEHAVIOR; NEURONS; MOSQUITOS; SENSILLA; OXYGEN	Blood-feeding insects, including the malaria mosquito Anopheles gambiae, use highly specialized and sensitive olfactory systems to locate their hosts. This is accomplished by detecting and following plumes of volatile host emissions, which include carbon dioxide (CO2)(1). CO2 is sensed by a population of olfactory sensory neurons in the maxillary palps of mosquitoes(2,3) and in the antennae of the more genetically tractable fruitfly, Drosophila melanogaster(4). The molecular identity of the chemosensory CO2 receptor, however, remains unknown. Here we report that CO2-responsive neurons in Drosophila co-express a pair of chemosensory receptors, Gr21a and Gr63a, at both larval and adult life stages. We identify mosquito homologues of Gr21a and Gr63a, GPRGR22 and GPRGR24, and show that these are co-expressed in A. gambiae maxillary palps. We show that Gr21a and Gr63a together are sufficient for olfactory CO2-chemosensation in Drosophila. Ectopic expression of Gr21a and Gr63a together confers CO2 sensitivity on CO2-insensitive olfactory neurons, but neither gustatory receptor alone has this function. Mutant flies lacking Gr63a lose both electrophysiological and behavioural responses to CO2. Knowledge of the molecular identity of the insect olfactory CO2 receptors may spur the development of novel mosquito control strategies designed to take advantage of this unique and critical olfactory pathway. This in turn could bolster the worldwide fight against malaria and other insect-borne diseases.	Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA; Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	Rockefeller University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10021 USA.	leslie@mail.rockefeller.edu	Jones, Walton/A-2417-2011	Jones, Walton/0000-0001-8642-627X; Grunwald Kadow, Ilona/0000-0002-9085-4274; Vosshall, Leslie/0000-0002-6060-8099				Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Laissue PP, 1999, J COMP NEUROL, V405, P543; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; NICOLAS G, 1989, ANNU REV ENTOMOL, V34, P97, DOI 10.1146/annurev.en.34.010189.000525; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; SOUTHWICK EE, 1987, J INSECT PHYSIOL, V33, P623, DOI 10.1016/0022-1910(87)90130-2; Stange G, 1999, MICROSC RES TECHNIQ, V47, P416, DOI 10.1002/(SICI)1097-0029(19991215)47:6<416::AID-JEMT5>3.0.CO;2-X; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8	29	440	467	9	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2007	445	7123					86	90		10.1038/nature05466	http://dx.doi.org/10.1038/nature05466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17167414				2022-12-28	WOS:000243225100041
J	Hanauer, DI; Jacobs-Sera, D; Pedulla, ML; Cresawn, SG; Hendrix, RW; Hatfull, GF				Hanauer, David I.; Jacobs-Sera, Deborah; Pedulla, Marisa L.; Cresawn, Steven G.; Hendrix, Roger W.; Hatfull, Graham F.			Teaching scientific inquiry	SCIENCE			English	Editorial Material							SCIENCE; PHAGE		Indiana Univ Penn, Dept English, Grad Program Composit & TESOL, Indiana, PA 15705 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Montana, Dept Biol Sci, Butte, MT 59701 USA	Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Montana System; University of Montana	Hanauer, DI (corresponding author), Indiana Univ Penn, Dept English, Grad Program Composit & TESOL, Indiana, PA 15705 USA.	hanauer@iup.edu; gfh@pitt.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051975] Funding Source: NIH RePORTER; NCRR NIH HHS [RR16455] Funding Source: Medline; NIGMS NIH HHS [GM51975] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2006, AM LAB REP INV HIGH; Dunbar K., 1995, NATURE INSIGHT, P365, DOI DOI 10.1016/S0193-3973(99)00050-7; Dunbar K., 1997, CREATIVE THOUGHT INV, P461, DOI [10.1037/10227-017, DOI 10.1037/10227-017]; HANAUER D, 2006, AM ASS APPL LING C M; Hanauer D., 2006, SCI DISCOURSE MULTIL; Harris Richard, 1997, LANDMARK ESSAYS RHET; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Ivezic Z, 2001, ASTRON J, V122, P2749, DOI 10.1086/323452; KUHN D, 1993, SCI EDUC, V77, P319, DOI 10.1002/sce.3730770306; Lemke J., 1990, TALKING SCI LANGUAGE; Lewis Jennifer R, 2002, Cell Biol Educ, V1, P26, DOI 10.1187/cbe.02-02-0003; Lopatto David, 2004, Cell Biol Educ, V3, P270, DOI 10.1187/cbe.04-07-0045; National Research Council (NRC), 1996, NAT SCI ED STAND; NOTT M, 1995, INT J SCI EDUC, V17, P399, DOI 10.1080/0950069950170310; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pfund C, 2006, SCIENCE, V311, P473, DOI 10.1126/science.1123806; Prelli LawrenceJ., 1989, RHETORIC SCI INVENTI; QIN Y, 1990, COGNITIVE SCI, V14, P281, DOI 10.1207/s15516709cog1402_4; Seymour E, 2004, SCI EDUC, V88, P493, DOI 10.1002/sce.10131	20	93	93	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1880	1881		10.1126/science.1136796	http://dx.doi.org/10.1126/science.1136796			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	119EY	17185586				2022-12-28	WOS:000242996800030
J	Itani, KMF; Wilson, SE; Awad, SS; Jensen, EH; Finn, TS; Abramson, MA				Itani, Kamal M. F.; Wilson, Samuel E.; Awad, Samir S.; Jensen, Erin H.; Finn, Tyler S.; Abramson, Murray A.			Ertapenem versus cefotetan prophylaxis in elective colorectal surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURGICAL SITE INFECTION; COMPLICATED INTRAABDOMINAL INFECTIONS; ANTIMICROBIAL PROPHYLAXIS; PLUS METRONIDAZOLE; COMPARE CEFOTETAN; DOUBLE-BLIND; PREVENTION; MULTICENTER	BACKGROUND: Ertapenem, a long-acting carbapenem, may be an alternative to the recommended prophylactic antibiotic cefotetan. METHODS: In this randomized, double-blind trial, we assessed the efficacy and safety of antibiotic prophylaxis with ertapenem, as compared with cefotetan, in patients undergoing elective colorectal surgery. A successful outcome was defined as the absence of surgical-site infection, anastomotic leakage, or antibiotic use 4 weeks postoperatively. All adverse events were collected until 14 days after the administration of antibiotic prophylaxis. RESULTS: Of the 1002 patients randomly assigned to study groups, 901 (451 in the ertapenem group and 450 in the cefotetan group) qualified for the modified intention-to-treat analysis, and 672 (338 in the ertapenem group and 334 in the cefotetan group) were included in the per-protocol analysis. After adjustment for strata, in the modified intention-to-treat analysis, the rate of overall prophylactic failure was 40.2% in the ertapenem group and 50.9% in the cefotetan group (absolute difference, -10.7%; 95% confidence interval [CI], -17.1 to -4.2); in the per-protocol analysis, the failure rate was 28.0% in the ertapenem group and 42.8% in the cefotetan group (absolute difference, -14.8%; 95% CI, -21.9 to -7.5). Both analyses fulfilled statistical criteria for the superiority of ertapenem. In the modified intention-to-treat analysis, the most common reason for failure of prophylaxis in both groups was surgical-site infection: 17.1% in the ertapenem group and 26.2% in the cefotetan group (absolute difference, -9.1; 95% CI, -14.4 to -3.7). In the treated population, the overall incidence of Clostridium difficile infection was 1.7% in the ertapenem group and 0.6% in the cefotetan group (P=0.22). CONCLUSIONS: Ertapenem is more effective than cefotetan in the prevention of surgical-site infection in patients undergoing elective colorectal surgery but may be associated with an increase in C. difficile infection.	Vet Affairs Boston Healthcare Syst, W Roxbury, MA 02132 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Univ Calif Irvine, Sch Med, Orange, CA 92668 USA; Baylor Coll Med, Houston, TX 77030 USA; Houston Helathcare Syst, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX USA; Merck Res Labs, Upper Gwynedd, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; University of California System; University of California Irvine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Merck & Company	Itani, KMF (corresponding author), Vet Affairs Boston Healthcare Syst, 1400 VFW Pkwy,112A, W Roxbury, MA 02132 USA.	kitani@med.va.gov						[Anonymous], 1999, AM J HEALTH-SYST PH, V56, P1839; [Anonymous], 1996, INT C HARM TECHN REQ; ARNAUD JP, 1992, J HOSP INFECT, V22, P23, DOI 10.1016/S0195-6701(05)80004-0; BELLANTONE R, 1988, DRUG EXP CLIN RES, V14, P763; Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174, DOI 10.1001/archsurg.140.2.174; Bratzler DW, 2005, AM J SURG, V189, P395, DOI 10.1016/j.amjsurg.2005.01.015; *CTR DRUG EV RES, 2006, DISC DRUGS; DELLINGER EP, 1994, CLIN INFECT DIS, V18, P422, DOI 10.1093/clinids/18.3.422; GORBACH SL, 1991, REV INFECT DIS, V13, pS815; HERSHMAN M J, 1990, Journal of the Royal College of Surgeons of Edinburgh, V35, P29; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; JAGELMAN DG, 1988, AM J SURG, V155, P71, DOI 10.1016/S0002-9610(88)80217-4; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Milsom JW, 1998, AM J SURG, V176, p46S, DOI 10.1016/S0002-9610(98)00220-7; Miransky J, 2001, DIS COLON RECTUM, V44, P1100, DOI 10.1007/BF02234629; MORTON AL, 1989, SURG GYNECOL OBSTET, V169, P41; *NAT COMM CLIN LAB, 2000, M11A5 NAT COMM CLIN; *NAT COMM CLIN LAB, 2000, M7A5 NAWT COMM CLIN; *NAT COMM CLIN LAB, 2000, M2A7 NAT COMM CLIN L; PAGE CP, 1993, ARCH SURG-CHICAGO, V128, P410; PERITI P, 1993, J CHEMOTHERAPY, V5, P37; PETITI P, 1989, DIS COLON RECTUM, V32, P121; Shah PM, 2003, J ANTIMICROB CHEMOTH, V52, P538, DOI 10.1093/jac/dkg404; SKIPPER D, 1992, J HOSP INFECT, V21, P73, DOI 10.1016/0195-6701(92)90155-F; Smith RL, 2004, ANN SURG, V239, P599, DOI 10.1097/01.sla.0000124292.21605.99; Solomkin JS, 2003, ANN SURG, V237, P235, DOI 10.1097/00000658-200302000-00013; Tang RP, 2001, ANN SURG, V234, P181, DOI 10.1097/00000658-200108000-00007; Yellin AE, 2002, INT J ANTIMICROB AG, V20, P165, DOI 10.1016/S0924-8579(02)00160-7	28	181	187	2	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2640	2651		10.1056/NEJMoa054408	http://dx.doi.org/10.1056/NEJMoa054408			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182989	Bronze			2022-12-28	WOS:000242956200005
J	Small, GW; Kepe, V; Ercoli, LM; Siddarth, P; Bookheimer, SY; Miller, KJ; Lavretsky, H; Burggren, AC; Cole, GM; Vinters, HV; Thompson, PM; Huang, SC; Satyamurthy, N; Phelps, ME; Barrio, JR				Small, Gary W.; Kepe, Vladimir; Ercoli, Linda M.; Siddarth, Prabha; Bookheimer, Susan Y.; Miller, Karen J.; Lavretsky, Helen; Burggren, Alison C.; Cole, Greg M.; Vinters, Harry V.; Thompson, Paul M.; Huang, S. -C.; Satyamurthy, N.; Phelps, Michael E.; Barrio, Jorge R.			PET of brain amyloid and tau in mild cognitive impairment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; PLAQUES; DEMENTIA; CLASSIFICATION; BINDING; TANGLES; HEALTH; RISK; AGE	BACKGROUND Amyloid senile plaques and tau neurofibrillary tangles are neuropathological hallmarks of Alzheimer's disease that accumulate in the cortical regions of the brain in persons with mild cognitive impairment who are at risk for Alzheimer's disease. Noninvasive methods to detect these abnormal proteins are potentially useful in developing surrogate markers for drug discovery and diagnostics. METHODS We enrolled 83 volunteers with self-reported memory problems who had undergone neurologic and psychiatric evaluation and positron-emission tomography ( PET). On the basis of cognitive testing, 25 volunteers were classified as having Alzheimer's disease, 28 as having mild cognitive impairment, and 30 as having no cognitive impairment ( healthy controls). PET was performed after injection of 2-(1-{6-[(2-[F-18] fluoroethyl) ( methyl) amino]-2-naphthyl} ethylidene) malononitrile (FDDNP), a molecule that binds to plaques and tangles in vitro. All subjects also underwent 2- deoxy-2-[ F-18] fluoro-D-glucose (FDG) PET, and 72 underwent magnetic resonance imaging (MRI). RESULTS Global values for FDDNP-PET binding ( average of the values for the temporal, parietal, posterior cingulate, and frontal regions) were lower in the control group than in the group with mild cognitive impairment ( P< 0.001), and the values for binding in the group with mild cognitive impairment were lower than in the group with Alzheimer's disease ( P< 0.001). FDDNP-PET binding differentiated among the diagnostic groups better than did metabolism on FDG-PET or volume on MRI. CONCLUSIONS FDDNP-PET scanning can differentiate persons with mild cognitive impairment from those with Alzheimer's disease and those with no cognitive impairment. This technique is potentially useful as a noninvasive method to determine regional cerebral patterns of amyloid plaques and tau neurofibrillary tangles.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; Univ Calif Los Angeles, Brain Mapping Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Lab Neuro Imaging, Los Angeles, CA USA; Univ Calif Los Angeles, Alzheimers Dis Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Ctr Aging, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Small, GW (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Suite 88-201,760 Westwood Plaza, Los Angeles, CA 90024 USA.	gsmall@mednet.ucla.edu	Thompson, Paul M/C-4194-2018; Lavretsky, Helen/M-5711-2015	Thompson, Paul M/0000-0002-4720-8867; Lavretsky, Helen/0000-0001-9990-5085; Bookheimer, Susan/0000-0002-3417-5891	NCRR NIH HHS [M01-RR00865] Funding Source: Medline; NIA NIH HHS [AG10123, MH/AG58156, P01AG025831, AG13308, P50AG16570] Funding Source: Medline; NIMH NIH HHS [MH52453, K23 MH001948] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052453, K23MH001948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013308, P50AG016570, P01AG025831, P30AG010123] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agdeppa ED, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0004.2001; Agdeppa ED, 2003, NEUROSCIENCE, V117, P723, DOI 10.1016/S0306-4522(02)00907-7; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; De Jager CA, 2005, NEUROCASE, V11, P72, DOI 10.1080/13554790490896820; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gilewski M.J., 1986, CLIN MEMORY ASSESSME, P93, DOI [10.1037/10057-008, DOI 10.1037/10057-008]; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Kepe V, 2006, P NATL ACAD SCI USA, V103, P702, DOI 10.1073/pnas.0510237103; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Korf ESC, 2004, NEUROLOGY, V63, P94, DOI 10.1212/01.WNL.0000133114.92694.93; Lemaitre H, 2005, NEUROIMAGE, V26, P900, DOI 10.1016/j.neuroimage.2005.02.042; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lopez OL, 2006, J NEUROL NEUROSUR PS, V77, P159, DOI 10.1136/jnnp.2004.045567; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Silverman DHS, 2001, JAMA-J AM MED ASSOC, V286, P2120, DOI 10.1001/jama.286.17.2120; SMALL GW, 1989, ARCH GEN PSYCHIAT, V46, P527; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; SMALL GW, 2004, 9 INT C ALZH DIS REL; Stoub TR, 2005, NEUROLOGY, V64, P1520, DOI 10.1212/01.WNL.0000160089.43264.1A; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Verhoeff NPLG, 2004, AM J GERIAT PSYCHIAT, V12, P584, DOI 10.1176/appi.ajgp.12.6.584; Vinters HV, 2004, CLIN NEUROSCI RES, V3, P413, DOI 10.1016/j.cnr.2004.04.007; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	32	523	550	0	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2652	2663		10.1056/NEJMoa054625	http://dx.doi.org/10.1056/NEJMoa054625			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182990				2022-12-28	WOS:000242956200006
J	Gehi, AK; Mehta, D; Gomes, JA				Gehi, Anil K.; Mehta, Davendra; Gomes, J. Anthony			Evaluation and management of patients after implantable cardioverter-defibrillator shock	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY-OF-LIFE; ANTIARRHYTHMIC-DRUG THERAPY; ENHANCED DETECTION CRITERIA; SUSTAINED VENTRICULAR TACHYARRHYTHMIAS; DUAL-CHAMBER DEFIBRILLATOR; LOW-ENERGY CARDIOVERSION; ELECTRICAL STORM; SUPRAVENTRICULAR TACHYCARDIA; DETECTION ALGORITHMS; SINGLE-CHAMBER	Context There has been a tremendous increase in the use of implantable cardioverter-defibrillators (ICDs) after several large clinical trials demonstrated their ability to effectively reduce mortality in selected populations of patients with cardiac disease. Thus, the nonelectrophysiologist will often encounter patients who have received an ICD shock. Objective To assess options for the evaluation and management of patients who have received an ICD shock. Evidence Acquisition Literature search using the PubMed and MEDLINE databases to identify articles published from January 1990 to September 2006, using the Medical Subject Headings defibrillators, implantable; defibrillators, implantable/ adverse effects; anti-arrhythmic agents; electric countershock; quality of life; tachycardia therapy; algorithm; ventricular tachycardia/diagnosis; and supraventricular tachycardia/ diagnosis. Case reports were excluded and articles were limited to those published in English. Scientific statements and guidelines from the American College of Cardiology, the American Heart Association, and the Heart Rhythm Society were also reviewed, as were the reference lists of retrieved articles, to identify any additional articles for inclusion. Evidence Synthesis There are multiple causes of both appropriate and inappropriate ICD shocks. Irrespective of appropriateness, receiving ICD shocks substantially impairs a patient's quality of life. A variety of techniques are available using ICD programming to reliably limit the occurrence of appropriate or inappropriate ICD shocks. Antiarrhythmic medications can also effectively reduce the occurrence of shocks. Conclusions Through the use of effective ICD programming and antiarrhythmic medications, the occurrence of ICD shocks can be reduced while maintaining the lifesaving ability of the ICD. A basic understanding of the range of available options is fundamental for evaluation and management of the patient who has received an ICD shock.	Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; CUNY Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA	Emory University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Gehi, AK (corresponding author), Emory Univ Hosp, 1364 Clifton Rd NE,Suite 414, Atlanta, GA 30322 USA.	anilgehi@gmail.com	GOMES, JOSÉ ALVARO PEREIRA/J-2761-2013					AHERN TS, 1994, J AM COLL CARDIOL, V23, P1521; Arya A, 2006, AM J CARDIOL, V97, P389, DOI 10.1016/j.amjcard.2005.08.058; Bailin SJ, 2003, J CARDIOVASC ELECTR, V14, P144, DOI 10.1046/j.1540-8167.2003.02285.x; Bansch D, 2003, CIRCULATION, V108, P3011, DOI 10.1161/01.CIR.0000103701.30662.5C; BARDY GH, 1993, CIRCULATION, V87, P1889, DOI 10.1161/01.CIR.87.6.1889; Brugada J, 1998, J CARDIOVASC ELECTR, V9, P261, DOI 10.1111/j.1540-8167.1998.tb00911.x; Burjorjee JE, 2002, CAN J ANAESTH, V49, P973, DOI 10.1007/BF03016886; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Connolly SJ, 2006, JAMA-J AM MED ASSOC, V295, P165, DOI 10.1001/jama.295.2.165; Credner SC, 1998, J AM COLL CARDIOL, V32, P1909, DOI 10.1016/S0735-1097(98)00495-1; Deisenhofer I, 2001, J CARDIOVASC ELECTR, V12, P134, DOI 10.1046/j.1540-8167.2001.00134.x; DIJKMAN B, 1995, PACE, V18, P148, DOI 10.1111/j.1540-8159.1995.tb02494.x; DiMarco JP, 2003, NEW ENGL J MED, V349, P1836, DOI 10.1056/NEJMra035432; Dorian P, 2004, CIRCULATION, V110, P3646, DOI 10.1161/01.CIR.0000149240.98971.A8; Duru F, 2000, PACE, V23, P1365, DOI 10.1111/j.1540-8159.2000.tb00964.x; ESTES NAM, 1994, AM HEART J, V127, P1038, DOI 10.1016/0002-8703(94)90084-1; Exner DV, 2001, CIRCULATION, V103, P2066; Friedman PA, 2006, CIRCULATION, V113, P2871, DOI 10.1161/CIRCULATIONAHA.105.594531; Godemann F, 2004, CLIN CARDIOL, V27, P321, DOI 10.1002/clc.4960270604; Gold MR, 2002, J CARDIOVASC ELECTR, V13, P1092, DOI 10.1046/j.1540-8167.2002.01092.x; Goldberger Z, 2006, JAMA-J AM MED ASSOC, V295, P809, DOI 10.1001/jama.295.7.809; HAMMILL SC, 1995, PACE, V18, P3, DOI 10.1111/j.1540-8159.1995.tb02469.x; Hintringer F, 2004, PACE, V27, P976, DOI 10.1111/j.1540-8159.2004.00568.x; Irvine J, 2002, AM HEART J, V144, P282, DOI 10.1067/mhj.2002.124049; JUNG W, 1992, AM J CARDIOL, V70, P1023, DOI 10.1016/0002-9149(92)90354-2; Kamphuis HCM, 2003, EUROPACE, V5, P381, DOI 10.1016/S1099-5129(03)00078-3; Kettering K, 2002, PACE, V25, P1571, DOI 10.1046/j.1460-9592.2002.01571.x; Kettering K, 2001, PACE, V24, P1325, DOI 10.1046/j.1460-9592.2001.01325.x; Klein Richard C, 2003, J Cardiovasc Electrophysiol, V14, P940, DOI 10.1046/j.1540-8167.2003.01554.x; Kohn CS, 2000, PACE, V23, P450, DOI 10.1111/j.1540-8159.2000.tb00826.x; Kolb C, 2006, PACE, V29, P946, DOI 10.1111/j.1540-8159.2006.00467.x; Korte T, 1998, J CARDIOVASC ELECTR, V9, P70, DOI 10.1111/j.1540-8167.1998.tb00868.x; Kouakam C, 2004, EUROPACE, V6, P32, DOI 10.1016/j.eupc.2003.09.007; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; Kuhlkamp V, 1999, J AM COLL CARDIOL, V33, P46, DOI 10.1016/S0735-1097(98)00521-X; Kurisu S, 2005, CIRC J, V 69, P613, DOI 10.1253/circj.69.613; MANZ M, 1994, AM HEART J, V127, P978, DOI 10.1016/0002-8703(94)90076-0; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; MIROWSKI M, 1980, NEW ENGL J MED, V303, P322, DOI 10.1056/NEJM198008073030607; Nademanee K, 2000, CIRCULATION, V102, P742, DOI 10.1161/01.CIR.102.7.742; Nair M, 1997, CIRCULATION, V95, P967; Namerow PB, 1999, PACE, V22, P1305, DOI 10.1111/j.1540-8159.1999.tb00623.x; Nasir N, 1997, AM J CARDIOL, V79, P820, DOI 10.1016/S0002-9149(96)00881-8; Pacifico A, 1999, NEW ENGL J MED, V340, P1855, DOI 10.1056/NEJM199906173402402; Page RL, 2000, AM J CARDIOL, V85, P1481, DOI 10.1016/S0002-9149(00)00799-2; QUILL TE, 1994, AM J CARDIOL, V74, P205, DOI 10.1016/0002-9149(94)90107-4; Rosenqvist M, 1998, CIRCULATION, V98, P663, DOI 10.1161/01.CIR.98.7.663; Sadoul N, 2002, J CARDIOVASC ELECTR, V13, P25, DOI 10.1046/j.1540-8167.2002.00025.x; SAKSENA S, 1985, CIRCULATION, V72, P153, DOI 10.1161/01.CIR.72.1.153; Schaumann A, 1996, AM J CARDIOL, V78, P42, DOI 10.1016/S0002-9149(96)00501-2; Schreieck J, 2005, HEART RHYTHM, V2, P10, DOI 10.1016/j.hrthm.2004.10.037; Schron EB, 2002, CIRCULATION, V105, P589, DOI 10.1161/hc0502.103330; Sears SF, 2000, PACE, V23, P939, DOI 10.1111/j.1540-8159.2000.tb00878.x; Sears SF, 2002, HEART, V87, P488, DOI 10.1136/heart.87.5.488; Singer I, 2004, J AM COLL CARDIOL, V43, P39, DOI 10.1016/j.jacc.2003.07.033; Sinha AM, 2004, J CARDIOVASC ELECTR, V15, P646, DOI 10.1046/j.1540-8167.2004.03290.x; Stein KM, 2002, J AM COLL CARDIOL, V40, P335, DOI 10.1016/S0735-1097(02)01957-5; SWERDLOW CD, 1994, J AM COLL CARDIOL, V23, P1342, DOI 10.1016/0735-1097(94)90376-X; Swerdlow CD, 2002, J CARDIOVASC ELECTR, V13, P432, DOI 10.1046/j.1540-8167.2002.00432.x; Tanabe Y, 2003, PACE, V26, P101, DOI 10.1046/j.1460-9592.2003.00156.x; Theuns DAMJ, 2004, J AM COLL CARDIOL, V44, P2362, DOI 10.1016/j.jacc.2004.09.039; TRAPPE HJ, 1994, PACE, V17, P506, DOI 10.1111/j.1540-8159.1994.tb01418.x; Verma A, 2004, J CARDIOVASC ELECTR, V15, P1265, DOI 10.1046/j.1540-8167.2004.04352.x; Villacastin J, 1996, CIRCULATION, V93, P753, DOI 10.1161/01.CIR.93.4.753; Vyas AK, 2006, J AM COLL CARDIOL, V47, P769, DOI 10.1016/j.jacc.2005.09.053; Wathen MS, 2004, CIRCULATION, V110, P2591, DOI 10.1161/01.CIR.0000145610.64014.E4; Weber M, 1999, J CARDIOVASC ELECTR, V10, P145, DOI 10.1111/j.1540-8167.1999.tb00655.x; WIETHOLT D, 1993, J AM COLL CARDIOL, V21, P885, DOI 10.1016/0735-1097(93)90343-Y; Wilkoff BL, 2001, CIRCULATION, V103, P381; Wolbrette DL, 2003, AM J CARDIOL, V91, p39D, DOI 10.1016/S0002-9149(02)03378-7; WOOD MA, 1994, J AM COLL CARDIOL, V24, P1692, DOI 10.1016/0735-1097(94)90176-7	72	22	23	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2839	2847		10.1001/jama.296.23.2839	http://dx.doi.org/10.1001/jama.296.23.2839			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179461	Bronze			2022-12-28	WOS:000242826400026
J	Willis, SL; Tennstedt, SL; Marsiske, M; Ball, K; Elias, J; Koepke, KM; Morris, JN; Rebok, GW; Unverzagt, FW; Stoddard, AM; Wright, E				Willis, Sherry L.; Tennstedt, Sharon L.; Marsiske, Michael; Ball, Karlene; Elias, Jeffrey; Koepke, Kathy Mann; Morris, John N.; Rebok, George W.; Unverzagt, Frederick W.; Stoddard, Anne M.; Wright, Elizabeth		ACTIVE Study Grp	Long-term effects of cognitive training on everyday functional outcomes in older adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMER-DISEASE; INSTRUMENTAL ACTIVITIES; INTELLECTUAL ABILITY; AFRICAN-AMERICANS; PERFORMANCE; RISK; INTERVENTION; SPEED; AGE; DISABILITY	Context Cognitive training has been shown to improve cognitive abilities in older adults but the effects of cognitive training on everyday function have not been demonstrated. Objective To determine the effects of cognitive training on daily function and durability of training on cognitive abilities. Design, Setting, and Participants Five-year follow-up of a randomized controlled single-blind trial with 4 treatment groups. A volunteer sample of 2832 persons ( mean age, 73.6 years; 26% black), living independently in 6 US cities, was recruited from senior housing, community centers, and hospitals and clinics. The study was conducted between April 1998 and December 2004. Five-year follow-up was completed in 67% of the sample. Interventions Ten-session training for memory ( verbal episodic memory), reasoning ( inductive reasoning), or speed of processing ( visual search and identification); 4-session booster training at 11 and 35 months after training in a random sample of those who completed training. Main Outcome Measures Self-reported and performance-based measures of daily function and cognitive abilities. Results The reasoning group reported significantly less difficulty in the instrumental activities of daily living ( IADL) than the control group ( effect size, 0.29; 99% confidence interval [CI], 0.03- 0.55). Neither speed of processing training ( effect size, 0.26; 99% CI, - 0.002 to 0.51) nor memory training ( effect size, 0.20; 99% CI, - 0.06 to 0.46) had a significant effect on IADL. The booster training for the speed of processing group, but not for the other 2 groups, showed a significant effect on the performance-based functional measure of everyday speed of processing ( effect size, 0.30; 99% CI, 0.08-0.52). No booster effects were seen for any of the groups for everyday problem-solving or self-reported difficulty in IADL. Each intervention maintained effects on its specific targeted cognitive ability through 5 years ( memory: effect size, 0.23 [ 99% CI, 0.11-0.35]; reasoning: effect size, 0.26 [ 99% CI, 0.17-0.35]; speed of processing: effect size, 0.76 [ 99% CI, 0.62-0.90]). Booster training produced additional improvement with the reasoning intervention for reasoning performance ( effect size, 0.28; 99% CI, 0.12-0.43) and the speed of processing intervention for speed of processing performance ( effect size, 0.85; 99% CI, 0.61-1.09). Conclusions Reasoning training resulted in less functional decline in self-reported IADL. Compared with the control group, cognitive training resulted in improved cognitive abilities specific to the abilities trained that continued 5 years after the initiation of the intervention.	Penn State Univ, Dept Human Dev & Family Studies, State Coll, PA 16801 USA; New England Res Inst, Watertown, MA 02172 USA; Univ Florida, Inst Aging, Gainesville, FL USA; Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; NIA, Bethesda, MD 20892 USA; NINR, Bethesda, MD 20892 USA; Hebrew Senior Life, Boston, MA USA; Johns Hopkins Univ, Dept Mental Hlth, Baltimore, MD USA; Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; HealthCore, Inc; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); Harvard University; Hebrew SeniorLife; Johns Hopkins University; Indiana University System; Indiana University-Purdue University Indianapolis	Willis, SL (corresponding author), Penn State Univ, Dept Human Dev & Family Studies, 135 E Nittany Ave,Suite 405, State Coll, PA 16801 USA.	slw@psu.edu	Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026; Marsiske, Michael/0000-0001-5973-2116; Ball, Karlene/0000-0003-1811-9870	NATIONAL INSTITUTE OF NURSING RESEARCH [U01NR004507, U01NR004508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG024102, U01AG014289, U01AG014276, U01AG014263, U01AG014260, U01AG014282] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allaire JC, 2002, PSYCHOL AGING, V17, P101, DOI [10.1037//0882-7974.17.1.101, 10.1037/0882-7974.17.1.101]; Allaire JC, 1999, PSYCHOL AGING, V14, P627, DOI 10.1037/0882-7974.14.4.627; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; BALL K, 2000, MOBILITY TRANSPORTAT, V5, P213; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Blom G., 1958, STAT ESTIMATES TRANS; Boyle PA, 2004, CLIN NEUROPSYCHOL, V18, P75, DOI 10.1080/13854040490507172; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Cherry KE, 2005, EXP AGING RES, V31, P261, DOI 10.1080/03610730590948186; Clark F, 1997, JAMA-J AM MED ASSOC, V278, P1321, DOI 10.1001/jama.278.16.1321; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Davis RN, 2001, ALZ DIS ASSOC DIS, V15, P1, DOI 10.1097/00002093-200101000-00001; Derwinger A, 2005, GERONTOLOGY, V51, P277, DOI 10.1159/000085124; Diehl M, 2005, J APPL GERONTOL, V24, P211, DOI 10.1177/0733464804273772; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Ekstrom R., 1976, MANUAL KIT FACTOR RE; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried TR, 2001, ARCH INTERN MED, V161, P2602, DOI 10.1001/archinte.161.21.2602; Gonda J, 1985, SCHAIE THURSTONE MEN; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Jobe JB, 2001, CONTROL CLIN TRIALS, V22, P453, DOI 10.1016/S0197-2456(01)00139-8; Kane R.A., 1998, HEART LONG TERM CARE; KELLYHAYES M, 1992, AM J PUBLIC HEALTH, V82, P841, DOI 10.2105/AJPH.82.6.841; Koltai DC, 2001, NEUROPSYCHOL REHABIL, V11, P455, DOI 10.1080/09602010042000097; LAZARIDIS EN, 1994, J GERONTOL, V49, pM47, DOI 10.1093/geronj/49.2.M47; O'Hara R, 2007, J PSYCHIATR RES, V41, P585, DOI 10.1016/j.jpsychires.2006.04.010; OWSLEY C, 1991, PSYCHOL AGING, V6, P403, DOI 10.1037/0882-7974.6.3.403; Owsley C, 2002, GERONTOLOGY, V48, P254, DOI 10.1159/000058360; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Plehn K, 2004, CLIN NEUROPSYCHOL, V18, P101, DOI 10.1080/13854040490507190; Rasmusson DX, 1999, AGING NEUROPSYCHOL C, V6, P56, DOI 10.1076/anec.6.1.56.790; REBOK GW, 1989, DEV PSYCHOL, V25, P714, DOI 10.1037/0012-1649.25.5.714; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Royall DR, 2005, J INT NEUROPSYCH SOC, V11, P899, DOI 10.1017/S135561770505109X; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schupf N, 2005, NEUROLOGY, V65, P1218, DOI 10.1212/01.wnl.0000180970.07386.cb; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; TERESI J, 1997, ADL ASSESSMENT MEASU; Thurstone L. L., 1949, EXAMINER MANUAL SRA; Wadley VG, 2003, J AM GERIATR SOC, V51, P1621, DOI 10.1046/j.1532-5415.2003.51514.x; WILLIS S, 1997, SOC MECH MAINTAINING; Willis S L, 1986, Psychol Aging, V1, P239, DOI 10.1037/0882-7974.1.3.239; Willis S L, 1987, Annu Rev Gerontol Geriatr, V7, P159; Willis SL, 1996, GERONTOLOGIST, V36, P595, DOI 10.1093/geront/36.5.595; WILLIS SL, 1983, J EDUC PSYCHOL, V75, P257, DOI 10.1037/0022-0663.75.2.257; Willis SL., 1993, MANUAL EVERYDAY PROB; Wilson B, 1985, RIVERMEAD BEHAVIOURA; WOLINSKY F, 2006, GERONTOLOGY PERSPECT; WOLINSKY FD, 1993, J GERONTOL, V48, pS93; WOLINSKY FD, 1992, J GERONTOL, V47, pS173, DOI 10.1093/geronj/47.4.S173	55	943	988	2	155	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2805	2814		10.1001/jama.296.23.2805	http://dx.doi.org/10.1001/jama.296.23.2805			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116TR	17179457	Green Accepted, Bronze			2022-12-28	WOS:000242826400022
J	Denberg, TD; Coombes, JM; Byers, TE; Marcus, AC; Feinberg, LE; Steiner, JF; Ahnen, DJ				Denberg, Thomas D.; Coombes, John M.; Byers, Tim E.; Marcus, Alfred C.; Feinberg, Lawrence E.; Steiner, John F.; Ahnen, Dennis J.			Effect of a mailed brochure on appointment-keeping for screening colonoscopy - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							COLORECTAL-CANCER; MEDICARE CONSUMERS; DECISION-MAKING; PRIMARY-CARE; WOMEN; INTERVENTIONS; MAMMOGRAPHY; DISPARITIES; GENDER; IMPACT	Background: Even when primary care physicians have face-to-face discussions with patients before referring them for screening colonoscopy, patient nonadherence can be substantial. Often, primary care physicians lack sufficient time to educate patients and address their potential misconceptions and fears about this procedure. Objective: To test whether an informational brochure sent to patients' home addresses after referral for screening colonoscopy would increase patient completion of the procedure. Design: Randomized, controlled trial. Setting: 2 general internal medicine practices affiliated with the University of Colorado Health Sciences Center. Patients: 781 consecutive patients 50 years of age or older referred by their primary care physicians for screening colonoscopy. Intervention: Patients were randomly assigned to receive usual care (control group) versus usual care plus an informational brochure (intervention group). The brochure was mailed within 10 days of referral for screening colonoscopy; it mentioned the name of the patient's primary care physician and encouraged patients to schedule a procedure. It also described colorectal cancer and polyps and the similar lifetime risks for colorectal cancer for men and women, colonoscopy and risk for perforation, the nature of bowel preparation for the procedure, and alternative screening tests. Measurements: Rates of adherence to screening colonoscopy in the 2 study groups. Results: The overall adherence rate was 11.7 percentage points (95% Cl, 5.1 to 18.4 percentage points) greater in the intervention group than in the control group (70.7% vs. 59.0%). Older patients were more adherent than younger patients. Patients with low-income insurance plans, such as Medicaid, were less adherent despite being sent a brochure. Limitations: The small number of clinical practices and minority patients may limit generalizability. In addition, it was not possible to determine the degree to which adherence was influenced by a reminder to schedule a procedure versus detailed information about colonoscopy. Conclusions: An inexpensive mailed brochure is an effective way to increase patient adherence to primary care physician referral for screening colonoscopy.	Univ Colorado, Div Gen Internal Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Denberg, TD (corresponding author), Univ Colorado, Div Gen Internal Med, 4200 E 9th Ave,B-180, Denver, CO 80262 USA.	tom.denberg@uchsc.edu						[Anonymous], RES RANDOMIZER; Charles RJ, 2003, GASTROINTEST ENDOSC, V57, P183, DOI 10.1067/mge.2003.55; Denberg TD, 2005, J GEN INTERN MED, V20, P989, DOI 10.1111/j.1525-1497.2005.00164.x; Elderkin-Thompson V, 1999, J GEN INTERN MED, V14, P112, DOI 10.1046/j.1525-1497.1999.00296.x; FRANKS P, 1993, MED CARE, V31, P213, DOI 10.1097/00005650-199303000-00003; Klabunde CN, 2006, AM J PREV MED, V30, P313, DOI 10.1016/j.amepre.2005.11.006; Lees KA, 2005, AM J PREV MED, V29, P404, DOI 10.1016/j.amepre.2005.08.009; LERMAN C, 1992, AM J PUBLIC HEALTH, V82, P729, DOI 10.2105/AJPH.82.5.729; Lurie N, 1997, J GEN INTERN MED, V12, P34; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; O'Donnell M P, 1989, Am J Health Promot, V3, P5; O'Malley AS, 2005, ARCH INTERN MED, V165, P2129, DOI 10.1001/archinte.165.18.2129; Richardson JL, 1996, CANCER EPIDEM BIOMAR, V5, P71; Schenck AP, 2006, AM J PREV MED, V30, P320, DOI 10.1016/j.amepre.2005.11.005; Taylor VM, 2002, J NATL CANCER I, V94, P670, DOI 10.1093/jnci/94.9.670; Vernon SW, 1997, JNCI-J NATL CANCER I, V89, P1406, DOI 10.1093/jnci/89.19.1406; Wagner TH, 1998, AM J PREV MED, V14, P64, DOI 10.1016/S0749-3797(97)00003-2; Wardle J, 2003, HEALTH PSYCHOL, V22, P99, DOI 10.1037/0278-6133.22.1.99; Whitney SN, 2004, ANN INTERN MED, V140, P54, DOI 10.7326/0003-4819-140-1-200401060-00012; Whynes DK, 2003, PUBLIC HEALTH, V117, P389, DOI 10.1016/S0033-3506(03)00146-X; Zapka JG, 2004, CANCER-AM CANCER SOC, V101, P1165, DOI 10.1002/cncr.20504; 2006, MMWR MORB MORTAL WKL, V55, P308	23	71	71	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2006	145	12					895	900		10.7326/0003-4819-145-12-200612190-00006	http://dx.doi.org/10.7326/0003-4819-145-12-200612190-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120BB	17179058				2022-12-28	WOS:000243057400004
J	Boothroyd, AI				Boothroyd, Arnold I.			Heavy elements in stars	SCIENCE			English	Editorial Material							ASYMPTOTIC GIANT BRANCH; S-PROCESS; NUCLEOSYNTHESIS		Univ Toronto, Canadian Inst Theoret Astrophys, Toronto, ON M5S 3H8, Canada	University of Toronto	Boothroyd, AI (corresponding author), Univ Toronto, Canadian Inst Theoret Astrophys, Toronto, ON M5S 3H8, Canada.	boothroy@cita.utoronto.ca						Abia C, 2001, ASTROPHYS J, V559, P1117, DOI 10.1086/322383; Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239; Busso M, 2001, ASTROPHYS J, V557, P802, DOI 10.1086/322258; Garcia-Hernandez DA, 2006, SCIENCE, V314, P1751, DOI 10.1126/science.1133706; Herwig F, 2005, ANNU REV ASTRON ASTR, V43, P435, DOI 10.1146/annurev.astro.43.072103.150600; Lattanzio JC, 2005, NUCL PHYS A, V758, p477C, DOI 10.1016/j.nuclphysa.2005.05.088	6	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1690	1691		10.1126/science.1136842	http://dx.doi.org/10.1126/science.1136842			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170281				2022-12-28	WOS:000242833600032
J	Garry, DJ; Olson, EN				Garry, Daniel J.; Olson, Eric N.			A common progenitor at the heart of development	CELL			English	Review							CARDIAC STEM-CELLS; MYOCARDIAL-CELLS; SMOOTH-MUSCLE; CLONAL ORIGIN; MOUSE HEART; MULTIPOTENT; LINEAGES; DIFFERENTIATION; CARDIOMYOCYTE; EXPRESSION	Formation of the heart requires the coordinated functions of cardiac myocytes, smooth muscle cells, endothelial cells, and connective tissue elements. Several recent studies now reveal that these different cell types arise from a common progenitor (Kattman et al., 2006; Moretti et al., 2006; Wu et al., 2006). These findings raise interesting questions about the lineage relationships of cardiovascular progenitor cell populations and suggest possibilities for cardiac repair in both congenital and acquired heart disease.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu						Abu-Issa R, 2004, DEV BIOL, V272, P281, DOI 10.1016/j.ydbio.2004.05.016; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Esner M, 2006, DEVELOPMENT, V133, P737, DOI 10.1242/dev.02226; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; KAUFMAN MH, 1992, ATLAS MOUSE DEV, P442; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Masino AM, 2004, CIRC RES, V95, P389, DOI 10.1161/01.RES.0000138302.02691.be; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045	18	121	126	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1101	1104		10.1016/j.cell.2006.11.031	http://dx.doi.org/10.1016/j.cell.2006.11.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174889	Bronze			2022-12-28	WOS:000242991000009
J	Saeij, JPJ; Boyle, JP; Coller, S; Taylor, S; Sibley, LD; Brooke-Powell, ET; Ajioka, JW; Boothroyd, JC				Saeij, J. P. J.; Boyle, J. P.; Coller, S.; Taylor, S.; Sibley, L. D.; Brooke-Powell, E. T.; Ajioka, J. W.; Boothroyd, J. C.			Polymorphic secreted kinases are key virulence factors in toxoplasmosis	SCIENCE			English	Article							POPULATION BIOLOGY; PARASITE GENOTYPE; GONDII; STRAINS; RECOMBINATION; LINEAGES; DISEASE; GENOME; IL-12; HOST	The majority of known Toxoplasma gondii isolates from Europe and North America belong to three clonal lines that differ dramatically in their virulence, depending on the host. To identify the responsible genes, we mapped virulence in F-1 progeny derived from crosses between type II and type III strains, which we introduced into mice. Five virulence ( VIR) loci were thus identified, and for two of these, genetic complementation showed that a predicted protein kinase (ROP18 and ROP16, respectively) is the key molecule. Both are hypervariable rhoptry proteins that are secreted into the host cell upon invasion. These results suggest that secreted kinases unique to the Apicomplexa are crucial in the host-pathogen interaction.	Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	Stanford University; Washington University (WUSTL); University of Cambridge	Boothroyd, JC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu	Sibley, L. David/C-4616-2008	Saeij, Jeroen/0000-0003-0289-7109; Boothroyd, John C./0000-0001-9719-745X	NIAID NIH HHS [1R01AI045806-01A1, AI41014, AI059176, R01 AI021423, AI30230, AI36629, AI21423, AI05093, R01 AI036629, R01 AI021423-20, F32AI60306] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059176, R01AI036629, R01AI045806, Z01AI005093, R37AI021423, R01AI021423, R01AI041014, F32AI060306] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305; El Hajj H, 2007, CELL MICROBIOL, V9, P54, DOI 10.1111/j.1462-5822.2006.00767.x; ELHAJJ H, IN PRESS PLOS PATHOG; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Honore S, 2000, PATHOL BIOL, V48, P541; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; Li L, 2003, GENOME RES, V13, P443, DOI 10.1101/gr.693203; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; SAEIJ JP, IN PRESS NATURE; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; SIBLEY LD, 1992, GENETICS, V132, P1003; SIBLEY LD, 1992, MOL BIOCHEM PARASIT, V51, P291, DOI 10.1016/0166-6851(92)90079-Y; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Su CL, 2002, P NATL ACAD SCI USA, V99, P10753, DOI 10.1073/pnas.172117099; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Wille U, 2002, INFECT IMMUN, V70, P6940, DOI 10.1128/IAI.70.12.6940-6947.2002	26	410	436	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1780	1783		10.1126/science.1133690	http://dx.doi.org/10.1126/science.1133690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170306	Green Accepted			2022-12-28	WOS:000242833600060
J	Van Gaal, LF; Mertens, IL; De Block, CE				Van Gaal, Luc F.; Mertens, Ilse L.; De Block, Christophe E.			Mechanisms linking obesity with cardiovascular disease	NATURE			English	Article							CORONARY-HEART-DISEASE; FREE FATTY-ACIDS; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; ADIPOSE-TISSUE; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; RISK-FACTORS; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS	Obesity increases the risk of cardiovascular disease and premature death. Adipose tissue releases a large number of bioactive mediators that influence not only body weight homeostasis but also insulin resistance - the core feature of type 2 diabetes - as well as alterations in lipids, blood pressure, coagulation, fibrinolysis and inflammation, leading to endothelial dysfunction and atherosclerosis. We are now beginning to understand the underlying mechanisms as well as the ways in which smoking and dyslipidaemia increase, and physical activity attenuates, the adverse effects of obesity on cardiovascular health.	Univ Antwerp, Univ Antwerp Hosp, Fac Med, Dept Diabetol Metab & Clin Nutr, B-2650 Antwerp, Belgium	University of Antwerp	Van Gaal, LF (corresponding author), Univ Antwerp, Univ Antwerp Hosp, Fac Med, Dept Diabetol Metab & Clin Nutr, Wilrijkstr 10, B-2650 Antwerp, Belgium.	luc.van.gaal@uza.be	Robles-Sardin, Alma E/M-7714-2015; Eckhardt, Erik/G-1567-2010; Adiels, Martin/C-9278-2011; De+Block, Christophe/ABE-1600-2020	Robles-Sardin, Alma E/0000-0003-2044-7793; 				Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Alessi MC, 2006, ARTERIOSCL THROM VAS, V26, P2200, DOI 10.1161/01.ATV.0000242905.41404.68; Alessi MC, 2003, ARTERIOSCL THROM VAS, V23, P1262, DOI 10.1161/01.ATV.0000077401.36885.BB; Arita Y, 2002, CIRCULATION, V105, P2893, DOI 10.1161/01.CIR.0000018622.84402.FF; Bastelica D, 2002, ARTERIOSCL THROM VAS, V22, P173, DOI 10.1161/hq0102.101552; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Berg AH, 2004, AM J PHYSIOL-ENDOC M, V287, pE1178, DOI 10.1152/ajpendo.00002.2004; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; Blair SN, 2004, JAMA-J AM MED ASSOC, V292, P1232, DOI 10.1001/jama.292.10.1232; Blann AD, 1997, THROMB RES, V85, P433, DOI 10.1016/S0049-3848(97)00031-5; Bornstein SR, 2000, DIABETES, V49, P532, DOI 10.2337/diabetes.49.4.532; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Chan DC, 2002, METABOLISM, V51, P1041, DOI 10.1053/meta.2002.33339; Despres JP, 2001, BMJ-BRIT MED J, V322, P716, DOI 10.1136/bmj.322.7288.716; Devaraj S, 2003, CIRCULATION, V107, P398, DOI 10.1161/01.CIR.0000052617.91920.FD; Eckel RH, 2006, CIRCULATION, V113, P2943, DOI 10.1161/CIRCULATIONAHA.106.176583; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Ferrannini E, 2006, ATHEROSCLEROSIS SUPP, V7, P5, DOI 10.1016/j.atherosclerosissup.2006.05.006; Frenais R, 2001, J CLIN ENDOCR METAB, V86, P1962, DOI 10.1210/jc.86.5.1962; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gaudet D, 1998, CIRCULATION, V97, P871, DOI 10.1161/01.CIR.97.9.871; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Haider DG, 2006, DIABETOLOGIA, V49, P1909, DOI 10.1007/s00125-006-0303-7; Hanley AJG, 2004, DIABETES, V53, P1773, DOI 10.2337/diabetes.53.7.1773; Holvoet P, 2004, DIABETES, V53, P1068, DOI 10.2337/diabetes.53.4.1068; Howard BV, 2000, ARTERIOSCL THROM VAS, V20, P830, DOI 10.1161/01.ATV.20.3.830; Howard BV, 2003, ENDOCRIN METAB CLIN, V32, P855, DOI 10.1016/S0889-8529(03)00073-2; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Iwashima Y, 2005, HYPERTENSION, V45, P1094, DOI 10.1161/01.HYP.0000169444.05588.4c; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Konstantinides S, 2001, J CLIN INVEST, V108, P1533, DOI 10.1172/JCI200113143; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Kwiterovich PO, 2002, AM J CARDIOL, V90, p30I; Lakka TA, 2001, ATHEROSCLEROSIS, V154, P497, DOI 10.1016/S0021-9150(00)00514-1; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; Li TY, 2006, CIRCULATION, V113, P499, DOI 10.1161/CIRCULATIONAHA.105.574087; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu RH, 2004, J PHARMACOL EXP THER, V310, P52, DOI 10.1124/jpet.103.065037; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028; McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011; Mertens I, 2006, J THROMB HAEMOST, V4, P1164, DOI 10.1111/j.1538-7836.2006.01919.x; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Mertens I, 2006, EUR J ENDOCRINOL, V155, P477, DOI 10.1530/eje.1.02239; Montani JP, 2004, INT J OBESITY, V28, pS58, DOI 10.1038/sj.ijo.0802858; Nicholls SJ, 2006, AM J CARDIOL, V97, P1553, DOI 10.1016/j.amjcard.2005.12.042; Nigro J, 2006, ENDOCR REV, V27, P242, DOI 10.1210/er.2005-0007; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P2542, DOI 10.1210/jc.2006-0195; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Pontiroli AF, 2004, EUR J ENDOCRINOL, V150, P195, DOI 10.1530/eje.0.1500195; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Rutter MK, 2003, CIRCULATION, V107, P448, DOI 10.1161/01.CIR.0000045671.62860.98; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Singhal A, 2002, CIRCULATION, V106, P1919, DOI 10.1161/01.CIR.0000033219.24717.52; Smith SR, 2006, J CLIN ENDOCR METAB, V91, P2506, DOI 10.1210/jc.2006-1018; Stevens J, 2002, AM J EPIDEMIOL, V156, P832, DOI 10.1093/aje/kwf114; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; TASKINEN M-R, 1987, Diabetes Metabolism Reviews, V3, P551; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Verlohren S, 2004, HYPERTENSION, V44, P271, DOI 10.1161/01.HYP.0000140058.28994.ec; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yki-Jarvinen H, 2005, CURR MOL MED, V5, P287, DOI 10.2174/1566524053766031; Young ME, 2002, CIRCULATION, V105, P1861, DOI 10.1161/01.CIR.0000012467.61045.87; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	81	1889	1948	1	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					875	880		10.1038/nature05487	http://dx.doi.org/10.1038/nature05487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167476				2022-12-28	WOS:000242805400045
J	Chong, YS; Mattar, CN				Chong, Yap-Seng; Mattar, Citra Nurfarah			Mid-level providers: a safe solution for unsafe abortion	LANCET			English	Editorial Material							PHYSICIAN ASSISTANTS		Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119074, Singapore; Natl Univ Singapore Hosp, Singapore 119074, Singapore	National University of Singapore; National University of Singapore	Chong, YS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119074, Singapore.	obgcys@nus.edu.sg		Chong, Yap Seng/0000-0002-7232-8473; Mattar, Citra Nurfarah/0000-0003-0068-6957				*A GUTTM I, 1999, SHAR RESP WOM SOC AB; Dovlo Delanyo, 2004, Hum Resour Health, V2, P7, DOI 10.1186/1478-4491-2-7; FREEDMAN MA, 1986, AM J PUBLIC HEALTH, V76, P550, DOI 10.2105/AJPH.76.5.550; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Goldman MB, 2004, AM J PUBLIC HEALTH, V94, P1352, DOI 10.2105/AJPH.94.8.1352; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; Kulczycki A, 1996, LANCET, V347, P1663, DOI 10.1016/S0140-6736(96)91491-9; VLASSOFF M, 2004, 11 A GUTTM I; WARRINER IK, 2006, LANCET          1129, DOI DOI 10.1016/S0140-6736(06)69742-0; World Health Organization, 2004, UNS AB GLOB REG EST; World Health Organization, 2003, SAF AB TECHN POL GUI	12	8	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					1939	1940		10.1016/S0140-6736(06)69743-2	http://dx.doi.org/10.1016/S0140-6736(06)69743-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141683				2022-12-28	WOS:000242593300004
J	Chen, Y; Flanagan, JG				Chen, Yao; Flanagan, John G.			Follow your nose: Axon pathfinding in olfactory map formation	CELL			English	Editorial Material							ODORANT RECEPTORS; SENSORY MAP; GRADIENTS; GUIDANCE		Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	flanagan@hms.harvard.edu	Flanagan, John/AAM-2995-2020					BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Gierer A, 1998, EUR J NEUROSCI, V10, P388, DOI 10.1046/j.1460-9568.1998.00017.x; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2	8	12	12	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					881	884		10.1016/j.cell.2006.11.017	http://dx.doi.org/10.1016/j.cell.2006.11.017			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129775	Bronze			2022-12-28	WOS:000242613800006
J	Chow, CW; Davis, RJ				Chow, Chi-Wing; Davis, Roger J.			Proteins kinases: Chromatin-associated enzymes?	CELL			English	Review							NUCLEAR-LOCALIZATION; SIGNALING PATHWAY; HOG1 KINASE; TRANSCRIPTION; RECRUITMENT; ACTIVATION; COMPLEX; PHOSPHORYLATION		Univ Massachusetts, Sch Med, Program Mol Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Yeshiva University; Albert Einstein College of Medicine	Chow, CW (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	cchow@aecom.yu.edu; roger.davis@umassmed.edu		Davis, Roger/0000-0002-0130-1652				Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Howe KJ, 2002, BBA-GENE STRUCT EXPR, V1577, P308, DOI 10.1016/S0167-4781(02)00460-8; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Powers T, 2003, CURR TOP MICROBIOL, V279, P39; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Yang TTC, 2005, MOL CELL BIOL, V25, P907, DOI 10.1128/MCB.25.3.907-920.2005	20	44	45	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					887	890		10.1016/j.cell.2006.11.015	http://dx.doi.org/10.1016/j.cell.2006.11.015			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129776	Bronze			2022-12-28	WOS:000242613800007
J	Fabian, AC				Fabian, A. C.			Variable high-energy gamma rays from the elliptical galaxy M87	SCIENCE			English	Editorial Material									Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England	University of Cambridge	Fabian, AC (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	acf@ast.cam.ac.uk						Aharonian F, 2006, SCIENCE, V314, P1424, DOI 10.1126/science.1134408; Aharonian F, 2003, ASTRON ASTROPHYS, V403, pL1, DOI 10.1051/0004-6361:20030372; Beilicke M, 2004, NEW ASTRON REV, V48, P407, DOI 10.1016/j.newar.2003.12.018; Biretta JA, 1999, ASTROPHYS J, V520, P621, DOI 10.1086/307499; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; Young AJ, 2002, ASTROPHYS J, V579, P560, DOI 10.1086/342918; ZNAJEK RL, 1978, MON NOT R ASTRON SOC, V185, P833, DOI 10.1093/mnras/185.4.833	7	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1398	1399		10.1126/science.1136199	http://dx.doi.org/10.1126/science.1136199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138886				2022-12-28	WOS:000242406100021
J	Wang, D; Bushnell, DA; Westover, KD; Kaplan, CD; Kornberg, RD				Wang, Dong; Bushnell, David A.; Westover, Kenneth D.; Kaplan, Craig D.; Kornberg, Roger D.			Structural basis of transcription: Role of the trigger loop in substrate specificity and catalysis	CELL			English	Article							RNA-POLYMERASE-II; RIBONUCLEIC-ACID POLYMERASE; ESCHERICHIA-COLI; DEOXYRIBONUCLEIC ACID; ELONGATION COMPLEX; BETA' SUBUNIT; ACTIVE-CENTER; SECONDARY CHANNEL; MICROCIN J25; ANGSTROM RESOLUTION	New structures of RNA polymerase II (pol II) transcribing complexes reveal a likely key to transcription. The trigger loop swings beneath a correct nucleoside triphosphate (NTP) in the nucleotide addition site, closing off the active center and forming an extensive network of interactions with the NTP base, sugar, phosphates, and additional pol II residues. A histidine side chain in the trigger loop, precisely positioned by these interactions, may literally "trigger" phosphodiester bond formation. Recognition and catalysis are thus coupled, ensuring the fidelity of transcription.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu	Kaplan, Craig/AAO-4500-2021; Wang, Dong/C-8943-2012; Westover, Ken/AAZ-1795-2020	Kaplan, Craig/0000-0002-7518-695X; Westover, Ken/0000-0003-3653-5923	NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049985, R37GM036659] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009151] Funding Source: Medline; NIGMS NIH HHS [GM49985, GM36559, R37 GM036659, R01 GM049985] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERT DA, 1985, J BIOL CHEM, V260, P679; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; Archambault J, 1998, J BACTERIOL, V180, P2590, DOI 10.1128/JB.180.10.2590-2598.1998; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; BORUKHOV S, 1991, J BIOL CHEM, V266, P23932; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; CHAMBERLIN M, 1962, P NATL ACAD SCI USA, V48, P81, DOI 10.1073/pnas.48.1.81; Chlenov M, 2005, J MOL BIOL, V353, P138, DOI 10.1016/j.jmb.2005.07.073; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DeLano W.L, PYMOL MOL GRAPHICS S; Delgado MA, 2001, J BACTERIOL, V183, P4543, DOI 10.1128/JB.183.15.4543-4550.2001; Ederth J, 2006, J MOL BIOL, V356, P1163, DOI 10.1016/j.jmb.2005.11.080; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; FOX CF, 1964, J BIOL CHEM, V239, P175; FURTH JJ, 1962, J BIOL CHEM, V237, P2611; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; HEKMATPANAH DS, 1991, MOL CELL BIOL, V11, P5781, DOI 10.1128/MCB.11.11.5781; Ito K, 1996, MOL GEN GENET, V251, P699, DOI 10.1007/BF02174119; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; KORNBERG A, 1992, DNA REPLICATION, P54; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; LINDSLEY JE, 1994, BIOCHEMISTRY-US, V33, P764, DOI 10.1021/bi00169a018; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; MATHEWS CK, 1972, J BIOL CHEM, V247, P7430; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palangat M, 2004, J MOL BIOL, V341, P429, DOI 10.1016/j.jmb.2004.06.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reichard P, 1985, Basic Life Sci, V31, P33; RHODES G, 1974, J BIOL CHEM, V249, P6675; SILVERMAN RB, 2000, ORGANIC CHEM ENZYME, P85; Svetlov V, 2004, J BIOL CHEM, V279, P38087, DOI 10.1074/jbc.C400316200; Symersky J, 2006, J BIOL CHEM, V281, P1309, DOI 10.1074/jbc.C500405200; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Thuillier V, 1996, EMBO J, V15, P618, DOI 10.1002/j.1460-2075.1996.tb00394.x; Trinh V, 2006, MICROBIOL MOL BIOL R, V70, P12, DOI 10.1128/MMBR.70.1.12-36.2006; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; WEILBAECHER R, 1994, GENE DEV, V8, P2913, DOI 10.1101/gad.8.23.2913; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YANG XF, 1995, J BIOL CHEM, V270, P23930, DOI 10.1074/jbc.270.41.23930; Yuzenkova J, 2002, J BIOL CHEM, V277, P50867, DOI 10.1074/jbc.M209425200; Zakharova N, 1998, J BIOL CHEM, V273, P24912, DOI 10.1074/jbc.273.38.24912; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l	59	348	358	3	39	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 1	2006	127	5					941	954		10.1016/j.cell.2006.11.023	http://dx.doi.org/10.1016/j.cell.2006.11.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129781	Bronze, Green Accepted			2022-12-28	WOS:000242613800012
J	Chung, DC; Faquin, WC; Maher, MM; Harris, NL				Chung, Daniel C.; Faquin, William C.; Maher, Michael M.; Harris, Nancy Lee			Case 37-2006: A 19-year-old woman with thyroid cancer and lower gastrointestinal bleeding - Cribriform-morular variant of papillary thyroid carcinoma, with associated familial adenomatous polyposis caused by a new mutation arising in the APC gene	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SULINDAC; COLI		Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Chung, DC (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Bishop PR, 2001, J CLIN GASTROENTEROL, V33, P72, DOI 10.1097/00004836-200107000-00018; Bulow C, 1997, INT J COLORECTAL DIS, V12, P240, DOI 10.1007/s003840050097; Cameselle-Teijeiro J, 1999, MODERN PATHOL, V12, P400; Cetta F, 1999, AM J PATHOL, V155, P7, DOI 10.1016/S0002-9440(10)65091-2; Cetta F, 2000, J CLIN ENDOCR METAB, V85, P286, DOI 10.1210/jc.85.1.286; Cetta F, 1998, J CLIN ENDOCR METAB, V83, P1003, DOI 10.1210/jc.83.3.1003; Cetta F, 2001, J CLIN ENDOCR METAB, V86, P427, DOI 10.1210/jc.86.1.427; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; HARACH HR, 1994, HISTOPATHOLOGY, V25, P549, DOI 10.1111/j.1365-2559.1994.tb01374.x; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jo WS, 2005, SEMIN ONCOL, V32, P11, DOI 10.1053/j.seminoncol.2004.09.034; NUGENT KP, 1993, GASTROENTEROLOGY, V105, P698, DOI 10.1016/0016-5085(93)90885-G; Park JJ, 2005, ANN SURG, V241, P529, DOI 10.1097/01.sla.0000154270.14308.5f; Perrier ND, 1998, WORLD J SURG, V22, P738, DOI 10.1007/s002689900462; Sklar C, 2000, J CLIN ENDOCR METAB, V85, P3227, DOI 10.1210/jc.85.9.3227; Soravia C, 1999, AM J PATHOL, V154, P127, DOI 10.1016/S0002-9440(10)65259-5; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Tomoda C, 2004, WORLD J SURG, V28, P886, DOI 10.1007/s00268-004-7475-4; Truta Brindusa, 2003, Fam Cancer, V2, P95, DOI 10.1023/A:1025762706854; Zwick A, 1997, GASTROENTEROLOGY, V113, P659, DOI 10.1053/gast.1997.v113.pm9247488	22	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2349	2357		10.1056/NEJMcpc069028	http://dx.doi.org/10.1056/NEJMcpc069028			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110CG	17135589				2022-12-28	WOS:000242355300012
J	Rahmstorf, S				Rahmstorf, Stefan			A semi-empirical approach to projecting future sea-level rise	SCIENCE			English	Article						ocean		A semi-empirical relation is presented that connects global sea-level rise to global mean surface temperature. It is proposed that, for time scales relevant to anthropogenic warming, the rate of sea-level rise is roughly proportional to the magnitude of warming above the temperatures of the pre-Industrial Age. This holds to good approximation for temperature and sea-level changes during the 20th century, with a proportionality constant of 3.4 millimeters/year per degrees C. When applied to future warming scenarios of the Intergovernmental Panel on Climate Change, this relationship results in a projected sea-level rise in 2100 of 0.5 to 1.4 meters above the 1990 level.	Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung	Rahmstorf, S (corresponding author), Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany.	rahmstorf@ozean-klima.de	Rahmstorf, Stefan/A-8465-2010	Rahmstorf, Stefan/0000-0001-6786-7723				Bell R., 2005, EOS T AM GEOPHYS UNI, V86, P226, DOI [10.1029/2005eo240003, 10.1029/2005EO240003, DOI 10.1029/2005EO240003]; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; DOWSETT H, 1994, GLOBAL PLANET CHANGE, V9, P169, DOI 10.1016/0921-8181(94)90015-9; German Advisory Council on Global Change, 2006, FUT OC WARM RIS HIGH; Hansen J, 2001, J GEOPHYS RES-ATMOS, V106, P23947, DOI 10.1029/2001JD000354; Houghton J. T., 2001, CLIMATE CHANGE 2001; Jevrejeva S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003229; Jones PD, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000143; Montoya M, 2005, CLIM DYNAM, V25, P237, DOI 10.1007/s00382-005-0044-l; Raper SCB, 2006, NATURE, V439, P311, DOI 10.1038/nature04448; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; VONDIEMLING TS, 2006, GEOPHYS RES LETT, V333; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	14	1025	1052	13	381	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					368	370		10.1126/science.1135456	http://dx.doi.org/10.1126/science.1135456			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17170254	Green Submitted			2022-12-28	WOS:000243535400039
J	Ye, QZ; Krug, RM; Tao, YZJ				Ye, Qiaozhen; Krug, Robert M.; Tao, Yizhi Jane			The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA	NATURE			English	Article							NUCLEAR-LOCALIZATION; CRYSTAL-STRUCTURE; POLYMERASE; IDENTIFICATION; IMPORT; NP	Influenza A viruses pose a serious threat to world public health, particularly the currently circulating avian H5N1 viruses. The influenza viral nucleoprotein forms the protein scaffold of the helical genomic ribonucleoprotein complexes, and has a critical role in viral RNA replication(1). Here we report a 3.2 angstrom crystal structure of this nucleoprotein, the overall shape of which resembles a crescent with a head and a body domain, with a protein fold different compared with that of the rhabdovirus nucleoprotein(2,3). Oligomerization of the influenza virus nucleoprotein is mediated by a flexible tail loop that is inserted inside a neighbouring molecule. This flexibility in the tail loop enables the nucleoprotein to form loose polymers as well as rigid helices, both of which are important for nucleoprotein functions. Single residue mutations in the tail loop result in the complete loss of nucleoprotein oligomerization. An RNA-binding groove, which is found between the head and body domains at the exterior of the nucleoprotein oligomer, is lined with highly conserved basic residues widely distributed in the primary sequence. The nucleoprotein structure shows that only one of two proposed nuclear localization signals are accessible, and suggests that the body domain of nucleoprotein contains the binding site for the viral polymerase. Our results identify the tail loop binding pocket as a potential target for antiviral development.	Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	Rice University; University of Texas System; University of Texas Austin	Tao, YZJ (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 Main St,MS140, Houston, TX 77005 USA.	ytao@rice.edu		Ye, Qiaozhen/0000-0002-3942-4121				Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; ALBO C, 1995, J VIROL, V69, P3799, DOI 10.1128/JVI.69.6.3799-3806.1995; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Cros JF, 2005, TRAFFIC, V6, P205, DOI 10.1111/j.1600-0854.2005.00263.x; Digard P, 1999, J VIROL, V73, P2222, DOI 10.1128/JVI.73.3.2222-2231.1999; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; HONDA A, 1988, J BIOCHEM-TOKYO, V104, P1021, DOI 10.1093/oxfordjournals.jbchem.a122569; Iseni F, 1998, J GEN VIROL, V79, P2909, DOI 10.1099/0022-1317-79-12-2909; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOBAYASHI M, 1994, J VIROL, V68, P8433, DOI 10.1128/JVI.68.12.8433-8436.1994; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Medcalf L, 1999, J VIROL, V73, P7349, DOI 10.1128/JVI.73.9.7349-7356.1999; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neumann G, 1997, J VIROL, V71, P9690, DOI 10.1128/JVI.71.12.9690-9700.1997; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Rudolph MG, 2003, STRUCTURE, V11, P1219, DOI 10.1016/j.str.2003.08.011; SHAPIRO GI, 1988, J VIROL, V62, P2285, DOI 10.1128/JVI.62.7.2285-2290.1988; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang P, 1997, J VIROL, V71, P1850, DOI 10.1128/JVI.71.3.1850-1856.1997; Weber F, 1998, VIROLOGY, V250, P9, DOI 10.1006/viro.1998.9329	30	328	354	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1078	1082		10.1038/nature05379	http://dx.doi.org/10.1038/nature05379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17151603				2022-12-28	WOS:000242971100058
J	Bergeson, SC; Dean, JD				Bergeson, Steven C.; Dean, John D.			A systems approach to patient-centered care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ADVANCED ACCESS; CHRONIC ILLNESS; MANAGEMENT; OUTCOMES; CONTINUITY; MODEL		Allina Hosp & Clin, Shoreview, MN 55126 USA; Inst Healthcare Improvement, Cambridge, MA USA; Bolton Primary Care Trust, Bolton, England	Institute for Healthcare Improvement	Bergeson, SC (corresponding author), Allina Hosp & Clin, 4194 Lexington Ave N, Shoreview, MN 55126 USA.	steven.bergeson@allina.com						Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Cabana MD, 2004, J FAM PRACTICE, V53, P974; Campion P, 2002, BRIT MED J, V325, P691, DOI 10.1136/bmj.325.7366.691; Cimino JJ, 2002, INT J MED INFORM, V68, P113, DOI 10.1016/S1386-5056(02)00070-9; Connor Maureen, 2002, Crit Care Nurs Clin North Am, V14, P359, DOI 10.1016/S0899-5885(02)00017-5; Delbanco T, 2004, NEW ENGL J MED, V350, P1705, DOI 10.1056/NEJMp038209; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; Griffin SJ, 2004, ANN FAM MED, V2, P595, DOI 10.1370/afm.142; Institute of Medicine, 2001, CROSSING QUALITY CHA; KRAVITZ RL, 1993, ARCH INTERN MED, V153, P1869, DOI 10.1001/archinte.153.16.1869; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283; Montgomery JE, 2004, J GEN INTERN MED, V19, P991, DOI 10.1111/j.1525-1497.2004.30381.x; Moore LG, 2006, J AMBUL CARE MANAG, V29, P195, DOI 10.1097/00004479-200607000-00003; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1035, DOI 10.1001/jama.289.8.1035; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1042, DOI 10.1001/jama.289.8.1042; Sadur CN, 1999, DIABETES CARE, V22, P2011, DOI 10.2337/diacare.22.12.2011; SCHOEN C, 2005, HLTH AFF MILLWO 1128; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; Young RJ, 2005, DIABETES CARE, V28, P278, DOI 10.2337/diacare.28.2.278	24	192	194	0	24	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2848	2851		10.1001/jama.296.23.2848	http://dx.doi.org/10.1001/jama.296.23.2848			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179462				2022-12-28	WOS:000242826400027
J	Grandjean, P; Landrigan, PJ				Grandjean, P.; Landrigan, P. J.			Developmental neurotoxicity of industrial chemicals	LANCET			English	Review							CHILDRENS INTELLECTUAL FUNCTION; POLYCHLORINATED-BIPHENYLS; ENVIRONMENTAL EXPOSURE; PRENATAL EXPOSURE; NEUROBEHAVIORAL DEVELOPMENT; MANGANESE NEUROTOXICITY; OCCUPATIONAL-EXPOSURE; TOLUENE EMBRYOPATHY; PRESCHOOL-CHILDREN; PESTICIDE EXPOSURE	Neurodevelopmental disorders such as autism, attention deficit disorder, mental retardation, and cerebral palsy are common, costly, and can cause lifelong disability. Their causes are mostly unknown. A few industrial chemicals (eg, lead, methylmercury, polychlorinated biphenyls [PCBs], arsenic, and toluene) are recognised causes of neurodevelopmental disorders and subclinical brain dysfunction. Exposure to these chemicals during early fetal development can cause brain injury at doses much lower than those affecting adult brain function. Recognition of these risks has led to evidence-based programmes of prevention, such as elimination of lead additives in petrol. Although these prevention campaigns are highly successful, most were initiated only after substantial delays. Another 200 chemicals are known to cause clinical neurotoxic effects in adults. Despite an absence of systematic testing, many additional chemicals have been shown to be neurotoxic in laboratory models. The toxic effects of such chemicals in the developing human brain are not known and they are not regulated to protect children. The two main impediments to prevention of neurodevelopmental deficits of chemical origin are the great gaps in testing chemicals for developmental neurotoxicity and the high level of proof required for regulation. New, precautionary approaches that recognise the unique vulnerability of the developing brain are needed for testing and control of chemicals.	Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA; Univ So Denmark, Inst Publ Hlth, Odense, Denmark; Mt Sinai Sch Med, Dept Community Med, New York, NY USA; Mt Sinai Sch Med, Dept Pediat, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Southern Denmark; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Grandjean, P (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Landmark Ctr 3E-110,401 Park Dr, Boston, MA 02215 USA.	pgrand@hsph.harvard.edu	Grandjean, Philippe/I-2962-2014	Grandjean, Philippe/0000-0003-4046-9658	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009797, U01ES009797, P42ES007384, P01ES009584] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES11687, ES09584, ES09797, ES07384] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADINOLFI M, 1985, DEV MED CHILD NEUROL, V27, P532; Andersen HR, 2000, TOXICOLOGY, V144, P121, DOI 10.1016/S0300-483X(99)00198-5; ARNOLD GL, 1994, PEDIATRICS, V93, P216; Axelson Olav, 2004, Int J Occup Med Environ Health, V17, P115; BAGHURST PA, 1987, NEUROTOXICOLOGY, V8, P395; Bellinger DC, 2004, ENVIRON RES, V95, P394, DOI 10.1016/j.envres.2003.07.013; Berkowitz GS, 2004, ENVIRON HEALTH PERSP, V112, P388, DOI 10.1289/ehp.6414; BOYLE CA, 1994, PEDIATRICS, V93, P399; Byers RK, 1943, AM J DIS CHILD, V66, P471; Calderon J, 2001, ENVIRON RES, V85, P69, DOI 10.1006/enrs.2000.4106; CALNE DB, 1986, LANCET, V2, P1067, DOI 10.1016/S0140-6736(86)90469-1; *CDCP, 2005, 3 NAT REP HUM EXP EN; CHEN YCJ, 1992, JAMA-J AM MED ASSOC, V268, P3213, DOI 10.1001/jama.268.22.3213; Claudio L, 2000, TOXICOL APPL PHARM, V164, P1, DOI 10.1006/taap.2000.8890; Commission of the European Communities, 2001, COM200188 COMM EUR C; DIETRICH KN, 1987, PEDIATRICS, V80, P721; Dobbing J., 1968, APPLIED NEUROCHEMIST, P287; Eddleston M, 2002, LANCET, V360, P1163, DOI 10.1016/S0140-6736(02)11204-9; ELHASSANI SB, 1983, J TOXICOL-CLIN TOXIC, V19, P875, DOI 10.3109/15563658208992523; Eriksson P, 1997, NEUROTOXICOLOGY, V18, P719; ESKENAZI B, 1988, DEV MED CHILD NEUROL, V30, P492, DOI 10.1111/j.1469-8749.1988.tb04776.x; *EUR FOOD SAF AUTH, OP CONTAM PAN REL PR; Gibson J. L, 1904, AUSTR MED GAZETTE, V23, P149; Ginsberg G, 2004, TOXICOL APPL PHARM, V198, P164, DOI 10.1016/j.taap.2003.10.010; GLADEN BC, 1988, J PEDIATR-US, V113, P991, DOI 10.1016/S0022-3476(88)80569-9; GOLDEY ES, 1995, NEUROTOXICOL TERATOL, V17, P313, DOI 10.1016/0892-0362(94)00073-M; Grandjean P, 2006, PEDIATRICS, V117, pE546, DOI 10.1542/peds.2005-1781; Grandjean P, 2004, ANNU REV PUBL HEALTH, V25, P199, DOI 10.1146/annurev.publhealth.25.050503.153941; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Grandjean P, 2005, DYNAMICS OF MERCURY POLLUTION ON REGIONAL AND GLOBAL SCALES: ATMOSPHERIC PROCESSES AND HUMAN EXPOSURES AROUND THE WORLD, P511, DOI 10.1007/0-387-24494-8_22; GRANDJEAN P, 1991, SCI TOTAL ENVIRON, V101, P25, DOI 10.1016/0048-9697(91)90099-Z; GRANDJEAN P, 2002, CHILDRENS HLTH ENV R, P66; Grosse SD, 2002, ENVIRON HEALTH PERSP, V110, P563, DOI 10.1289/ehp.02110563; Guillette EA, 1998, ENVIRON HEALTH PERSP, V106, P347, DOI 10.2307/3434041; Guo YLL, 2004, INT ARCH OCC ENV HEA, V77, P153, DOI 10.1007/s00420-003-0487-9; HARADA M, 1995, CRIT REV TOXICOL, V25, P1, DOI 10.3109/10408449509089885; Hass U, 2003, TOXICOL LETT, V140, P155, DOI 10.1016/S0378-4274(02)00499-X; HERSH JH, 1985, J PEDIATR-US, V106, P922, DOI 10.1016/S0022-3476(85)80238-9; HUNTER D, 1954, J NEUROL NEUROSUR PS, V17, P235, DOI 10.1136/jnnp.17.4.235; Hviid A, 2003, JAMA-J AM MED ASSOC, V290, P1763, DOI 10.1001/jama.290.13.1763; *INT PROGR CHEM SA, 2001, ENV HLTH CRIT, V244; JACOBSON JL, 1990, J PEDIATR-US, V116, P38, DOI 10.1016/S0022-3476(05)81642-7; Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104; Jensen A.A., 1991, CHEM CONTAMINANTS HU; KIMBROUGH RD, 1989, CLIN EFFECTS ENV CHE; KITAMURA S., 1957, J KUMAMOTO MED SOC S, V32, P1; Kjellstrom T, 1989, 3642 NAT SWED ENV PR; Kogevinas M, 2004, INT J EPIDEMIOL, V33, P1172, DOI 10.1093/ije/dyh318; Landrigan PJ, 2002, ENVIRON HEALTH PERSP, V110, P721, DOI 10.1289/ehp.02110721; Landrigan PJ, 2002, B WORLD HEALTH ORGAN, V80, P768; Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571; LANDRIGAN PJ, 1975, LANCET, V1, P708; LANDRIGAN PJ, 1989, BRIT J IND MED, V46, P593; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Laslo-Baker D, 2004, ARCH PEDIAT ADOL MED, V158, P956, DOI 10.1001/archpedi.158.10.956; Lu Y, 2000, FLUORIDE, V33, P74; MARSH DO, 1981, CLIN TOXICOL, V18, P1311, DOI 10.3109/00099308109035071; Mendola P, 2002, MENT RETARD DEV D R, V8, P188, DOI 10.1002/mrdd.10033; Mergler D, 1999, NEUROTOXICOLOGY, V20, P327; MULLENIX PJ, 1995, NEUROTOXICOL TERATOL, V17, P169, DOI 10.1016/0892-0362(94)00070-T; Myers GJ, 2003, LANCET, V361, P1686, DOI 10.1016/S0140-6736(03)13371-5; National Research Council, 2005, HLTH IMPL PERCHL ING; National Research Council, 2000, TOX EFF METH; National Research Council, 1999, ARS DRINK WAT; National Research Council (US) Committee on Pesticides in the Diets of Infants and Children, 1993, PEST DIETINF CHILD; NEEDLEMAN HL, 1979, NEW ENGL J MED, V300, P689, DOI 10.1056/NEJM197903293001301; Needleman HL, 2002, NEUROTOXICOL TERATOL, V24, P711, DOI 10.1016/S0892-0362(02)00269-6; NEEDLEMAN HL, 1982, NEW ENGL J MED, V306, P367; NRC (National Research Council), 2000, SCI FRONT DEV TOX RI; Oira M, 1973, Nihon Eiseigaku Zasshi, V27, P500; Pal PK, 1999, NEUROTOXICOLOGY, V20, P227; Patandin S, 1999, J PEDIATR-US, V134, P33, DOI 10.1016/S0022-3476(99)70369-0; PEARSON MA, 1994, PEDIATRICS, V93, P211; PIERCE PE, 1972, J AMER MED ASSOC, V220, P1439; QIN LS, 1990, CHINESE J CONTROL EP, V5, P203; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; RODIER PM, 1995, ENVIRON HEALTH PERSP, V103, P73, DOI 10.2307/3432351; Rohlman DS, 2005, NEUROTOXICOLOGY, V26, P589, DOI 10.1016/j.neuro.2004.12.002; Ruckart PZ, 2004, ENVIRON HEALTH PERSP, V112, P46, DOI 10.1289/ehp.6430; Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124; Sakamoto M, 2004, ENVIRON SCI TECHNOL, V38, P3860, DOI 10.1021/es034983m; Scheuplein R, 2002, REGUL TOXICOL PHARM, V35, P429, DOI 10.1006/rtph.2002.1558; SMITH AB, 1982, BRIT J IND MED, V39, P361; Sokol RJ, 2003, JAMA-J AM MED ASSOC, V290, P2996, DOI 10.1001/jama.290.22.2996; STREISSGUTH AP, 1990, ALCOHOL CLIN EXP RES, V14, P662, DOI 10.1111/j.1530-0277.1990.tb01224.x; Takser L, 2005, ENVIRON HEALTH PERSP, V113, P1039, DOI 10.1289/ehp.7685; Takser L, 2003, NEUROTOXICOLOGY, V24, P667, DOI 10.1016/S0161-813X(03)00058-5; Till C, 2001, NEUROTOXICOL TERATOL, V23, P235, DOI 10.1016/S0892-0362(01)00141-6; Tilson HA, 2000, NEUROTOXICOLOGY, V21, P189; Trasande L, 2004, ENVIRON HEALTH PERSP, V112, pA789, DOI 10.1289/ehp.112-a789; Trasande L, 2005, ENVIRON HEALTH PERSP, V113, P590, DOI 10.1289/ehp.7743; Tsai SY, 2003, NEUROTOXICOLOGY, V24, P747, DOI 10.1016/S0161-813X(03)00029-9; U.S. Environmental Protection Agency, 1998, CHEM HAZ DAT AV STUD; United Nations Environment Programme, 2002, GLOB MERC ASS; Vreugdenhil HJI, 2004, NEUROPSYCHOLOGY, V18, P185, DOI 10.1037/0894-4105.18.1.185; Walkowiak J, 2001, LANCET, V358, P1602, DOI 10.1016/S0140-6736(01)06654-5; Warren KR, 2005, BIRTH DEFECTS RES A, V73, P195, DOI 10.1002/bdra.20125; Wasserman GA, 2006, ENVIRON HEALTH PERSP, V114, P124, DOI 10.1289/ehp.8030; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; WHITE RF, 1993, BRIT J IND MED, V50, P613; White RF, 1997, LANCET, V349, P1239, DOI 10.1016/S0140-6736(96)07218-2; Whyatt RM, 2004, ENVIRON HEALTH PERSP, V112, P1125, DOI 10.1289/ehp.6641; WINNEKE G, 1990, NEUROTOXICOL TERATOL, V12, P553, DOI 10.1016/0892-0362(90)90022-5; Wright RO, 2006, NEUROTOXICOLOGY, V27, P210, DOI 10.1016/j.neuro.2005.10.001; Xiang Q, 2003, FLUORIDE, V36, P84; Yamashita N., 1972, Japanese Journal of Hygiene, V27, P364; YOSHIMURA T, 1974, FUKUOKA ACTA MED, V65, P74; Young JG, 2005, NEUROTOXICOLOGY, V26, P199, DOI 10.1016/j.neuro.2004.10.004	110	1323	1354	10	248	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2006	368	9553					2167	2178		10.1016/S0140-6736(06)69665-7	http://dx.doi.org/10.1016/S0140-6736(06)69665-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174709	Green Submitted			2022-12-28	WOS:000242856900025
J	Liu, QS; Greimann, JC; Lima, CD				Liu, Quansheng; Greimann, Jaclyn C.; Lima, Christopher D.			Reconstitution, activities, and structure of the eukaryotic RNA exosome	CELL			English	Article							MESSENGER-RNA; POLY(A) POLYMERASE; PROTEIN; DEGRADATION; COMPLEX; COMPONENTS; MECHANISM; SUBUNITS	The RNA exosome is a multisubunit 3' to 5' exoribonuclease complex that participates in degradation and processing of cellular RNA. To determine the activities and structure of the eukaryotic exosome, we report the reconstitution of 9-subunit exosomes from yeast and human and reconstitution of 10- and 11-subunit exosomes from yeast. Comparative biochemical analysis between purified subunits and reconstituted exosomes using AU-rich, polyadenylated (poly[A]), generic, and structured RNA substrates reveals processive phosphorolytic activities for human Rrp41/Rrp45 and the 9-subunit human exosome, processive hydrolytic activities for yeast Rrp44 and the yeast 10-sub-unit exosome, distributive hydrolytic activities for Rrp6, and processive and distributive hydrolytic activities for the yeast 11-subunit exosome. To elucidate the architecture of a eukaryotic exosome, its conserved surfaces, and the structural basis for RNA decay, we report the X-ray structure determination for the 286 kDa nine-subunit human exosome at 3.35 angstrom.	Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA; Sloan Kettering Inst, Training Program Chem Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA.	limac@mskcc.org		Lima, Christopher/0000-0002-9163-6092	NCI NIH HHS [Y1-CO-1020] Funding Source: Medline; NCRR NIH HHS [RR-15301] Funding Source: Medline; NIGMS NIH HHS [Y1-GM-1104] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Aloy P, 2002, EMBO REP, V3, P628, DOI 10.1093/embo-reports/kvf135; Anderson JR, 2006, RNA, V12, P1810, DOI 10.1261/rna.144606; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; ARAKI Y, 2001, J BIOL CHEM, V277, P21624; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; DeLano W.L, PYMOL MOL GRAPHICS S; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Evguenieva-Hackenberg E, 2003, EMBO REP, V4, P889, DOI 10.1038/sj.embor.embor929; Graham AC, 2006, MOL BIOL CELL, V17, P1399, DOI 10.1091/mbc.e05-08-0805; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Jiang TJ, 2002, P NATL ACAD SCI USA, V99, P5295, DOI 10.1073/pnas.072083699; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Lorentzen E, 2006, CELL, V125, P651, DOI 10.1016/j.cell.2006.05.002; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raijmakers R, 2004, EUR J CELL BIOL, V83, P175, DOI 10.1078/0171-9335-00385; Raijmakers R, 2002, J MOL BIOL, V323, P653, DOI 10.1016/S0022-2836(02)00947-6; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	44	404	438	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1223	1237		10.1016/j.cell.2006.10.037	http://dx.doi.org/10.1016/j.cell.2006.10.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174896	Bronze			2022-12-28	WOS:000242991000019
J	Briseno, AL; Mannsfeld, SCB; Ling, MM; Liu, SH; Tseng, RJ; Reese, C; Roberts, ME; Yang, Y; Wudl, F; Bao, ZN				Briseno, Alejandro L.; Mannsfeld, Stefan C. B.; Ling, Mang M.; Liu, Shuhong; Tseng, Ricky J.; Reese, Colin; Roberts, Mark E.; Yang, Yang; Wudl, Fred; Bao, Zhenan			Patterning organic single-crystal transistor arrays	NATURE			English	Article							THIN-FILM TRANSISTORS; SELF-ASSEMBLED MONOLAYERS; GROWTH; PENTACENE; NUCLEATION; PERFORMANCE; DEVICES	Field-effect transistors made of organic single crystals are ideal for studying the charge transport characteristics of organic semiconductor materials(1). Their outstanding device performance(2-8), relative to that of transistors made of organic thin films, makes them also attractive candidates for electronic applications such as active matrix displays and sensor arrays. These applications require minimal cross-talk between neighbouring devices. In the case of thin film systems, simple patterning of the active semiconductor layer(9,10) minimizes cross-talk. But when using organic single crystals, the only approach currently available for creating arrays of separate devices is manual selection and placing of individual crystals - a process prohibitive for producing devices at high density and with reasonable throughput. In contrast, inorganic crystals have been grown in extended arrays(11-13), and efficient and large-area fabrication of silicon crystalline islands with high mobilities for electronic applications has been reported(14,15). Here we describe a method for effectively fabricating large arrays of single crystals of a wide range of organic semiconductor materials directly onto transistor source - drain electrodes. We find that film domains of octadecyltriethoxysilane microcontact-printed onto either clean Si/SiO2 surfaces or flexible plastic provide control over the nucleation of vapour-grown organic single crystals. This allows us to fabricate large arrays of high-performance organic single-crystal field-effect transistors with mobilities as high as 2.4 cm(2) V-1 s(-1) and on/off ratios greater than 10(7), and devices on flexible substrates that retain their performance after significant bending. These results suggest that our fabrication approach constitutes a promising step that might ultimately allow us to utilize high-performance organic single-crystal field-effect transistors for large-area electronics applications.	Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mat Sci & Engn, Exot Mat Inst, Los Angeles, CA 90095 USA	Stanford University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bao, ZN (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	zbao@chemeng.stanford.edu	Mannsfeld, Stefan/Q-1924-2019; yang, yang/GVT-5210-2022; Lang, Ming/HIK-0758-2022; Roberts, Mark/H-9865-2016; yang, yang/GWB-9426-2022; yang, yang/HGT-7999-2022; Bao, Zhenan/AAC-5044-2019; Yang, Yang/A-2944-2011	Roberts, Mark/0000-0001-5971-6650; Bao, Zhenan/0000-0002-0972-1715; 				Aizenberg J, 1998, NATURE, V394, P868, DOI 10.1038/29730; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; Briseno AL, 2005, J AM CHEM SOC, V127, P12164, DOI 10.1021/ja052919u; Briseno AL, 2006, ADV MATER, V18, P2320, DOI 10.1002/adma.200600634; Choi HY, 2004, ADV MATER, V16, P732, DOI 10.1002/adma.200306244; de Boer RWI, 2004, PHYS STATUS SOLIDI A, V201, P1302, DOI 10.1002/pssa.200404336; De Vusser S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2182008; Granasy L, 2006, J MATER RES, V21, P309, DOI 10.1557/JMR.2006.0011; Granasy L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.206105; He JH, 2006, J PHYS CHEM B, V110, P50, DOI 10.1021/jp055180j; Heringdorf FJMZ, 2001, NATURE, V412, P517, DOI 10.1038/35087532; Huitema HEA, 2001, NATURE, V414, P599, DOI 10.1038/414599a; Kelley TW, 2004, CHEM MATER, V16, P4413, DOI 10.1021/cm049614j; Klauk H, 1999, IEEE T ELECTRON DEV, V46, P1258, DOI 10.1109/16.766895; Klauk H, 2002, J APPL PHYS, V92, P5259, DOI 10.1063/1.1511826; Kloc C, 1997, J CRYST GROWTH, V182, P416, DOI 10.1016/S0022-0248(97)00370-9; Markov I. V, 2003, CRYSTAL GROWTH BEGIN, DOI [10.1142/5172, DOI 10.1142/5172]; Moon H, 2004, J AM CHEM SOC, V126, P15322, DOI 10.1021/ja045208p; Podzorov V, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086602; Pope M., 1999, ELECT PROCESSES ORGA; Ruiz R, 2004, CHEM MATER, V16, P4497, DOI 10.1021/cm049563q; Steudel S, 2004, APPL PHYS LETT, V85, P5550, DOI 10.1063/1.1832732; Sundar VC, 2004, SCIENCE, V303, P1644, DOI 10.1126/science.1094196; van der Wilt PC, 2001, APPL PHYS LETT, V79, P1819, DOI 10.1063/1.1402641; VENABLES JA, 1984, REP PROG PHYS, V47, P399, DOI 10.1088/0034-4885/47/4/002; Verlaak S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.195409; VIKAS R, 2005, P INT EL DEV M 2005, P919; Zeis R, 2006, CHEM MATER, V18, P244, DOI 10.1021/cm0502626	28	892	914	24	794	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					913	917		10.1038/nature05427	http://dx.doi.org/10.1038/nature05427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167482				2022-12-28	WOS:000242805400052
J	Faulkner, DR; Mitchell, TM; Healy, D; Heap, MJ				Faulkner, D. R.; Mitchell, T. M.; Healy, D.; Heap, M. J.			Slip on 'weak' faults by the rotation of regional stress in the fracture damage zone	NATURE			English	Article							SAN-ANDREAS FAULT; INTERNAL STRUCTURE; FRICTION; GROWTH; SYSTEM; MECHANICS; FLUIDS; ROCKS	Slip on unfavourably oriented faults with respect to a remotely applied stress is well documented and implies that faults such as the San Andreas fault(1) and low- angle normal faults(2) are weak when compared to laboratory-measured frictional strength(3). If high pore pressure within fault zones is the cause of such weakness, then stress reorientation within or close to a fault is necessary to allow sufficient fault weakening without the occurrence of hydrofracture(4). From field observations of a major tectonic fault, and using laboratory experiments and numerical modelling, here we show that stress rotation occurs within the fractured damage zone surrounding faults. In particular, we find that stress rotation is considerable for unfavourably oriented 'weak' faults. In the 'weak' fault case, the damage-induced change in elastic properties provides the necessary stress rotation to allow high pore pressure faulting without inducing hydrofracture.	Univ Liverpool, Dept Earth & Ocean Sci, Rock Deformat Lab, Liverpool L69 3GP, Merseyside, England	University of Liverpool	Faulkner, DR (corresponding author), Univ Liverpool, Dept Earth & Ocean Sci, Rock Deformat Lab, Liverpool L69 3GP, Merseyside, England.	faulkner@liv.ac.uk	Mitchell, Thomas/D-9903-2011; Healy, David/G-2005-2010; Faulkner, Daniel/F-7589-2011; Healy, David/A-5305-2009; Mitchell, Thomas M/U-1891-2018; Heap, Michael/C-7215-2011	Mitchell, Thomas M/0000-0003-0809-1528; Heap, Michael/0000-0002-4748-735X	Natural Environment Research Council [NE/C001117/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ANDERS MH, 1994, J STRUCT GEOL, V16, P795, DOI 10.1016/0191-8141(94)90146-5; AYLING MR, 1995, TECTONOPHYSICS, V245, P205, DOI 10.1016/0040-1951(94)00235-2; BYERLEE J, 1990, GEOPHYS RES LETT, V17, P2109, DOI 10.1029/GL017i012p02109; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; CASEY M, 1980, J STRUCT GEOL, V2, P143, DOI 10.1016/0191-8141(80)90044-9; Cembrano J, 2005, TECTONOPHYSICS, V400, P105, DOI 10.1016/j.tecto.2005.02.012; CHESTER FM, 1993, J GEOPHYS RES-SOL EA, V98, P771, DOI 10.1029/92JB01866; Collettini C, 2001, GEOLOGY, V29, P927, DOI 10.1130/0091-7613(2001)029<0927:NFNF>2.0.CO;2; Di Toro G, 2006, SCIENCE, V311, P647, DOI 10.1126/science.1121012; Faulkner DR, 2003, TECTONOPHYSICS, V367, P235, DOI 10.1016/S0040-1951(03)00134-3; Faulkner DR, 2001, GEOLOGY, V29, P503, DOI 10.1130/0091-7613(2001)029<0503:CTMOOF>2.0.CO;2; Hardebeck JL, 1999, SCIENCE, V285, P236, DOI 10.1126/science.285.5425.236; HEAP MJ, UNPUB J STRUCT GEOL; JAEGER JC, 1976, FUNDAMENTALS ROCK ME, P11; LACHENBRUCH AH, 1980, J GEOPHYS RES, V85, P6185, DOI 10.1029/JB085iB11p06185; LOCKNER DA, 1993, NATURE, V363, P250, DOI 10.1038/363250a0; Morrow CA, 2000, GEOPHYS RES LETT, V27, P815, DOI 10.1029/1999GL008401; Provost AS, 2001, J GEOPHYS RES-SOL EA, V106, P11373, DOI 10.1029/2001JB900007; Rice J., 1992, FAULT MECH TRANSPORT, P475, DOI DOI 10.1016/S0074-6142(08)62835-1; Rice JR, 2005, B SEISMOL SOC AM, V95, P109, DOI 10.1785/0120030166; Scholz CH, 2000, GEOLOGY, V28, P163, DOI 10.1130/0091-7613(2000)28<163:EFASSA>2.0.CO;2; SIBSON RH, 1994, PURE APPL GEOPHYS, V142, P645, DOI 10.1007/BF00876058; Townend J, 2000, GEOLOGY, V28, P399, DOI 10.1130/0091-7613(2000)28<399:HFKTCS>2.0.CO;2; Vermilye JM, 1998, J GEOPHYS RES-SOL EA, V103, P12223, DOI 10.1029/98JB00957; Wibberley CAJ, 2005, NATURE, V436, P689, DOI 10.1038/nature03901; Wilson JE, 2003, J STRUCT GEOL, V25, P1855, DOI 10.1016/S0191-8141(03)00036-1; ZOBACK MD, 1987, SCIENCE, V238, P1105, DOI 10.1126/science.238.4830.1105	27	304	312	7	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					922	925		10.1038/nature05353	http://dx.doi.org/10.1038/nature05353			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167484				2022-12-28	WOS:000242805400054
J	Lange, LA; Carlson, CS; Hindorff, LA; Lange, EM; Walston, J; Durda, JP; Cushman, M; Bis, JC; Zeng, DL; Lin, D; Kuller, LH; Nickerson, DA; Psaty, BM; Tracy, RP; Reiner, AP				Lange, Leslie A.; Carlson, Christopher S.; Hindorff, Lucia A.; Lange, Ethan M.; Walston, Jeremy; Durda, J. Peter; Cushman, Mary; Bis, Joshua C.; Zeng, Donglin; Lin, Danyu; Kuller, Lewis H.; Nickerson, Deborah A.; Psaty, Bruce M.; Tracy, Russell P.; Reiner, Alexander P.			Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; INTIMA-MEDIA THICKNESS; MENDELIAN RANDOMIZATION; INFLAMMATORY RESPONSE; RISK-FACTORS; HEALTH; ATHEROSCLEROSIS; PROMOTER; LINKAGE	Context C-reactive protein (CRP) is an inflammation protein that may play a role in the pathogenesis of cardiovascular disease (CVD). Objective To assess whether polymorphisms in the CRP gene are associated with plasma CRP, carotid intima-media thickness (CIMT), and CVD events. Design, Setting, and Participants In the prospective, population-based Cardiovascular Health Study, 4 tag single-nucleotide polymorphisms ( SNPs) (1919A/ T, 2667G/C, 3872G/A, 5237A/G) were genotyped in 3941 white ( European American) participants and 5 tag SNPs ( addition of 790A/T) were genotyped in 700 black ( African American) participants, aged 65 years or older, all of whom were without myocardial infarction (MI) or stroke before study entry. Median follow-up was 13 years (1989-2003). Main Outcome Measures Baseline CIMT; occurrence of MI, stroke, and CVD mortality during follow-up. Results In white participants, 461 incident MIs, 491 incident strokes, and 490 CVD-related deaths occurred; in black participants, 67 incident MIs, 78 incident strokes, and 75 CVD-related deaths occurred. The 1919T and 790T alleles were associated with higher CRP levels in white and black participants, respectively. The 3872A allele was associated with lower CRP levels in both populations, and the 2667C allele was associated with lower CRP levels in white participants only. There was no association between CIMT and any CRP gene polymorphism in either population. In white participants, the 1919T allele was associated with increased risk of stroke for TT vs AA ( hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.06- 1.87) and for CVD mortality ( HR, 1.40; 95% CI, 1.10-1.90). In black participants, homozygosity for the 790T allele was associated with a 4-fold increased risk of MI compared with homozygosity for the 790A allele ( 95% CI, 1.58-10.53). The minor alleles of the 2 SNPs associated with lower plasma CRP concentration in white participants ( 2667C and 3872A) were associated with decreased risk of CVD mortality. Conclusions Genetic variation in the CRP gene is associated with plasma CRP levels and CVD risk in older adults.	Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Johns Hopkins Univ, Sch Med, Ctr Aging & Hlth, Baltimore, MD USA; Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University; University of Vermont; University of Vermont; University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lange, LA (corresponding author), Univ N Carolina, Dept Genet, Campus Box 7264,103 Mason Farm Rd, Chapel Hill, NC 27599 USA.	leslie_lange@med.unc.edu			NHLBI NIH HHS [N01 HC-15103, N01-HC-85083, N01-HC-85086, N01-HC-85084, N01-HC-85085, N01-HC-85081, N01-HC-85080, N01-HC-85079, N01-HC-85082, N01-HC-35129, R01 HL-071862-03] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035129, N01HC085081, N01HC085080, N01HC085084, N01HC085083, N01HC015103, N01HC085085, N01HC085082, N01HC085079, N01HC085086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071862] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; CUSHMAN M, 1995, CLIN CHEM, V41, P264; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Danenberg HD, 2003, CIRCULATION, V108, P512, DOI 10.1161/01.CIR.0000085568.13915.1E; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Danik JS, 2006, ANN HUM GENET, V70, P705, DOI 10.1111/j.1469-1809.2006.00272.x; de Maat MPM, 2004, ARTERIOSCL THROM VAS, V24, P2168, DOI 10.1161/01.ATV.0000143856.01669.e7; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gill R, 2004, J CEREBR BLOOD F MET, V24, P1214, DOI 10.1097/01.WCB.0000136517.61642.99; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Jialal I, 2004, HYPERTENSION, V44, P6, DOI 10.1161/01.HYP.0000130484.20501.df; Juonala M, 2006, ARTERIOSCL THROM VAS, V26, P1883, DOI 10.1161/01.ATV.0000228818.11968.7a; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Kobayashi S, 2003, ARTERIOSCL THROM VAS, V23, P1398, DOI 10.1161/01.ATV.0000081637.36475.BC; KULLER L, 1994, AM J EPIDEMIOL, V139, P1164, DOI 10.1093/oxfordjournals.aje.a116963; Ledue TB, 2003, CLIN CHEM, V49, P1258, DOI 10.1373/49.8.1258; LEWONTIN RC, 1964, GENETICS, V49, P49; Lin DY, 2004, GENET EPIDEMIOL, V26, P255, DOI 10.1002/gepi.10317; Macy EM, 1997, CLIN CHEM, V43, P52; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Reiner AP, 2005, AM J HUM GENET, V76, P463, DOI 10.1086/428654; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sano T, 2003, CIRCULATION, V108, P282, DOI 10.1161/01.CIR.0000079173.84669.4F; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, P1051, DOI 10.1161/01.ATV.0000160351.95181.d0; Smith GD, 2004, QJM-INT J MED, V97, P163, DOI 10.1093/qjmed/hch025; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167; Vickers MA, 2002, CARDIOVASC RES, V53, P1029, DOI 10.1016/S0008-6363(01)00534-X; Williams TN, 2004, ARTERIOSCL THROM VAS, V24, P61, DOI 10.1161/01.ATV.0000104014.24367.16; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	45	209	222	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2703	2711		10.1001/jama.296.22.2703	http://dx.doi.org/10.1001/jama.296.22.2703			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164456	Bronze			2022-12-28	WOS:000242765700025
J	Boyd, R				Boyd, Robert			The puzzle of human sociality	SCIENCE			English	Editorial Material							EVOLUTION; ALTRUISM		Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Boyd, R (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA.	rboyd@anthro.ucla.edu						Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Darwin Charles, 1871, DESCENT MAN; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Richerson P. J., 2005, NOT GENES ALONE CULT; ROGERS AR, 1990, AM NAT, V135, P398, DOI 10.1086/285053; Smith EA, 2003, DAHL WS ENV, P401; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971	7	47	48	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1555	1556		10.1126/science.1136841	http://dx.doi.org/10.1126/science.1136841			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158313				2022-12-28	WOS:000242624600027
J	Faure, J; Rechatin, C; Norlin, A; Lifschitz, A; Glinec, Y; Malka, V				Faure, J.; Rechatin, C.; Norlin, A.; Lifschitz, A.; Glinec, Y.; Malka, V.			Controlled injection and acceleration of electrons in plasma wakefields by colliding laser pulses	NATURE			English	Article							BEAMS	In laser-plasma-based accelerators(1), an intense laser pulse drives a large electric field ( the wakefield) which accelerates particles to high energies in distances much shorter than in conventional accelerators. These high acceleration gradients, of a few hundreds of gigavolts per metre, hold the promise of compact high-energy particle accelerators. Recently, several experiments have shown that laser-plasma accelerators can produce high-quality electron beams, with quasi-monoenergetic energy distributions at the 100 MeV level(2-4). However, these beams do not have the stability and reproducibility that are required for applications. This is because the mechanism responsible for injecting electrons into the wakefield is based on highly nonlinear phenomena(5), and is therefore hard to control. Here we demonstrate that the injection and subsequent acceleration of electrons can be controlled by using a second laser pulse(6). The collision of the two laser pulses provides a pre-acceleration stage which provokes the injection of electrons into the wakefield. The experimental results show that the electron beams obtained in this manner are collimated ( 5 mrad divergence), monoenergetic ( with energy spread <10 per cent), tuneable ( between 15 and 250 MeV) and, most importantly, stable. In addition, the experimental observations are compatible with electron bunch durations shorter than 10 fs. We anticipate that this stable and compact electron source will have a strong impact on applications requiring short bunches, such as the femtolysis of water 7, or high stability, such as radiotherapy with high- energy electrons(8,9) or radiography(10) for materials science.	Ecole Polytech, CNRS, UMR 7639, ENSTA,Lab Opt Appl, F-91761 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut Polytechnique de Paris	Malka, V (corresponding author), Ecole Polytech, CNRS, UMR 7639, ENSTA,Lab Opt Appl, F-91761 Palaiseau, France.	victor.malka@ensta.fr	Malka, Victor/AAU-2963-2020; Malka, Victor/F-5260-2010; Faure, Jerome/N-5873-2017	Malka, Victor/0000-0002-0488-2587; Malka, Victor/0000-0002-0488-2587; Faure, Jerome/0000-0003-0538-5774				Brozek-Pluska B, 2005, RADIAT PHYS CHEM, V72, P149, DOI 10.1016/j.radphyschem.2004.06.014; DesRosiers C, 2000, PHYS MED BIOL, V45, P1781, DOI 10.1088/0031-9155/45/7/306; Esarey E, 1997, PHYS REV LETT, V79, P2682, DOI 10.1103/PhysRevLett.79.2682; Faure J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.205003; Faure J, 2004, NATURE, V431, P541, DOI 10.1038/nature02963; Fubiani G, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016402; Geddes CGR, 2004, NATURE, V431, P538, DOI 10.1038/nature02900; Glinec Y, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2360988; Glinec Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.025003; Glinec Y, 2006, MED PHYS, V33, P155, DOI 10.1118/1.2140115; Hsieh CT, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.095001; Kotaki H, 2004, PHYS PLASMAS, V11, P3296, DOI 10.1063/1.1751171; Leemans WP, 2006, NAT PHYS, V2, P696, DOI 10.1038/nphys418; Mangles SPD, 2004, NATURE, V431, P535, DOI 10.1038/nature02939; Pukhov A, 2002, APPL PHYS B-LASERS O, V74, P355, DOI 10.1007/s003400200795; Semushin S, 2001, REV SCI INSTRUM, V72, P2961, DOI 10.1063/1.1380393; SUN GZ, 1987, PHYS FLUIDS, V30, P526, DOI 10.1063/1.866349; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Tsung FS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.185002; Umstadter D, 1996, PHYS REV LETT, V76, P2073, DOI 10.1103/PhysRevLett.76.2073	20	689	706	2	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					737	739		10.1038/nature05393	http://dx.doi.org/10.1038/nature05393			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151663				2022-12-28	WOS:000242581100055
J	Pronyk, PM; Hargreaves, JR; Kim, JC; Morison, LA; Phetla, G; Watts, C; Busza, J; Porter, JDH				Pronyk, Paul M.; Hargreaves, James R.; Kim, Julia C.; Morison, Linda A.; Phetla, Godfrey; Watts, Charlotte; Busza, Joanna; Porter, John D. H.			Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial	LANCET			English	Article							CREDIT PROGRAMS; WOMEN; POWER; RISK	Background HIV infection and intimate-partner violence share a common risk environment in much of southern Africa. The aim of the Intervention with Microfinance for AIDS and Gender Equity (IMAGE) study was to assess a structural intervention that combined a microfinance programme with a gender and HIV training curriculum. Methods Villages in the rural Limpopo province of South Africa were pair-matched and randomly allocated to receive the intervention at study onset (intervention group, n=4) or 3 years later (comparison group, n=4). Loans were provided to poor women who enrolled in the intervention group. A participatory learning and action curriculum was integrated into loan meetings, which took place every 2 weeks. Both arms of the trial were divided into three groups: direct programme participants or matched controls (cohort one), randomly selected 14-35-year-old household co-residents (cohort two), and randomly selected community members (cohort three). Primary outcomes were experience of intimate-partner violence either physical or sexual-in the past 12 months by a spouse or other sexual intimate (cohort one), unprotected sexual intercourse at last occurrence with a non-spousal partner in the past 12 months (cohorts two and three), and HIV incidence (cohort three). Analyses were done on a per-protocol basis. This trial is registered with ClinicalTrials.gov, number NCT00242957. Findings in cohort one, experience of intimate-partner violence was reduced by 55% (adjusted risk ratio [aRR] 0.45, 95% CI 0.23-0.91; adjusted risk difference -7.3%,-16.2 to 1.5). The intervention did not affect the rate of unprotected sexual intercourse with a non-spousal partner in cohort two (aRR 1.02, 0.85-1.23), and there was no effect on the rate of unprotected sexual intercourse at last occurrence with a non-spousal partner (0.89, 0.66-1.19) or HIV incidence (1.06, 0.66-1.69) in cohort three. Interpretation A combined microfinance and training intervention can lead to reductions in levels of intimate-partner violence in programme participants. Social and economic development interventions have the potential to alter risk environments for HIV and intimate-partner violence in southern Africa.	Univ Witwatersrand, Rural AIDS & Dev Act Res Programme, Sch Publ Hlth, ZA-1360 Acornhoek, South Africa; London Sch Hyg & Trop Med, London WC1, England	University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine	Pronyk, PM (corresponding author), Univ Witwatersrand, Rural AIDS & Dev Act Res Programme, Sch Publ Hlth, POB 2, ZA-1360 Acornhoek, South Africa.	pronyk@soft.co.za	Morison, Linda A/H-9738-2013; de Groot, M/A-2025-2012	Busza, Joanna/0000-0001-6334-0318; Hargreaves, James/0000-0002-3509-3572	Economic and Social Research Council [ES/E003818/1] Funding Source: researchfish; ESRC [ES/E003818/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Armendaritz de Aghion B, 2005, EC MICROFINANCE; Armitage P., 2001, STAT METHODS MED RES; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; Bonell C, 2006, SOC SCI MED, V63, P1135, DOI 10.1016/j.socscimed.2006.03.026; CHESTON S, 2002, PATHWAYS OUT POVERTY, P167; COLLINSON MA, IN PRESS AFRICAN MIG; *DEP HLTH, 2004, NAT HIV SYPH ANT SER; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Fenton L, 2004, LANCET, V364, P1186, DOI 10.1016/S0140-6736(04)17109-2; Friedman SR, 1997, AIDS, V11, pS201; Garcia-Moreno C, 2000, AIDS, V14, pS253; Goetz AM, 1996, WORLD DEV, V24, P45, DOI 10.1016/0305-750X(95)00124-U; GOLDBERG N, 2005, GRAMEEN FDN US PUBLI; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Gupta GR, 2002, BRIT MED J, V324, P183, DOI 10.1136/bmj.324.7331.183; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; HARGREAVES J, INTERVENTION MICROFI; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; *HUM SCI RES COUNC, 2002, S AFR NAT HIV PREV B; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; LESTRADEJEFFERI.J, 2000, PEOPLE S AFRICA POPU; Merson MH, 2000, AIDS, V14, pS68; *MICR SUMM CAMP, 2005, STAT MICR SUMM CAMP; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Pisani E, 2003, BRIT MED J, V326, P1384, DOI 10.1136/bmj.326.7403.1384; PRONYK PM, 2005, SMALL ENTERPRISE DEV, V16, P26, DOI [DOI 10.1016/S0140-6736(06)69744-4, DOI 10.3362/0957-1329.2005.030]; *RADAR, IMAGE STUD INT MON, V2; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rose D, 2002, PUBLIC HEALTH NUTR, V5, P383, DOI 10.1079/PHN2001320; SCHULER SR, 1994, STUD FAMILY PLANN, V25, P65, DOI 10.2307/2138085; Sorensen G, 1998, ANNU REV PUBL HEALTH, V19, P379, DOI 10.1146/annurev.publhealth.19.1.379; Sumartojo E, 2000, AIDS, V14, pS1, DOI 10.1097/00002030-200006001-00001; *UNAIDS, 2002, UN GEN ASS SPEC SESS; *UNAIDS, 1999, GEND HIV AIDS TAK ST; Waldo CR, 2000, AIDS, V14, pS18; Weiss Ellen, 1994, AIDS S1, V8, pS325; WHO, 2001, WHOEIPGPE992; Wright GAN, 2000, MICROFINANCE SYSTEMS; Yunus M, 1999, SCI AM, V281, P114, DOI 10.1038/scientificamerican1199-114	39	605	611	1	93	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					1973	1983		10.1016/S0140-6736(06)69744-4	http://dx.doi.org/10.1016/S0140-6736(06)69744-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141704				2022-12-28	WOS:000242593300029
J	Sepulveda, J; Bustreo, F; Tapia, R; Rivera, J; Lozano, R; Olaiz, G; Partida, V; Garcia-Garcia, L; Valdespino, JL				Sepulveda, Jaime; Bustreo, Flavia; Tapia, Roberto; Rivera, Juan; Lozano, Rafael; Olaiz, Gustavo; Partida, Virgilio; Garcia-Garcia, Lourdes; Luis Valdespino, Jose			Health system reform in Mexico 6 - Improvement of child survival in Mexico: the diagonal approach	LANCET			English	Article							NUTRITION SURVEY 1999; DEVELOPING-COUNTRIES; NEONATAL SURVIVAL; YOUNG-CHILDREN; NEWBORN BABIES; MORTALITY; DIARRHEA; MALNUTRITION; POLICY; DISEASES	Public health interventions aimed at children in Mexico have placed the country among the seven countries on track to achieve the goal of child mortality reduction by 2015. We analysed census data, mortality registries, the nominal registry of children, national nutrition surveys, and explored temporal association and biological plausibility to explain the reduction of child, infant, and neonatal mortality rates. During the past 25 years, child mortality rates declined from 64 to 23 per 1000 livebirths. A dramatic decline in diarrhoea mortality rates was recorded. Polio, diphtheria, and measles were eliminated. Nutritional status of children improved significantly for wasting, stunting, and underweight. A selection of highly cost-effective interventions bridging clinics and homes, what we called the diagonal approach, were central to this progress. Although a causal link to the reduction of child mortality was not possible to establish, we saw evidence of temporal association and biological plausibility to the high level of coverage of public health interventions, as well as significant association to the investments in women education, social protection, water, and sanitation. Leadership and continuity of public health policies, along with investments on institutions and human resources strengthening, were also among the reasons for these achievements.	Inst Nacl Salud Publ, Norwegian Govt Initiat MDG4, Cuernavaca, Morelos, Mexico; Secretaria Salud Mexico, Mexico City, DF, Mexico; Consejo Nacl Poblac, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica	Sepulveda, J (corresponding author), Coordinac Gen Inst Nacl Salud, Calle Periferico Sur 4118,1er Piso Edif Zafiro 1, Mexico City 1900, DF, Mexico.	jsepulveda@insp.mx	Lozano, Rafael/T-5352-2018; García, Maria de Lourdes/I-2724-2019	Lozano, Rafael/0000-0002-7356-8823; García, Maria de Lourdes/0000-0001-5262-1157				Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BRASS W, 1975, OCCATIONAL PUBLICATI; Brown KH, 2003, J NUTR, V133, p328S, DOI 10.1093/jn/133.1.328S; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; CAULFIELD L, 2006, STUNTING WASTING MIC, P551; Cifuentes E, 2002, INT J ENVIRON HEAL R, V12, P53, DOI 10.1080/09603120120110059; Cifuentes E, 1999, HEALTH PLACE, V5, P247, DOI 10.1016/S1353-8292(99)00013-1; *CONAPO, 2006, EST PROYECC CONS NAC; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; DORFMAN R, 1979, REV ECON STAT, V61, P146, DOI 10.2307/1924845; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; FRENK J, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69564-0; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; HERNANDEZLAOS E, 2003, GLOBALIZACION DESIGU; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Lawn JE, 2004, LANCET, V364, P399, DOI 10.1016/S0140-6736(04)16783-4; Lee LF, 1997, J ECONOMETRICS, V77, P209, DOI 10.1016/S0304-4076(96)01813-1; LOZANO R, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69566-4; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; MERRICK TW, 1985, DEMOGRAPHY, V22, P1, DOI 10.2307/2060983; Mosley WH, 2003, B WORLD HEALTH ORGAN, V81, P140; PARTIDABUSH V, 2005, MORTALIDAD PRIMEROS, P193; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Ravallion, 2001, DOES PIPED WATER RED; Resano-Perez E, 2003, SALUD PUBLICA MEXICO, V45, pS558; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Rivera JA, 2003, SALUD PUBLICA MEXICO, V45, pS565; Robles-Sardin AE, 1998, SALUD PUBLICA MEXICO, V40, P309, DOI 10.1590/S0036-36341998000400002; SCRIMSHAW NS, 1968, WHO MONOGRAPH SERIES, V57; *SECR SAL PROGR AC, 2002, ARR PAR VID; Sepulveda J, 2006, INT J INFECT DIS, V10, P4, DOI 10.1016/j.ijid.2005.05.005; SEPULVEDA J, 1988, AM J EPIDEMIOL, V127, P365, DOI 10.1093/oxfordjournals.aje.a114810; Sepulveda J, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, pXIII; Sepulveda-Amor J, 1990, Gac Med Mex, V126, P207; Tinker A, 2005, LANCET, V365, P822, DOI 10.1016/S0140-6736(05)71016-3; VALDESPINO JL, 1996, WHOCTDSIP962; Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246; Victora CG, 1996, HEALTH POLICY PLANN, V11, P132, DOI 10.1093/heapol/11.2.132; Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19; Wagstaff A, 2004, AM J PUBLIC HEALTH, V94, P726, DOI 10.2105/AJPH.94.5.726; [No title captured]; [No title captured]	46	132	134	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					2017	2027		10.1016/S0140-6736(06)69569-X	http://dx.doi.org/10.1016/S0140-6736(06)69569-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141709				2022-12-28	WOS:000242593300034
J	Niessen, CM; Yap, AS				Niessen, Carien M.; Yap, Alpha S.			Another job for the talented p120-catenin	CELL			English	Editorial Material							P120 CATENIN; P190RHOGAP; RHOA		Univ Cologne, CMMC, D-50931 Cologne, Germany; Univ Queensland, Inst Mol Biosci, Div Mol Cell Biol, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Cologne; University of Queensland	Niessen, CM (corresponding author), Univ Cologne, CMMC, Joseph Stelzmannstr 9, D-50931 Cologne, Germany.	carien.niessen@uni-koeln.de; a.yap@imb.uq.edu.au	Yap, Alpha S./J-1554-2014	Yap, Alpha S./0000-0002-1038-8956; Niessen, Carien M./0000-0002-4892-9391				Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Braga VMM, 2005, CURR OPIN CELL BIOL, V17, P466, DOI 10.1016/j.ceb.2005.08.012; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; ETIENNEMANNEVIL.S, 2006, BIOCH BIOPHYS A 0701, DOI DOI 10.1016/J.BBAMCR.2006.06.009; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022	8	9	10	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 1	2006	127	5					875	877		10.1016/j.cell.2006.11.014	http://dx.doi.org/10.1016/j.cell.2006.11.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129772	Bronze			2022-12-28	WOS:000242613800003
J	McDearmon, EL; Patel, KN; Ko, CH; Walisser, JA; Schook, AC; Chong, JL; Wilsbacher, LD; Song, EJ; Hong, HK; Bradfield, CA; Takahashi, JS				McDearmon, Erin L.; Patel, Kush N.; Ko, Caroline H.; Walisser, Jacqueline A.; Schook, Andrew C.; Chong, Jason L.; Wilsbacher, Lisa D.; Song, Eun J.; Hong, Hee-Kyung; Bradfield, Christopher A.; Takahashi, Joseph S.			Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice	SCIENCE			English	Article							GENE-EXPRESSION; CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; TRANSCRIPTION; COMPONENT; MOUSE; LIVER; MOP3	The basic helix-loop-helix ( bHLH) - Per-Arnt-Sim ( PAS) domain transcription factor BMAL1 is an essential component of the mammalian circadian pacemaker. Bmal1(-/-) mice lose circadian rhythmicity but also display tendon calcification and decreased activity, body weight, and longevity. To investigate whether these diverse functions of BMAL1 are tissue-specific, we produced transgenic mice that constitutively express Bmal1 in brain or muscle and examined the effects of rescued gene expression in Bmal1(-/-) mice. Circadian rhythms of wheel-running activity were restored in brain-rescued Bmal1(-/-) mice in a conditional manner; however, activity levels and body weight were lower than those of wild-type mice. In contrast, muscle-rescued Bmal1(-/-) mice exhibited normal activity levels and body weight yet remained behaviorally arrhythmic. Thus, Bmal1 has distinct tissue-specific functions that regulate integrative physiology.	Northwestern Univ, Dept Neurobiol & Physiol, Howard Hughes Med Inst, Evanston, IL 60208 USA; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	Howard Hughes Medical Institute; Northwestern University; University of Toronto; University of Wisconsin System; University of Wisconsin Madison	Takahashi, JS (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Howard Hughes Med Inst, 2153 Sheridan Rd, Evanston, IL 60208 USA.	j-takahashi@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012; Ko, Caroline/E-6877-2010	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; 	Howard Hughes Medical Institute Funding Source: Medline; NIEHS NIH HHS [R01 ES005703] Funding Source: Medline; NIMH NIH HHS [P50 MH074924] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; HONG H, 2006, BIENN M SOC RES BIOL; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kornmann B, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.11.e51; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Sujino M, 2003, CURR BIOL, V13, P664, DOI 10.1016/S0960-9822(03)00222-7; SUN Y, 2006, J BIOMED SCI; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906	23	235	240	3	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2006	314	5803					1304	1308		10.1126/science.1132430	http://dx.doi.org/10.1126/science.1132430			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124323	Green Accepted			2022-12-28	WOS:000242215800045
J	Uauy, C; Distelfeld, A; Fahima, T; Blechl, A; Dubcovsky, J				Uauy, Cristobal; Distelfeld, Assaf; Fahima, Tzion; Blechl, Ann; Dubcovsky, Jorge			A NAC gene regulating senescence improves grain protein, zinc, and iron content in wheat	SCIENCE			English	Article							L. VAR. DICOCCOIDES; DURUM-WHEAT; GPC-B1	Enhancing the nutritional value of food crops is a means of improving human nutrition and health. We report here the positional cloning of Gpc-B1, a wheat quantitative trait locus associated with increased grain protein, zinc, and iron content. The ancestral wild wheat allele encodes a NAC transcription factor (NAM-B1) that accelerates senescence and increases nutrient remobilization from leaves to developing grains, whereas modern wheat varieties carry a nonfunctional NAM-B1 allele. Reduction in RNA levels of the multiple NAM homologs by RNA interference delayed senescence by more than 3 weeks and reduced wheat grain protein, zinc, and iron content by more than 30%.	Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; Univ Haifa, Inst Evolut, IL-31905 Haifa, Israel; ARS, USDA, Western Reg Res Ctr, Albany, CA 94710 USA	University of California System; University of California Davis; University of Haifa; United States Department of Agriculture (USDA)	Dubcovsky, J (corresponding author), Univ Calif Davis, Dept Plant Sci, 1 Shields Ave, Davis, CA 95616 USA.	jdubcovsky@ucdavis.edu	Distelfeld, Assaf/D-4951-2014; Uauy, Cristobal/T-4382-2019; Dubcovsky, Jorge/T-5214-2019; Dubcovsky, Jorge/A-4969-2008; Uauy, Cristobal/B-3879-2011; Uauy, Cristobal/B-7912-2014	Distelfeld, Assaf/0000-0003-1777-3053; Uauy, Cristobal/0000-0002-9814-1770; Dubcovsky, Jorge/0000-0002-7571-4345; Uauy, Cristobal/0000-0002-9814-1770; Fahima, Tzion/0000-0001-5555-0040	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		AVIVI L, 1978, HIGH PROTEIN CONTENT; Cakmak I, 2004, SOIL SCI PLANT NUTR, V50, P1047, DOI 10.1080/00380768.2004.10408573; Chee PW, 2001, CROP SCI, V41, P295, DOI 10.2135/cropsci2001.412295x; Distelfeld A, 2006, NEW PHYTOL, V169, P753, DOI 10.1111/j.1469-8137.2005.01627.x; DISTELFELD A, IN PRESS PHYSL PLANT; Distelfeld Assaf, 2004, Functional & Integrative Genomics, V4, P59, DOI 10.1007/s10142-003-0097-3; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Joppa LR, 1997, CROP SCI, V37, P1586, DOI 10.2135/cropsci1997.0011183X003700050030x; Maccaferri M, 2003, THEOR APPL GENET, V107, P783, DOI 10.1007/s00122-003-1319-8; Mesfin A, 1999, CROP SCI, V39, P508, DOI 10.2135/cropsci1999.0011183X003900020035x; Olmos S, 2003, THEOR APPL GENET, V107, P1243, DOI 10.1007/s00122-003-1377-y; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; SIMMONDS NW, 1995, J SCI FOOD AGR, V67, P309, DOI 10.1002/jsfa.2740670306; Uauy C, 2006, J EXP BOT, V57, P2785, DOI 10.1093/jxb/erl047; *UN FOOD AGR ORG, 2005, FOOD OUTL; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; *WHO, 2001, M INT PART NUTR	18	991	1134	11	329	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2006	314	5803					1298	1301		10.1126/science.1133649	http://dx.doi.org/10.1126/science.1133649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124321	Green Accepted			2022-12-28	WOS:000242215800043
J	Walden, WE; Selezneva, AI; Dupuy, J; Volbeda, A; Fontecilla-Camps, JC; Theil, EC; Volz, K				Walden, William E.; Selezneva, Anna I.; Dupuy, Jerome; Volbeda, Anne; Fontecilla-Camps, Juan C.; Theil, Elizabeth C.; Volz, Karl			Structure of dual function iron regulatory protein 1 complexed with ferritin IRE-RNA	SCIENCE			English	Article							ELEMENT-BINDING-PROTEIN; RECEPTOR MESSENGER-RNA; RESPONSIVE ELEMENT; CYTOSOLIC ACONITASE; MOLECULAR CONTROL; RECOGNITION; METABOLISM; LOCALIZATION; LOOP/BULGE; REGION	Iron regulatory protein 1 (IRP1) binds iron-responsive elements (IREs) in messenger RNAs (mRNAs), to repress translation or degradation, or binds an iron-sulfur cluster, to become a cytosolic aconitase enzyme. The 2.8 angstrom resolution crystal structure of the IRP1: ferritin H IRE complex shows an open protein conformation compared with that of cytosolic aconitase. The extended, L-shaped IRP1 molecule embraces the IRE stem-loop through interactions at two sites separated by similar to 30 angstroms, each involving about a dozen protein: RNA bonds. Extensive conformational changes related to binding the IRE or an iron-sulfur cluster explain the alternate functions of IRP1 as an mRNA regulator or enzyme.	Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; Univ Grenoble 1, Inst Biol Struct Jean Pierre Horowitz, IBS, Lab Cristallog & Cristallog Prot, F-38207 Grenoble, France; Univ Grenoble 1, CEA, F-38207 Grenoble, France; Univ Grenoble 1, CNRS, F-38207 Grenoble, France; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Univ Calif Berkeley, Dept Nutr Sci & Mol Toxicol, Berkeley, CA 94720 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley	Volz, K (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	kvolz@uic.edu	Dupuy, Jerome/AAD-3438-2020	Dupuy, Jerome/0000-0002-2721-5365; Volbeda, Anne/0000-0002-6038-0979	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK020251, R56DK020251, R01DK020251, R01DK047281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047522] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK20251, DK47281] Funding Source: Medline; NIGMS NIH HHS [GM47522] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; BASILION JP, 1994, P NATL ACAD SCI USA, V91, P574, DOI 10.1073/pnas.91.2.574; Beuning PJ, 1999, BIOPOLYMERS, V52, P1; Brazzolotto X, 2002, J BIOL CHEM, V277, P11995, DOI 10.1074/jbc.M110938200; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; DeLano W.L, PYMOL MOL GRAPHICS S; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; Dupuy J, 2006, STRUCTURE, V14, P129, DOI 10.1016/j.str.2005.09.009; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Gdaniec Z, 1998, BIOCHEMISTRY-US, V37, P1505, DOI 10.1021/bi9719814; Gegout V, 1999, J BIOL CHEM, V274, P15052, DOI 10.1074/jbc.274.21.15052; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; Haasnoot PCJ, 2003, P NATL ACAD SCI USA, V100, P12596, DOI 10.1073/pnas.2135413100; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; HENDERSON BR, 1995, J BIOL CHEM, V270, P20509, DOI 10.1074/jbc.270.35.20509; Henderson ER, 1996, J BIOL CHEM, V271, P4900; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Kaldy P, 1999, EMBO J, V18, P6073, DOI 10.1093/emboj/18.21.6073; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Ke YH, 2002, J BIOL CHEM, V277, P2373, DOI 10.1074/jbc.C100614200; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KIKINIS Z, 1995, NUCLEIC ACIDS RES, V23, P4190, DOI 10.1093/nar/23.20.4190; Laing LG, 1996, BIOCHEMISTRY-US, V35, P13586, DOI 10.1021/bi961310q; *MOL SIM INC, 1997, QUANTA; PHILPOTT CC, 1994, P NATL ACAD SCI USA, V91, P7321, DOI 10.1073/pnas.91.15.7321; PHILPOTT CC, 1993, J BIOL CHEM, V268, P17655; Schlegl J, 1997, RNA, V3, P1159; Selezneva AI, 2006, ACTA CRYSTALLOGR F, V62, P249, DOI 10.1107/S1744309106004192; SWENSON GR, 1994, NUCLEIC ACIDS RES, V22, P2627, DOI 10.1093/nar/22.13.2627; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; TOUAULT TA, 2006, NAT CHEM BIOL, V2, P406	37	213	219	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1903	1908		10.1126/science.1133116	http://dx.doi.org/10.1126/science.1133116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185597				2022-12-28	WOS:000242996800041
J	Chai, Q; Arndt, JW; Dong, M; Tepp, WH; Johnson, EA; Chapman, ER; Stevens, RC				Chai, Qing; Arndt, Joseph W.; Dong, Min; Tepp, William H.; Johnson, Eric A.; Chapman, Edwin R.; Stevens, Raymond C.			Structural basis of cell surface receptor recognition by botulinum neurotoxin B	NATURE			English	Article							H-CC-DOMAIN; CRYSTAL-STRUCTURE; SYNAPTOTAGMIN-I; BINDING-SITES; TETANUS; TOXIN; IDENTIFICATION; GANGLIOSIDES; FRAGMENT; GT1B	Botulinum neurotoxins (BoNTs) are potent bacterial toxins that cause paralysis at femtomolar concentrations 1 by blocking neurotransmitter release. A 'double receptor' model has been proposed in which BoNTs recognize nerve terminals via interactions with both gangliosides and protein receptors that mediate their entry(2). Of seven BoNTs (subtypes A-G), the putative receptors for BoNT/A(3,4), BoNT/B-5,B-6 and BoNT/G(7) have been identified, but the molecular details that govern recognition remain undefined. Here we report the crystal structure of full-length BoNT/B in complex with the synaptotagmin II (Syt-II) recognition domain at 2.6 angstrom resolution. The structure of the complex reveals that Syt-II forms a short helix that binds to a hydrophobic groove within the binding domain of BoNT/B. In addition, mutagenesis of amino acid residues within this interface on Syt-II affects binding of BoNT/B. Structural and sequence analysis reveals that this hydrophobic groove is conserved in the BoNT/G and BoNT/B subtypes, but varies in other clostridial neurotoxins. Furthermore, molecular docking studies using the ganglioside G(T1b) indicate that its binding site is more extensive than previously proposed and might form contacts with both BoNT/B and synaptotagmin. The results provide structural insights into how BoNTs recognize protein receptors and reveal a promising target for blocking toxin-receptor recognition.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Food Res Inst, Dept Food Microbiol & Toxicol, Madison, WI 53706 USA	Scripps Research Institute; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chapman@physiology.wisc.edu; stevens@scripps.edu	Taylor, Graham/A-4027-2012; Stevens, Raymond/K-7272-2015	Stevens, Raymond/0000-0002-4522-8725; Chapman, Edwin/0000-0001-9787-8140				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaramoorthy S, 2004, BIOCHEMISTRY-US, V43, P2209, DOI 10.1021/bi035844k; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Ginalski K, 2000, FEBS LETT, V482, P119, DOI 10.1016/S0014-5793(00)01954-2; Jayaraman S, 2005, PROTEINS, V61, P288, DOI 10.1002/prot.20595; Kitamura M, 1999, BBA-MOL CELL BIOL L, V1441, P1, DOI 10.1016/S1388-1981(99)00140-7; Kozaki S, 1998, MICROB PATHOGENESIS, V25, P91, DOI 10.1006/mpat.1998.0214; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Nishiki T, 1996, NEUROSCI LETT, V208, P105, DOI 10.1016/0304-3940(96)12557-X; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Simpson LL, 2000, BIOCHIMIE, V82, P943, DOI 10.1016/S0300-9084(00)01169-X; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weis WI, 1997, CURR OPIN STRUC BIOL, V7, P624, DOI 10.1016/S0959-440X(97)80070-X; Yowler BC, 2002, J BIOL CHEM, V277, P32815, DOI 10.1074/jbc.M205258200	29	162	172	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1096	1100		10.1038/nature05411	http://dx.doi.org/10.1038/nature05411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17167418				2022-12-28	WOS:000242971100062
J	Ledford, H				Ledford, Heidi			Better, faster - and easier to use	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					993	993		10.1038/444993a	http://dx.doi.org/10.1038/444993a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183287	Bronze			2022-12-28	WOS:000242971100021
J	Ley, RE; Turnbaugh, PJ; Klein, S; Gordon, JI				Ley, Ruth E.; Turnbaugh, Peter J.; Klein, Samuel; Gordon, Jeffrey I.			Microbial ecology - Human gut microbes associated with obesity	NATURE			English	Article									Washington Univ, Sch Med, St Louis, MO 63108 USA	Washington University (WUSTL)	Ley, RE (corresponding author), Washington Univ, Sch Med, St Louis, MO 63108 USA.	jgordon@wustl.edu	Ley, Ruth E/M-8542-2014	Ley, Ruth E/0000-0002-9087-1672; Turnbaugh, Peter/0000-0002-0888-2875	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK056341-05S2, P30 DK056341, P30 DK056341-06] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414	6	5547	5995	63	1339	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1022	1023		10.1038/4441022a	http://dx.doi.org/10.1038/4441022a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183309				2022-12-28	WOS:000242971100042
J	Okie, S				Okie, Susan			Reconstructing lives - A tale of two soldiers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*DEF MANP DAT CTR, GLOB WAR TERR OP END; *DEF MANP DAT CTR, GLOB WAR TERR OP IR; *DEP VET AFF OFF, 0501818165 DEP VET A; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102	4	33	36	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2609	2615		10.1056/NEJMp068235	http://dx.doi.org/10.1056/NEJMp068235			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182985	Bronze			2022-12-28	WOS:000242956200001
J	Heine, RJ; Diamant, M; Mbanya, JC; Nathan, DM				Heine, R. J.; Diamant, M.; Mbanya, J-C; Nathan, D. M.			Management of hyperglycaemia in type 2 diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MICROVASCULAR COMPLICATIONS; INSULIN GLARGINE; GLYCEMIC CONTROL; THERAPY; METFORMIN; SULFONYLUREAS; ASSOCIATION; PROGRESSION; TRIAL		VU Univ Med Ctr Amsterdam, Dept Endocrinol, Ctr Diabet, Amsterdam, Netherlands; Univ Yaounde, Dept Internal Med & Specialties, Diabet & Endocrine Unit, Yaounde, Cameroon; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Diabet, Boston, MA USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Yaounde I; Harvard University; Harvard Medical School; Massachusetts General Hospital	Heine, RJ (corresponding author), VU Univ Med Ctr Amsterdam, Dept Endocrinol, Ctr Diabet, De Boelelaan 1117, Amsterdam, Netherlands.	RJ.Heine@vumc.nl	Mbanya, Jean Claude N/T-5147-2018	Mbanya, Jean Claude N/0000-0001-9651-8653				*AM DIAB ASS, 2005, DIABETES CARE S1, V28, pS15; [Anonymous], 1999, Diabet Med, V16, P716; Cook MN, 2005, DIABETES CARE, V28, P995, DOI 10.2337/diacare.28.5.995; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Drucker DJ, 2005, NAT CLIN PRACT ENDOC, V1, P22, DOI 10.1038/ncpendmet0017; GROOP LC, 1992, DIABETES CARE, V15, P737, DOI 10.2337/diacare.15.6.737; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Holst JJ, 2006, DIABETOLOGIA, V49, P253, DOI 10.1007/s00125-005-0107-1; Holstein A, 2001, DIABETES-METAB RES, V17, P467, DOI 10.1002/dmrr.235; Malaisse Willy J, 2003, Treat Endocrinol, V2, P401, DOI 10.2165/00024677-200302060-00004; Matschinsky FM, 2006, DIABETES, V55, P1; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; MOORE H, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004097.PUB3; Nathan DM, 2006, DIABETOLOGIA, V49, P1711, DOI 10.1007/s00125-006-0316-2; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Osei-Hyiaman D, 2006, INT J OBESITY, V30, pS33, DOI 10.1038/sj.ijo.0803276; Rosenstock J, 2005, ANN INTERN MED, V143, P549, DOI 10.7326/0003-4819-143-8-200510180-00005; Salpeter S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub2; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Van de Laar FA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003639.pub2; Viberti G, 2002, DIABETES CARE, V25, P1737, DOI 10.2337/diacare.25.10.1737; Yki-Jarvinen H, 2006, DIABETOLOGIA, V49, P442, DOI 10.1007/s00125-005-0132-0; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	30	47	49	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2006	333	7580					1200	1204A		10.1136/bmj.39022.462546.80	http://dx.doi.org/10.1136/bmj.39022.462546.80			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	119JW	17158386	Green Published			2022-12-28	WOS:000243009600016
J	Philpott, A; Knerr, W; Maher, D				Philpott, Anne; Knerr, Wendy; Maher, Dermot			Promoting protection and pleasure: amplifying the effectiveness of barriers against sexually transmitted infections and pregnancy	LANCET			English	Editorial Material							CONDOMS; FEMALE; RISK; HIV		Pleasure Project, London NW10 3QD, England; Dept Int Dev, London, England; WHO, CH-1211 Geneva, Switzerland	World Health Organization	Knerr, W (corresponding author), Pleasure Project, 6 Liddell Gardens,Kensal Rise, London NW10 3QD, England.	info@the-pleasure-project.org		Maher, Dermot/0000-0003-0466-1976				Basuki E, 2002, AIDS EDUC PREV, V14, P102, DOI 10.1521/aeap.14.2.102.23901; BHAUMIK S, 2003, KAMA SUTRA GUIDE SAF; Bounds W., 1992, British Journal of Family Planning, V18, P36; BURT K, 2005, GUARDIAN        0823; *COMM DEV SERV, ACC FEM COND STREET; ESWARAPRASAD CH, 2004, FEMALE CONDON INDIAN; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FARR G, 1994, AM J PUBLIC HEALTH, V84, P1960, DOI 10.2105/AJPH.84.12.1960; Foss AM, 2004, BRIT MED J, V329, P185, DOI 10.1136/bmj.329.7459.185; French PP, 2003, SEX TRANSM DIS, V30, P433, DOI 10.1097/00007435-200305000-00010; Garc?a S.G., 2003, UNDERSTANDING SUCCES; Garc?a S.G., 2004, UNDERSTANDING SUCCES; GOSINE A, 228 IDS; HOLLAND J, 1992, AIDS CARE, V4, P273, DOI 10.1080/09540129208253099; *I DEV STUD, POW PLEAS; Ingham R., 2005, SEX ED, V5, P375, DOI [DOI 10.1080/14681810500278451, 10.1080/14681810500278451]; Khan Sharful Islam, 2004, Sex Health, V1, P217, DOI 10.1071/SH04009; *M STOP INT, 2001, FUT PERF M STOP SEAR; *M STOP INT MONG, COND SOC MARK LADY T; MEHRYAR A, 1995, SEXUAL BEHAV AIDS DE; Minnis AM, 2005, SEX TRANSM INFECT, V81, P193, DOI 10.1136/sti.2003.007153; Oncale RM, 2001, ARCH SEX BEHAV, V30, P379, DOI 10.1023/A:1010209331697; OVER M, 1993, DIS CONTROL PRIORITI; PHILPOTT A, 2004, 15 INT AIDS C JUL 11; PHILPOTT A, 13 INT C AIDS SEX TR; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; *POP COUNC, 2005, DOM REP MEX PROM CON; *POP SERV INT, PSI LAOS; *POP SERV INT, PSI CAMB; Rivers K., 1998, CRITICAL PUBLIC HLTH, V8, P273, DOI DOI 10.1080/09581599808402916; Solomon S, 2004, AIDS EDUC PREV, V16, P155, DOI 10.1521/aeap.16.3.5.155.35534; Steiner MJ, 2006, SEX TRANSM DIS, V33, P31, DOI 10.1097/01.olq.0000187200.07639.c6; Thomsen S, 2004, SEX TRANSM INFECT, V80, P430, DOI 10.1136/sti.2004.010421; United States Department of Health and Human Services, WORKSH SUMM SCI EV C; Venis S, 2005, LANCET, V365, P565; WEINSTOCK HS, 1993, SEX TRANSM DIS, V20, P14, DOI 10.1097/00007435-199301000-00004; Weller S, 2002, Cochrane Database Syst Rev, pCD003255; *WHO, GEND REPR RIGHTS SEX; *WHO, FEM COND GUID PLANN, pCH2; *WORLD ASS SEX HLT, 2005, 17 WORLD C SEX MONTR; World Health Organization, 2004, WORLD HLTH REP 2004	41	83	83	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					2028	2031		10.1016/S0140-6736(06)69810-3	http://dx.doi.org/10.1016/S0140-6736(06)69810-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141710				2022-12-28	WOS:000242593300035
J	Shelton, JD				Shelton, James D.			Confessions of a condom lover	LANCET			English	Editorial Material							HIV INCIDENCE; RISK; POPULATION; PREVALENCE; BEHAVIOR; AFRICA		US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	JShelton@USAID.GOV						Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; [Anonymous], 2003, KEN DEM HLTH SURV 20; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Hearst N, 2004, STUD FAMILY PLANN, V35, P39, DOI 10.1111/j.1728-4465.2004.00004.x; Kajubi P, 2005, JAIDS-J ACQ IMM DEF, V40, P77, DOI 10.1097/01.qai.0000157391.63127.b2; Kirungi WL, 2006, SEX TRANSM INFECT, V82, pI36, DOI 10.1136/sti.2005.017111; Shelton JD, 2006, LANCET, V367, P1120, DOI 10.1016/S0140-6736(06)68436-5; Shelton JD, 2001, BRIT MED J, V323, P139, DOI 10.1136/bmj.323.7305.139; Shisana O, 2002, S AFRICAN NATL HIV P; SHISANA O, 2005, S AFRICAN NATL PREVA; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Underwood Carol, 2006, J Adolesc Health, V38, P55; DEMOGRAPHIC HLTH SUR	15	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					1947	1949		10.1016/S0140-6736(06)69787-0	http://dx.doi.org/10.1016/S0140-6736(06)69787-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141688				2022-12-28	WOS:000242593300009
J	Maini, PK; Baker, RE; Chuong, CM				Maini, Philip K.; Baker, Ruth E.; Chuong, Cheng-Ming			The turing model comes of molecular age	SCIENCE			English	Editorial Material							REACTION-DIFFUSION SYSTEM; MECHANISM; PATTERNS		Univ Oxford, Ctr Math Biol, Oxford OX1 3LB, England; Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA	University of Oxford; University of Oxford; University of Southern California	Maini, PK (corresponding author), Univ Oxford, Ctr Math Biol, Oxford OX1 3LB, England.	maini@maths.ox.ac.uk		Baker, Ruth/0000-0002-6304-9333	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042177, R01AR047364] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR047364-04, R01 AR042177-11, R01 AR042177, R01 AR047364-05, R01 AR042177-12, R01 AR047364] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AKAM M, 1989, NATURE, V341, P282, DOI 10.1038/341282a0; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Jiang TX, 1999, DEVELOPMENT, V126, P4997; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; MOONEY JR, 1985, J THEOR BIOL, V115, P299, DOI 10.1016/S0022-5193(85)80102-8; MYERSCOUGH MR, 1990, MATH MOD, V6, P65; NAGORCKA BN, 1983, BIOSYSTEMS, V16, P323, DOI 10.1016/0303-2647(83)90015-1; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012	9	141	146	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1397	1398		10.1126/science.1136396	http://dx.doi.org/10.1126/science.1136396			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138885	Green Submitted, Green Accepted			2022-12-28	WOS:000242406100020
J	Wildenberg, GA; Dohn, MR; Carnahan, RH; Davis, MA; Lobdell, NA; Settleman, J; Reynolds, AB				Wildenberg, Gregg A.; Dohn, Michael R.; Carnahan, Robert H.; Davis, Michael A.; Lobdell, Nichole A.; Settleman, Jeffrey; Reynolds, Albert B.			p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho	CELL			English	Article							P120 CATENIN; FAMILY GTPASES; ACTIN CYTOSKELETON; INHIBITION; MODULATION; EXPRESSION; P120RASGAP; PROTEIN; ABL	Integration of receptor tyrosine kinase, integrin, and cadherin activities is crucial for normal cell growth, motility, and adhesion. Here, we describe roles for p120-catenin (p120) and p190RhoGAP that coordinate crosstalk between these systems and regulate cadherin function. Surprisingly, PDGFR-induced actin remodeling in NIH3T3 cells is blocked in the absence of p120, and the cells are partially transformed via constitutive activation of Rho. We have traced the mechanism to unexpected codependent roles for p120 and p190RhoGAP in regulating Rac-dependent antagonism of Rho. Receptor-induced Rac activity causes translocation of p190RhoGAP to adherens junctions (AJs), where it couples to the cadherin complex via interaction with p120. AJ formation is dependent on this p120-p190RhoGAP interaction and fails altogether if either of these proteins are compromised. We propose that Rac activation links diverse signaling systems to AJ assembly by controlling transient p190RhoGAP interactions with p120 and localized inhibition of Rho.	Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University	Reynolds, AB (corresponding author), Vanderbilt Univ, Dept Canc Biol, 438 Preston Bldg, Nashville, TN 37232 USA.	al.reynolds@vanderbilt.edu	Carnahan, Robert H/N-7429-2013	Carnahan, Robert H/0000-0001-5230-1532; Davis, Michael/0000-0002-5406-4128	NCI NIH HHS [R01-CA111947, R01-CA55724, T32 CA009592, CA04-013] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055724, R01CA111947, T32CA009592] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Braga VMM, 2005, CURR OPIN CELL BIOL, V17, P466, DOI 10.1016/j.ceb.2005.08.012; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fang X, 2004, J CELL BIOL, V165, P87, DOI 10.1083/jcb.200307109; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Grosheva I, 2001, J CELL SCI, V114, P695; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Sharma SV, 1998, ONCOGENE, V17, P271, DOI 10.1038/sj.onc.1201921; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Vincent S, 1999, EUR J CELL BIOL, V78, P539, DOI 10.1016/S0171-9335(99)80019-3; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Wrobel CN, 2004, J CELL BIOL, V165, P263, DOI 10.1083/jcb.200309102; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	36	311	317	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					1027	1039		10.1016/j.cell.2006.09.046	http://dx.doi.org/10.1016/j.cell.2006.09.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129786	Green Submitted, Bronze			2022-12-28	WOS:000242613800018
J	Bartkova, J; Rezaei, N; Liontos, M; Karakaidos, P; Kletsas, D; Issaeva, N; Vassiliou, LVF; Kolettas, E; Niforou, K; Zoumpourlis, VC; Takaoka, M; Nakagawa, H; Tort, F; Fugger, K; Johansson, F; Sehested, M; Andersen, CL; Dyrskjot, L; Orntoft, T; Lukas, J; Kittas, C; Helleday, T; Halazonetis, TD; Bartek, J; Gorgoulis, VG				Bartkova, Jirina; Rezaei, Nousin; Liontos, Michalis; Karakaidos, Panagiotis; Kletsas, Dimitris; Issaeva, Natalia; Vassiliou, Leandros-Vassilios F.; Kolettas, Evangelos; Niforou, Katerina; Zoumpourlis, Vassilis C.; Takaoka, Munenori; Nakagawa, Hiroshi; Tort, Frederic; Fugger, Kasper; Johansson, Fredrik; Sehested, Maxwell; Andersen, Claus L.; Dyrskjot, Lars; Orntoft, Torben; Lukas, Jiri; Kittas, Christos; Helleday, Thomas; Halazonetis, Thanos D.; Bartek, Jiri; Gorgoulis, Vassilis G.			Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints	NATURE			English	Article							PREMATURE SENESCENCE; CELLULAR SENESCENCE; HUMAN-CELLS; REPLICATION; ATM; P53; SUPPRESSION; INSTABILITY; P16(INK4A); ACTIVATION	Recent studies have indicated the existence of tumorigenesis barriers that slow or inhibit the progression of preneoplastic lesions to neoplasia. One such barrier involves DNA replication stress, which leads to activation of the DNA damage checkpoint and thereby to apoptosis or cell cycle arrest(1,2), whereas a second barrier is mediated by oncogene-induced senescence(3-6). The relationship between these two barriers, if any, has not been elucidated. Here we show that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks. Inhibiting the DNA double-strand break response kinase ataxia telangiectasia mutated (ATM) suppressed the induction of senescence and in a mouse model led to increased tumour size and invasiveness. Analysis of human precancerous lesions further indicated that DNA damage and senescence markers cosegregate closely. Thus, senescence in human preneoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; Univ Athens, Sch Med, Dept Histol & Embryol, GR-11527 Athens, Greece; Demokritos Natl Ctr Sci Res, Inst Biol, GR-15310 Athens, Greece; Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; Univ Ioannina, Sch Med, Dept Physiol, GR-45110 Ioannina, Greece; Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, GR-11635 Athens, Greece; Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; Univ Copenhagen Hosp, Dept Pathol, DK-2100 Copenhagen, Denmark; Aarhus Univ Hosp, Dept Clin Biochem, DK-8200 Aarhus N, Denmark; Univ Sheffield, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England; Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland	The Wistar Institute; Danish Cancer Society; Danish Cancer Society; Athens Medical School; National & Kapodistrian University of Athens; National Centre of Scientific Research "Demokritos"; Stockholm University; University of Ioannina; National Hellenic Research Foundation; University of Pennsylvania; University of Copenhagen; Aarhus University; University of Sheffield; University of Geneva	Halazonetis, TD (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	Thanos.Halazonetis@molbio.unige.ch; jb@cancer.dk	Issaeva, Natalia/K-4577-2019; Karakaidos, Panagiotis/AAR-5858-2020; Kletsas, Dimitris/F-6953-2010; Bartek, Jiri/G-5870-2014; Liontos, Michalis/AAF-1965-2019; Gorgoulis, Vassilis/AAD-3630-2019; Liontos, Michalis/ABA-7587-2020; Kolettas, Evangelos/AAY-5009-2021; Andersen, Claus L/C-1477-2017; Dyrskjot, Lars/H-4922-2012; Fugger, Kasper/J-1231-2014; Halazonetis, Thanos/D-7923-2011; Helleday, Thomas/D-5224-2013; Andersen, Claus Lindbjerg/A-9217-2012	Karakaidos, Panagiotis/0000-0002-1156-4755; Liontos, Michalis/0000-0001-7192-4575; Gorgoulis, Vassilis/0000-0001-9001-4112; Kolettas, Evangelos/0000-0002-5820-487X; Fugger, Kasper/0000-0001-9811-3983; Lukas, Jiri/0000-0001-9087-506X; Issaeva, Natalia/0000-0001-5483-6610; Dyrskjot, Lars/0000-0001-7061-9851; Andersen, Claus Lindbjerg/0000-0002-7406-2103; Helleday, Thomas/0000-0002-7384-092X; Tort, Frederic/0000-0003-2733-1603; Kletsas, Dimitris/0000-0002-9828-3963				Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DIMICCO R, IN PRESS NATURE; Ferbeyre G, 2000, GENE DEV, V14, P2015; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Katsanakis KD, 2002, MOL MED, V8, P624, DOI 10.1007/BF03402173; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Sarkaria JN, 1999, CANCER RES, V59, P4375; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHIBUYA EK, 1993, MOL BIOL CELL, V4, P781, DOI 10.1091/mbc.4.8.781; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932; Zgheib O, 2005, RADIOTHER ONCOL, V76, P119, DOI 10.1016/j.radonc.2005.06.026	30	1434	1477	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					633	637		10.1038/nature05268	http://dx.doi.org/10.1038/nature05268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136093				2022-12-28	WOS:000242377600051
J	Nagyvary, J; DiVerdi, JA; Owen, NL; Tolley, HD				Nagyvary, Joseph; DiVerdi, Joseph A.; Owen, Noel L.; Tolley, H. Dennis			Wood used by Stradivari and Guarneri	NATURE			English	Article							SOFTWOODS		Texas A&M Univ, Dept Biochem, College Stn, TX 77843 USA; Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; Brigham Young Univ, Dept Stat, Provo, UT 84602 USA	Texas A&M University System; Texas A&M University College Station; Colorado State University; Brigham Young University; Brigham Young University	Nagyvary, J (corresponding author), Texas A&M Univ, Dept Biochem, College Stn, TX 77843 USA.	nagyvary@nagyvaryviolins.com						ANDERSON EL, 1991, APPL SPECTROSC, V45, P641, DOI 10.1366/0003702914336930; GOUGH C, 2000, PHYS WORLD       APR; Haines D., 1980, CATGUT ACOUST SOC NE, V33, P19; KOLODZIEJSKI W, 1982, ANAL CHEM, V54, P1419, DOI 10.1021/ac00245a035; Kosikova B, 1999, WOOD SCI TECHNOL, V33, P373, DOI 10.1007/s002260050123; Nagyvary J., 2005, EDUC CHEM, V42, P96; Orton CR, 2004, APPL SPECTROSC, V58, P1265, DOI 10.1366/0003702042475385; Sacconi SF, 1972, SEGRETI STRADIVARI	8	41	43	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2006	444	7119					565	565		10.1038/444565a	http://dx.doi.org/10.1038/444565a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136084	Bronze			2022-12-28	WOS:000242377600032
J	Cheong, I; Huang, X; Bettegowda, C; Diaz, LA; Kinzler, KW; Zhou, SB; Vogelstein, B				Cheong, Ian; Huang, Xin; Bettegowda, Chetan; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Zhou, Shibin; Vogelstein, Bert			A bacterial protein enhances the release and efficacy of liposomal cancer drugs	SCIENCE			English	Article							BACTERIOLYTIC THERAPY; EXPERIMENTAL-TUMORS; ENDOTHELIAL-CELLS	Clostridium novyi-NT is an anaerobic bacterium that can infect hypoxic regions within experimental tumors. Because C. novyi-NT lyses red blood cells, we hypothesized that its membrane-disrupting properties could be exploited to enhance the release of liposome-encapsulated drugs within tumors. Here, we show that treatment of mice bearing large, established tumors with C. novyi-NT plus a single dose of liposomal doxorubicin often led to eradication of the tumors. The bacterial factor responsible for the enhanced drug release was identified as a previously unrecognized protein termed liposomase. This protein could potentially be incorporated into diverse experimental approaches for the specific delivery of chemotherapeutic agents to tumors.	Johns Hopkins Kimmel Comprehens Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Kimmel Comprehens Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Zhou, SB (corresponding author), Johns Hopkins Kimmel Comprehens Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA.	sbzhou@jhmi.edu; vogelbe@jhmi.edu	Diaz, Luis A/A-6018-2008	Cheong, Ian/0000-0002-3062-6878; Diaz, Luis/0000-0002-7079-8914	NCI NIH HHS [CA062924] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Barbe S, 2006, J APPL MICROBIOL, V101, P571, DOI 10.1111/j.1365-2672.2006.02886.x; BETTEGWODA C, IN PRESS NAT BIOTECH; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; Drummond DC, 1999, PHARMACOL REV, V51, P691; Fang J, 2003, ADV EXP MED BIOL, V519, P29; Govindan SV, 2005, TECHNOL CANCER RES T, V4, P375, DOI 10.1177/153303460500400406; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Ryan RM, 2006, BIOESSAYS, V28, P84, DOI 10.1002/bies.20336; Sakurai J, 2004, J BIOCHEM, V136, P569, DOI 10.1093/jb/mvh161; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Thurston G, 1998, J CLIN INVEST, V101, P1401, DOI 10.1172/JCI965; VONHOFF DD, 2006, CANC MED, P600; Yamamoto M, 2005, TECHNOL CANCER RES T, V4, P315, DOI 10.1177/153303460500400402	18	122	135	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1308	1311		10.1126/science.1130651	http://dx.doi.org/10.1126/science.1130651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124324				2022-12-28	WOS:000242215800046
J	Pinkett, HW; Lee, AT; Lum, P; Locher, KP; Rees, DC				Pinkett, H. W.; Lee, A. T.; Lum, P.; Locher, K. P.; Rees, D. C.			An inward-facing conformation of a putative metal-chelate-type ABC transporter	SCIENCE			English	Article							BINDING CASSETTE DIMER; ATP-BINDING; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; MECHANISM; ARCHITECTURE; SUBUNIT; DOMAINS; CHANNEL; MEMBRANE	The crystal structure of a putative metal-chelate-type adenosine triphosphate (ATP)-binding cassette (ABC) transporter encoded by genes HI1470 and HI1471 of Haemophilus influenzae has been solved at 2.4 angstrom resolution. The permeation pathway exhibits an inward-facing conformation, in contrast to the outward-facing state previously observed for the homologous vitamin B-12 importer BtuCD. Although the structures of both HI1470/1 and BtuCD have been solved in nucleotide-free states, the pairs of ABC subunits in these two structures differ by a translational shift in the plane of the membrane that coincides with a repositioning of the membrane-spanning subunits. The differences observed between these ABC transporters involve relatively modest rearrangements and may serve as structural models for inward- and outward-facing conformations relevant to the alternating access mechanism of substrate translocation.	CALTECH, Howard Hughes Med Inst, Div Chem & Chem Engn, Pasadena, CA 91125 USA; ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	California Institute of Technology; Howard Hughes Medical Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rees, DC (corresponding author), CALTECH, Howard Hughes Med Inst, Div Chem & Chem Engn, MC 114-96, Pasadena, CA 91125 USA.	dcrees@caltech.edu	Pinkett, Heather Wendy/M-9235-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045162, R37GM045162] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45162] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Crosa JH., 2004, IRON TRANSPORT BACTE; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DeLano W.L, PYMOL MOL GRAPHICS S; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; HEISCHMANN RD, 1995, SCIENCE, V269, P496; Holland I. B., 2003, ABC PROTEINS BACTERI; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Jones PM, 2002, P NATL ACAD SCI USA, V99, P12639, DOI 10.1073/pnas.152439599; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Pornillos O, 2006, FEBS LETT, V580, P358, DOI 10.1016/j.febslet.2005.12.054; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208	32	235	242	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					373	377		10.1126/science.1133488	http://dx.doi.org/10.1126/science.1133488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17158291				2022-12-28	WOS:000243535400041
J	Martins, CP; Brown-Swigart, L; Evan, GI				Martins, Carla P.; Brown-Swigart, Lamorna; Evan, Gerard I.			Modeling the therapeutic efficacy of p53 restoration in tumors	CELL			English	Article							DNA-DAMAGE; C-MYC; INDUCED TUMORIGENESIS; P53-DEFICIENT MICE; SMALL MOLECULES; APOPTOSIS; LYMPHOMAGENESIS; SUPPRESSOR; ACTIVATION; CANCER	Although restoration of p53 function is an attractive tumor-specific therapeutic strategy, it remains unclear whether p53 loss is required only for transition through early bottlenecks in tumorigenesis or also for maintenance of established tumors. To explore the efficacy of p53 reinstatement as a tumor therapy, we used a reversibly switchable p53 knockin (KI) mouse model that permits modulation of p53 status from wild-type to knockout, at will. Using the well-characterized E mu-myc lymphoma model, we show that p53 is spontaneously activated when restored in established E mu-myc lymphomas in vivo, triggering rapid apoptosis and conferring a significant increase in survival. Nonetheless, reimposition of p53 function potently selects for emergence of p53-resistant tumors through inactivation of p19(ARF) or p53. Our study provides important insights into the nature and timing of p53-activating signals in established tumors and how resistance to p53 evolves, which will aid in the optimization of p53-based tumor therapies.	Univ Calif San Francisco, Ctr Comprehens Canc, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Evan, GI (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, Canc Res Inst, San Francisco, CA 94143 USA.	gevan@cc.ucsf.edu			NATIONAL CANCER INSTITUTE [R01CA100193] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA100193] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; CHRISTOPHOROU M, 2006, IN PRESS NATURE, P53; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Del Toro Gustavo, 2005, Clin Adv Hematol Oncol, V3, P54; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HSU B, 1995, ONCOGENE, V11, P175; Kamijo T, 1999, CANCER RES, V59, P2464; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Khan SH, 2000, P NATL ACAD SCI USA, V97, P3266, DOI 10.1073/pnas.050560997; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li YX, 2004, ONCOGENE, V23, P7355, DOI 10.1038/sj.onc.1207957; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; MOORE JP, 1987, ONCOGENE RES, V2, P65; Munro AJ, 2005, BRIT J CANCER, V92, P434, DOI 10.1038/sj.bjc.6602358; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Ring D, 2001, J SHOULDER ELB SURG, V10, P501, DOI 10.1067/mse.2001.118414; Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sigal A, 2000, CANCER RES, V60, P6788; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vassilev LT, 2005, J MED CHEM, V48, P4491, DOI 10.1021/jm058174k; Vater CA, 1996, ONCOGENE, V13, P739; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	39	478	494	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1323	1334		10.1016/j.cell.2006.12.007	http://dx.doi.org/10.1016/j.cell.2006.12.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17182091	Bronze			2022-12-28	WOS:000243690000013
J	Fynbo, JPU; Watson, D; Thone, CC; Sollerman, J; Bloom, JS; Davis, TM; Hjorth, J; Jakobsson, P; Jorgensen, UG; Graham, JF; Fruchter, AS; Bersier, D; Kewley, L; Cassan, A; Ceron, JMC; Foley, S; Gorosabel, J; Hinse, TC; Horne, KD; Jensen, BL; Klose, S; Kocevski, D; Marquette, JB; Perley, D; Ramirez-Ruiz, E; Stritzinger, MD; Vreeswijk, PM; Wijers, RAM; Woller, KG; Xu, D; Zub, M				Fynbo, Johan P. U.; Watson, Darach; Thone, Christina C.; Sollerman, Jesper; Bloom, Joshua S.; Davis, Tamara M.; Hjorth, Jens; Jakobsson, Pall; Jorgensen, Uffe G.; Graham, John F.; Fruchter, Andrew S.; Bersier, David; Kewley, Lisa; Cassan, Arnaud; Ceron, Jose Maria Castro; Foley, Suzanne; Gorosabel, Javier; Hinse, Tobias C.; Horne, Keith D.; Jensen, Brian L.; Klose, Sylvio; Kocevski, Daniel; Marquette, Jean-Baptiste; Perley, Daniel; Ramirez-Ruiz, Enrico; Stritzinger, Maximilian D.; Vreeswijk, Paul M.; Wijers, Ralph A. M.; Woller, Kristian G.; Xu, Dong; Zub, Marta			No supernovae associated with two long-duration gamma-ray bursts	NATURE			English	Article							EMISSION; COLLAPSE; LIGHT; DISKS; HST	It is now accepted that long-duration gamma-ray bursts (GRBs) are produced during the collapse of a massive star(1,2). The standard 'collapsar' model(3) predicts that a broad-lined and luminous type Ic core-collapse supernova accompanies every long- duration GRB(4). This association has been confirmed in observations of several nearby GRBs(5-9). Here we report that GRB 060505 ( ref. 10) and GRB 060614 ( ref. 11) were not accompanied by supernova emission down to limits hundreds of times fainter than the archetypal supernova SN 1998bw that accompanied GRB 980425, and fainter than any type Ic supernova ever observed(12). Multi-band observations of the early afterglows, as well as spectroscopy of the host galaxies, exclude the possibility of significant dust obscuration and show that the bursts originated in actively star-forming regions. The absence of a supernova to such deep limits is qualitatively different from all previous nearby long- duration GRBs and suggests a new phenomenological type of massive stellar death.	Univ Copenhagen, Dark Cosmol Ctr, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; Univ Stockholm, AlbaNova, Dept Astron, S-10691 Stockholm, Sweden; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; Space Telescope Sci Inst, Baltimore, MD 21218 USA; Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead CH41 1LD, Merseyside, England; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; Univ Heidelberg ZAH, Zentrum AStron, ARI, D-69120 Heidelberg, Germany; Univ Coll Dublin, Sch Phys, Dublin 4, Ireland; CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; Univ St Andrews, SUPA Phys Astron, St Andrews KY16 9SS, Fife, Scotland; Thuringer Landessternwarte Tautenburg, D-07778 Tautenburg, Germany; Univ Paris 06, CNRS, UMR 70951, Inst Astrophys Paris, F-75014 Paris, France; Inst Adv Study, Princeton, NJ 08540 USA; Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; Univ Chile, Dept Astron, Santiago, Chile; Univ Amsterdam, Astron Inst Anton Pannekoek, Fac Sci, NL-1098 SJ Amsterdam, Netherlands	University of Copenhagen; University of Copenhagen; Niels Bohr Institute; Stockholm University; University of California System; University of California Berkeley; University of Hertfordshire; Space Telescope Science Institute; Liverpool John Moores University; University of Hawaii System; Ruprecht Karls University Heidelberg; University College Dublin; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of St Andrews; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institute for Advanced Study - USA; University of California System; University of California Santa Cruz; Universidad de Chile; University of Amsterdam	Fynbo, JPU (corresponding author), Univ Copenhagen, Dark Cosmol Ctr, Juliane Maries Vej 30, DK-2100 Copenhagen, Denmark.	jfynbo@dark-cosmology.dk	Hinse, Tobias/W-5579-2018; Hjorth, Jens/M-5787-2014; Jakobsson, Pall/L-9950-2015; Watson, Darach/E-4521-2015; Davis, Tamara/A-4280-2008; Fynbo, Johan P. U./L-8496-2014; Jensen, Brian Lindgren/E-1275-2015; Thone, Christina/Q-3938-2017	Hinse, Tobias/0000-0001-8870-3146; Hjorth, Jens/0000-0002-4571-2306; Jakobsson, Pall/0000-0002-9404-5650; Watson, Darach/0000-0002-4465-8264; Davis, Tamara/0000-0002-4213-8783; Fynbo, Johan P. U./0000-0002-8149-8298; Jensen, Brian Lindgren/0000-0002-0906-9771; Wijers, Ralph/0000-0002-3101-1808; Thone, Christina/0000-0002-7978-7648; stritzinger, maximilian/0000-0002-5571-1833; Bloom, Joshua/0000-0002-7777-216X	STFC [PP/D000890/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000890/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Ferrero P, 2006, ASTRON ASTROPHYS, V457, P857, DOI 10.1051/0004-6361:20065530; Fruchter AS, 2006, NATURE, V441, P463, DOI 10.1038/nature04787; Fryer CL, 2006, ASTROPHYS J, V650, P1028, DOI 10.1086/506250; Fynbo JPU, 2004, ASTROPHYS J, V609, P962, DOI 10.1086/421260; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Heger A, 2003, ASTROPHYS J, V591, P288, DOI 10.1086/375341; Hjorth J, 2003, NATURE, V423, P847, DOI 10.1038/nature01750; HOLLAND ST, 2006, 5255 GCN; HULLINGER D, 2006, 5142 GCN; Levan A, 2005, ASTROPHYS J, V622, P977, DOI 10.1086/426938; MacFadyen AI, 2003, AIP CONF PROC, V662, P202; MacFadyen AI, 1999, ASTROPHYS J, V524, P262, DOI 10.1086/307790; MALESANI D, 2004, APJ, V609, P5; OFEK EO, 2006, 5123 GCN; Pedersen H, 1998, ASTROPHYS J, V496, P311, DOI 10.1086/305385; Pian E, 2006, NATURE, V442, P1011, DOI 10.1038/nature05082; Richardson D, 2006, ASTRON J, V131, P2233, DOI 10.1086/500578; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; SCHMIDT BP, 2006, 5258 GCN; Soderberg AM, 2006, ASTROPHYS J, V636, P391, DOI 10.1086/498009; Soderberg AM, 2005, ASTROPHYS J, V627, P877, DOI 10.1086/430405; Sollerman J, 2006, ASTRON ASTROPHYS, V454, P503, DOI 10.1051/0004-6361:20065226; Sollerman J, 2005, NEW ASTRON, V11, P103, DOI 10.1016/j.newast.2005.06.004; Stanek KZ, 2003, ASTROPHYS J, V591, pL17, DOI 10.1086/376976; Woosley SE, 2006, ANNU REV ASTRON ASTR, V44, P507, DOI 10.1146/annurev.astro.43.072103.150558; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359; Zeh A, 2004, ASTROPHYS J, V609, P952, DOI 10.1086/421100	27	356	361	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1047	1049		10.1038/nature05375	http://dx.doi.org/10.1038/nature05375			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183316	Green Submitted, Green Accepted			2022-12-28	WOS:000242971100049
J	Vajdic, CM; McDonald, SP; McCredie, MRE; van Leeuwen, MT; Stewart, JH; Law, M; Chapman, JR; Webster, AC; Kaldor, JM; Grulich, AE				Vajdic, Claire M.; McDonald, Stephen P.; McCredie, Margaret R. E.; van Leeuwen, Marina T.; Stewart, John H.; Law, Matthew; Chapman, Jeremy R.; Webster, Angela C.; Kaldor, John M.; Grulich, Andrew E.			Cancer incidence before and after kidney transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; RENAL-TRANSPLANTATION; RISK; INFECTION; DIALYSIS; PEOPLE; VIRUS; AIDS	Context Immune suppression after organ transplantation is associated with a markedly increased risk of nonmelanoma skin cancer and a few virus-associated cancers. Although it is generally accepted that other cancers do not occur at increased rates, there have been few long-term population-based cohort studies performed. Objective To compare the incidence of cancer in patients receiving immune suppression after kidney transplantation with incidence in the same population in 2 periods before receipt of immune suppression: during dialysis and during end-stage kidney disease before renal replacement therapy (RRT). Design, Setting, and Participants A population-based cohort study of 28 855 patients with end-stage kidney disease who received RRT, with 273 407 person-years of follow-up. Incident cancers (1982-2003) were ascertained by record linkage between the Australia and New Zealand Dialysis and Transplant Registry and the Australian National Cancer Statistics Clearing House. Main Outcome Measure Standardized incidence ratios (SIRs) of cancer, using age-specific, sex-specific, calendar year - specific, and state/territory-specific population cancer incidence rates. Results The overall incidence of cancer, excluding nonmelanoma skin cancer and those cancers known to frequently cause end-stage kidney disease, was markedly increased after transplantation (n= 1236; SIR, 3.27; 95% confidence interval [CI], 3.09-3.46). In contrast, cancer incidence was only slightly increased during dialysis ( n= 870; SIR, 1.35; 95% CI, 1.27-1.45) and before RRT ( n= 689; SIR, 1.16; 95% CI, 1.08-1.25). After transplantation, cancer occurred at significantly increased incidence at 25 sites, and risk exceeded 3-fold at 18 of these sites. Most of these cancers were of known or suspected viral etiology. Conclusions Kidney transplantation is associated with a marked increase in cancer risk at a wide variety of sites. Because SIRs for most types of cancer were not increased before transplantation, immune suppression may be responsible for the increased risk. These data suggest a broader than previously appreciated role of the interaction between the immune system and common viral infections in the etiology of cancer.	Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; Queen Elizabeth Hosp, Australia & New Zealand Dialysis & Transplant Reg, Adelaide, SA, Australia; Univ Adelaide, Discipline Med, Adelaide, SA, Australia; Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; Univ Sydney, Westmead Hosp, Millennium Inst, Ctr Transplant & Renal Res, Sydney, NSW 2006, Australia	University of New South Wales Sydney; Kirby Institute; University of Adelaide; University of Adelaide; University of Otago; University of Sydney	Vajdic, CM (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, 376 Victoria St,Level 2, Darlinghurst, NSW 2010, Australia.	cvajdic@nchecr.unsw.edu.au	McDonald, Stephen/G-4010-2013; Vajdic, Claire/AAP-5940-2020; van Leeuwen, Marina T/AAQ-5339-2021; Kaldor, John M/D-4545-2011; Webster, Angela/J-2186-2012	McDonald, Stephen/0000-0001-6103-1386; van Leeuwen, Marina T/0000-0002-1570-2852; Webster, Angela/0000-0001-7509-0512; Vajdic, Claire/0000-0002-3612-8298; Law, Matthew/0000-0002-3540-8837				*AIHW, 2005, 57 AIHW PHE; *AIHW AACR, 2001, CANC SER, V19; *AIHW AACR, 2004, CANC SER, V28; [Anonymous], 1994, IARC MON EV CARC RIS, V61; [Anonymous], 1997, IARC MON EV CARC RIS, V70; [Anonymous], 1996, IARC MON EV CARC RIS; Birkeland SA, 2000, LANCET, V355, P1886, DOI 10.1016/S0140-6736(00)02298-4; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Girndt M, 2001, KIDNEY INT, V59, pS206, DOI 10.1046/j.1523-1755.2001.59780206.x; GOLDBLUM SE, 1980, ANN INTERN MED, V93, P597, DOI 10.7326/0003-4819-93-4-597; Grulich AE, 1999, AIDS, V13, P839, DOI 10.1097/00002030-199905070-00014; Grulich AE, 2002, AIDS, V16, P1155, DOI 10.1097/00002030-200205240-00009; Grulich AE, 1996, J EPIDEMIOL BIOSTAT, V1, P207; *IARC, 1994, IARC MON EV CARC RIS, V59; *IARC, 1995, IARC MON EV CARC RIS, V64; International Agency for Research on Cancer (IARC), 2004, INT RUL MULT PRIM CA; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Kinlen L J, 1992, IARC Sci Publ, P237; Li YM, 2002, AM J EPIDEMIOL, V155, P153, DOI 10.1093/aje/155.2.153; MAYNE ST, 2006, CANC EPIDEMIOLOGY PR, P686; MCDONALD SP, 2005, ANZDATA REG REPORT 2; Mitsuishi T, 2005, CANCER LETT, V222, P139, DOI 10.1016/j.canlet.2004.09.019; Parkin DM, 2002, IARC SCI PUBLICATION, VVIII; PORT FK, 1989, AM J KIDNEY DIS, V14, P119, DOI 10.1016/S0272-6386(89)80187-8; *S AUSTR CANC REG, 2000, EP CANC S AUSTR; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Winkelspecht B, 1997, NEPHROL DIAL TRANSPL, V12, P2099, DOI 10.1093/ndt/12.10.2099; World Health Organization, 1992, INT STAT CLASS DIS 1	31	794	809	4	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2823	2831		10.1001/jama.296.23.2823	http://dx.doi.org/10.1001/jama.296.23.2823			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179459	Bronze			2022-12-28	WOS:000242826400024
J	Hughes, M; Leach, M				Hughes, Marie; Leach, Mike			Dietary folate deficiency and bilateral retinal haemorrhages	LANCET			English	Editorial Material									Crosshouse Hosp, Dept Haematol, Kilmarnock KA2 0BE, Scotland; Stobhill Hosp, Dept Haematol, Glasgow, Lanark, Scotland		Hughes, M (corresponding author), Crosshouse Hosp, Dept Haematol, Kilmarnock KA2 0BE, Scotland.	marie@hughes1.co.uk							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 16	2006	368	9553					2155	2155		10.1016/S0140-6736(06)69864-4	http://dx.doi.org/10.1016/S0140-6736(06)69864-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174707				2022-12-28	WOS:000242856900023
J	Tyrer, P; Baldwin, D				Tyrer, Peter; Baldwin, David			Generalised anxiety disorder	LANCET			English	Review							COGNITIVE-BEHAVIORAL THERAPY; MAJOR DEPRESSIVE DISORDER; LONG-TERM TREATMENT; SEROTONIN REUPTAKE INHIBITORS; RANDOMIZED CONTROLLED-TRIAL; NATIONAL COMORBIDITY SURVEY; SELF-HELP TREATMENTS; QUALITY-OF-LIFE; PRIMARY-CARE; NEUROTIC DISORDER	Generalised anxiety disorder is a persistent and common disorder, in which the patient has unfocused worry and anxiety that is not connected to recent stressful events, although it can be aggravated by certain situations. This disorder is twice as common in women than it is in men. Generalised anxiety disorder is characterised by feelings of threat, restlessness, irritability, sleep disturbance, and tension, and symptoms such as palpitations, dry mouth, and sweating. These symptoms are recognised as part of the anxiety syndrome rather than independent complaints. The symptoms overlap greatly with those of other common mental disorders and we could regard the disorder as part of a spectrum of mood and related disorders rather than an independent disorder. Generalised anxiety disorder has a relapsing course, and intervention rarely results in complete resolution of symptoms, but in the short term and medium term, effective treatments include psychological therapies, such as cognitive behavioural therapy; self-help approaches based on cognitive behavioural, therapy principles; and pharmacological treatments, mainly selective serotonin reuptake inhibitors.	Univ London Imperial Coll Sci Technol & Med, Dept Psychol Med, Div Neurosci & Mental Hlth, London W6 8RP, England; Univ Southampton, Clin Neurosci Div, Sch Med, Southampton SO14 0YG, Hants, England	Imperial College London; University of Southampton	Tyrer, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Psychol Med, Div Neurosci & Mental Hlth, London W6 8RP, England.	p.tyrer@imperial.ac.uk	Gale, Christopher Kennington/C-6513-2009	Gale, Christopher Kennington/0000-0001-8032-765X; Baldwin, David/0000-0003-3343-0907				ABELSON JL, 1991, ARCH GEN PSYCHIAT, V48, P157; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P45, DOI 10.1016/j.jad.2003.10.012; Akiskal HS, 1998, ACTA PSYCHIAT SCAND, V98, P66, DOI 10.1111/j.1600-0447.1998.tb05969.x; Allgulander C, 2006, INT J NEUROPSYCHOPH, V9, P495, DOI 10.1017/S1461145705005973; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P472; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; Angst J, 1996, BRIT J PSYCHIAT, V168, P31, DOI 10.1192/S0007125000298383; Angst J, 2005, EUR ARCH PSY CLIN N, V255, P65, DOI 10.1007/s00406-005-0576-8; Ashton C, 1997, J CARDIOVASC SURG, V38, P69; Baldwin DS, 2006, BRIT J PSYCHIAT, V189, P264, DOI 10.1192/bjp.bp.105.012799; Baldwin DS, 2005, J PSYCHOPHARMACOL, V19, P567, DOI 10.1177/0269881105059253; Baldwin DS, 2005, INT J NEUROPSYCHOPH, V8, P293, DOI 10.1017/S1461145704004870; Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P11; Bandelow Borwin, 2002, World J Biol Psychiatry, V3, P171, DOI 10.3109/15622970209150621; Bielski Robert J, 2005, Ann Clin Psychiatry, V17, P65, DOI 10.1080/10401230590932326; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bower P, 2001, BRIT J GEN PRACT, V51, P838; BOYD JH, 1984, ARCH GEN PSYCHIAT, V41, P983; Brawman-Mintzer O, 2005, J CLIN PSYCHIAT, V66, P1321, DOI 10.4088/JCP.v66n1016; BRAWMANMINTZER O, 1993, AM J PSYCHIAT, V150, P1216; BRESLAU N, 1985, PSYCHIAT RES, V15, P231, DOI 10.1016/0165-1781(85)90080-0; Brown JSL, 2004, BRIT J PSYCHIAT, V185, P511, DOI 10.1192/bjp.185.6.511; BROWN TA, 1994, AM J PSYCHIAT, V151, P1272; Bruce SE, 2005, AM J PSYCHIAT, V162, P1179, DOI 10.1176/appi.ajp.162.6.1179; BUTLER G, 1991, J CONSULT CLIN PSYCH, V59, P167, DOI 10.1037/0022-006X.59.1.167; Casacalenda N, 1998, CAN J PSYCHIAT, V43, P722, DOI 10.1177/070674379804300707; CASEY PR, 1985, SOC PSYCHIATR, V20, P5, DOI 10.1007/BF00595042; Chavira DA, 2004, J AFFECT DISORDERS, V80, P163, DOI 10.1016/S0165-0327(03)00103-4; CLARK DA, 1994, AM J PSYCHIAT, V151, P205; Conner KM, 1998, BIOL PSYCHIAT, V44, P1286, DOI 10.1016/S0006-3223(98)00285-6; COTTRAUX J, 1995, BRIT J PSYCHIAT, V167, P635, DOI 10.1192/bjp.167.5.635; DARCIS T, 1995, HUM PSYCHOPHARM CLIN, V10, P181, DOI 10.1002/hup.470100303; DEANS HG, 1992, J ROY SOC MED, V85, P83; DURHAM RC, 1987, BEHAV RES THER, V25, P229, DOI 10.1016/0005-7967(87)90051-9; DURHAM RC, 1993, BRIT J PSYCHIAT, V163, P19, DOI 10.1192/bjp.163.1.19; DURHAM RC, 1994, BRIT J PSYCHIAT, V165, P315, DOI 10.1192/bjp.165.3.315; Durham RC, 2005, HEALTH TECHNOL ASSES, V9, P1; Durham RC, 2003, PSYCHOL MED, V33, P499, DOI 10.1017/S0033291702007079; Fava GA, 2005, J CLIN PSYCHIAT, V66, P1392, DOI 10.4088/JCP.v66n1108; Fawcett J, 2000, ALCOHOL CLIN EXP RES, V24, P666, DOI 10.1111/j.1530-0277.2000.tb02038.x; Flint AJ, 2005, DRUG AGING, V22, P101, DOI 10.2165/00002512-200522020-00002; Freud S., 1924, COMPLETE PSYCHOL WOR, V3, P85; GERMINE M, 1992, BIOL PSYCHIAT, V32, P457, DOI 10.1016/0006-3223(92)90133-K; Goodman WK, 2005, J AFFECT DISORDERS, V87, P161, DOI 10.1016/j.jad.2004.11.011; Gould RA, 1997, BEHAV THER, V28, P285, DOI 10.1016/S0005-7894(97)80048-2; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Haddad P, 1997, J CLIN PSYCHIAT, V58, P17; HALLSTROM C, 1981, BRIT J PSYCHIAT, V139, P417, DOI 10.1192/bjp.139.5.417; Hamilton J, 1996, J ROY COLL PHYS LOND, V30, P18; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; HELZER JE, 1988, J STUD ALCOHOL, V49, P219, DOI 10.15288/jsa.1988.49.219; Hettema JM, 2004, AM J PSYCHIAT, V161, P1581, DOI 10.1176/appi.ajp.161.9.1581; HOEHNSARIC R, 1985, PSYCHIAT CLIN N AM, V8, P73; Hunt C, 2004, DEPRESS ANXIETY, V20, P23, DOI 10.1002/da.20019; Jenkins R, 1997, PSYCHOL MED, V27, P775, DOI 10.1017/S0033291797005308; Jorm AF, 2004, MED J AUSTRALIA, V181, pS29; Judd LL, 1998, ACTA PSYCHIAT SCAND, V98, P6, DOI 10.1111/j.1600-0447.1998.tb05960.x; KAHN RJ, 1986, ARCH GEN PSYCHIAT, V43, P79; Kaye WH, 2004, AM J PSYCHIAT, V161, P2215, DOI 10.1176/appi.ajp.161.12.2215; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P716; Kessler RC, 2005, PSYCHOL MED, V35, P1073, DOI 10.1017/S0033291705004538; Kessler RC, 1997, NEW ENGL J MED, V336, P551, DOI 10.1056/NEJM199702203360806; Kessler RC, 2001, PSYCHIAT CLIN N AM, V24, P19, DOI 10.1016/S0193-953X(05)70204-5; Khan AA, 2005, BRIT J PSYCHIAT, V186, P190, DOI 10.1192/bjp.186.3.190; Kingdon D, 1996, BRIT J PSYCHIAT, V169, P93, DOI 10.1192/bjp.169.1.93; KLEIN DF, 1964, PSYCHOPHARMACOLOGIA, V5, P397, DOI 10.1007/BF02193476; KLEIN DF, 1967, ARCH GEN PSYCHIAT, V16, P118; Knerer G, 2005, ACTA PSYCHIAT SCAND, V112, P224, DOI 10.1111/j.1600-0447.2005.00552.x; Kool S, 2003, HARVARD REV PSYCHIAT, V11, P133, DOI 10.1080/10673220303950; Korpi ER, 2006, PHARMACOL THERAPEUT, V109, P12, DOI 10.1016/j.pharmthera.2005.05.009; Lader MH, 1998, BRIT J PSYCHIAT, V173, P42, DOI 10.1192/S0007125000293513; LARKIN BA, 1992, BRIT J PSYCHIAT, V160, P681, DOI 10.1192/bjp.160.5.681; LESCH KP, 2002, GEN ANXIETY DISORDER, P71; Llorca PM, 2002, J CLIN PSYCHIAT, V63, P1020, DOI 10.4088/JCP.v63n1112; MANN AH, 1981, PSYCHOL MED, V11, P535, DOI 10.1017/S0033291700052855; Marks IM, 2003, BRIT J PSYCHIAT, V183, P57, DOI 10.1192/bjp.183.1.57; MASSION AO, 1993, AM J PSYCHIAT, V150, P600; McCrone P, 2004, BRIT J PSYCHIAT, V185, P55, DOI 10.1192/bjp.185.1.55; Meibach R. C., 2001, J CLIN PSYCHIAT, V62, P523; MENDELS J, 1986, J CLIN PSYCHIAT, V47, P170; Mendlowicz MV, 2000, AM J PSYCHIAT, V157, P669, DOI 10.1176/appi.ajp.157.5.669; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mitte K, 2005, J CLIN PSYCHOPHARM, V25, P141, DOI 10.1097/01.jcp.0000155821.74832.f9; MOGG K, 1995, BEHAV RES THER, V33, P927, DOI 10.1016/0005-7967(95)00031-R; Mogg K, 2004, PSYCHOPHARMACOLOGY, V176, P466, DOI 10.1007/s00213-004-1902-y; Montgomery SA, 2002, J CLIN PSYCHOPHARM, V22, P561, DOI 10.1097/00004714-200212000-00005; *NAT I CLIN EXC, 2002, HLTH TECHN APPR GUID, V51; *NAT I CLIN EXC, 2004, MAN PAN DIS GEN ANX; Newman MG, 2002, BEHAV THER, V33, P215, DOI 10.1016/S0005-7894(02)80026-0; NISITA C, 1990, COMPR PSYCHIAT, V31, P409, DOI 10.1016/0010-440X(90)90025-N; Noyes R, 1999, GEN HOSP PSYCHIAT, V21, P8, DOI 10.1016/S0163-8343(98)00063-2; Nutt DJ, 2001, BRIT J PSYCHIAT, V179, P390, DOI 10.1192/bjp.179.5.390; Piercy MA, 1996, ANN PHARMACOTHER, V30, P1013, DOI 10.1177/106002809603000917; Pollack MH, 2006, BIOL PSYCHIAT, V59, P211, DOI 10.1016/j.biopsych.2005.07.005; Pollack MH, 2005, J CLIN PSYCHIAT, V66, P1401, DOI 10.4088/JCP.v66n1109; POWER KG, 1990, BRIT J GEN PRACT, V40, P289; Proudfoot J, 2004, BRIT J PSYCHIAT, V185, P46, DOI 10.1192/bjp.185.1.46; RICKELS K, 1988, ARCH GEN PSYCHIAT, V45, P444; Rickels K, 2002, J CLIN PSYCHIAT, V63, P9; Rogers MP, 1999, DEPRESS ANXIETY, V10, P1; ROMACH M, 1995, AM J PSYCHIAT, V152, P1161; Salzman C, 2001, J CLIN PSYCHIAT, V62, P149, DOI 10.4088/JCP.v62n0302; Sareen J, 2005, J NERV MENT DIS, V193, P450, DOI 10.1097/01.nmd.0000168263.89652.6b; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; Seivewright H, 1998, PSYCHOL MED, V28, P1149, DOI 10.1017/S0033291798007119; Seivewright H, 2004, INT J STD AIDS, V15, P519, DOI 10.1258/0956462041558122; SEIVEWRIGHT H, 1991, PSYCHOL MED, V21, P495, DOI 10.1017/S0033291700020602; Seivewright H, 2002, LANCET, V359, P2253, DOI 10.1016/S0140-6736(02)09266-8; Shea MT, 2003, J PERS DISORD, V17, P373, DOI 10.1521/pedi.17.5.373.22973; SHEEHAN DV, 1980, ARCH GEN PSYCHIAT, V37, P51; Silverstone PH, 2001, J CLIN PSYCHIAT, V62, P523, DOI 10.4088/JCP.v62n07a04; Stein DJ, 2001, J CLIN PSYCHIAT, V62, P29; Stocchi F, 2003, J CLIN PSYCHIAT, V64, P250, DOI 10.4088/JCP.v64n0305; Surtees PG, 2003, BRIT J PSYCHIAT, V183, P299, DOI 10.1192/bjp.183.4.299; Tiihonen J, 1997, MOL PSYCHIATR, V2, P463, DOI 10.1038/sj.mp.4000329; TURNER SM, 1991, J ABNORM PSYCHOL, V100, P102, DOI 10.1037/0021-843X.100.1.102; TYRER P, 1981, LANCET, V1, P520; TYRER P, 1983, LANCET, V1, P1402; TYRER P, 1988, LANCET, V2, P235; TYRER P, 1985, LANCET, V1, P685; Tyrer P, 1996, BRIT J PSYCHIAT, V168, P669, DOI 10.1192/bjp.168.6.669; Tyrer P, 2004, PSYCHOL MED, V34, P1385, DOI 10.1017/S0033291704002569; Tyrer P, 2001, BRIT J PSYCHIAT, V179, P191, DOI 10.1192/bjp.179.3.191; TYRER P, 1988, DRUGS, V36, P773, DOI 10.2165/00003495-198836060-00006; TYRER P, 2003, J PERSONALITY DISORD, V17, P109; Uhlenhuth E H, 1999, Depress Anxiety, V9, P107, DOI 10.1002/(SICI)1520-6394(1999)9:3<107::AID-DA2>3.0.CO;2-T; van Boeijen CA, 2005, FAM PRACT, V22, P192, DOI 10.1093/fampra/cmh708; VERSIANI M, 1992, BRIT J PSYCHIAT, V161, P353, DOI 10.1192/bjp.161.3.353; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; *WHO, 1994, POCK GUID ICD 10 CLA, P158; WIDIGER TA, 1992, J ABNORM PSYCHOL, V101, P340, DOI 10.1037/0021-843X.101.2.340; WINOKUR G, 1990, PSYCHIAT CLIN N AM, V13, P567; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; Yonkers KA, 2000, BRIT J PSYCHIAT, V176, P544, DOI 10.1192/bjp.176.6.544; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmerman M, 2003, AM J PSYCHIAT, V160, P504, DOI 10.1176/appi.ajp.160.3.504; Zohar J, 2000, ACTA PSYCHIAT SCAND, V101, P39, DOI 10.1111/j.1600-0447.2000.tb10947.x	140	182	192	2	109	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2006	368	9553					2156	2166		10.1016/S0140-6736(06)69865-6	http://dx.doi.org/10.1016/S0140-6736(06)69865-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117EZ	17174708				2022-12-28	WOS:000242856900024
J	Gilchrist, A; Au, CE; Hiding, J; Bell, AW; Fernandez-Rodriguez, J; Lesimple, S; Nagaya, H; Roy, L; Gosline, SJC; Hallett, M; Paiement, J; Kearney, RE; Nilsson, T; Bergeron, JJM				Gilchrist, Annalyn; Au, Catherine E.; Hiding, Johan; Bell, Alexander W.; Fernandez-Rodriguez, Julia; Lesimple, Souad; Nagaya, Hisao; Roy, Line; Gosline, Sara J. C.; Hallett, Michael; Paiement, Jacques; Kearney, Robert E.; Nilsson, Tommy; Bergeron, John J. M.			Quantitative proteomics analysis of the secretory pathway	CELL			English	Article							CLATHRIN-COATED VESICLES; ENDOPLASMIC-RETICULUM; PROTEIN EXPRESSION; MEMBRANE-PROTEINS; GOLGI-APPARATUS; COMPLEX; COPI; LOCALIZATION; TRAFFICKING; REVEALS	We report more than 1400 proteins of the secretory-pathway proteome and provide spatial information on the relative presence of each protein in the rough and smooth ER Golgi cisternae and Golgi-derived COPT vesicles. The data support a role for COPT vesicles in recycling and cisternal maturation, showing that Golgi-resident proteins are present at a higher concentration than secretory cargo. Of the 1400 proteins, 345 were identified as previously uncharacterized. Of these, 230 had their subcellular location deduced by proteomics. This study provides a comprehensive catalog of the ER and Golgi proteomes with insight into their identity and function.	McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; McGill Univ, McGill Ctr Bioinformat, Sch Comp Sci, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada; Gothenburg Univ, Inst Biomed, Dept Med & Clin Genet, S-41390 Gothenburg, Sweden; Gothenburg Univ, Sahlgrenska Acad, Proteom Ctr, S-41390 Gothenburg, Sweden; Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; McGill University; University of Gothenburg; University of Gothenburg; Universite de Montreal	Bergeron, JJM (corresponding author), McGill Univ, Dept Anat & Cell Biol, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.	john.bergeron@mcgill.ca	Bergeron, John/AAW-1893-2021; Kearney, Robert E/D-3917-2012	Kearney, Robert/0000-0002-5107-6190; Gosline, Sara/0000-0002-6534-4774; Hallett, Michael/0000-0001-6738-6786; Fernandez-Rodriguez, Julia/0000-0003-4522-0966				Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bornhauser BC, 2003, J BIOL CHEM, V278, P35412, DOI 10.1074/jbc.M306271200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; DAHAN S, 1994, J CELL BIOL, V127, P1859, DOI 10.1083/jcb.127.6.1859; Dominguez M, 1999, J CELL BIOL, V145, P673, DOI 10.1083/jcb.145.4.673; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Girard M, 2005, MOL CELL PROTEOMICS, V4, P1145, DOI 10.1074/mcp.M500043-MCP200; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Goolsby KM, 2003, NUCLEIC ACIDS RES, V31, P5644, DOI 10.1093/nar/gkg768; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Hay JC, 1996, J BIOL CHEM, V271, P5671, DOI 10.1074/jbc.271.10.5671; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Jermy AJ, 2006, J BIOL CHEM, V281, P7899, DOI 10.1074/jbc.M511402200; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; KARTBERG F, 2005, CELL BIOL LAB HDB, P45; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Malhotra V, 2006, NATURE, V441, P939, DOI 10.1038/441939a; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; MARINEZMENARGUE.JA, 2001, J CELL BIOL, V155, P1213; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; PAIEMENT J, 2005, CELL BIOL LAB HDB, P41; Peng RW, 2005, THESCIENTIFICWORLDJO, V5, P471, DOI 10.1100/tsw.2005.53; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Scott M, 2004, BIOINFORMATICS, V20, P937, DOI 10.1093/bioinformatics/bth010; Scott MS, 2004, GENOME RES, V14, P1957, DOI 10.1101/gr.2650004; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Stojanovic M, 2005, J BIOL CHEM, V280, P30018, DOI 10.1074/jbc.M501306200; Valsdottir R, 2001, FEBS LETT, V508, P201, DOI 10.1016/S0014-5793(01)02993-3; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711	45	349	366	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1265	1281		10.1016/j.cell.2006.10.036	http://dx.doi.org/10.1016/j.cell.2006.10.036			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174899	Bronze			2022-12-28	WOS:000242991000022
J	McKeegan, KD; Aleon, J; Bradley, J; Brownlee, D; Busemann, H; Butterworth, A; Chaussidon, M; Fallon, S; Floss, C; Gilmour, J; Gounelle, M; Graham, G; Guan, YB; Heck, PR; Hoppe, P; Hutcheon, ID; Huth, J; Ishii, H; Ito, M; Jacobsen, SB; Kearsley, A; Leshin, LA; Liu, MC; Lyon, I; Marhas, K; Marty, B; Matrajt, G; Meibom, A; Messenger, S; Mostefaoui, S; Mukhopadhyay, S; Nakamura-Messenger, K; Nittler, L; Palma, R; Pepin, RO; Papanastassiou, DA; Robert, F; Schlutter, D; Snead, CJ; Stadermann, FJ; Stroud, R; Tsou, P; Westphal, A; Young, ED; Ziegler, K; Zimmermann, L; Zinner, E				McKeegan, Kevin D.; Aleon, Jerome; Bradley, John; Brownlee, Donald; Busemann, Henner; Butterworth, Anna; Chaussidon, Marc; Fallon, Stewart; Floss, Christine; Gilmour, Jamie; Gounelle, Matthieu; Graham, Giles; Guan, Yunbin; Heck, Philipp R.; Hoppe, Peter; Hutcheon, Ian D.; Huth, Joachim; Ishii, Hope; Ito, Motoo; Jacobsen, Stein B.; Kearsley, Anton; Leshin, Laurie A.; Liu, Ming-Chang; Lyon, Ian; Marhas, Kuljeet; Marty, Bernard; Matrajt, Graciela; Meibom, Anders; Messenger, Scott; Mostefaoui, Smail; Mukhopadhyay, Sujoy; Nakamura-Messenger, Keiko; Nittler, Larry; Palma, Russ; Pepin, Robert O.; Papanastassiou, Dimitri A.; Robert, Francois; Schlutter, Dennis; Snead, Christopher J.; Stadermann, Frank J.; Stroud, Rhonda; Tsou, Peter; Westphal, Andrew; Young, Edward D.; Ziegler, Karen; Zimmermann, Laurent; Zinner, Ernst			Isotopic compositions of cometary matter returned by Stardust	SCIENCE			English	Article							INTERPLANETARY DUST PARTICLES; CRYSTALLINE SILICATES; HALE-BOPP; OXYGEN ISOTOPES; ORGANIC-MATTER; METEORITES; NITROGEN; PRESOLAR; ORIGIN; RATIOS	Hydrogen, carbon, nitrogen, and oxygen isotopic compositions are heterogeneous among comet 81P/Wild 2 particle fragments; however, extreme isotopic anomalies are rare, indicating that the comet is not a pristine aggregate of presolar materials. Nonterrestrial nitrogen and neon isotope ratios suggest that indigenous organic matter and highly volatile materials were successfully collected. Except for a single O-17-enriched circumstellar stardust grain, silicate and oxide minerals have oxygen isotopic compositions consistent with solar system origin. One refractory grain is O-16-enriched, like refractory inclusions in meteorites, suggesting that Wild 2 contains material formed at high temperature in the inner solar system and transported to the Kuiper belt before comet accretion.	Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Ctr Spectrometrie Nucl & Spectrometrie Masse, F-91405 Orsay, France; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA 94550 USA; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; Washington Univ, Dept Phys, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; Museum Natl Hist Nat, Lab Etud Mat Extraterr, F-75005 Paris, France; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Max Planck Inst Chem, Particle Chem Dept, D-55128 Mainz, Germany; NASA, Lyndon B Johnson Space Ctr, Robert M Walker Lab Space Sci, Astromat Res Explorat Sci Directorate, Houston, TX 77058 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Nat Hist Museum, Dept Mineral, Impacts & Astromat Res Ctr, London SW7 5BD, England; NASA, Goddard Space Flight Ctr, Sci & Explorat Directorate, Greenbelt, MD 20771 USA; Jacobs Sverdrup, Houston, TX 77058 USA; Minnesota State Univ, Dept Phys & Astron, Mankato, MN 56001 USA; Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; CALTECH, Jet Prop Lab, Div Sci, Pasadena, CA 91109 USA; USN, Res Lab, Washington, DC 20375 USA	University of California System; University of California Los Angeles; UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Washington; University of Washington Seattle; Carnegie Institution for Science; University of California System; University of California Berkeley; Universite de Lorraine; Washington University (WUSTL); University of Manchester; Museum National d'Histoire Naturelle (MNHN); California Institute of Technology; Max Planck Society; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Harvard University; Imperial College London; Natural History Museum London; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Minnesota State Colleges & Universities; Minnesota State University Mankato; University of Minnesota System; University of Minnesota Twin Cities; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of Defense; United States Navy; Naval Research Laboratory	McKeegan, KD (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	mckeegan@ess.ucla.edu	Fallon, Stewart J/G-6645-2011; Heck, Philipp R/AAU-1433-2021; Hoppe, Peter/B-3032-2015; Stroud, Rhonda M./C-5503-2008; Jacobsen, Stein/ABA-1063-2021; Chaussidon, Marc/E-7067-2017; Heck, Philipp/C-6092-2012; McKeegan, Kevin D/A-4107-2008; Matrajt, Graciela/A-4812-2017; Stroud, Rhonda/GQZ-0151-2022; Gilmour, Jamie/G-7515-2011; Liu, Ming-Chang/D-1885-2010; Jacobsen, Stein/B-1759-2013; Stroud, Rhonda M/S-4584-2018	Fallon, Stewart J/0000-0002-8064-5903; Heck, Philipp R/0000-0002-6319-2594; Hoppe, Peter/0000-0003-3681-050X; Stroud, Rhonda M./0000-0001-5242-8015; Jacobsen, Stein/0000-0003-2164-0720; McKeegan, Kevin D/0000-0002-1827-729X; Stroud, Rhonda/0000-0001-5242-8015; Liu, Ming-Chang/0000-0003-4030-5258; Stroud, Rhonda M/0000-0001-5242-8015; Gilmour, Jamie/0000-0003-1990-8636; Ishii, Hope/0000-0002-7976-5078; Marhas, Kuljeet/0000-0002-3375-3047; Young, Edward/0000-0002-1299-0801; Busemann, Henner/0000-0002-0867-6908; Butterworth, Anna/0000-0002-6439-1472; Meibom, Anders/0000-0002-4542-2819	STFC [PP/E000894/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E000894/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Aleon J, 2003, GEOCHIM COSMOCHIM AC, V67, P3773, DOI [10.1016/S0016-7037(03)00170-4, 10.1016/S0016-7037(00)00170-4]; Aleon M, 2001, GEOCHIM COSMOCHIM AC, V65, P4399, DOI 10.1016/S0016-7037(01)00720-7; Arpigny C, 2003, SCIENCE, V301, P1522, DOI 10.1126/science.1086711; Bar-Nun A, 1998, ASTROPHYS SPACE SC L, V227, P353, DOI 10.1007/978-94-011-5252-5_15; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Bouwman J, 2003, ASTRON ASTROPHYS, V401, P577, DOI 10.1051/0004-6361:20030043; Bouwman J, 2001, ASTRON ASTROPHYS, V375, P950, DOI 10.1051/0004-6361:20010878; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; Clayton DD, 2004, ANNU REV ASTRON ASTR, V42, P39, DOI 10.1146/annurev.astro.42.053102.134022; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; EBERHARDT P, 1995, ASTRON ASTROPHYS, V302, P301; Floss C, 2006, GEOCHIM COSMOCHIM AC, V70, P2371, DOI 10.1016/j.gca.2006.01.023; Hashizume K, 2000, SCIENCE, V290, P1142, DOI 10.1126/science.290.5494.1142; Hashizume K, 2004, ASTROPHYS J, V600, P480, DOI 10.1086/379637; HUISEMEKERS D, 2005, ASTRON ASTROPHYS, V440, pL21; Jehin E, 2004, ASTROPHYS J, V613, pL161, DOI 10.1086/425254; Jessberger EK, 1999, SPACE SCI REV, V90, P91, DOI 10.1023/A:1005233727874; Jewitt DC, 1997, SCIENCE, V278, P90, DOI 10.1126/science.278.5335.90; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; LIFFMAN K, 1995, ICARUS, V116, P275, DOI 10.1006/icar.1995.1126; MCKEEGAN KD, 1987, SCIENCE, V237, P1468, DOI 10.1126/science.237.4821.1468; McKeegan KD, 2001, REV MINERAL GEOCHEM, V43, P279, DOI 10.2138/gsrmg.43.1.279; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 2003, SPACE SCI REV, V106, P155, DOI 10.1023/A:1024637704533; MESSENGER S, 1997, AIP C P, V402, P545; Molster F, 2005, SPACE SCI REV, V119, P3, DOI 10.1007/s11214-005-8066-x; Nittler LR, 1997, AIP CONF PROC, P59, DOI 10.1063/1.51767; Owen T, 2003, SPACE SCI REV, V106, P121, DOI 10.1023/A:1024633603624; ROBERT F, 1982, GEOCHIM COSMOCHIM AC, V46, P81, DOI 10.1016/0016-7037(82)90293-9; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	33	329	331	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1724	1728		10.1126/science.1135992	http://dx.doi.org/10.1126/science.1135992			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170292				2022-12-28	WOS:000242833600044
J	Hotamisligil, GS				Hotamisligil, Goekhan S.			Inflammation and metabolic disorders	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RECEPTOR SUBSTRATE-1; BINDING PROTEIN AP2; FACTOR-KAPPA-B; FACTOR-ALPHA; TNF-ALPHA; ADIPOSE-TISSUE; NUCLEAR RECEPTORS; SERINE PHOSPHORYLATION	Metabolic and immune systems are among the most fundamental requirements for survival. Many metabolic and immune response pathways or nutrient- and pathogen-sensing systems have been evolutionarily conserved throughout species. As a result, immune response and metabolic regulation are highly integrated and the proper function of each is dependent on the other. This interface can be viewed as a central homeostatic mechanism, dysfunction of which can lead to a cluster of chronic metabolic disorders, particularly obesity, type 2 diabetes and cardiovascular disease. Collectively, these diseases constitute the greatest current threat to global human health and welfare.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Eckhardt, Erik/G-1567-2010					Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Baumgartl J, 2006, CELL METAB, V3, P247, DOI 10.1016/j.cmet.2006.02.010; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Charlton MR, 2006, HEPATOLOGY, V43, P1177, DOI 10.1002/hep.21239; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kiortsis DN, 2005, ANN RHEUM DIS, V64, P765, DOI 10.1136/ard.2004.026534; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Krogh-Madsen R, 2006, AM J PHYSIOL-ENDOC M, V291, pE108, DOI 10.1152/ajpendo.00471.2005; LARSEN GL, 1983, ANNU REV IMMUNOL, V1, P335, DOI 10.1146/annurev.iy.01.040183.002003; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Liu Gang, 2005, Curr Opin Investig Drugs, V6, P979; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754; Makowski L, 2004, J NUTR, V134, p2464S, DOI 10.1093/jn/134.9.2464S; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Prada PO, 2005, ENDOCRINOLOGY, V146, P1576, DOI 10.1210/en.2004-0767; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Rocchini AP, 2002, NEW ENGL J MED, V346, P854, DOI 10.1056/NEJM200203143461112; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Semenkovich CF, 2006, J CLIN INVEST, V116, P1813, DOI 10.1172/JCI29024; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; SONDERGAARD L, 1993, TRENDS GENET, V9, P193, DOI 10.1016/0168-9525(93)90113-V; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Waeber G, 2000, NAT GENET, V24, P291, DOI 10.1038/73523; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	99	5820	6129	45	1182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					860	867		10.1038/nature05485	http://dx.doi.org/10.1038/nature05485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167474				2022-12-28	WOS:000242805400043
J	Littlefair, SP; Dhillon, VS; Marsh, TR; Gansicke, BT; Southworth, J; Watson, CA				Littlefair, S. P.; Dhillon, V. S.; Marsh, T. R.; Gaensicke, Boris T.; Southworth, John; Watson, C. A.			A brown dwarf mass donor in an accreting binary	SCIENCE			English	Article							DIGITAL SKY SURVEY; CATACLYSMIC VARIABLES; SECONDARY STARS; PERIOD GAP; EVOLUTION; SPECTROSCOPY; SEARCH	A long-standing and unverified prediction of binary star evolution theory is the existence of a population of white dwarfs accreting from substellar donor stars. Such systems ought to be common, but the difficulty of finding them, combined with the challenge of detecting the donor against the light from accretion, means that no donor star to date has a measured mass below the hydrogen burning limit. We applied a technique that allowed us to reliably measure the mass of the unseen donor star in eclipsing systems. We were able to identify a brown dwarf donor star, with a mass of 0.052 +/- 0.002 solar mass. The relatively high mass of the donor star for its orbital period suggests that current evolutionary models may underestimate the radii of brown dwarfs.	Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Sheffield; University of Warwick	Littlefair, SP (corresponding author), Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England.	s.littlefair@shef.ac.uk	Dhillon, Vikram/AAB-5180-2019; Gaensicke, Boris T/A-9421-2012	Dhillon, Vikram/0000-0003-4236-9642; Gaensicke, Boris T/0000-0002-2761-3005; Watson, Christopher/0000-0002-9718-3266; Littlefair, Stuart/0000-0001-7221-855X	STFC [PP/D002370/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D002370/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Araujo-Betancor S, 2005, ASTRON ASTROPHYS, V430, P629, DOI 10.1051/0004-6361:20041736; Baraffe I, 2000, MON NOT R ASTRON SOC, V318, P354, DOI 10.1046/j.1365-8711.2000.03628.x; Barthelmy SD, 2005, NATURE, V438, P994, DOI 10.1038/nature04392; Beuermann K, 2000, ASTRON ASTROPHYS, V354, pL49; Bildsten L, 2001, ASTROPHYS J, V557, P292, DOI 10.1086/321633; Chabrier G, 1997, ASTRON ASTROPHYS, V327, P1039; Dhillon VS, 2000, MON NOT R ASTRON SOC, V314, P826, DOI 10.1046/j.1365-8711.2000.03427.x; DUQUENNOY A, 1991, ASTRON ASTROPHYS, V248, P485; Grether D, 2006, ASTROPHYS J, V640, P1051, DOI 10.1086/500161; HORNE K, 1994, ASTROPHYS J, V426, P294, DOI 10.1086/174064; Howell SB, 1997, MON NOT R ASTRON SOC, V287, P929, DOI 10.1093/mnras/287.4.929; Howell SB, 2001, ASTROPHYS J, V550, pL57, DOI 10.1086/319499; Kolb U, 1999, MON NOT R ASTRON SOC, V309, P1034, DOI 10.1046/j.1365-8711.1999.02926.x; KOLB U, 1993, ASTRON ASTROPHYS, V271, P149; Littlefair SP, 2000, MON NOT R ASTRON SOC, V313, P117, DOI 10.1046/j.1365-8711.2000.03234.x; Littlefair SP, 2003, MON NOT R ASTRON SOC, V340, P264, DOI 10.1046/j.1365-8711.2003.06295.x; Maxted PFL, 2006, NATURE, V442, P543, DOI 10.1038/nature04987; Mennickent RE, 2004, MON NOT R ASTRON SOC, V347, P1180, DOI 10.1111/j.1365-2966.2004.07282.x; Mennickent RE, 2002, MON NOT R ASTRON SOC, V336, P767, DOI 10.1046/j.1365-8711.2002.05789.x; PACZYNSKI B, 1981, ASTROPHYS J, V248, pL27, DOI 10.1086/183616; Politano M, 2004, ASTROPHYS J, V604, P817, DOI 10.1086/381958; Renvoize V, 2002, ASTRON ASTROPHYS, V389, P485, DOI 10.1051/0004-6361:20020622; SAUMON D, 1995, ASTROPHYS J SUPPL S, V99, P713, DOI 10.1086/192204; SOUTHWORTH J, IN PRESS MON NOT R A; Szkody P, 2006, ASTRON J, V131, P973, DOI 10.1086/499308; Szkody P, 2005, ASTRON J, V129, P2386, DOI 10.1086/429595; Szkody P, 2004, ASTRON J, V128, P1882, DOI 10.1086/423997; Szkody P, 2003, ASTRON J, V126, P1499, DOI 10.1086/377346; Szkody P, 2002, ASTRON J, V123, P430, DOI 10.1086/324734; Taam RE, 2001, ASTROPHYS J, V561, P329, DOI 10.1086/322331; Townsley DM, 2003, ASTROPHYS J, V596, pL227, DOI 10.1086/379535; Willems B, 2005, ASTROPHYS J, V635, P1263, DOI 10.1086/498010; WOOD J, 1986, MON NOT R ASTRON SOC, V219, P629, DOI 10.1093/mnras/219.3.629; Yungelson L, 1998, ASTROPHYS J, V497, P168, DOI 10.1086/305455; [No title captured]	35	85	85	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1578	1580		10.1126/science.1133333	http://dx.doi.org/10.1126/science.1133333			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158322	Green Published, Green Accepted			2022-12-28	WOS:000242624600035
J	Behrenfeld, MJ; O'Malley, RT; Siegel, DA; McClain, CR; Sarmiento, JL; Feldman, GC; Milligan, AJ; Falkowski, PG; Letelier, RM; Boss, ES				Behrenfeld, Michael J.; O'Malley, Robert T.; Siegel, David A.; McClain, Charles R.; Sarmiento, Jorge L.; Feldman, Gene C.; Milligan, Allen J.; Falkowski, Paul G.; Letelier, Ricardo M.; Boss, Emmanuel S.			Climate-driven trends in contemporary ocean productivity	NATURE			English	Article							EL-NINO; EQUATORIAL PACIFIC; EXPORT PRODUCTION; WORLDS OCEANS; PERIOD	Contributing roughly half of the biosphere's net primary production (NPP)(1,2), photosynthesis by oceanic phytoplankton is a vital link in the cycling of carbon between living and inorganic stocks. Each day, more than a hundred million tons of carbon in the form of CO2 are fixed into organic material by these ubiquitous, microscopic plants of the upper ocean, and each day a similar amount of organic carbon is transferred into marine ecosystems by sinking and grazing. The distribution of phytoplankton biomass and NPP is defined by the availability of light and nutrients ( nitrogen, phosphate, iron). These growth-limiting factors are in turn regulated by physical processes of ocean circulation, mixed-layer dynamics, upwelling, atmospheric dust deposition, and the solar cycle. Satellite measurements of ocean colour provide a means of quantifying ocean productivity on a global scale and linking its variability to environmental factors. Here we describe global ocean NPP changes detected from space over the past decade. The period is dominated by an initial increase in NPP of 1,930 teragrams of carbon a year (Tg C yr(-1)), followed by a prolonged decrease averaging 190 Tg C yr(-1). These trends are driven by changes occurring in the expansive stratified low-latitude oceans and are tightly coupled to coincident climate variability. This link between the physical environment and ocean biology functions through changes in upper-ocean temperature and stratification, which influence the availability of nutrients for phytoplankton growth. The observed reductions in ocean productivity during the recent post-1999 warming period provide insight on how future climate change can alter marine food webs.	Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; Oregon State Univ, Coll Oceanog & Atmospher Sci, Corvallis, OR 97331 USA; Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Computat Earth Syst Sci, Santa Barbara, CA 93106 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Univ Maine, Sch Marine Sci, Orono, ME 04469 USA	Oregon State University; Oregon State University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Maine System; University of Maine Orono	Behrenfeld, MJ (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, 2082 Cordley Hall, Corvallis, OR 97331 USA.	mjb@science.oregonstate.edu	Siegel, David A/C-5587-2008; Boss, Emmanuel/C-5765-2009; Letelier, Ricardo/A-6953-2009; Boss, Emmanuel/AAF-2336-2019; Smith, Christa/G-3187-2010	Boss, Emmanuel/0000-0002-8334-9595; Letelier, Ricardo/0000-0003-3376-4026; Boss, Emmanuel/0000-0002-8334-9595; 				Bailey SW, 2006, REMOTE SENS ENVIRON, V102, P12, DOI 10.1016/j.rse.2006.01.015; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Le Quere C, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000920; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; McClain CR, 2004, DEEP-SEA RES PT II, V51, P5, DOI 10.1016/j.dsr2.2003.11.001; MOREL A, 1989, LIMNOL OCEANOGR, V34, P1545, DOI 10.4319/lo.1989.34.8.1545; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Siegel DA, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002527; Turk D, 2001, SCIENCE, V293, P471, DOI 10.1126/science.1056449; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; WOLTER K, 1987, J CLIM APPL METEOROL, V26, P540, DOI 10.1175/1520-0450(1987)026<0540:TSOISC>2.0.CO;2; Wolter K, 1993, PROC 17 CLIMATE DIAG, V52	26	1484	1543	50	1105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					752	755		10.1038/nature05317	http://dx.doi.org/10.1038/nature05317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151666				2022-12-28	WOS:000242581100059
J	Bourdon, B; Ribe, NM; Stracke, A; Saal, AE; Turner, SP				Bourdon, Bernard; Ribe, Neil M.; Stracke, Andreas; Saal, Alberto E.; Turner, Simon P.			Insights into the dynamics of mantle plumes from uranium-series geochemistry	NATURE			English	Article							TH-PA-RA; RIDGE INTERACTION; EXCESS TEMPERATURE; BENEATH HAWAII; CANARY-ISLANDS; DISEQUILIBRIA; ICELAND; SYSTEMATICS; GENERATION; CONSTRAINTS	The long-standing paradigm that hotspot volcanoes such as Hawaii or Iceland represent the surface expression of mantle plumes - hot, buoyant upwelling regions beneath the Earth's lithosphere - has recently been the focus of controversy. Whether mantle plumes exist or not is pivotal for our understanding of the thermal, dynamic and compositional evolution of the Earth's mantle. Here we show that uranium-series disequilibria measured in hotspot lavas indicate that hotspots are indeed associated with hot and buoyant upwellings and that weaker ( low buoyancy flux) hotspots such as Iceland and the Azores are characterized by lower excess temperatures than stronger hotspots such as Hawaii. This direct link between buoyancy flux and mantle temperature is evidence for the existence of mantle plumes.	CNRS, Inst Phys Globe Paris, Lab Geochim & Cosmochim, F-75252 Paris 05, France; CNRS, Inst Phys Globe Paris, Lab Dynam Syst Geol, F-75252 Paris 05, France; Max Planck Inst Chem, Abt Geochem, D-55020 Mainz, Germany; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Macquarie Univ, GEMOC, Dept Earth & Planetary Sci, Sydney, NSW 2109, Australia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society; Brown University; Macquarie University	Bourdon, B (corresponding author), ETH, Dept Earth Sci, Inst Isotope Geochem & Mineral Resources, CH-8092 Zurich, Switzerland.	bourdon@erdw.ethz.ch	Bourdon, Bernard/A-3303-2008; GAU, geochemist/H-1985-2016; Turner, Simon/0000-0002-6426-6495	Stracke, Andreas/0000-0002-9719-4213; Turner, Simon/0000-0002-6426-6495				Albers M, 1996, GEOPHYS RES LETT, V23, P3567, DOI 10.1029/96GL03311; Asimow PD, 2003, NATURE, V421, P815, DOI 10.1038/nature01429; ASIMOW PD, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI DOI 10.1029/2003GC000568; BOEHLER R, 1995, CHEM GEOL, V120, P199, DOI 10.1016/0009-2541(94)00138-X; Bourdon B, 2005, EARTH PLANET SC LETT, V239, P42, DOI 10.1016/j.epsl.2005.08.008; Bourdon B, 1996, EARTH PLANET SC LETT, V142, P175, DOI 10.1016/0012-821X(96)00092-1; Bourdon B, 2003, REV MINERAL GEOCHEM, V52, P215, DOI 10.2113/0520215; Bourdon B, 1998, EARTH PLANET SC LETT, V164, P119, DOI 10.1016/S0012-821X(98)00227-1; CHABAUX F, 1994, EARTH PLANET SC LETT, V126, P61, DOI 10.1016/0012-821X(94)90242-9; Courtillot V, 2003, EARTH PLANET SC LETT, V205, P295, DOI 10.1016/S0012-821X(02)01048-8; DePaolo DJ, 1996, J GEOPHYS RES-SOL EA, V101, P11643, DOI 10.1029/96JB00070; Farnetani CG, 1997, GEOPHYS RES LETT, V24, P1583, DOI 10.1029/97GL01548; Foulger GR, 2001, GEOPHYS J INT, V146, P504, DOI 10.1046/j.0956-540x.2001.01470.x; Ito G, 1999, EARTH PLANET SC LETT, V165, P81, DOI 10.1016/S0012-821X(98)00216-7; Kokfelt TF, 2003, EARTH PLANET SC LETT, V214, P167, DOI 10.1016/S0012-821X(03)00306-6; Lundstrom CC, 2003, GEOCHIM COSMOCHIM AC, V67, P4153, DOI 10.1016/S0016-7037(03)00308-9; MACLENNAN J, 2002, EARTH PLANET SC LETT, P67; McKenzie D, 2004, GEOCHIM COSMOCHIM AC, V68, P2699, DOI 10.1016/j.gca.2003.10.029; Meibom A, 2003, EARTH PLANET SC LETT, V208, P197, DOI 10.1016/S0012-821X(03)00038-4; Montelli R, 2004, SCIENCE, V303, P338, DOI 10.1126/science.1092485; Moreira M, 1999, EARTH PLANET SC LETT, V169, P189, DOI 10.1016/S0012-821X(99)00071-0; Murton BJ, 2002, J PETROL, V43, P1987, DOI 10.1093/petrology/43.11.1987; OLSON P, 1993, J GEOPHYS RES-SOL EA, V98, P6829, DOI 10.1029/92JB01013; Peate DW, 2001, EARTH PLANET SC LETT, V187, P259, DOI 10.1016/S0012-821X(01)00266-7; RIBE NM, 1995, EARTH PLANET SC LETT, V134, P155, DOI 10.1016/0012-821X(95)00116-T; Ribe NM, 1996, J GEOPHYS RES-SOL EA, V101, P16195, DOI 10.1029/96JB01187; RICHARDSON C, 1994, EARTH PLANET SC LETT, V128, P425, DOI 10.1016/0012-821X(94)90160-0; SCHILLING JG, 1991, NATURE, V352, P397, DOI 10.1038/352397a0; Sigmarsson O, 1998, EARTH PLANET SC LETT, V162, P137, DOI 10.1016/S0012-821X(98)00162-9; SIMS KWW, 1995, SCIENCE, V267, P508, DOI 10.1126/science.267.5197.508; Sims KWW, 1999, GEOCHIM COSMOCHIM AC, V63, P4119, DOI 10.1016/S0016-7037(99)00313-0; SLEEP NH, 1990, J GEOPHYS RES-SOLID, V95, P6715, DOI 10.1029/JB095iB05p06715; Stracke A, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000347; Stracke A, 2006, EARTH PLANET SC LETT, V244, P97, DOI 10.1016/j.epsl.2006.01.057; Stracke A, 1999, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000013; Turner S, 1997, CHEM GEOL, V139, P145, DOI 10.1016/S0009-2541(97)00031-4; Vigier N, 1999, EARTH PLANET SC LETT, V174, P81, DOI 10.1016/S0012-821X(99)00256-3; Wolfe CJ, 1997, NATURE, V385, P245, DOI 10.1038/385245a0	38	42	44	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					713	717		10.1038/nature05341	http://dx.doi.org/10.1038/nature05341			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151659				2022-12-28	WOS:000242581100050
J	Schmidt, D; Jiang, QX; MacKinnon, R				Schmidt, Daniel; Jiang, Qiu-Xing; MacKinnon, Roderick			Phospholipids and the origin of cationic gating charges in voltage sensors	NATURE			English	Article							DEPENDENT K+ CHANNEL; CRYSTAL-STRUCTURE; ACTIVATION; MEMBRANE	Cells communicate with their external environment through physical and chemical processes that take place in the cell-surrounding membrane. The membrane serves as a barrier as well as a special environment in which membrane proteins are able to carry out important processes. Certain membrane proteins have the ability to detect the membrane voltage and regulate ion conduction or enzyme activity(1,2). Such voltage-dependent processes rely on the action of protein domains known as voltage sensors, which are embedded inside the cell membrane and contain an excess of positively charged amino acids, which react to an electric field. How does the membrane create an environment suitable for voltage sensors? Here we show under a variety of conditions that the function of a voltage-dependent K+ channel is dependent on the negatively charged phosphodiester of phospholipid molecules. A non-voltage-dependent K+ channel does not exhibit the same dependence. The data lead us to propose that the phospholipid membrane, by providing stabilizing interactions between positively charged voltage-sensor arginine residues and negatively charged lipid phosphodiester groups, provides an appropriate environment for the energetic stability and operation of the voltage-sensing machinery. We suggest that the usage of arginine residues in voltage sensors is an adaptation to the phospholipid composition of cell membranes.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockefeller.edu	Jiang, Qiu-Xing/ABF-1143-2021; Jiang, Qiu-Xing/AAI-8579-2020		NIGMS NIH HHS [R01 GM043949] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Campbell RB, 2001, BBA-BIOMEMBRANES, V1512, P27, DOI 10.1016/S0005-2736(01)00290-5; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hui KY, 2003, J GEN PHYSIOL, V122, P63, DOI 10.1085/jgp.200308842; ISRAELACHVILI JN, 1991, INTERMOLECULAR SURFA, P366; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; MacDonald RC, 1999, BIOPHYS J, V77, P2612, DOI 10.1016/S0006-3495(99)77095-5; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; Miller C., 1986, ION CHANNEL RECONSTI; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SUN TY, 1994, BIOCHEMISTRY-US, V33, P9992, DOI 10.1021/bi00199a024	20	336	341	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					775	779		10.1038/nature05416	http://dx.doi.org/10.1038/nature05416			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17136096				2022-12-28	WOS:000242581100064
J	Parrish, JA				Parrish, John A.			An unquiet death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												japarrish@partners.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2006	296	21					2531	2532		10.1001/jama.296.21.2531	http://dx.doi.org/10.1001/jama.296.21.2531			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112ND	17148713				2022-12-28	WOS:000242532000001
J	Shaw, D				Shaw, Dorothy			Sexual and reproductive health: rights and responsibilities	LANCET			English	Editorial Material									Univ British Columbia, Dept Obstet & Gynaecol & Med Genet, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Shaw, D (corresponding author), Univ British Columbia, Dept Obstet & Gynaecol & Med Genet, Vancouver, BC V6T 1Z3, Canada.	dshaw@medd.med.ubc.ca						CLELAND J, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6730(06)69480-4; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; *OFF HIGH COMM HUM, 1968, ACONF3241 UN OFF HIG; Office of the High Commissioner for Human Rights, 1948, UN DECL HUM RIGHTS; *UN, 1994, UN INT C POP DEV CAI	5	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					1941	1943		10.1016/S0140-6736(06)69487-7	http://dx.doi.org/10.1016/S0140-6736(06)69487-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141685				2022-12-28	WOS:000242593300006
J	Taylor, DM				Taylor, David McD			Reverse triage: useful for day-to-day access block?	LANCET			English	Editorial Material							AMBULANCE DIVERSION		Austin Hosp, Dept Emergency Med, Heidelberg, Vic 3084, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Taylor, DM (corresponding author), Austin Hosp, Dept Emergency Med, Heidelberg, Vic 3084, Australia.	david.taylor@austin.org.au						Dara SI, 2005, CRIT CARE MED, V33, P2667, DOI 10.1097/01.CCM.0000151062.00501.60; Fatovich DM, 2003, EMERG MED J, V20, P406, DOI 10.1136/emj.20.5.406; Kelen GD, 2006, LANCET, V368, P1984, DOI 10.1016/S0140-6736(06)69808-5; Lane HC, 2001, JAMA-J AM MED ASSOC, V286, P2595, DOI 10.1001/jama.286.20.2595; Miro O, 1999, Eur J Emerg Med, V6, P105; Richardson DB, 2006, MED J AUSTRALIA, V184, P213, DOI 10.5694/j.1326-5377.2006.tb00204.x; Schneider SM, 2003, ANN EMERG MED, V42, P167, DOI 10.1067/mem.2003.258; Schull MJ, 2003, ANN EMERG MED, V41, P467, DOI 10.1067/mem.2003.23; SPIVULIS PC, 2006, MED J AUSTRALIA, V184, P208; Vilke GM, 2004, J EMERG MED, V26, P189, DOI 10.1016/j.jemermed.2003.07.003	10	5	5	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					1940	1941						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141684				2022-12-28	WOS:000242593300005
J	Chen, HT; Padilla, WJ; Zide, JMO; Gossard, AC; Taylor, AJ; Averitt, RD				Chen, Hou-Tong; Padilla, Willie J.; Zide, Joshua M. O.; Gossard, Arthur C.; Taylor, Antoinette J.; Averitt, Richard D.			Active terahertz metamaterial devices	NATURE			English	Article							TIME-DOMAIN SPECTROSCOPY; NEGATIVE PERMEABILITY; EXPLOSIVES; SPECTRA	The development of artificially structured electromagnetic materials, termed metamaterials, has led to the realization of phenomena that cannot be obtained with natural materials(1). This is especially important for the technologically relevant terahertz ( 1 THz = 10(12) Hz) frequency regime; many materials inherently do not respond to THz radiation, and the tools that are necessary to construct devices operating within this range - sources, lenses, switches, modulators and detectors - largely do not exist. Considerable efforts are underway to fill this 'THz gap' in view of the useful potential applications of THz radiation(2-7). Moderate progress has been made in THz generation and detection(8); THz quantum cascade lasers are a recent example(9). However, techniques to control and manipulate THz waves are lagging behind. Here we demonstrate an active metamaterial device capable of efficient real-time control and manipulation of THz radiation. The device consists of an array of gold electric resonator elements ( the metamaterial) fabricated on a semiconductor substrate. The metamaterial array and substrate together effectively form a Schottky diode, which enables modulation of THz transmission by 50 per cent, an order of magnitude improvement over existing devices(10).	Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Mat Phys & Applicat Div, Los Alamos, NM 87545 USA; Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Santa Barbara	Chen, HT (corresponding author), Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Mat Phys & Applicat Div, POB 1663, Los Alamos, NM 87545 USA.	chenht@lanl.gov	Padilla, Willie John/K-2131-2019; Murad, Masoud K/E-7715-2011; Padilla, Willie J/A-7235-2008; Chen, Hou-Tong/C-6860-2009; Averitt, Richard/AAX-4178-2021; Zide, Joshua/B-5105-2010	Padilla, Willie John/0000-0001-7734-8847; Padilla, Willie J/0000-0001-7734-8847; Chen, Hou-Tong/0000-0003-2014-7571; Averitt, Richard/0000-0003-0451-1935; Zide, Joshua/0000-0002-6378-7221				Barber J, 2005, J PHYS CHEM A, V109, P3501, DOI 10.1021/jp044384h; Federici JF, 2005, SEMICOND SCI TECH, V20, pS266, DOI 10.1088/0268-1242/20/7/018; Ferguson B, 2002, NAT MATER, V1, P26, DOI 10.1038/nmat708; Grigorenko AN, 2005, NATURE, V438, P335, DOI 10.1038/nature04242; GRISCHKOWSKY D, 1990, J OPT SOC AM B, V7, P2006, DOI 10.1364/JOSAB.7.002006; IKONEN P, 2006, GEN PERMEABILITY FUN; Kawase K, 2003, OPT EXPRESS, V11, P2549, DOI 10.1364/OE.11.002549; Kersting R, 2000, ELECTRON LETT, V36, P1156, DOI 10.1049/el:20000837; Kleine-Ostmann T, 2004, APPL PHYS LETT, V84, P3555, DOI 10.1063/1.1723689; Kohler R, 2002, NATURE, V417, P156, DOI 10.1038/417156a; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Liu HB, 2006, OPT EXPRESS, V14, P415, DOI 10.1364/OPEX.14.000415; Mendis R, 2001, IEEE MICROW WIREL CO, V11, P444, DOI 10.1109/7260.966036; O'Hara JF, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2216026; Oliveira F, 2003, P SOC PHOTO-OPT INS, V5070, P60, DOI 10.1117/12.500875; Padilla WJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107401; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Schurig D, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2166681; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Wang KL, 2004, NATURE, V432, P376, DOI 10.1038/nature03040; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025; Zhang S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.137404; Zhou J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.223902; Zimdars D, 2003, P SOC PHOTO-OPT INS, V5070, P108, DOI 10.1117/12.519632	29	1859	1941	93	1386	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					597	600		10.1038/nature05343	http://dx.doi.org/10.1038/nature05343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136089	Green Published			2022-12-28	WOS:000242377600043
J	Jones-Smith, K; Mathur, H				Jones-Smith, Katherine; Mathur, Harsh			Revisiting Pollock's drip paintings	NATURE			English	Letter									Case Western Reserve Univ, Dept Phys, Cleveland, OH 44106 USA	Case Western Reserve University	Jones-Smith, K (corresponding author), Case Western Reserve Univ, Dept Phys, Cleveland, OH 44106 USA.	hxm7@case.edu						Abbott A, 2006, NATURE, V439, P648, DOI 10.1038/439648a; Avnir D, 1998, SCIENCE, V279, P39, DOI 10.1126/science.279.5347.39; Landau E., 1989, JACKSON POLLOCK; Mandelbrot B. B., 1977, FRACTAL GEOMETRY NAT; Mandelbrot BB, 1998, SCIENCE, V279, P783; Mureika JR, 2004, LEONARDO, V37, P53, DOI 10.1162/002409404772828139; NAMUTH H, 1950, COLLECTORS SERIES FI; Ott E, 2002, CHAOS DYNAMICAL SYST; Taylor R, 2003, ART AND COMPLEXITY, P117, DOI 10.1016/B978-044450944-4/50012-8; Taylor R, 1999, PHYS WORLD, V12, P25; Taylor RP, 1999, NATURE, V399, P422, DOI 10.1038/20833; Taylor RP, 2002, LEONARDO, V35, P203, DOI 10.1162/00240940252940603; TAYLOR RP, IN PRESS PATT RECOGN	13	55	55	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					E9	E10		10.1038/nature05398	http://dx.doi.org/10.1038/nature05398			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136047				2022-12-28	WOS:000242377600036
J	Swallen, SF; Kearns, KL; Mapes, MK; Kim, YS; McMahon, RJ; Ediger, MD; Wu, T; Yu, L; Satija, S				Swallen, Stephen F.; Kearns, Kenneth L.; Mapes, Marie K.; Kim, Yong Seol; McMahon, Robert J.; Ediger, M. D.; Wu, Tian; Yu, Lian; Satija, Sushil			Organic glasses with exceptional thermodynamic and kinetic stability	SCIENCE			English	Article							SUPERCOOLED LIQUIDS; STRUCTURAL RELAXATION; AROMATIC HYDROCARBONS; PHYSICAL PROPERTIES; HEAT-CAPACITY; TRANSITION; TEMPERATURE; FORMERS; PARADOX	Vapor deposition has been used to create glassy materials with extraordinary thermodynamic and kinetic stability and high density. For glasses prepared from indomethacin or 1,3-bis-(1-naphthyl)-5(2-naphthyl) benzene, stability is optimized when deposition occurs on substrates at a temperature of 50 K below the conventional glass transition temperature. We attribute the substantial improvement in thermodynamic and kinetic properties to enhanced mobility within a few nanometers of the glass surface during deposition. This technique provides an efficient means of producing glassy materials that are low on the energy landscape and could affect technologies such as amorphous pharmaceuticals.	Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA; Natl Inst Stand & Technol, Ctr Neutron Res, Gaithersburg, MD 20899 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Institute of Standards & Technology (NIST) - USA	Ediger, MD (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	ediger@chem.wisc.edu	McMahon, Robert J./AAR-3868-2020; Ediger, Mark/AGZ-4130-2022	Ediger, Mark/0000-0003-4715-8473				Angell CA, 1997, J RES NATL INST STAN, V102, P171, DOI 10.6028/jres.102.013; Bell RC, 2003, J AM CHEM SOC, V125, P5176, DOI 10.1021/ja0291437; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Ediger MD, 1996, J PHYS CHEM-US, V100, P13200, DOI 10.1021/jp953538d; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Faupel F, 2003, REV MOD PHYS, V75, P237, DOI 10.1103/RevModPhys.75.237; Forrest JA, 1996, PHYS REV LETT, V77, P2002, DOI 10.1103/PhysRevLett.77.2002; Huang DH, 2003, J CHEM PHYS, V119, P3590, DOI 10.1063/1.1599271; Ishii K, 2003, J PHYS CHEM B, V107, P876, DOI 10.1021/jp0260604; KAUZMANN W, 1948, CHEM REV, V43, P219, DOI 10.1021/cr60135a002; Kawana S, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021501; KEDDIE JL, 1994, FARADAY DISCUSS, V98, P219, DOI 10.1039/fd9949800219; Kovacs AJ, 1963, FORTSCH HOCHPOLYM FO, V3, P394, DOI DOI 10.1007/BFB0050366; MAGILL JH, 1967, J CHEM PHYS, V47, P2802, DOI 10.1063/1.1712301; Matyushov DV, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1949211; PLAZEK DJ, 1966, J CHEM PHYS, V45, P3038, DOI 10.1063/1.1728059; Richert R, 2003, J CHEM PHYS, V118, P1828, DOI 10.1063/1.1531587; Saksaengwijit A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.235701; Speedy RJ, 2003, BIOPHYS CHEM, V105, P411, DOI 10.1016/S0301-4622(03)00105-4; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; STILLINGER FH, 1988, J CHEM PHYS, V88, P7818, DOI 10.1063/1.454295; Swallen SF, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2191492; TAKEDA K, 1995, J PHYS CHEM-US, V99, P1602, DOI 10.1021/j100005a035; Tanaka H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025701; Tanaka H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011505; TURNBULL D, 1981, METALL TRANS A, V12, P695, DOI 10.1007/BF02648333; Whitaker CM, 1996, J PHYS CHEM-US, V100, P1081, DOI 10.1021/jp9529329	27	547	550	7	295	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					353	356		10.1126/science.1135795	http://dx.doi.org/10.1126/science.1135795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17158289				2022-12-28	WOS:000243535400034
J	Venkatesh, B; Kirkness, EF; Loh, YH; Halpern, AL; Lee, AP; Johnson, J; Dandona, N; Viswanathan, LD; Tay, A; Venter, JC; Strausberg, RL; Brenner, S				Venkatesh, Byrappa; Kirkness, Ewen F.; Loh, Yong-Hwee; Halpern, Aaron L.; Lee, Alison P.; Johnson, Justin; Dandona, Nidhi; Viswanathan, Lakshmi D.; Tay, Alice; Venter, J. Craig; Strausberg, Robert L.; Brenner, Sydney			Ancient noncoding elements conserved in the human genome	SCIENCE			English	Article							EVOLUTION		Inst Genome Res, Rockville, MD 20850 USA; Inst Mol & Cell Biol, Singapore 138673, Singapore; J Craig Venter Inst, Rockville, MD 20850 USA	J. Craig Venter Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); J. Craig Venter Institute	Venkatesh, B (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbbv@imcb.a-star.edu.sg; ekirknes@tigr.org	Lee, Alison/HCH-1286-2022	Lee, Alison/0000-0002-3773-1021; Venkatesh, Byrappa/0000-0003-3620-0277				Chiu CH, 2002, P NATL ACAD SCI USA, V99, P5492, DOI 10.1073/pnas.052709899; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Shin JT, 2005, NUCLEIC ACIDS RES, V33, P5437, DOI 10.1093/nar/gki853; Venkatesh B, 2005, CURR BIOL, V15, pR82, DOI 10.1016/j.cub.2005.01.021; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	7	92	94	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1892	1892		10.1126/science.1130708	http://dx.doi.org/10.1126/science.1130708			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185593				2022-12-28	WOS:000242996800037
J	Niedernhofer, LJ; Garinis, GA; Raams, A; Lalai, AS; Robinson, AR; Appeldoorn, E; Odijk, H; Oostendorp, R; Ahmad, A; Van Leeuwen, W; Theil, AF; Vermeulen, W; van der Horst, GTJ; Meinecke, P; Kleijer, WJ; Vijg, J; Jaspers, NGJ; Hoeijmakers, JHJ				Niedernhofer, Laura J.; Garinis, George A.; Raams, Anja; Lalai, Astrid S.; Robinson, Andria Rasile; Appeldoorn, Esther; Odijk, Hanny; Oostendorp, Roos; Ahmad, Anwaar; Van Leeuwen, Wibeke; Theil, Arjan F.; Vermeulen, Wim; van der Horst, Gijsbertus T. J.; Meinecke, Peter; Kleijer, Wim J.; Vijg, Jan; Jaspers, Nicolaas G. J.; Hoeijmakers, Jan H. J.			A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis	NATURE			English	Article							PIGMENTOSUM GROUP-F; DNA-REPAIR DEFECTS; XERODERMA-PIGMENTOSUM; LIFE-SPAN; GROWTH-HORMONE; NUCLEAR ABNORMALITIES; GENOMIC INSTABILITY; CALORIC RESTRICTION; GENE; MICE	XPF-ERCC1 endonuclease is required for repair of helix-distorting DNA lesions and cytotoxic DNA interstrand crosslinks. Mild mutations in XPF cause the cancer-prone syndrome xeroderma pigmentosum. A patient presented with a severe XPF mutation leading to profound crosslink sensitivity and dramatic progeroid symptoms. It is not known how unrepaired DNA damage accelerates ageing or its relevance to natural ageing. Here we show a highly significant correlation between the liver transcriptome of old mice and a mouse model of this progeroid syndrome. Expression data from XPF-ERCC1-deficient mice indicate increased cell death and anti-oxidant defences, a shift towards anabolism and reduced growth hormone/insulin-like growth factor 1 (IGF1) signalling, a known regulator of lifespan. Similar changes are seen in wild-type mice in response to chronic genotoxic stress, caloric restriction, or with ageing. We conclude that unrepaired cytotoxic DNA damage induces a highly conserved metabolic response mediated by the IGF1/insulin pathway, which re-allocates resources from growth to somatic preservation and life extension. This highlights a causal contribution of DNA damage to ageing and demonstrates that ageing and end-of-life fitness are determined both by stochastic damage, which is the cause of functional decline, and genetics, which determines the rates of damage accumulation and decline.	Erasmus Univ, Med Ctr, Ctr Biomed Genet Med Genet Ctr, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Expt Radiol, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Univ Pittsburgh, Sch Med, Inst Canc, Dept Mol Genet & Biochem, Pittsburgh, PA 15213 USA; Altonaer kinderkrankenhaus, Abt Med Genet, D-22763 Hamburg, Germany; Buck Inst Age Res, Novato, CA 94945 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Hamburg; University Medical Center Hamburg-Eppendorf; Buck Institute for Research on Aging	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Med Ctr, Ctr Biomed Genet Med Genet Ctr, Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	j.hoeijmakers@erasmusmc.nl	van der Horst, Gijsbertus TJ/E-3661-2015; Garinis, George A./B-2943-2012; Vermeulen, Wim/W-8708-2019; Hoeijmakers, Jan/AAX-6972-2021	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Garinis, George A./0000-0002-3200-5004; Vermeulen, Wim/0000-0003-3616-734X; 	NCI NIH HHS [K22 CA111525] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA111525] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; Bootsma D., 2001, METABOLIC MOL BASES, V1, P677; Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Carter CS, 2002, TRENDS GENET, V18, P295, DOI 10.1016/S0168-9525(02)02696-3; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dolle MET, 2006, MUTAT RES-FUND MOL M, V596, P22, DOI 10.1016/j.mrfmmm.2005.11.008; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Ghoshal AK, 2000, P SOC EXP BIOL MED, V225, P128, DOI 10.1046/j.1525-1373.2000.22516.x; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Huang Q, 2001, TOXICOL SCI, V63, P196, DOI 10.1093/toxsci/63.2.196; Kasai H, 1998, CARCINOGENESIS, V19, P1459, DOI 10.1093/carcin/19.8.1459; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kipling D, 2004, SCIENCE, V305, P1426, DOI 10.1126/science.1102587; Kirkwood TBL, 2000, HUM EXP TOXICOL, V19, P338, DOI 10.1191/096032700678816025; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; LEE PDK, 1993, P SOC EXP BIOL MED, V204, P4; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lombardi G, 2005, J Endocrinol Invest, V28, P99; Maccormick RE, 2006, MED HYPOTHESES, V67, P212, DOI 10.1016/j.mehy.2006.01.045; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matsumura Y, 1998, HUM MOL GENET, V7, P969, DOI 10.1093/hmg/7.6.969; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Miller RA, 2005, SCIENCE, V310, P441, DOI 10.1126/science.310.5747.441; Mitchell JR, 2003, CURR OPIN CELL BIOL, V15, P232, DOI 10.1016/S0955-0674(03)00018-8; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Muller EE, 1999, PHYSIOL REV, V79, P511, DOI 10.1152/physrev.1999.79.2.511; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542; Sijbers AM, 1998, J INVEST DERMATOL, V110, P832, DOI 10.1046/j.1523-1747.1998.00171.x; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058; Spindler SR, 2005, MECH AGEING DEV, V126, P960, DOI 10.1016/j.mad.2005.03.016; Takahashi Y, 2003, BBA-MOL CELL BIOL L, V1631, P265, DOI 10.1016/S1388-1981(03)00038-6; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; VANDERPLUIJM I, IN PRESS PLOS BIOL, DOI DOI 10.1037/JOURNAL.PBIO.0050002; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	49	517	526	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1038	1043		10.1038/nature05456	http://dx.doi.org/10.1038/nature05456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183314				2022-12-28	WOS:000242971100047
J	Wang, TJ; Gona, P; Larson, MG; Tofler, GH; Levy, D; Newton-Cheh, C; Jacques, PF; Rifai, N; Selhub, J; Robins, SJ; Benjamin, EJ; D'Agostino, RB; Vasan, RS				Wang, Thomas J.; Gona, Philimon; Larson, Martin G.; Tofler, Geoffrey H.; Levy, Daniel; Newton-Cheh, Christopher; Jacques, Paul F.; Rifai, Nader; Selhub, Jacob; Robins, Sander J.; Benjamin, Emelia J.; D'Agostino, Ralph B.; Vasan, Ramachandran S.			Multiple biomarkers for the prediction of first major cardiovascular events and death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; PLASMINOGEN-ACTIVATOR INHIBITOR; DENSITY-LIPOPROTEIN CHOLESTEROL; BRAIN NATRIURETIC PEPTIDE; CONVENTIONAL RISK-FACTORS; MYOCARDIAL-INFARCTION; PHOSPHOLIPASE A(2); FOLLOW-UP; PLASMA	BACKGROUND: Few investigations have evaluated the incremental usefulness of multiple biomarkers from distinct biologic pathways for predicting the risk of cardiovascular events. METHODS: We measured 10 biomarkers in 3209 participants attending a routine examination cycle of the Framingham Heart Study: the levels of C-reactive protein, B-type natriuretic peptide, N-terminal pro-atrial natriuretic peptide, aldosterone, renin, fibrinogen, d-dimer, plasminogen-activator inhibitor type 1, and homocysteine; and the urinary albumin-to-creatinine ratio. RESULTS: During follow-up (median, 7.4 years), 207 participants died and 169 had a first major cardiovascular event. In Cox proportional-hazards models adjusting for conventional risk factors, the following biomarkers most strongly predicted the risk of death (each biomarker is followed by the adjusted hazard ratio per 1 SD increment in the log values): B-type natriuretic peptide level (1.40), C-reactive protein level (1.39), the urinary albumin-to-creatinine ratio (1.22), homocysteine level (1.20), and renin level (1.17). The biomarkers that most strongly predicted major cardiovascular events were B-type natriuretic peptide level (adjusted hazard ratio, 1.25 per 1 SD increment in the log values) and the urinary albumin-to-creatinine ratio (1.20). Persons with ``multimarker'' scores (based on regression coefficients of significant biomarkers) in the highest quintile as compared with those with scores in the lowest two quintiles had elevated risks of death (adjusted hazard ratio, 4.08; P<0.001) and major cardiovascular events (adjusted hazard ratio, 1.84; P=0.02). However, the addition of multimarker scores to conventional risk factors resulted in only small increases in the ability to classify risk, as measured by the C statistic. CONCLUSIONS: For assessing risk in individual persons, the use of the 10 contemporary biomarkers that we studied adds only moderately to standard risk factors.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Div Cardiol, Boston, MA 02114 USA; Framingham Heart Dis Epidemiol Study, Framingham, MA USA; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; Royal N Shore Hosp, Sydney, NSW, Australia; NHLBI, Bethesda, MD 20892 USA; Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer Dept Agr, Boston, MA 02111 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Lab Med, Boston, MA 02115 USA; Boston Univ, Sch Med, Boston Med Ctr, Prevent Med & Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston Med Ctr, Div Endocrinol Nutr & Diabet, Boston, MA 02118 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Framingham Heart Study; Boston University; Royal North Shore Hospital; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tufts University; United States Department of Agriculture (USDA); Harvard University; Boston Children's Hospital; Harvard Medical School; Boston Medical Center; Boston University; Boston Medical Center; Boston University	Wang, TJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Div Cardiol, GRB-800,55 Fruit St, Boston, MA 02114 USA.	tjwang@partners.org	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Gona, Philimon/K-1477-2019; Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336; Robins, Sander/0000-0002-3735-8415	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL074077, R01HL076784, K24HL004334, R01HL048157] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-25195, K23-HL-074077, R01-HL-076784, R01-HL-48157, 2K24-HL-04334] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alderman MH, 1997, AM J HYPERTENS, V10, P1, DOI 10.1016/S0895-7061(96)00301-9; ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; Best LG, 2005, CIRCULATION, V112, P1289, DOI 10.1161/CIRCULATIONAHA.104.489260; Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COX DR, 1972, J R STAT SOC B, V34, P187; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P493, DOI 10.1161/01.ATV.19.3.493; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P2848; Danesh J, 2001, CIRCULATION, V103, P2323; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Festa A, 2003, CIRCULATION, V108, P1822, DOI 10.1161/01.CIR.0000091339.70120.53; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; FRANCIS RB, 1988, AM HEART J, V115, P776, DOI 10.1016/0002-8703(88)90878-2; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Greenland P, 2005, ARCH INTERN MED, V165, P2454, DOI 10.1001/archinte.165.21.2454; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hoekstra T, 2004, THROMB HAEMOSTASIS, V91, P861, DOI 10.1160/TH03-08-0546; Hoogeveen EK, 2000, CIRCULATION, V101, P1506, DOI 10.1161/01.CIR.101.13.1506; KANNEL WB, 1987, NIH PUBLICATION; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Koenig W, 2004, CIRCULATION, V110, P1903, DOI 10.1161/01.CIR.0000143377.53389.C8; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; Mangoni AA, 2002, AM J MED, V112, P556, DOI 10.1016/S0002-9343(02)01021-5; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Ridker PM, 2004, CIRCULATION, V109, P6, DOI 10.1161/01.CIR.0000133444.17867.56; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Tice JA, 2003, AM J MED, V114, P199, DOI 10.1016/S0002-9343(02)01497-3; Vollset SE, 2001, AM J CLIN NUTR, V74, P130; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	40	989	1070	0	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2631	2639		10.1056/NEJMoa055373	http://dx.doi.org/10.1056/NEJMoa055373			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182988				2022-12-28	WOS:000242956200004
J	Ahn, JH; Kim, HS; Lee, KJ; Jeon, S; Kang, SJ; Sun, YG; Nuzzo, RG; Rogers, JA				Ahn, Jong-Hyun; Kim, Hoon-Sik; Lee, Keon Jae; Jeon, Seokwoo; Kang, Seong Jun; Sun, Yugang; Nuzzo, Ralph G.; Rogers, John A.			Heterogeneous three-dimensional electronics by use of printed semiconductor nanomaterials	SCIENCE			English	Article							THIN-FILM TRANSISTORS; INTEGRATION; SILICON; PHOTODETECTORS; PERFORMANCE; TECHNOLOGY; NANOWIRES; CIRCUITS; DEVICES; ARRAYS	We developed a simple approach to combine broad classes of dissimilar materials into heterogeneously integrated electronic systems with two- or three-dimensional layouts. The process begins with the synthesis of different semiconductor nanomaterials, such as single-walled carbon nanotubes and single-crystal micro- and nanoscale wires and ribbons of gallium nitride, silicon, and gallium arsenide on separate substrates. Repeated application of an additive, transfer printing process that uses soft stamps with these substrates as donors, followed by device and interconnect formation, yields high-performance heterogeneously integrated electronics that incorporate any combination of semiconductor nanomaterials on rigid or flexible device substrates. This versatile methodology can produce a wide range of unusual electronic systems that would be impossible to achieve with other techniques.	Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.	jrogers@uiuc.edu	JEON, SEOKWOO/C-1701-2011; Lee, Keon Jae/GXF-5235-2022; Kang, Seong Jun/AAG-7631-2019; Ahn, Jong-Hyun/L-9825-2016; Sun, Yugang/A-3683-2010; huang, yonggang/O-6236-2019; Rogers, John/L-2798-2016; Lee, Keon Jae/C-1722-2011	Ahn, Jong-Hyun/0000-0002-8135-7719; Sun, Yugang/0000-0001-6351-6977; Jeon, Seokwoo/0000-0002-5338-0671				Ahn JH, 2006, IEEE ELECTR DEVICE L, V27, P460, DOI 10.1109/LED.2006.874764; Al-Sarawi SF, 1998, IEEE T COMPON PACK B, V21, P2, DOI 10.1109/96.659500; AMANO H, 1986, APPL PHYS LETT, V48, P353, DOI 10.1063/1.96549; Banerjee K, 2001, P IEEE, V89, P602, DOI 10.1109/5.929647; BEAN JC, 1992, P IEEE, V80, P571, DOI 10.1109/5.135380; Brown AS, 2001, MAT SCI ENG B-SOLID, V87, P317, DOI 10.1016/S0921-5107(01)00730-9; GARROU P, 2005, SEMICOND INT, V28, pSP10; Huang Y, 2005, SMALL, V1, P142, DOI 10.1002/smll.200400030; Hur SH, 2004, APPL PHYS LETT, V85, P5730, DOI 10.1063/1.1829774; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Kong J, 1998, NATURE, V395, P878, DOI 10.1038/27632; Kuykendall T, 2004, NAT MATER, V3, P524, DOI 10.1038/nmat1177; Law M, 2004, SCIENCE, V305, P1269, DOI 10.1126/science.1100999; Linder S., 1994, Proceedings IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robotic Systems (Cat. No.94CH3404-1), P349, DOI 10.1109/MEMSYS.1994.556165; Meitl MA, 2006, NAT MATER, V5, P33, DOI 10.1038/nmat1532; Menard E, 2004, APPL PHYS LETT, V84, P5398, DOI 10.1063/1.1767591; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Roelkens G, 2005, OPT EXPRESS, V13, P10102, DOI 10.1364/OPEX.13.010102; Schmidt MA, 1998, P IEEE, V86, P1575, DOI 10.1109/5.704262; SOOLE JBD, 1991, IEEE J QUANTUM ELECT, V27, P737, DOI 10.1109/3.81384; Strukov DB, 2005, NANOTECHNOLOGY, V16, P888, DOI 10.1088/0957-4484/16/6/045; Sun YG, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2032609; Tong Q.-Y., 1999, SEMICONDUCTOR WAFER; Tseng YC, 2004, NANO LETT, V4, P123, DOI 10.1021/nl0349707	25	572	637	7	437	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1754	1757		10.1126/science.1132394	http://dx.doi.org/10.1126/science.1132394			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170298				2022-12-28	WOS:000242833600052
J	Kieffer, SW; Lu, XL; Bethke, CM; Spencer, JR; Marshak, S; Navrotsky, A				Kieffer, Susan W.; Lu, Xinli; Bethke, Craig M.; Spencer, John R.; Marshak, Stephen; Navrotsky, Alexandra			A clathrate reservoir hypothesis for Enceladus' south polar plume	SCIENCE			English	Article							GAS-PRODUCTION; HYDRATE; ICE; WELL	We hypothesize that active tectonic processes in the south polar terrain of Enceladus, the 500-kilometer-diameter moon of Saturn, are creating fractures that cause degassing of a clathrate reservoir to produce the plume documented by the instruments on the Cassini spacecraft. Advection of gas and ice transports energy, supplied at depth as latent heat of clathrate decomposition, to shallower levels, where it reappears as latent heat of condensation of ice. The plume itself, which has a discharge rate comparable to Old Faithful Geyser in Yellowstone National Park, probably represents small leaks from this massive advective system.	Univ Illinois, Dept Geol, Urbana, IL 61801 USA; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; Univ Calif Davis, Thermochem Facil, Davis, CA 95616 USA; Univ Calif Davis, NEAT, ORU, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis; University of California System; University of California Davis	Kieffer, SW (corresponding author), Univ Illinois, Dept Geol, 1301 W Green St, Urbana, IL 61801 USA.	skieffer@uiuc.edu						Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Hong H, 2003, J CAN PETROL TECHNOL, V42, P45, DOI 10.2118/03-11-05; Ji C, 2001, CHEM ENG SCI, V56, P5801, DOI 10.1016/S0009-2509(01)00265-2; Kargel JS, 2006, SCIENCE, V311, P1389, DOI 10.1126/science.1124495; KIEFFER SW, 1989, REV GEOPHYS, V27, P28; Kuhs WF, 1997, J INCLUS PHENOM MOL, V29, P65, DOI 10.1023/A:1007960217691; Laufer D, 2005, ICARUS, V178, P248, DOI 10.1016/j.icarus.2005.04.019; Longhi J, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002552; Lu X, 2004, THESIS U AUCKLAND AU; Lu XL, 2006, GEOTHERMICS, V35, P409, DOI 10.1016/j.geothermics.2006.07.001; Lu XL, 2005, GEOTHERMICS, V34, P389, DOI 10.1016/j.geothermics.2005.05.001; LUNINE JI, 1985, ASTROPHYS J SUPPL S, V58, P493, DOI 10.1086/191050; MILLER SL, 1969, SCIENCE, V165, P489, DOI 10.1126/science.165.3892.489; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Sloan E. D., 1997, CLATHRATE HYDRATES N; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Tian F.H., UNPUB; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Wilder JW, 2002, J PHYS CHEM B, V106, P6298, DOI 10.1021/jp014256i	21	115	117	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1764	1766		10.1126/science.1133519	http://dx.doi.org/10.1126/science.1133519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170301				2022-12-28	WOS:000242833600055
J	Caviness, VS; Sagar, P; Israel, EJ; Mackool, BT; Grabowski, EF; Frosch, MP; Zanger, K; Mackool, BT; Harris, NL				Caviness, Verne S., Jr.; Sagar, Pallavi; Israel, Esther J.; Mackool, Bonnie T.; Grabowski, Eric F.; Frosch, Matthew P.; Zanger, Kirsten; Mackool, Bonnie T.; Harris, Nancy Lee			A boy with headache and abdominal pain - Degos's disease, involving the brain, gastrointestinal tract, and skin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MALIGNANT ATROPHIC PAPULOSIS; CENTRAL NERVOUS SYSTEM; KOHLMEIER-DEGOS; VASCULOPATHY; INVOLVEMENT		Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Med Sch, Dept Neurol, Boston, MA USA; Harvard Med Sch, Dept Radiol, Boston, MA USA; Harvard Med Sch, Dept Pediat, Boston, MA USA; Harvard Med Sch, Dept Dermatol, Boston, MA USA; Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Caviness, VS (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861				Atchabahian A, 1996, AM J GASTROENTEROL, V91, P2208; Ball E, 2003, AM J DERMATOPATH, V25, P308, DOI 10.1097/00000372-200308000-00005; BURROW JN, 1991, AUST NZ J MED, V21, P49, DOI 10.1111/j.1445-5994.1991.tb03002.x; Caldarelli M, 2002, ACTA NEUROCHIR, V144, P581, DOI 10.1007/s00701-002-0947-0; CULICCHIA CF, 1962, NEUROLOGY, V12, P503, DOI 10.1212/WNL.12.8.503; DASTUR DK, 1981, J NEUROL NEUROSUR PS, V44, P156, DOI 10.1136/jnnp.44.2.156; DEGOS R, 1952, Ann Dermatol Syphiligr (Paris), V79, P410; DEGOS R, 1979, BRIT J DERMATOL, V100, P21, DOI 10.1111/j.1365-2133.1979.tb03566.x; Evans G H, 1987, J R Coll Surg Edinb, V32, P371; Farrell AM, 1998, BRIT J DERMATOL, V139, P708; GEVER SG, 1962, SOUTHERN MED J, V55, P56, DOI 10.1097/00007611-196201000-00014; HABBEMA L, 1986, BRIT J DERMATOL, V114, P134, DOI 10.1111/j.1365-2133.1986.tb02789.x; Harvell JD, 2001, AM J DERMATOPATH, V23, P116, DOI 10.1097/00000372-200104000-00006; High WA, 2004, J AM ACAD DERMATOL, V50, P895, DOI 10.1016/j.jaad.2003.11.063; Kohlmeier W, 1941, ARCH DERMATOL SYPH-G, V181, P783, DOI 10.1007/BF01828450; LABEL LS, 1983, NEUROLOGY, V33, P936, DOI 10.1212/WNL.33.7.936; Lankisch MR, 1999, AM J GASTROENTEROL, V94, P1098; MAGRINAT G, 1989, ARCH PATHOL LAB MED, V113, P354; MCFARLAND HR, 1978, ANN NEUROL, V3, P388, DOI 10.1002/ana.410030504; PETIT WA, 1982, NEUROLOGY, V32, P1305, DOI 10.1212/WNL.32.11.1305; PLANTIN P, 1989, J AM ACAD DERMATOL, V21, P136, DOI 10.1016/S0190-9622(89)80354-8; Powell J, 1999, BRIT J DERMATOL, V141, P524; ROBERTS WG, 1995, J CELL SCI, V108, P2369; RUNYON BA, 1992, ANN INTERN MED, V117, P215, DOI 10.7326/0003-4819-117-3-215; Rybarczyk BJ, 2003, BLOOD, V102, P4035, DOI 10.1182/blood-2003-03-0822; Scheinfeld N, 2005, J AM ACAD DERMATOL, V52, P375, DOI 10.1016/j.jaad.2004.06.049; STROLE WE, 1967, NEW ENGL J MED, V276, P195, DOI 10.1056/NEJM196701262760402; Subbiah P, 1996, NEUROLOGY, V46, P636, DOI 10.1212/WNL.46.3.636; Valverde FMG, 2003, ARCH SURG-CHICAGO, V138, P57, DOI 10.1001/archsurg.138.1.57; WINKELMANN RK, 1963, ARCH DERMATOL, V87, P54, DOI 10.1001/archderm.1963.01590130060011; Zouros A, 2004, J NEUROSURG, V100, P512, DOI 10.3171/ped.2004.100.5.0512	31	20	20	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2575	2584		10.1056/NEJMcpc069029	http://dx.doi.org/10.1056/NEJMcpc069029			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116BZ	17167141				2022-12-28	WOS:000242778800011
J	Kumar, KA; Sano, G; Boscardin, S; Nussenzweig, RS; Nussenzweig, MC; Zavala, F; Nussenzweig, V				Kumar, Kota Arun; Sano, Gen-ichiro; Boscardin, Silvia; Nussenzweig, Ruth S.; Nussenzweig, Michel C.; Zavala, Fidel; Nussenzweig, Victor			The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites	NATURE			English	Article							LIVER-STAGES; T-CELLS; MALARIA; IMMUNITY; VACCINE; TRANSCRIPTOME; IMMUNIZATION; INFECTION; VIRULENCE; EPITOPES	Malaria infection starts when mosquitoes inject sporozoites into the skin. The parasites enter the blood stream and make their way to the liver where they develop into the exo-erythrocytic forms (EEFs). Immunization with irradiated sporozoites (IrSp) leads to robust protection against malaria infection in rodents(1), monkeys(2) and humans(3) by eliciting antibodies to circumsporozoite protein (CS) that inhibit sporozoite infectivity, and T cells that destroy the EEFs(4). To study the role of non-CS antigens in protection, we produced CS transgenic mice that were tolerant to CS T-cell epitopes. Here we show that in the absence of T-cell-dependent immune responses to CS, protection induced by immunization with two doses of IrSp was greatly reduced. Thus, although hundreds of other Plasmodium genes are expressed in sporozoites(5) and EEFs(6), CS is a dominant protective antigen. Nevertheless, sterile immunity could be obtained by immunization of CS transgenics with three doses of IrSp.	NYU, Sch Med, Dept Pathol, Michael Heidelberger Div Immunol, New York, NY 10016 USA; Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Inst, New York, NY 10021 USA; NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10016 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	New York University; Keio University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; New York University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kumar, KA (corresponding author), NYU, Sch Med, Dept Pathol, Michael Heidelberger Div Immunol, New York, NY 10016 USA.	arun.kumar@med.nyu.edu	Boscardin, Silvia Beatriz/C-3397-2012; Nussenzweig, Michel/AAE-7292-2019	Boscardin, Silvia Beatriz/0000-0002-7845-7110; 				Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Carvalho LH, 2001, J IMMUNOL METHODS, V252, P207, DOI 10.1016/S0022-1759(01)00331-3; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hoffman SL, 2000, NAT MED, V6, P1218, DOI 10.1038/81315; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 1998, NAT MED, V4, P1351, DOI 10.1038/3934; Kappe SHI, 2001, P NATL ACAD SCI USA, V98, P9895, DOI 10.1073/pnas.171185198; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; ROBSON KJH, 1988, NATURE, V335, P79, DOI 10.1038/335079a0; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; SANO G, 1994, MOL BIOCHEM PARASIT, V63, P265, DOI 10.1016/0166-6851(94)90062-0; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; SINNIS P, 1994, J EXP MED, V180, P297, DOI 10.1084/jem.180.1.297; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Wang QA, 2004, MOL BIOCHEM PARASIT, V137, P161, DOI 10.1016/j.molbiopara.2004.06.001; Wang Q, 2005, PLOS PATHOG, V1, P72, DOI 10.1371/journal.ppat.0010009; WEISS WR, 1989, J IMMUNOL, V143, P4263; WIZEL B, 1995, J EXP MED, V182, P1435, DOI 10.1084/jem.182.5.1435	30	204	215	0	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					937	940		10.1038/nature05361	http://dx.doi.org/10.1038/nature05361			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17151604				2022-12-28	WOS:000242805400058
J	Melmed, S				Melmed, Shlomo			Medical progress: Acromegaly	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GROWTH-FACTOR-I; HORMONE-RELEASING-HORMONE; HUMAN PITUITARY-ADENOMAS; LONG-TERM; SOMATOSTATIN ANALOGS; TRANSSPHENOIDAL SURGERY; INCREASED PREVALENCE; PROLACTIN SECRETION; DISEASE-ACTIVITY; PREDICTIVE-VALUE		Univ Calif Los Angeles, Cedars Sinai Med Ctr, David Geffen Sch Med, Dept Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Melmed, S (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, David Geffen Sch Med, Dept Med, 8700 Beverly Blvd,Rm 2015, Los Angeles, CA 90048 USA.	melmed@cshs.org	Hug, Balthasar L./G-1568-2010		NCI NIH HHS [CA 75979] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075979] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Shraim M, 2006, ACTA NEUROPATHOL, V111, P1, DOI 10.1007/s00401-005-1093-6; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Asa Sylvia L, 2005, Endocrine, V28, P43, DOI 10.1385/ENDO:28:1:043; Attanasio R, 2003, J CLIN ENDOCR METAB, V88, P5258, DOI 10.1210/jc.2003-030266; Ayuk J, 2004, J CLIN ENDOCR METAB, V89, P1613, DOI 10.1210/jc.2003-031584; Barkan AL, 2005, J CLIN ENDOCR METAB, V90, P5684, DOI 10.1210/jc.2005-0331; Barrande G, 2000, J CLIN ENDOCR METAB, V85, P3779, DOI 10.1210/jc.85.10.3779; Ben-Shlomo A, 2003, J CLIN ENDOCR METAB, V88, P963, DOI 10.1210/jc.2002-020072; Beuschlein F, 2000, NEW ENGL J MED, V342, P1871, DOI 10.1056/NEJM200006223422504; Bevan JS, 2005, J CLIN ENDOCR METAB, V90, P1856, DOI 10.1210/jc.2004-1093; Biering H, 2006, EUR J ENDOCRINOL, V154, P213, DOI 10.1530/eje.1.02079; Biermasz NR, 2005, J CLIN ENDOCR METAB, V90, P2731, DOI 10.1210/jc.2004-2297; Biermasz NR, 2004, J CLIN ENDOCR METAB, V89, P2789, DOI 10.1210/jc.2003-032041; Bonadonna S, 2005, J BONE MINER RES, V20, P1837, DOI 10.1359/JBMR.050603; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Cappabianca P, 2003, NEUROSURGERY, V52, P483, DOI 10.1227/01.NEU.0000309197.74504.44; Castinetti F, 2005, J CLIN ENDOCR METAB, V90, P4483, DOI 10.1210/jc.2005-0311; Cats A, 1996, CANCER RES, V56, P523; Clayton RN, 2003, ENDOCR REV, V24, P272, DOI 10.1210/er.2003-0009; Clemmons DR, 2005, ENDOCRIN DEV, V9, P55, DOI 10.1159/000085756; Colao A, 2006, J CLIN ENDOCR METAB, V91, P85, DOI 10.1210/jc.2005-1208; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Colao A, 2003, EUR J ENDOCRINOL, V148, P31, DOI 10.1530/eje.0.1480031; Colao A, 2006, J CLIN ENDOCR METAB, V91, P2112, DOI 10.1210/jc.2005-2110; Costa ACF, 2002, J CLIN ENDOCR METAB, V87, P3142, DOI 10.1210/jc.87.7.3142; Cozzi R, 2006, J CLIN ENDOCR METAB, V91, P1397, DOI 10.1210/jc.2005-2347; Cozzi R, 2004, CLIN ENDOCRINOL, V61, P209, DOI 10.1111/j.1365-2265.2004.02082.x; Dimaraki EV, 2002, J CLIN ENDOCR METAB, V87, P3537, DOI 10.1210/jc.87.8.3537; Drange MR, 2000, J CLIN ENDOCR METAB, V85, P168, DOI 10.1210/jc.85.1.168; Fahlbusch R, 2005, EUR J ENDOCRINOL, V153, P239, DOI 10.1530/eje.1.01970; Fedele M, 2005, ONCOGENE, V24, P3427, DOI 10.1038/sj.onc.1208501; Feenstra J, 2005, LANCET, V365, P1644, DOI 10.1016/S0140-6736(05)63011-5; Freda Pamela U, 2003, Pituitary, V6, P175, DOI 10.1023/B:PITU.0000023424.72021.e2; Freda PU, 2004, J CLIN ENDOCR METAB, V89, P495, DOI 10.1210/jc.2003-031316; FROHMAN LA, 1984, NEUROENDOCRINE PERSP, V3, P201; Gittoes NJL, 1999, QJM-MON J ASSOC PHYS, V92, P741, DOI 10.1093/qjmed/92.12.741; Giustina A, 2000, J CLIN ENDOCR METAB, V85, P526, DOI 10.1210/jc.85.2.526; GIUSTINA A, 1995, AM J CARDIOL, V75, P1042, DOI 10.1016/S0002-9149(99)80721-8; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; GRUNSTEIN RR, 1994, ANN INTERN MED, V121, P478, DOI 10.7326/0003-4819-121-7-199410010-00002; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Herman-Bonert VS, 2000, J CLIN ENDOCR METAB, V85, P2958, DOI 10.1210/jc.85.8.2958; HO KY, 1988, J CLIN INVEST, V81, P968, DOI 10.1172/JCI113450; Holdaway I M, 1999, Pituitary, V2, P29, DOI 10.1023/A:1009965803750; Holdaway IM, 2004, J CLIN ENDOCR METAB, V89, P667, DOI 10.1210/jc.2003-031199; Jagannathan Jay, 2005, Neurosurg Focus, V19, pE4; Jenkins PJ, 2006, J CLIN ENDOCR METAB, V91, P1239, DOI 10.1210/jc.2005-1616; Jenkins PJ, 2001, J CLIN ENDOCR METAB, V86, P2935, DOI 10.1210/jc.86.7.2935; Jorgensen JOL, 2005, J CLIN ENDOCR METAB, V90, P5627, DOI 10.1210/jc.2005-0531; Kauppinen-Makelin R, 2005, J CLIN ENDOCR METAB, V90, P4081, DOI 10.1210/jc.2004-1381; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kopchick JJ, 2002, ENDOCR REV, V23, P623, DOI 10.1210/er.2001-0022; Kreutzer J, 2001, J CLIN ENDOCR METAB, V86, P4072, DOI 10.1210/jc.86.9.4072; Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Le Roith D, 2001, TRENDS ENDOCRIN MET, V12, P48; Leung KC, 2003, P NATL ACAD SCI USA, V100, P1016, DOI 10.1073/pnas.0337600100; Levy A, 2003, FRONT NEUROENDOCRIN, V24, P94, DOI 10.1016/S0091-3022(03)00012-8; LIEBERMAN SA, 1992, ENDOCRIN METAB CLIN, V21, P615, DOI 10.1016/S0889-8529(18)30205-6; Maheshwari HG, 2000, J CLIN ENDOCR METAB, V85, P3409, DOI 10.1210/jc.85.9.3409; Melmed S, 2005, J CLIN ENDOCR METAB, V90, P4405, DOI 10.1210/jc.2004-2466; MELMED S, 1985, NEW ENGL J MED, V312, P9, DOI 10.1056/NEJM198501033120103; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Melmed S, 2002, J CLIN ENDOCR METAB, V87, P4054, DOI 10.1210/jc.2002-011841; Melmed S, 2001, J CLIN ENDOCR METAB, V86, P2929, DOI 10.1210/jc.86.7.2929; MELMED S, 1990, NEW ENGL J MED, V322, P966, DOI 10.1056/NEJM199004053221405; MILANI D, 2001, J CLIN ENDOCR METAB, V89, P2271; Minniti G, 2005, J CLIN ENDOCR METAB, V90, P800, DOI 10.1210/jc.2004-1152; Murray RD, 2004, J CLIN INVEST, V114, P349, DOI 10.1172/jci200419933; Newman CB, 1998, J CLIN ENDOCR METAB, V83, P3034, DOI 10.1210/jc.83.9.3034; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; Peacey SR, 2001, J CLIN ENDOCR METAB, V86, P259, DOI 10.1210/jc.86.1.259; Pereira AM, 2004, J CLIN ENDOCR METAB, V89, P71, DOI 10.1210/jc.2003-030849; Powell JS, 2000, J CLIN ENDOCR METAB, V85, P2068, DOI 10.1210/jc.85.5.2068; Puder JJ, 2005, J CLIN ENDOCR METAB, V90, P1972, DOI 10.1210/jc.2004-2009; RAJASOORYA C, 1994, CLIN ENDOCRINOL, V41, P95, DOI 10.1111/j.1365-2265.1994.tb03789.x; Ren SG, 2003, J CLIN ENDOCR METAB, V88, P5414, DOI 10.1210/jc.2003-030302; Renehan AG, 2002, J CLIN ENDOCR METAB, V87, P1909, DOI 10.1210/jc.87.4.1909; Ronchi CL, 2006, J CLIN ENDOCR METAB, V91, P121, DOI 10.1210/jc.2005-1704; Ronchi CL, 2005, J CLIN ENDOCR METAB, V90, P1377, DOI 10.1210/jc.2004-1974; Rosenow F, 1996, CLIN ENDOCRINOL, V45, P563, DOI 10.1046/j.1365-2265.1996.00852.x; Sakharova AA, 2005, J CLIN ENDOCR METAB, V90, P2117, DOI 10.1210/jc.2004-0875; Sanno N, 2003, NEUROSURG CLIN N AM, V14, P25, DOI 10.1016/S1042-3680(02)00035-9; Saveanu A, 2002, J CLIN ENDOCR METAB, V87, P5545, DOI 10.1210/jc.2002-020934; Sheppard M C, 2005, J Endocrinol Invest, V28, P92; Sheppard MC, 2003, CLIN ENDOCRINOL, V58, P387, DOI 10.1046/j.1365-2265.2003.01734.x; Shimon I, 1997, J CLIN INVEST, V100, P2386, DOI 10.1172/JCI119779; Shimon I, 2001, NEUROSURGERY, V48, P1239, DOI 10.1097/00006123-200106000-00008; Sivan Manoj, 2006, Neurosurgery, V58, pE799, DOI 10.1227/01.NEU.0000214117.87793.6F; Strasburger CJ, 2005, HORM RES, V64, P1, DOI 10.1159/000087745; Swearingen B, 1998, J CLIN ENDOCR METAB, V83, P3419, DOI 10.1210/jc.83.10.3419; Tahara S, 2002, MODERN PATHOL, V15, P1102, DOI 10.1097/01.MP.0000030451.28828.00; Tannenbaum GS, 2003, ENDOCRINOLOGY, V144, P967, DOI 10.1210/en.2002-220852; Thapar K, 1997, AM J PATHOL, V151, P769; THORNER MO, 1982, J CLIN INVEST, V70, P965, DOI 10.1172/JCI110708; Trainer PJ, 2000, NEW ENGL J MED, V342, P1171, DOI 10.1056/NEJM200004203421604; van der Hoek J, 2004, J CLIN ENDOCR METAB, V89, P638, DOI 10.1210/jc.2003-031052; van der Lely AJ, 2001, LANCET, V358, P1754, DOI 10.1016/S0140-6736(01)06844-1; Weckbecker G, 2003, NAT REV DRUG DISCOV, V2, P999, DOI 10.1038/nrd1255; Weckbecker G, 2005, NAT REV DRUG DISCOV, V4, P975, DOI 10.1038/nrd1924; Zhang X, 2002, J CLIN ENDOCR METAB, V87, P1262, DOI 10.1210/jc.87.3.1262	103	785	816	1	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2558	2573		10.1056/NEJMra062453	http://dx.doi.org/10.1056/NEJMra062453			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116BZ	17167139				2022-12-28	WOS:000242778800008
J	Rosenthal, E				Rosenthal, Elisabeth			HIV injustice in Libya - Scapegoating foreign medical professionals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NOSOCOMIAL OUTBREAK											MONTAGNIER L, COMMUNICATION; Visco-Comandini U, 2002, AIDS RES HUM RETROV, V18, P727, DOI 10.1089/088922202760072366; Yerly S, 2001, J INFECT DIS, V184, P369, DOI 10.1086/322036	3	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2505	2508		10.1056/NEJMp068241	http://dx.doi.org/10.1056/NEJMp068241			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116BZ	17167132	Bronze			2022-12-28	WOS:000242778800001
J	Kang, SW; Rane, NS; Kim, SJ; Garrison, JL; Taunton, J; Hegde, RS				Kang, Sang-Wook; Rane, Neena S.; Kim, Soo Jung; Garrison, Jennifer L.; Taunton, Jack; Hegde, Ramanujan S.			Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; UNFOLDED PROTEIN RESPONSE; PRION PROTEIN; COTRANSLATIONAL TRANSLOCATION; CHANNEL; CYTOSOL; PRP; NEURODEGENERATION; DEGRADATION	Eukaryotic proteins entering the secretory pathway are translocated into the ER by signal sequences that vary widely in primary structure. We now provide a functional rationale for this long-observed sequence diversity by demonstrating that differences among signals facilitate substrate-selective modulation of protein translocation. We find that during acute ER stress, translocation of secretory and membrane proteins is rapidly and transiently attenuated in a signal sequence-selective manner. Their cotranslational rerouting to the cytosol for degradation reduces the burden of misfolded substrates entering the ER and represents a pathway for pre-emptive quality control (pQC). Bypassing the pQC pathway for the prion protein increases its rate of aggregation in the ER lumen during prolonged stress and renders cells less capable of viable recovery. Conversely, pharmacologically augmenting pQC during ER stress proved protective. Thus, protein translocation is a physiologically regulated process that is utilized for pQC as part of the ER stress response.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; Korea Res Inst Biosci & Biotechnol, Funct Genom Res Ctr, Taejon 305333, South Korea; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of California System; University of California San Francisco	Hegde, RS (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, 18 Lib Dr,Bldg 18T,Room 101, Bethesda, MD 20892 USA.	hegder@mail.nih.gov		Hegde, Ramanujan/0000-0001-8338-852X; Kang, Sang-Wook/0000-0002-8000-4823	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008752, Z01HD008835] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [R01 GM071434-04] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hegde RS, 1998, CELL, V92, P621, DOI 10.1016/S0092-8674(00)81130-7; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kim SJ, 2002, MOL BIOL CELL, V13, P3775, DOI 10.1091/mbc.E02-05-0293; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; Kim SJ, 2001, J BIOL CHEM, V276, P26132, DOI 10.1074/jbc.M101638200; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; ORSI A, 2006, J BIOL CHEM, V13, P2067; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Williams EJB, 2000, GENE, V253, P313, DOI 10.1016/S0378-1119(00)00233-X; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	32	211	212	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 1	2006	127	5					999	1013		10.1016/j.cell.2006.10.032	http://dx.doi.org/10.1016/j.cell.2006.10.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129784	Green Accepted, Bronze			2022-12-28	WOS:000242613800016
J	Catania, KC				Catania, Kenneth C.			Olfaction - Underwater 'sniffing' by semi-aquatic mammals	NATURE			English	Article							EVOLUTION		Vanderbilt Univ, Dept Biol Sci, VU Stn B, Nashville, TN 37235 USA	Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B, Box 35-1634, Nashville, TN 37235 USA.	ken.catania@vanderbilt.edu						Catania KC, 2000, BRAIN BEHAV EVOLUT, V56, P146, DOI 10.1159/000047201; ESTES JA, 1989, CARNIVORE BEHAV ECOL, V1, P242; Howell A.B., 1930, AQUATIC MAMMALS THEI; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; REPENNING CA, 1976, SYST ZOOL, V25, P375, DOI 10.2307/2412512; Sanchez-Villagra MR, 2002, MAMMALIA, V66, P93, DOI 10.1515/mamm.2002.66.1.93; STEPHAN H, 1984, Z ZOOL SYST EVOL, V22, P328; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4	9	44	45	5	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1024	1025		10.1038/4441024a	http://dx.doi.org/10.1038/4441024a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183311				2022-12-28	WOS:000242971100044
J	Schapira, A				Schapira, Allan			DDT: a polluted debate in malaria control	LANCET			English	Editorial Material												a.schapira@bluewin.ch	Schapira, Allan/AAZ-8116-2020					[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Etang J, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-46; *GLOB MAL PROGR, 2006, IND RES SPRAY US IND; *PEST ACT NETW N A, 2006, GLOB COAL HLTH TOX E; Schapira A, 2004, NATURE, V432, P439, DOI 10.1038/432439b; STOSSEL J, 2006, HOORAY DDTS LIFE SAV; *WHO, 2006, WHO GIV IND US DDT C	7	14	14	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 16	2006	368	9553					2111	2113		10.1016/S0140-6736(06)69812-7	http://dx.doi.org/10.1016/S0140-6736(06)69812-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174693				2022-12-28	WOS:000242856900006
J	Smellie, WSA				Smellie, W. Stuart A.			Cases in primary care laboratory medicine - Hypertriglyceridaemia in diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIVER	Mild hypertriglyceridaemia is common in diabetes, but patients with newly presenting or poorly controlled diabetes may have a quantitatively different syndrome of gross hypertriglyceridaemia, which should be treated by optimising glycaemic control before use of lipid lowering drugs.	Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England		Smellie, WSA (corresponding author), Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England.	info@smellic.com						ALLAWAY SL, 1988, J ROY SOC MED, V81, P149, DOI 10.1177/014107688808100310; *AM DIAB ASS, 1996, DIABETES CARE S1, V19, pS96; CHAIT A, 1977, LANCET, V2, P1176; DAVERN TJ, 2002, SLEISENGER FORDTRANS, P1227; DURRINGTON PN, 1995, HYPERLIPIDEMIA DIAGN, P25; FORTSON MR, 1995, AM J GASTROENTEROL, V90, P2134; Mingrone G, 1999, DIABETES, V48, P1258, DOI 10.2337/diabetes.48.6.1258; *NHS NAT LIB HLTH, PRODIGY HYP GUID; Nikkila E A, 1973, Prog Biochem Pharmacol, V8, P271; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Smellie WSA, 2006, BMJ-BRIT MED J, V333, P83, DOI 10.1136/bmj.333.7558.83; Smellie WS, 2006, J CLIN PATHOL, V59, P113, DOI 10.1136/jcp.2005.031526; Stuart W, 2001, BRIT MED J, V323, P1224	13	12	13	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2006	333	7581					1257	1260		10.1136/bmj.39043.398738.DE	http://dx.doi.org/10.1136/bmj.39043.398738.DE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122AB	17170417	Green Published			2022-12-28	WOS:000243197000022
J	Shen, V; Kiledjian, M				Shen, Vincent; Kiledjian, Megerditch			A view to a kill: Structure of the RNA exosome	CELL			English	Editorial Material							MESSENGER-RNAS; DEGRADATION; COMPLEX; DECAY	The exosome is a 3' to 5' exoribonuclease central to many cellular processes, including mRNA decay. Liu et al. (2006) now present the biochemical reconstitution and crystal structure of the eukaryotic exosome. This remarkable achievement provides key insights into the composition and assembly of the human and yeast exosomes, revealing functions of individual subunits.	Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Kiledjian, M (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	kiledjian@biology.rutgers.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067005] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067005, R01 GM067005-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2006, CELL, V125, P651, DOI 10.1016/j.cell.2006.05.002; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Raijmakers R, 2004, EUR J CELL BIOL, V83, P175, DOI 10.1078/0171-9335-00385	9	10	10	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1093	1095		10.1016/j.cell.2006.11.035	http://dx.doi.org/10.1016/j.cell.2006.11.035			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174886	Green Accepted, Bronze			2022-12-28	WOS:000242991000006
J	Foster, GL; Vance, D				Foster, Gavin L.; Vance, Derek			Negligible glacial-interglacial variation in continental chemical weathering rates	NATURE			English	Article							NORTH-ATLANTIC; ISOTOPIC COMPOSITION; SOIL AGE; PB; EROSION; LEAD; ND; PROVENANCE; EVOLUTION; SEDIMENTS	Chemical weathering of the continents is central to the regulation of atmospheric carbon dioxide concentrations, and hence global climate(1,2). On million-year timescales silicate weathering leads to the draw-down of carbon dioxide(1), and on millennial timescales chemical weathering affects the calcium carbonate saturation state of the oceans and hence their uptake of carbon dioxide(2). However, variations in chemical weathering rates over glacial - interglacial cycles remain uncertain. During glacial periods, cold and dry conditions reduce the rate of chemical weathering(3), but intense physical weathering(3,4) and the exposure of carbonates on continental shelves due to low sea levels(5,6) may increase this rate. Here we present high-resolution records of the lead isotope composition of ferromanganese crusts from the North Atlantic Ocean that cover the past 550,000 years. Combining these records with a simple quantitative model of changes in the lead isotope composition of the deep North Atlantic Ocean in response to chemical weathering, we find that chemical weathering rates were two to three times lower in the glaciated interior of the North Atlantic Region during glacial periods than during the intervening interglacial periods. This decrease roughly balances the increase in chemical weathering caused by the exposure of continental shelves, indicating that chemical weathering rates remained relatively constant on glacial - interglacial timescales. On timescales of more than a million years, however, we suggest that enhanced weathering of silicate glacial sediments during interglacial periods results in a net draw-down of atmospheric carbon dioxide, creating a positive feedback on global climate that, once initiated, promotes cooling and further glaciation.	Univ Bristol, Dept Earth Sci, Bristol Isotope Grp, Bristol BS8 1RJ, Avon, England	University of Bristol	Foster, GL (corresponding author), Univ Bristol, Dept Earth Sci, Bristol Isotope Grp, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	g.l.foster@bristol.ac.uk	Foster, Gavin/CAF-4654-2022; Foster, Gavin/W-5968-2019	Foster, Gavin/0000-0003-3688-9668; 	Natural Environment Research Council [NER/I/S/2002/00720] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Archer D, 2000, REV GEOPHYS, V38, P159, DOI 10.1029/1999RG000066; BLUM JD, 1997, TECTONIC UPLIFT CLIM, P259, DOI DOI 10.1007/978-1-4615-5935-1_11; Broecker WS, 1999, PALEOCEANOGRAPHY, V14, P744, DOI 10.1029/1999PA900038; CATUBIG N, 1998, PALEOCEANOGRAPHY, V13, P691; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; EREL Y, 1992, GEOCHIM COSMOCHIM AC, V56, P4157, DOI 10.1016/0016-7037(92)90258-K; Fagel N, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000993; Farmer GL, 2003, EARTH PLANET SC LETT, V209, P227, DOI 10.1016/S0012-821X(03)00068-2; FOSTER GL, IN PRESS GEOLOGY; Frank M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000094; GIBBS MT, 1994, PALEOCEANOGRAPHY, V9, P529, DOI 10.1029/94PA01009; Harlavan Y, 2002, GEOCHIM COSMOCHIM AC, V66, P837, DOI 10.1016/S0016-7037(01)00806-7; Harlavan Y, 1998, GEOCHIM COSMOCHIM AC, V62, P33, DOI 10.1016/S0016-7037(97)00328-1; Henderson GM, 2002, GEOCHIM COSMOCHIM AC, V66, P257, DOI 10.1016/S0016-7037(01)00779-7; HENDERSON GM, 1994, EARTH PLANET SC LETT, V128, P643, DOI 10.1016/0012-821X(94)90176-7; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; Jones IW, 2002, GLOBAL PLANET CHANGE, V33, P139, DOI 10.1016/S0921-8181(02)00067-X; Kump L. R., 1994, MAT FLUXES SURF EART, P46; Millot R, 2004, CHEM GEOL, V203, P75, DOI 10.1016/j.chemgeo.2003.09.002; Millot R, 2002, EARTH PLANET SC LETT, V196, P83, DOI 10.1016/S0012-821X(01)00599-4; PIEPGRAS DJ, 1987, GEOCHIM COSMOCHIM AC, V51, P1257, DOI 10.1016/0016-7037(87)90217-1; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Reynolds BC, 2004, GEOLOGY, V32, P861, DOI 10.1130/G20734.1; Reynolds BC, 1999, EARTH PLANET SC LETT, V173, P381, DOI 10.1016/S0012-821X(99)00243-5; Riebe CS, 2004, EARTH PLANET SC LETT, V224, P547, DOI 10.1016/j.epsl.2004.05.019; Roy M, 2004, EARTH PLANET SC LETT, V227, P281, DOI 10.1016/j.epsl.2004.09.001; TAYLOR A, 1995, GEOLOGY, V23, P979, DOI 10.1130/0091-7613(1995)023<0979:RBSAAS>2.3.CO;2; Vance D, 1999, EARTH PLANET SC LETT, V173, P365, DOI 10.1016/S0012-821X(99)00244-7; von Blanckenburg F, 2001, PALEOCEANOGRAPHY, V16, P424, DOI 10.1029/2000PA000550	29	108	113	5	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					918	921		10.1038/nature05365	http://dx.doi.org/10.1038/nature05365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167483				2022-12-28	WOS:000242805400053
J	Ohmit, SE; Victor, JC; Rotthoff, JR; Teich, ER; Truscon, RK; Baum, LL; Rangarajan, B; Newton, DW; Boulton, ML; Monto, AS				Ohmit, Suzanne E.; Victor, John C.; Rotthoff, Judy R.; Teich, Esther R.; Truscon, Rachel K.; Baum, Laura L.; Rangarajan, Bhavya; Newton, Duane W.; Boulton, Matthew L.; Monto, Arnold S.			Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WORKING ADULTS; VIRUS VACCINE; TRIVALENT; HEALTHY; IMMUNOGENICITY; EFFICACY; SAFETY	BACKGROUND: The efficacy of influenza vaccines may decline during years when the circulating viruses have antigenically drifted from those included in the vaccine. METHODS: We carried out a randomized, double-blind, placebo-controlled trial of inactivated and live attenuated influenza vaccines in healthy adults during the 2004-2005 influenza season and estimated both absolute and relative efficacies. RESULTS: A total of 1247 persons were vaccinated between October and December 2004. Influenza activity in Michigan began in January 2005 with the circulation of an antigenically drifted type A (H3N2) virus, the A/California/07/2004-like strain, and of type B viruses from two lineages. The absolute efficacy of the inactivated vaccine against both types of virus was 77% (95% confidence interval [CI], 37 to 92) as measured by isolating the virus in cell culture, 75% (95% CI, 42 to 90) as measured by either isolating the virus in cell culture or identifying it through real-time polymerase chain reaction, and 67% (95% CI, 16 to 87) as measured by either isolating the virus or observing a rise in the serum antibody titer. The absolute efficacies of the live attenuated vaccine were 57% (95% CI, -3 to 82), 48% (95% CI, -7 to 74), and 30% (95% CI, -57 to 67), respectively. The difference in efficacy between the two vaccines appeared to be related mainly to reduced protection of the live attenuated vaccine against type B viruses. CONCLUSIONS: In the 2004-2005 season, in which most circulating viruses were dissimilar to those included in the vaccine, the inactivated vaccine was efficacious in preventing laboratory-confirmed symptomatic illnesses from influenza in healthy adults. The live attenuated vaccine also prevented influenza illnesses but was less efficacious.	Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan Hosp, Dept Pathol Virol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ohmit, SE (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, 109 Observ St, Ann Arbor, MI 48109 USA.	sohmit@umich.edu		Boulton, Matthew/0000-0002-0565-9010; Victor, John/0000-0002-7970-6588	NIAID NIH HHS [U01 AI057853-01A1, U01 AI057853] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI057853] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2004, Wkly Epidemiol Rec, V79, P88; BELSCHE R, 2006, PED AC SOC M SAN FRA; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; *CDCP, 2004, US INFL SEAS SUMM; Davenport F M, 1973, Med J Aust, V1, P33; *DEP COMM DIS SURV, 2002, WHOCDSCSRNCS20025 DE; EDWARDS KM, 1994, J INFECT DIS, V169, P68, DOI 10.1093/infdis/169.1.68; Gruber WC, 1996, J INFECT DIS, V173, P1313, DOI 10.1093/infdis/173.6.1313; Harper SA, 2004, MMWR RECOMM REP, V53, P743; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; King JC, 1998, J INFECT DIS, V177, P1394, DOI 10.1086/517822; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; STODDARD J, 2005, P PED AC SOC 2005 AN; Treanor JJ, 1999, VACCINE, V18, P899, DOI 10.1016/S0264-410X(99)00334-5; Weinberg GA, 2004, J INFECT DIS, V189, P706, DOI 10.1086/381456; Zambon M., 1998, TXB INFLUENZA, P291; 2005, WKLY EPIDEMIOL REC, V80, P71; 1998, MMWR MORB MORTAL WKL, V47, P196	23	223	238	5	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2513	2522		10.1056/NEJMoa061850	http://dx.doi.org/10.1056/NEJMoa061850			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116BZ	17167134	Green Accepted			2022-12-28	WOS:000242778800003
J	Yamaguchi, A; Kobayashi, S; Ishimoto, H; Kojima, H				Yamaguchi, A.; Kobayashi, S.; Ishimoto, H.; Kojima, H.			Minority spin condensate in the spin-polarized superfluid He-3 A(1) phase	NATURE			English	Article							MAGNETIC-FIELDS; RELAXATION; LIQUID-HE-3; DYNAMICS; RESONANCE	The magnetic properties of He-3 in its various phases originate from the interactions among the nuclear spins(1). The spin-polarized 'ferromagnetic' superfluid He-3 A(1) phase(2) ( which forms below 3 mK between two transition temperatures, T-c1 and T-c2, in an external magnetic field) serves as a material in which theories of fundamental magnetic processes and macroscopic quantum spin phenomena may be tested. Conventionally, the superfluid component of the A(1) phase is understood(3-6) to contain only the majority spin condensate, having energetically favoured paired spins directed along the external field and no minority spin condensate having paired spins in the opposite direction. Because of difficulties in satisfying both the ultralow temperature and high magnetic field required to produce a substantial phase space, there exist few studies of spin dynamics phenomena that could be used to test the conventional view of the A(1) phase. Here we develop a mechanical spin density detector that operates in the required regime, enabling us to perform measurements of spin relaxation in the A(1) phase as a function of temperature, pressure and magnetic field. Our mechanical spin detector is based in principle on the magnetic fountain effect(7); spin-polarized superfluid motion can be induced both magnetically and mechanically, and we demonstrate the feasibility of increasing spin polarization by a mechanical spin filtering process. In the high temperature range of the A(1) phase near T-c1, the measured spin relaxation time is long, as expected(2,8,9). Unexpectedly, the spin relaxation rate increases rapidly as the temperature is decreased towards T-c2. Our measurements, together with Leggett - Takagi theory(5), demonstrate that a minute presence of minority spin pairs is responsible for this unexpected spin relaxation behaviour. Thus, the long-held conventional view(2) that the A(1) phase contains only the majority spin condensate is inadequate.	Rutgers State Univ, Serin Phys Lab, Piscataway, NJ 08854 USA; Univ Tokyo, Inst Solid State Phys, Chiba 2778581, Japan	Rutgers State University New Brunswick; University of Tokyo	Kojima, H (corresponding author), Rutgers State Univ, Serin Phys Lab, POB 849, Piscataway, NJ 08854 USA.	kojima@physics.rutgers.edu	Yamaguchi, Akira/N-1696-2014					Bastea M, 2004, J LOW TEMP PHYS, V137, P539, DOI 10.1007/s10909-004-0892-9; CORRUCCINI LR, 1975, PHYS REV LETT, V34, P564, DOI 10.1103/PhysRevLett.34.564; DEVEGVAR PGN, 1984, PHYS REV B, V30, P6349, DOI 10.1103/PhysRevB.30.6349; Dobbs E. R., 2000, HELIUM 3; EINZEL D, 1990, J LOW TEMP PHYS, V80, P31, DOI 10.1007/BF00683113; FREEMAN MR, 1988, PHYS REV LETT, V60, P596, DOI 10.1103/PhysRevLett.60.596; GULLY WJ, 1976, J LOW TEMP PHYS, V24, P563, DOI 10.1007/BF00657167; HAMMEL PC, 1984, PHYS REV LETT, V52, P1441, DOI 10.1103/PhysRevLett.52.1441; LEGGETT AJ, 1977, ANN PHYS-NEW YORK, V106, P79, DOI 10.1016/0003-4916(77)90005-7; LEGGETT AJ, 1975, REV MOD PHYS, V47, P331, DOI 10.1103/RevModPhys.47.331; LIU M, 1979, PHYS REV LETT, V43, P1740, DOI 10.1103/PhysRevLett.43.1740; MORIEN H, 1985, J LOW TEMP PHYS, V60, P323; OSHEROFF DD, 1974, PHYS REV LETT, V33, P686, DOI 10.1103/PhysRevLett.33.686; PARPIA JM, 1979, PHYS REV LETT, V43, P1332, DOI 10.1103/PhysRevLett.43.1332; Roobol LP, 1997, PHYS REV LETT, V79, P685, DOI 10.1103/PhysRevLett.79.685; SCHOPOHL N, 1985, J LOW TEMP PHYS, V59, P469, DOI 10.1007/BF00682444; SCHUHL A, 1987, PHYS REV B, V36, P6811, DOI 10.1103/PhysRevB.36.6811; vanSteenbergen AS, 1997, PHYS REV LETT, V79, P115, DOI 10.1103/PhysRevLett.79.115; VOLLHARDT D, 1981, PHYS REV LETT, V47, P190, DOI 10.1103/PhysRevLett.47.190; Vollhardt D., 1990, SUPERFLUID PHASES HE; WHEATLEY JC, 1975, REV MOD PHYS, V47, P415, DOI 10.1103/RevModPhys.47.415; Wilks J., 1987, INTRO LIQUID HELIUM	22	12	13	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					909	912		10.1038/nature05391	http://dx.doi.org/10.1038/nature05391			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167481	Green Submitted			2022-12-28	WOS:000242805400051
J	Alper, H; Moxley, J; Nevoigt, E; Fink, GR; Stephanopoulos, G				Alper, Hal; Moxley, Joel; Nevoigt, Elke; Fink, Gerald R.; Stephanopoulos, Gregory			Engineering yeast transcription machinery for improved ethanol tolerance and production	SCIENCE			English	Article							TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; POLYMERASE-II; STRESS; MECHANISM; GROWTH; SAGA; DNA	Global transcription machinery engineering (gTME) is an approach for reprogramming gene transcription to elicit cellular phenotypes important for technological applications. Here we show the application of gTME to Saccharomyces cerevisiae for improved glucose/ethanol tolerance, a key trait for many biofuels programs. Mutagenesis of the transcription factor Spt15p and selection led to dominant mutations that conferred increased tolerance and more efficient glucose conversion to ethanol. The desired phenotype results from the combined effect of three separate mutations in the SPT15 gene [ serine substituted for phenylalanine ( Phe(177)Ser) and, similarly, Tyr(195)His, and Lys(218)Arg]. Thus, gTME can provide a route to complex phenotypes that are not readily accessible by traditional methods.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Berlin Univ Technol, Dept Microbiol & Genet, D-13353 Berlin, Germany; MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Technical University of Berlin; Massachusetts Institute of Technology (MIT); Whitehead Institute	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Room 56-469, Cambridge, MA 02139 USA.	gregstep@mit.edu	Nevoigt, Elke/F-5887-2010		NIGMS NIH HHS [GM035010] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035010, R37GM035010] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALPER HHS, 2006, THESIS MIT; Bai FW, 2004, J BIOTECHNOL, V110, P287, DOI 10.1016/j.jbiotec.2004.01.017; Cakar ZP, 2005, FEMS YEAST RES, V5, P569, DOI 10.1016/j.femsyr.2004.10.010; Cang Y, 1999, EMBO J, V18, P6662, DOI 10.1093/emboj/18.23.6662; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; EISENMANN DM, 1992, GENE DEV, V6, P1319, DOI 10.1101/gad.6.7.1319; Furukawa K, 2004, J BIOSCI BIOENG, V98, P107, DOI [10.1016/S1389-1723(04)70250-9, 10.1263/jbb.98.107]; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Klejman MP, 2005, NUCLEIC ACIDS RES, V33, P5426, DOI 10.1093/nar/gki850; Kou HP, 2003, MOL CELL BIOL, V23, P3186, DOI 10.1128/MCB.23.9.3186-3201.2003; LEE DK, 1992, MOL CELL BIOL, V12, P5189, DOI 10.1128/MCB.12.11.5189; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Nissen TL, 2000, METAB ENG, V2, P69, DOI 10.1006/mben.1999.0140; Nozawa M, 2002, J BIOSCI BIOENG, V93, P288, DOI 10.1263/jbb.93.288; OCONNOR GM, 1992, BIOTECHNOL BIOENG, V39, P293, DOI 10.1002/bit.260390307; Ogawa Y, 2000, J BIOSCI BIOENG, V90, P313, DOI 10.1016/S1389-1723(00)80087-0; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; STININGER B, 2005, APPL MICROBIAL BIOTE, DOI DOI 10.1007/S00253-006-0435-1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takagi H, 2005, APPL ENVIRON MICROB, V71, P8656, DOI 10.1128/AEM.71.12.8656-8662.2005; THATIPAMALA R, 1992, BIOTECHNOL BIOENG, V40, P289, DOI 10.1002/bit.260400213; van Voorst F, 2006, YEAST, V23, P351, DOI 10.1002/yea.1359	27	562	680	5	340	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1565	1568		10.1126/science.1131969	http://dx.doi.org/10.1126/science.1131969			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158319				2022-12-28	WOS:000242624600032
J	Bernards, R				Bernards, Rene			Exploring the uses of RNAi - Gene knockdown and the Nobel Prize	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERFERENCE		Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands	Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands.			Bernards, Rene/0000-0001-8677-3423				Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Morris KV, 2006, BIOTECHNIQUES, V40, P7, DOI 10.2144/000112166; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102	4	29	30	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2391	2393		10.1056/NEJMp068242	http://dx.doi.org/10.1056/NEJMp068242			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113EO	17151363	Green Published			2022-12-28	WOS:000242581400002
J	Druker, BJ; Guilhot, F; O'Brien, SG; Gathmann, I; Kantarjian, H; Gattermann, N; Deininger, MWN; Silver, RT; Goldman, JM; Stone, RM; Cervantes, F; Hochhaus, A; Powell, BL; Gabrilove, JL; Rousselot, P; Reiffers, J; Cornelissen, JJ; Hughes, T; Agis, H; Fischer, T; Verhoef, G; Shepherd, J; Saglio, G; Gratwohl, A; Nielsen, JL; Radich, JP; Simonsson, B; Taylor, K; Baccarani, M; So, C; Letvak, L; Larson, RA				Druker, Brian J.; Guilhot, Francois; O'Brien, Stephen G.; Gathmann, Insa; Kantarjian, Hagop; Gattermann, Norbert; Deininger, Michael W. N.; Silver, Richard T.; Goldman, John M.; Stone, Richard M.; Cervantes, Francisco; Hochhaus, Andreas; Powell, Bayard L.; Gabrilove, Janice L.; Rousselot, Philippe; Reiffers, Josy; Cornelissen, Jan J.; Hughes, Timothy; Agis, Hermine; Fischer, Thomas; Verhoef, Gregor; Shepherd, John; Saglio, Giuseppe; Gratwohl, Alois; Nielsen, Johan L.; Radich, Jerald P.; Simonsson, Bengt; Taylor, Kerry; Baccarani, Michele; So, Charlene; Letvak, Laurie; Larson, Richard A.		IRIS Investigators	Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ABL TYROSINE KINASE; COMPLETE CYTOGENETIC REMISSION; ALPHA PLUS CYTARABINE; INTERFERON-ALPHA; CHRONIC-PHASE; BLAST CRISIS; CHROMOSOME; RESPONSES; CELLS	BACKGROUND: The cause of chronic myeloid leukemia (CML) is a constitutively active BCR-ABL tyrosine kinase. Imatinib inhibits this kinase, and in a short-term study was superior to interferon alfa plus cytarabine for newly diagnosed CML in the chronic phase. For 5 years, we followed patients with CML who received imatinib as initial therapy. METHODS: We randomly assigned 553 patients to receive imatinib and 553 to receive interferon alfa plus cytarabine and then evaluated them for overall and event-free survival; progression to accelerated-phase CML or blast crisis; hematologic, cytogenetic, and molecular responses; and adverse events. RESULTS: The median follow-up was 60 months. Kaplan-Meier estimates of cumulative best rates of complete cytogenetic response among patients receiving imatinib were 69% by 12 months and 87% by 60 months. An estimated 7% of patients progressed to accelerated-phase CML or blast crisis, and the estimated overall survival of patients who received imatinib as initial therapy was 89% at 60 months. Patients who had a complete cytogenetic response or in whom levels of BCR-ABL transcripts had fallen by at least 3 log had a significantly lower risk of disease progression than did patients without a complete cytogenetic response (P<0.001). Grade 3 or 4 adverse events diminished over time, and there was no clinically significant change in the profile of adverse events. CONCLUSIONS: After 5 years of follow-up, continuous treatment of chronic-phase CML with imatinib as initial therapy was found to induce durable responses in a high proportion of patients.	Oregon Hlth & Sci Univ, Inst Canc, Portland, OR 97239 USA; CHU, Poitiers, France; Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England; Novartis, Basel, Switzerland; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Univ Dusseldorf, D-4000 Dusseldorf, Germany; Univ Leipzig, D-7010 Leipzig, Germany; Weill Cornell Med Ctr, New York, NY USA; NHLBI, Bethesda, MD 20892 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Hosp Clin Barcelona, Barcelona, Spain; Heidelberg Univ, D-6800 Mannheim, Germany; Wake Forest Univ, Baptist Med Ctr, Winston Salem, NC 27109 USA; Mt Sinai Sch Med, New York, NY USA; Hop St Louis, Paris, France; CHU Bordeaux, Pessac, France; Erasmus MC, Rotterdam, Netherlands; Royal Adelaide Hosp, Adelaide, SA 5000, Australia; Univ Vienna, Innere Med Klin 1, Vienna, Austria; Johannes Gutenberg Univ Mainz, D-6500 Mainz, Germany; Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; Vancover Hosp, Vancouver, BC, Canada; Azienda Osped S Luigi Gonzaga, Orbassano, Italy; Univ Basel Hosp, CH-4031 Basel, Switzerland; Aarhus Kommune Hosp, DK-8000 Aarhus, Denmark; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Akad Sjukhuset, Uppsala, Sweden; Mater Hosp, Brisbane, Qld, Australia; Policlin O Orsola Malpighi, Bologna, Italy; Novarits, Florham Pk, NJ USA; Univ Chicago, Chicago, IL 60637 USA	Oregon Health & Science University; CHU Poitiers; Newcastle University - UK; University of Texas System; UTMD Anderson Cancer Center; Heinrich Heine University Dusseldorf; Leipzig University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Dana-Farber Cancer Institute; University of Barcelona; Hospital Clinic de Barcelona; Ruprecht Karls University Heidelberg; Wake Forest University; Wake Forest Baptist Medical Center; Icahn School of Medicine at Mount Sinai; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Erasmus University Rotterdam; Erasmus MC; Royal Adelaide Hospital; University of Vienna; Johannes Gutenberg University of Mainz; KU Leuven; University Hospital Leuven; University of Basel; Aarhus University; Fred Hutchinson Cancer Center; Uppsala University; Uppsala University Hospital; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Chicago	Druker, BJ (corresponding author), Oregon Hlth & Sci Univ, Inst Canc, L592,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	drukerb@ohsu.edu	Silver MD, Richard T/GRE-5925-2022; Hughes, Tim/AAO-9975-2021; Kovacs, Michael/G-3315-2011; Larson, Richard A./AAE-7223-2019	Larson, Richard A./0000-0001-9168-3203; Guilhot, Francois/0000-0001-7222-487X; Hochhaus, Andreas/0000-0003-0626-0834; Saglio, Giuseppe/0000-0002-1046-3514; Druker, Brian/0000-0001-8331-8206				Baccarani M, 2002, BLOOD, V99, P1527, DOI 10.1182/blood.V99.5.1527; Bonifazi F, 2001, BLOOD, V98, P3074, DOI 10.1182/blood.V98.10.3074; Breccia M, 2006, LEUKEMIA RES, V30, P1577, DOI 10.1016/j.leukres.2006.03.011; Chu S, 2005, BLOOD, V105, P2093, DOI 10.1182/blood-2004-03-1114; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2001, NEW ENGL J MED, V345, P232; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; Guilhot F, 1997, NEW ENGL J MED, V337, P223, DOI 10.1056/NEJM199707243370402; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; Mauro MJ, 2004, LEUKEMIA RES, V28, pS71, DOI 10.1016/j.leukres.2003.10.017; Merante S, 2005, HAEMATOLOGICA, V90, P979; NOWELL PC, 1960, SCIENCE, V132, P1497; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Roche-Lestienne C, 2003, SEMIN HEMATOL, V40, P80, DOI 10.1053/shem.2003.50046; ROUSSELOT P, IN PRESS BLOOD; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Roy L, 2006, BLOOD, V108, P1478, DOI 10.1182/blood-2006-02-001495; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Shah NP, 2003, ONCOGENE, V22, P7389, DOI 10.1038/sj.onc.1206942; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Silver RT, 1999, BLOOD, V94, P1517; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; Willis SG, 2005, BLOOD, V106, P2128, DOI 10.1182/blood-2005-03-1036	35	2566	2711	2	192	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2408	2417		10.1056/NEJMoa062867	http://dx.doi.org/10.1056/NEJMoa062867			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113EO	17151364				2022-12-28	WOS:000242581400005
J	Morimatsu, Y; Kawano, F; Aizawa, H				Morimatsu, Yoshitaka; Kawano, Fumio; Aizawa, Hisamichi			Pneumopericardium following rupture of the oesophagus	LANCET			English	Editorial Material									Natl Hosp Org, Kumamoto Med Ctr, Div Internal Med, Kumamoto 8600008, Japan; Kurume Univ, Sch Med, Dept Internal Med 1, Kurume, Fukuoka 8300011, Japan	Kurume University	Morimatsu, Y (corresponding author), Natl Hosp Org, Kumamoto Med Ctr, Div Internal Med, 1-5 Ninomaru, Kumamoto 8600008, Japan.	morimatu@kumamoto2.hosp.go.jp							0	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 2	2006	368	9551					1991	1991		10.1016/S0140-6736(06)69809-7	http://dx.doi.org/10.1016/S0140-6736(06)69809-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141706				2022-12-28	WOS:000242593300031
J	Kaste, M				Kaste, Markku			Snake venom, vampire bat saliva, or rt-PA: time matters	LANCET			English	Editorial Material							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INTRAVENOUS THROMBOLYSIS; CONTROLLED-TRIAL; ECASS; DESMOTEPLASE		Univ Helsinki, Dept Neurol, Cent Hosp, Helsinki 00029, Finland	University of Helsinki; Helsinki University Central Hospital	Kaste, M (corresponding author), Univ Helsinki, Dept Neurol, Cent Hosp, Helsinki 00029, Finland.	markku.kaste@hus.fi		Kaste, Markku/0000-0001-6557-6412				Furlan AJ, 2006, STROKE, V37, P1227, DOI 10.1161/01.STR.0000217403.66996.6d; Hacke W, 2005, STROKE, V36, P66, DOI 10.1161/01.STR.0000149938.08731.2c; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2004, LANCET, V363, P768; Hennerici MG, 2006, LANCET, V368, P1871, DOI 10.1016/S0140-6736(06)69776-6; Kaste M, 2006, CEREBROVASC DIS, V22, P342, DOI 10.1159/000094849; Lindsberg PJ, 2004, JAMA-J AM MED ASSOC, V292, P1862, DOI 10.1001/jama.292.15.1862; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marler JR, 2000, NEUROLOGY, V55, P1649, DOI 10.1212/WNL.55.11.1649; *NAT I NEUR DIS ST, 2005, TASK FORC REP IMPR C; Sherman DG, 2000, JAMA-J AM MED ASSOC, V283, P2395, DOI 10.1001/jama.283.18.2395	12	1	1	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1845	1846		10.1016/S0140-6736(06)69750-X	http://dx.doi.org/10.1016/S0140-6736(06)69750-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	109YQ	17126698				2022-12-28	WOS:000242345900004
J	Royo-Torres, R; Cobos, A; Alcala, L				Royo-Torres, Rafael; Cobos, Alberto; Alcala, Luis			A giant European dinosaur and a new sauropod clade	SCIENCE			English	Article								Fossils of a giant sauropod dinosaur, Turiasaurus riodevensis, have been recovered from terrestrial deposits of the Villar del Arzobispo Formation (Jurassic-Cretaceous boundary) of Riodeva (Teruel Province, Spain). Its humerus length ( 1790 millimeters) and estimated mass ( 40 to 48 metric tons) indicate that it may have been the most massive terrestrial animal in Europe and one of the largest in the world. Phylogenetic analysis indicates that the fossil represents a member of a hitherto unrecognized group of primitive European eusauropods that evolved in the Jurassic.	Fdn Conjurito Paleontol Tereul Dinopolis, E-44002 Teruel, Spain		Royo-Torres, R (corresponding author), Fdn Conjurito Paleontol Tereul Dinopolis, Ave Sagunto, E-44002 Teruel, Spain.	royo@dinopolis.com	Alcalá, Luis/A-7413-2009; Alcalá, Luis/P-5793-2014; Torres, Rafael Royo/AAE-3183-2019	Alcalá, Luis/0000-0002-6369-6186; Torres, Rafael Royo/0000-0001-5116-3000; Cobos, Alberto/0000-0001-9162-334X				[Anonymous], 1999, REV MUSEO ARGENTINE, V5, P13; Barco Jose Luis, 2005, Naturaleza Aragonesa, V15, P4; Bonaparte Jose F., 1993, Ameghiniana, V30, P271; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Buffetaut Eric, 1994, Revue de Paleobiologie Volume Special, V7, P17; Casanovas Maria Lourdes, 2001, Paleontologia i Evolucio, V32-33, P99; Fezer R., 1988, Arbeiten aus dem Institut fuer Geologie und Palaeontologie an der Universitaet Stuttgart Neue Folge, V84, P1; Gillette D.D., 1991, Journal of Vertebrate Paleontology, V11, P417; Lapparent A. F., 1957, Memorias Servicos Geologicos Portugal NS, V2, P1; Luquetti AO, 2005, REV SOC BRAS MED TRO, V38, P27; Mazzetta Gerardo V., 2004, Historical Biology, V16, P71, DOI 10.1080/08912960410001715132; Naish D, 2004, CRETACEOUS RES, V25, P787, DOI 10.1016/j.cretres.2004.07.002; Novas Fernando E., 2005, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V7, P167; Paul G.S., 1988, HUNTERIA, V2, P1; Royo-Torres R., 2005, Geogaceta, V38, P23; ROYOTORRES R, 2004, GEOTEMAS, V6, P59; Sanchez-Hernandez B, 2005, ZOOTAXA, P1; Sanchez-Hernandez B, 2006, ZOOTAXA, P63, DOI 10.11646/zootaxa.1201.1.3; SANZ J L, 1987, Estudios Geologicos (Madrid), P45; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wedel MJ, 2000, J VERTEBR PALEONTOL, V20, P109, DOI 10.1671/0272-4634(2000)020[0109:SPANSF]2.0.CO;2; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wiman C, 1929, PALAEONTOLOGIA SINIC, V6, P1; You HL, 2004, ACTA GEOL SIN-ENGL, V78, P907; YOUNG CC, 1972, VERT PALEONTOL PALEO, V8, P1	27	99	105	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1925	1927		10.1126/science.1132885	http://dx.doi.org/10.1126/science.1132885			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185599	Green Submitted			2022-12-28	WOS:000242996800048
J	van Nimwegen, E				van Nimwegen, Erik			Influenza escapes immunity along neutral networks	SCIENCE			English	Editorial Material							MUTATIONAL ROBUSTNESS; PROTEIN EVOLUTION; DYNAMICS; PATHOGENS; SELECTION; SEARCH; SPACE; RNA		Univ Basel, Biozentrum, Div Bioinformat, CH-4056 Basel, Switzerland	University of Basel	van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, Div Bioinformat, CH-4056 Basel, Switzerland.	erik.vannimwegen@unibas.ch	van Nimwegen, Erik/ABF-1085-2021	van Nimwegen, Erik/0000-0001-6338-1312				Bastolla U, 2003, J MOL EVOL, V56, P243, DOI 10.1007/s00239-002-2350-0; Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Elena SF, 1996, SCIENCE, V272, P1802, DOI 10.1126/science.272.5269.1802; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; LAU KF, 1990, P NATL ACAD SCI USA, V87, P638, DOI 10.1073/pnas.87.2.638; Newman MEJ, 1998, P ROY SOC B-BIOL SCI, V265, P1333, DOI 10.1098/rspb.1998.0438; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; van Nimwegen E, 1999, THEOR COMPUT SCI, V229, P41, DOI 10.1016/S0304-3975(99)00119-X; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; vanNimwegen E, 1997, PHYS LETT A, V229, P144, DOI 10.1016/S0375-9601(97)00192-8; Voigt CA, 2001, P NATL ACAD SCI USA, V98, P3778, DOI 10.1073/pnas.051614498; Wagner A, 1999, J EXP ZOOL, V285, P119	20	42	42	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1884	1886		10.1126/science.1137300	http://dx.doi.org/10.1126/science.1137300			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185589				2022-12-28	WOS:000242996800033
J	Jin, RS; Rummel, A; Binz, T; Brunger, AT				Jin, Rongsheng; Rummel, Andreas; Binz, Thomas; Brunger, Axel T.			Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity	NATURE			English	Article							H-CC-DOMAIN; SYNAPTOTAGMIN-I; BINDING-SITES; TETANUS; THERMODYNAMICS; TRANSLOCATION; MEMBRANES; TOXINS	Botulinum neurotoxins (BoNTs) are produced by Clostridium botulinum and cause the neuroparalytic syndrome of botulism. With a lethal dose of 1 ng kg(-1), they pose a biological hazard to humans and a serious potential bioweapon threat(1). BoNTs bind with high specificity at neuromuscular junctions and they impair exocytosis of synaptic vesicles containing acetylcholine through specific proteolysis of SNAREs (soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors), which constitute part of the synaptic vesicle fusion machinery(2,3). The molecular details of the toxin-cell recognition have been elusive. Here we report the structure of a BoNT in complex with its protein receptor: the receptor-binding domain of botulinum neurotoxin serotype B (BoNT/B) bound to the luminal domain of synaptotagmin II, determined at 2.15 angstrom resolution. On binding, a helix is induced in the luminal domain which binds to a saddle-shaped crevice on a distal tip of BoNT/B. This crevice is adjacent to the non-overlapping ganglioside-binding site of BoNT/B. Synaptotagmin II interacts with BoNT/B with nanomolar affinity, at both neutral and acidic endosomal pH. Biochemical and neuronal ex vivo studies of structure-based mutations indicate high specificity and affinity of the interaction, and high selectivity of BoNT/B among synaptotagmin I and II isoforms. Synergistic binding of both synaptotagmin and ganglioside imposes geometric restrictions on the initiation of BoNT/B translocation after endocytosis. Our results provide the basis for the rational development of preventive vaccines or inhibitors against these neurotoxins.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; Hannover Med Sch, Inst Toxikol, D-30625 Hannover, Germany	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Hannover Medical School; Hannover Medical School	Brunger, AT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	brunger@stanford.edu	Rummel, Andreas/I-7449-2013; Jin, Rongsheng/M-7797-2013	Jin, Rongsheng/0000-0003-0348-7363; Rummel, Andreas/0000-0002-0645-1641; Brunger, Axel/0000-0001-5121-2036				Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaramoorthy S, 2001, ACTA CRYSTALLOGR D, V57, P1743, DOI 10.1107/S0907444901013531; HABERMANN E, 1980, N-S ARCH PHARMACOL, V311, P33, DOI 10.1007/BF00500299; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; Jayaraman S, 2005, BIOCHEM BIOPH RES CO, V330, P97, DOI 10.1016/j.bbrc.2005.02.123; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kozaki S, 1998, MICROB PATHOGENESIS, V25, P91, DOI 10.1006/mpat.1998.0214; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; PANG ZP, IN PRESS J NEUROSCI; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; RUMMEL A, IN PRESS P NATL ACAD; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005	30	188	199	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1092	1095		10.1038/nature05387	http://dx.doi.org/10.1038/nature05387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17167421				2022-12-28	WOS:000242971100061
J	Watts, PC; Buley, KR; Boardman, W; Ciofi, C; GibsonO, R				Watts, Phillip C.; Buley, Kevin R.; Boardman, Wayne; Ciofi, Claudio; GibsonO, Richard			Parthenogenesis in komodo dragons	NATURE			English	Article							EXTINCTION		Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; N England Zool Soc, Chester Zoo, Upton By Chester CH2 1LH, England; Zool Soc London, London NW1 4RY, England; Univ Florence, Dept Anim Biol & Genet, I-50125 Florence, Italy	University of Liverpool; Zoological Society of London; University of Florence	Watts, PC (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England.	p.c.watts@liv.ac.uk	Boardman, Wayne S.J/J-6479-2013; Boardman, Wayne/ABE-7528-2020; Watts, Phill/G-7257-2011; Ciofi, Claudio/AAH-9461-2019	Boardman, Wayne/0000-0002-1746-0682; Watts, Phillip/0000-0001-7755-187X; CIOFI, CLAUDIO/0000-0001-8537-8659				AVISE JC, 1992, EVOL BIOL, V26, P225; Ciofi C, 2004, HERPETOL J, V14, P99; Ciofi C, 1998, MOL ECOL, V7, P134; Groot TVM, 2003, HEREDITY, V90, P130, DOI 10.1038/sj.hdy.6800210; HALVERSON J, 2002, BIOL CONSERVATION KO, P165; Lenk P, 2005, AMPHIBIA-REPTILIA, V26, P507, DOI 10.1163/156853805774806296; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Sherratt TN, 2005, NATURE, V435, P1039, DOI 10.1038/4351039a; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL	10	100	105	1	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1021	1022		10.1038/4441021a	http://dx.doi.org/10.1038/4441021a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183308				2022-12-28	WOS:000242971100041
J	Capone, DG				Capone, Douglas G.			Ramping up the heat on nitrogenase	SCIENCE			English	Editorial Material							FIXATION; ENVIRONMENTS; SEA		Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Capone, DG (corresponding author), Lab Oceanog Villefranche, F-063234 Villefranche Sur Mer, France.	capone@usc.edu						BELAY N, 1984, NATURE, V312, P286, DOI 10.1038/312286a0; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Codispoti LA., 2006, BIOGEOSCI DISCUSS, V3, P1203, DOI DOI 10.5194/BGD-3-1203-2006; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; JANNASCH HW, 1979, BIOSCIENCE, V29, P592, DOI 10.2307/1307765; Kletzin A, 1996, FEMS MICROBIOL REV, V18, P5, DOI 10.1016/0168-6445(95)00025-9; Mehta MP, 2006, SCIENCE, V314, P1783, DOI 10.1126/science.1134772; Mehta MP, 2003, APPL ENVIRON MICROB, V69, P960, DOI 10.1128/AEM.69.2.960-970.2003; MURRAY PA, 1984, NATURE, V312, P284, DOI 10.1038/312284a0; RAU GH, 1981, NATURE, V289, P484, DOI 10.1038/289484a0; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	14	2	2	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1691	1692		10.1126/science.1136980	http://dx.doi.org/10.1126/science.1136980			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170282				2022-12-28	WOS:000242833600033
J	Schussler, A; Martin, H; Cohen, D; Fitz, M; Wipf, D				Schuessler, Arthur; Martin, Holger; Cohen, David; Fitz, Michael; Wipf, Daniel			Characterization of a carbohydrate transporter from symbiotic glomeromycotan fungi	NATURE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGUS; GLOMUS-INTRARADICES; CARBON; PHYLOGENY; HYPHAE; GENOME; ROOTS; GENES	The symbiotic relationships between mycorrhizal fungi and plants have an enormous impact on terrestrial ecosystems(1). Most common are the arbuscular mycorrhizas, formed by fungi belonging to the phylum Glomeromycota(2). Arbuscular mycorrhizal fungi facilitate the uptake of soil nutrients by plants(3) and in exchange obtain carbohydrates, thus representing a large sink(4) for atmospheric plant-fixed CO2. However, how carbohydrates are transported through the symbiotic interface is still unknown. Here we report the characterization of the first known glomeromycotan monosaccharide transporter, GpMST1, by exploiting the unique symbiosis of a glomeromycotan fungus (Geosiphon pyriformis) with cyanobacteria(5). The GpMST1 gene has a very low GC content and contains six introns with unusual boundaries. GpMST1 possesses twelve predicted transmembrane domains and functions as a proton cotransporter with highest affinity for glucose, then mannose, galactose and fructose. It belongs to an as yet uncharacterized phylogenetic monosaccharide transporter clade. This initial characterization of a new transporter family involved in fungal symbiosis will lead to a better understanding of carbon flows in terrestrial environments.	Tech Univ Darmstadt, Inst Bot, D-64287 Darmstadt, Germany; Univ Bonn, IZMB, NWG Transport Mycorrhiza, D-53115 Bonn, Germany	Technical University of Darmstadt; University of Bonn	Schussler, A (corresponding author), Dept Biol 1, Bereich Genet, Maria Ward Str 1A, D-80638 Munich, Germany.	arthur.schuessler@lrz.uni-muenchen.de	Schüßler, Arthur/F-1681-2011	Wipf, Daniel/0000-0001-7197-5612; Cohen, David/0000-0002-0320-8865; Fitz, Michael/0000-0001-9192-0280				Bago B, 2003, PLANT PHYSIOL, V131, P1496, DOI 10.1104/pp.102.007765; BONFANTE P, 2001, MYCOTA, V9, P45; GARCIA M, 2006, 5 INT C MYC 23 27 JU, P200; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gould G.W., 1997, FACILITATIVE GLUCOSE, P1; Hamacher T, 2002, MICROBIOL-SGM, V148, P2783, DOI 10.1099/00221287-148-9-2783; Hildebrandt U, 2006, FEMS MICROBIOL LETT, V254, P258, DOI 10.1111/j.1574-6968.2005.00027.x; KLUGE M, 1991, PLANTA, V185, P311, DOI 10.1007/BF00201049; KNOBLAUCH M, 1995, THESIS, P1; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Marx J, 2004, SCIENCE, V304, P234, DOI 10.1126/science.304.5668.234; Meeks JC, 2001, PHOTOSYNTH RES, V70, P85, DOI 10.1023/A:1013840025518; Sawaki H, 2001, FEMS MICROBIOL LETT, V195, P109, DOI 10.1111/j.1574-6968.2001.tb10506.x; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schussler A, 2002, PLANT SOIL, V244, P75, DOI 10.1023/A:1020238728910; Schussler A, 2005, SOIL BIOL, V4, P271; Schussler A, 1996, PROTOPLASMA, V190, P53, DOI 10.1007/BF01281194; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Solaiman MDZ, 1997, NEW PHYTOL, V136, P533, DOI 10.1046/j.1469-8137.1997.00757.x; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; vanKuyk PA, 2004, BIOCHEM J, V379, P375, DOI 10.1042/BJ20030624; VELA GM, 2006, 5 INT C MYC 23 27 JU, P40; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Wipf D, 2003, GENOME, V46, P177, DOI [10.1139/g02-121, 10.1139/G02-121]	25	95	108	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					933	936		10.1038/nature05364	http://dx.doi.org/10.1038/nature05364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167486				2022-12-28	WOS:000242805400057
J	Maxted, PFL				Maxted, Pierre F. L.			A ghostly star revealed in silhouette	SCIENCE			English	Editorial Material									Keele Univ, Astrophys Grp, Keele ST5 5BG, Staffs, England	Keele University	Maxted, PFL (corresponding author), Keele Univ, Astrophys Grp, Keele ST5 5BG, Staffs, England.	pflm@astro.keele.ac.uk			Science and Technology Facilities Council [PP/D000955/1] Funding Source: researchfish; STFC [PP/D000955/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Littlefair SP, 2006, SCIENCE, V314, P1578, DOI 10.1126/science.1133333; Szkody P, 2006, ASTRON J, V131, P973, DOI 10.1086/499308	2	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1550	1551		10.1126/science.1135545	http://dx.doi.org/10.1126/science.1135545			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158309				2022-12-28	WOS:000242624600023
J	Sanderson, K				Sanderson, Katharine			A field in ferment	NATURE			English	News Item																			0	76	86	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2006	444	7120					673	676		10.1038/444673a	http://dx.doi.org/10.1038/444673a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151628				2022-12-28	WOS:000242581100015
J	Bennett, CL; Angelotta, C; Yarnold, PR; Evens, AM; Zonder, JA; Raisch, DW; Richardson, P				Bennett, Charles L.; Angelotta, Cara; Yarnold, Paul R.; Evens, Andrew M.; Zonder, Jeffrey A.; Raisch, Dennis W.; Richardson, Paul			Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							THROMBOSIS		Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA; Wayne State Univ, Karmanos Canc Inst, Div Hematol Oncol, Detroit, MI USA; Univ New Mexico, VA Cooperat Studies Program Clin Res Pharm Coordi, Albuquerque, NM 87131 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Hematol Malignancy, Boston, MA 02115 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of New Mexico; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Bennett, CL (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA.	cbenne@northwestern.edu	Bennett, Charles L/C-2050-2008	Evens, Andrew/0000-0002-6900-1824; Yarnold, Paul/0000-0002-1648-739X	NATIONAL CANCER INSTITUTE [K23CA109613, R01CA102713] Funding Source: NIH RePORTER; NCI NIH HHS [1K23 CA109613-01A1, 1R01CA 102713-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bennett CL, 2002, AM J MED, V113, P603, DOI 10.1016/S0002-9343(02)01300-1; DIMOPOULOS M, 2005, BLOOD, V106, P4050; Knight R, 2006, NEW ENGL J MED, V354, P2079; Richardson PG, 2006, BLOOD; Zonder JA, 2006, BLOOD, V108, P403, DOI 10.1182/blood-2006-01-0154	5	110	115	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2006	296	21					2558	2560		10.1001/jama.296.21.2558-c	http://dx.doi.org/10.1001/jama.296.21.2558-c			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112ND	17148721				2022-12-28	WOS:000242532000017
J	Di Micco, R; Fumagalli, M; Cicalese, A; Piccinin, S; Gasparini, P; Luise, C; Schurra, C; Garre, M; Nuciforo, PG; Bensimon, A; Maestro, R; Pelicci, PG; di Fagagna, FD				Di Micco, Raffaella; Fumagalli, Marzia; Cicalese, Angelo; Piccinin, Sara; Gasparini, Patrizia; Luise, Chiara; Schurra, Catherine; Garre, Massimiliano; Nuciforo, Paolo Giovanni; Bensimon, Aaron; Maestro, Roberta; Pelicci, Pier Giuseppe; di Fagagna, Fabrizio d'Adda			Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication	NATURE			English	Article							HUMAN-CELLS; GENOMIC INSTABILITY; GENETIC INSTABILITY; CELLULAR SENESCENCE; HA-RAS; P53; CYCLE; CDC6; REREPLICATION; TUMORIGENESIS	Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response(DDR)(1,2). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence(3-6). It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.	IFOM Fdn, FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Ctr Riferimento Oncol, IRCCS, I-33081 Aviano, Italy; Inst Pasteur, Genome Stabil Unit, F-75724 Paris, France; Genom Vis, F-75724 Paris, France	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); IRCCS Aviano (CRO); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	di Fagagna, FD (corresponding author), IFOM Fdn, FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy.	fabrizio.dadda@ifom-ieo-campus.it	Nuciforo, Paolo/Q-2885-2019; Gasparini, Patrizia/Q-7626-2016; Pelicci, Pier Giuseppe/AAL-6572-2020; PICCININ, SARA/AAZ-2679-2020; Di MICCO, RAFFAELLA/ABH-7906-2020; Maestro, Roberta/M-1846-2015; d'Adda di Fagagna, Fabrizio/AAC-4683-2022; Maestro, Roberta/P-9748-2019	Gasparini, Patrizia/0000-0002-9548-3724; PICCININ, SARA/0000-0002-7987-4020; Maestro, Roberta/0000-0002-6642-5592; d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; Maestro, Roberta/0000-0002-6642-5592; Nuciforo, Paolo/0000-0003-1380-0990; Fumagalli, Marzia/0000-0002-2036-4544; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185; Di Micco, Raffaella/0000-0002-0639-8238; Garre', Massimiliano/0000-0001-9332-0270				Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lebofsky Ronald, 2003, Briefings in Functional Genomics & Proteomics, V1, P385, DOI 10.1093/bfgp/1.4.385; Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Takeda DY, 2005, GENE DEV, V19, P2827, DOI 10.1101/gad.1369805; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932	29	1309	1335	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					638	642		10.1038/nature05327	http://dx.doi.org/10.1038/nature05327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136094				2022-12-28	WOS:000242377600052
J	Tsironi, E; Gatselis, N; Kotoula, MG; Chatzoulis, DZ; Dalekos, GN				Tsironi, Evangelia; Gatselis, Nikolaos; Kotoula, Maria G.; Chatzoulis, Dimitrios Z.; Dalekos, George N.			Unexplained choroidal embolisation: remember the antiphospholipid syndrome	LANCET			English	Editorial Material							ANTICARDIOLIPIN ANTIBODIES		Univ Thessaly, Sch Med, Dept Med, Div Internal Med, Larisa 41222, Greece; Univ Thessaly, Sch Med, Dept Ophthalmol, Larisa 41222, Greece; Univ Thessaly, Sch Med, Res Lab Internal Med, Larisa 41222, Greece	University of Thessaly; University of Thessaly; University of Thessaly	Dalekos, GN (corresponding author), Univ Thessaly, Sch Med, Dept Med, Div Internal Med, Papakiriazi 22 Str, Larisa 41222, Greece.	dalekos@med.uth.gr	Kotoula, Maria/Y-6539-2019					Cabrita FVL, 2005, OCUL IMMUNOL INFLAMM, V13, P265, DOI 10.1080/09273940490912434; Dalekos G N, 2001, Curr Rheumatol Rep, V3, P277, DOI 10.1007/s11926-001-0031-4; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; SCHVED JF, 1994, HAEMOSTASIS, V24, P175; Zachou K, 2006, CLIN IMMUNOL, V119, P203, DOI 10.1016/j.clim.2006.01.002	5	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1936	1936		10.1016/S0140-6736(06)69781-X	http://dx.doi.org/10.1016/S0140-6736(06)69781-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	109YQ	17126726				2022-12-28	WOS:000242345900035
J	Smittenberg, RH; Eglinton, TI; Schouten, S; Damste, JSS				Smittenberg, R. H.; Eglinton, T. I.; Schouten, S.; Damste, J. S. Sinninghe			Ongoing buildup of refractory organic carbon in boreal soils during the Holocene	SCIENCE			English	Article							SAANICH INLET; BRITISH-COLUMBIA; N-ALKANES; MATTER; SEDIMENTS; DYNAMICS; PRESERVATION; DEGRADATION; CLIMATE; STORAGE	Radiocarbon ages of vascular plant wax - derived n-alkanes preserved in well-dated Holocene sediments in an anoxic fjord (Saanich Inlet, Canada) were found to be not only substantially older than the depositional age but increasingly so during the Holocene. Assuming that n-alkanes serve as a proxy for recalcitrant terrigenous organic matter, this indicates that the accumulation of refractory organic carbon in soils that developed after the deglaciation of the American Pacific Northwest is ongoing and may still be far from equilibrium with mineralization and erosion rates.	Royal Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Woods Hole Oceanographic Institution	Smittenberg, RH (corresponding author), Univ Washington, Sch Oceanog, Box 355351, Seattle, WA 98195 USA.	smitten@u.washington.edu	Smittenberg, Rienk/A-3296-2008; Damste, Jaap S Sinninghe/F-6128-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854; Smittenberg, Rienk/0000-0001-5578-9916; Eglinton, Timothy/0000-0001-5060-2155				Adams JM, 1998, GLOBAL PLANET CHANGE, V17, P3; Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; BORNHOLD BD, 1998, P OCEAN DRILL PROG S, V169, P5; BROWN FS, 1972, GEOCHIM COSMOCHIM AC, V36, P1185, DOI 10.1016/0016-7037(72)90045-2; CHURCH M, 1989, NATURE, V337, P452, DOI 10.1038/337452a0; COLLISTER JW, 1994, ORG GEOCHEM, V21, P619, DOI 10.1016/0146-6380(94)90008-6; COLLISTER JW, 1994, ORG GEOCHEM, V21, P645, DOI 10.1016/0146-6380(94)90010-8; Conte MH, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001922; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Falloon PD, 2000, BIOL FERT SOILS, V30, P388; Gleixner G, 2002, ORG GEOCHEM, V33, P357, DOI 10.1016/S0146-6380(01)00166-8; GUCLUER SM, 1964, LIMNOL OCEANOGR, V9, P359, DOI 10.4319/lo.1964.9.3.0359; HARDEN JW, 1992, SCIENCE, V258, P1921, DOI 10.1126/science.258.5090.1921; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Huang Y, 1999, SOIL SCI SOC AM J, V63, P1181, DOI 10.2136/sssaj1999.6351181x; Kennedy MJ, 2002, SCIENCE, V295, P657, DOI 10.1126/science.1066611; Kovanen DJ, 2002, QUATERNARY RES, V57, P208, DOI 10.1006/qres.2001.2307; Lichtfouse E, 1997, GEOCHIM COSMOCHIM AC, V61, P1891, DOI 10.1016/S0016-7037(97)00021-5; Mayer LM, 2004, GEOCHIM COSMOCHIM AC, V68, P3863, DOI 10.1016/j.gca.2004.03.019; MCLAREN P, 1999, HLTH FRASER RIVER AQ, V1; McQuoid MR, 2001, MAR GEOL, V174, P273, DOI 10.1016/S0025-3227(00)00155-9; Nederbragt AJ, 2001, MAR GEOL, V174, P95, DOI 10.1016/S0025-3227(00)00144-4; Paul EA, 2001, GEODERMA, V104, P239, DOI 10.1016/S0016-7061(01)00083-0; Prahl FG, 1997, ORG GEOCHEM, V27, P141, DOI 10.1016/S0146-6380(97)00078-8; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Smittenberg RH, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000927; SUN MY, 1994, GEOCHIM COSMOCHIM AC, V58, P3395, DOI 10.1016/0016-7037(94)90094-9; Torn MS, 1997, NATURE, V389, P170, DOI 10.1038/38260; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Yunker MB, 2003, ORG GEOCHEM, V34, P1429, DOI 10.1016/S0146-6380(03)00136-0	30	46	47	3	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1283	1286		10.1126/science.1129376	http://dx.doi.org/10.1126/science.1129376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124318	Green Published			2022-12-28	WOS:000242215800038
J	Kimchi-Sarfaty, C; Oh, JM; Kim, IW; Sauna, ZE; Calcagno, AM; Ambudkar, SV; Gottesman, MM				Kimchi-Sarfaty, Chava; Oh, Jung Mi; Kim, In-Wha; Sauna, Zuben E.; Calcagno, Anna Maria; Ambudkar, Suresh V.; Gottesman, Michael M.			A "silent" polymorphism in the MDR1 gene changes substrate specificity	SCIENCE			English	Article							SYNONYMOUS CODON USAGE; SINGLE-NUCLEOTIDE POLYMORPHISMS; MULTIDRUG-RESISTANCE GENE; P-GLYCOPROTEIN; MESSENGER-RNA; IN-VIVO; EXPRESSION; LINKAGE		NCI, Cell Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gottesman, MM (corresponding author), US FDA, Ctr Biol Evaluat & Res, 29 Lincoln Dr,Room 316, Bethesda, MD 20892 USA.	kimchi@cber.fda.gov; jmoh@snu.ac.kr; mgottesman@nih.gov	Ambudkar, Suresh V/L-1317-2016; Calcagno, Anna Maria/A-5617-2012; Sauna, Zuben E./AAA-7149-2019	Calcagno, Anna Maria/0000-0002-0804-2753; Kimchi-Sarfaty, Chava/0000-0002-9355-8585	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010030, ZIABC010030] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adzhubei AA, 1996, FEBS LETT, V399, P78, DOI 10.1016/S0014-5793(96)01287-2; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Anthony V, 2002, CURR PROTEIN PEPT SC, V3, P485, DOI 10.2174/1389203023380503; Bercovitch L, 2004, J AM ACAD DERMATOL, V51, pS13, DOI 10.1016/j.jaad.2004.01.015; Brunak S, 1996, PROTEINS, V25, P237, DOI 10.1002/(SICI)1097-0134(199606)25:2<237::AID-PROT9>3.3.CO;2-Y; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Drescher S, 2002, BRIT J CLIN PHARMACO, V53, P526, DOI 10.1046/j.1365-2125.2002.01591.x; Frittitta L, 2001, DIABETES, V50, P1952, DOI 10.2337/diabetes.50.8.1952; Goto M, 2002, PHARMACOGENETICS, V12, P451, DOI 10.1097/00008571-200208000-00005; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gribar JJ, 2000, J MEMBRANE BIOL, V173, P203, DOI 10.1007/s002320001020; Gupta SK, 2000, BIOCHEM BIOPH RES CO, V269, P692, DOI 10.1006/bbrc.2000.2351; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Horinouchi M, 2002, PHARMACEUT RES, V19, P1581, DOI 10.1023/A:1020433422259; Kimchi-Sarfaty C, 2002, MOL PHARMACOL, V62, P1, DOI 10.1124/mol.62.1.1; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Perloff MD, 2001, BRIT J PHARMACOL, V134, P1601, DOI 10.1038/sj.bjp.0704399; Ruth A, 2001, BIOCHEMISTRY-US, V40, P4332, DOI 10.1021/bi001373f; Salama NN, 2006, J PHARM SCI-US, V95, P2293, DOI 10.1002/jps.20717; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; SIEMION IZ, 1994, BIOSYSTEMS, V33, P139, DOI 10.1016/0303-2647(94)90053-1; Supek F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-182; Tang K, 2002, PHARMACOGENETICS, V12, P437, DOI 10.1097/00008571-200208000-00004; Tran HTT, 2005, MOL GENET METAB, V85, P213, DOI 10.1016/j.ymgme.2005.03.006; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Xie T, 1998, FEBS LETT, V434, P93	29	1856	2111	1	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					525	528		10.1126/science.1135308	http://dx.doi.org/10.1126/science.1135308			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17185560	Green Published			2022-12-28	WOS:000243726600050
J	Gutierrez, E; Wiggins, D; Fielding, B; Gould, AP				Gutierrez, Eugenio; Wiggins, David; Fielding, Barbara; Gould, Alex P.			Specialized hepatocyte-like cells regulate Drosophila lipid metabolism	NATURE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; FAT STORAGE; BETA-OXIDATION; EGF RECEPTOR; MELANOGASTER; ACIDS; TRIACYLGLYCEROL; RESCUE; GROWTH; TISSUE	Lipid metabolism is essential for growth and generates much of the energy needed during periods of starvation. In Drosophila, fasting larvae release large quantities of lipid from the fat body but it is unclear how and where this is processed. Here we identify the oenocyte as the principal cell type accumulating lipid droplets during starvation. Tissue-specific manipulations of the Slimfast amino-acid channel, the Lsd2 fat-storage regulator and the Brummer lipase indicate that oenocytes act downstream of the fat body. In turn, oenocytes are required for depleting stored lipid from the fat body during fasting. Hence, lipid-metabolic coupling between the fat body and oenocytes is bidirectional. When food is plentiful, oenocytes have critical roles in regulating growth, development and feeding behaviour. In addition, they specifically express many different lipid-metabolizing proteins, including Cyp4g1, an omega-hydroxylase regulating triacylglycerol composition. These findings provide evidence that some lipid-processing functions of the mammalian liver are performed in insects by oenocytes.	Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Natl Inst Med Res, MRC, London NW7 1AA, England	University of Oxford; MRC National Institute for Medical Research	Gould, AP (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	agould@nimr.mrc.ac.uk	Gould, Alex/M-5353-2019; Gould, Alex/A-7479-2010	Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985	Medical Research Council [MC_U117584237] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U117584237] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Beadle GW, 1938, BIOL BULL-US, V75, P447, DOI 10.2307/1537573; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brodu V, 2004, DEV CELL, V7, P885, DOI 10.1016/j.devcel.2004.10.016; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Burdge GC, 2000, BRIT J NUTR, V84, P781; BUTTERWORTH FM, 1965, J EXP ZOOL, V158, P141, DOI 10.1002/jez.1401580203; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Dantuma NP, 1999, J LIPID RES, V40, P973; Dean R.L., 1985, P155; DUERDEN JM, 1988, BIOCHEM J, V255, P929, DOI 10.1042/bj2550929; Elstob PR, 2001, DEVELOPMENT, V128, P723; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; GRISWOLD CM, 1993, GENETICS, V134, P781; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Keeley L.L., 1985, P211; KOLLER G, 1928, BIOL REV, V4, P269; KOSCHEVNIKOV G, 2000, Z ANZ, V23, P657; Landois L, 1865, Z WISS ZOOL, V15, P371; LAWRENCE PA, 1986, J EMBRYOL EXP MORPH, V91, P251; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee CS, 2003, INSECT BIOCHEM MOLEC, V33, P761, DOI 10.1016/S0965-1748(03)00066-3; Lillie RD, 1944, STAIN TECHNOL, V19, P55, DOI 10.3109/10520294409105827; Martin JF, 2000, MECH DEVELOP, V92, P155, DOI 10.1016/S0925-4773(99)00338-X; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Riddiford Lynn M., 1993, P899; Rusten TE, 2001, DEVELOPMENT, V128, P711; Simpson AECM, 1997, GEN PHARMACOL-VASC S, V28, P351, DOI 10.1016/S0306-3623(96)00246-7; SUNDSETH SS, 1990, BIOCHEM J, V265, P213, DOI 10.1042/bj2650213; Teixeira L, 2003, MECH DEVELOP, V120, P1071, DOI 10.1016/S0925-4773(03)00158-8; TORNANCAK P, 2002, GENOME BIOL, V3, DOI UNSP RESEARCH0088; Ueyama M, 2005, INSECT BIOCHEM MOLEC, V35, P911, DOI 10.1016/j.ibmb.2005.03.007; Wanders RJA, 2003, ADV EXP MED BIOL, V544, P293; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Wigglesworth VB, 1933, Q J MICROSC SCI, V76, P269; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102; Yu ST, 2003, CURR MOL MED, V3, P561, DOI 10.2174/1566524033479537; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zinke I, 1999, DEVELOPMENT, V126, P5275	49	286	291	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2007	445	7125					275	280		10.1038/nature05382	http://dx.doi.org/10.1038/nature05382			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17136098				2022-12-28	WOS:000243504700036
J	Stuart, LM; Boulais, J; Charriere, GM; Hennessy, EJ; Brunet, S; Jutras, I; Goyette, G; Rondeau, C; Letarte, S; Huang, H; Ye, P; Morales, F; Kocks, C; Bader, JS; Desjardins, M; Ezekowitz, RAB				Stuart, L. M.; Boulais, J.; Charriere, G. M.; Hennessy, E. J.; Brunet, S.; Jutras, I.; Goyette, G.; Rondeau, C.; Letarte, S.; Huang, H.; Ye, P.; Morales, F.; Kocks, C.; Bader, J. S.; Desjardins, M.; Ezekowitz, R. A. B.			A systems biology analysis of the Drosophila phagosome	NATURE			English	Article							INTERACTION NETWORKS; PROTEIN NETWORKS; PHAGOCYTOSIS; EXOCYST; MACROPHAGES; IDENTIFICATION; EFFECTOR; RECEPTOR; EXOCYTOSIS; CONFIDENCE	Phagocytes have a critical function in remodelling tissues during embryogenesis and thereafter are central effectors of immune defence(1,2). During phagocytosis, particles are internalized into 'phagosomes', organelles from which immune processes such as microbial destruction and antigen presentation are initiated(3). Certain pathogens have evolved mechanisms to evade the immune system and persist undetected within phagocytes, and it is therefore evident that a detailed knowledge of this process is essential to an understanding of many aspects of innate and adaptive immunity. However, despite the crucial role of phagosomes in immunity, their components and organization are not fully defined. Here we present a systems biology analysis of phagosomes isolated from cells derived from the genetically tractable model organism Drosophila melanogaster and address the complex dynamic interactions between proteins within this organelle and their involvement in particle engulfment. Proteomic analysis identified 617 proteins potentially associated with Drosophila phagosomes; these were organized by protein - protein interactions to generate the 'phagosome interactome', a detailed protein - protein interaction network of this subcellular compartment. These networks predicted both the architecture of the phagosome and putative biomodules. The contribution of each protein and complex to bacterial internalization was tested by RNA-mediated interference and identified known components of the phagocytic machinery. In addition, the prediction and validation of regulators of phagocytosis such as the 'exocyst'(4), a macromolecular complex required for exocytosis but not previously implicated in phagocytosis, validates this strategy. In generating this 'systems-based model', we show the power of applying this approach to the study of complex cellular processes and organelles and expect that this detailed model of the phagosome will provide a new framework for studying host pathogen interactions and innate immunity.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lab Dev Immunol, Boston, MA 02114 USA; Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland; Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; Johns Hopkins Univ, Dept Biomed Engn & High Throughput Biol Ctr, Baltimore, MD 21218 USA; McGill Univ, Fac Med, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Edinburgh; Universite de Montreal; Johns Hopkins University; McGill University	Stuart, LM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lab Dev Immunol, 55 Fruit St, Boston, MA 02114 USA.	lstuart@partners.org	Boulais, jonathan/Y-4019-2019; Bader, Joel/A-1818-2009; Charriere, Guillaume/Z-1574-2019; Hennessy, Elizabeth/AAJ-4800-2021; Charriere, Guillaume M/O-8317-2014	Bader, Joel/0000-0002-6020-4625; Charriere, Guillaume/0000-0002-4796-1488; Hennessy, Elizabeth/0000-0002-1231-5777; Charriere, Guillaume M/0000-0002-4796-1488; Boulais, Jonathan/0000-0003-1848-0068; Desjardins, Michel/0000-0002-5684-5980; Goyette, Guillaume/0000-0003-3277-568X; Huang, Hailiang/0000-0003-1461-5762	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Asthana S, 2004, GENOME RES, V14, P1170, DOI 10.1101/gr.2203804; Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Bader JS, 2003, BIOINFORMATICS, V19, P1869, DOI 10.1093/bioinformatics/btg358; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Clandinin TR, 2005, NEURON, V46, P164, DOI 10.1016/j.neuron.2005.04.003; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Cox D, 2000, P NATL ACAD SCI USA, V97, P680, DOI 10.1073/pnas.97.2.680; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Gold ES, 2000, IMMUNITY, V12, P285, DOI 10.1016/S1074-7613(00)80181-8; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Niedergang F, 2003, J CELL BIOL, V161, P1143, DOI 10.1083/jcb.200210069; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Uetz P, 2005, FEBS LETT, V579, P1821, DOI 10.1016/j.febslet.2005.02.001; Vidal M, 2005, FEBS LETT, V579, P1834, DOI 10.1016/j.febslet.2005.02.030; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	29	176	183	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2007	445	7123					95	101		10.1038/nature05380	http://dx.doi.org/10.1038/nature05380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17151602				2022-12-28	WOS:000243225100043
J	Gansicke, BT; Marsh, TR; Southworth, J; Rebassa-Mansergas, A				Gaensicke, B. T.; Marsh, T. R.; Southworth, J.; Rebassa-Mansergas, A.			A gaseous metal disk around a white dwarf	SCIENCE			English	Article							EXCESS INFRARED RADIATION; STELLAR EVOLUTION; STARS; MASS; GD-362	The destiny of planetary systems through the late evolution of their host stars is very uncertain. We report a metal-rich gas disk around a moderately hot and young white dwarf. A dynamical model of the double-peaked emission lines constrains the outer disk radius to just 1.2 solar radii. The likely origin of the disk is a tidally disrupted asteroid, which has been destabilized from its initial orbit at a distance of more than 1000 solar radii by the interaction with a relatively massive planetesimal object or a planet. The white dwarf mass of 0.77 solar mass implies that planetary systems may form around high-mass stars.	Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Warwick	Gansicke, BT (corresponding author), Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.	boris.gaensicke@warwick.ac.uk	Gaensicke, Boris T/A-9421-2012; Rebassa-Mansergas, Alberto/AAY-9526-2021	Gaensicke, Boris T/0000-0002-2761-3005; 				Adelman-McCarthy JK, 2006, ASTROPHYS J SUPPL S, V162, P38, DOI 10.1086/497917; Becklin EE, 2005, ASTROPHYS J, V632, pL119, DOI 10.1086/497826; BLOCKER T, 1995, ASTRON ASTROPHYS, V299, P755; Burleigh MR, 2002, MON NOT R ASTRON SOC, V331, pL41, DOI 10.1046/j.1365-8711.2002.05417.x; Davidsson BJR, 1999, ICARUS, V142, P525, DOI 10.1006/icar.1999.6214; Debes JH, 2002, ASTROPHYS J, V572, P556, DOI 10.1086/340291; Dobbie PD, 2006, MON NOT R ASTRON SOC, V369, P383, DOI 10.1111/j.1365-2966.2006.10311.x; Eisenstein DJ, 2006, ASTROPHYS J SUPPL S, V167, P40, DOI 10.1086/507110; Farihi J, 2005, ASTROPHYS J SUPPL S, V161, P394, DOI 10.1086/444362; GRAHAM JR, 1990, ASTROPHYS J, V357, P216, DOI 10.1086/168907; HORNE K, 1986, MON NOT R ASTRON SOC, V218, P761, DOI 10.1093/mnras/218.4.761; HUBENY I, 1995, ASTROPHYS J, V439, P875, DOI 10.1086/175226; Hurley JR, 2000, MON NOT R ASTRON SOC, V315, P543, DOI 10.1046/j.1365-8711.2000.03426.x; Jura M, 2003, ASTROPHYS J, V584, pL91, DOI 10.1086/374036; Kilic M, 2005, ASTROPHYS J, V632, pL115, DOI 10.1086/497825; Kilic M, 2006, ASTROPHYS J, V646, P474, DOI 10.1086/504682; Koester D, 1997, ASTRON ASTROPHYS, V320, pL57; Koester D, 2006, ASTRON ASTROPHYS, V453, P1051, DOI 10.1051/0004-6361:20064843; Kuchner MJ, 1998, ASTROPHYS J, V508, pL81, DOI 10.1086/311725; Meilland A, 2006, ASTRON ASTROPHYS, V455, P953, DOI 10.1051/0004-6361:20054690; PAQUETTE C, 1986, ASTROPHYS J SUPPL S, V61, P177, DOI 10.1086/191111; Reach WT, 2005, ASTROPHYS J, V635, pL161, DOI 10.1086/499561; YOUNG P, 1981, ASTROPHYS J, V245, P1035, DOI 10.1086/158880; ZUCKERMAN B, 1987, NATURE, V330, P138, DOI 10.1038/330138a0	25	254	254	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1908	1910		10.1126/science.1135033	http://dx.doi.org/10.1126/science.1135033			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185598	Green Submitted			2022-12-28	WOS:000242996800042
J	Pawar, KS; Bhoite, RR; Pillay, CP; Chavan, SC; Malshikare, DS; Garad, SG				Pawar, Kirti S.; Bhoite, Ramesh R.; Pillay, Chandrakant P.; Chavan, Sujata C.; Malshikare, Dhananjay S.; Garad, Saraswati G.			Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial	LANCET			English	Article								Background The role of oximes for the treatment of organophosphorus pesticide poisoning has not been conclusively established. We aimed to assess the effectiveness of a constant pralidoxime infusion compared with repeated bolus doses to treat patients with moderately severe poisoning from organophosphorus pesticides. Methods 200 patients were recruited to our single-centre, open randomised controlled trial after moderately severe poisoning by anticholinesterase pesticide. All were given a 2 g loading dose of pralidoxime over 30 min. Patients were then randomly assigned to control and study groups. Controls were given a bolus dose of 1 g pralidoxime over 1 h every 4 h for 48 h. The study group had a constant infusion of 1 g over an hour every hour for 48 h. Thereafter, all patients were given 1 g every 4 h until they could be weaned from ventilators. Analysis was by intention to treat. Primary outcome measures were median atropine dose needed within 24 h, proportion of patients who needed intubation, and number of days on ventilation. The study is registered at http://www.clinicaltrials.gov with the identifier NCT00333944. Findings 100 patients were assigned the high-dose regimen, and 100 the control regimen. There were no drop-outs. Patients receiving the high-dose pralidoxime regimen required less atropine during the first 24 h than controls (median 6 mg vs 30 mg; difference 24 mg [95% CI 24-26, p<0.0001]). 88 (88%) and 64 (64%) of controls and high-dose patients, respectively, needed intubation during admission to hospital (relative risk=0.72, 0.62-0.86, p=0.0001). Control patients required ventilatory support for longer (median 10 days vs 5 days; difference 5 days [5-6, p<0.0001]). Interpretation A high-dose regimen of pralidoxime, consisting of a constant infusion of 1 g/h for 48 h after a 2 g loading dose, reduces morbidity and mortality in moderately severe cases of acute organophosphorus-pesticide poisoning.	Giriraj Hosp, Baramati 413102, Maharashtra, India; Intens Care Unit, Baramati 413102, Maharashtra, India; BJ Med Coll, Dept Prevent & Social Med, Pune, Maharashtra, India	B.J. Govt. Medical College & Sassoon General Hospitals, Pune	Pawar, KS (corresponding author), Giriraj Hosp, Indapur Rd, Baramati 413102, Maharashtra, India.	kirtispawar@yahoo.co.in						Buckley NA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005085; CHERIAN AM, 1997, J ASSOC PHYSICIAN I, V45, P22; Eddleston M, 2005, LANCET, V366, P1452, DOI 10.1016/S0140-6736(05)67598-8; Eddleston M, 2004, CRIT CARE, V8, pR391, DOI 10.1186/cc2953; Eddleston M, 2002, QJM-INT J MED, V95, P275, DOI 10.1093/qjmed/95.5.275; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Eyer Peter, 2003, Toxicological Reviews, V22, P165, DOI 10.2165/00139709-200322030-00004; JAGER BV, 1958, B JOHNS HOPKINS HOSP, V102, P203; JOHNSON MK, 1992, LANCET, V340, P64, DOI 10.1016/0140-6736(92)92487-Z; Johnson MK., 2000, EMERGEN MED, V12, P22, DOI [DOI 10.1046/J.1442-2026.2000.00087.X, 10.1046/j.1442-2026.2000.00087.x]; Johnson S, 1996, J Assoc Physicians India, V44, P529; JOSSELSON J, 1978, CLIN PHARMACOL THER, V24, P95; LOTTI M, 2003, J TOXICOL-CLIN TOXIC, V41, P440; Medicis JJ, 1996, J TOXICOL-CLIN TOXIC, V34, P289, DOI 10.3109/15563659609013791; MUTALIK G S, 1962, J Indian Med Assoc, V38, P67; Peter JV, 2000, ANAESTH INTENS CARE, V28, P11, DOI 10.1177/0310057X0002800102; Peter JV., 2004, CRITICAL CARE UPDATE, P153; SUNDWALL A, 1961, BIOCHEM PHARMACOL, V8, P413, DOI 10.1016/0006-2952(61)90059-4; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	19	106	112	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2006	368	9553					2136	2141		10.1016/S0140-6736(06)69862-0	http://dx.doi.org/10.1016/S0140-6736(06)69862-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174705				2022-12-28	WOS:000242856900021
J	Poole, KES; Compston, JE				Poole, Kenneth E. S.; Compston, Juliet E.			Osteoporosis and its management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VERTEBRAL FRACTURE RISK; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; NONVERTEBRAL FRACTURES; PARATHYROID-HORMONE; STRONTIUM RANELATE; RANDOMIZED-TRIAL; HIP FRACTURE; VITAMIN-D; METAANALYSIS		Addenbrookes Hosp, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Compston, JE (corresponding author), Addenbrookes Hosp, Hills Rd, Cambridge CB2 2QQ, England.	jec1001@cam.ac.uk						Avenell A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub2; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Boonen S, 2005, OSTEOPOROSIS INT, V16, P1291, DOI 10.1007/s00198-005-1945-x; Boonen S, 2006, CALCIFIED TISSUE INT, V78, P257, DOI 10.1007/s00223-005-0009-8; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Compston J, 2005, BEST PRACT RES CL RH, V19, P1007, DOI 10.1016/j.berh.2005.06.010; Compston JE, 2001, PHYSIOL REV, V81, P419, DOI 10.1152/physrev.2001.81.1.419; Compston JE, 2006, LANCET, V368, P973, DOI 10.1016/S0140-6736(06)69394-X; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; Cranney A, 2006, CAN MED ASSOC J, V175, P52, DOI 10.1503/cmaj.050929; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Delmas PD, 2004, OSTEOPOROSIS INT, V15, P792, DOI 10.1007/s00198-004-1602-9; Delmas PD, 2006, ARTHRITIS RHEUM-US, V54, P1838, DOI 10.1002/art.21918; Dennison E, 2005, CURR OPIN RHEUMATOL, V17, P456, DOI 10.1097/01.bor.0000166384.80777.0d; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; HIND K, 2006, BONE            0904; Howe TE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000333.pub2; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2004, BONE, V35, P1029, DOI 10.1016/j.bone.2004.06.017; Kanis JA, 2004, J BONE MINER RES, V19, P893, DOI 10.1359/JBMR.040134; Kanis JA, 2002, BONE, V31, P26, DOI 10.1016/S8756-3282(02)00813-X; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Lock CA, 2006, OSTEOPOROSIS INT, V17, P20, DOI 10.1007/s00198-005-1942-0; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nguyen ND, 2006, J BONE MINER RES, V21, P340, DOI 10.1359/JBMR.050903; ODONNELL S, 2006, COCHRANE DB SYST REV, V3; Papapoulos SE, 2005, OSTEOPOROSIS INT, V16, P468, DOI 10.1007/s00198-004-1725-z; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Seeman E, 2006, OSTEOPOROSIS INT, V17, P313, DOI 10.1007/s00198-005-2030-1; Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108; Stevenson M, 2005, HEALTH TECHNOL ASSES, V9, P1; Torgerson DJ, 2000, OSTEOPOROSIS INT, V11, P551; *WHO STUD GROUP, 1984, WHO TECH SER	45	152	159	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2006	333	7581					1251	1256B		10.1136/bmj.39050.597350.47	http://dx.doi.org/10.1136/bmj.39050.597350.47			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122AB	17170416	Green Published			2022-12-28	WOS:000243197000021
J	Bishop, DK				Bishop, Douglas K.			Multiple mechanisms of meiotic recombination	CELL			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; INITIATION; MEIOSIS; PROMOTE; YEAST	In this issue, Cromie et al. (2006) reveal that different meiotic recombination mechanisms predominate in fission yeast and budding yeast. Budding yeast usually form crossover recombinants through double Holliday junctions, whereas fission yeast unexpectedly appear to form crossover recombinants through single junctions.	Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Bishop, DK (corresponding author), Univ Chicago, Dept Radiat & Cellular Oncol, 920 E 58th St, Chicago, IL 60637 USA.	dbishop@uchicago.edu						Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; de los Santos T, 2003, GENETICS, V164, P81; Jessop L, 2005, GENETICS, V169, P1353, DOI 10.1534/genetics.104.036509; Merker JD, 2003, GENETICS, V165, P47; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8	9	8	8	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1095	1097		10.1016/j.cell.2006.11.029	http://dx.doi.org/10.1016/j.cell.2006.11.029			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174887	Bronze			2022-12-28	WOS:000242991000007
J	Kane, CL; Mele, EJ				Kane, Charles L.; Mele, Eugene J.			A new spin on the insulating state	SCIENCE			English	Editorial Material									Univ Penn, Dept Phys, Philadelphia, PA 19104 USA	University of Pennsylvania	Kane, CL (corresponding author), Univ Penn, Dept Phys, Philadelphia, PA 19104 USA.	kane@physics.upenn.edu	Kane, Charles L/A-1035-2007	Mele, Eugene/0000-0001-7140-5353				Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Kohn W., 1965, PHYS REV A, V133, P171; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405	5	67	67	4	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1692	1693		10.1126/science.1136573	http://dx.doi.org/10.1126/science.1136573			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170283				2022-12-28	WOS:000242833600034
J	Zamore, PD				Zamore, Phillip D.			RNA interference: Big applause for silencing in Stockholm	CELL			English	Editorial Material							DOUBLE-STRANDED-RNA; C-ELEGANS; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; SUPPRESSION; EXPRESSION; ENCODES; PETUNIA; PLANTS	Eight years ago, Craig Mello, Andrew Fire, and their coworkers provided the first demonstration that double-stranded RNA (dsRNA) triggers the gene-silencing technique that we now call RNA interference (RNAi). For this landmark discovery, Mello and Fire are honored with this year's Nobel Prize in Physiology or Medicine.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618				Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291	15	40	44	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1083	1086		10.1016/j.cell.2006.12.001	http://dx.doi.org/10.1016/j.cell.2006.12.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174883	Bronze			2022-12-28	WOS:000242991000003
J	Bendell, J				Bendell, Johanna			Optimum chemotherapy for metastatic colorectal cancer	LANCET			English	Editorial Material							FLUOROURACIL PLUS LEUCOVORIN; RANDOMIZED CONTROLLED-TRIAL; OXALIPLATIN; IRINOTECAN; INTERGROUP; GERCOR; BOLUS		Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Bendell, J (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.	bende007@mc.duke.edu						deGramont A, 1997, J CLIN ONCOL, V15, P808, DOI 10.1200/JCO.1997.15.2.808; FALCONE A, 2006, J CLIN ONCOL S, V24, P3513; FUCHS C, 2006, J CLIN ONCOL, V24, P3506; Goldberg RM, 2006, J CLIN ONCOL, V24, P3347, DOI 10.1200/JCO.2006.06.1317; Goldberg RM, 2002, J CLIN ONCOL, V20, P4591, DOI 10.1200/JCO.2002.03.039; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; HOCHSTER H, 2006, 2006 GASTR CANC S SA; Maindrault-Goebel F., 2006, J CLIN ONCOL, V24, P3504, DOI [10.1200/jco.2006.24.18_suppl.3504, DOI 10.1200/JCO.2006.24.18_SUPPL.3504]; Tournigand C, 2006, J CLIN ONCOL, V24, P394, DOI 10.1200/JCO.2005.03.0106; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113	11	7	8	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 9	2006	368	9552					2039	2041		10.1016/S0140-6736(06)69818-8	http://dx.doi.org/10.1016/S0140-6736(06)69818-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114JY	17161715				2022-12-28	WOS:000242663700006
J	Podsiadlowski, P; Justham, S				Podsiadlowski, Philipp; Justham, Stephen			Big Bang points to stellar mix-up	SCIENCE			English	Editorial Material									Univ Oxford, Dept Astrophys, Oxford OX1 3RH, England	University of Oxford	Podsiadlowski, P (corresponding author), Univ Oxford, Dept Astrophys, Oxford OX1 3RH, England.	podsi@astro.ox.ac.uk						Dearborn DSP, 2006, ASTROPHYS J, V639, P405, DOI 10.1086/499263; Eggleton PP, 2006, SCIENCE, V314, P1580, DOI 10.1126/science.1133065; EGGLETON PP, 1971, MON NOT R ASTRON SOC, V151, P351, DOI 10.1093/mnras/151.3.351; ROOD RT, 1992, NATURE, V355, P618, DOI 10.1038/355618a0; SPERGEL DN, ASTROPH0603449; [No title captured]	6	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1551	1552		10.1126/science.1134924	http://dx.doi.org/10.1126/science.1134924			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158310				2022-12-28	WOS:000242624600024
J	Tilman, D; Hill, J; Lehman, C				Tilman, David; Hill, Jason; Lehman, Clarence			Carbon-negative biofuels from low-input high-diversity grassland biomass	SCIENCE			English	Article							ECOSYSTEM; ENERGY; CROPS; SWITCHGRASS; BIODIESEL; DYNAMICS; NITROGEN; ETHANOL	Biofuels derived from low-input high-diversity (LIHD) mixtures of native grassland perennials can provide more usable energy, greater greenhouse gas reductions, and less agrichemical pollution per hectare than can corn grain ethanol or soybean biodiesel. High-diversity grasslands had increasingly higher bioenergy yields that were 238% greater than monoculture yields after a decade. LIHD biofuels are carbon negative because net ecosystem carbon dioxide sequestration (4.4 megagram hectare(-1) year(-1) of carbon dioxide in soil and roots) exceeds fossil carbon dioxide release during biofuel production (0.32 megagram hectare(-1) year(-1)). Moreover, LIHD biofuels can be produced on agriculturally degraded lands and thus need to neither displace food production nor cause loss of biodiversity via habitat destruction.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu	Hill, Jason/A-8919-2008; Tilman, David/ABD-5309-2021	Hill, Jason/0000-0001-7609-6713; 				Berndes G, 2002, GLOBAL ENVIRON CHANG, V12, P253, DOI 10.1016/S0959-3780(02)00040-7; Camill P, 2004, ECOL APPL, V14, P1680, DOI 10.1890/03-5273; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Fedoroff NV, 1999, P NATL ACAD SCI USA, V96, P5903, DOI 10.1073/pnas.96.11.5903; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gallagher PW, 2003, ENVIRON RESOUR ECON, V24, P335, DOI 10.1023/A:1023630823210; Hamelinck CN, 2004, ENERGY, V29, P1743, DOI 10.1016/j.energy.2004.01.002; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Hoogwijk M, 2003, BIOMASS BIOENERG, V25, P119, DOI 10.1016/S0961-9534(02)00191-5; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Keoleian GA, 2005, CRIT REV PLANT SCI, V24, P385, DOI 10.1080/07352680500316334; Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Knops JMH, 2000, ECOLOGY, V81, P88, DOI 10.1890/0012-9658(2000)081[0088:DOSNAC]2.0.CO;2; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Mann M, 2001, CLEAN PROD PROCESS, V3, P81, DOI DOI 10.1007/S100980100109; Outlaw J, 2005, AGR PRODUCER CONSUME; Owensby CE, 1999, GLOB CHANGE BIOL, V5, P497, DOI 10.1046/j.1365-2486.1999.00245.x; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Sheehan John, 2003, Journal of Industrial Ecology, V7, P117; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; *US DEP EN EN INF, 2006, DOEEIA0484; *USDA NAT AGR STAT, 2006, AGR CHEM US 2004 200; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vogel KP, 2002, AGRON J, V94, P413, DOI 10.2134/agronj2002.0413; Zhang Y, 2003, BIORESOURCE TECHNOL, V89, P1, DOI 10.1016/S0960-8524(03)00040-3	28	1224	1263	17	676	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1598	1600		10.1126/science.1133306	http://dx.doi.org/10.1126/science.1133306			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158327				2022-12-28	WOS:000242624600042
J	Wassarman, KM; Saecker, RM				Wassarman, Karen M.; Saecker, Ruth M.			Synthesis-mediated release of a small RNA inhibitor of RNA polymerase	SCIENCE			English	Article							ESCHERICHIA-COLI; LID ELEMENT; TRANSCRIPTION; ELONGATION; PROMOTER; REGULATORS; STRAND	Noncoding small RNAs regulate gene expression in all organisms, in some cases through direct association with RNA polymerase ( RNAP). Here we report that the mechanism of 6S RNA inhibition of transcription is through specific, stable interactions with the active site of Escherichia coli RNAP that exclude promoter DNA binding. In fact, the DNA-dependent RNAP uses bound 6S RNA as a template for RNA synthesis, producing 14- to 20-nucleotide RNA products (pRNA). These results demonstrate that 6S RNA is functionally engaged in the active site of RNAP. Synthesis of pRNA destabilizes 6S RNA-RNAP complexes leading to release of the pRNA-6S RNA hybrid. In vivo, 6S RNA-directed RNA synthesis occurs during outgrowth from the stationary phase and likely is responsible for liberating RNAP from 6S RNA in response to nutrient availability.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wassarman, KM (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	wassarman@bact.wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023467, R37GM023467, R01GM067955] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23467, R01 GM067955, GM67955] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMANN CR, 1994, P NATL ACAD SCI USA, V91, P3784, DOI 10.1073/pnas.91.9.3784; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; BIEBRICH.CK, 1973, P NATL ACAD SCI USA, V70, P934, DOI 10.1073/pnas.70.3.934; Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Gopal V, 1999, J MOL BIOL, V290, P411, DOI 10.1006/jmbi.1999.2836; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Kettenberger H, 2006, NAT STRUCT MOL BIOL, V13, P44, DOI 10.1038/nsmb1032; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Massirer KB, 2006, BIOESSAYS, V28, P449, DOI 10.1002/bies.20406; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Pelchat M, 2002, BIOCHEMISTRY-US, V41, P6561, DOI 10.1021/bi025595k; Schroeder LA, 2005, J BIOL CHEM, V280, P17422, DOI 10.1074/jbc.M501281200; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Trotochaud AE, 2005, NAT STRUCT MOL BIOL, V12, P313, DOI 10.1038/nsmb917; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Trotochaud AE, 2006, J BACTERIOL, V188, P3936, DOI 10.1128/JB.00079-06; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Wettich A, 2001, BIOCHEMISTRY-US, V40, P3308, DOI 10.1021/bi002756g; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zenkin N, 2006, NATURE, V439, P617, DOI 10.1038/nature04337	25	132	135	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1601	1603		10.1126/science.1134830	http://dx.doi.org/10.1126/science.1134830			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158328				2022-12-28	WOS:000242624600043
J	Nakamura-Messenger, K; Messenger, S; Keller, LP; Clemett, SJ; Zolensky, ME				Nakamura-Messenger, Keiko; Messenger, Scott; Keller, Lindsay P.; Clemett, Simon J.; Zolensky, Michael E.			Organic globules in the Tagish Lake meteorite: Remnants of the protosolar disk	SCIENCE			English	Article							MOLECULAR-CLOUD MATERIAL; DEUTERIUM FRACTIONATION; NITROGEN; CARBON; MATTER; ABUNDANCES; CHONDRITE; CHEMISTRY; ICE	Coordinated transmission electron microscopy and isotopic measurements of organic globules in the Tagish Lake meteorite shows that they have elevated ratios of nitrogen-15 to nitrogen-14 (1.2 to 2 times terrestrial) and of deuterium to hydrogen (2.5 to 9 times terrestrial). These isotopic anomalies are indicative of mass fractionation during chemical reactions at extremely low temperatures ( 10 to 20 kelvin), characteristic of cold molecular clouds and the outer protosolar disk. The globules probably originated as organic ice coatings on preexisting grains that were photochemically processed into refractory organic matter. The globules resemble cometary carbon, hydrogen, oxygen, and nitrogen (CHON) particles, suggesting that such grains were important constituents of the solar system starting materials.	NASA, Lyndon B Johnson Space Ctr, Robert M Walker Lab Space Sci, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA; NASA, Lyndon B Johnson Space Ctr, ESC Grp Jacobs Sverdrup, Houston, TX 77058 USA; NASA, Lyndon B Johnson Space Ctr, ESC Grp ERC Inc, Houston, TX 77058 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Nakamura-Messenger, K (corresponding author), NASA, Lyndon B Johnson Space Ctr, Robert M Walker Lab Space Sci, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA.	keiko.nakamura-1@nasa.gov		Zolensky, Michael/0000-0002-3181-1303				Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Alexander CMO, 1998, METEORIT PLANET SCI, V33, P603, DOI 10.1111/j.1945-5100.1998.tb01667.x; Bernstein MP, 2003, ASTROPHYS J, V582, pL25, DOI 10.1086/345941; Brown PG, 2000, SCIENCE, V290, P320, DOI 10.1126/science.290.5490.320; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; CLAUS G, 1961, NATURE, V192, P594, DOI 10.1038/192594a0; Cody GD, 2005, GEOCHIM COSMOCHIM AC, V69, P1085, DOI 10.1016/j.gca.2004.08.031; Dworkin JP, 2001, P NATL ACAD SCI USA, V98, P815, DOI 10.1073/pnas.98.3.815; Floss C, 2004, SCIENCE, V303, P1355, DOI 10.1126/science.1093283; GARVIE LAJ, 2006, LUNAR PLANET SCI, V37; Gibb EL, 2004, ASTROPHYS J SUPPL S, V151, P35, DOI 10.1086/381182; Grady MM, 2002, METEORIT PLANET SCI, V37, P713, DOI 10.1111/j.1945-5100.2002.tb00851.x; Hiroi T, 2001, SCIENCE, V293, P2234, DOI 10.1126/science.1063734; Keller LP, 2004, GEOCHIM COSMOCHIM AC, V68, P2577, DOI 10.1016/j.gca.2003.10.044; LACY JH, 1998, APJ, V501, P105; LANGER WD, 1989, ASTROPHYS J SUPPL S, V69, P241, DOI 10.1086/191313; Li AG, 1997, ASTRON ASTROPHYS, V323, P566; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 1997, AIP CONF PROC, P545, DOI 10.1063/1.53336; MILLAR TJ, 1989, ASTROPHYS J, V340, P906, DOI 10.1086/167444; Nakamura K., 2002, INT J ASTROBIOL, V1, P179, DOI DOI 10.1017/; Pizzarello S., 2006, METEORITES EARLY SOL, P625; Rodgers SD, 2004, MON NOT R ASTRON SOC, V352, P600, DOI 10.1111/j.1365-2966.2004.07953.x; Tielens AGGM, 1997, AIP CONF PROC, P523, DOI 10.1063/1.53335; Zinner EK, 2005, TREATISE GEOCHEM, V1, P17; Zolensky M., 1988, METEORITES EARLY SOL, P114; ZOLENSKY ME, 1989, ICARUS, V78, P411, DOI 10.1016/0019-1035(89)90188-7	29	195	197	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1439	1442		10.1126/science.1132175	http://dx.doi.org/10.1126/science.1132175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138898				2022-12-28	WOS:000242406100037
J	Pelletier, L; O'Toole, E; Schwager, A; Hyman, AA; Muller-Reichert, T				Pelletier, Laurence; O'Toole, Eileen; Schwager, Anne; Hyman, Anthony A.; Mueller-Reichert, Thomas			Centriole assembly in Caenorhabditis elegans	NATURE			English	Article							C-ELEGANS; CENTROSOME DUPLICATION; PROTEIN SPD-2; CELL-DIVISION; CYCLE; RECRUITMENT; GENES; ROLES; SAS-4; RNAI	Centrioles are necessary for flagella and cilia formation(1,2), cytokinesis(3,4), cell-cycle control(5) and centrosome organization/ spindle assembly(6). They duplicate once per cell cycle, but the mechanisms underlying their duplication remain unclear. Here we show using electron tomography of staged C. elegans one-cell embryos that daughter centriole assembly begins with the formation and elongation of a central tube followed by the peripheral assembly of nine singlet microtubules. Tube formation and elongation is dependent on the SAS-5 and SAS-6 proteins, whereas the assembly of singlet microtubules onto the central tube depends on SAS-4. We further show that centriole assembly is triggered by an upstream signal mediated by SPD-2 and ZYG-1. These results define a structural pathway for the assembly of a daughter centriole and should have general relevance for future studies on centriole assembly in other organisms.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder Lab 3D Electron Microscopy Cells, Boulder, CO 80309 USA	Max Planck Society; University of Colorado System; University of Colorado Boulder	Pelletier, L (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	pelletie@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Pelletier, Laurence/F-8858-2013	Hyman, Anthony A/0000-0003-3664-154X; 				Azimzadeh J., 2004, CENTROSOMES DEV DIS, P93; Briggs LJ, 2004, CURR BIOL, V14, pR611, DOI 10.1016/j.cub.2004.07.041; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; DIPPELL RV, 1968, P NATL ACAD SCI USA, V61, P461, DOI 10.1073/pnas.61.2.461; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Leidel S, 2005, DEV CELL, V9, P317, DOI 10.1016/j.devcel.2005.08.004; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; MULLERREICHERT T, METH CELL BIOL, V79, P99; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; O'Connell KF, 1998, GENETICS, V149, P1303; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; ROBBINS E, 1968, J CELL BIOL, V36, P329, DOI 10.1083/jcb.36.2.329; SLUDER G, 1985, J CELL BIOL, V100, P887, DOI 10.1083/jcb.100.3.887; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	29	290	295	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2006	444	7119					619	623		10.1038/nature05318	http://dx.doi.org/10.1038/nature05318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136092				2022-12-28	WOS:000242377600048
J	Gotzsche, PC; Maehlen, J; Zahl, PH				Gotzsche, Peter C.; Maehlen, Jan; Zahl, Per-Henrik			What is publication?	LANCET			English	Editorial Material									HS Rigshosp, Nordic Cochrane Ctr, DK-2100 Copenhagen O, Denmark; Ullevaal Univ Hosp, Dept Pathol, Oslo, Norway; Norwegian Inst Publ Hlth, Oslo, Norway	Rigshospitalet; University of Oslo; Norwegian Institute of Public Health (NIPH)	Gotzsche, PC (corresponding author), HS Rigshosp, Nordic Cochrane Ctr, DK-2100 Copenhagen O, Denmark.	pcg@cochrane.dk						Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; Gotzsche PC, 2004, INT J EPIDEMIOL, V33, P56, DOI 10.1093/ije/dyh014; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; Zahl PH, 2006, DAN MED BULL, V53, P438; ZAHL PH, 2006, EUR J CANC      0309; UNIFORM REQUIREMENTS	6	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2006	368	9550					1854	1856		10.1016/S0140-6736(06)69756-0	http://dx.doi.org/10.1016/S0140-6736(06)69756-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	109YQ	17126704				2022-12-28	WOS:000242345900010
J	Wagner, PJ; Kosnik, MA; Lidgard, S				Wagner, Peter J.; Kosnik, Matthew A.; Lidgard, Scott			Abundance distributions imply elevated complexity of post-Paleozoic marine ecosystems	SCIENCE			English	Article							PERMIAN MASS EXTINCTION; COMMUNITIES; DIVERSITY; ASSEMBLAGES; INCREASE; EVENNESS; SHELF	Likelihood analyses of 1176 fossil assemblages of marine organisms from Phanerozoic (i.e., Cambrian to Recent) assemblages indicate a shift in typical relative-abundance distributions after the Paleozoic. Ecological theory associated with these abundance distributions implies that complex ecosystems are far more common among Meso-Cenozoic assemblages than among the Paleozoic assemblages that preceded them. This transition coincides not with any major change in the way fossils are preserved or collected but with a shift from communities dominated by sessile epifaunal suspension feeders to communities with elevated diversities of mobile and infaunal taxa. This suggests that the end-Permian extinction permanently altered prevailing marine ecosystem structure and precipitated high levels of ecological complexity and alpha diversity in the Meso-Cenozoic.	Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	Field Museum of Natural History (Chicago); James Cook University	Wagner, PJ (corresponding author), Field Museum Nat Hist, Dept Geol, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	pwagner@fmnh.org	Kosnik, Matthew/G-2312-2010; Kosnik, Matthew A./P-9632-2019; Wagner, Peter/A-5514-2009	Kosnik, Matthew/0000-0001-5380-7041; Kosnik, Matthew A./0000-0001-5380-7041; Wagner, Peter/0000-0002-9083-9787				ABERHAN M, 1994, PALAIOS, V9, P516, DOI 10.2307/3515126; Ausich W.I., 1985, P255; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; BAMBACH RK, 1983, BIOTIC INTERACTIONS, P719; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Bush AM, 2004, J GEOL, V112, P625, DOI 10.1086/424576; Buzas MA, 2005, PALEOBIOLOGY, V31, P199, DOI 10.1666/0094-8373(2005)031[0199:ORAEWA]2.0.CO;2; Clapham ME, 2006, PALAIOS, V21, P431, DOI 10.2110/palo.2005.P05-017R; Edwards AWF, 1992, LIKELIHOOD EXPANDED; Erwin D. H., 2006, EXTINCTION LIFE EART; Foote M, 2006, PALEOBIOLOGY, V32, P345, DOI 10.1666/05062.1; Fraiser ML, 2005, CR PALEVOL, V4, P583, DOI 10.1016/j.crpv.2005.02.002; FRONTIER S, 1985, OCEANOGR MAR BIOL, V23, P253; Gray J.S., 1987, P53; Hubbell Stephen P., 2001, V32, pi; Kidwell SM, 2001, SCIENCE, V294, P1091, DOI 10.1126/science.1064539; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; Kosnik MA, 2006, EVOL ECOL RES, V8, P195; Kowalewski M, 2006, PALEOBIOLOGY, V32, P533, DOI 10.1666/05074.1; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Olszewski TD, 2004, NATURE, V428, P738, DOI 10.1038/nature02464; Powell MG, 2002, GEOLOGY, V30, P331, DOI 10.1130/0091-7613(2002)030<0331:IIEASA>2.0.CO;2; RAUP DM, 1991, ANAL PALEOBIOLOGY, V4, P136; Roopnarine PD, 2006, PALEOBIOLOGY, V32, P1; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; Royall R., 1997, STAT EVIDENCE LIKELI; Walker LJ, 2002, J GEOL, V110, P75, DOI 10.1086/324318; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190	28	135	142	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1289	1292		10.1126/science.1133795	http://dx.doi.org/10.1126/science.1133795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124319				2022-12-28	WOS:000242215800040
J	Glenner, H; Thomsen, PF; Hebsgaard, MB; Sorensen, MV; Willerslev, E				Glenner, Henrik; Thomsen, Philip Francis; Hebsgaard, Martin Bay; Sorensen, Martin Vinther; Willerslev, Eske			The origin of insects	SCIENCE			English	Editorial Material							TERRESTRIAL CRUSTACEANS; ARTHROPOD PHYLOGENY; GENES; SEQUENCES; CLASSIFY; HEXAPODS; 28S		Univ Copenhagen, Inst Biol, Dept Evolutionary Biol, Ctr Ancient Genet, DK-2100 Copenhagen, Denmark	University of Copenhagen	Willerslev, E (corresponding author), Univ Copenhagen, Inst Biol, Dept Evolutionary Biol, Ctr Ancient Genet, Univ Pk 15, DK-2100 Copenhagen, Denmark.	ewillerslev@bi.ku.dk	Sørensen, Martin V/A-8852-2013; Thomsen, Philip Francis/AAE-9354-2019; Willerslev, Eske/A-9619-2011; Hebsgaard, Martin B/C-8220-2009; Willerslev, Eske/AAA-5686-2019	Sørensen, Martin V/0000-0002-0377-0276; Thomsen, Philip Francis/0000-0002-9867-4366; Willerslev, Eske/0000-0002-7081-6748; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; Budd G E, 2001, Science, V294, P2047; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; Cook CE, 2001, CURR BIOL, V11, P759, DOI 10.1016/S0960-9822(01)00222-6; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; Dove H, 2003, DEVELOPMENT, V130, P2161, DOI 10.1242/dev.00442; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Fayers SR, 2003, T ROY SOC EDIN-EARTH, V93, P355; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Giribet G, 2000, CLADISTICS, V16, P204, DOI 10.1111/j.1096-0031.2000.tb00353.x; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Haas F, 2003, ORG DIVERS EVOL, V3, P39, DOI 10.1078/1439-6092-00057; Harzsch S, 2006, INTEGR COMP BIOL, V46, P162, DOI 10.1093/icb/icj011; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Luan YX, 2005, MOL BIOL EVOL, V22, P1579, DOI 10.1093/molbev/msi148; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Regier JC, 1997, MOL BIOL EVOL, V14, P902, DOI 10.1093/oxfordjournals.molbev.a025833; Regier JC, 2001, MOL PHYLOGENET EVOL, V20, P136, DOI 10.1006/mpev.2001.0956; Shultz JW, 2000, P ROY SOC B-BIOL SCI, V267, P1011, DOI 10.1098/rspb.2000.1104; Strausfeld NJ, 2005, ARTHROPOD STRUCT DEV, V34, P235, DOI 10.1016/j.asd.2005.04.001; WALOSSEK D, 1993, FOSSILS STRATA, V52, P54; Willmann R, 2005, ORG DIVERS EVOL, V5, P199, DOI 10.1016/j.ode.2004.11.011	24	134	142	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1883	1884		10.1126/science.1129844	http://dx.doi.org/10.1126/science.1129844			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	119EY	17185588				2022-12-28	WOS:000242996800032
J	Turnbaugh, PJ; Ley, RE; Mahowald, MA; Magrini, V; Mardis, ER; Gordon, JI				Turnbaugh, Peter J.; Ley, Ruth E.; Mahowald, Michael A.; Magrini, Vincent; Mardis, Elaine R.; Gordon, Jeffrey I.			An obesity-associated gut microbiome with increased capacity for energy harvest	NATURE			English	Article							BACTERIAL MUTUALISM; HUMAN INTESTINE; DIVERSITY; SOFTWARE	The worldwide obesity epidemic is stimulating efforts to identify host and environmental factors that affect energy balance. Comparisons of the distal gut microbiota of genetically obese mice and their lean littermates, as well as those of obese and lean human volunteers have revealed that obesity is associated with changes in the relative abundance of the two dominant bacterial divisions, the Bacteroidetes and the Firmicutes. Here we demonstrate through metagenomic and biochemical analyses that these changes affect the metabolic potential of the mouse gut microbiota. Our results indicate that the obese microbiome has an increased capacity to harvest energy from the diet. Furthermore, this trait is transmissible: colonization of germ-free mice with an `obese microbiota' results in a significantly greater increase in total body fat than colonization with a 'lean microbiota'. These results identify the gut microbiota as an additional contributing factor to the pathophysiology of obesity.	Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA.	jgordon@wustl.edu	Mardis, Elaine/W-2202-2019; Eckhardt, Erik/G-1567-2010; Ley, Ruth E/M-8542-2014; Magrini, Vincent/AAT-5830-2020; Puigbò, Pere/A-2214-2008	Ley, Ruth E/0000-0002-9087-1672; Magrini, Vincent/0000-0002-2019-4872; Turnbaugh, Peter/0000-0002-0888-2875	NIDDK NIH HHS [P30 DK056341-05S2, P30 DK056341, P30 DK056341-06] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P1615, DOI [10.1099/ijs.0.02143-0, 10.1099/00207713-52-5-1615]; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; WEBB P, 1983, HUM NUTR-CLIN NUTR, V37, P117; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	24	7516	8088	101	2654	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1027	1031		10.1038/nature05414	http://dx.doi.org/10.1038/nature05414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183312				2022-12-28	WOS:000242971100045
J	MacArthur, RD; Novak, RM; Peng, G; Chen, L; Xiang, Y; Hullsiek, KH; Kozal, MJ; van den Berg-Wolf, M; Henely, C; Schmetter, B; Dehlinger, M				MacArthur, Rodger D.; Novak, Richard M.; Peng, Grace; Chen, Li; Xiang, Ying; Hullsiek, Katherine Huppler; Kozal, Michael J.; van den Berg-Wolf, Mary; Henely, Christopher; Schmetter, Barry; Dehlinger, Marjorie		CPCRA 058 Study Team; Terry Beirn Community Programs	A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial	LANCET			English	Article							COMBINATION THERAPY; HIV-RNA; NELFINAVIR; LAMIVUDINE; INFECTION; APOPTOSIS; DRUGS; COUNT; AIDS	Background Long-term data from randomised trials on the consequences of treatment with a protease inhibitor (PI), non-nucleoside reverse transcriptase inhibitor (NNRTI), or both are lacking. Here, we report results from the FIRST trial, which compared initial treatment strategies for clinical, immunological, and virological outcomes. Methods Between 1999 and 2002, 1397 antiretroviral-treatment-naive patients, presenting at 18 clinical trial units with 80 research sites in the USA, were randomly assigned in a ratio of 1:1:1 to a protease inhibitor (PI) strategy (PI plus nucleoside reverse transcriptase inhibitor [NRTI]; n=470), a non-nucleoside reverse transcriptase inhibitor (NNRTI) strategy (NNRTI plus NRTI; n=463), or a three-class strategy (PI plus NNRTI plus NRTI; n=464). Primary endpoints were a composite of an AIDS-defining event, death, or CD4 cell count decline to less than 200 cells per mm(3) for the PI versus NNRTI comparison, and average change in CD4 cell count at or after 32 months for the three-class versus combined two-class comparison. Analyses were by intention-to-treat. This study is registered with ClinicalTrials.gov, number NCT00000922. Findings 1397 patients were assessed for the composite endpoint. A total of 388 participants developed the composite endpoint, 302 developed AIDS or died, and 188 died. NNRTI versus PI hazard ratios (HRs) for the composite endpoint, for AIDS or death, for death, and for virological failure were 1.02 (95% Cl 0.79-1.31), 1.07 (0.80-1.41), 0.95 (0.66-1.37), and 0.66 (0.56-0.78), respectively. 1196 patients were assessed for the three-class versus combined two-class primary endpoint. Mean change in CD4 cell count at or after 32 months was +234 cells per mm(3) and +227 cells per mm(3) for the three-class and the combined two-class strategies (p=0.62), respectively. HRs (three-class vs combined two-class) for AIDS or death and virological failure were 1.15 (0.91-1.45) and 0.87 (0.75-1.00), respectively. HRs (three-class vs combined two-class) for AIDS or death were similar for participants with baseline CD4 cell counts of 200 cells per mm3 or less and of more than 200 cells per mm(3) (p=0.38 for interaction), and for participants with baseline HIV RNA concentrations less than 100000 copies per ml, and 100000 copies per mL or more (p=0.26 for interaction). Participants assigned the three-class strategy were significantly more likely to discontinue treatment because of toxic effects than were those assigned to the two-class strategies (HR 1.58; p<0.0001). Interpretation Initial treatment with either an NNRTI-based regimen or a PI-based regimen, but not both together, is a good strategy for long-term antiretroviral management in treatment-naive patients with HIV.	Wayne State Univ, Detroit, MI USA; Univ Illinois, Chicago, IL USA; Univ Minnesota, Minneapolis, MN USA; Yale Univ, New Haven, CT USA; Temple Univ, Philadelphia, PA 19122 USA; Meridian Hlth Syst, Neptune, NJ USA; Social & Sci Syst, Silver Spring, MD USA; NIAID, Div AIDS, Bethesda, MD 20892 USA	Wayne State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; University of Minnesota Twin Cities; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Social & Scientific Systems; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	MacArthur, RD (corresponding author), Div Infect Dis, UHC 7D,4201 St Antoine, Detroit, MI 48201 USA.	rdmacarthur@mac.com		Kozal, Michael/0000-0002-3100-8254; , Michael/0000-0002-7719-7396	NIAID NIH HHS [5U01AI046362-03, 5U01AI042170-10] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046362, U01AI042170] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balding DJ, 2004, APPL LONGITUDINAL AN; Benito JM, 2002, AIDS RES HUM RETROV, V18, P1379, DOI 10.1089/088922202320935456; CDC, 1993, MMWR-MORBID MORTAL W, V41, P1; *DEP HLTH HUM SERV, 2006, GUID US ANT AG HIV 1; Friedl AC, 2001, AIDS, V15, P1793, DOI 10.1097/00002030-200109280-00008; Johnson Victoria A, 2004, Top HIV Med, V12, P119; KOZAL MJ, 2006, 15 INT HIV DRUG RES; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; MacArthur RD, 2005, HIV CLIN TRIALS, V6, P127, DOI 10.1310/A9B9-RQD7-U8KA-503U; MacArthur RD, 2004, HIV CLIN TRIALS, V5, P361, DOI 10.1310/WEQG-QTHL-DL3X-FTXC; MacArthur RD, 2001, CONTROL CLIN TRIALS, V22, P176, DOI 10.1016/S0197-2456(01)00111-8; Marschner IC, 1998, J INFECT DIS, V177, P40, DOI 10.1086/513823; *NIH DIV AIDS, 1998, TABL GRAD SEV AD ADV; Olsen CH, 2005, AIDS, V19, P319; Phenix BN, 2000, AIDS RES HUM RETROV, V16, P559, DOI 10.1089/088922200308972; Phillips AN, 2004, AIDS, V18, P1795, DOI 10.1097/00002030-200409030-00008; Podzamczer D, 2002, ANTIVIR THER, V7, P81; Raffanti SP, 2004, JAIDS-J ACQ IMM DEF, V37, P1147, DOI 10.1097/01.qai.0000136738.24090.d0; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Torti C, 2005, J ANTIMICROB CHEMOTH, V56, P190, DOI 10.1093/jac/dki172; van Leeuwen R, 2003, AIDS, V17, P987, DOI 10.1097/00002030-200305020-00007; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; Yeni P, 2006, LANCET, V368, P287, DOI 10.1016/S0140-6736(06)69074-0	24	106	114	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2006	368	9553					2125	2135		10.1016/S0140-6736(06)69861-9	http://dx.doi.org/10.1016/S0140-6736(06)69861-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174704				2022-12-28	WOS:000242856900020
J	Levine, JS; Ahnen, DJ				Levine, Joel S.; Ahnen, Dennis J.			Adenomatous polyps of the colon	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLORECTAL-CANCER; COLONOSCOPIC POLYPECTOMY; UNRESECTED POLYPS; RANDOMIZED-TRIAL; NATURAL-HISTORY; LOW-FAT; RISK; PREVENTION; SURVEILLANCE; RECURRENCE		Denver Dept Vet Affairs Med Ctr, Gastroenterol Sect, Denver, CO 80220 USA; Univ Colorado, Sch Med, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ahnen, DJ (corresponding author), Denver Dept Vet Affairs Med Ctr, Gastroenterol Sect, 111E,1055 Clermont St, Denver, CO 80220 USA.	dennis.ahnen@uchsc.edu						Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Atkin W, 2004, GASTROENTEROLOGY, V126, P1247, DOI 10.1053/j.gastro.2004.01.023; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; Avidan B, 2002, AM J GASTROENTEROL, V97, P1524, DOI 10.1016/S0002-9270(02)04157-6; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; BAZZOLI F, 1995, GASTROENTEROLOGY, V109, P783, DOI 10.1016/0016-5085(95)90385-2; Beresford SAA, 2006, JAMA-J AM MED ASSOC, V295, P643, DOI 10.1001/jama.295.6.643; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Chow E, 2006, GASTROENTEROLOGY, V131, P30, DOI 10.1053/j.gastro.2006.03.046; Citarda F, 2001, GUT, V48, P812, DOI 10.1136/gut.48.6.812; Gatof D, 2002, GASTROENTEROL CLIN N, V31, P587, DOI 10.1016/S0889-8553(02)00011-0; HOFF G, 1986, SCAND J GASTROENTERO, V21, P853, DOI 10.3109/00365528609011130; Hofstad B, 1996, GUT, V39, P449, DOI 10.1136/gut.39.3.449; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; JORGENSEN OD, 1995, SCAND J GASTROENTERO, V30, P686, DOI 10.3109/00365529509096314; Kelloff GJ, 2004, CLIN CANCER RES, V10, P3908, DOI 10.1158/1078-0432.CCR-03-0789; Loeve F, 2004, INT J CANCER, V111, P147, DOI 10.1002/ijc.20241; LOTFI AM, 1986, MAYO CLIN PROC, V61, P337, DOI 10.1016/S0025-6196(12)61950-8; Lynch KL, 2003, CLIN GASTROENTEROL H, V1, P96, DOI 10.1053/cgh.2003.50018; Martinez ME, 2001, GASTROENTEROLOGY, V120, P1077, DOI 10.1053/gast.2001.23247; MEAGHER AP, 1994, AUST NZ J SURG, V64, P400, DOI 10.1111/j.1445-2197.1994.tb02238.x; MURAKAMI R, 1990, INT J CANCER, V46, P159, DOI 10.1002/ijc.2910460203; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Noshirwani KC, 2000, GASTROINTEST ENDOSC, V51, P433, DOI 10.1016/S0016-5107(00)70444-5; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Psaty BM, 2006, NEW ENGL J MED, V355, P950, DOI 10.1056/NEJMe068158; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 2003, NEW ENGL J MED, V348, P1939; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; Snover DC, 2005, AM J CLIN PATHOL, V124, P380, DOI 10.1309/V2EPTPLJRB3FGHJL; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; van Stolk RU, 1998, GASTROENTEROLOGY, V115, P13, DOI 10.1016/S0016-5085(98)70359-2; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P1102; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; WILLIAMS CB, 1986, SECONDARY PREVENTION, P226; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Winawer SJ, 1996, NEW ENGL J MED, V334, P82, DOI 10.1056/NEJM199601113340204; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; 2006, MMWR MORB MORTAL WKL, V55, P308	50	108	116	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2551	2557		10.1056/NEJMcp063038	http://dx.doi.org/10.1056/NEJMcp063038			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116BZ	17167138				2022-12-28	WOS:000242778800007
J	Horn, SD				Horn, Susan D.			Performance measures and clinical outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							REHABILITATION		Inst Clin Outcomes Res, Salt Lake City, UT 84102 USA		Horn, SD (corresponding author), Inst Clin Outcomes Res, 699 E S Temple,Suite 100, Salt Lake City, UT 84102 USA.	shorn@isisicor.com						Gassaway J, 2005, ARCH PHYS MED REHAB, V86, pS16, DOI 10.1016/j.apmr.2005.08.114; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS8, DOI 10.1016/j.apmr.2005.08.116; Horn SD, 2004, J AM GERIATR SOC, V52, P359, DOI 10.1111/j.1532-5415.2004.52106.x; Horn SD, 1997, CLIN PRACTICE IMPROV; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Neumayer LA, 2001, J SURG RES, V95, P73, DOI 10.1006/jsre.2000.6047; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Pearl, 2001, HLTH SERVICES OUTCOM, V2, P189, DOI [DOI 10.1023/A:1020315127304, https://doi.org/10.1023/A:1020315127304]; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694	9	37	37	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2731	2732		10.1001/jama.296.22.2731	http://dx.doi.org/10.1001/jama.296.22.2731			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	115WY	17164460				2022-12-28	WOS:000242765700029
J	Munk-Olsen, T; Laursen, TM; Pedersen, CB; Mors, O; Mortensen, PB				Munk-Olsen, Trine; Laursen, Thomas Munk; Pedersen, Carsten Bocker; Mors, Ole; Mortensen, Preben Bo			New parents and mental disorders - A population-based register study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	International Biennial Scientific Meeting of the Marce-Society	SEP 13, 2006	Keele Univ, Keele, ENGLAND		Keele Univ		POSTPARTUM DEPRESSION; POSTNATAL DEPRESSION; RISK; MOTHERS; ADMISSION	Context Studies on postpartum mental disorders among mothers have primarily focused on either depression or psychoses and have generally not included the broader spectrum of mental disorders. A few studies have found that some men have symptoms of depression after becoming fathers, but these studies have not documented whether this exceeds the morbidity among men in general. Objectives To estimate the risk of postpartum mental disorders necessitating hospital admission or outpatient contact for mothers as well as fathers during a 1-year postnatal follow-up period after birth of first live-born child and to investigate whether parents in general differ from nonparents in the risk of admission with a mental disorder and how this difference varies with age. Design, Setting, and Patients Register-based cohort formed by linking information from Danish health and civil service registers. A total of 2 357 942 Danish-born persons were followed up from their 15th birthday or January 1, 1973, whichever came later, until date of onset of the disorder in question, date of death, date of emigration from Denmark, or July 1, 2005, whichever came first. From 1973 to 2005, a total of 630 373 women and 547 431 men became parents for the first time, and during the first year after childbirth, these parents contributed 1 115 639 person-years at risk. Main Outcome Measure First-time psychiatric hospital admission or outpatient contact 0 to 12 months after becoming a parent. Results A total of 1171 mothers and 658 fathers were admitted with a mental disorder to a psychiatric hospital during the first 12 months after parenthood, and the corresponding prevalence of severe mental disorders through the first 3 months after childbirth was 1.03 per 1000 births for mothers and 0.37 per 1000 births for fathers. Compared with women who had given birth 11 to 12 months prior, primiparous women had an increased risk of incident hospital admission with any mental disorder through the first 3 months after childbirth, with the highest risk 10 to 19 days postpartum (relative risk [RR], 7.31; 95% confidence interval [CI], 5.44-9.81). Among mothers, risk was also increased for psychiatric outpatient contacts through the first 3 months after childbirth, also with the highest risk occurring 10 to 19 days postpartum (RR, 2.67; 95% CI, 1.99-3.59). Unlike motherhood, fatherhood was not associated with any increased risk of hospital admission or outpatient contact. Conclusion In Denmark, the risk of postpartum mental disorders among primiparous mothers is increased for several months after childbirth, but among fathers there is no excess of severe mental disorders necessitating admission or outpatient contacts.	Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark; Aarhus Univ Hosp, Psychiat Hosp Aarhus, Ctr Basic Psychiat Res, Risskov, Denmark	Aarhus University; Aarhus University	Munk-Olsen, T (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, Taasingegade 1, DK-8000 Aarhus C, Denmark.	tmo@ncrr.dk	Laursen, Thomas Munk/AFQ-8066-2022; Munk-olsen, Trine/AAS-3546-2021; Pedersen, Carsten Bøcker/B-8441-2013; Mortensen, Preben B/D-2358-2015	Munk-olsen, Trine/0000-0002-0786-7147; Pedersen, Carsten Bøcker/0000-0003-2077-8533; Mortensen, Preben B/0000-0002-5230-9865; Laursen, Thomas Munk/0000-0001-6934-1784; Mors, Ole/0000-0002-5660-0393				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersen P. K., 2012, STAT MODELS BASED CO; Areias MEG, 1996, BRIT J PSYCHIAT, V169, P36, DOI 10.1192/bjp.169.1.36; Ballard C, 1996, INT REV PSYCHIATR, V8, P65, DOI 10.3109/09540269609037818; Blackmore ER, 2006, BRIT J PSYCHIAT, V188, P32, DOI 10.1192/bjp.188.1.32; Bloch M, 2000, AM J PSYCHIAT, V157, P924, DOI 10.1176/appi.ajp.157.6.924; Brockington I, 2004, LANCET, V363, P303, DOI 10.1016/S0140-6736(03)15390-1; Brockington IF., 1999, INFANT OBSERV, V2, P116, DOI [10.1080/13698039908400552, DOI 10.1080/13698039908400552]; Clayton D, 2002, STAT MODELS EPIDEMIO; Deater-Deckard K, 1998, AM J PSYCHIAT, V155, P818; Forman DN, 2000, BRIT J OBSTET GYNAEC, V107, P1210; Gale S, 2003, J PSYCHOSOM OBST GYN, V24, P257, DOI 10.3109/01674820309074690; Goodman JH, 2004, J ADV NURS, V45, P26, DOI 10.1046/j.1365-2648.2003.02857.x; Halbreich U, 2005, J AFFECT DISORDERS, V88, P1, DOI 10.1016/j.jad.2005.05.002; KENDELL RE, 1987, BRIT J PSYCHIAT, V150, P662, DOI 10.1192/bjp.150.5.662; LAIRD N, 1981, J AM STAT ASSOC, V76, P231, DOI 10.2307/2287816; Lane A, 1997, BRIT J PSYCHIAT, V171, P550, DOI 10.1192/bjp.171.6.550; Matthey S, 2003, J AFFECT DISORDERS, V74, P139, DOI 10.1016/S0165-0327(02)00012-5; Miller LJ, 2002, JAMA-J AM MED ASSOC, V287, P762, DOI 10.1001/jama.287.6.762; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; PEDERSEN CB, IN PRESS DANISH MED; Pfuhlmann Bruno, 2002, Curr Psychiatry Rep, V4, P185, DOI 10.1007/s11920-002-0025-6; Ramchandani P, 2005, LANCET, V365, P2201, DOI 10.1016/S0140-6736(05)66778-5; Robertson E, 2005, BRIT J PSYCHIAT, V186, P258, DOI 10.1192/bjp.186.3.258; Terp IM, 1998, BRIT J PSYCHIAT, V172, P521, DOI 10.1192/bjp.172.6.521; VIDEBECH P, 1995, ACTA PSYCHIAT SCAND, V91, P167, DOI 10.1111/j.1600-0447.1995.tb09761.x; World Health Organization, 1994, WHO ICD 10 PSYK LID; World Health Organization, 1971, KLASS SYGD UDV DANSK, V8; [No title captured]	30	445	451	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2006	296	21					2582	2589		10.1001/jama.296.21.2582	http://dx.doi.org/10.1001/jama.296.21.2582			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	112ND	17148723	Bronze			2022-12-28	WOS:000242532000020
J	Low, N; Broutet, N; Adu-Sarkodie, Y; Barton, P; Hossain, M; Hawkes, S				Low, Nicola; Broutet, Nathalie; Adu-Sarkodie, Yaw; Barton, Pelham; Hossain, Mazeda; Hawkes, Sarah			Sexual and reproductive health 5 - Global control of sexually transmitted infections	LANCET			English	Review							SIMPLEX-VIRUS TYPE-2; RANDOMIZED CONTROLLED-TRIALS; PELVIC-INFLAMMATORY-DISEASE; CHLAMYDIA-TRACHOMATIS; SYPHILIS CONTROL; SYNDROMIC MANAGEMENT; MALE CIRCUMCISION; HIV-INFECTION; ANTENATAL SYPHILIS; FOLLOW-UP	Sexually transmitted infections other than HIV are important global health issues. They have, however, been neglected as a public-health priority and control efforts continue to fail. Sexually transmitted infections, by their nature, affect individuals, who are part of partnerships and larger sexual networks, and in turn populations. We propose a framework of individual, partnership, and population levels for examining the effects of sexually transmitted infections and interventions to control them. At the individual level we have a range of effective diagnostic tests, treatments, and vaccines. These options are unavailable or inaccessible in many resource-poor settings, where syndromic management remains the core intervention for individual case management. At the partnership level, partner notification and antenatal syphilis screening have the potential to prevent infection and re-infection. Interventions delivered to whole populations, or groups in whom the risks of infection and onward transmission are very high, have the greatest potential effect. Improvements to the infrastructure of treatment services can reduce the incidence of syphilis and gonorrhoea or urethritis. Strong evidence for the effectiveness of most other interventions on population-level outcomes is, however, scarce. Effective action requires a multifaceted approach including better basic epidemiological and surveillance data, high quality evidence about effectiveness of individual interventions and programmes, better methods to get effective interventions onto the policy agenda, and better advocacy and more commitment to get them implemented properly. We must not allow stigma, prejudice, and moral opposition to obstruct the goals of infectious disease control.	Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; Kwame Nkruma Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; Univ Birmingham, Hlth Serv Management Ctr, Birmingham, W Midlands, England; London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England	University of Bern; World Health Organization; Kwame Nkrumah University Science & Technology; University of Birmingham; University of London; London School of Hygiene & Tropical Medicine	Low, N (corresponding author), Univ Bern, Dept Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	low@ispm.unibe.ch	Low, Nicola/H-4718-2019; Hawkes, Sarah/AAK-7375-2020; Hossain, Mazeda/AAL-3202-2020	Low, Nicola/0000-0003-4817-8986; Hossain, Mazeda/0000-0002-1878-8145; Hawkes, Sarah/0000-0003-1062-3538				[Anonymous], 2005, SEXUALLY TRANSMITTED; [Anonymous], FDA APPROVES MERCKS; Aral SO, 2004, EMERG INFECT DIS, V10, P2029, DOI 10.3201/eid1011.040623_02; Aral SO, 1996, J INFECT DIS, V174, pS127, DOI 10.1093/infdis/174.Supplement_2.S127; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; BIQUE ON, 2000, SEX TRANSM INFECT, V76, P203; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; BOLAN G, 1999, SEXUALLY TRANSMITTED, P117; Brandt Allan M, 1985, NO MAGIC BULLET SOCI; BRANDT AM, 1999, SEXUALLY TRANSMITTED, P15; Briggs CJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub2; Brocklehurst P, 2000, COCHRANE DB SYST REV, V2; Brown AE, 2006, SEX TRANSM INFECT, V82, P4, DOI 10.1136/sti.2005.016386; Bulatao RA, 2002, B WORLD HEALTH ORGAN, V80, P721; Celum CL, 2005, J INFECT DIS, V191, pS107, DOI 10.1086/425272; Centers for Disease Control and Prevention,, 2006, EXP PARTN THER MAN S; Centers for Disease Control and Prevention, 2005, SEX TRANSM DIS SUR S; COHEN I, 1990, JAMA-J AM MED ASSOC, V263, P3160, DOI 10.1001/jama.263.23.3160; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Collumbien M, 2000, Cult Health Sex, V2, P135, DOI 10.1080/136910500300769; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; COUTINHO RA, 1992, GENITOURIN MED, V68, P353; DALLABETTA GA, 1998, SEX TRANSM INFECT S1, V74, P1; Day S, 1998, SOC SCI MED, V47, P1981, DOI 10.1016/S0277-9536(98)00306-2; Doherty IA, 2005, J INFECT DIS, V191, pS42, DOI 10.1086/425277; Egger M, 1998, BRIT MED J, V316, P1776, DOI 10.1136/bmj.316.7147.1776; Fitzgerald DW, 2003, AM J PUBLIC HEALTH, V93, P444, DOI 10.2105/AJPH.93.3.444; Fonck K, 2001, AM J PUBLIC HEALTH, V91, P705, DOI 10.2105/AJPH.91.5.705; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Garcia PJ, 1998, SEX TRANSM INFECT, V74, pS153; Garnett GP, 2002, SEX TRANSM INFECT, V78, P7, DOI 10.1136/sti.78.1.7; GLAZIER A, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69478-6; Gloyd S, 2001, HEALTH POLICY PLANN, V16, P29, DOI 10.1093/heapol/16.1.29; GRAY JA, 1997, SCREENING, P46; Gray RH, 1999, AIDS, V13, P2113, DOI 10.1097/00002030-199910220-00015; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Handsfield HH, 2005, AM J MED, V118, P69, DOI 10.1016/j.amjmed.2005.07.023; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hawkes S, 2004, B WORLD HEALTH ORGAN, V82, P417; Hawkes S, 2003, BRIT MED J, V327, P633, DOI 10.1136/bmj.327.7416.633; Hawkes S, 1999, LANCET, V354, P1776, DOI 10.1016/S0140-6736(99)02463-0; HAWKES S, IN PRESS REPROD TRAC; Hayes RJ, 2005, CONTEMP CLIN TRIALS, V26, P430, DOI 10.1016/j.cct.2005.04.006; HILLIS SD, 1995, FAM PLANN PERSPECT, V27, P108, DOI 10.2307/2136107; HIRA SK, 1990, GENITOURIN MED, V66, P159; Hodgins S, 2002, SEX TRANSM INFECT, V78, pI64, DOI 10.1136/sti.78.suppl_1.i64; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Hu D, 2006, SEX TRANSM DIS, V33, P428, DOI 10.1097/01.olq.0000200577.46261.b0; JENNISKENS F, 1995, INT J GYNECOL OBSTET, V48, pS121, DOI 10.1016/0020-7292(95)02326-8; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kamwendo F, 1998, LANCET, V351, P25; Korenromp EL, 2005, J INFECT DIS, V191, pS168, DOI 10.1086/425274; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; LaMontagne DS, 2004, SEX TRANSM INFECT, V80, P335, DOI 10.1136/sti.2004.012856; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Low N, 2006, SEX TRANSM INFECT, V82, P212, DOI 10.1136/sti.2005.017186; Low N, 2004, SEX TRANSM INFECT, V80, P223, DOI 10.1136/sti.2003.005165; Low N, 2002, SEX TRANSM INFECT, V78, pI133, DOI 10.1136/sti.78.suppl_1.i133; LOW N, PHIAC 4 5 RAPID REV; LOW N, IN PRESS HLTH TECHNO; Lush L, 2003, HEALTH POLICY PLANN, V18, P18, DOI 10.1093/heapol/18.1.18; Manhart LE, 2005, J INFECT DIS, V191, pS7, DOI 10.1086/425275; Mardh PA, 1997, GENITOURIN MED, V73, P96; MATHEWS C, 2001, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD002843; Mayaud P, 1998, LANCET, V351, P29; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; Michel CEC, 2006, LANCET, V367, P1585, DOI 10.1016/S0140-6736(06)68695-9; MOYO W, 2002, AIDS BEHAV, V6, P237, DOI DOI 10.1023/A:1019891808383; Myer L, 2003, SEX TRANSM INFECT, V79, P208, DOI 10.1136/sti.79.3.208; NAGOT N, 2006, 13 C RETR OPP INF DE; Nicoll A, 2001, SEX TRANSM INFECT, V77, P242, DOI 10.1136/sti.77.4.242; Nuwaha F, 2001, SEX TRANSM DIS, V28, P105, DOI 10.1097/00007435-200102000-00008; OReilly KR, 1996, J INFECT DIS, V174, pS214, DOI 10.1093/infdis/174.Supplement_2.S214; Ostergaard L, 2000, CLIN INFECT DIS, V31, P951, DOI 10.1086/318139; Over M, 1996, J INFECT DIS, V174, pS162, DOI 10.1093/infdis/174.Supplement_2.S162; *OXF CTR EV BAS ME, LEV EV GRAD REC; PARRAN T, 1937, SHADOW LAND; Patel V, 2005, INT J EPIDEMIOL, V34, P853, DOI 10.1093/ije/dyi072; Paz-Bailey G, 2005, CLIN INFECT DIS, V41, P1304, DOI 10.1086/496979; Pettifor A, 2000, SEX TRANSM DIS, V27, P371, DOI 10.1097/00007435-200008000-00002; Sangani P, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001220.PUB2; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Schmid G, 2004, B WORLD HEALTH ORGAN, V82, P402; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; *SEX TRANSM DIS DI, DIAGN NEEDS SEX TRAN; SHATTOCK R, INVITED PRESENTATION; SIEGAL FP, 1981, NEW ENGL J MED, V305, P1439, DOI 10.1056/NEJM198112103052403; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; *SMITTSK, SURV STAT GEN CHLAM; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Sumartojo E, 2000, AIDS, V14, pS3, DOI 10.1097/00002030-200006001-00002; Temmerman M, 1999, INT J STD AIDS, V10, P405, DOI 10.1258/0956462991914339; Temmerman M, 2000, SEX TRANSM INFECT, V76, P117, DOI 10.1136/sti.76.2.117; TRELLE S, PHIAC 4 6 RAPID REV; Trollope-Kumar K, 2006, LANCET, V367, P1380, DOI 10.1016/S0140-6736(06)68593-0; *UN, 2006, MILL DEV GOALS REP 2, P1; Vickerman P, 2003, SEX TRANSM INFECT, V79, P363, DOI 10.1136/sti.79.5.363; Walker DG, 2002, LANCET INFECT DIS, V2, P432, DOI 10.1016/S1473-3099(02)00319-5; Walker G J, 2001, Cochrane Database Syst Rev, pCD001143, DOI 10.1002/14651858.CD001143; Wasserheit JN, 1996, J INFECT DIS, V174, pS201, DOI 10.1093/infdis/174.Supplement_2.S201; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; WELLINGS K, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69479-8; *WHO, 2003, WHORHR0110; *WHO, 2005, WHOIVB0516; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; *WHO, BURD DIS PROJ; *WHO CMH SUPP UN, 2006, INV HLTH SUMM FIND C; *WHO DEP REPR HLTH, REPR TRACT INF SEX T; *WHO UNAIDS, 1999, SEX TRANSM DIS POL P; Wilkinson D, 2002, LANCET INFECT DIS, V2, P613, DOI 10.1016/S1473-3099(02)00396-1; WILSON JM, 1968, PRINCIPLES PRACTICE, P1; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; Workowski Kimberly A., 2006, Morbidity and Mortality Weekly Report, V55, P1; World Health Organization, WHO MOD LIST ESS MED; World Health Organization, PREV CONTR SEX TRANS; 2006, LANCET, V367, P2034; UN AIDS WARNING FRUS; DEMOGRAPHIC HLTH SUR	120	170	179	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					2001	2016		10.1016/S0140-6736(06)69482-8	http://dx.doi.org/10.1016/S0140-6736(06)69482-8			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141708				2022-12-28	WOS:000242593300033
J	Goswami, BN; Venugopal, V; Sengupta, D; Madhusoodanan, MS; Xavier, PK				Goswami, B. N.; Venugopal, V.; Sengupta, D.; Madhusoodanan, M. S.; Xavier, Prince K.			Increasing trend of extreme rain events over India in a warming environment	SCIENCE			English	Article							DAILY PRECIPITATION; HEAVY PRECIPITATION; INTENSITY; CLIMATE; INDEXES	Against a backdrop of rising global surface temperature, the stability of the Indian monsoon rainfall over the past century has been a puzzle. By using a daily rainfall data set, we show (i) significant rising trends in the frequency and the magnitude of extreme rain events and (ii) a significant decreasing trend in the frequency of moderate events over central India during the monsoon seasons from 1951 to 2000. The seasonal mean rainfall does not show a significant trend, because the contribution from increasing heavy events is offset by decreasing moderate events. A substantial increase in hazards related to heavy rain is expected over central India in the future.	Indian Inst Trop Meteorol, Pune 411008, Maharashtra, India; Indian Inst Sci, Ctr Atmospher & Ocean Sci, Bangalore 560012, Karnataka, India	Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM); Indian Institute of Science (IISC) - Bangalore	Goswami, BN (corresponding author), Indian Inst Trop Meteorol, Doctor Homi Bhabha Rd, Pune 411008, Maharashtra, India.	goswami@tropmet.res.in	M.S., Madhusoodanan/H-9790-2013	M.S., Madhusoodanan/0000-0002-9559-1047				Alexander LV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006290; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Brunetti M, 2001, INT J CLIMATOL, V21, P299, DOI 10.1002/joc.613; Francis PA, 2006, METEOROL ATMOS PHYS, V94, P27, DOI 10.1007/s00703-005-0167-2; Frei C, 2001, J CLIMATE, V14, P1568, DOI 10.1175/1520-0442(2001)014<1568:DPOTIR>2.0.CO;2; Frich P, 2002, CLIMATE RES, V19, P193, DOI 10.3354/cr019193; GORDON HB, 1992, CLIM DYNAM, V8, P83, DOI 10.1007/BF00209165; Goswami B. N., 2005, ASIAN MONSOON, P295; Groisman PY, 2005, J CLIMATE, V18, P1326, DOI 10.1175/JCLI3339.1; Haylock M, 2000, INT J CLIMATOL, V20, P1533, DOI 10.1002/1097-0088(20001115)20:13&lt;1533::AID-JOC586&gt;3.0.CO;2-J; Hennessy KJ, 1997, CLIM DYNAM, V13, P667, DOI 10.1007/s003820050189; Houghton J. T., 2001, CLIMATE CHANGE 2001; Krishnakumar K, 1997, WORKSH IND IND CLIM; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Manton MJ, 2001, INT J CLIMATOL, V21, P269, DOI 10.1002/joc.610; Meehl GA, 2000, B AM METEOROL SOC, V81, P427, DOI 10.1175/1520-0477(2000)081<0427:TIEWAC>2.3.CO;2; Parthasarathy B., 1996, RR065 IND I TROP MET; Rajeevan M, 2006, CURR SCI INDIA, V91, P296; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rupa Kumar K., 2002, CLIMATE CHANGE INDIA, P24; Semenov VA, 2002, CLIM DYNAM, V19, P123, DOI 10.1007/s00382-001-0218-4; Sen Roy S, 2004, INT J CLIMATOL, V24, P457, DOI 10.1002/joc.995; Stone DA, 2000, ATMOS OCEAN, V38, P321, DOI 10.1080/07055900.2000.9649651; Trenberth KE, 2005, CLIM DYNAM, V24, P741, DOI 10.1007/s00382-005-0017-4; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; Zhang XB, 2004, J CLIMATE, V17, P1945, DOI 10.1175/1520-0442(2004)017<1945:MCEOTD>2.0.CO;2; Zhang XB, 2001, J CLIMATE, V14, P1923, DOI 10.1175/1520-0442(2001)014<1923:SATCOH>2.0.CO;2	28	1210	1274	12	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1442	1445		10.1126/science.1132027	http://dx.doi.org/10.1126/science.1132027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138899				2022-12-28	WOS:000242406100038
J	Qiu, AD; Jansen, M; Sakaris, A; Min, SH; Chattopadhyay, S; Tsai, E; Sandoval, C; Zhao, RB; Akabas, MH; Goldman, ID				Qiu, Andong; Jansen, Michaela; Sakaris, Antoinette; Min, Sang Hee; Chattopadhyay, Shrikanta; Tsai, Eugenia; Sandoval, Claudio; Zhao, Rongbao; Akabas, Myles H.; Goldman, I. David			Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption	CELL			English	Article							LOW-PH OPTIMUM; MEMBRANE-TRANSPORT; SOLID TUMORS; HELA-CELLS; IN-VIVO; PRESERVATION; MECHANISM; AFFINITY; HEALTH; ACID	Folates are essential nutrients that are required for one-carbon biosynthetic and epigenetic processes. While folates are absorbed in the acidic milieu of the upper small intestine, the underlying absorption mechanism has not been defined. We now report the identification of a human proton-coupled, high-affinity folate transporter that recapitulates properties of folate transport and absorption in intestine and in various cell types at low pH. We demonstrate that a loss-of-function mutation in this gene is the molecular basis for hereditary folate malabsorption in a family with this disease. This transporter was previously reported to be a lower-affinity, pH-independent heme carrier protein, HCP1. However, the current study establishes that a major function of this gene product is proton-coupled folate transport required for folate homeostasis in man, and we have thus amended the name to PCFT/HCP1.	Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Obstet & Gynecol, Bronx, NY 10461 USA; New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York Medical College	Goldman, ID (corresponding author), Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	igoldman@aecom.yu.edu	Qiu, Andong/AAY-1179-2021; kevin, zhang/ABB-3755-2021	Akabas, Myles/0000-0001-8781-7846; Tsai, Eugenia/0000-0002-4619-6067; Jansen, Michaela/0000-0003-1325-9700	NATIONAL CANCER INSTITUTE [R01CA082621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077660] Funding Source: NIH RePORTER; NCI NIH HHS [CA82621] Funding Source: Medline; NIGMS NIH HHS [GM77660] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; BENZ R, 1983, BIOPHYS J, V41, P381, DOI 10.1016/S0006-3495(83)84449-X; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; Eichholzer M, 2006, LANCET, V367, P1352, DOI 10.1016/S0140-6736(06)68582-6; Geller J, 2002, MEDICINE, V81, P51, DOI 10.1097/00005792-200201000-00004; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; HORNE DW, 1993, P SOC EXP BIOL MED, V202, P385, DOI 10.3181/00379727-202-43550A; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Koepsell H, 2004, PFLUG ARCH EUR J PHY, V447, P666, DOI 10.1007/s00424-003-1089-9; MASON JB, 1990, BIOCHIM BIOPHYS ACTA, V1024, P331, DOI 10.1016/0005-2736(90)90362-R; Mason Joel B., 1994, P1979; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; MCEWAN GTA, 1990, J MED ENG TECHNOL, V14, P16, DOI 10.3109/03091909009028758; MURPHY RF, 1984, J CELL BIOL, V98, P1757, DOI 10.1083/jcb.98.5.1757; Opladen T, 2006, MOL GENET METAB, V87, P61, DOI 10.1016/j.ymgme.2005.08.011; Paulos CM, 2004, MOL PHARMACOL, V66, P1406, DOI 10.1124/mol.104.003723; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Said HM, 2004, ANNU REV PHYSIOL, V66, P419, DOI 10.1146/annurev.physiol.66.032102.144611; SELHUB J, 1981, J BIOL CHEM, V256, P4489; Sharif KA, 2000, BIOTECHNIQUES, V28, P926, DOI 10.2144/00285st06; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Wang YH, 2005, AM J PHYSIOL-CELL PH, V288, pC65, DOI 10.1152/ajpcell.00307.2004; Wang YH, 2004, CLIN CANCER RES, V10, P6256, DOI 10.1158/1078-0432.CCR-04-0645; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Zhao RB, 2005, BBA-BIOMEMBRANES, V1715, P57, DOI 10.1016/j.bbamem.2005.07.003; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03	30	607	627	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					917	928		10.1016/j.cell.2006.09.041	http://dx.doi.org/10.1016/j.cell.2006.09.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129779	Bronze			2022-12-28	WOS:000242613800010
J	Zhou, GY; Liu, SG; Li, Z; Zhang, DQ; Tang, XL; Zhou, CY; Yan, JH; Mo, JM				Zhou, Guoyi; Liu, Shuguang; Li, Zhian; Zhang, Deqiang; Tang, Xuli; Zhou, Chuanyan; Yan, Junhua; Mo, Jiangming			Old-growth forests can accumulate carbon in soils	SCIENCE			English	Article							ORGANIC-CARBON; CLIMATE-CHANGE		Chinese Acad Sci, S China Bot Garden, Guangzhou 510650, Peoples R China; US Geol Survey, SAIC, Ctr Earth Resources Observat & Sci, Sioux Falls, SD 57198 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Science Applications International Corporation (SAIC); United States Department of the Interior; United States Geological Survey	Zhou, GY (corresponding author), Chinese Acad Sci, S China Bot Garden, Guangzhou 510650, Peoples R China.	gyzhou@scib.ac.cn	Mo, Jiangming/M-2104-2014					Conen F, 2003, GLOBAL CHANGE BIOL, V9, P1515, DOI 10.1046/j.1365-2486.2003.00689.x; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Johnston CA, 2004, FRONT ECOL ENVIRON, V2, P522, DOI 10.1890/1540-9295(2004)002[0522:CCIS]2.0.CO;2; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Post WM, 2001, CLIMATIC CHANGE, V51, P73, DOI 10.1023/A:1017514802028; Shen CD, 1999, CHINESE SCI BULL, V44, P251, DOI 10.1007/BF02896286	7	339	469	31	422	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1417	1417		10.1126/science.1130168	http://dx.doi.org/10.1126/science.1130168			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138894				2022-12-28	WOS:000242406100030
J	Campbell, EG; Weissman, JS; Vogeli, C; Clarridge, BR; Abraham, M; Marder, JE; Koski, G				Campbell, Eric G.; Weissman, Joel S.; Vogeli, Christine; Clarridge, Brian R.; Abraham, Melissa; Marder, Jessica E.; Koski, Greg			Financial relationships between institutional review board members and industry	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONFLICTS-OF-INTEREST; FACULTY; SALE	BACKGROUND: Little is known about the nature, extent, and consequences of financial relationships between industry and institutional review board (IRB) members in academic institutions. We surveyed IRB members about such relationships. METHODS: We surveyed a random sample of 893 IRB members at 100 academic institutions (response rate, 67.2%). The questionnaire focused on the financial relationships that the members had with industry (e.g., employment, membership on boards, consulting, receipt of royalties, and paid speaking). RESULTS: We found that 36% of IRB members had had at least one relationship with industry in the past year. Of the respondents, 85.5% said they never thought that the relationships that another IRB member had with industry affected his or her IRB-related decisions in an inappropriate way, 11.9% said they thought this occurred rarely, 2.4% thought it occurred sometimes, and 0.2% thought it occurred often. Seventy-eight respondents (15.1%) reported that at least one protocol came before their IRB during the previous year that was sponsored either by a company with which they had a relationship or by a competitor of that company, both of which could be considered conflicts of interest. Of these 78 members (62 voting members and 16 nonvoting members), 57.7% reported that they always disclosed the relationship to an IRB official, 7.7% said they sometimes did, 11.5% said they rarely did, and 23.1% said they never did. Of the 62 voting members who reported conflicts, 64.5% reported that they never voted on the protocol, 4.8% said they rarely did, 11.3% said they sometimes did, and 19.4% said they always did. Most respondents reported that the views of IRB members who had experience working with industry were beneficial in reviewing industry-sponsored protocols. CONCLUSIONS: Relationships between IRB members and industry are common, and members sometimes participate in decisions about protocols sponsored by companies with which they have a financial relationship. Current regulations and policies should be examined to be sure that there is an appropriate way to handle conflicts of interest stemming from relationships with industry.	Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA	Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Boston	Campbell, EG (corresponding author), 50 Staniford St,9th Fl, Boston, MA 02114 USA.	ecampbell@partners.org			NCI NIH HHS [3R01CA095400-02-51] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095400] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; Angell M., 2004, TRUTH DRUG CO THEY D; *ASS AM MED COLL, 2002, PRINC REC OV I FIN I; Association of American Universities, 2001, REP IND I FIN CONFL; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Blumenthal D, 1996, NEW ENGL J MED, V335, P1734, DOI 10.1056/NEJM199612053352305; Boyd EA, 2000, JAMA-J AM MED ASSOC, V284, P2209, DOI 10.1001/jama.284.17.2209; Campbell EG, 2003, ACAD MED, V78, P831, DOI 10.1097/00001888-200308000-00019; Campbell Eric G, 2004, Account Res, V11, P103, DOI 10.1080/03050620490512296; Fowler F.J, 1995, IMPROVING SURVEY QUE; Kassirer J, 2005, TAKE AM COMPLICITY B; Krimsky S., 2004, SCI PRIVATE INTEREST; Lemmens T, 2000, MILBANK Q, V78, P547, DOI 10.1111/1468-0009.00185; Shalala D, 2000, NEW ENGL J MED, V343, P808, DOI 10.1056/NEJM200009143431112; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; Weissman JS, 1999, JAMA-J AM MED ASSOC, V281, P1093, DOI 10.1001/jama.281.12.1093	16	74	76	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2321	2329		10.1056/NEJMsa061457	http://dx.doi.org/10.1056/NEJMsa061457			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110CG	17135585				2022-12-28	WOS:000242355300007
J	Eisenstein, EL; Anstrom, KJ; Kong, DF; Shaw, LK; Tuttle, RH; Mark, DB; Kramer, JM; Harrington, RA; Matchar, DB; Kandzari, DE; Peterson, ED; Schulman, KA; Califf, RM				Eisenstein, Eric L.; Anstrom, Kevin J.; Kong, David F.; Shaw, Linda K.; Tuttle, Robert H.; Mark, Daniel B.; Kramer, Judith M.; Harrington, Robert A.; Matchar, David B.; Kandzari, David E.; Peterson, Eric D.; Schulman, Kevin A.; Califf, Robert M.			Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY; ANTIPLATELET THERAPY; SIROLIMUS; TRIAL; THROMBOSIS; SURVIVAL; PREDICTORS; OCCLUSION; DISEASE	Context Recent studies of drug-eluting intracoronary stents suggest that current antiplatelet regimens may not be sufficient to prevent late stent thrombosis. Objective To assess the association between clopidogrel use and long-term clinical outcomes of patients receiving drug-eluting stents (DES) and bare-metal stents (BMS) for treatment of coronary artery disease. Design, Setting, and Patients An observational study examining consecutive patients receiving intracoronary stents at Duke Heart Center, a tertiary care medical center in Durham, NC, between January 1, 2000, and July 31, 2005, with follow-up contact at 6, 12, and 24 months through September 7, 2006. Study population included 4666 patients undergoing initial percutaneous coronary intervention with BMS (n = 3165) or DES (n = 1501). Landmark analyses were performed among patients who were event-free (no death, myocardial infarction [MI], or revascularization) at 6- and 12-month follow-up. At these points, patients were divided into 4 groups based on stent type and self-reported clopidogrel use: DES with clopidogrel, DES without clopidogrel, BMS with clopidogrel, and BMS without clopidogrel. Main Outcome Measures Death, nonfatal MI, and the composite of death or MI at 24-month follow-up. Results Among patients with DES who were event-free at 6 months (637 with and 579 without clopidogrel), clopidogrel use was a significant predictor of lower adjusted rates of death (2.0% with vs 5.3% without; difference, -3.3%; 95% CI, -6.3% to -0.3%; P = .03) and death or MI (3.1% vs 7.2%; difference, -4.1%; 95% CI, -7.6% to -0.6%; P = .02) at 24 months. However, among patients with BMS (417 with and 1976 without clopidogrel), there were no differences in death (3.7% vs 4.5%; difference, -0.7%; 95% CI, -2.9% to 1.4%; P = .50) and death or MI (5.5% vs 6.0%; difference, -0.5%; 95% CI, -3.2% to 2.2%; P = .70). Among patients with DES who were event-free at 12 months (252 with and 276 without clopidogrel), clopidogrel use continued to predict lower rates of death (0% vs 3.5%; difference, -3.5%; 95% CI, -5.9% to -1.1%; P = .004) and death or MI (0% vs 4.5%; difference, -4.5%; 95% CI, -7.1% to -1.9%; P < .001) at 24 months. However, among patients with BMS (346 with and 1644 without clopidogrel), there continued to be no differences in death (3.3% vs 2.7%; difference, 0.6%; 95% CI, -1.5% to 2.8%; P = .57) and death or MI (4.7% vs 3.6%; difference, 1.0%; 95% CI, -1.6% to 3.6%; P = .44). Conclusions The extended use of clopidogrel in patients with DES may be associated with a reduced risk for death and death or MI. However, the appropriate duration for clopidogrel administration can only be determined within the context of a large-scale randomized clinical trial.	Duke Univ, Med Ctr, Duke Clin Res Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke Clin Res Inst, Dept Biostat & Bioinformat, Durham, NC 27710 USA; Duke Translat Med Inst, Durham, NC 27710 USA; Duke Ctr Clin Hlth Policy Res, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Eisenstein, EL (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Dept Med, Box 3865,2400 Pratt St,Room 0311, Durham, NC 27710 USA.	eric.eisenstein@duke.edu	Peterson, Eric David/ABF-5033-2021; Matchar, David/M-3951-2019	Mark, Daniel/0000-0001-6340-8087; Matchar, David/0000-0003-3020-2108	PHS HHS [290-05-0032] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710; Anstrom KJ, 2001, BIOMETRICS, V57, P1207, DOI 10.1111/j.0006-341X.2001.01207.x; Bang H, 2000, BIOMETRIKA, V87, P329, DOI 10.1093/biomet/87.2.329; Berger PB, 2002, AM HEART J, V143, P841, DOI 10.1067/mhj.2002.121929; CALIFF RM, 1989, JAMA-J AM MED ASSOC, V261, P2077, DOI 10.1001/jama.261.14.2077; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; *CORD CORP, COMMUNICATION   0707; Cutlip DE, 2001, CIRCULATION, V103, P1967; FORTIN DF, 1995, AM J CARDIOL, V76, P1177, DOI 10.1016/S0002-9149(99)80331-2; GOOLEY TA, 2006, HDB STAT CLIN ONCOLO, P557; Harrington RA, 2006, J AM COLL CARDIOL, V48, P2592, DOI 10.1016/j.jacc.2006.10.025; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; MOSES JW, 2006, AM COLL CARD ANN SCI; Ong ATL, 2005, J AM COLL CARDIOL, V45, P947, DOI 10.1016/j.jacc.2004.09.079; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Regar E, 2004, AM J CARDIOL, V93, P1271, DOI 10.1016/j.amjcard.2004.02.013; ROSATI RA, 1975, ARCH INTERN MED, V135, P1017, DOI 10.1001/archinte.135.8.1017; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; *US FDA, CYPHER SIR EL COR ST; *US FDA, TAXUS EXPR 2 PACL EL	28	711	770	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2007	297	2					159	168		10.1001/jama.297.2.joc60179	http://dx.doi.org/10.1001/jama.297.2.joc60179			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124GI	17148711	Bronze			2022-12-28	WOS:000243355900025
J	Boutin, S; Wauters, LA; McAdam, AG; Humphries, MM; Tosi, G; Dhondt, AA				Boutin, Stan; Wauters, Lucas A.; McAdam, Andrew G.; Humphries, Murray M.; Tosi, Guido; Dhondt, Andre A.			Anticipatory reproduction and population growth in seed predators	SCIENCE			English	Article							SCIURUS-VULGARIS; LIFE-HISTORY; RED; DYNAMICS	Mast seeding, the intermittent, synchronous production of large seed crops by a population of plants, is a well-known example of resource pulses that create lagged responses in successive trophic levels of ecological communities. These lags arise because seed predators are thought capable of increasing reproduction and population size only after the resource pulse is available for consumption. The resulting satiation of predators is a widely cited explanation for the evolution of masting. Our study shows that both American and Eurasian tree squirrels anticipate resource pulses and increase reproductive output before a masting event, thereby increasing population size in synchrony with the resource pulse and eliminating the population lag thought to be universal in resource pulse systems.	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Insubria, Dept Environm Hlth & Safety, I-21100 Varese, Italy; Michigan State Univ, Dept Zool, Dept Fisheries & Wildlife, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA; McGill Univ, Ste Anne De Bellevue, PQ H9X 3V9, Canada; Cornell Univ, Ornithol Lab, Ithaca, NY 14850 USA; Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium	University of Alberta; University of Insubria; Michigan State University; McGill University; Cornell University; University of Antwerp	Boutin, S (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	stan.boutin@ualberta.ca	Boutin, Stan A/A-2619-2014; McAdam, Andrew G/G-1802-2010; Dhondt, André/A-8292-2008	Boutin, Stan A/0000-0001-6317-038X; McAdam, Andrew G/0000-0001-7323-2572; Wauters, Lucas Armand/0000-0002-7012-9200; Wauters, Lucas/0000-0002-4871-5035; Dhondt, Andre/0000-0002-4946-1401				Bayliss P, 2002, PHILOS T ROY SOC B, V357, P1233, DOI 10.1098/rstb.2002.1124; BECKER CD, 1993, CAN J ZOOL, V71, P1326, DOI 10.1139/z93-183; BERGER PJ, 1981, SCIENCE, V214, P69, DOI 10.1126/science.7025210; BRONSON FH, 1989, REPROD BIOL; CAUGHLEY G, 1981, THEORETICAL ECOLOGY, pCH6; Clutton-Brock T. H., 1988, REPROD SUCCESS; CLUTTONBROCK TH, 1999, EVOLUTION PARENTAL C; Curran LM, 2000, ECOL MONOGR, V70, P101, DOI 10.1890/0012-9615(2000)070[0101:VRTSVI]2.0.CO;2; EIS S, 1972, Canadian Journal of Forest Research, V2, P460, DOI 10.1139/x72-070; Fitzgerald BM, 2004, NEW ZEAL J ZOOL, V31, P167, DOI 10.1080/03014223.2004.9518370; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; HEDLIN A. F., 1964, FOREST SCI, V10, P124; Humphries MM, 2000, ECOLOGY, V81, P2867, DOI 10.2307/177347; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Jones CG, 1998, SCIENCE, V279, P1023, DOI 10.1126/science.279.5353.1023; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Koenig WD, 2005, AM SCI, V93, P340, DOI 10.1511/2005.54.970; Larsen KW, 1997, J MAMMAL, V78, P192, DOI 10.2307/1382652; LIGON JD, 1974, NATURE, V250, P80, DOI 10.1038/250080a0; McAdam AG, 2003, EVOLUTION, V57, P1689; McKone MJ, 2001, NEW ZEAL J ZOOL, V28, P89, DOI 10.1080/03014223.2001.9518259; McNeilly AS, 2001, REPROD FERT DEVELOP, V13, P583, DOI 10.1071/RD01056; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Ruf T, 2006, ECOLOGY, V87, P372, DOI 10.1890/05-0672; RUSCH DA, 1978, ECOLOGY, V59, P400, DOI 10.2307/1936382; SMITH MC, 1968, J WILDLIFE MANAGE, V32, P305, DOI 10.2307/3798975; WAUTERS L, 1992, J ZOOL, V227, P71, DOI 10.1111/j.1469-7998.1992.tb04345.x; Wauters LA, 2004, J ANIM ECOL, V73, P11, DOI 10.1111/j.1365-2656.2004.00792.x; WAUTERS LA, 1989, J ZOOL, V217, P93, DOI 10.1111/j.1469-7998.1989.tb02477.x; Wilson PR, 1998, BIOL CONSERV, V83, P175, DOI 10.1016/S0006-3207(97)00055-4; Wolff JO, 1996, J MAMMAL, V77, P850, DOI 10.2307/1382690	31	197	201	5	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1928	1930		10.1126/science.1135520	http://dx.doi.org/10.1126/science.1135520			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185600				2022-12-28	WOS:000242996800049
J	Clutton-Brock, TH; Hodge, SJ; Spong, G; Russell, AF; Jordan, NR; Bennett, NC; Sharpe, LL; Manser, MB				Clutton-Brock, T. H.; Hodge, S. J.; Spong, G.; Russell, A. F.; Jordan, N. R.; Bennett, N. C.; Sharpe, L. L.; Manser, M. B.			Intrasexual competition and sexual selection in cooperative mammals	NATURE			English	Article							FEMALE; DOMINANCE; EVOLUTION; BEHAVIOR; RANK	In most animals, the sex that invests least in its offspring competes more intensely for access to the opposite sex and shows greater development of secondary sexual characters than the sex that invests most(1,2). However, in some mammals where females are the primary care-givers, females compete more frequently or intensely with each other than males(3-5). A possible explanation is that, in these species, the resources necessary for successful female reproduction are heavily concentrated and intrasexual competition for breeding opportunities is more intense among females than among males. Intrasexual competition between females is likely to be particularly intense in cooperative breeders where a single female monopolizes reproduction in each group(6). Here, we use data from a twelve-year study of wild meerkats (Suricata suricatta), where females show high levels of reproductive skew, to show that females gain greater benefits from acquiring dominant status than males and traits that increase competitive ability exert a stronger influence on their breeding success. Females that acquire dominant status also develop a suite of morphological, physiological and behavioural characteristics that help them to control other group members. Our results show that sex differences in parental investment are not the only mechanism capable of generating sex differences in reproductive competition and emphasize the extent to which competition for breeding opportunities between females can affect the evolution of sex differences and the operation of sexual selection.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; Uppsala Univ, Dept Anim Ecol, SE-75236 Uppsala, Sweden; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Stellenbosch, Dept Zool, ZA-7602 Matieland, South Africa; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	University of Cambridge; University of Pretoria; Uppsala University; University of Sheffield; Stellenbosch University; University of Zurich	Clutton-Brock, TH (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	thcb@cam.ac.uk	Bennett, Nigel Charles/E-4238-2010	Bennett, Nigel Charles/0000-0001-9748-2947; Jordan, Neil/0000-0002-0712-8301; Spong, Goran/0000-0002-1246-5046	Natural Environment Research Council [NE/C511348/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Andersson Malte, 1994; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BRETT RA, 1991, REPROD NAKED MOLE RA, P67; Buston P, 2003, BEHAV ECOL, V14, P576, DOI 10.1093/beheco/arg036; Carlson AA, 2004, HORM BEHAV, V46, P141, DOI 10.1016/j.yhbeh.2004.01.009; Clutton-Brock T.H., 1983, P457; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P2291, DOI 10.1098/rspb.1998.0573; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 2002, SCIENCE, V297, P253, DOI 10.1126/science.1071412; Clutton-Brock TH, 2004, ANIM BEHAV, V68, P1029, DOI 10.1016/j.anbehav.2003.10.024; CLUTTONBROCK TH, 2004, SEXUAL SELECTION PRI; Darwin C., 1871, P475; Dloniak SM, 2006, NATURE, V440, P1190, DOI 10.1038/nature04540; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; ENGH A, 2002, SOCIAL COMPLEXITY; Engh AL, 2002, BEHAV ECOL, V13, P193, DOI 10.1093/beheco/13.2.193; Faulkes Christopher G., 1997, P302; Forsgren E, 2004, NATURE, V429, P551, DOI 10.1038/nature02562; FRICKE H, 1977, NATURE, V266, P830, DOI 10.1038/266830a0; Griffin AS, 2003, BEHAV ECOL, V14, P472, DOI 10.1093/beheco/arg040; Hauber ME, 2005, INTEGR COMP BIOL, V45, P903, DOI 10.1093/icb/45.5.903; Heinsohn R, 2005, SCIENCE, V309, P617, DOI 10.1126/science.1112774; Holekamp KE, 1996, J REPROD FERTIL, V108, P229; Isaac JL, 2005, MAMMAL REV, V35, P101, DOI 10.1111/j.1365-2907.2005.00045.x; O'Riain MJ, 2000, P NATL ACAD SCI USA, V97, P13194, DOI 10.1073/pnas.97.24.13194; Scantlebury M, 2002, P ROY SOC B-BIOL SCI, V269, P2147, DOI 10.1098/rspb.2002.2108; Shellman-Reeve Janet S., 1997, P52; Sherman PW, 2002, J ZOOL, V258, P307, DOI 10.1017/S0952836902001437; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215	30	225	227	2	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1065	1068		10.1038/nature05386	http://dx.doi.org/10.1038/nature05386			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183322				2022-12-28	WOS:000242971100055
J	Rome, LC; Flynn, L; Yoo, TD				Rome, Lawrence C.; Flynn, Louis; Yoo, Taeseung D.			Biomechanics - Rubber bands reduce the cost of carrying loads	NATURE			English	Article							BACK-PAIN; WALKING; CHILDREN; MASS		Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Rome, LC (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.	lrome@sas.upenn.edu		Flynn, Louis/0000-0003-2966-0355				BALOGUN JA, 1986, ERGONOMICS, V29, P1623, DOI 10.1080/00140138608967274; Chatterjee A, 2002, INT J ROBOT RES, V21, P621, DOI 10.1177/027836402322023213; Donelan JM, 2002, J EXP BIOL, V205, P3717; Gard SA, 2004, HUM MOVEMENT SCI, V22, P597, DOI 10.1016/j.humov.2003.11.002; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; KRAM R, 1991, J APPL PHYSIOL, V71, P1119, DOI 10.1152/jappl.1991.71.3.1119; Negrini S, 2002, SPINE, V27, P187, DOI 10.1097/00007632-200201150-00014; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Taimela S, 1997, SPINE, V22, P1132, DOI 10.1097/00007632-199705150-00013; TROUSSIER B, 1994, SCAND J REHABIL MED, V26, P143	10	102	104	12	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1023	1024		10.1038/4441023a	http://dx.doi.org/10.1038/4441023a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183310				2022-12-28	WOS:000242971100043
J	Gross, CP; Andersen, MS; Krumholz, HM; McAvay, GJ; Proctor, D; Tinetti, ME				Gross, Cary P.; Andersen, Martin S.; Krumholz, Harlan M.; McAvay, Gail J.; Proctor, Deborah; Tinetti, Mary E.			Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; BREAST-CANCER; UNITED-STATES; COVERAGE; US; COLONOSCOPY; POPULATION; PREDICTORS; INSURANCE; CARCINOMA	Context Medicare's reimbursement policy was changed in 1998 to provide coverage for screening colonoscopies for patients with increased colon cancer risk, and expanded further in 2001 to cover screening colonoscopies for all individuals. Objective To determine whether the Medicare reimbursement policy changes were associated with an increase in either colonoscopy use or early stage colon cancer diagnosis. Design, Setting, and Participants Patients in the Surveillance, Epidemiology, and End Results Medicare linked database who were 67 years of age and older and had a primary diagnosis of colon cancer during 1992-2002, as well as a group of Medicare beneficiaries who resided in Surveillance, Epidemiology, and End Results areas but who were not diagnosed with cancer. Main Outcome Measures Trends in colonoscopy and sigmoidoscopy use among Medicare beneficiaries without cancer were assessed using multivariate Poisson regression. Among the patients with cancer, stage was classified as early ( stage I) vs all other ( stages II-IV). Time was categorized as period 1 ( no screening coverage, 19921997), period 2 ( limited coverage, January 1998-June 2001), and period 3 ( universal coverage, July 2001-December 2002). A multivariate logistic regression (outcome = early stage) was used to assess temporal trends in stage at diagnosis; an interaction term between tumor site and time was included. Results Colonoscopy use increased from an average rate of 285/ 100 000 per quarter in period 1 to 889 and 1919/100 000 per quarter in periods 2 ( P <. 001) and 3 ( P vs 2 <. 001), respectively. During the study period, 44 924 eligible patients were diagnosed with colorectal cancer. The proportion of patients diagnosed at an early stage increased from 22.5% in period 1 to 25.5% in period 2 and 26.3% in period 3 ( P <. 001 for each pair-wise comparison). The changes in Medicare coverage were strongly associated with early stage at diagnosis for patients with proximal colon lesions ( adjusted relative risk period 2 vs 1, 1.19; 95% confidence interval, 1.13-1.26; adjusted relative risk period 3 vs 2, 1.10; 95% confidence interval, 1.02-1.17) but weakly associated, if at all, for patients with distal colon lesions ( adjusted relative risk period 2 vs 1, 1.07; 95% confidence interval, 1.01-1.13; adjusted relative risk period 3 vs 2, 0.97; 95% confidence interval, 0.90-1.05). Conclusions Expansion of Medicare reimbursement to cover colon cancer screening was associated with an increased use of colonoscopy for Medicare beneficiaries, and for those who were diagnosed with colon cancer, an increased probability of being diagnosed at an early stage. The selective effect of the coverage change on proximal colon lesions suggests that increased use of whole-colon screening modalities such as colonoscopy may have played a pivotal role.	Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Geriatr, New Haven, CT 06520 USA; Yale Univ, Sch Med, Gastroenterol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Scholars Program, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	cary.gross@yale.edu	Andersen, Martin/J-7018-2019; , Harlan/AAI-2875-2020	Andersen, Martin/0000-0001-5982-2541; 	NATIONAL INSTITUTE ON AGING [P30AG021342, K08AG024842] Funding Source: NIH RePORTER; NIA NIH HHS [P30AG21342, 1 K08 AG24842] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams EK, 2004, PREV MED, V38, P551, DOI 10.1016/j.ypmed.2003.12.014; *AM CANC SOC, 2005, CANC FACTS FIG; *AM CANC SOC, EST NEW CANC CAS DEA; [Anonymous], 2001, FED REGISTER, V66, P55246; Berg AO, 2002, AM J NURS, V102, P107; BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; Brenes GA, 2000, PREV MED, V31, P410, DOI 10.1006/pmed.2000.0729; Chao A, 2004, AM J PUBLIC HEALTH, V94, P1775, DOI 10.2105/AJPH.94.10.1775; Cooper GS, 2005, CANCER, V103, P696, DOI 10.1002/cncr.20839; Cooper GS, 2004, AM J GASTROENTEROL, V99, P1544, DOI 10.1111/j.1572-0241.2004.30902.x; Cress RD, 2000, PREV MED, V31, P447, DOI 10.1006/pmed.2000.0730; Dans PE, 1996, RADIOLOGY, V198, P657, DOI 10.1148/radiology.198.3.8628850; Etzioni DA, 2004, CANCER-AM CANCER SOC, V101, P2523, DOI 10.1002/cncr.20692; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Greene J, 2001, HEALTH CARE FINANC R, V22, P141; Gross CP, 2006, ANN INTERN MED, V145, P646, DOI 10.7326/0003-4819-145-9-200611070-00006; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; Ioannou GN, 2003, AM J GASTROENTEROL, V98, P2082, DOI 10.1016/S0002-9270(03)00423-4; Jain T, 2002, NEW ENGL J MED, V347, P661, DOI 10.1056/NEJMsa013491; Keating NL, 2005, J GEN INTERN MED, V20, P38, DOI 10.1111/j.1525-1497.2004.40079.x; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Ko CW, 2002, ARCH INTERN MED, V162, P2581, DOI 10.1001/archinte.162.22.2581; MILLER BA, 1992, NIH PUBLICATION, V92, P2789; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; POTOSKY AL, 1993, MED CARE, V31, P732; Prajapati DN, 2003, AM J GASTROENTEROL, V98, P194; Ries L, 2004, SEER CANC STAT REV 1; Ries L., 2005, SEER CANC STAT REV 1; RIES LAG, 1999, SEER CANC STAT REV; Riley GF, 1999, JAMA-J AM MED ASSOC, V281, P720, DOI 10.1001/jama.281.8.720; RILEY GF, 1994, AM J PUBLIC HEALTH, V84, P1598, DOI 10.2105/AJPH.84.10.1598; SAS Institute, 2008, SAS STAT US GUID; Seeff LC, 2004, CANCER-AM CANCER SOC, V100, P2093, DOI 10.1002/cncr.20276; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Shih YCT, 2006, HEALTH AFFAIR, V25, P1153, DOI 10.1377/hlthaff.25.4.1153; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Smith S, 2003, HIST TODAY, V53, P43; Tomoda H, 1998, ONCOL REP, V5, P481; Troisi RJ, 1999, CANCER, V85, P1670, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1670::AID-CNCR5>3.0.CO;2-M; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	43	163	164	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2815	2822		10.1001/jama.296.23.2815	http://dx.doi.org/10.1001/jama.296.23.2815			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179458				2022-12-28	WOS:000242826400023
J	Razavi, R; Chan, Y; Afifiyan, FN; Liu, XJ; Wan, X; Yantha, J; Tsui, H; Tang, L; Tsai, S; Santamaria, P; Drivers, JP; Serreze, D; Salter, MW; Dosch, HM				Razavi, Rozita; Chan, Yin; Afifiyan, F. Nikoo; Liu, Xue Jun; Wan, Xiang; Yantha, Jason; Tsui, Hubert; Tang, Lan; Tsai, Sue; Santamaria, Pere; Drivers, John P.; Serreze, David; Salter, Michael W.; Dosch, H. -Michael			TRPV1(+) sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes	CELL			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; GENE-RELATED PEPTIDE; DELAYED-TYPE HYPERSENSITIVITY; REGULATORY T-CELLS; SUBSTANCE-P; INSULIN-SECRETION; NOD MICE; RECEPTOR; MOUSE; SUSCEPTIBILITY	In type 1 diabetes, T cell-mediated death of pancreatic beta cells produces insulin deficiency. However, what attracts or restricts broadly autoreactive lymphocyte pools to the pancreas remains unclear. We report that TRPV1(+) pancreatic sensory neurons control islet inflammation and insulin resistance. Eliminating these neurons in diabetes-prone NOD mice prevents insulitis and diabetes, despite systemic persistence of pathogenic T cell pools. Insulin resistance and beta cell stress of prediabetic NOD mice are prevented when TRPV1(+) neurons are eliminated. TRPV1(NOD), localized to the Idd4.1 diabetes-risk locus, is a hypofunctional mutant, mediating depressed neurogenic inflammation. Delivering the neuropeptide substance P by intra-arterial injection into the NOD pancreas reverses abnormal insulin resistance, insulitis, and diabetes for weeks. Concordantly, insulin sensitivity is enhanced in trpv1(-/-) mice, whereas insulitis/diabetes-resistant NODxB6Idd4-congenic mice, carrying wild-type TRPV1, show restored TRPV1 function and insulin sensitivity. Our data uncover a fundamental role for insulin-responsive TRPV1(+) sensory neurons in beta cell function and diabetes pathoetiology.	Univ Toronto, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Immunol, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; Univ Calgary, Fac Med, Julia McFarlane Diabet Res Ctr, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada; Jackson Lab, Bar Harbor, ME 04609 USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Calgary; University of Calgary; Jackson Laboratory	Dosch, HM (corresponding author), Univ Toronto, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada.	hmdosch@sickkids.ca	Santamaria, Pere/ABF-6823-2021	Chan, Yin/0000-0003-2741-8258; Tsai, Sue/0000-0002-6261-5233				Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Amrani A, 2001, J IMMUNOL, V167, P655, DOI 10.4049/jimmunol.167.2.655; Amrani A, 1998, ENDOCRINOLOGY, V139, P1115, DOI 10.1210/en.139.3.1115; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Babaya N, 2005, BIOCHEM BIOPH RES CO, V328, P158, DOI 10.1016/j.bbrc.2004.12.149; BARAKAT A, 1994, BIOSCIENCE REP, V14, P1, DOI 10.1007/BF01901633; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Boulard O, 2002, J IMMUNOL, V168, P4192, DOI 10.4049/jimmunol.168.8.4192; BRETHERTONWATT D, 1992, ANN NY ACAD SCI, V657, P299, DOI 10.1111/j.1749-6632.1992.tb22777.x; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Butterfield RJ, 1999, J IMMUNOL, V162, P3096; Carrillo J, 2005, DIABETES, V54, P69, DOI 10.2337/diabetes.54.1.69; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cha S, 2002, ARTHRITIS RHEUM-US, V46, P1390, DOI 10.1002/art.10258; ChancellorFreeland C, 1995, ANN NY ACAD SCI, V771, P472, DOI 10.1111/j.1749-6632.1995.tb44703.x; Chaparro RJ, 2006, P NATL ACAD SCI USA, V103, P12475, DOI 10.1073/pnas.0604317103; CUA DJ, 1995, EUR J IMMUNOL, V25, P2318, DOI 10.1002/eji.1830250830; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Grattan M, 2002, DIABETES, V51, P215, DOI 10.2337/diabetes.51.1.215; Hadaya K, 2005, J AUTOIMMUN, V24, P125, DOI 10.1016/j.jaut.2005.01.001; HELME RD, 1987, J IMMUNOL, V139, P3470; HERMANSEN K, 1990, REGUL PEPTIDES, V27, P149, DOI 10.1016/0167-0115(90)90213-G; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Ivakine EA, 2005, J IMMUNOL, V174, P7129, DOI 10.4049/jimmunol.174.11.7129; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; Ji H, 1999, IMMUNOL REV, V169, P139, DOI 10.1111/j.1600-065X.1999.tb01312.x; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Khachatryan A, 1997, J IMMUNOL, V158, P1409; LeRoith D, 2006, INT J BIOCHEM CELL B, V38, P904, DOI 10.1016/j.biocel.2005.01.019; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; Moesgaard SG, 2005, AM J PHYSIOL-ENDOC M, V288, pE1137, DOI 10.1152/ajpendo.00356.2004; MORIKAWA Y, 1993, CELL IMMUNOL, V152, P200, DOI 10.1006/cimm.1993.1279; Nielsen K, 2004, DIABETOLOGIA, V47, P2185, DOI 10.1007/s00125-004-1578-1; NILSSON G, 1991, INT J IMMUNOPHARMACO, V13, P21, DOI 10.1016/0192-0561(91)90021-X; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Parekh PI, 1998, METABOLISM, V47, P1089, DOI 10.1016/S0026-0495(98)90283-9; Persson-Sjogren S, 2005, J AUTOIMMUN, V24, P269, DOI 10.1016/j.jaut.2005.02.003; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rosmalen JGM, 2002, TRENDS ENDOCRIN MET, V13, P209, DOI 10.1016/S1043-2760(02)00600-8; Rosmalen JGM, 2000, LAB INVEST, V80, P769, DOI 10.1038/labinvest.3780080; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Santoni G, 1996, J NEUROIMMUNOL, V68, P131, DOI 10.1016/0165-5728(96)00081-1; Sathianathan V, 2003, EUR J NEUROSCI, V18, P2477, DOI 10.1046/j.1460-9568.2003.03004.x; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Van Buren JJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-17; van de Wall EHEM, 2005, LIFE SCI, V77, P1283, DOI 10.1016/j.lfs.2005.03.011; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Winer S, 2001, J IMMUNOL, V166, P2831, DOI 10.4049/jimmunol.166.4.2831; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818; Zhang YQ, 2002, J IMMUNOL, V168, P1466, DOI 10.4049/jimmunol.168.3.1466	60	242	289	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1123	1135		10.1016/j.cell.2006.10.038	http://dx.doi.org/10.1016/j.cell.2006.10.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174891	Bronze			2022-12-28	WOS:000242991000012
J	Tyzio, R; Cossart, R; Khalilov, I; Minlebaev, M; Hubner, CA; Represa, A; Ben-Ari, Y; Khazipov, R				Tyzio, Roman; Cossart, Rosa; Khalilov, Ilgam; Minlebaev, Marat; Huebner, Christian A.; Represa, Alfonso; Ben-Ari, Yehezkel; Khazipov, Rustem			Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery	SCIENCE			English	Article							EXCITATORY ACTIONS; NEONATAL HIPPOCAMPUS; NEURONS; CELLS; OSCILLATIONS; VASOPRESSIN; SYNAPSES; CHANNELS; SEIZURES; SLICES	We report a signaling mechanism in rats between mother and fetus aimed at preparing fetal neurons for delivery. In immature neurons, gamma-aminobutyric acid (GABA) is the primary excitatory neurotransmitter. We found that, shortly before delivery, there is a transient reduction in the intracellular chloride concentration and an excitatory-to-inhibitory switch of GABA actions. These events were triggered by oxytocin, an essential maternal hormone for labor. In vivo administration of an oxytocin receptor antagonist before delivery prevented the switch of GABA actions in fetal neurons and aggravated the severity of anoxic episodes. Thus, maternal oxytocin inhibits fetal neurons and increases their resistance to insults during delivery.	Univ Mediterranee, Inst Neurobiol Mediterranee, INSERM, U29, F-13273 Marseille 09, France; Univ Hamburg, Klinikum Eppendorf, Inst Human Genet, D-20251 Hamburg, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Hamburg	Ben-Ari, Y (corresponding author), Univ Mediterranee, Inst Neurobiol Mediterranee, INSERM, U29, Campus Sci Luminy,Boite Postale 13, F-13273 Marseille 09, France.	ben-ari@inmed.univ-mrs.fr	Khalilov, Ilgam/B-5267-2015; Represa, Alfonso/M-7383-2016; Hübner, Christian/A-2950-2017; Khazipov, Roustem/M-1834-2016; Cossart, Rosa/AAT-7934-2020; MINLEBAEV, Marat/B-4927-2015; MINLEBAEV, Marat/R-4794-2019; Cossart, Rosa/E-7674-2014	Khalilov, Ilgam/0000-0002-9468-4778; Represa, Alfonso/0000-0002-5096-8939; Hübner, Christian/0000-0002-1030-4943; Khazipov, Roustem/0000-0002-6763-2841; Cossart, Rosa/0000-0003-2111-6638; MINLEBAEV, Marat/0000-0002-0722-7027; MINLEBAEV, Marat/0000-0002-0722-7027; Cossart, Rosa/0000-0003-2111-6638; Ben-Ari, Yehezkel/0000-0001-6208-8480				ARGIOLAS A, 1991, NEUROSCI BIOBEHAV R, V15, P217, DOI 10.1016/S0149-7634(05)80002-8; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; CONNOR JA, 1987, J NEUROSCI, V7, P1384; Dzhala V, 2000, ANN NEUROL, V48, P632, DOI 10.1002/1531-8249(200010)48:4<632::AID-ANA10>3.3.CO;2-V; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Malek A, 1996, J Matern Fetal Med, V5, P245, DOI 10.1002/(SICI)1520-6661(199609/10)5:5<245::AID-MFM3>3.3.CO;2-L; Marandi N, 2002, PFLUG ARCH EUR J PHY, V445, P357, DOI 10.1007/s00424-002-0933-7; Maric D, 1998, EUR J NEUROSCI, V10, P2532, DOI 10.1046/j.1460-9568.1998.00284.x; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Raggenbass M, 2001, PROG NEUROBIOL, V64, P307, DOI 10.1016/S0301-0082(00)00064-2; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SERAFINI R, 1995, J PHYSIOL-LONDON, V488, P371, DOI 10.1113/jphysiol.1995.sp020973; Serradeil-Le Gal C, 2004, J PHARMACOL EXP THER, V309, P414, DOI 10.1124/jpet.103.061200; Theodosis DT, 2006, MOL CELL NEUROSCI, V31, P785, DOI 10.1016/j.mcn.2006.01.006; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Tyzio R, 1999, J NEUROSCI, V19, P10372; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Volpe J., 2017, VOLPES NEUROLOGY NEW, V6th edn; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	32	328	340	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1788	1792		10.1126/science.1133212	http://dx.doi.org/10.1126/science.1133212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170309	Green Published			2022-12-28	WOS:000242833600063
J	de Oliveira, T; Pybus, OG; Rambaut, A; Salemi, M; Cassol, S; Ciccozzi, M; Rezza, G; Gattinara, GC; D'Arrigo, R; Amicosante, M; Perrin, L; Colizzi, V; Perno, CF				de Oliveira, Tulio; Pybus, Oliver G.; Rambaut, Andrew; Salemi, Marco; Cassol, Sharon; Ciccozzi, Massimo; Rezza, Giovanni; Gattinara, Guido Castelli; D'Arrigo, Roberta; Amicosante, Massimo; Perrin, Luc; Colizzi, Vittorio; Perno, Carlo Federico		Benghazi Study Grp	Molecular epidemiology - HIV-1 and HCV sequences from Libyan outbreak	NATURE			English	Article							HEPATITIS-C VIRUS; NOSOCOMIAL OUTBREAK		Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Florida, Coll Med, Gainesville, FL 32610 USA; Univ Pretoria, Fac Hlth Sci, ZA-0001 Pretoria, South Africa; Ist Super Sanita, Dept Infect Dis, I-00161 Rome, Italy; Bambino Gesu Pediat Hosp, Dept Immunol & Infect Dis, I-00165 Rome, Italy; Spallanzani Inst Infect Dis, I-00149 Rome, Italy; Univ Roma Tor Vergata, Dept Internal Med, I-00133 Rome, Italy; Univ Hosp Geneva, CH-1211 Geneva, Switzerland; Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy	University of Oxford; University of Edinburgh; State University System of Florida; University of Florida; University of Pretoria; Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; University of Rome Tor Vergata; University of Geneva; University of Rome Tor Vergata; University of Rome Tor Vergata	de Oliveira, T (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	tulio.deoliveira@zoo.ox.ac.uk	Pybus, Oliver G/B-2640-2012; castelli, guido/AAA-1507-2020; Rambaut, Andrew/B-2481-2009; perno, carlo federico/O-1544-2016; rezza, giovanni/D-4393-2016; Ciccozzi, Massimo/AAC-3271-2022; CICCOZZI, MASSIMO/C-6484-2016	Pybus, Oliver G/0000-0002-8797-2667; castelli, guido/0000-0002-3282-7462; Rambaut, Andrew/0000-0003-4337-3707; rezza, giovanni/0000-0003-0268-6790; Ciccozzi, Massimo/0000-0003-3866-9239; CICCOZZI, MASSIMO/0000-0003-3866-9239; Amicosante, Massimo/0000-0002-2372-3311; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X				Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; *EUR COMM, 2006, TECHN MISS LIB ILL I; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Goldmann DA, 2002, J ALLERGY CLIN IMMUN, V110, pS21, DOI 10.1067/mai.2002.125337; *HUMAN RIGHTS WATC, 2006, STEMM FLOW, V18; MONTAGNIER L, 2006, REPORT BENGHAZI OUTB; Ndjomou J, 2003, J GEN VIROL, V84, P2333, DOI 10.1099/vir.0.19240-0; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Visco-Comandini U, 2002, AIDS RES HUM RETROV, V18, P727, DOI 10.1089/088922202760072366; Yerly S, 2001, J INFECT DIS, V184, P369, DOI 10.1086/322036	12	99	100	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					836	837		10.1038/444836a	http://dx.doi.org/10.1038/444836a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17171825	Bronze			2022-12-28	WOS:000242805400034
J	Bazzano, LA; Reynolds, K; Holder, KN; He, J				Bazzano, Lydia A.; Reynolds, Kristi; Holder, Kevin N.; He, Jiang			Effect of folic acid supplementation on risk of cardiovascular diseases - A meta-analysis of randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMA HOMOCYSTEINE; MYOCARDIAL-INFARCTION; VITAMIN INTERVENTION; HEART-DISEASE; STROKE; FOLATE; EVENTS; PREVENTION; THERAPY; ASSOCIATION	Context Epidemiologic studies have suggested that folate intake decreases risk of cardiovascular diseases. However, the results of randomized controlled trials on dietary supplementation with folic acid to date have been inconsistent. Objective To evaluate the effects of folic acid supplementation on risk of cardiovascular diseases and all-cause mortality in randomized controlled trials among persons with preexisting cardiovascular or renal disease. Data Sources Studies were retrieved by searching MEDLINE ( January 1966-July 2006) using the Medical Subject Headings cardiovascular disease, coronary disease, coronary thrombosis, myocardial ischemia, coronary stenosis, coronary restenosis, cerebrovascular accident, randomized controlled trial, clinical trials, homofolic acid, and folic acid, and the text words folic acid and folate. Bibliographies of all retrieved articles were also searched, and experts in the field were contacted. Study Selection From 165 relevant retrieved reports, 12 randomized controlled trials compared folic acid supplementation with either placebo or usual care for a minimum duration of 6 months and with clinical cardiovascular disease events reported as an end point. Data Extraction Data on study design, characteristics of participants, changes in homocysteine levels, and cardiovascular disease outcomes were independently abstracted by 2 investigators using a standardized protocol. Data Synthesis Studies including data from 16 958 participants with preexisting vascular disease were analyzed using a random-effects model. The overall relative risks (95% confidence intervals) of outcomes for patients treated with folic acid supplementation compared with controls were 0.95 (0.88-1.03) for cardiovascular diseases, 1.04 (0.92-1.17) for coronary heart disease, 0.86 (0.71-1.04) for stroke, and 0.96 (0.88-1.04) for all-cause mortality. The relative risk was consistent among participants with preexisting cardiovascular or renal disease. Conclusions Folic acid supplementation has not been shown to reduce risk of cardiovascular diseases or all-cause mortality among participants with prior history of vascular disease. Several ongoing trials with large sample sizes might provide a definitive answer to this important clinical and public health question.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA	Tulane University; Tulane University	Bazzano, LA (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol & Med, 1440 Canal St,SL-18, New Orleans, LA 70112 USA.	lbazzano@tulane.edu	Reynolds, Kristi/AAN-1434-2021; He, Jiang/AAF-5303-2020	Reynolds, Kristi/0000-0001-7619-1649; He, Jiang/0000-0002-8286-9652	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER; NCRR NIH HHS [P20-RR17659] Funding Source: Medline; NICHD NIH HHS [K12 HD43451] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baker F, 2002, CIRCULATION, V106, P741; Baker RI, 2002, CEREBROVASC DIS, V13, P120; Bassuk SS, 2004, J WOMENS HEALTH, V13, P99, DOI 10.1089/154099904322836519; Bazzano LA, 2002, STROKE, V33, P1183, DOI 10.1161/01.STR.0000014607.90464.88; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERGG C, 1994, HDB RES SYNTHESIS, P399; Bleie O, 2004, AM J CLIN NUTR, V80, P641; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Bostom AG, 1996, KIDNEY INT, V49, P147, DOI 10.1038/ki.1996.19; Bostom AG, 2001, ANN INTERN MED, V135, P133, DOI 10.7326/0003-4819-135-2-200107170-00014; Bostom AG, 2006, AM HEART J, V152, P448, DOI 10.1016/j.ahj.2006.03.004; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brattstrom L, 1996, J NUTR, V126, pS1276, DOI 10.1093/jn/126.suppl_4.1276S; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Clarke R, 2006, AM HEART J, V151, P282, DOI 10.1016/j.ahj.2005.04.025; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Galan P, 2003, J Nutr Health Aging, V7, P428; JACOB RA, 1994, J NUTR, V124, P1072, DOI 10.1093/jn/124.7.1072; Jamison Rex L, 2004, Clin Trials, V1, P451, DOI 10.1191/1740774504cn038oa; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Liem A, 2005, HEART, V91, P1213, DOI 10.1136/hrt.2004.035030; Liem AH, 2004, INT J CARDIOL, V93, P175, DOI 10.1016/j.ijcard.2003.02.001; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; MacMahon M, 2000, NUTR METAB CARDIOVAS, V10, P195; Mason PJ, 2004, CIRCULATION, V109, P1623, DOI 10.1161/01.CIR.0000124488.06377.77; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MUDD SH, 1964, SCIENCE, V143, P1443, DOI 10.1126/science.143.3613.1443; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Righetti M, 2006, BLOOD PURIFICAT, V24, P379, DOI 10.1159/000093680; Righetti Marco, 2003, Med Sci Monit, V9, pPI19; Schnyder G, 2002, JAMA-J AM MED ASSOC, V288, P973, DOI 10.1001/jama.288.8.973; Schnyder G, 2001, NEW ENGL J MED, V345, P1593, DOI 10.1056/NEJMoa011364; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; Smith GD, 2005, LANCET, V366, P1679, DOI 10.1016/S0140-6736(05)67676-3; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Toole JF, 2002, J NEUROL SCI, V203, P121, DOI 10.1016/S0022-510X(02)00265-4; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Van Guelpen B, 2005, STROKE, V36, P1426, DOI 10.1161/01.STR.0000169934.96354.3a; Wald NJ, 1998, ARCH INTERN MED, V158, P862, DOI 10.1001/archinte.158.8.862; Wrone EM, 2004, J AM SOC NEPHROL, V15, P420, DOI 10.1097/01.ASN.0000110181.64655.6C; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zoungas S, 2006, J AM COLL CARDIOL, V47, P1108, DOI 10.1016/j.jacc.2005.10.064	47	312	330	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2720	2726		10.1001/jama.296.22.2720	http://dx.doi.org/10.1001/jama.296.22.2720			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164458				2022-12-28	WOS:000242765700027
J	Moss, SM; Cuckle, H; Evans, A; Johns, L; Waller, M; Bobrow, L				Moss, Sue M.; Cuckle, Howard; Evans, Andy; Johns, Louise; Waller, Michael; Bobrow, Lynda		Trial Management Grp	Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial	LANCET			English	Article							SWEDISH 2-COUNTY TRIAL; WOMEN; EFFICACY; PROGRAM; BENEFIT; DEATH; END; UK	Background The efficacy of screening by mammography has been shown in randomised controlled trials in women aged 50 years and older, but is less dear in younger women. A meta-analysis of all previous trials showed a 15% mortality reduction in invited women aged 40-49 years at study entry, but this finding could be due in part to screening of women after age 50 years. The Age trial was designed to study the effect on mortality of inviting women for annual mammography from age 40 years. Methods 160 921 women aged 39-41 years were randomly assigned in the ratio 1:2 to an intervention group of annual mammography to age 48 years or to a control group of usual medical care. The trial was undertaken in 23 NHS breast-screening units in England, Wales, and Scotland. The primary analysis was based on the intention-to-treat principle and compared mortality rates in the two groups at 10 years' follow-up. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN24647151. Findings At a mean follow-up of 10.7 years there was a reduction in breast-cancer mortality in the intervention group, in relative and absolute terms, which did not reach statistical significance (relative risk 0.83 [95% Cl 0.66-1.04], p=0.11; absolute risk reduction 0.40 per 1000 women invited to screening [95% Cl -0.07 to 0.87]). Mortality reduction adjusted for non-compliance in women actually screened was estimated as 24% (RR 0.76, 95% CI 0.51-1.01). Interpretation Although the reduction in breast-cancer mortality observed in this trial is not significant, it is consistent with results of other trials of mammography alone in this age-group. Future decisions on screening policy should be informed by further follow-up from this trial and should take account of possible costs and harms as well as benefits.	Inst Canc Res, Canc Screening Evaluat Unit, Sutton, Surrey, England; Univ Leeds, Leeds, W Yorkshire, England; City Hosp, Nottingham Breast Inst, Nottingham NG5 1PB, England; Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England	University of London; Institute of Cancer Research - UK; University of Leeds; University of Nottingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Moss, SM (corresponding author), Inst Canc Res, Canc Screening Evaluat Unit, Sutton, Surrey, England.	sue.moss@icr.ac.uk	Waller, Michael/R-6231-2016	Waller, Michael/0000-0002-1050-4574	Medical Research Council [G9000793] Funding Source: Medline; MRC [G9000793] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Advisory Committee on Breast Cancer Screening, 2006, NHSBSP PUBL, V61; Alexander FE, 1999, LANCET, V353, P1903, DOI 10.1016/S0140-6736(98)07413-3; Anderson TJ, 2000, BRIT J CANCER, V83, P487, DOI 10.1054/bjoc.2000.1286; Andersson I, 1997, J Natl Cancer Inst Monogr, P63; [Anonymous], 2005, SOC VAL JUDG PRINC D; Bjurstam N, 2003, CANCER-AM CANCER SOC, V97, P2387, DOI 10.1002/cncr.11361; Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Blamey RY, 1996, BREAST, V5, P156; Blanks RG, 2005, CLIN RADIOL, V60, P674, DOI 10.1016/j.crad.2005.01.008; Breslow NE, 1980, IARC SCI PUBL, P5; CHAMBERLAIN J, 1991, BRIT J CANCER, V64, P1151, DOI 10.1038/bjc.1991.480; Cornford EJ, 2005, CLIN RADIOL, V60, P1182, DOI 10.1016/j.crad.2005.06.003; Cuzick J, 1997, STAT MED, V16, P1017, DOI 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V; de Gonzalez AB, 2005, BRIT J CANCER, V93, P590, DOI 10.1038/sj.bjc.6602683; Hendrick R E, 1997, J Natl Cancer Inst Monogr, P87; International Agency for Research on Cancer, 2002, BREAST CANC SCREEN; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; KOPANS DB, 1993, AM J ROENTGENOL, V161, P755, DOI 10.2214/ajr.161.4.8372752; Law J, 2001, BRIT J RADIOL, V74, P1121, DOI 10.1259/bjr.74.888.741121; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; MORRISON AS, 1991, INT J EPIDEMIOL, V20, P642, DOI 10.1093/ije/20.3.642; Moss S, 2005, BRIT J CANCER, V92, P949, DOI 10.1038/sj.bjc.6602396; Moss S, 2005, BRIT J CANCER, V92, P955, DOI 10.1038/sj.bjc.6602395; Moss S, 1999, J MED SCREEN, V6, P144, DOI 10.1136/jms.6.3.144; NYSTROM L, 1995, ACTA ONCOL, V34, P145, DOI 10.3109/02841869509093948; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Rembold CM, 1998, BMJ-BRIT MED J, V317, P307, DOI 10.1136/bmj.317.7154.307; Scholefield JH, 2002, GUT, V50, P840, DOI 10.1136/gut.50.6.840; Shapiro S, 1988, PERIODIC SCREENING B; SMART CR, 1995, CANCER, V75, P1619, DOI 10.1002/1097-0142(19950401)75:7<1619::AID-CNCR2820750711>3.0.CO;2-T; Smith RA, 2004, RADIOL CLIN N AM, V42, P793, DOI 10.1016/j.rcl.2004.06.014; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; WALD NJ, 1994, CLIN ONCOL, V4, P261; YOUNG KC, 2001, BRIT J RADIOL, V74, P1121; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	37	335	346	1	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2006	368	9552					2053	2060		10.1016/S0140-6736(06)69834-6	http://dx.doi.org/10.1016/S0140-6736(06)69834-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114JY	17161727				2022-12-28	WOS:000242663700020
J	Fontana, W				Fontana, Walter			Pulling strings	SCIENCE			English	Editorial Material							DNA		Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA	Harvard University	Fontana, W (corresponding author), Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA.	walter@hms.harvard.edu						ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Ding B, 2006, SCIENCE, V314, P1583, DOI 10.1126/science.1131372; LANDAUER R, 1991, PHYS TODAY, V44, P23, DOI 10.1063/1.881299; Milner R., 1980, CALCULUS COMMUNICATI; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seelig G, 2006, J AM CHEM SOC, V128, P12211, DOI 10.1021/ja0635635; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	13	13	14	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1552	1553		10.1126/science.1135101	http://dx.doi.org/10.1126/science.1135101			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158311				2022-12-28	WOS:000242624600025
J	Nowak, MA				Nowak, Martin A.			Five rules for the evolution of cooperation	SCIENCE			English	Review							TIT-FOR-TAT; INDIRECT RECIPROCITY; INCLUSIVE FITNESS; ALTRUISM; SELECTION; DYNAMICS; POPULATIONS; PUNISHMENT; CONFLICT; LOGIC	Cooperation is needed for evolution to construct new levels of organization. Genomes, cells, multicellular organisms, social insects, and human society are all based on cooperation. Cooperation means that selfish replicators forgo some of their reproductive potential to help one another. But natural selection implies competition and therefore opposes cooperation unless a specific mechanism is at work. Here I discuss five mechanisms for the evolution of cooperation: kin selection, direct reciprocity, indirect reciprocity, network reciprocity, and group selection. For each mechanism, a simple rule is derived that specifies whether natural selection can lead to cooperation.	Harvard Univ, Dept Organism & Evolutionary Biol, Program Evolut Dynam, Cambridge, MA 02138 USA; Harvard Univ, Dept Math, Cambridge, MA 02138 USA	Harvard University; Harvard University	Nowak, MA (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Program Evolut Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Nowak, Martin A/A-6977-2008		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01GM078986-01, R01 GM078986, R01 GM078986-04] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander R., 1987, BIOL MORAL SYSTEMS; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Brandt H, 2004, J THEOR BIOL, V231, P475, DOI 10.1016/j.jtbi.2004.06.032; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; Dawkins Richard, 1976, SELFISH GENE; Dugatkin L.A., 1997, COOPERATION ANIMALS; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fishman MA, 2003, J THEOR BIOL, V225, P285, DOI 10.1016/S0022-5193(03)00246-7; Fletcher JA, 2006, AM NAT, V168, P252, DOI 10.1086/506529; Foster KR, 2006, TRENDS ECOL EVOL, V21, P57, DOI 10.1016/j.tree.2005.11.020; Frank, 1998, FDN SOCIAL EVOLUTION; FUDENBERG D, 1990, AM ECON REV, V80, P274; Grafen A., 1985, Oxford Surveys in Evolutionary Biology, V2, P28; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; Hofbauer J, 2003, B AM MATH SOC, V40, P479, DOI 10.1090/S0273-0979-03-00988-1; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; Keller L, 1999, LEVELS SELECTION EVO; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; Maynard Smith J., 1982, pi; Michod RE, 1999, DARWINIAN DYNAMICS; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Nakamaru M, 2005, EVOL ECOL RES, V7, P853; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Paulsson J, 2002, GENETICS, V161, P1373; QUELLER DC, 1992, AM NAT, V139, P540, DOI 10.1086/285343; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; ROGERS AR, 1990, AM NAT, V135, P398, DOI 10.1086/285053; SELTEN R, 1984, BEHAV BRAIN SCI, V7, P115, DOI 10.1017/S0140525X00026479; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; TAYLOR PD, 1988, EVOLUTION, V42, P193, DOI [10.2307/2409127, 10.1111/j.1558-5646.1988.tb04119.x]; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Traulsen A, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046129; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; WILLIAMS GC, 1957, EVOLUTION, V11, P32, DOI 10.2307/2405809; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; Wilson E.O., 1975, P1; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	69	3253	3351	64	1646	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1560	1563		10.1126/science.1133755	http://dx.doi.org/10.1126/science.1133755			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158317	Green Accepted			2022-12-28	WOS:000242624600030
J	Kouros-Mehr, H; Slorach, EM; Sternlicht, MD; Werb, Z				Kouros-Mehr, Hosein; Slorach, Euan M.; Sternlicht, Mark D.; Werb, Zena			GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland	CELL			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; REGULATORY NETWORKS; STEM-CELLS; GENE; EXPRESSION; PROLIFERATION; MORPHOGENESIS; REVEALS; IDENTIFICATION	The GATA family of transcription factors plays fundamental roles in cell-fate specification. However, it is unclear if these genes are necessary for the maintenance of cellular differentiation after development. We identified GATA-3 as the most highly enriched transcription factor in the mammary epithelium of pubertal mice. GATA-3 was found in the luminal cells of mammary ducts and the body cells of terminal end buds (TEBs). Upon conditional deletion of GATA-3, mice exhibited severe defects in mammary development due to failure in TEB formation during puberty. After acute GATA-3 loss, adult mice exhibited undifferentiated luminal cell expansion with basement-membrane detachment, which led to caspase-mediated cell death in the long term. Further, FOXA1 was identified as a downstream target of GATA-3 in the mammary gland. This suggests that GATA-3 actively maintains luminal epithelial differentiation in the adult mammary gland, which raises important implications for the pathogenesis of breast cancer.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, 513 Parnassus Ave, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu			NCI NIH HHS [R01 CA057621, CA057621, R01 CA057621-15, R01 CA057621-16A1] Funding Source: Medline; NIEHS NIH HHS [U01 ES012801, U01 ES012801-04S3, ES012801] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES012801] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barczak A, 2003, GENOME RES, V13, P1775, DOI 10.1101/gr.1048803; Bertucci F, 2000, HUM MOL GENET, V9, P2981, DOI 10.1093/hmg/9.20.2981; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cheng GJ, 2004, P NATL ACAD SCI USA, V101, P3739, DOI 10.1073/pnas.0307864100; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; El Wakil A, 2006, DEVELOPMENT, V133, P2155, DOI 10.1242/dev.02377; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Gruvberger S, 2001, CANCER RES, V61, P5979; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hoch RV, 1999, INT J CANCER, V84, P122; Jacobsen CM, 2002, DEV BIOL, V241, P34, DOI 10.1006/dbio.2001.0424; Jenssen TK, 2002, HUM GENET, V111, P411, DOI 10.1007/s00439-002-0804-5; Jones FE, 1996, CELL GROWTH DIFFER, V7, P1031; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Tsarovina K, 2004, DEVELOPMENT, V131, P4775, DOI 10.1242/dev.01370; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Utomo ARH, 1999, NAT BIOTECHNOL, V17, P1091, DOI 10.1038/15073; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Welm AL, 2005, P NATL ACAD SCI USA, V102, P4324, DOI 10.1073/pnas.0500470102; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yang HH, 2002, DEVELOPMENT, V129, P2233	45	492	510	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					1041	1055		10.1016/j.cell.2006.09.048	http://dx.doi.org/10.1016/j.cell.2006.09.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129787	Green Accepted, Bronze			2022-12-28	WOS:000242613800019
J	Galan, JE; Wolf-Watz, H				Galan, Jorge E.; Wolf-Watz, Hans			Protein delivery into eukaryotic cells by type III secretion machines	NATURE			English	Review							ENTEROPATHOGENIC ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; NEEDLE COMPLEX; YERSINIA-ENTEROCOLITICA; PSEUDOMONAS-AERUGINOSA; SHIGELLA-FLEXNERI; EFFECTOR PROTEINS; MOLECULAR CHARACTERIZATION; BACTERIAL INJECTISOMES; VIRULENCE FACTORS	Bacteria that have sustained long-standing close associations with eukaryotic hosts have evolved specific adaptations to survive and replicate in this environment. Perhaps one of the most remarkable of those adaptations is the type III secretion system (T3SS) - a bacterial organelle that has specifically evolved to deliver bacterial proteins into eukaryotic cells. Although originally identified in a handful of pathogenic bacteria, T3SSs are encoded by a large number of bacterial species that are symbiotic or pathogenic for humans, other animals including insects or nematodes, and plants. The study of these systems is leading to unique insights into not only organelle assembly and protein secretion but also mechanisms of symbiosis and pathogenesis.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden	Yale University; Umea University	Galan, JE (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA.	jorge.galan@yale.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030492] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI030492] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Collazo CM, 1996, INFECT IMMUN, V64, P3524, DOI 10.1128/IAI.64.9.3524-3531.1996; Cordes FS, 2005, J MOL BIOL, V354, P206, DOI 10.1016/j.jmb.2005.09.062; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Crago AM, 1998, MOL MICROBIOL, V30, P47, DOI 10.1046/j.1365-2958.1998.01036.x; Crepin VF, 2005, J BACTERIOL, V187, P2881, DOI 10.1128/JB.187.8.2881-2889.2005; Crepin VF, 2005, MOL MICROBIOL, V55, P1658, DOI 10.1111/j.1365-2958.2005.04508.x; Daefler S, 1998, MOL MICROBIOL, V28, P1367, DOI 10.1046/j.1365-2958.1998.00908.x; Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x; Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x; Demers B, 1998, EMBO J, V17, P2894, DOI 10.1093/emboj/17.10.2894; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Francis MS, 2002, CURR OPIN MICROBIOL, V5, P166, DOI 10.1016/S1369-5274(02)00301-6; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Goehring UM, 1999, J BIOL CHEM, V274, P36369, DOI 10.1074/jbc.274.51.36369; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Iriarte M, 1998, EMBO J, V17, P1907, DOI 10.1093/emboj/17.7.1907; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; LI J, 1995, P NATL ACAD SCI USA, V92, P7252, DOI 10.1073/pnas.92.16.7252; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717; Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005; Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; O'Connell CB, 2004, MOL MICROBIOL, V52, P1613, DOI 10.1111/j.1365-2958.2004.04101.x; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; Russmann H, 2002, MOL MICROBIOL, V46, P769, DOI 10.1046/j.1365-2958.2002.03196.x; Russmann H, 1998, SCIENCE, V281, P565, DOI 10.1126/science.281.5376.565; Saier MH, 2004, TRENDS MICROBIOL, V12, P113, DOI 10.1016/j.tim.2004.01.003; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Sorg JA, 2005, CELL MICROBIOL, V7, P1217, DOI 10.1111/j.1462-5822.2005.00563.x; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stebbins CE, 2003, NAT REV MOL CELL BIO, V4, P738, DOI 10.1038/nrm1201; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Woestyn S, 1996, MOL MICROBIOL, V20, P1261, DOI 10.1111/j.1365-2958.1996.tb02645.x; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; Wurtele M, 2001, NAT STRUCT BIOL, V8, P23; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554	84	790	829	4	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2006	444	7119					567	573		10.1038/nature05272	http://dx.doi.org/10.1038/nature05272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136086				2022-12-28	WOS:000242377600038
J	Grady, D				Grady, Deborah			Management of menopausal symptoms	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONJUGATED EQUINE ESTROGENS; HORMONE REPLACEMENT THERAPY; MILD COGNITIVE IMPAIRMENT; HOT FLASHES; POSTMENOPAUSAL WOMEN; BREAST-CANCER; DOUBLE-BLIND; VASOMOTOR SYMPTOMS; VAGINAL ATROPHY; PLUS PROGESTIN		Univ Calif San Francisco, Womens Hlth Clin Res Ctr, San Francisco, CA 94115 USA; San Francisco VA Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Grady, D (corresponding author), Univ Calif San Francisco, Womens Hlth Clin Res Ctr, 1635 Divisadero St,Suite 600, San Francisco, CA 94115 USA.							Aiello EJ, 2004, MENOPAUSE, V11, P382, DOI 10.1097/01.GME.0000113932.56832.27; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Avis NE, 2001, SOC SCI MED, V52, P345, DOI 10.1016/S0277-9536(00)00147-7; Barton DL, 1998, J CLIN ONCOL, V16, P495, DOI 10.1200/JCO.1998.16.2.495; Cardozo L, 1998, OBSTET GYNECOL, V92, P722, DOI 10.1016/S0029-7844(98)00175-6; CASPER RF, 1985, CLIN ENDOCRINOL, V22, P293, DOI 10.1111/j.1365-2265.1985.tb03243.x; Dennerstein L, 2000, OBSTET GYNECOL, V96, P351, DOI 10.1016/S0029-7844(00)00930-3; EPOCRATES, EPOCRATES RX PRO LIS; Ettinger Bruce, 2005, Am J Med, V118 Suppl 12B, P74, DOI 10.1016/j.amjmed.2005.09.035; Evans ML, 2005, OBSTET GYNECOL, V105, P161, DOI 10.1097/01.AOG.0000147840.06947.46; FREEDMAN RR, 1992, AM J OBSTET GYNECOL, V167, P436, DOI 10.1016/S0002-9378(11)91425-2; Gold EB, 2000, AM J EPIDEMIOL, V152, P463, DOI 10.1093/aje/152.5.463; Goldberg, 1996, J CLIN ONCOL, V14, P2411, DOI 10.1200/JCO.1996.14.8.2411; GOLDBERG RM, 1994, J CLIN ONCOL, V12, P155, DOI 10.1200/JCO.1994.12.1.155; Gomes MPV, 2004, ARCH INTERN MED, V164, P1965, DOI 10.1001/archinte.164.18.1965; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; Grady Deborah, 2005, Am J Med, V118 Suppl 12B, P163, DOI 10.1016/j.amjmed.2005.09.051; Guttuso T, 2003, OBSTET GYNECOL, V101, P337, DOI 10.1016/S0029-7844(02)02712-6; Henriksson L, 1996, AM J OBSTET GYNECOL, V174, P85, DOI 10.1016/S0002-9378(96)70378-2; Jin Y, 2005, JNCI-J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; Judd HL, 1996, JAMA-J AM MED ASSOC, V275, P370, DOI 10.1001/jama.1996.03530290040035; Kimmick GG, 2006, BREAST J, V12, P114, DOI 10.1111/j.1075-122X.2006.00218.x; Kronenberg F, 2002, ANN INTERN MED, V137, P805, DOI 10.7326/0003-4819-137-10-200211190-00009; KRONENBERG F, 1990, ANN NY ACAD SCI, V592, P52; KRONENBERG F, 1992, J THERM BIOL, V17, P43, DOI 10.1016/0306-4565(92)90018-B; KRONENBERG F, 1990, ANN NY ACAD SCI, V592, P123; Landgren MB, 2005, MATURITAS, V50, P222, DOI 10.1016/j.maturitas.2004.06.001; LEIBLUM S, 1983, JAMA-J AM MED ASSOC, V249, P2195, DOI 10.1001/jama.249.16.2195; Lethaby A., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000402, DOI 10.1002/14651858.CD000402, 10.1002/14651858.CD000402.pub2]; Loprinzi CL, 2002, J CLIN ONCOL, V20, P1578, DOI 10.1200/JCO.20.6.1578; Loprinzi CL, 2000, LANCET, V356, P2059, DOI 10.1016/S0140-6736(00)03403-6; LOPRINZI CL, 1994, NEW ENGL J MED, V331, P347, DOI 10.1056/NEJM199408113310602; Low Dog Tieraona, 2005, Am J Med, V118 Suppl 12B, P98; *N AM MEN SOC, 2004, MENOPAUSE, V11, P589; NACHTIGALL LE, 1994, FERTIL STERIL, V61, P178; Nelson H D, 2005, Evid Rep Technol Assess (Summ), P1; Nelson HD, 2004, JAMA-J AM MED ASSOC, V291, P1610, DOI 10.1001/jama.291.13.1610; Nikander E, 2005, FERTIL STERIL, V83, P137, DOI 10.1016/j.fertnstert.2004.09.003; Notelovitz M, 2000, OBSTET GYNECOL, V95, P726, DOI 10.1016/S0029-7844(99)00643-2; Pandya KJ, 2005, LANCET, V366, P818, DOI 10.1016/S0140-6736(05)67215-7; Pandya KJ, 2000, ANN INTERN MED, V132, P788, DOI 10.7326/0003-4819-132-10-200005160-00004; Randolph JF, 2004, J CLIN ENDOCR METAB, V89, P1555, DOI 10.1210/jc.2003-031183; Rioux JE, 2000, MENOPAUSE, V7, P156, DOI 10.1097/00042192-200007030-00005; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SCHIFF I, 1980, JAMA-J AM MED ASSOC, V244, P1443, DOI 10.1001/jama.244.13.1443; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Society of Obstetricians and Gynaecologists of Canada, 2005, Int J Gynaecol Obstet, V88, P222; Soules MR, 2005, MENOPAUSE, V12, P117, DOI 10.1097/00042192-200512020-00001; Stearns V, 2005, J CLIN ONCOL, V23, P6919, DOI 10.1200/JCO.2005.10.081; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Stearns V, 2003, JAMA-J AM MED ASSOC, V289, P2827, DOI 10.1001/jama.289.21.2827; Stephenson J, 2003, JAMA-J AM MED ASSOC, V289, P537, DOI 10.1001/jama.289.5.537; SUCKLING J, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001500.PUB2; Suvanto-Luukkonen E, 2005, MENOPAUSE, V12, P18, DOI 10.1097/00042192-200512010-00006; Utian WH, 1999, AM J OBSTET GYNECOL, V181, P71, DOI 10.1016/S0002-9378(99)70438-2; Utian WH, 2001, FERTIL STERIL, V75, P1065, DOI 10.1016/S0015-0282(01)01791-5; *WOM HLTH IN, SCI RES WEBS; *WRIT GROUP PEPI T, 1996, ARCH INTERN MED, V275, P370; 2004, QUESTIONS ANSWERS HO	60	115	126	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2338	2347		10.1056/NEJMcp054015	http://dx.doi.org/10.1056/NEJMcp054015			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110CG	17135587				2022-12-28	WOS:000242355300009
J	Hampson, LA; Agrawal, M; Joffe, S; Gross, CP; Verter, J; Emanuel, EJ				Hampson, Lindsay A.; Agrawal, Manish; Joffe, Steven; Gross, Cary P.; Verter, Joel; Emanuel, Ezekiel J.			Patients' views on financial conflicts of interest in cancer research trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POTENTIAL RESEARCH PARTICIPANTS; ACADEMIC MEDICAL-CENTERS; INFORMED CONSENT; TRUST; PHYSICIANS; DISCLOSURE; PROFESSION	BACKGROUND: Financial ties between researchers or medical centers and companies whose drugs are being tested have come under increasing scrutiny. METHODS: We conducted in-person interviews with 253 patients in cancer-research trials (a 93% response rate) at five U.S. medical centers to determine their attitudes regarding potential financial conflicts of interest among researchers and medical centers. RESULTS: More than 90% of patients expressed little or no worry about financial ties that researchers or institutions might have with drug companies. Most patients said they would have enrolled in the trial even if the drug company had paid the researcher for speaking (82% of those interviewed) or consulting (75%) or if the researcher had received royalty payments (70%) or owned stock in the company (76%). Similarly, most patients would have enrolled in the trial if their cancer center had owned stock in the drug company (77%) or received royalty payments from the company (79%). Most patients believed it was ethical for researchers to receive speaking fees (81%) or consulting fees (82%) from the company. However, a substantial minority of patients wanted disclosure of the oversight system for researchers (40%) and of researchers' financial interests (31%); 17% thought no disclosure to patients was necessary. CONCLUSIONS: Most patients in cancer-research trials were not worried about financial ties between researchers or medical centers and drug companies and would still have enrolled in the trial if they had known about such financial ties. A substantial minority wanted to be informed about the oversight system to protect against financial conflicts of interest and about researchers' financial interests.	NIH, Dept Clin Bioeth, Ctr Clin, Bethesda, MD 20892 USA; Univ Michigan, Sch Med, Ann Arbor, MI USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA; Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT USA; Stat Collaborat, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Yale University; Yale University	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, Ctr Clin, Bldg 10,Rm 1C118, Bethesda, MD 20892 USA.	eemanuel@nih.gov	Hampson, Lindsay A./GZL-8235-2022; Joffe, Steven/H-3941-2019	Hampson, Lindsay A./0000-0002-0740-7984; Joffe, Steven/0000-0002-0667-7384				ANGELL M, 2000, HHS C HUM SUBJ PROT; Balkrishnan R, 2003, MED CARE, V41, P1058, DOI 10.1097/01.MLR.0000083743.15238.9F; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; *COUNC ETH JUD AFF, 2000, MAN CONFL INT COND C; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; *DEP HHS, 2003, FED REGISTER, V68, P15456; Forster HP, 2001, LANCET, V358, P1449, DOI 10.1016/S0140-6736(01)06534-5; Foster RS, 2003, J AM COLL SURGEONS, V196, P505, DOI 10.1016/S1072-7515(03)00110-8; Hall MA, 2002, MED CARE RES REV, V59, P293, DOI 10.1177/1077558702059003004; Hall MA, 2001, MILBANK Q, V79, P613, DOI 10.1111/1468-0009.00223; Hall MA, 2002, HEALTH SERV RES, V37, P1419, DOI 10.1111/1475-6773.01070; Hall MA, 2003, MED CARE RES REV, V60, P118; HORSTMANN E, 2004, 2004 ASCO ANN M P S, V22, P6059; Jellinek Michael S, 1982, IRB, V4, P9, DOI 10.2307/3564273; Kim SYH, 2004, J MED ETHICS, V30, P73, DOI 10.1136/jme.2002.001461; LAPUMA J, 1995, BRIT MED J, V310, P1660, DOI 10.1136/bmj.310.6995.1660; LAPUMA J, 1995, BRIT MED J, V311, P373; *NAT I MENT HLTH, 2004, SUMM ALL RES PROGR M; RODWIN MA, 1989, NEW ENGL J MED, V321, P1405, DOI 10.1056/NEJM198911163212010; Roizen Ron, 1988, IRB, V10, P9, DOI 10.2307/3564103; ROTHMAN KJ, 1993, JAMA-J AM MED ASSOC, V269, P2782, DOI 10.1001/jama.269.21.2782; SPIRO HM, 1986, JAMA-J AM MED ASSOC, V255, P1174; *TASK FORC FIN CON, 2001, PROT SUBJ PRES TRUST; Task Force on Research Accountability, 2001, REP IND I FIN CONFL; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; Ubel PA, 1997, SOC SCI MED, V44, P647, DOI 10.1016/S0277-9536(96)00217-1; Weinfurt KP, 2006, J GEN INTERN MED, V21, P901, DOI 10.1111/j.1525-1497.2006.00502.x; Weinfurt KP, 2006, ACAD MED, V81, P113, DOI 10.1097/00001888-200602000-00003; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019; *WORLD MED ASS, 2006, DECL HELS; Zubrod C.G., 1960, J CHRON DIS, V11, P7	33	100	103	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2330	2337		10.1056/NEJMsa064160	http://dx.doi.org/10.1056/NEJMsa064160			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	110CG	17135586	Bronze			2022-12-28	WOS:000242355300008
J	Shaffer, CH				Shaffer, Catherine H.			The charge-up man - Last delivery before the Singularity.	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2006	444	7119					652	652		10.1038/444652a	http://dx.doi.org/10.1038/444652a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136095	Bronze			2022-12-28	WOS:000242377600054
J	Guerado, E; Aguiar, F				Guerado, Enrique; Aguiar, Francisco			Rectum compression by a gluteal lipoma	LANCET			English	Editorial Material									Hosp Costa Sol, Dept Trauma & Orthopaed Surg, Malaga 29600, Spain		Guerado, E (corresponding author), Hosp Costa Sol, Dept Trauma & Orthopaed Surg, Malaga 29600, Spain.	equerado@hcs.es		Guerado, Enrique/0000-0002-8711-5307					0	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2006	368	9550					1893	1893		10.1016/S0140-6736(06)69779-1	http://dx.doi.org/10.1016/S0140-6736(06)69779-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	109YQ	17126722				2022-12-28	WOS:000242345900031
J	Nyanzi, S				Nyanzi, Stella			From minuscule biomedical models to sexuality's depths	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Publ Hlth & Policy Dept, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Nyanzi, S (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Publ Hlth & Policy Dept, Keppel St, London WC1E 7HT, England.	snyanzi@yahoo.com		Nyanzi, Stella/0000-0002-6400-4014				Aggleton, 2000, FRAMING SEXUAL SUBJE, P241; BOYCE P, 2006, 16 INT AIDS C TOR CA; Caceres C, 1996, BISEXUALITIES AIDS I, P136; DIXONMUELLER R, 1993, STUD FAMILY PLANN, V24, P269, DOI 10.2307/2939221; Jackson S, 1997, SOCIOL REV, V45, P551, DOI 10.1111/1467-954X.00077; Miller A., 2000, HLTH HUMAN RIGHTS, V4, P69; Nyanzi S, 2004, CULT HEALTH SEX, V6, P239, DOI 10.1080/13691050310001658208; Parker Richard, 2000, FRAMING SEXUAL SUBJE; VANCE CS, 1991, SOC SCI MED, V33, P875, DOI 10.1016/0277-9536(91)90259-F; VANCE CS, 1992, PLEASURE DANGER EXPL; Weeks J., 1985, SEXUALITY ITS DISCON	11	2	2	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1851	1852		10.1016/S0140-6736(06)69754-7	http://dx.doi.org/10.1016/S0140-6736(06)69754-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126702				2022-12-28	WOS:000242345900008
J	Shen, QH; Saijo, Y; Mauch, S; Biskup, C; Bieri, S; Keller, B; Seki, H; Ulker, B; Somssich, IE; Schulze-Lefert, P				Shen, Qian-Hua; Saijo, Yusuke; Mauch, Stefan; Biskup, Christoph; Bieri, Stephane; Keller, Beat; Seki, Hikaru; Uelker, Bekir; Somssich, Imre E.; Schulze-Lefert, Paul			Nuclear activity of MLA immune receptors links isolate-specific and basal disease-resistance responses	SCIENCE			English	Article							WRKY TRANSCRIPTION FACTORS; POWDERY MILDEW FUNGUS; PSEUDOMONAS-SYRINGAE; SIGNALING PATHWAYS; DNA-BINDING; MAP KINASE; BARLEY; ARABIDOPSIS; PLANT; PROTEINS	Plant immune responses are triggered by pattern recognition receptors that detect conserved pathogen-associated molecular patterns (PAMPs) or by resistance ( R) proteins recognizing isolate-specific pathogen effectors. We show that in barley, intracellular mildew A (MLA) R proteins function in the nucleus to confer resistance against the powdery mildew fungus. Recognition of the fungal avirulence A10 effector by MLA10 induces nuclear associations between receptor and WRKY transcription factors. The identified WRKY proteins act as repressors of PAMP-triggered basal defense. MLA appears to interfere with the WRKY repressor function, thereby de-repressing PAMP-triggered basal defense. Our findings reveal a mechanism by which these polymorphic immune receptors integrate distinct pathogen signals.	Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany; Univ Jena, Inst Physiol 2, D-07740 Jena, Germany; Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland	Max Planck Society; Friedrich Schiller University of Jena; University of Zurich	Schulze-Lefert, P (corresponding author), Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, Carl Von Linne Weg 10, D-50829 Cologne, Germany.	schlef@mpiz-koeln.mpg.de	Bruening, Stefan/B-8505-2011; Keller, Beat/K-3093-2019; Schulze-Lefert, Paul/A-7746-2008; Seki, Hikaru/C-9730-2017; Schulze-Lefert, Paul/B-6707-2011; Somssich, Imre/GLT-3738-2022; Shen, Qian-Hua/D-2734-2013	Keller, Beat/0000-0003-2379-9225; Somssich, Imre/0000-0003-3066-5794; Shen, Qian-Hua/0000-0002-9446-3086				Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Cormack RS, 2002, BBA-GENE STRUCT EXPR, V1576, P92, DOI 10.1016/S0167-4781(02)00298-1; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; Eckey C, 2004, PLANT MOL BIOL, V55, P1, DOI 10.1007/s11103-004-0275-2; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; GORG R, 1993, PLANT J, V3, P857, DOI 10.1111/j.1365-313X.1993.00857.x; Halterman D, 2001, PLANT J, V25, P335, DOI 10.1046/j.1365-313x.2001.00982.x; Halterman DA, 2004, PLANT J, V38, P215, DOI 10.1111/j.1365-313X.2004.02032.x; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Leister RT, 2005, PLANT CELL, V17, P1268, DOI 10.1105/tpc.104.029637; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Schulze-Lefert P, 2004, CURR BIOL, V14, pR22, DOI 10.1016/j.cub.2003.12.017; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337	34	527	577	5	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1098	1103		10.1126/science.1136372	http://dx.doi.org/10.1126/science.1136372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17185563	Green Published			2022-12-28	WOS:000244387600029
J	Christensen, UR				Christensen, Ulrich R.			A deep dynamo generating Mercury's magnetic field	NATURE			English	Article							CONVECTION; GEODYNAMO; SHELL; CORE; REVERSALS	Mercury has a global magnetic field of internal origin and it is thought that a dynamo operating in the fluid part of Mercury's large iron core is the most probable cause. However, the low intensity of Mercury's magnetic field-about 1% the strength of the Earth's field-cannot be reconciled with an Earth-like dynamo. With the common assumption that Coriolis and Lorentz forces balance in planetary dynamos(1), a field thirty times stronger is expected. Here I present a numerical model of a dynamo driven by thermo-compositional convection associated with inner core solidification. The thermal gradient at the core mantle boundary is subadiabatic(2,3), and hence the outer region of the liquid core is stably stratified with the dynamo operating only at depth, where a strong field is generated. Because of the planet's slow rotation the resulting magnetic field is dominated by small-scale components that fluctuate rapidly with time. The dynamo field diffuses through the stable conducting region, where rapidly varying parts are strongly attenuated by the skin effect, while the slowly varying dipole and quadrupole components pass to some degree. The model explains the observed structure and strength of Mercury's surface magnetic field and makes predictions that are testable with space missions both presently flying and planned.	Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany	Max Planck Society	Christensen, UR (corresponding author), Max Planck Inst Solar Syst Res, Max Planck Str 2, D-37191 Katlenburg Lindau, Germany.	christensen@mps.mpg.de						Aharonson O, 2004, EARTH PLANET SC LETT, V218, P261, DOI 10.1016/S0012-821X(03)00682-4; BRAGINSKY SI, 1995, GEOPHYS ASTRO FLUID, V79, P1, DOI 10.1080/03091929508228992; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Christensen UR, 2004, NATURE, V429, P169, DOI 10.1038/nature02508; CONNERNEY JEP, 1988, MERCURY, P494; Hauck SA, 2004, EARTH PLANET SC LETT, V222, P713, DOI 10.1016/j.epsl.2004.03.037; Heimpel MH, 2005, EARTH PLANET SC LETT, V236, P542, DOI 10.1016/j.epsl.2005.04.032; HOLLERBACH R, 1993, NATURE, V365, P541, DOI 10.1038/365541a0; Kutzner C, 2004, GEOPHYS J INT, V157, P1105, DOI 10.1111/j.1365-246X.2004.02309.x; LISTER JR, 1995, PHYS EARTH PLANET IN, V91, P17, DOI 10.1016/0031-9201(95)03042-U; NESS NF, 1979, PHYS EARTH PLANET IN, V20, P209, DOI 10.1016/0031-9201(79)90044-X; Olsen N, 2006, GEOPHYS J INT, V166, P67, DOI 10.1111/j.1365-246X.2006.02959.x; Olson P, 2006, EARTH PLANET SC LETT, V250, P561, DOI 10.1016/j.epsl.2006.08.008; Peale SJ, 2002, METEORIT PLANET SCI, V37, P1269, DOI 10.1111/j.1945-5100.2002.tb00895.x; Schubert G., 1988, MERCURY, P429; Stanley S, 2005, EARTH PLANET SC LETT, V234, P27, DOI 10.1016/j.epsl.2005.02.040; Stevenson DJ, 2003, EARTH PLANET SC LETT, V208, P1, DOI 10.1016/S0012-821X(02)01126-3; Takahashi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025792; TURNER JS, 1973, BUOYANCY EFFECTS FLU, pCH8; Van Hoolst T, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002126; Zhang KK, 2000, SCIENCE, V290, P1944, DOI 10.1126/science.290.5498.1944	22	166	166	4	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1056	1058		10.1038/nature05342	http://dx.doi.org/10.1038/nature05342			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183319				2022-12-28	WOS:000242971100052
J	Della Valle, M; Chincarini, G; Panagia, N; Tagliaferri, G; Malesani, D; Testa, V; Fugazza, D; Campana, S; Covino, S; Mangano, V; Antonelli, LA; D'Avanzo, P; Hurley, K; Mirabel, IF; Pellizza, LJ; Piranomonte, S; Stella, L				Della Valle, M.; Chincarini, G.; Panagia, N.; Tagliaferri, G.; Malesani, D.; Testa, V.; Fugazza, D.; Campana, S.; Covino, S.; Mangano, V.; Antonelli, L. A.; D'Avanzo, P.; Hurley, K.; Mirabel, I. F.; Pellizza, L. J.; Piranomonte, S.; Stella, L.			An enigmatic long-lasting gamma-ray burst not accompanied by a bright supernova	NATURE			English	Article								Gamma-ray bursts (GRBs) are short, intense flashes of soft gamma-rays coming from the distant Universe. Long-duration GRBs ( those lasting more than similar to 2 s) are believed to originate from the deaths of massive stars 1, mainly on the basis of a handful of solid associations between GRBs and supernovae(2-7). GRB 060614, one of the closest GRBs discovered, consisted of a 5-s hard spike followed by softer, brighter emission that lasted for similar to 100 s (refs 8, 9). Here we report deep optical observations of GRB 060614 showing no emerging supernova with absolute visual magnitude brighter than M-V = -13.7. Any supernova associated with GRB 060614 was therefore at least 100 times fainter, at optical wavelengths, than the other supernovae associated with GRBs(10). This demonstrates that some long-lasting GRBs can either be associated with a very faint supernova or produced by different phenomena.	Osserv Astrofis Arcetri, INAF, I-50125 Florence, Italy; Univ Milano Bicocca, Dipartimento Fis, I-20126 Milan, Italy; Osserv Astron Brera, INAF, I-23807 Merate, Lc, Italy; Space Telescope Sci Inst, Baltimore, MD 21218 USA; Ist Nazl Astrofis, I-00136 Rome, Italy; Supernova Ltd, Virgin Gorda, VI USA; SISSA, ISAS, I-34014 Trieste, Italy; Osserv Astron Roma, INAF, I-00040 Rome, Italy; Ist Astrofis Spaziale & Fis Cosm, INAF, I-90146 Palermo, Italy; ASI Sci Data Ctr, I-00044 Frascati, Italy; Univ Insubria, Dipartimento Matemat & Fis, I-22100 Como, Italy; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; European So Observ, Santiago 19, Chile; Univ Buenos Aires, CONICET, Inst Astron & Fis Espacio, RA-1428 Buenos Aires, DF, Argentina	Istituto Nazionale Astrofisica (INAF); University of Milano-Bicocca; Istituto Nazionale Astrofisica (INAF); Space Telescope Science Institute; Istituto Nazionale Astrofisica (INAF); International School for Advanced Studies (SISSA); Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Agenzia Spaziale Italiana (ASI); University of Insubria; University of California System; University of California Berkeley; European Southern Observatory; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto de Astronomia y Fisica del Espacio (IAFE); University of Buenos Aires	Della Valle, M (corresponding author), Osserv Astrofis Arcetri, INAF, Largo E Fermi 5, I-50125 Florence, Italy.	massimo@arcetri.astro.it	Campana, Sergio/AAL-6012-2020; Covino, Stefano/AAQ-5188-2021; Della Valle, Massimo/AAE-8884-2021	Campana, Sergio/0000-0001-6278-1576; Covino, Stefano/0000-0001-9078-5507; Della Valle, Massimo/0000-0003-3142-5020				Belczynski K, 2002, ASTROPHYS J, V571, P394, DOI 10.1086/339860; Blinnikov SI, 1998, MON NOT R ASTRON SOC, V293, pL29, DOI 10.1046/j.1365-8711.1998.01251.x; Campana S, 2006, NATURE, V442, P1008, DOI 10.1038/natureO4892; Christensen L, 2004, ASTRON ASTROPHYS, V425, P913, DOI 10.1051/0004-6361:20040361; Della Valle M, 2006, ASTROPHYS J, V642, pL103, DOI 10.1086/504636; EICHLER D, 1989, NATURE, V340, P126, DOI 10.1038/340126a0; Ferrero P, 2006, ASTRON ASTROPHYS, V457, P857, DOI 10.1051/0004-6361:20065530; Foley RJ, 2003, PUBL ASTRON SOC PAC, V115, P1220, DOI 10.1086/378242; FRENCH F, 2006, 5257 GCN; Fruchter AS, 2006, NATURE, V441, P463, DOI 10.1038/nature04787; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Hamuy M, 2003, ASTROPHYS J, V582, P905, DOI 10.1086/344689; Hjorth J, 2003, NATURE, V423, P847, DOI 10.1038/nature01750; MALESANI D, 2004, APJ, V609, P5; Nomoto K, 2004, ASTROPHYS SPACE SC L, V302, P277; Panagia N, 2003, LECT NOTES PHYS, V598, P113; PARSONS AM, 2006, 5252 GCN; Pastorello A, 2004, MON NOT R ASTRON SOC, V347, P74, DOI 10.1111/j.1365-2966.2004.07173.x; Patat F, 2001, ASTROPHYS J, V555, P900, DOI 10.1086/321526; Pian E, 2006, NATURE, V442, P1011, DOI 10.1038/nature05082; PRICE PA, 2006, 5275 GCN; Romaniello M, 2002, ASTRON J, V123, P915, DOI 10.1086/338430; Stanek KZ, 2003, ASTROPHYS J, V591, pL17, DOI 10.1086/376976; Vietri M, 1998, ASTROPHYS J, V507, pL45, DOI 10.1086/311674; Woosley SE, 2006, ANNU REV ASTRON ASTR, V44, P507, DOI 10.1146/annurev.astro.43.072103.150558; Woosley SE, 2003, AIP CONF PROC, V662, P185	26	328	329	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1050	1052		10.1038/nature05374	http://dx.doi.org/10.1038/nature05374			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183317	Green Published			2022-12-28	WOS:000242971100050
J	Noguera-Troise, I; Daly, C; Papadopoulos, NJ; Coetzee, S; Boland, P; Gale, NW; Lin, HC; Yancopoulos, GD; Thurston, G				Noguera-Troise, Irene; Daly, Christopher; Papadopoulos, Nicholas J.; Coetzee, Sandra; Boland, Pat; Gale, Nicholas W.; Lin, Hsin Chieh; Yancopoulos, George D.; Thurston, Gavin			Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis	NATURE			English	Article							CLINICAL-TRIALS; VEGF-TRAP; NOTCH; VASCULATURE; MOUSE; EXPRESSION; RESISTANCE; LETHALITY; THERAPY; PROTEIN	Tumour growth requires accompanying expansion of the host vasculature, with tumour progression often correlated with vascular density. Vascular endothelial growth factor (VEGF) is the best-characterized inducer of tumour angiogenesis. We report that VEGF dynamically regulates tumour endothelial expression of Delta-like ligand 4 (Dll4), which was previously shown to be absolutely required for normal embryonic vascular development. To define Dll4 function in tumour angiogenesis, we manipulated this pathway in murine tumour models using several approaches. Here we show that blockade resulted in markedly increased tumour vascularity, associated with enhanced angiogenic sprouting and branching. Paradoxically, this increased vascularity was non-productive - as shown by poor perfusion and increased hypoxia, and most importantly, by decreased tumour growth - even for tumours resistant to anti-VEGF therapy. Thus, VEGF-induced Dll4 acts as a negative regulator of tumour angiogenesis; its blockade results in a striking uncoupling of tumour growth from vessel density, presenting a novel therapeutic approach even for tumours resistant to anti-VEGF therapies.	Regeneron Pharmaceut Inc, Res Labs, Tarrytown, NY 10591 USA	Regeneron	Thurston, G (corresponding author), Regeneron Pharmaceut Inc, Res Labs, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	Gavin.Thurston@Regeneron.com	Wang, Zegen/H-3018-2011	Thurston, Gavin/0000-0002-4105-5919; Daly, Christopher/0000-0003-3800-8174				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Folkman J, 1992, Semin Cancer Biol, V3, P65; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gridley T, 2001, P NATL ACAD SCI USA, V98, P5377, DOI 10.1073/pnas.101138098; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jain Rakesh K, 2005, Oncology (Williston Park), V19, P7; Jain RK, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37265; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Karsan A, 2005, CAN J PHYSIOL PHARM, V83, P14, DOI 10.1139/Y04-125; Kerbel RS, 2001, CANCER METAST REV, V20, P79, DOI 10.1023/A:1013172910858; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Krneta J, 2006, CANCER RES, V66, P5686, DOI 10.1158/0008-5472.CAN-05-3821; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Laskin JJ, 2005, ONCOLOGY-NY, V19, P1671; Lee CG, 2000, CANCER RES, V60, P5565; Liu ZJ, 2006, FASEB J, V20, P1009, DOI 10.1096/fj.05-4880fje; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Rudge JS, 2005, COLD SH Q B, V70, P411, DOI 10.1101/sqb.2005.70.052; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Shawber CJ, 2003, ANN NY ACAD SCI, V995, P162, DOI 10.1111/j.1749-6632.2003.tb03219.x; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Thurston G, 1996, AM J PHYSIOL-HEART C, V271, pH2547, DOI 10.1152/ajpheart.1996.271.6.H2547; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	34	802	914	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1032	1037		10.1038/nature05355	http://dx.doi.org/10.1038/nature05355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183313				2022-12-28	WOS:000242971100046
J	Cromie, GA; Hyppa, RW; Taylor, AF; Zakharyevich, K; Hunter, N; Smith, GR				Cromie, Gareth A.; Hyppa, Randy W.; Taylor, Andrew F.; Zakharyevich, Kseniya; Hunter, Neil; Smith, Gerald R.			Single Holliday junctions are intermediates of meiotic recombination	CELL			English	Article							DOUBLE-STRAND BREAKS; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GENE CONVERSION; CROSSING-OVER; FISSION YEAST; REPLICATION ORIGINS; DNA-DAMAGE; S.-POMBE	Crossing-over between homologous chromosomes facilitates their accurate segregation at the first division of meiosis. Current models for crossing-over invoke an intermediate in which homologs are connected by two crossed-strand structures called Holliday junctions. Such double Holliday junctions are a prominent intermediate in Saccharomyces cerevisiae meiosis, where they form preferentially between homologs rather than between sister chromatids. In sharp contrast, we find that single Holliday junctions are the predominant intermediate in Schizosaccharomyces pombe meiosis. Furthermore, these single Holliday junctions arise preferentially between sister chromatids rather than between homologs. We show that Mus81 is required for Holliday junction resolution, providing further in vivo evidence that the structure-specific endonuclease Mus81-Eme1 is a Holliday junction resolvase. To reconcile these observations, we present a unifying recombination model applicable for both meiosis and mitosis in which single Holliday junctions arise from single- or double-strand breaks, lesions postulated by previous models to initiate recombination.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA	Fred Hutchinson Cancer Center; University of California System; University of California Davis; University of California System; University of California Davis	Smith, GR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,POB 19024, Seattle, WA 98109 USA.	gsmith@fhcrc.org		Smith, Gerald/0000-0002-8747-1352	NIGMS NIH HHS [R01 GM074223, R56 GM031693, R01 GM031693, R01 GM074223-02, GM074223, GM031693, R01 GM031693-25] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031693, R56GM031693, R01GM074223] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; BENSON FE, 1994, J BIOL CHEM, V269, P5195; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Cromie GA, 2005, GENETICS, V169, P595, DOI 10.1534/genetics.104.037176; de los Santos T, 2003, GENETICS, V164, P81; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; DEVEAUX LC, 1992, GENETICS, V130, P251; Doe CL, 2002, J BIOL CHEM, V277, P32753, DOI 10.1074/jbc.M202120200; Fogg JM, 1999, BIOCHEMISTRY-US, V38, P11349, DOI 10.1021/bi990926n; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; GRIMM C, 1994, GENETICS, V136, P41; Her C, 2001, MAMM GENOME, V12, P73, DOI 10.1007/s003350010231; Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kunz C, 2004, CURR BIOL, V14, pR962, DOI 10.1016/j.cub.2004.10.043; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; MESELSON MS, 1975, P NATL ACAD SCI USA, V72, P358, DOI 10.1073/pnas.72.1.358; MUNZ P, 1994, GENETICS, V137, P701; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; RADDING CM, 1982, ANNU REV GENET, V16, P405, DOI 10.1146/annurev.ge.16.120182.002201; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; SCHUCHERT P, 1988, GENETICS, V119, P507; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; Smith GR, 2003, GENETICS, V165, P2289; Steiner WW, 2002, MOL CELL, V9, P847, DOI 10.1016/S1097-2765(02)00489-6; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TEASE C, 1979, CHROMOSOMA, V73, P75, DOI 10.1007/BF00294847; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762; Young JA, 2002, MOL CELL, V9, P253, DOI 10.1016/S1097-2765(02)00452-5	48	154	162	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1167	1178		10.1016/j.cell.2006.09.050	http://dx.doi.org/10.1016/j.cell.2006.09.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174892	Green Accepted, Bronze			2022-12-28	WOS:000242991000015
J	Lollar, BS; McCollom, TM				Lollar, Barbara Sherwood; McCollom, Thomas M.			Geochemistry - Biosignatures and abiotic constraints on early life	NATURE			English	Letter							HYDROTHERMAL CONDITIONS; HYDROCARBONS; METHANE; CARBON		Univ Toronto, Dept Geol, Toronto, ON M5S 3B1, Canada; Univ Colorado, Ctr Astrobiol, Boulder, CO 80309 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	University of Toronto; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Lollar, BS (corresponding author), Univ Toronto, Dept Geol, Toronto, ON M5S 3B1, Canada.	bslollar@chem.utoronto.ca						Brasier MD, 2005, PRECAMBRIAN RES, V140, P55, DOI 10.1016/j.precamres.2005.06.008; Foustoukos DI, 2004, SCIENCE, V304, P1002, DOI 10.1126/science.1096033; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; Lindsay JF, 2005, PRECAMBRIAN RES, V143, P1, DOI 10.1016/j.precamres.2005.09.003; Lollar BS, 2006, CHEM GEOL, V226, P328, DOI 10.1016/j.chemgeo.2005.09.027; Lollar BS, 2002, NATURE, V416, P522, DOI 10.1038/416522a; McCollom TM, 2006, EARTH PLANET SC LETT, V243, P74, DOI 10.1016/j.epsl.2006.01.027; McCollom TM, 2003, GEOCHIM COSMOCHIM AC, V67, P3625, DOI 10.1016/S0016-7037(03)00136-4; McCollom TM, 2001, GEOCHIM COSMOCHIM AC, V65, P3769, DOI 10.1016/S0016-7037(01)00655-X; Ueno Y, 2006, NATURE, V440, P516, DOI 10.1038/nature04584	10	24	25	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					E18	E18		10.1038/nature05499	http://dx.doi.org/10.1038/nature05499			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167427				2022-12-28	WOS:000242805400037
J	Rosen, ED; Spiegelman, BM				Rosen, Evan D.; Spiegelman, Bruce M.			Adipocytes as regulators of energy balance and glucose homeostasis	NATURE			English	Review							INDUCED INSULIN-RESISTANCE; FATTY-ACID OXIDATION; ACTIVATED PROTEIN-KINASE; BROWN ADIPOSE-TISSUE; TOTAL-BODY FAT; PPAR-GAMMA; IN-VITRO; CHEMOATTRACTANT PROTEIN-1; ADIPONECTIN RECEPTORS; TRANSCRIPTION FACTOR	Adipocytes have been studied with increasing intensity as a result of the emergence of obesity as a serious public health problem and the realization that adipose tissue serves as an integrator of various physiological pathways. In particular, their role in calorie storage makes adipocytes well suited to the regulation of energy balance. Adipose tissue also serves as a crucial integrator of glucose homeostasis. Knowledge of adipocyte biology is therefore crucial for understanding the pathophysiological basis of obesity and metabolic diseases such as type 2 diabetes. Furthermore, the rational manipulation of adipose physiology is a promising avenue for therapy of these conditions.	Dana Farber Canc Inst, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Endocrinol & Metab, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center	Spiegelman, BM (corresponding author), Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK040561-11, P30 DK040561] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Abizaid A, 2006, NEURON, V51, P691, DOI 10.1016/j.neuron.2006.08.025; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Akerblad P, 2002, MOL CELL BIOL, V22, P8015, DOI 10.1128/MCB.22.22.8015-8025.2002; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Bartness TJ, 2005, P NUTR SOC, V64, P53, DOI 10.1079/PNS2004409; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; Eldor R, 2006, DIABETES RES CLIN PR, V74, pS3, DOI 10.1016/j.diabres.2006.06.004; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Friedman J M, 1999, Harvey Lect, V95, P107; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Fukuchi K, 2004, EXP CLIN ENDOCR DIAB, V112, P601, DOI 10.1055/s-2004-830407; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Giorgino F, 2005, ACTA PHYSIOL SCAND, V183, P13, DOI 10.1111/j.1365-201X.2004.01385.x; GNUDI L, 1995, ENDOCRINOLOGY, V136, P995, DOI 10.1210/en.136.3.995; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kahn BB, 1996, DIABETES, V45, P1644, DOI 10.2337/diabetes.45.11.1644; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; Kieffer TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1, DOI 10.1152/ajpendo.2000.278.1.E1; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Mauer MM, 2001, NEUROSCI BIOBEHAV R, V25, P15, DOI 10.1016/S0149-7634(00)00047-6; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Paolisso G, 1996, J CLIN ENDOCR METAB, V81, P4244, DOI 10.1210/jc.81.12.4244; Parker MG, 2006, BIOCHEM SOC T, V34, P1103, DOI 10.1042/BST0341103; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Patel SD, 2004, SCIENCE, V304, P1154, DOI 10.1126/science.1093466; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Pond C.M., 1998, FATS LIFE; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; Simha V, 2006, CURR OPIN LIPIDOL, V17, P162, DOI 10.1097/01.mol.0000217898.52197.18; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Stephens JM, 2006, CURR OPIN LIPIDOL, V17, P128, DOI 10.1097/01.mol.0000217893.77746.4b; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Tirone TA, 2001, WORLD J SURG, V25, P461, DOI 10.1007/s002680020338; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winzell MS, 2004, BIOCHEM BIOPH RES CO, V321, P154, DOI 10.1016/j.bbrc.2004.06.130; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamada T, 2006, CELL METAB, V3, P223, DOI 10.1016/j.cmet.2006.02.001; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang HY, 2006, EXP GERONTOL, V41, P718, DOI 10.1016/j.exger.2006.06.003; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1	111	1515	1590	3	269	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					847	853		10.1038/nature05483	http://dx.doi.org/10.1038/nature05483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167472	Green Accepted			2022-12-28	WOS:000242805400041
J	Buse, K; Martin-Hilber, A; Widyantoro, N; Hawkes, SJ				Buse, Kent; Martin-Hilber, Adriane; Widyantoro, Ninuk; Hawkes, Sarah J.			Management of the politics of evidence-based sexual and reproductive health policy	LANCET			English	Editorial Material							ANTENATAL SYPHILIS; ABORTION; INDONESIA; PROGRAMS; SERVICES; AFRICA; SECTOR; REFORM		Overseas Dev Inst, Poverty & Publ Policy Grp, London SE1 7JD, England; Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; Womens Hlth Fdn, Jakarta, Indonesia; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of Bern; University of London; London School of Hygiene & Tropical Medicine	Buse, K (corresponding author), Overseas Dev Inst, Poverty & Publ Policy Grp, 111 Westminster Bridge Rd, London SE1 7JD, England.	k.buse@odi.org.uk	Buse, Kent/AAK-6688-2020; Hawkes, Sarah/AAK-7375-2020	Buse, Kent/0000-0002-5485-0110; Hawkes, Sarah/0000-0003-1062-3538				Ahmad K, 2002, LANCET, V360, P64, DOI 10.1016/S0140-6736(02)09379-0; *ARROW, 1999, TAK CAIR CHALL COUNT; Bennett LR, 2001, REPROD HEALTH MATTER, V9, P37, DOI 10.1016/S0968-8080(01)90006-0; Berer M, 2002, REPROD HEALTH MATTER, V10, P6, DOI 10.1016/S0968-8080(02)00094-0; Bruckner H, 2005, J ADOLESCENT HEALTH, V36, P271, DOI 10.1016/j.jadohealth.2005.01.005; Buse K., 2005, MAKING HLTH POLICY; Cook R, 2003, REPROD HLTH HUMAN RI; Donaldson PJ, 2002, POP STUD-J DEMOG, V56, P97, DOI 10.1080/00324720213793; GAY J, 2003, WHAT WORKS POLICY PR; Glassman A, 1999, HEALTH POLICY PLANN, V14, P115, DOI 10.1093/heapol/14.2.115; Gloyd S, 2001, HEALTH POLICY PLANN, V16, P29, DOI 10.1093/heapol/16.1.29; Grimes DA, 2004, OBSTET GYNECOL, V104, P220, DOI 10.1097/01.AOG.0000135804.89369.59; Hawkes S, 2004, B WORLD HEALTH ORGAN, V82, P417; Kirby D., 2001, EMERGING ANSWERS RES; NELSON JM, 2004, POLITICS HLTH ED REF; Ngwena C, 2004, J LAW MED ETHICS, V32, P708, DOI 10.1111/j.1748-720X.2004.tb01976.x; Oliff M, 2003, REPROD HEALTH MATTER, V11, P37, DOI 10.1016/S096-88080(03)02174-8; RAVINDRAN TKS, 2005, RIGHT REFORMS HLTH S; Roberts JM, 2002, BRIT MED J, V325, P609, DOI 10.1136/bmj.325.7365.609; SABTIER PA, 1993, POLICY CHANGE LEARNI; Santelli J, 2006, J ADOLESCENT HEALTH, V38, P72, DOI 10.1016/j.jadohealth.2005.10.006; Schneider H, 2002, AFRICAN STUDIES, V61, P145, DOI DOI 10.1080/00020180220140118; Sen Gita, 1994, POPULATION POLICIES; Shiffman J, 2003, SOC SCI MED, V56, P1197, DOI 10.1016/S0277-9536(02)00119-3; TANTCHOU J, 2000, POSTCAIRO REPROD HLT; Thapa S, 2004, REPROD HEALTH MATTER, V12, P85, DOI 10.1016/S0968-8080(04)24006-X; *UNFPA, 2004, INV PEOPL NAT PROGR; *WORLD BANK, 1993, WORLD DEV REP 1993 I; *WORLD BANK I, HLTH OUTC POOR; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2001, TRANSF HLTH SYST GEN; WYSS K, 2002, PRIMARY HLTH CARE SU	32	18	19	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 9	2006	368	9552					2101	2103		10.1016/S0140-6736(06)69837-1	http://dx.doi.org/10.1016/S0140-6736(06)69837-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114JY	17161732				2022-12-28	WOS:000242663700025
J	Shepherd, CB				Shepherd, Charles B.			Shark cartilage in the water - Effective legislation is already in place but is not being properly used	BRITISH MEDICAL JOURNAL			English	Letter												charlesbshepherd@lineone.net						Campbell D, 1997, BRIT MED J, V315, P625; DYER O, 1994, BRIT MED J, V308, P158, DOI 10.1136/bmj.308.6922.158; Waxman J, 2006, BRIT MED J, V333, P1129, DOI 10.1136/bmj.39037.692743.59	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 9	2006	333	7580					1222	1222		10.1136/bmj.39051.725162.3A	http://dx.doi.org/10.1136/bmj.39051.725162.3A			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	119JW	17158403	Green Published			2022-12-28	WOS:000243009600031
J	Bermejo, M; Rodriguez-Teijeiro, JD; Illera, G; Barroso, A; Vila, C; Walsh, PD				Bermejo, Magdalena; Rodriguez-Teijeiro, Jose Domingo; Illera, German; Barroso, Alex; Vila, Carles; Walsh, Peter D.			Ebola outbreak killed 5000 gorillas	SCIENCE			English	Article							DECLINE; VIRUS		Ecosyst Forestiers Afrique Cent ECOFAC, Libreville, Gabon; Univ Barcelona, Dept Anim Biol, ES-08028 Barcelona, Spain; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	University of Barcelona; Max Planck Society	Bermejo, M (corresponding author), Ecosyst Forestiers Afrique Cent ECOFAC, Box Postale 15115, Libreville, Gabon.	magda_bermejo@yahoo.es	Rodríguez-Teijeiro, José Domingo/AAV-7830-2021; Vila, Carles/H-4893-2013; Rodriguez-Teijeiro, Jose D/G-2768-2016	Rodríguez-Teijeiro, José Domingo/0000-0001-7787-9293; Vila, Carles/0000-0002-4206-5246; Rodriguez-Teijeiro, Jose D/0000-0001-7787-9293				Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Oates JF, 2006, PRIMATES, V47, P102, DOI 10.1007/s10329-005-0149-5; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Sleeman JM, 2004, ORYX, V38, P136, DOI 10.1017/S0030605304000237; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566	7	254	268	17	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1564	1564		10.1126/science.1133105	http://dx.doi.org/10.1126/science.1133105			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158318				2022-12-28	WOS:000242624600031
J	Campbell, PJ; Green, AR				Campbell, Peter J.; Green, Anthony R.			Mechanisms of disease: The myeloproliferative disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							JAK2 V617F MUTATION; TYROSINE KINASE MUTATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; STEM-CELL; ACTIVATING MUTATION; ERYTHROPOIETIN RECEPTOR; PHILADELPHIA-CHROMOSOME; THROMBOPOIETIN RECEPTOR		Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England	University of Cambridge	Green, AR (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Hills Rd, Cambridge CB2 2XY, England.	arg1000@cam.ac.uk		Green, Anthony/0000-0002-9795-0218	Wellcome Trust [088340] Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abkowitz JL, 1998, P NATL ACAD SCI USA, V95, P3862, DOI 10.1073/pnas.95.7.3862; ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Antonioli E, 2005, LEUKEMIA, V19, P1847, DOI 10.1038/sj.leu.2403902; Arellano-Rodrigo E, 2006, HAEMATOL-HEMATOL J, V91, P169; Barbui T, 2004, SEMIN HEMATOL, V41, P15, DOI 10.1053/j.seminhematol.2004.02.006; Barosi G, 1999, BRIT J HAEMATOL, V104, P730, DOI 10.1046/j.1365-2141.1999.01262.x; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; Baxter EJ, 2005, LANCET, V366, P122; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bellanne-Chantelot C, 2006, BLOOD, V108, P346, DOI 10.1182/blood-2005-12-4852; Bench AJ, 1998, BAILLIERE CLIN HAEM, V11, P819, DOI 10.1016/S0950-3536(98)80041-3; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; BERK PD, 1986, SEMIN HEMATOL, V23, P132; Bumm TGP, 2005, BLOOD, V106, p114A; Buttner C, 1998, J INVEST DERMATOL, V111, P1227, DOI 10.1046/j.1523-1747.1998.00414.x; Campbell PJ, 2006, METH MOLEC MED, V125, P253; Campbell Peter J, 2005, Hematology Am Soc Hematol Educ Program, P201; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; CAMPBELL PJ, IN PRESS BLOOD; Cervantes F, 2002, BRIT J HAEMATOL, V118, P786, DOI 10.1046/j.1365-2141.2002.03688.x; Cheung B, 2006, BRIT J HAEMATOL, V132, P244, DOI 10.1111/j.1365-2141.2005.05858.x; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; CORTELAZZO S, 1995, NEW ENGL J MED, V332, P1132, DOI 10.1056/NEJM199504273321704; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; Epstein E, 1934, VIRCHOWS ARCH A, V292, P233, DOI 10.1007/BF01891529; Falanga A, 2005, EXP HEMATOL, V33, P523, DOI 10.1016/j.exphem.2005.01.015; FIALKOW PJ, 1981, BLOOD, V58, P916; Frohling S, 2006, BLOOD, V107, P1242, DOI 10.1182/blood-2005-09-3644; Gale RE, 1999, SEMIN HEMATOL, V36, P361; Goerttler PS, 2005, BLOOD, V106, P2862, DOI 10.1182/blood-2005-04-1515; Goerttler PS, 2005, BRIT J HAEMATOL, V129, P138, DOI 10.1111/j.1365-2141.2005.05416.x; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Harrison CN, 2005, NEW ENGL J MED, V353, P33, DOI 10.1056/NEJMoa043800; Heuck G, 1879, VIRCHOWN ARCH, V78, P475; Holt D, 1999, AM J HUM GENET, V65, P1423, DOI 10.1086/302614; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; James C, 2006, LEUKEMIA, V20, P350, DOI 10.1038/sj.leu.2404069; James C, 2005, TRENDS MOL MED, V11, P546, DOI 10.1016/j.molmed.2005.10.003; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Johansson P, 2004, J INTERN MED, V256, P161, DOI 10.1111/j.1365-2796.2004.01357.x; Jones AV, 2006, BLOOD, V107, P3339, DOI 10.1182/blood-2005-09-3917; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kieslinger M, 2000, GENE DEV, V14, P232; Kiladjian JJ, 2006, BLOOD, V108, P2037, DOI 10.1182/blood-2006-03-009860; Kiladjian JJ, 2006, LEUKEMIA, V20, P1181, DOI 10.1038/sj.leu.2404214; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Klippel S, 2002, BLOOD, V100, P2441, DOI 10.1182/blood-2002-03-0949; Komura E, 2005, CANCER RES, V65, P3281, DOI 10.1158/0008-5472.CAN-04-2339; Komura E, 2003, EXP HEMATOL, V31, P622, DOI 10.1016/S0301-472X(03)00085-7; Kralovics R, 2005, BLOOD, V106, P3374, DOI 10.1182/blood-2005-05-1889; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; LABBAYE C, 1995, J CLIN INVEST, V95, P2346, DOI 10.1172/JCI117927; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Lasho TL, 2005, BRIT J HAEMATOL, V130, P797, DOI 10.1111/j.1365-2141.2005.05682.x; Lee JW, 2006, ONCOGENE, V25, P1434, DOI 10.1038/sj.onc.1209163; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2006, BLOOD, V107, P4139, DOI 10.1182/blood-2005-09-3900; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Marchioli R, 2005, J CLIN ONCOL, V23, P2224, DOI 10.1200/JCO.2005.07.062; McMullin MF, 2005, BRIT J HAEMATOL, V130, P174, DOI 10.1111/j.1365-2141.2005.05535.x; Melzner I, 2006, LEUKEMIA, V20, P157, DOI 10.1038/sj.leu.2404036; Mesa RA, 2006, LEUKEMIA RES, V30, P1457, DOI 10.1016/j.leukres.2006.01.008; Mesa RA, 2006, HAEMATOLOGICA, V91, P415; Moliterno AR, 1999, BLOOD, V94, P2555, DOI 10.1182/blood.V94.8.2555.420k14_2555_2561; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Myklebust JH, 2002, EXP HEMATOL, V30, P990, DOI 10.1016/S0301-472X(02)00868-8; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Pardanani A, 2004, BLOOD, V104, P3038, DOI 10.1182/blood-2004-03-0787; PARDANANI AD, IN PRESS BLOOD; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Patel RK, 2006, GASTROENTEROLOGY, V130, P2031, DOI 10.1053/j.gastro.2006.04.008; Percy MJ, 2006, HAEMATOLOGICA, V91, P413; PIERRE R, 2001, WHO CLASSIFICATION T, P61; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Roder S, 2001, EXP HEMATOL, V29, P694, DOI 10.1016/S0301-472X(01)00637-3; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Sandberg EM, 2004, CELL BIOCHEM BIOPHYS, V41, P207, DOI 10.1385/CBB:41:2:207; Sayer MS, 2000, J BIOL CHEM, V275, P25292, DOI 10.1074/jbc.M908695199; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Scott LM, 2005, BLOOD, V106, P2920, DOI 10.1182/blood-2005-05-2087; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Silva M, 1998, NEW ENGL J MED, V338, P564, DOI 10.1056/NEJM199802263380902; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Staerk J, 2006, BLOOD, V107, P1864, DOI 10.1182/blood-2005-06-2600; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Tefferi A, 2005, J CLIN ONCOL, V23, P8520, DOI 10.1200/JCO.2004.00.9316; Tefferi A, 2005, BRIT J HAEMATOL, V131, P320, DOI 10.1111/j.1365-2141.2005.05776.x; Tefferi A, 2000, NEW ENGL J MED, V342, P1255, DOI 10.1056/NEJM200004273421706; Tefferi A, 2001, BLOOD REV, V15, P121, DOI 10.1054/blre.2001.0158; Thiele J, 2000, HAEMATOLOGICA, V85, P1126; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; Vainchenker William, 2005, Hematology Am Soc Hematol Educ Program, P195; Vannucchi AM, 2005, BLOOD, V105, P3493, DOI 10.1182/blood-2004-04-1320; Vaquez H., 1895, COMPT REND SOC BIOL, V4, P384; Villeval JL, 1997, BLOOD, V90, P4369; Walz C, 2006, J BIOL CHEM, V281, P18177, DOI 10.1074/jbc.M600064200; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Wolanskyj AP, 2005, BRIT J HAEMATOL, V131, P208, DOI 10.1111/j.1365-2141.2005.05764.x; Xiao S, 1998, NAT GENET, V18, P84, DOI 10.1038/ng0198-84; Zaleskas VM, 2005, BLOOD, V106, p38A; Zeuner A, 2006, BLOOD, V107, P3495, DOI 10.1182/blood-2005-07-3037; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	119	461	499	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2452	2466		10.1056/NEJMra063728	http://dx.doi.org/10.1056/NEJMra063728			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113EO	17151367				2022-12-28	WOS:000242581400009
J	Cesaroni, R; Galli, D; Lodato, G; Walmsley, M; Zhang, QZ				Cesaroni, Riccardo; Galli, Daniele; Lodato, Giuseppe; Walmsley, Malcolm; Zhang, Qizhou			The critical role of disks in the formation of high-mass stars	NATURE			English	Article							GRAVITATING ACCRETION DISCS; MAIN-SEQUENCE EVOLUTION; MOLECULAR CLOUDS; PROTOSTAR; OUTFLOWS; STELLAR; COLLAPSE; OBJECT; SYSTEM; DUST	Although massive stars ( commonly defined as those in excess of about eight solar masses, or with initial luminosities of a thousand times the solar luminosity or more) have an enormous impact on the galactic environment, how they form has been a mystery. The solution probably involves the existence of accretion disks. Rotational motions have been found in the gas surrounding young high-mass stars, which suggests that non-spherical accretion could be the fundamental ingredient of the massive-star formation recipe.	Osserv Astrofis Arcetri, INAF, I-50125 Florence, Italy; Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Istituto Nazionale Astrofisica (INAF); University of Cambridge; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Cesaroni, R (corresponding author), Osserv Astrofis Arcetri, INAF, Largo E Fermi 5, I-50125 Florence, Italy.	cesa@arcetri.inaf.it		Zhang, Qizhou/0000-0003-2384-6589; Cesaroni, Riccardo/0000-0002-2430-5103; LODATO, GIUSEPPE/0000-0002-2357-7692; Galli, Daniele/0000-0001-7706-6049				Bernard JP, 1999, ASTRON ASTROPHYS, V350, P197; Bertin G, 1999, ASTRON ASTROPHYS, V350, P694; Beuther H, 2002, ASTRON ASTROPHYS, V383, P892, DOI 10.1051/0004-6361:20011808; Beuther H, 2006, ASTROPHYS J, V636, P323, DOI 10.1086/498015; Beuther H, 2005, ASTROPHYS SPACE SC L, V324, P105; Beuther H, 2005, ASTROPHYS J, V628, P800, DOI 10.1086/431277; Bonnell IA, 2005, MON NOT R ASTRON SOC, V362, P915, DOI 10.1111/j.1365-2966.2005.09360.x; Bonnell IA, 2004, MON NOT R ASTRON SOC, V349, P735, DOI 10.1111/j.1365-2966.2004.07543.x; Cesaroni R, 2005, ASTRON ASTROPHYS, V434, P1039, DOI 10.1051/0004-6361:20041639; CESARONI R, IN PRESS PROTOSTARS, V5; Chini R, 2006, ASTROPHYS J, V645, pL61, DOI 10.1086/505862; Chini R, 2004, NATURE, V429, P155, DOI 10.1038/nature02507; FERREIRA J, 1995, ASTRON ASTROPHYS, V295, P807; GALLI D, 1993, ASTROPHYS J, V417, P243, DOI 10.1086/173306; GREENHILL LJ, 2004, IAU S, V221, P155; Hollenbach D. J., 2000, Protostars and planets 4, P401; Hutawarakorn B, 1999, MON NOT R ASTRON SOC, V303, P845, DOI 10.1046/j.1365-8711.1999.02286.x; Jiang ZB, 2005, NATURE, V437, P112, DOI 10.1038/nature04012; Jijina J, 1996, ASTROPHYS J, V462, P874, DOI 10.1086/177201; KAHN FD, 1974, ASTRON ASTROPHYS, V37, P149; Krumholz M. R., 2005, IAU S, P231; Krumholz MR, 2005, ASTROPHYS J, V618, pL33, DOI 10.1086/427555; Krumholz MR, 2005, NATURE, V438, P332, DOI 10.1038/nature04280; Kurtz S., 2000, Protostars and planets 4, P299; Lodato G, 2005, MON NOT R ASTRON SOC, V358, P1489, DOI 10.1111/j.1365-2966.2005.08875.x; McKee CF, 2002, NATURE, V416, P59, DOI 10.1038/416059a; Mejia AC, 2005, ASTROPHYS J, V619, P1098, DOI 10.1086/426707; Moscadelli L, 2005, ASTRON ASTROPHYS, V438, P889, DOI 10.1051/0004-6361:20052685; NAKANO T, 1989, ASTROPHYS J, V345, P464, DOI 10.1086/167919; Osterloh M, 1997, ASTROPHYS J SUPPL S, V110, P71, DOI 10.1086/312990; PALLA F, 1993, ASTROPHYS J, V418, P414, DOI 10.1086/173402; Patel NA, 2005, NATURE, V437, P109, DOI 10.1038/nature04011; Rice WKM, 2005, MON NOT R ASTRON SOC, V364, pL56, DOI 10.1111/j.1745-3933.2005.00105.x; Richling S, 1997, ASTRON ASTROPHYS, V327, P317; Sako S, 2005, NATURE, V434, P995, DOI 10.1038/nature03471; Schreyer K, 2002, ASTRON ASTROPHYS, V394, P561, DOI 10.1051/0004-6361:20021160; Shepherd D., 2005, IAU S, V227, P237; Shepherd DS, 1996, ASTROPHYS J, V457, P267, DOI 10.1086/176727; Shepherd DS, 2001, SCIENCE, V292, P1513, DOI 10.1126/science.1059475; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323; Simon M, 2000, ASTROPHYS J, V545, P1034, DOI 10.1086/317838; Sridharan TK, 2005, ASTROPHYS J, V631, pL73, DOI 10.1086/497093; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; van der Tak FFS, 2005, ASTRON ASTROPHYS, V437, P947, DOI 10.1051/0004-6361:20052872; Whitehouse SC, 2004, MON NOT R ASTRON SOC, V353, P1078, DOI 10.1111/j.1365-2966.2004.08131.x; Yorke HW, 2002, ASTROPHYS J, V569, P846, DOI 10.1086/339264; Zhang Q., 2005, IAU S, P135; Zhang QZ, 2002, ASTROPHYS J, V566, P982, DOI 10.1086/338278; Zhang QZ, 2001, ASTROPHYS J, V552, pL167, DOI 10.1086/320345	50	41	41	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					703	706		10.1038/nature05344	http://dx.doi.org/10.1038/nature05344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151657				2022-12-28	WOS:000242581100048
J	Holland, RA; Thorup, K; Vonhof, MJ; Cochran, WW; Wikelski, M				Holland, Richard A.; Thorup, Kasper; Vonhof, Maarten J.; Cochran, William W.; Wikelski, Martin			Navigation - Bat orientation using Earth's magnetic field	NATURE			English	Article							PIGEONS; CUES		Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Copenhagen, Inst Biol, Ctr Macroecol, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Museum Zool, DK-2100 Copenhagen, Denmark; Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; Illinois Nat Hist Survey, Champaign, IL 61820 USA	Princeton University; University of Leeds; University of Copenhagen; University of Copenhagen; Western Michigan University; Illinois Natural History Survey	Holland, RA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	rahollan@princeton.edu	Holland, Richard A/A-6107-2010; Thorup, Kasper/A-4835-2013	Holland, Richard A/0000-0003-4495-8061; Thorup, Kasper/0000-0002-0320-0601				Berthold P, 2001, AUK, V2nd; Bonadona F, 2000, J EXP BIOL, V203, P207; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; MICHENER MC, 1967, J EXP BIOL, V47, P99; Muheim R, 2006, J EXP BIOL, V209, P2, DOI 10.1242/jeb.01960; Neuweiler G., 2000, BIOL BATS; Simmons JA., 1995, HEARING BATS SPRINGE, P146; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487	8	107	116	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					702	702		10.1038/444702a	http://dx.doi.org/10.1038/444702a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151656				2022-12-28	WOS:000242581100043
J	Muchhala, N				Muchhala, Nathan			Nectar bat stows huge tongue in its rib cage	NATURE			English	Article							POLLINATION		Univ Miami, Dept Biol, Coral Gables, FL 33143 USA	University of Miami	Muchhala, N (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33143 USA.	muchhala@bio.miami.edu	Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Self, Casey J/B-6871-2011					[Anonymous], 1862, VARIOUS CONTRIVANCES; CHAN LK, 1995, J MAMMAL, V76, P472, DOI 10.2307/1382356; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fleming T.H., 2005, CONTRIBUCIONES MASTO, P163; Griffiths TA., 1982, AM MUS NOVIT, V2742, P1, DOI DOI 10.1097/; Herrel A, 2001, J EXP BIOL, V204, P3621; Muchhala N, 2005, J MAMMAL, V86, P457, DOI 10.1644/1545-1542(2005)86[457:ANSOAC]2.0.CO;2; Peikert-Holle T., 1985, BLUTEN FLEDERMAUSE; STILES FG, 1978, AM ZOOL, V18, P715; von Helversen O, 2003, BAT ECOLOGY, P346; Winter Y, 2003, J MAMMAL, V84, P886, DOI 10.1644/BWG-032	11	61	62	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2006	444	7120					701	702		10.1038/444701a	http://dx.doi.org/10.1038/444701a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151655				2022-12-28	WOS:000242581100042
J	Greener, I; Mannion, R				Greener, Ian; Mannion, Russell			Does practice based commissioning avoid the problems of fundholding?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Manchester Business Sch, Ctr Publ Policy & Management, Manchester M15 6PB, Lancs, England; Univ York, Ctr Hlth & Publ Serv Management, Dept Management Studies, York YO10 5DD, N Yorkshire, England	University of Manchester; University of York - UK	Greener, I (corresponding author), Manchester Business Sch, Ctr Publ Policy & Management, Manchester M15 6PB, Lancs, England.	ian.greener@mbs.ac.uk		Mannion, Russell/0000-0002-0680-8049				BAINES D, 1997, PRESCRIBING BUDGETS; COULTER A, 1995, EUROPEAN J PUBLIC HL, V5, P233; Department of Health, 2004, PRACT BAS COMM ENG P; DOWLING B, 2000, GPS PURCHASING NHS; Dusheiko M, 2004, HEALTH ECON, V13, P941, DOI 10.1002/hec.937; DUSHEIKO M, 2003, EFFECTS BUDGETS DOCT; DUSHEIKO M, 2004, 30 U YORK DEP EC; *HLTH POL EC RES U, 2006, SURV GP PRACT PREM; Mannion R., 2005, PRACTICE BASED BUDGE; PLACE M, 1998, T COSTS TOTAL PURCHA; Secretary of State for Health, 1997, NEW NHS MOD DEP; Smith J, 2005, BRIT MED J, V331, P1397, DOI 10.1136/bmj.331.7529.1397	12	6	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 2	2006	333	7579					1168	1170		10.1136/bmj.39022.486921.94	http://dx.doi.org/10.1136/bmj.39022.486921.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114LG	17139000	Green Published			2022-12-28	WOS:000242667100021
J	Freeth, T; Bitsakis, Y; Moussas, X; Seiradakis, JH; Tselikas, A; Mangou, H; Zafeiropoulou, M; Hadland, R; Bate, D; Ramsey, A; Allen, M; Crawley, A; Hockley, P; Malzbender, T; Gelb, D; Ambrisco, W; Edmunds, MG				Freeth, T.; Bitsakis, Y.; Moussas, X.; Seiradakis, J. H.; Tselikas, A.; Mangou, H.; Zafeiropoulou, M.; Hadland, R.; Bate, D.; Ramsey, A.; Allen, M.; Crawley, A.; Hockley, P.; Malzbender, T.; Gelb, D.; Ambrisco, W.; Edmunds, M. G.			Decoding the ancient Greek astronomical calculator known as the Antikythera Mechanism	NATURE			English	Article								The Antikythera Mechanism is a unique Greek geared device, constructed around the end of the second century BC. It is known(1-9) that it calculated and displayed celestial information, particularly cycles such as the phases of the moon and a luni-solar calendar. Calendars were important to ancient societies(10) for timing agricultural activity and fixing religious festivals. Eclipses and planetary motions were often interpreted as omens, while the calm regularity of the astronomical cycles must have been philosophically attractive in an uncertain and violent world. Named after its place of discovery in 1901 in a Roman shipwreck, the Antikythera Mechanism is technically more complex than any known device for at least a millennium afterwards. Its specific functions have remained controversial(11-14) because its gears and the inscriptions upon its faces are only fragmentary. Here we report surface imaging and high-resolution X-ray tomography of the surviving fragments, enabling us to reconstruct the gear function and double the number of deciphered inscriptions. The mechanism predicted lunar and solar eclipses on the basis of Babylonian arithmetic-progression cycles. The inscriptions support suggestions of mechanical display of planetary positions(9,14,15), now lost. In the second century BC, Hipparchos developed a theory to explain the irregularities of the Moon's motion across the sky caused by its elliptic orbit. We find a mechanical realization of this theory in the gearing of the mechanism, revealing an unexpected degree of technical sophistication for the period.	Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, Wales; Images First Ltd, London W5 4SE, England; Natl & Kapodistrian Univ Athens, Dept Astrophys Astron & Mech, GR-15783 Panepistimiopolis, Zographos, Greece; Aristotle Univ Thessaloniki, Dept Phys, Sect Astrophys Astron & Mech, GR-54124 Thessaloniki, Greece; Natl Bank Greece Cultural Fdn, Ctr Hist & Palaeog, GR-10560 Athens, Greece; Natl Archaeol Museum Athens, GR-10682 Athens, Greece; X Tek Syst Ltd, Tring Business Ctr, Tring HP23 4JX, Herts, England; Hewlett Packard Labs, Palo Alto, CA 94304 USA; Foxhollow Technol Inc, Redwood City, CA 94063 USA	Cardiff University; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; Hewlett-Packard	Edmunds, MG (corresponding author), Cardiff Univ, Sch Phys & Astron, Queens Bldg, Cardiff CF24 3AA, Wales.	mge@astro.cf.ac.uk	Smejda, Ladislav/B-8474-2008	Freeth, Tony/0000-0001-9375-4247; Moussas, Xenophon/0000-0002-5553-9017				BRITTON JP, 1993, ROLLE ASTRONOMIE KUL, P61; Bromley A. G., 1990, HOROL J, V132, P412; BROMLEY AG, 1963, BASSERNET, V2; Brooks M, 2001, NEW SCI, V170, P38; CHAPMAN A, 1995, DIVIDING CIRCLE; EDMUNDS M, 2000, ASTRON GEOPHYS, V41; ESPENAK F, 2005, NASA ECLIPSE HOME PA; Freeth T., 2002, MEDITERRANEAN ARCHAE, V2, P45; Freeth T, 2002, MEDITERR ARCHAEOL AR, V2, P21; ILLSLEY JS, 1998, HIST ARCHAEOLOGY SHI; JONES A, 1991, ISIS, V82, P440; Malzbender T., 2006, POLYNOMIAL TEXTURE M; North J.D., 1994, FONTANA HIST ASTRONO; PRICE DJD, 1974, T AM PHILOS SOC, V64, P1; Steele J.M., 2000, OBSERVATIONS PREDICT; Steele JM, 2000, ARCH HIST EXACT SCI, V54, P421, DOI 10.1007/s004070050007; Stephenson F.R., 1997, HIST ECLIPSES EARTHS; Toomer Gerald J., 1998, PTOLEMYS ALMAGEST; Wright M. T., 2003, ANTIQUARIAN HOROLOGY, Vxxvii, P270; Wright M. T., 2002, HOROLOGICAL J, V144, P169; Wright M. T., 2006, ANTIQUARIAN HOROLOGY, V29, P319; Wright M. T., 2006, P 2 INT C ANC GREEK, P49; Wright MT, 2005, B SCI INSTRUM SOC, V85, P2; Wright MT, 2003, B SCI INSTRUM SOC, Vlxxx, P4; WRIGHT MT, 2005, ANTIQUAR HOROL, V29, P51; WRIGHT MT, 1995, PACT J EUR STUDY GRO, V45, P531; WRIGHT MT, 2005, B SCI INSTRUMENT SOC, V87, P8; Wright MT, 2002, HOROLOGICAL J, V144, P193; *X TEK SYST LTD, 2006, 3D COMP TOM	29	155	158	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					587	591		10.1038/nature05357	http://dx.doi.org/10.1038/nature05357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	110KK	17136087				2022-12-28	WOS:000242377600041
J	Berer, M				Berer, Marge			Hospital admission for complications of unsafe abortion	LANCET			English	Editorial Material									Reprod Hlth Matters, London NW5 1TL, England		Berer, M (corresponding author), Reprod Hlth Matters, London NW5 1TL, England.	RHMjournal@compuserve.com						AAHMAN E, 2004, UNSAFE ABORTION GLOB; Berer M, 2004, REPROD HEALTH MATTER, V12, P1, DOI 10.1016/S0968-8080(04)24024-1; Chowdury SNM, 2004, REPROD HEALTH MATTER, V12, P95; Dickson KE, 2003, STUD FAMILY PLANN, V34, P277, DOI 10.1111/j.1728-4465.2003.00277.x; Hessini L, 2005, REPROD HEALTH MATTER, V13, P88, DOI 10.1016/S0968-8080(05)25168-6; Iyengar SD, 2005, REPROD HEALTH MATTER, V13, P13, DOI 10.1016/S0968-8080(05)26217-1; Kestler E, 2006, REPROD HEALTH MATTER, V14, P138, DOI 10.1016/S0968-8080(06)27235-5; Lane SD, 1998, SOC SCI MED, V47, P1089, DOI 10.1016/S0277-9536(98)00129-4; Misago C, 1998, INT J EPIDEMIOL, V27, P833, DOI 10.1093/ije/27.5.833; Oye-Adeniran BA, 2002, REPROD HEALTH MATTER, V10, P18, DOI 10.1016/S0968-8080(02)00024-1; Singh S, 2006, LANCET, V368, P1887, DOI 10.1016/S0140-6736(06)69778-X; Walker D, 2004, REPROD HEALTH MATTER, V12, P27, DOI 10.1016/S0968-8080(04)24019-8	12	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2006	368	9550					1848	1849		10.1016/S0140-6736(06)69752-3	http://dx.doi.org/10.1016/S0140-6736(06)69752-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126700				2022-12-28	WOS:000242345900006
J	Estey, E; Dohner, H				Estey, Elihu; Doehner, Hartmut			Acute myeloid leukaemia	LANCET			English	Review							ACUTE MYELOGENOUS LEUKEMIA; HIGH-DOSE CYTARABINE; INTERNAL TANDEM DUPLICATION; ACUTE NONLYMPHOCYTIC LEUKEMIA; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; TRIAL COMPARING IDARUBICIN; SOUTHWEST-ONCOLOGY-GROUP; AML 10 TRIAL	Acute myeloid leukaemia (AML) is a heterogeneous clonal disorder of haemopoietic progenitor cells and the most common malignant myeloid disorder in adults. The median age at presentation for patients with AML is 70 years. In the past few years, research in molecular biology has been instrumental in deciphering the pathogenesis of the disease. Genetic defects are thought to be the most important factors in determining the response to chemotherapy and outcome. Whereas significant progress has been made in the treatment of younger adults, the prospects for elderly patients have remained dismal, with median survival times of only a few months. This difference is related to comorbidities associated with ageing and to disease biology. Current efforts in clinical research focus on the assessment of targeted therapies. Such new approaches will probably lead to an increase in the cure rate.	Univ Texas, MD Anderson Canc Ctr, Leukemia Dept, Houston, TX 77030 USA; Univ Ulm, Dept Internal Med 3, D-7900 Ulm, Germany	University of Texas System; UTMD Anderson Cancer Center; Ulm University	Estey, E (corresponding author), Univ Texas, MD Anderson Canc Ctr, Leukemia Dept, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ehestey@mdanderson.org	Döhner, Hartmut/C-8933-2016	Döhner, Hartmut/0000-0003-2116-5536				Alyea EP, 2005, BLOOD, V105, P1810, DOI 10.1182/blood-2004-05-1947; Amadori S, 2005, LEUKEMIA, V19, P1768, DOI 10.1038/sj.leu.2403901; Anderlini P, 1996, LEUKEMIA, V10, P600; Anderson JE, 2002, BLOOD, V100, P3869, DOI 10.1182/blood-2001-12-0354; Appelbaum FR, 2006, BRIT J HAEMATOL, V135, P165, DOI 10.1111/j.1365-2141.2006.06276.x; ARLIN Z, 1990, LEUKEMIA, V4, P177; Attar EC, 2004, BLOOD, V104, p498A, DOI 10.1182/blood.V104.11.1799.1799; Azuma T, 2002, BRIT J HAEMATOL, V116, P601, DOI 10.1046/j.0007-1048.2001.03329.x; Baer MR, 2002, BLOOD, V100, P1224, DOI 10.1182/blood.V100.4.1224.h81602001224_1224_1232; Baldus CD, 2003, BLOOD, V102, P1613, DOI 10.1182/blood-2003-02-0359; Barjesteh van Waalwijk van Doorn-Khosrovani S, 2003, HEMATOL J, V4, P31; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; BERMAN E, 1991, BLOOD, V77, P1666; Bienz M, 2005, CLIN CANCER RES, V11, P1416, DOI 10.1158/1078-0432.CCR-04-1552; BISHOP JF, 1990, BLOOD, V75, P27; Bishop JF, 1996, BLOOD, V87, P1710, DOI 10.1182/blood.V87.5.1710.bloodjournal8751710; Bloomfield CD, 1998, CANCER RES, V58, P4173; Bowen DT, 2005, BLOOD, V106, P2113, DOI 10.1182/blood-2005-03-0867; Bowen DT, 2003, BLOOD, V101, P2770, DOI 10.1182/blood-2002-01-0228; Bradstock KF, 2005, BLOOD, V105, P481, DOI 10.1182/blood-2004-01-0326; Breems DA, 2005, J CLIN ONCOL, V23, P1969, DOI 10.1200/JCO.2005.06.027; Buchner T, 1999, BLOOD, V93, P4116; Bullinger L, 2005, J CLIN ONCOL, V23, P6296, DOI 10.1200/JCO.2005.05.020; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Burke John M, 2002, Cancer Control, V9, P106; Burnett AK, 2004, BLOOD, V104, p248A, DOI 10.1182/blood.V104.11.869.869; Burnett AK, 2004, BLOOD, V104, p249A, DOI 10.1182/blood.V104.11.872.872; Burnett AK, 1998, LANCET, V351, P700, DOI 10.1016/S0140-6736(97)09214-3; Byrd JC, 1999, J CLIN ONCOL, V17, P3767, DOI 10.1200/JCO.1999.17.12.3767; Byrd JC, 2004, J CLIN ONCOL, V22, P1087, DOI 10.1200/JCO.2004.07.012; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Cahn JY, 2000, BRIT J HAEMATOL, V110, P308, DOI 10.1046/j.1365-2141.2000.02178.x; Cairoli R, 2006, BLOOD, V107, P3463, DOI 10.1182/blood-2005-09-3640; CALIGIURI MA, 1994, CANCER RES, V54, P370; Caligiuri MA, 1998, CANCER RES, V58, P55; Caligiuri MA, 1996, CANCER RES, V56, P1418; Cammenga J, 2005, BLOOD, V106, P3958, DOI 10.1182/blood-2005-02-0583; CARDIS E, 1995, RADIAT RES, V142, P117, DOI 10.2307/3579020; Care RS, 2003, BRIT J HAEMATOL, V121, P775, DOI 10.1046/j.1365-2141.2003.04362.x; Cassileth PA, 1998, NEW ENGL J MED, V339, P1649, DOI 10.1056/NEJM199812033392301; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Davico L, 1998, CANCER EPIDEM BIOMAR, V7, P1123; De Angelo DJ, 2003, BLOOD, V102, p100A; Decker WK, 2006, BIOL BLOOD MARROW TR, V12, P113, DOI 10.1016/j.bbmt.2005.09.003; Delaunay J, 2003, BLOOD, V102, P462, DOI 10.1182/blood-2002-11-3527; deLima M, 1997, BLOOD, V90, P4719, DOI 10.1182/blood.V90.12.4719.4719_4719_4724; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Dohner K, 2002, J CLIN ONCOL, V20, P3254, DOI 10.1200/JCO.2002.09.088; DOHNER K, IN PRESS LEUKEMIAS D; Downing JR, 2003, CURR OPIN GENET DEV, V13, P48, DOI 10.1016/S0959-437X(02)00018-7; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Estey E, 1996, BLOOD, V88, P756, DOI 10.1182/blood.V88.2.756.bloodjournal882756; Estey E, 1997, BLOOD, V90, P2969, DOI 10.1182/blood.V90.8.2969; ESTEY E, 2005, BLOOD; Estey EH, 2000, LEUKEMIA, V14, P476, DOI 10.1038/sj.leu.2401568; Estey EH, 2006, SEMIN HEMATOL, V43, P89, DOI 10.1053/j.seminhematol.2006.01.002; Estey EH, 2004, BLOOD, V104, p251A, DOI 10.1182/blood.V104.11.879.879; Estey EH, 2002, BLOOD, V99, P4343, DOI 10.1182/blood.V99.12.4343; Estey EH, 2000, BLOOD, V95, P72, DOI 10.1182/blood.V95.1.72.001k26_72_77; Estey EH, 2001, BLOOD, V98, P3575, DOI 10.1182/blood.V98.13.3575; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; FREIREICH E, 1961, J CHRON DIS, V14, P593, DOI 10.1016/0021-9681(61)90118-7; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Frohling S, 2005, GENE CHROMOSOME CANC, V42, P427, DOI 10.1002/gcc.20152; Frohling S, 2004, J CLIN ONCOL, V22, P624, DOI 10.1200/JCO.2004.06.060; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Gale RE, 2005, BLOOD, V106, P3658, DOI 10.1182/blood-2005-03-1323; Garcia-Manero G, 2005, CANCER INVEST, V23, P635, DOI 10.1080/07357900500283119; Gerrard G, 2004, HAEMATOLOGICA, V89, P782; Giles F, 2004, CLIN CANCER RES, V10, P2908, DOI 10.1158/1078-0432.CCR-03-0738; Giralt S, 1997, BLOOD, V89, P4531, DOI 10.1182/blood.V89.12.4531; Goldstone AH, 2002, BLOOD, V100, p88A; Goldstone AH, 2001, BLOOD, V98, P1302, DOI 10.1182/blood.V98.5.1302; Gorello P, 2006, LEUKEMIA, V20, P1103, DOI 10.1038/sj.leu.2404149; Greiner J, 2004, INT J CANCER, V108, P704, DOI 10.1002/ijc.11623; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Gundestrup M, 1999, LANCET, V354, P2029, DOI 10.1016/S0140-6736(99)05093-X; GUTTERMA.JU, 1974, LANCET, V2, P1405; Hann IM, 1997, BLOOD, V89, P2311, DOI 10.1182/blood.V89.7.2311; Harousseau JL, 1997, BLOOD, V90, P2978; Head DR, 1996, LEUKEMIA, V10, P1826; Jaffe ES, 2001, WHO CLASSIFICATION T; KAHN SB, 1984, J CLIN ONCOL, V2, P865, DOI 10.1200/JCO.1984.2.8.865; Kane EV, 1999, BRIT J CANCER, V81, P1228, DOI 10.1038/sj.bjc.6690833; Kantarjian HM, 2004, BLOOD, V104, p402A, DOI 10.1182/blood.V104.11.1437.1437; Keilholz U, 2005, BLOOD, V106, p122A; Kell WJ, 2003, BLOOD, V102, P4277, DOI 10.1182/blood-2003-05-1620; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; Kern W, 2004, BLOOD, V104, P3078, DOI 10.1182/blood-2004-03-1036; Knapper S, 2004, BLOOD, V104, p246A, DOI 10.1182/blood.V104.11.864.864; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Lancet JE, 2004, BLOOD, V104, p249A, DOI 10.1182/blood.V104.11.874.874; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Larson RA, 1999, BLOOD, V94, P803, DOI 10.1182/blood.V94.2.803.414k44_803_807; List AF, 2001, BLOOD, V98, P3212, DOI 10.1182/blood.V98.12.3212; Lo Coco F, 1999, BLOOD, V94, P2225, DOI 10.1182/blood.V94.7.2225.419k03_2225_2229; LOWENBERG B, 1989, J CLIN ONCOL, V7, P1268; Lowenberg B, 2003, NEW ENGL J MED, V349, P743, DOI 10.1056/NEJMoa025406; Lowenberg Bob, 2003, Hematology Am Soc Hematol Educ Program, P82; Lubbert M, 2005, BLOOD, V106, p527A; MANDELLI F, 1991, EUR J CANCER, V27, P750, DOI 10.1016/0277-5379(91)90181-C; Marcucci G, 2005, BLOOD, V106, p223A, DOI 10.1182/blood.V106.11.755.755; Marcucci G, 2005, J CLIN ONCOL, V23, P3404, DOI 10.1200/JCO.2005.09.118; Marcucci G, 2005, J CLIN ONCOL, V23, P5705, DOI 10.1200/JCO.2005.15.610; MATHE G, 1977, EUR J CANCER, V13, P445, DOI 10.1016/0014-2964(77)90101-3; MAYER RJ, 1994, NEW ENGL J MED, V331, P896, DOI 10.1056/NEJM199410063311402; McQueen T, 2005, BLOOD, V106, p648A; Mead A, 2005, BLOOD, V106, p101A; Molldrem JJ, 2006, BIOL BLOOD MARROW TR, V12, P13, DOI 10.1016/j.bbmt.2005.10.014; Molldrem JJ, 2003, J CLIN INVEST, V111, P639, DOI 10.1172/JCI200316398; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; Moore JO, 2005, BLOOD, V105, P3420, DOI 10.1182/blood-2004-08-2977; Moorman AV, 2002, BRIT J CANCER, V86, P60, DOI 10.1038/sj.bjc.6600010; Mrozek K, 2001, BEST PRACT RES CL HA, V14, P19, DOI 10.1053/beha.2000.0114; Nakanishi M, 1999, J RADIAT RES, V40, P159, DOI 10.1269/jrr.40.159; National Cancer Institute, AC MYEL LEUK; *NCCN, 2003, J NCCN, V1, P520; Nguyen S, 2002, BLOOD, V99, P3517, DOI 10.1182/blood.V99.10.3517; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Platzbecker U, 2001, BONE MARROW TRANSPL, V27, P543, DOI 10.1038/sj.bmt.1702819; Pogoda JM, 2002, AM J EPIDEMIOL, V155, P546, DOI 10.1093/aje/155.6.546; Preudhomme C, 2000, BLOOD, V96, P2862, DOI 10.1182/blood.V96.8.2862.h8002862_2862_2869; Preudhomme C, 2002, BLOOD, V100, P2717, DOI 10.1182/blood-2002-03-0990; Qazilbash MH, 2004, BLOOD, V104, p77A, DOI 10.1182/blood.V104.11.259.259; Rowe JM, 2004, BLOOD, V103, P479, DOI 10.1182/blood-2003-05-1686; San Miguel JF, 2001, BLOOD, V98, P1746, DOI 10.1182/blood.V98.6.1746; SANDLER DP, 1993, J NATL CANCER I, V85, P1994, DOI 10.1093/jnci/85.24.1994; Schlenk RF, 2004, J CLIN ONCOL, V22, P3741, DOI 10.1200/JCO.2004.03.012; Schmid C, 2005, J CLIN ONCOL, V23, P5675, DOI 10.1200/JCO.2005.07.061; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Schnittger S, 2006, BLOOD, V107, P1791, DOI 10.1182/blood-2005-04-1466; Sekeres MA, 2004, LEUKEMIA, V18, P809, DOI 10.1038/sj.leu.2403289; SEYMOUR JF, 1994, LEUKEMIA, V8, P823; Sievers EL, 2001, J CLIN ONCOL, V19, P3244, DOI 10.1200/JCO.2001.19.13.3244; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Smith BD, 2004, BLOOD, V103, P3669, DOI 10.1182/blood-2003-11-3775; Smith MT, 2001, BLOOD, V97, P1422, DOI 10.1182/blood.V97.5.1422; Smith MT, 1999, P NATL ACAD SCI USA, V96, P7624, DOI 10.1073/pnas.96.14.7624; Smith SM, 2003, BLOOD, V102, P43, DOI 10.1182/blood-2002-11-3343; Smyth MJ, 2006, NEW ENGL J MED, V354, P2282, DOI 10.1056/NEJMcibr061878; Sorror ML, 2004, BLOOD, V104, P961, DOI 10.1182/blood-2004-02-0545; Steudel C, 2003, GENE CHROMOSOME CANC, V37, P237, DOI 10.1002/gcc.10219; Stone Richard M, 2004, Hematology Am Soc Hematol Educ Program, P98; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; Suciu S, 2003, BLOOD, V102, P1232, DOI 10.1182/blood-2002-12-3714; Suzuki T, 2005, BLOOD, V106, P2854, DOI 10.1182/blood-2005-04-1733; Tallman MS, 2000, BLOOD, V96, P1254; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Thall PF, 2001, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, P411; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Thompson A, 2002, BLOOD, V100, p734A; TIBES R, 2005, P AN M AM SOC CLIN, P6655; TILLY H, 1990, J CLIN ONCOL, V8, P272, DOI 10.1200/JCO.1990.8.2.272; Toyota M, 2001, BLOOD, V97, P2823, DOI 10.1182/blood.V97.9.2823; TRAVIS LB, 1994, LEUKEMIA LYMPHOMA, V14, P91, DOI 10.3109/10428199409049654; Valk PJM, 2004, HAEMATOLOGICA, V89, P106; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van der Holt B, 2005, BLOOD, V106, P2646, DOI 10.1182/blood-2005-04-1395; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Vidriales MB, 2003, BEST PRACT RES CL HA, V16, P599, DOI 10.1016/S1521-6926(03)00067-7; VOGLER WR, 1992, J CLIN ONCOL, V10, P1103, DOI 10.1200/JCO.1992.10.7.1103; von Muhlendahl KE, 1998, EUR J PEDIATR, V157, P602, DOI 10.1007/s004310050888; Watson M, 2004, EUR J CANCER, V40, P971, DOI 10.1016/S0959-8049(03)00628-2; Weick JK, 1996, BLOOD, V88, P2841, DOI 10.1182/blood.V88.8.2841.bloodjournal8882841; Westers TM, 2003, CANCER IMMUNOL IMMUN, V52, P17, DOI 10.1007/s00262-002-0316-0; Wheatley K, 1999, BRIT J HAEMATOL, V107, P69, DOI 10.1046/j.1365-2141.1999.01684.x; Whitman SP, 2001, CANCER RES, V61, P7233; WIERNIK PH, 1992, BLOOD, V79, P313; Wong R, 2005, BIOL BLOOD MARROW TR, V11, P108, DOI 10.1016/j.bbmt.2004.10.008; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yanada M, 2005, LEUKEMIA, V19, P1345, DOI 10.1038/sj.leu.2403838; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Yokota S, 1997, LEUKEMIA, V11, P1605, DOI 10.1038/sj.leu.2400812; Youn BS, 2000, IMMUNOL REV, V177, P150, DOI 10.1034/j.1600-065X.2000.17701.x	178	967	1005	5	145	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2006	368	9550					1894	1907		10.1016/S0140-6736(06)69780-8	http://dx.doi.org/10.1016/S0140-6736(06)69780-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	109YQ	17126723				2022-12-28	WOS:000242345900032
J	Aziz, MA; Wright, A; Laszlo, A; De Muynck, A; Portaels, F; Van Deun, A; Wells, C; Nunn, P; Blanc, L; Raviglione, M				Aziz, Mohamed Abdel; Wright, Abigail; Laszlo, Adalbert; De Muynck, Aime; Portaels, Francois; Van Deun, Armand; Wells, Charles; Nunn, Paul; Blanc, Leopold; Raviglione, Mario		WHO Int Union Against Tub	Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis	LANCET			English	Article							TUBERCULOSIS-CONTROL; MYCOBACTERIA; SENSITIVITY; HEALTH; TRENDS	Background The burden of tuberculosis is compounded by drug-resistant forms of the disease. This study aimed to analyse data on antituberculosis drug resistance gathered by the WHO and International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance. Methods Data on drug susceptibility testing for four antituberculosis drugs-isoniazid, rifampicin, ethambutol, and streptomycin-were gathered in the third round of the Global Project (1999-2002) from surveys or ongoing surveillance in 79 countries or geographical settings. These data were combined with those from the first two rounds of the project and analyses were done. Countries that participated followed a standardised set of guidelines to ensure comparability both between and within countries. Findings The median prevalence of resistance to any of the four antituberculosis drugs in new cases of tuberculosis identified in 76 countries or geographical settings was 10.2% (range 0.0-57.1). The median prevalence of multidrug resistance in new cases was 1.0% (range 0.0-14.2). Kazakhstan, Tomsk Oblast (Russia), Karakalpakstan (Uzbekistan), Estonia, Israel, the Chinese provinces Liaoning and Henan, Lithuania, and Latvia reported prevalence of multidrug resistance above 6.5%. Trend analysis showed a significant increase in the prevalence of multidrug resistance in new cases in Tomsk Oblast (p<0.0001). Hong Kong (p=0.01) and the USA (p=0.0002) reported significant decreasing trends in multidrug resistance in new cases of tuberculosis. Interpretation Multidrug resistance represents a serious challenge for tuberculosis control in countries of the former Soviet Union and in some provinces of China. Gaps in coverage of the Global Project are substantial, and baseline information is urgently required from several countries with high tuberculosis burden to develop appropriate control interventions.	WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA	World Health Organization; Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA	Raviglione, M (corresponding author), WHO, Stop TB Dept, 20 Ave Appia, CH-1211 Geneva, Switzerland.	raviglionem@who.int	ROBERT, Jérôme/C-3993-2011	ROBERT, Jérôme/0000-0002-9380-0570; RAVIGLIONE, Mario/0000-0002-9331-2067				CANETTI G, 1965, AM REV RESPIR DIS, V92, P687; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cohn DL, 1997, CLIN INFECT DIS   S1, V24, P121; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; CROFTON J, 1948, BMJ-BRIT MED J, V2, P1009, DOI 10.1136/bmj.2.4588.1009; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; *HONG KONG GOV TUB, 1964, TUBERCLE, V45, P77; KOCHI A, 1993, RES MICROBIOL, V73, P219; Maher D, 2005, CLIN CHEST MED, V26, P167, DOI 10.1016/j.ccm.2005.02.009; MAHMOUDI A, 1993, JAMA-J AM MED ASSOC, V270, P65, DOI 10.1001/jama.270.1.65; MITCHISON DA, 1950, THORAX, V4, P144; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; *PHS COOP INV, 1964, AM RESP DIS, V89, P327; PYLE MM, 1947, P STAFF M MAYO CLIN, V22, P465; Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631; RAVIGLIONE MC, 1997, AIDS, V11, P115; Siddiqi S. H., 1996, BACTEC 460TB SYSTEM; VESTAL AL, 1967, SCAND J RESPIR DIS, V48, P142; WHO, 2003, WHOCDSCSRRMD20033; *WHO, 2005, WHOHTMTB2005349; WHO, 2000, WHOCDSTB2000279; WHO, 2001, WHOCDSCSRDRS20012; *WHOIUATLD, 2000, WHOCDSTB200278 IUATL; *WHOIUATLD, 1997, WHOTB97229 IUATLD; *WHOIUATLD, 2004, WHOHTMTB2004343 IUAT; World Health Organization, 2006, STOP TB STRATEGY BUI; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2006, WHOHTM2006361; World Health Organization (WHO), 1998, LAB SERVICES TUBERCU; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	38	251	274	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 16	2006	368	9553					2142	2154		10.1016/S0140-6736(06)69863-2	http://dx.doi.org/10.1016/S0140-6736(06)69863-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174706				2022-12-28	WOS:000242856900022
J	Brownlee, D; Tsou, P; Aleon, J; Alexander, CMO; Araki, T; Bajt, S; Baratta, GA; Bastien, R; Bland, P; Bleuet, P; Borg, J; Bradley, JP; Brearley, A; Brenker, F; Brennan, S; Bridges, JC; Browning, ND; Brucato, JR; Bullock, E; Burchell, MJ; Busemann, H; Butterworth, A; Chaussidon, M; Cheuvront, A; Chi, MF; Cintala, MJ; Clark, BC; Clemett, SJ; Cody, G; Colangeli, L; Cooper, G; Cordier, P; Daghlian, C; Dai, ZR; D'Hendecourt, L; Djouadi, Z; Dominguez, G; Duxbury, T; Dworkin, JP; Ebel, DS; Economou, TE; Fakra, S; Fairey, SAJ; Fallon, S; Ferrini, G; Ferroir, T; Fleckenstein, H; Floss, C; Flynn, G; Franchi, IA; Fries, M; Gainsforth, Z; Gallien, JP; Genge, M; Gilles, MK; Gillet, P; Gilmour, J; Glavin, DP; Gounelle, M; Grady, MM; Graham, GA; Grant, PG; Green, SF; Grossemy, F; Grossman, L; Grossman, JN; Guan, Y; Hagiya, K; Harvey, R; Heck, P; Herzog, GF; Hoppe, P; Horz, F; Huth, J; Hutcheon, ID; Ignatyev, K; Ishii, H; Ito, M; Jacob, D; Jacobsen, C; Jacobsen, S; Jones, S; Joswiak, D; Jurewicz, A; Kearsley, AT; Keller, LP; Khodja, H; Kilcoyne, ALD; Kissel, J; Krot, A; Langenhorst, F; Lanzirotti, A; Le, L; Leshin, LA; Leitner, J; Lemelle, L; Leroux, H; Liu, MC; Luening, K; Lyon, I; MacPherson, G; Marcus, MA; Marhas, K; Marty, B; Matrajt, G; McKeegan, K; Meibom, A; Mennella, V; Messenger, K; Messenger, S; Mikouchi, T; Mostefaoui, S; Nakamura, T; Nakano, T; Newville, M; Nittler, LR; Ohnishi, I; Ohsumi, K; Okudaira, K; Papanastassiou, DA; Palma, R; Palumbo, ME; Pepin, RO; Perkins, D; Perronnet, M; Pianetta, P; Rao, W; Rietmeijer, FJM; Robert, F; Rost, D; Rotundi, A; Ryan, R; Sandford, SA; Schwandt, CS; See, TH; Schlutter, D; Sheffield-Parker, J; Simionovici, A; Simon, S; Sitnitsky, I; Snead, CJ; Spencer, MK; Stadermann, FJ; Steele, A; Stephan, T; Stroud, R; Susini, J; Sutton, SR; Suzuki, Y; Taheri, M; Taylor, S; Teslich, N; Tomeoka, K; Tomioka, N; Toppani, A; Trigo-Rodriguez, JM; Troadec, D; Tsuchiyama, A; Tuzzolino, AJ; Tyliszczak, T; Uesugi, K; Velbel, M; Vellenga, J; Vicenzi, E; Vincze, L; Warren, J; Weber, I; Weisberg, M; Westphal, AJ; Wirick, S; Wooden, D; Wopenka, B; Wozniakiewicz, P; Wright, I; Yabuta, H; Yano, H; Young, ED; Zare, RN; Zega, T; Ziegler, K; Zimmerman, L; Zinner, E; Zolensky, M				Brownlee, Don; Tsou, Peter; Aleon, Jerome; Alexander, Conel M. O'D.; Araki, Tohru; Bajt, Sasa; Baratta, Giuseppe A.; Bastien, Ron; Bland, Phil; Bleuet, Pierre; Borg, Janet; Bradley, John P.; Brearley, Adrian; Brenker, F.; Brennan, Sean; Bridges, John C.; Browning, Nigel D.; Brucato, John R.; Bullock, E.; Burchell, Mark J.; Busemann, Henner; Butterworth, Anna; Chaussidon, Marc; Cheuvront, Allan; Chi, Miaofang; Cintala, Mark J.; Clark, B. C.; Clemett, Simon J.; Cody, George; Colangeli, Luigi; Cooper, George; Cordier, Patrick; Daghlian, C.; Dai, Zurong; D'Hendecourt, Louis; Djouadi, Zahia; Dominguez, Gerardo; Duxbury, Tom; Dworkin, Jason P.; Ebel, Denton S.; Economou, Thanasis E.; Fakra, Sirine; Fairey, Sam A. J.; Fallon, Stewart; Ferrini, Gianluca; Ferroir, T.; Fleckenstein, Holger; Floss, Christine; Flynn, George; Franchi, Ian A.; Fries, Marc; Gainsforth, Z.; Gallien, J. -P.; Genge, Matt; Gilles, Mary K.; Gillet, Philipe; Gilmour, Jamie; Glavin, Daniel P.; Gounelle, Matthieu; Grady, Monica M.; Graham, Giles A.; Grant, P. G.; Green, Simon F.; Grossemy, Faustine; Grossman, Lawrence; Grossman, Jeffrey N.; Guan, Yunbin; Hagiya, Kenji; Harvey, Ralph; Heck, Philipp; Herzog, Gregory F.; Hoppe, Peter; Hoerz, Friedrich; Huth, Joachim; Hutcheon, Ian D.; Ignatyev, Konstantin; Ishii, Hope; Ito, Motoo; Jacob, Damien; Jacobsen, Chris; Jacobsen, Stein; Jones, Steven; Joswiak, David; Jurewicz, Amy; Kearsley, Anton T.; Keller, Lindsay P.; Khodja, H.; Kilcoyne, A. L. David; Kissel, Jochen; Krot, Alexander; Langenhorst, Falko; Lanzirotti, Antonio; Le, Loan; Leshin, Laurie A.; Leitner, J.; Lemelle, L.; Leroux, Hugues; Liu, Ming-Chang; Luening, K.; Lyon, Ian; MacPherson, Glen; Marcus, Matthew A.; Marhas, Kuljeet; Marty, Bernard; Matrajt, Graciela; McKeegan, Kevin; Meibom, Anders; Mennella, Vito; Messenger, Keiko; Messenger, Scott; Mikouchi, Takashi; Mostefaoui, Smail; Nakamura, Tomoki; Nakano, T.; Newville, M.; Nittler, Larry R.; Ohnishi, Ichiro; Ohsumi, Kazumasa; Okudaira, Kyoko; Papanastassiou, Dimitri A.; Palma, Russ; Palumbo, Maria E.; Pepin, Robert O.; Perkins, David; Perronnet, Murielle; Pianetta, P.; Rao, William; Rietmeijer, Frans J. M.; Robert, Francois; Rost, D.; Rotundi, Alessandra; Ryan, Robert; Sandford, Scott A.; Schwandt, Craig S.; See, Thomas H.; Schlutter, Dennis; Sheffield-Parker, J.; Simionovici, Alexandre; Simon, Steven; Sitnitsky, I.; Snead, Christopher J.; Spencer, Maegan K.; Stadermann, Frank J.; Steele, Andrew; Stephan, Thomas; Stroud, Rhonda; Susini, Jean; Sutton, S. R.; Suzuki, Y.; Taheri, Mitra; Taylor, Susan; Teslich, Nick; Tomeoka, Kazu; Tomioka, Naotaka; Toppani, Alice; Trigo-Rodriguez, Josep M.; Troadec, David; Tsuchiyama, Akira; Tuzzolino, Anthony J.; Tyliszczak, Tolek; Uesugi, K.; Velbel, Michael; Vellenga, Joe; Vicenzi, E.; Vincze, L.; Warren, Jack; Weber, Iris; Weisberg, Mike; Westphal, Andrew J.; Wirick, Sue; Wooden, Diane; Wopenka, Brigitte; Wozniakiewicz, Penelope; Wright, Ian; Yabuta, Hikaru; Yano, Hajime; Young, Edward D.; Zare, Richard N.; Zega, Thomas; Ziegler, Karen; Zimmerman, Laurent; Zinner, Ernst; Zolensky, Michael			Comet 81P/Wild 2 under a microscope	SCIENCE			English	Article							CRYSTALLINE SILICATES; REFRACTORY INCLUSIONS; SOLAR NEBULA; KUIPER BELT; P/WILD 2; GRAINS; MINERALOGY; NUCLEUS; ORIGIN	The Stardust spacecraft collected thousands of particles from comet 81P/Wild 2 and returned them to Earth for laboratory study. The preliminary examination of these samples shows that the nonvolatile portion of the comet is an unequilibrated assortment of materials that have both presolar and solar system origin. The comet contains an abundance of silicate grains that are much larger than predictions of interstellar grain models, and many of these are high-temperature minerals that appear to have formed in the inner regions of the solar nebula. Their presence in a comet proves that the formation of the solar system included mixing on the grandest scales.	Univ Washington, Dept Astron, Seattle, WA 98195 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Ctr Spectrometrie Nucl & Spectrometrie Masse, F-91405 Orsay, France; Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA 94550 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; Osserv Astrofis Catania, Ist Nazl Astrofis, I-95123 Catania, Italy; NASA, Engn Sci Contract Grp, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Nat Hist Museum, Dept Mineral, London SW7 5BD, England; Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, Impact & Astromat Res Ctr, London SW7 2AZ, England; European Synchrotron Radiat Facil, F-38043 Grenoble, France; Inst Astrophys Spatiale, F-91405 Orsay, France; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; Goethe Univ Frankfurt, D-6000 Frankfurt, Germany; Stanford Linear Accelerator Ctr, Menlo Pk, CA 94025 USA; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA; Lawrence Livermore Natl Lab, Chem & Mat Sci Directorate, Div Mat Sci & Technol, Livermore, CA 94550 USA; Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; Smithsonian Inst, Washington, DC 20560 USA; Univ Kent, Sch Phys Sci, Canterbury CT2 7NH, Kent, England; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; Lockheed Martin Space Syst, Littleton, CO 80125 USA; NASA, ERC Inc, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; NASA, Exobiol Branch, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Sci & Technol Lille, Lab Struct & Proprietes Etat Solide, F-59655 Villeneuve Dascq, France; Dartmouth Coll, Hanover, NH 03755 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; NASA, Goddard Ctr Astrobiol, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Amer Museum Nat Hist, Dept Earth & Planetary Sci, New York, NY 10024 USA; Univ Chicago, Enrico Fermi Inst, Lab Astrophys & Space Res, Chicago, IL 60637 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Univ Kent, Ctr Astrophys & Planetary Sci, Canterbury CT2 7NH, Kent, England; Novaetech SRL, Naples, Italy; Ecole Normale Super Lyon, Lab Sci Terre, F-69007 Lyon, France; SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; Washington Univ, Space Sci Lab, St Louis, MO 63160 USA; SUNY Coll Plattsburgh, Dept Phys, Plattsburgh, NY 12901 USA; Open Univ, Milton Keynes MK7 6AA, Bucks, England; CEA Saclay, Lab Pierre Sue, F-91191 Gif Sur Yvette, France; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA; Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; Museum Natl Hist Nat, Lab Etud Mat Extraterr, USM 0205, F-75005 Paris, France; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; US Geol Survey, Natl Ctr 954, Reston, VA 20192 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Case Western Reserve Univ, Dept Geol, Cleveland, OH 44106 USA; Max Planck Inst Chem, Particle Chem Dept, D-55020 Mainz, Germany; Rutgers State Univ, Piscataway, NJ USA; Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA; NASA, Robert M Walker Lab Space Sci, Astromat Res & Explorat Sci Directorate, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Arizona State Univ, Ctr Meteorite Studies, Tempe, AZ 85287 USA; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Univ Jena, Inst Geosci, D-07749 Jena, Germany; Univ Chicago, Ctr Adv Radiat Studies, Chicago, IL 60637 USA; ESCG, Jacobs Sverdrup, Houston, TX 77058 USA; NASA, Sci & Explorat Directorate, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Munster, Inst Planetol, D-4400 Munster, Germany; Univ Lille, Lille, France; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Washington Univ, Dept Phys, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; Museum Natl Hist Nat, Lab Etud Mat Extraterr, F-75005 Paris, France; Kyushu Univ, Fukuoka 812, Japan; Geol Survey Japan, Ibaraki, Japan; Kobe Univ, Fac Sci, Dept Earth & Planetary Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; Inst Mat Struct Sci, Tsukuba, Ibaraki 305, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Kanagawa 2298510, Japan; CALTECH, Jet Prop Lab, Div Sci, Pasadena, CA 91109 USA; Minnesota State Univ, Dept Phys & Astron, Mankato, MN 56001 USA; Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; Savannah River Ecol Lab, Aiken, SC 29801 USA; Univ Parthenope, Dipartimento Sci Applicate, Naples, Italy; NASA, Astrophys Branch, Ames Res Ctr, Moffett Field, CA 94035 USA; Engn Sci Contract Barrios Technol Astromat Res &, Houston, TX 77258 USA; USN, Res Lab, Washington, DC 20375 USA; SUNY Coll Plattsburgh, Plattsburgh, NY 12901 USA; Japan Synchrotron Radiat Inst, Hyogo, Japan; USA, Cold Reg Res & Engn Lab, Ctr Res Dev & Engn, Hanover, NH 03755 USA; Univ Autonoma Barcelona, CSIC, Inst Estudis Espacials Catalunya, Inst Space Sci, E-08193 Barcelona, Spain; IEEC, Barcelona 08034, Spain; Osaka Univ, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA; Univ Ghent, B-9000 Ghent, Belgium; CUNY, Kingsborough Community Coll, Brooklyn, NY 11235 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	University of Washington; University of Washington Seattle; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Carnegie Institution for Science; University of North Carolina; North Carolina State University; Istituto Nazionale Astrofisica (INAF); National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Natural History Museum London; Imperial College London; European Synchrotron Radiation Facility (ESRF); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of New Mexico; Goethe University Frankfurt; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Open University - UK; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Istituto Nazionale Astrofisica (INAF); Smithsonian Institution; University of Kent; University of California System; University of California Berkeley; Universite de Lorraine; Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Universite de Lille - ISITE; Universite de Lille; Dartmouth College; University of California System; University of California San Diego; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; American Museum of Natural History (AMNH); University of Chicago; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Kent; Ecole Normale Superieure de Lyon (ENS de LYON); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Washington University (WUSTL); State University of New York (SUNY) System; SUNY Plattsburgh; Open University - UK; CEA; UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Manchester; Museum National d'Histoire Naturelle (MNHN); University of Chicago; United States Department of the Interior; United States Geological Survey; California Institute of Technology; Case Western Reserve University; Max Planck Society; Rutgers State University New Brunswick; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Arizona State University; Arizona State University-Tempe; Max Planck Society; University of Hawaii System; Friedrich Schiller University of Jena; University of Chicago; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Munster; Universite de Lille - ISITE; Universite de Lille; University of California System; University of California Los Angeles; Washington University (WUSTL); Universite de Lorraine; Istituto Nazionale Astrofisica (INAF); University of Tokyo; Museum National d'Histoire Naturelle (MNHN); Kyushu University; National Institute of Advanced Industrial Science & Technology (AIST); Kobe University; High Energy Accelerator Research Organization (KEK); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Minnesota State Colleges & Universities; Minnesota State University Mankato; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Savannah River Ecology Laboratory; Parthenope University Naples; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Defense; United States Navy; Naval Research Laboratory; State University of New York (SUNY) System; SUNY Plattsburgh; Japan Synchrotron Radiation Research Institute; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Osaka University; Stanford University; Michigan State University; Ghent University; City University of New York (CUNY) System; Washington University (WUSTL)	Brownlee, D (corresponding author), Univ Washington, Dept Astron, Seattle, WA 98195 USA.	brownlee@astro.washington.edu	Stroud, Rhonda M/S-4584-2018; Kilcoyne, Arthur A L/I-1465-2013; Appourchaux, Thierry/F-4692-2010; Araki, Tohru/K-9301-2015; Khodja, Hicham/A-1869-2016; Gilmour, Jamie/G-7515-2011; Taheri, Mitra/F-1321-2011; Dworkin, Jason P./C-9417-2012; Bullock, Emma/A-3870-2016; Heck, Philipp R/AAU-1433-2021; Pianetta, Piero/GLS-9094-2022; Jacobsen, Stein/B-1759-2013; Green, Simon F/C-7408-2009; Dai, Zurong/E-6732-2010; Leitner, Jan/A-7391-2015; Alexander, Conel M. O'D./N-7533-2013; Simionovici, Alexandre S/E-5867-2018; Chi, Miaofang/Y-3603-2019; Stroud, Rhonda/GQZ-0151-2022; Heck, Philipp/C-6092-2012; Stephan, Thomas/C-1023-2008; Glavin, Daniel P/D-6194-2012; Liu, Ming-Chang/D-1885-2010; Chaussidon, Marc/E-7067-2017; Trigo-Rodríguez, Josep M./L-3870-2014; Fallon, Stewart J/G-6645-2011; Yabuta, Hikaru/S-2662-2018; 1.4, ALS Beamline/I-1886-2014; Matrajt, Graciela/A-4812-2017; Trigo-Rodriguez, Josep M./ABF-5444-2020; Jacobsen, Stein/ABA-1063-2021; Tomioka, Naotaka/AID-3472-2022; Jacobsen, Chris Johnson/E-2827-2015; Bajt, Sasa/G-2228-2010; Bajt, Sasa/O-4695-2019; Yabuta, Hikaru/M-9041-2014; Vicenzi, Edward P/T-9430-2017; Mikouchi, Takashi/AAY-7355-2021; Baratta, Giuseppe/AAY-6188-2021; Vincze, Laszlo/AAP-3914-2020; Leroux, Hugues/S-4570-2017; McKeegan, Kevin D/A-4107-2008; Tomioka, Naotaka/B-1888-2011; Steele, Andrew/A-3573-2013; Stroud, Rhonda M./C-5503-2008; Zare, Richard N./A-8410-2009; Cordier, Patrick/D-2357-2012; Hoppe, Peter/B-3032-2015; Newville, Matthew G/B-3372-2009; Chi, Miaofang/Q-2489-2015; Newville, Matthew/GNP-3282-2022; marcus, matthew/P-8023-2019; Bland, Phil/M-9392-2018; Jacob, Damien/N-8419-2013	Stroud, Rhonda M/0000-0001-5242-8015; Kilcoyne, Arthur A L/0000-0002-8805-8690; Araki, Tohru/0000-0002-2689-4642; Khodja, Hicham/0000-0001-8374-4539; Dworkin, Jason P./0000-0002-3961-8997; Bullock, Emma/0000-0002-5678-3695; Heck, Philipp R/0000-0002-6319-2594; Pianetta, Piero/0000-0002-4834-6014; Green, Simon F/0000-0002-9153-9786; Leitner, Jan/0000-0003-3655-6273; Alexander, Conel M. O'D./0000-0002-8558-1427; Simionovici, Alexandre S/0000-0001-5349-6482; Chi, Miaofang/0000-0003-0764-1567; Stroud, Rhonda/0000-0001-5242-8015; Stephan, Thomas/0000-0001-6377-8731; Glavin, Daniel P/0000-0001-7779-7765; Liu, Ming-Chang/0000-0003-4030-5258; Trigo-Rodríguez, Josep M./0000-0001-8417-702X; Fallon, Stewart J/0000-0002-8064-5903; Jacobsen, Stein/0000-0003-2164-0720; Jacobsen, Chris Johnson/0000-0001-8562-0353; Bajt, Sasa/0000-0002-7163-7602; Yabuta, Hikaru/0000-0002-4625-5362; Vicenzi, Edward P/0000-0003-2085-6546; Leroux, Hugues/0000-0002-8806-8434; McKeegan, Kevin D/0000-0002-1827-729X; Tomioka, Naotaka/0000-0001-5725-9513; Steele, Andrew/0000-0001-9643-2841; Stroud, Rhonda M./0000-0001-5242-8015; Cordier, Patrick/0000-0002-1883-2994; Hoppe, Peter/0000-0003-3681-050X; Newville, Matthew G/0000-0001-6938-1014; Chi, Miaofang/0000-0003-0764-1567; Ishii, Hope/0000-0002-7976-5078; Marhas, Kuljeet/0000-0002-3375-3047; Dai, Zurong/0000-0002-4209-8718; Mennella, Vito/0000-0001-9525-895X; Colangeli, Luigi/0000-0001-6801-9152; Burchell, Mark/0000-0002-2680-8943; Ignatyev, Konstantin/0000-0002-8937-5655; Brearley, Adrian/0000-0002-7364-8815; Meibom, Anders/0000-0002-4542-2819; Busemann, Henner/0000-0002-0867-6908; Langenhorst, Falko/0000-0003-4892-7713; Brenker, Frank Erich/0000-0002-9735-8206; Jurewicz, Amy/0000-0002-3282-5782; Baratta, Giuseppe/0000-0002-3688-160X; Bland, Phil/0000-0002-4681-7898; Zolensky, Michael/0000-0002-3181-1303; Zare, Richard/0000-0001-5266-4253; Grady, Monica/0000-0002-4055-533X; Mikouchi, Takashi/0000-0002-9998-8754; Gilmour, Jamie/0000-0003-1990-8636; Jacob, Damien/0000-0001-7931-7171; Butterworth, Anna/0000-0002-6439-1472; Brucato, John Robert/0000-0002-4738-5521; Rotundi, Alessandra/0000-0001-5467-157X; Browning, Nigel/0000-0003-0491-251X; Lanzirotti, Antonio/0000-0002-7597-5924; Young, Edward/0000-0002-1299-0801; Palumbo, MariaElisabetta/0000-0002-9122-491X	Science and Technology Facilities Council [PP/E000894/1] Funding Source: researchfish; STFC [PP/E000894/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; Cuzzi JN, 2003, ICARUS, V166, P385, DOI 10.1016/j.icarus.2003.08.016; Davis DR, 1997, ICARUS, V125, P50, DOI 10.1006/icar.1996.5595; Dominguez G, 2004, ICARUS, V172, P613, DOI 10.1016/j.icarus.2004.07.018; DORSCHNER J, 1995, ASTRON ASTROPHYS, V300, P503; ENGRAND C, 2006, METEORIT PLANET SCI, V41, P5237; GRAHAM GA, 2005, P C HELD 26 28 SEPT, P56; Greenberg J., 1982, COMETS, P131; Greenberg JM, 1998, ASTRON ASTROPHYS, V330, P375; HANNER MS, 1994, ASTROPHYS J, V425, P274, DOI 10.1086/173984; Horz F, 2006, SCIENCE, V314, P1716, DOI 10.1126/science.1135705; Horz F, 2000, ICARUS, V147, P559, DOI 10.1006/icar.2000.6450; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; Levison HF, 1997, ICARUS, V127, P13, DOI 10.1006/icar.1996.5637; Lisse CM, 2006, SCIENCE, V313, P635, DOI 10.1126/science.1124694; MATHIS JS, 1977, ASTROPHYS J, V217, P425, DOI 10.1086/155591; OKUDAIRA K, 2005, 36 ANN LUN PLAN SCI, V36, P1832; Pack A, 2005, GEOCHIM COSMOCHIM AC, V69, P3159, DOI 10.1016/j.gca.2005.01.013; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Scott E.R.D., 2005, ASTRONOMICAL SOC PAC, V341, P15; Sekanina Z, 2004, SCIENCE, V304, P1769, DOI 10.1126/science.1098388; Shu FH, 2001, ASTROPHYS J, V548, P1029, DOI 10.1086/319018; Simon SB, 2003, METEORIT PLANET SCI, V38, P813, DOI 10.1111/j.1945-5100.2003.tb00044.x; Wooden DH, 1999, ASTROPHYS J, V517, P1034, DOI 10.1086/307206	26	749	754	0	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1711	1716		10.1126/science.1135840	http://dx.doi.org/10.1126/science.1135840			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170289	Green Submitted, Green Published			2022-12-28	WOS:000242833600041
J	Tsushima, Y; Sasaki, Y; Watanabe, T				Tsushima, Yoshiaki; Sasaki, Yuka; Watanabe, Takeo			Greater disruption due to failure of inhibitory control on an ambiguous distractor	SCIENCE			English	Article							PREFRONTAL CORTEX; DISSOCIATION; BLINDNESS	Considerable evidence indicates that a stimulus that is subthreshold, and thus consciously invisible, influences brain activity and behavioral performance. However, it is not clear how subthreshold stimuli are processed in the brain. We found that a task-irrelevant subthreshold coherent motion led to a stronger disturbance in task performance than did suprathreshold motion. With the subthreshold motion, activity in the visual cortex measured by functional magnetic resonance imaging was higher, but activity in the lateral prefrontal cortex was lower, than with suprathreshold motion. These results suggest that subthreshold irrelevant signals are not subject to effective inhibitory control.	Boston Univ, Dept Psychol, Boston, MA 02215 USA; Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA 02129 USA; CALTECH, ERATO, Shimojo Implicit Brain Funct Project, Pasadena, CA 91125 USA	Boston University; Harvard University; Massachusetts General Hospital; California Institute of Technology	Watanabe, T (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.	takeo@bu.edu		Tsushima, Yoshiaki/0000-0001-7818-4602; Sasaki, Yuka/0000-0002-0061-0250	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015980, R21EY017737] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR14075] Funding Source: Medline; NEI NIH HHS [R01 EY015980, R21 EY017737] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bar M, 1998, PSYCHOL SCI, V9, P464, DOI 10.1111/1467-9280.00086; Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; Callan AM, 2005, NEUROIMAGE, V28, P553, DOI 10.1016/j.neuroimage.2005.06.031; Chun MM, 1997, J EXP PSYCHOL HUMAN, V23, P738, DOI 10.1037/0096-1523.23.3.738; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Friedman-Hill SR, 2003, P NATL ACAD SCI USA, V100, P4263, DOI 10.1073/pnas.0730772100; Fuster J., 2015, PREFRONTAL CORTEX, V5th; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mack A., 1998, INATTENTIONAL BLINDN; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Niedeggen M, 2002, COGNITIVE BRAIN RES, V13, P241, DOI 10.1016/S0926-6410(01)00122-7; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Sahraie A, 2001, VISION RES, V41, P1613, DOI 10.1016/S0042-6989(01)00065-7; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601	30	124	125	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1786	1788		10.1126/science.1133197	http://dx.doi.org/10.1126/science.1133197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	116WD	17170308				2022-12-28	WOS:000242833600062
J	Sandler, A; Gray, R; Perry, MC; Brahmer, J; Schiller, JH; Dowlati, A; Lilenbaum, R; Johnson, DH				Sandler, Alan; Gray, Robert; Perry, Michael C.; Brahmer, Julie; Schiller, Joan H.; Dowlati, Afshin; Lilenbaum, Rogerio; Johnson, David H.			Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	41st Annual Meeting of the American-Society-of-Clinical-Oncology	MAY 13-17, 2005	Orlando, FL	Amer Soc Clin Oncol			ENDOTHELIAL GROWTH-FACTOR; MICROVESSEL DENSITY; BREAST-CANCER; EXPRESSION; RECEPTORS; VEGF; ANTIBODY; THERAPY; TUMORS; TRIAL	BACKGROUND: Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has been shown to benefit patients with a variety of cancers. METHODS: Between July 2001 and April 2004, the Eastern Cooperative Oncology Group (ECOG) conducted a randomized study in which 878 patients with recurrent or advanced non-small-cell lung cancer (stage IIIB or IV) were assigned to chemotherapy with paclitaxel and carboplatin alone (444) or paclitaxel and carboplatin plus bevacizumab (434). Chemotherapy was administered every 3 weeks for six cycles, and bevacizumab was administered every 3 weeks until disease progression was evident or toxic effects were intolerable. Patients with squamous-cell tumors, brain metastases, clinically significant hemoptysis, or inadequate organ function or performance status (ECOG performance status, >1) were excluded. The primary end point was overall survival. RESULTS: The median survival was 12.3 months in the group assigned to chemotherapy plus bevacizumab, as compared with 10.3 months in the chemotherapy-alone group (hazard ratio for death, 0.79; P=0.003). The median progression-free survival in the two groups was 6.2 and 4.5 months, respectively (hazard ratio for disease progression, 0.66; P<0.001), with corresponding response rates of 35% and 15% (P<0.001). Rates of clinically significant bleeding were 4.4% and 0.7%, respectively (P<0.001). There were 15 treatment-related deaths in the chemotherapy-plus-bevacizumab group, including 5 from pulmonary hemorrhage. CONCLUSIONS: The addition of bevacizumab to paclitaxel plus carboplatin in the treatment of selected patients with non-small-cell lung cancer has a significant survival benefit with the risk of increased treatment-related deaths.	Vanderbilt Univ, Nashville, TN USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Missouri, Ellis Fischel Canc Ctr, Columbia, MO USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Wisconsin, Madison, WI USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Mt Sinai Hosp, Miami, FL USA	Vanderbilt University; Harvard University; Dana-Farber Cancer Institute; University of Missouri System; University of Missouri Columbia; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison; University Hospitals of Cleveland	Sandler, A (corresponding author), Vanderbilt Ingram Canc Ctr, 2220 Pierce Ave, Nashville, TN 37232 USA.	alan.sandler@vanderbilt.edu	Johnson, David H./A-7437-2009		NATIONAL CANCER INSTITUTE [U10CA012046, U10CA014548, U10CA021115, U10CA049957, U10CA023318, U10CA016116, U10CA031946, U10CA021076, U10CA066636] Funding Source: NIH RePORTER; NCI NIH HHS [CA21115, CA31946, CA16116, CA21076, CA23318, CA14548, CA12046, CA66636, CA49957] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Borgstrom P, 1999, ANTICANCER RES, V19, P4203; BROWN LF, 1995, HUM PATHOL, V26, P86, DOI 10.1016/0046-8177(95)90119-1; BROWN LF, 1993, CANCER RES, V53, P4727; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FERRARA N, 1995, BREAST CANCER RES TR, V36, P127, DOI 10.1007/BF00666035; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Giantonio BJ, 2005, J CLIN ONCOL, V23, p1S; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; James K, 1999, J NATL CANCER I, V91, P523, DOI 10.1093/jnci/91.6.523; Jemal A, 2005, CA-CANCER J CLIN, V55, P259; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; JENNISON C, 1989, J R STAT SOC B, V51, P305; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Jubb AM, 2006, J CLIN ONCOL, V24, P217, DOI 10.1200/JCO.2005.01.5388; Kabbinavar F. F., 1995, Proceedings of the American Association for Cancer Research Annual Meeting, V36, P488; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KOZLOFF M, 2005, J CLIN ONCOL S, V23, p16S; Mattern J, 1996, BRIT J CANCER, V73, P931, DOI 10.1038/bjc.1996.166; Miller KD, 2005, BREAST CANCER RES TR, V94, pS6; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Seto T, 2006, LUNG CANCER-J IASLC, V53, P91, DOI 10.1016/j.lungcan.2006.02.009; Willett CG, 2004, NAT MED, V10, P649, DOI 10.1038/nm0604-649c; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988	25	4629	4869	9	410	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2542	2550		10.1056/NEJMoa061884	http://dx.doi.org/10.1056/NEJMoa061884			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	116BZ	17167137				2022-12-28	WOS:000242778800006
J	Schmidt, AR; Ragazzi, E; Coppellotti, O; Roghi, G				Schmidt, Alexander R.; Ragazzi, Eugenio; Coppellotti, Olimpia; Roghi, Guido			A microworld in Triassic amber	NATURE			English	Article							ALPS		Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany; Univ Padua, Dept Pharmacol & Anaesthesiol, I-35131 Padua, Italy; Univ Padua, Dept Biol, I-35131 Padua, Italy; CNR, Inst Geosci & Earth Resources, I-35137 Padua, Italy; Univ Padua, Dept Geol Paleontol & Geophys, I-35137 Padua, Italy	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR); University of Padua	Schmidt, AR (corresponding author), Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany.	alexander.schmidt@museum.hu-berlin.de	Ragazzi, Eugenio/ACX-1875-2022	Ragazzi, Eugenio/0000-0002-0390-6823				Dorfelt H, 2006, PALAEONTOLOGY, V49, P1013, DOI 10.1111/j.1475-4983.2006.00582.x; Dorfelt H, 2000, HOPPEA DENKSCHRIFTEN, V61, P785; Rikkinen J, 2000, MYCOL RES, V104, P7, DOI 10.1017/S0953756299001884; Roghi G, 2006, PALAIOS, V21, P143, DOI 10.2110/palo.2005.p05-68; Roghi G, 2004, REV PALAEOBOT PALYNO, V132, P1, DOI 10.1016/j.revpalbo.2004.03.001; Schmidt AR, 2004, PALAEONTOLOGY, V47, P185, DOI 10.1111/j.0031-0239.2004.00368.x; Schonborn W, 1999, J EUKARYOT MICROBIOL, V46, P571, DOI 10.1111/j.1550-7408.1999.tb05133.x; SCHONBORN WILFRIED, 1962, LIMNOLOGICA, V1, P111; WAGGONER BM, 1994, LETHAIA, V27, P77, DOI 10.1111/j.1502-3931.1994.tb01559.x	9	76	79	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					835	835		10.1038/444835a	http://dx.doi.org/10.1038/444835a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167469	Bronze			2022-12-28	WOS:000242805400033
J	Wilson, K; Ricketts, MN				Wilson, Kumanan; Ricketts, Maura N.			A third episode of transfusion-derived vCJD	LANCET			English	Editorial Material							CREUTZFELDT-JAKOB-DISEASE; BLOOD-TRANSFUSION; TRANSMISSION; RISK		Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 2C4, Canada; Publ Hlth Agcy Canada, Ottawa, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Public Health Agency of Canada	Wilson, K (corresponding author), Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 2C4, Canada.	kumanan.wilson@uhn.on.ca						Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Ludlam CA, 2006, BRIT J HAEMATOL, V132, P13, DOI 10.1111/j.1365-2141.2005.05796.x; McCullough J, 2004, TRANSFUSION, V44, P675, DOI 10.1111/j.1537-2995.2004.03310.x; *NAT BLOOD SERV SC, 2006, TRANSF MED EP REV; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Wilson K, 2004, TRANSFUSION, V44, P1475, DOI 10.1111/j.1537-2995.2004.04116.x; Wilson K, 2004, LANCET, V364, P477, DOI 10.1016/S0140-6736(04)16820-7; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	13	7	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 9	2006	368	9552					2037	2039		10.1016/S0140-6736(06)69817-6	http://dx.doi.org/10.1016/S0140-6736(06)69817-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114JY	17161714				2022-12-28	WOS:000242663700005
J	Rom, T; Best, T; van Oosten, D; Schneider, U; Folling, S; Paredes, B; Bloch, I				Rom, T.; Best, Th.; van Oosten, D.; Schneider, U.; Foelling, S.; Paredes, B.; Bloch, I.			Free fermion antibunching in a degenerate atomic Fermi gas released from an optical lattice	NATURE			English	Article							HANBURY-BROWN; INTERFEROMETRY; PHYSICS; NOISE	Noise in a quantum system is fundamentally governed by the statistics and the many-body state of the underlying particles(1-4). The correlated noise(5-7) observed for bosonic particles ( for example, photons(8) or bosonic neutral atoms(9-14)) can be explained within a classical field description with fluctuating phases; however, the anticorrelations ('antibunching') observed in the detection of fermionic particles have no classical analogue. Observations of such fermionic antibunching are scarce and have been confined to electrons(15-17) and neutrons(18). Here we report the direct observation of antibunching of neutral fermionic atoms. By analysing the atomic shot noise(3,10,19) in a set of standard absorption images of a gas of fermionic K-40 atoms released from an optical lattice, we find reduced correlations for distances related to the original spacing of the trapped atoms. The detection of such quantum statistical correlations has allowed us to characterize the ordering and temperature of the Fermi gas in the lattice. Moreover, our findings are an important step towards revealing fundamental fermionic many-body quantum phases in periodic potentials, which are at the focus of current research.	Johannes Gutenberg Univ Mainz, Inst Phys, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz	Bloch, I (corresponding author), Johannes Gutenberg Univ Mainz, Inst Phys, Staudingerweg 7, D-55128 Mainz, Germany.	bloch@uni-mainz.de	Bloch, Immanuel/G-3174-2010; van Oosten, Dries/H-9287-2016; Bloch, Immanuel/N-9169-2019; Schneider, Ulrich/N-4820-2015	Bloch, Immanuel/0000-0002-0679-4759; Schneider, Ulrich/0000-0003-4345-9498; Folling, Simon/0000-0002-6951-3651				Ahufinger V, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.063616; Altman E, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.013603; Baym G, 1998, ACTA PHYS POL B, V29, P1839; Beenakker C, 2003, PHYS TODAY, V56, P37, DOI 10.1063/1.1583532; Blanter YM, 2000, PHYS REP, V336, P1, DOI 10.1016/S0370-1573(99)00123-4; BROWN RH, 1956, NATURE, V177, P27, DOI 10.1038/177027a0; BROWN RH, 1956, NATURE, V178, P1447; Esteve J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.130403; Folling S, 2005, NATURE, V434, P481, DOI 10.1038/nature03500; Greiner M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.110401; Greiner M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.160405; Henny M, 1999, SCIENCE, V284, P296, DOI 10.1126/science.284.5412.296; Hofstetter W, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.220407; Iannuzzi M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.080402; Kiesel H, 2002, NATURE, V418, P392, DOI 10.1038/nature00911; Kohl M, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.031601; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Mandel L, 1995, OPTICAL COHERENCE QU; MATHEY L, 2005, NOISE CORRELATIONS O; Oliver WD, 1999, SCIENCE, V284, P299, DOI 10.1126/science.284.5412.299; Ottl A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.090404; Polkovnikov A, 2006, P NATL ACAD SCI USA, V103, P6125, DOI 10.1073/pnas.0510276103; Rey AM, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.063610; Scarola VW, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.051601; Schellekens M, 2005, SCIENCE, V310, P648, DOI 10.1126/science.1118024; SPIELMAN IB, 2006, MOTT INSULATOR TRANS; Wang DW, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.051604; Werner F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.056401; WESTBROOK CI, 2006, PRODUCING DETECTING; Yasuda M, 1996, PHYS REV LETT, V77, P3090, DOI 10.1103/PhysRevLett.77.3090	30	213	213	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					733	736		10.1038/nature05319	http://dx.doi.org/10.1038/nature05319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151662	Green Submitted			2022-12-28	WOS:000242581100054
J	Gordon-Bennett, P; Ung, T; Stephenson, C; Hingorani, M				Gordon-Bennett, Patel; Ung, Tsiang; Stephenson, Chris; Hingorani, Melanie			Lesson of the week - Misdiagnosis of angle closure glaucoma	BRITISH MEDICAL JOURNAL			English	Article							INTRAOCULAR-PRESSURE		Hinchingbrooke Hosp, Dept Ophthalmol, Huntingdon PE29 6NT, England		Gordon-Bennett, P (corresponding author), Princess Alexandra Hosp, Dept Ophthalmol, Harlow CM20 1QX, Essex, England.	patelgordon@yahoo.co.uk						HYAMS SW, 1968, AM J OPHTHALMOL, V66, P661, DOI 10.1016/0002-9394(68)91287-7; Kondo T, 1997, AM J OPHTHALMOL, V124, P632, DOI 10.1016/S0002-9394(14)70901-8; REUSER T, 1992, J ROY SOC MED, V85, P499; Stevens WR, 1997, SPINE, V22, P1319, DOI 10.1097/00007632-199706150-00008; Tripathi RC, 2003, DRUG SAFETY, V26, P749, DOI 10.2165/00002018-200326110-00002	5	7	7	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 2	2006	333	7579					1157	1158		10.1136/bmj.39024.570313.AE	http://dx.doi.org/10.1136/bmj.39024.570313.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114LG	17138997	Green Published			2022-12-28	WOS:000242667100018
J	Belkhadir, Y; Chory, J				Belkhadir, Youssef; Chory, Joanne			Brassinosteroid signaling: A paradigm for steroid hormone signaling from the cell surface	SCIENCE			English	Editorial Material							RECEPTOR KINASE; ARABIDOPSIS; GROWTH; BRI1; BIOSYNTHESIS; ELONGATION		Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chory@salk.edu	Belkhadir, Youssef/GXM-6743-2022	Belkhadir, Youssef/0000-0001-7149-7139				BELKHADIR Y, 2006, SCI STKE         OCT; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; KARLOVA R, 2006, SCI STKE, pPE36; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Li L, 2005, TRENDS PLANT SCI, V10, P266, DOI 10.1016/j.tplants.2005.04.002; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	17	117	133	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1410	1411		10.1126/science.1134040	http://dx.doi.org/10.1126/science.1134040			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138891				2022-12-28	WOS:000242406100027
J	Ribeil, JA; Zermati, Y; Vandekerckhove, J; Cathelin, S; Kersual, J; Dussiot, M; Coulon, S; Moura, IC; Zeuner, A; Kirkegaard-Sorensen, T; Varet, B; Solary, E; Garrido, C; Hermine, O				Ribeil, Jean-Antoine; Zermati, Yael; Vandekerckhove, Julie; Cathelin, Severine; Kersual, Joelle; Dussiot, Michael; Coulon, Severine; Moura, Ivan Cruz; Zeuner, Ann; Kirkegaard-Sorensen, Thomas; Varet, Bruno; Solary, Eric; Garrido, Carmen; Hermine, Olivier			Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1	NATURE			English	Article							TRANSCRIPTION FACTOR GATA-1; ERYTHROID-DIFFERENTIATION; NEGATIVE REGULATION; CASPASE ACTIVATION; APAF-1 APOPTOSOME; CELL-SURVIVAL; CYTOCHROME-C; MATURATION; PROLIFERATION; PROGENITORS	Caspase-3 is activated during both terminal differentiation and erythropoietin-starvation-induced apoptosis of human erythroid precursors. The transcription factor GATA-1, which performs an essential function in erythroid differentiation(1,2) by positively regulating promoters of erythroid and anti-apoptotic genes(3-6), is cleaved by caspases in erythroid precursors undergoing cell death upon erythropoietin starvation or engagement of the death receptor Fas(7,8). In contrast, by an unknown mechanism, GATA-1 remains uncleaved when these cells undergo terminal differentiation upon stimulation with Epo(9-11). Here we show that during differentiation, but not during apoptosis, the chaperone protein Hsp70 protects GATA-1 fromcaspase-mediated proteolysis. At the onset of caspase activation, Hsp70 co-localizes and interacts with GATA-1 in the nucleus of erythroid precursors undergoing terminal differentiation. In contrast, erythropoietin starvation induces the nuclear export of Hsp70 and the cleavage of GATA-1. In an in vitro assay, Hsp70 protects GATA-1 from caspase-3-mediated proteolysis through its peptide-binding domain. The use of RNA-mediated interference to decrease the Hsp70 content of erythroid precursors cultured in the presence of erythropoietin leads to GATA-1 cleavage, a decrease in haemoglobin content, downregulation of the expression of the anti-apoptotic protein Bcl-X-L, and cell death by apoptosis. These effects are abrogated by the transduction of a caspase-resistant GATA-1 mutant. Thus, in erythroid precursors undergoing terminal differentiation, Hsp70 prevents active caspase-3 from cleaving GATA-1 and inducing apoptosis.	Univ Paris 05, Inst Federat Necker, CNRS,UMR 8147, Fac Med, F-75270 Paris, France; INSERM, UMR 517, F-21079 Dijon, France; Ist Super Sanita, Dept Hematol & Oncol, I-00161 Rome, Italy; Danish Canc Soc, Inst Canc Biol, Dept Apoptosis, DK-2100 Copenhagen, Denmark; Univ Paris 05, Assistance Publ Hop Paris, F-75270 Paris, France; Fac Med, Dept Hematol, F-75270 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Istituto Superiore di Sanita (ISS); Danish Cancer Society; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Hermine, O (corresponding author), Univ Paris 05, Inst Federat Necker, CNRS,UMR 8147, Fac Med, F-75270 Paris, France.	zermati@igr.fr; hermine@necker.fr	Ribeil, Jean-Antoine/F-7896-2017; Ribeil, Jean-Antoine/AAK-7979-2020; Garrido, carmen/G-1633-2018; Zeuner, Ann/K-8607-2016; Garrido, Carolina/GWM-5557-2022; Hermine, Olivier/Q-7072-2018; Moura, Ivan C/A-9510-2013; Zeuner, Ann/A-8529-2010; Cruz Moura, Ivan/A-9510-2013	Ribeil, Jean-Antoine/0000-0002-5733-9123; Ribeil, Jean-Antoine/0000-0002-4549-4783; Garrido, carmen/0000-0003-1368-1493; Moura, Ivan C/0000-0002-2977-0354; Zeuner, Ann/0000-0002-8295-3715; Solary, Eric/0000-0002-8629-1341; Hermine, Olivier/0000-0003-2574-3874; Cruz Moura, Ivan/0000-0002-8418-2803				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Gregoli PA, 1999, J CELL PHYSIOL, V178, P133, DOI 10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.3.CO;2-X; Gregoli PA, 1997, BLOOD, V90, P630, DOI 10.1182/blood.V90.2.630.630_630_640; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Kolbus A, 2002, J EXP MED, V196, P1347, DOI 10.1084/jem.20020562; Motoyama N, 1999, J EXP MED, V189, P1691, DOI 10.1084/jem.189.11.1691; Munugalavadla V, 2005, MOL CELL BIOL, V25, P6747, DOI 10.1128/MCB.25.15.6747-6759.2005; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; WINNING RS, 1988, DEV BIOL, V128, P111, DOI 10.1016/0012-1606(88)90272-2; Zermati Y, 2000, EXP HEMATOL, V28, P885, DOI 10.1016/S0301-472X(00)00488-4; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247	24	202	216	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					102	105		10.1038/nature05378	http://dx.doi.org/10.1038/nature05378			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17167422				2022-12-28	WOS:000243225100044
J	Gal-Yam, A; Fox, DB; Price, PA; Ofek, EO; Davis, MR; Leonard, DC; Soderberg, AM; Schmidt, BP; Lewis, KM; Peterson, BA; Kulkarni, SR; Berger, E; Cenko, SB; Sari, R; Sharon, K; Frail, D; Moon, DS; Brown, PJ; Cucchiara, A; Harrison, F; Piran, T; Persson, SE; McCarthy, PJ; Penprase, BE; Chevalier, RA; MacFadyen, AI				Gal-Yam, A.; Fox, D. B.; Price, P. A.; Ofek, E. O.; Davis, M. R.; Leonard, D. C.; Soderberg, A. M.; Schmidt, B. P.; Lewis, K. M.; Peterson, B. A.; Kulkarni, S. R.; Berger, E.; Cenko, S. B.; Sari, R.; Sharon, K.; Frail, D.; Moon, D. -S.; Brown, P. J.; Cucchiara, A.; Harrison, F.; Piran, T.; Persson, S. E.; McCarthy, P. J.; Penprase, B. E.; Chevalier, R. A.; MacFadyen, A. I.			A novel explosive process is required for the gamma-ray burst GRB 060614	NATURE			English	Article							SUPERNOVA 2002AP; HOST GALAXY; SPECTROSCOPY; AFTERGLOW; PHOTOMETRY; GRB-050709; RATES	Over the past decade, our physical understanding of gamma-ray bursts (GRBs) has progressed rapidly, thanks to the discovery and observation of their long-lived afterglow emission. Long-duration (greater than or similar to 2 s) GRBs are associated with the explosive deaths of massive stars ('collapsars', ref. 1), which produce accompanying supernovae(2-5); the short- duration (less than or similar to 2 s) GRBs have a different origin, which has been argued to be the merger of two compact objects(6-9). Here we report optical observations of GRB 060614 (duration 100 s, ref. 10) that rule out the presence of an associated supernova. This would seem to require a new explosive process: either a massive collapsar that powers a GRB without any associated supernova, or a new type of 'engine', as long-lived as the collapsar but without a massive star. We also show that the properties of the host galaxy (redshift z = 0.125) distinguish it from other long-duration GRB hosts and suggest that an entirely new type of GRB progenitor may be required.	CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; Penn State Univ, Dept Astron & Astrophys, Davey Lab 525, University Pk, PA 16802 USA; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; Australian Natl Univ, Mt Stromlo Observ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; Carnegie Inst Washington Observ, Pasadena, CA 91101 USA; Princeton Univ Observ, Princeton, NJ 08544 USA; Tel Aviv Univ, Dept Astrophys, IL-69978 Tel Aviv, Israel; Natl Radio Astron Observ, Socorro, NM 87801 USA; Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; Pomona Coll, Dept Phys & Astron, Claremont, CA 91711 USA; Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; Inst Adv Study, Princeton, NJ 08540 USA; NYU, Dept Phys, Ctr Cosmol & Particle Phys, New York, NY 10003 USA	California Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Hawaii System; California State University System; San Diego State University; Australian National University; Carnegie Institution for Science; Princeton University; Tel Aviv University; National Radio Astronomy Observatory (NRAO); Hebrew University of Jerusalem; Claremont Colleges; Pomona College; University of Virginia; Institute for Advanced Study - USA; New York University	Gal-Yam, A (corresponding author), CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA.	avishay@astro.caltech.edu		Schmidt, Brian/0000-0001-6589-1287; MacFadyen, Andrew/0000-0002-0106-9013				Berger E, 2005, NATURE, V438, P988, DOI 10.1038/nature04238; Bloom JS, 2006, ASTROPHYS J, V638, P354, DOI 10.1086/498107; Christensen L, 2004, ASTRON ASTROPHYS, V425, P913, DOI 10.1051/0004-6361:20040361; Foley RJ, 2003, PUBL ASTRON SOC PAC, V115, P1220, DOI 10.1086/378242; Fox DB, 2005, NATURE, V437, P845, DOI 10.1038/nature04189; FRENCH J, 2006, 5257 GCN; Fruchter AS, 2006, NATURE, V441, P463, DOI 10.1038/nature04787; Gal-Yam A, 2002, MON NOT R ASTRON SOC, V332, pL73, DOI 10.1046/j.1365-8711.2002.05535.x; Gal-Yam A, 2002, MON NOT R ASTRON SOC, V332, P37, DOI 10.1046/j.1365-8711.2002.05274.x; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; GALYAM A, IN PRESS ASTROPHYS J; Gehrels N, 2005, NATURE, V437, P851, DOI 10.1038/nature04142; GOLENETSKII SV, 2006, 5264 GCN; Hjorth J, 2003, NATURE, V423, P847, DOI 10.1038/nature01750; Hjorth J, 2005, NATURE, V437, P859, DOI 10.1038/nature04174; MacFadyen AI, 2001, ASTROPHYS J, V550, P410, DOI 10.1086/319698; MALESANI D, 2004, APJ, V609, P5; Modjaz M, 2006, ASTROPHYS J, V645, pL21, DOI 10.1086/505906; Narayan R, 2001, ASTROPHYS J, V557, P949, DOI 10.1086/322267; OFEK EO, UNPUB ASTROPHYS J; PARSONS AM, 2006, 5252 GCN; Pastorello A, 2004, MON NOT R ASTRON SOC, V347, P74, DOI 10.1111/j.1365-2966.2004.07173.x; Pian E, 2006, NATURE, V442, P1011, DOI 10.1038/nature05082; Soderberg AM, 2006, ASTROPHYS J, V636, P391, DOI 10.1086/498009; Stanek KZ, 2003, ASTROPHYS J, V591, pL17, DOI 10.1086/376976; Zeh A, 2004, ASTROPHYS J, V609, P952, DOI 10.1086/421100	26	301	306	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1053	1055		10.1038/nature05373	http://dx.doi.org/10.1038/nature05373			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183318	Green Submitted			2022-12-28	WOS:000242971100051
J	Merialdi, M; Requejo, JAH; Campana, A				Merialdi, Mario; Requejo, Jennifer A. Harris; Campana, Aldo		Art Hlth Project Team	Art for women's health	LANCET			English	Editorial Material									WHO, Reprod Hlth & Res Dept, CH-1211 Geneva, Switzerland; Univ Texas, Populat Res Ctr, Austin, TX 78712 USA; Geneva Fdn Med Educ & Res, Geneva, Switzerland; Thomas Jefferson Univ, Philadelphia, PA USA	World Health Organization; University of Texas System; University of Texas Austin; Jefferson University	Merialdi, M (corresponding author), WHO, Reprod Hlth & Res Dept, CH-1211 Geneva, Switzerland.	merialdim@who.int						*WHO, ART HLTH CONT ART WO; *WHO DEP REP HLTH, 2004, REPR HLTH STRAT	2	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 16	2006	368	9553					2113	2114		10.1016/S0140-6736(06)69642-6	http://dx.doi.org/10.1016/S0140-6736(06)69642-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117EZ	17174694				2022-12-28	WOS:000242856900007
J	Bethard, S				Bethard, Suzanne			Taking my poison	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sbethard@stanford.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2657	2658		10.1001/jama.296.22.2657	http://dx.doi.org/10.1001/jama.296.22.2657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164443				2022-12-28	WOS:000242765700001
J	Mawdsley, JED; Maleki, N; Benjamin, E; Gupta, N; Adams, ME; Bansi, D				Mawdsley, Joel E. D.; Maleki, Nima; Benjamin, Elliott; Gupta, Nirupam; Adams, Matthew E.; Bansi, Devinder			Oesophageal perforation with asymptomatic lung abscess formation	LANCET			English	Editorial Material							FOREIGN-BODIES; MANAGEMENT		Charing Cross Hosp, Dept Gastroenterol, London W6 8RF, England; Charing Cross Hosp, Dept Ear Nose & Throat Surg, London W6 8RF, England; Charing Cross Hosp, Dept Radiol, London W6 8RF, England	Imperial College London; Imperial College London; Imperial College London	Mawdsley, JED (corresponding author), Charing Cross Hosp, Dept Gastroenterol, London W6 8RF, England.	joelmawdsley@yahoo.com						DEROWE A, 1994, AM J OTOLARYNG, V15, P41, DOI 10.1016/0196-0709(94)90039-6; Eisen GM, 2002, GASTROINTEST ENDOSC, V55, P802, DOI 10.1016/S0016-5107(02)70407-0; HERRANZGONZALEZ J, 1991, OTOLARYNG HEAD NECK, V105, P649, DOI 10.1177/019459989110500503; Lacy PD, 1997, J LARYNGOL OTOL, V111, P1158, DOI 10.1017/S0022215100139593; Mosca S, 2001, ENDOSCOPY, V33, P692, DOI 10.1055/s-2001-16212	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 9	2006	368	9552					2104	2104		10.1016/S0140-6736(06)69838-3	http://dx.doi.org/10.1016/S0140-6736(06)69838-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114JY	17161733				2022-12-28	WOS:000242663700026
J	Collins, S; Dent, N; Binns, P; Bahwere, P; Sadler, K; Hallam, A				Collins, Steve; Dent, Nicky; Binns, Paul; Bahwere, Paluku; Sadler, Kate; Hallam, Alistair			Management of severe acute malnutrition in children	LANCET			English	Review							USE THERAPEUTIC FOOD; HOME-BASED THERAPY; MALNOURISHED MALAWIAN CHILDREN; IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-ENERGY MALNUTRITION; ANTHROPOMETRIC INDICATORS; ZAMBIAN CHILDREN; OUTPATIENT CARE; HIV-INFECTION; MORTALITY	Severe acute malnutrition (SAM) is defined as a weight-for-height measurement of 70% or less below the median, or three SD or more below the mean National Centre for Health Statistics reference values, the presence of bilateral pitting oedema. of nutritional origin, or a mid-upper-arm circumference of less than 110 mm in children age 1-5 years. 13 million children under age 5 years have SAM, and the disorder is associated with 1 million to 2 million preventable child deaths each year. Despite this global importance, child-survival programmes have ignored SAM, and WHO does not recognise the term "acute malnutrition". inpatient treatment is resource intensive and requires many skilled and motivated staff. Where SAM is common, the number of cases exceeds available inpatient capacity, which limits the effect of treatment; case-fatality rates are 20-30% and coverage is commonly under 10%. Programmes of community-based therapeutic care substantially reduce case-fatality rates and increase coverage rates. These programmes use new, ready-to-use, therapeutic foods and are designed to increase access to services, reduce opportunity costs, encourage early presentation and compliance, and thereby increase coverage and recovery rates. in community-based therapeutic care, all patients with SAM without complications are treated as outpatients. This approach promises to be a successful and cost-effective treatment strategy.	Valid Int Ltd, Unit 14, Oxford, England; Inst Child Hlth, Ctr Int Child Hlth, London, England	University of London; University College London	Collins, S (corresponding author), Valid Int Ltd, Unit 14, Standingford House,26 Cave St, Oxford, England.	steve@validinternational.org		Binns, Paul/0000-0001-8005-9835				Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; AHMED T, WHO UNICEF SCN INFOR; ALAM N, 1989, AM J CLIN NUTR, V49, P884, DOI 10.1093/ajcn/49.5.884; Amadi B, 2002, LANCET, V360, P1375, DOI 10.1016/S0140-6736(02)11401-2; Amadi B, 2001, J PEDIATR GASTR NUTR, V32, P550, DOI 10.1097/00005176-200105000-00011; [Anonymous], 2005, STAT WORLDS CHILDR 2; Ashworth A, 1996, Child Health Dialogue, P10; Ashworth A, 1998, NUTRITION, V14, P244, DOI 10.1016/S0899-9007(97)00433-4; Ashworth A, 2004, LANCET, V363, P2089, DOI 10.1016/S0140-6736(04)16467-2; Ashworth A, 2004, LANCET, V363, P1110, DOI 10.1016/S0140-6736(04)15894-7; Ashworth A, 2001, J PEDIATR GASTR NUTR, V32, P516, DOI 10.1097/00005176-200105000-00003; Ashworth A, 1997, HEALTH POLICY PLANN, V12, P115, DOI 10.1093/heapol/12.2.115; Ashworth A., 2001, COMMUNITY BASED REHA; Ashworth A, 2006, FOOD NUTR BULL, V27, pS24, DOI 10.1177/15648265060273S303; BAIRAGI R, 1981, AM J CLIN NUTR, V34, P2592, DOI 10.1093/ajcn/34.11.2592; Beaudry-Darisme M, 1973, J Trop Pediatr Environ Child Health, V19, P299; Beghin I D, 1973, J Trop Pediatr Environ Child Health, V19, P403; *BELL CHILD SURV S, 2003, LANCET, V361, P1; BENGOA JOSE M., 1967, J TROP PEDIAT, V13, P169; BERG A, 1993, AM J CLIN NUTR, V57, P3, DOI 10.1093/ajcn/57.1.3; Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; Bhan MK, 2003, BMJ-BRIT MED J, V326, P146, DOI 10.1136/bmj.326.7381.146; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BREDOW MT, 1994, ARCH DIS CHILD, V71, P297, DOI 10.1136/adc.71.4.297; Brewster D, 2004, LANCET, V363, P2088, DOI 10.1016/S0140-6736(04)16466-0; BREWSTER D, 1995, LANCET, V345, P453, DOI 10.1016/S0140-6736(95)90435-2; Brewster DR, 1997, EUR J CLIN NUTR, V51, P139, DOI 10.1038/sj.ejcn.1600367; BRIEND A, 1986, BRIT MED J, V293, P373, DOI 10.1136/bmj.293.6543.373; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Briend A, 2001, BRIT J NUTR, V85, pS175, DOI 10.1079/BJN2000311; Briend A, 2001, J PEDIATR GASTR NUTR, V32, P521, DOI 10.1097/00005176-200105000-00005; BRIEND A, 1989, EUR J CLIN NUTR, V43, P715; BRIEND A, 1997, FIELD EXCHANGE, V2, P15; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; CHEN LC, 1980, AM J CLIN NUTR, V33, P1836, DOI 10.1093/ajcn/33.8.1836; Chintu C, 1995, J TROP PEDIATRICS, V41, P348, DOI 10.1093/tropej/41.6.348; CHOPRA M, 1995, LANCET, V345, P788; CIA World Fact Book, CIA WORLD FACT BOOK; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; COLLINS H, 2004, EMERGENCY NUTR NET S, V2, P35; Collins S, 2003, LANCET, V362, P249, DOI 10.1016/S0140-6736(03)13926-8; Collins S, 2002, LANCET, V360, P1824, DOI 10.1016/S0140-6736(02)11770-3; Collins S, 2001, LANCET, V358, P498, DOI 10.1016/S0140-6736(01)05630-6; Collins S, 2004, COMMUNITY BASED THER; Collins S, 2004, COMMUNITY THERAPEUTI; Collins S, 2006, FOOD NUTR BULL, V27, pS49, DOI 10.1177/15648265060273S304; Cook R, 1971, J Trop Pediatr Environ Child Health, V17, P15; Cook R, 1968, J Trop Pediatr (1967), V14, P60; Deen JL, 2003, B WORLD HEALTH ORGAN, V81, P237; Diop EHI, 2003, AM J CLIN NUTR, V78, P302, DOI 10.1093/ajcn/78.2.302; *EM NUTR NETW, ENN REP INT WORKSH; FELIG P, 1970, NEW ENGL J MED, V282, P166; FELLOWS P, 2004, EMERGENCY NUTR NETWO, V2, P33; FORBES GB, 1979, AM J CLIN NUTR, V32, P1570, DOI 10.1093/ajcn/32.8.1570; GOLDEN M, 1988, T ROY SOC TROP MED H, V82, P3, DOI 10.1016/0035-9203(88)90245-3; GOLDEN MHN, 1977, CLIN SCI MOL MED, V53, P473, DOI 10.1042/cs0530473; Golden MHN., 1996, OXFORD TXB MED, V1, P1278; Grellety Y., 2000, THESIS U ABERDEEN; GUERI M, 1985, J TROP PEDIATRICS, V31, P101, DOI 10.1093/tropej/31.2.101; GUERRERO S, 2005, FIELD EXCHANGE, V25, P8; GUERRERO S, 2005, HUMANITARIAN EXCHANG, P20; Hamer C, 2004, ARCH DIS CHILD, V89, P181, DOI 10.1136/adc.2002.022715; HEIKENS GT, 1989, EUR J CLIN NUTR, V43, P145; HEIKENS GT, 1994, EUR J CLIN NUTR, V48, P873; International Institute for Population Sciences & ORC Macro, 2000, NAT FAM HLTH SURV NF; Jha P, 1998, HEALTH POLICY PLANN, V13, P249, DOI 10.1093/heapol/13.3.249; Kessler L, 2000, ANN TROP PAEDIATR, V20, P50, DOI 10.1080/02724930092075; Keys A, 1950, BIOL HUMAN STARVATIO; KHANUM S, 1994, LANCET, V344, P1728; KHARA T, 2004, EMERGENCY NUTR NET S, V2, P1; KING KW, 1978, AM J CLIN NUTR, V31, P679, DOI 10.1093/ajcn/31.4.679; LAWLESS J, 1966, LANCET, V2, P1175; Manary MJ, 2004, ARCH DIS CHILD, V89, P557, DOI 10.1136/adc.2003.034306; MCCANCE RA, 1951, STUDIES UNDERNUTRITI; MGONE CS, 1991, J ACQ IMMUN DEF SYND, V4, P910; Myatt M, 2005, B WORLD HEALTH ORGAN, V83, P20; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Ndekha MJ, 2005, ACTA PAEDIATR, V94, P222, DOI 10.1080/08035250410022503; PECOUL B, 1992, ANN TROP PAEDIATR, V12, P47, DOI 10.1080/02724936.1992.11747546; PELLETIER DL, 1994, J NUTR, V124, pS2047; Pelletier DL, 2003, J NUTR, V133, P107, DOI 10.1093/jn/133.1.107; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; PRAZUCK T, 1993, AIDS, V7, P103, DOI 10.1097/00002030-199301000-00016; Prudhon C, 1996, AM J EPIDEMIOL, V144, P116, DOI 10.1093/oxfordjournals.aje.a008898; Puoane T, 2001, S AFR MED J, V91, P137; Reid M, 2002, AM J CLIN NUTR, V76, P633, DOI 10.1093/ajcn/76.3.633; Reneman L, 1997, J TROP PEDIATRICS, V43, P293, DOI 10.1093/tropej/43.5.293; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; ROOSMALENWIEBEN.MW, 1987, J TROP PEDIATRICS, V33, P24; ROOSMALENWIEBEN.MW, 1986, J TROP PEDIATRICS, V32, P240; SADRE M, 1969, LANCET, V2, P112; Sandige H, 2004, J PEDIATR GASTR NUTR, V39, P141, DOI 10.1097/00005176-200408000-00003; Schofield C, 1996, B WORLD HEALTH ORGAN, V74, P223; Schofield C, 1997, Afr Health, V19, P17; *SPHERE PROJ TEAM, 2003, SPHERE HUM CHART MIN; Tectonidis M, 2006, NEW ENGL J MED, V354, P224, DOI 10.1056/NEJMp058240; Ticklay IMH, 1997, E AFR MED J, V74, P217; *UNHCR, 1999, HDB EM; UNICEF, 1990, STRAT IMPR NUTR CHIL; *UNICEF, UNICEF GLOB DAT CHIL; VANDAMME W, 1998, MED ASSISTANCE SELF; VELLA V, 1994, EUR J CLIN NUTR, V48, P189; VELZEBOER MI, 1983, J TROP PEDIATRICS, V29, P159, DOI 10.1093/tropej/29.3.159; Waterlow JC, 2000, ACTA PAEDIATR, V89, P138, DOI 10.1080/080352500750028717; WATERLOW JC, 1986, ANNU REV NUTR, V6, P495, DOI 10.1146/annurev.nu.06.070186.002431; Waterlow JC, 1992, PROTEIN ENERGY MALNU; *WHO, REP INF CONS COMM BA; WHO, 2006, ACTA PAEDIAT S450, V95, P1; WHO, 1997, IMPR CHILD HLTH IMCI; *WHO, 2005, WHO GLOB HLTH ATL HU; *WHO INF CONS, 2004, INF CONS REV CURR LI; Wilkinson D, 1996, J TROP PEDIATRICS, V42, P114, DOI 10.1093/tropej/42.2.114; Winick M, 1979, HUNGER DIS; World Bank, 2004, RIS CHALL MILL DEV G; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, 1999, MAN SEV MALN MAN PHY	117	257	262	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					1992	2000		10.1016/S0140-6736(06)69443-9	http://dx.doi.org/10.1016/S0140-6736(06)69443-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113JD	17141707				2022-12-28	WOS:000242593300032
J	Gakidou, E; Lozano, R; Gonzalez-Pier, E; Abbott-Klafter, J; Barofsky, JT; Bryson-Cahn, C; Feehan, DM; Lee, DK; Hernandez-Llamas, H; Murray, CJL				Gakidou, Emmanuela; Lozano, Rafael; Gonzalez-Pier, Eduardo; Abbott-Klafter, Jesse; Barofsky, Jeremy T.; Bryson-Cahn, Chloe; Feehan, Dennis M.; Lee, Diana K.; Hernandez-Llamas, Hector; Murray, Christopher J. L.			Health system reform in Mexico 5 - Assessing the effect of the 2001-06 Mexican health reform: an interim report card	LANCET			English	Article							UNIVERSAL COVERAGE; INSURANCE PROGRAM; LATIN-AMERICA; USER FEES; TAIWAN; PERFORMANCE; THAILAND; IMPACT; FRAMEWORK; LESSONS	Since 2001, Mexico has been designing, legislating, and implementing a major health-system reform. A key component was the creation of Seguro Popular, which is intended to expand insurance coverage over 7 years to uninsured people, nearly half the total population at the start of 2001. The reform included five actions: legislation of entitlement per family affiliated which, with full implementation, will increase public spending on health by 0.8-1.0% of gross domestic product; creation of explicit benefits packages; allocation of monies to decentralised state ministries of health in proportion to number of families affiliated; division of federal resources flowing to states into separate funds for personal and non-personal health services; and creation of a fund to protect families against catastrophic health expenditures. Using the WHO health-systems framework, we used a wide range of datasets to assess the effect of this reform on different dimensions of the health system. Key findings include: affiliation is preferentially reaching the poor and the marginalised communities; federal non-social security expenditure in real per-head terms increased by 38% from 2000 to 2005; equity of public-health expenditure across states improved; Seguro Popular affiliates used more inpatient and outpatient services than uninsured people; effective coverage of 11 interventions has improved between 2000 and 2005-06; inequalities in effective coverage across states and wealth deciles has decreased over this period; catastrophic expenditures for Seguro Popular affiliates are lower than for uninsured people even though use of services has increased. We present some lessons for Mexico based on this interim evaluation and explore implications for other countries considering health reforms.	Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; Minist Hlth, Mexico City, DF, Mexico	Harvard University; University of Queensland	Gakidou, E (corresponding author), Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA.	emmanuela_gakidou@harvard.edu	Lozano, Rafael/T-5352-2018; Gonzalez Pier, Eduardo/AIB-2488-2022	Lozano, Rafael/0000-0002-7356-8823; 				Barrientos A, 2002, B LAT AM RES, V21, P442; Bhagava A, 2001, J HEALTH ECON, V20, P423, DOI 10.1016/S0167-6296(01)00073-X; Brownell MD, 2001, SOC SCI MED, V52, P657, DOI 10.1016/S0277-9536(00)00168-4; Chen CS, 2005, AM J PUBLIC HEALTH, V95, P305, DOI 10.2105/AJPH.2002.012567; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cheng SH, 1997, JAMA-J AM MED ASSOC, V278, P89, DOI 10.1001/jama.278.2.89; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; *COM NAC PROT SOC, 2006, INF RES PRIM TRIM 20; *COM NAC PROT SOC, 2006, CRIT PRES 2006 GAST; Daniels N, 2005, B WORLD HEALTH ORGAN, V83, P534; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; *GAVI, 2006, 7 GAVI BOARD M; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; Gilson L, 2003, HEALTH POLICY PLANN, V18, P31, DOI 10.1093/heapol/18.1.31; GONZALEZPIER E, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69567-6; Gotsadze G, 2005, SOC SCI MED, V60, P809, DOI 10.1016/j.socscimed.2004.06.017; *HARV IN GLOB HLTH, 2005, MEX HLTH METR 2005; HOLST J, 2004, J PUBLIC HLTH, V12, P271; Homedes N, 2005, HEALTH POLICY, V71, P83, DOI 10.1016/j.healthpol.2004.01.011; Jeong HS, 2005, HEALTH POLICY, V74, P133, DOI 10.1016/j.healthpol.2004.12.017; Knaul FM, 2005, SALUD PUBLICA MEXICO, V47, P430; Knaul FM, 2005, HEALTH AFFAIR, V24, P1467, DOI 10.1377/hlthaff.24.6.1467; Knaul FM, 2003, CALEIDOSCOPIO SALUD, P275; KNAUL FM, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69565-2; Kwon S, 2003, HEALTH POLICY PLANN, V18, P84, DOI 10.1093/heapol/18.1.84; Laurell AC, 2003, AM J PUBLIC HEALTH, V93, P2028, DOI 10.2105/AJPH.93.12.2028; Lee JC, 2003, AM J PUBLIC HEALTH, V93, P48, DOI 10.2105/AJPH.93.1.48; Lloyd-Sherlock P, 2006, SOC POLICY ADMIN, V40, P353, DOI 10.1111/j.1467-9515.2006.00494.x; Londono JL, 1997, HEALTH POLICY, V41, P1, DOI 10.1016/S0168-8510(97)00010-9; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Lu CL, 2006, LANCET, V368, P1088, DOI 10.1016/S0140-6736(06)69337-9; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; McPake B, 2000, B WORLD HEALTH ORGAN, V78, P811; McPake B, 2003, HEALTH POLICY PLANN, V18, P182, DOI 10.1093/heapol/czg023; Mexican Ministry of Health, 2006, EFF COV HLTH SYST ME; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; NELSON J, 2004, CRUCIAL NEEDS WEAK I, P23; *ORG EC COOP DEV, 2005, OECD REV HLTH CAR SY; Pachanee CA, 2006, HEALTH POLICY PLANN, V21, P310, DOI 10.1093/heapol/czl017; Pannarunothai S, 2004, HEALTH POLICY, V68, P17, DOI 10.1016/S0168-8510(03)00024-1; Restrepo HE, 2002, J EPIDEMIOL COMMUN H, V56, P742, DOI 10.1136/jech.56.10.742; Roberts MJ., 2004, GETTING HLTH REFORM; ROSSETTI AG, 2004, CRUCIAL NEEDS WEAK I, P65; Savedoff W., 2003, HLTH SYSTEMS PERFORM; *SECR HAC CRED PUB, 2003, SEG RES MOD RES MISC; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Shengelia B., 2003, HLTH SYSTEMSPERFORMA, P221; Skoufias E, 2005, PROGRESA ITS IMPACTS; Suraratdecha C, 2005, HEALTH POLICY, V73, P272, DOI [10.1016/j.healthpol.2004.11.019, 10.1016/j.healthpol.2004.05.005]; TRAVIS P, 2003, HLTH SYSTEMS PERFORM, P809; Trujillo Antonio J, 2005, Int J Health Care Finance Econ, V5, P211, DOI 10.1007/s10754-005-1792-5; Twaddle A. C., 2002, HLTH CARE REFORM WOR; Van der Geest S, 2000, HEALTH POLICY PLANN, V15, P59, DOI 10.1093/heapol/15.1.59; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; World Bank, 2004, WORLD DEV REP 2004 M; World Health Organization, 2000, WORLD HLTH REP 2000; Xu K, 2006, SOC SCI MED, V62, P866, DOI 10.1016/j.socscimed.2005.07.004; Yip W, 2001, HEALTH ECON, V10, P207, DOI 10.1002/hec.589	59	137	145	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2006	368	9550					1920	1935		10.1016/S0140-6736(06)69568-8	http://dx.doi.org/10.1016/S0140-6736(06)69568-8			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126725				2022-12-28	WOS:000242345900034
J	de Oliveira, FT; Chanda, A; Banerjee, D; Shan, XP; Mondal, S; Que, L; Bominaar, EL; Munck, E; Collins, TJ				Tiago de Oliveira, Filipe; Chanda, Arani; Banerjee, Deboshri; Shan, Xiaopeng; Mondal, Sujit; Que, Lawrence, Jr.; Bominaar, Emile L.; Muenck, Eckard; Collins, Terrence J.			Chemical and spectroscopic evidence for an Fe-V-Oxo complex	SCIENCE			English	Article							HIGH-VALENT IRON; NONHEME; MONONUCLEAR; LIGANDS	Iron(V)-oxo species have been proposed as key reactive intermediates in the catalysis of oxygen-activating enzymes and synthetic catalysts. Here, we report the synthesis of [Fe(TAML)(O)](-) in nearly quantitative yield, where TAML is a macrocyclic tetraamide ligand. Mass spectrometry, Mossbauer, electron paramagnetic resonance, and x-ray absorption spectroscopies, as well as reactivity studies and density functional theory calculations show that this long-lived (hours at -60 degrees C) intermediate is a spin S=1/2 iron(V)-oxo complex. Iron-TAML systems have proven to be efficient catalysts in the decomposition of numerous pollutants by hydrogen peroxide, and the species we characterized is a likely reactive intermediate in these reactions.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; Univ Minnesota, Ctr Met Biocatalysis, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Carnegie Mellon University; University of Minnesota System; University of Minnesota Twin Cities	Que, L (corresponding author), Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA.	que@chem.umn.edu; eb7g@andrew.cmu.edu; emunck@cmu.edu; tc1u@andrew.cmu.edu	Tiago de Oliveira, Filipe/B-7065-2008; Collins, Terrence J/A-9807-2017	Tiago de Oliveira, Filipe/0000-0001-5149-5902; Collins, Terrence J/0000-0003-2611-9184	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038767] Funding Source: NIH RePORTER; NIBIB NIH HHS [EB001475] Funding Source: Medline; NIGMS NIH HHS [GM-38767] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aliaga-Alcalde N, 2005, ANGEW CHEM INT EDIT, V44, P2908, DOI 10.1002/anie.200462368; Banerjee D, 2006, ANGEW CHEM INT EDIT, V45, P3974, DOI 10.1002/anie.200504511; Bartos MJ, 1998, COORDIN CHEM REV, V174, P361, DOI 10.1016/S0010-8545(98)00142-8; BENDIX J, 1993, INORG CHEM, V32, P2838, DOI 10.1021/ic00065a010; Bukowski MR, 2005, SCIENCE, V310, P1000, DOI 10.1126/science.1119092; Chanda A, 2006, J INORG BIOCHEM, V100, P606, DOI 10.1016/j.jinorgbio.2005.12.016; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Decker A, 2006, J INORG BIOCHEM, V100, P697, DOI 10.1016/j.jinorgbio.2006.01.013; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Ghosh A, 2005, J AM CHEM SOC, V127, P2505, DOI 10.1021/ja0460458; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; Harischandra DN, 2005, J AM CHEM SOC, V127, P13776, DOI 10.1021/ja0542439; Neese F, 2006, J INORG BIOCHEM, V100, P716, DOI 10.1016/j.jinorgbio.2006.01.020; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Parsell TH, 2006, J AM CHEM SOC, V128, P8728, DOI 10.1021/ja062332v; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Sen Gupta S, 2002, SCIENCE, V296, P326, DOI 10.1126/science.1069297; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275	18	348	350	4	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					835	838		10.1126/science.1133417	http://dx.doi.org/10.1126/science.1133417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	134FN	17185561				2022-12-28	WOS:000244069000066
J	Chiritescu, C; Cahill, DG; Nguyen, N; Johnson, D; Bodapati, A; Keblinski, P; Zschack, P				Chiritescu, Catalin; Cahill, David G.; Nguyen, Ngoc; Johnson, David; Bodapati, Arun; Keblinski, Pawel; Zschack, Paul			Ultralow thermal conductivity in disordered, layered WSe2 crystals	SCIENCE			English	Article							HEAT-FLOW; METAL-FILMS; THERMOREFLECTANCE; INTERFEROMETRY; SOLIDS	The cross-plane thermal conductivity of thin films of WSe2 grown from alternating W and Se layers is as small as 0.05 watts per meter per degree kelvin at room temperature, 30 times smaller than the c-axis thermal conductivity of single-crystal WSe2 and a factor of 6 smaller than the predicted minimum thermal conductivity for this material. We attribute the ultralow thermal conductivity of these disordered, layered crystals to the localization of lattice vibrations induced by the random stacking of two-dimensional crystalline WSe2 sheets. Disordering of the layered structure by ion bombardment increases the thermal conductivity.	Univ Illinois, Dept Mat Sci & Engn, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA; Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA; Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Oregon; Rensselaer Polytechnic Institute; United States Department of Energy (DOE); Argonne National Laboratory	Cahill, DG (corresponding author), Univ Illinois, Dept Mat Sci & Engn, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA.	d-cahill@uiuc.edu	Cahill, David G./B-3495-2014					Allen M.P., 1991, COMPUTER SIMULATION; ALLEN PB, 1993, PHYS REV B, V48, P12581, DOI 10.1103/PhysRevB.48.12581; Cahill DG, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.235322; Cahill DG, 2004, REV SCI INSTRUM, V75, P5119, DOI 10.1063/1.1819431; CAHILL DG, 1992, PHYS REV B, V46, P6131, DOI 10.1103/PhysRevB.46.6131; Costescu RM, 2004, SCIENCE, V303, P989, DOI 10.1126/science.1093711; GRAHN HT, 1989, IEEE J QUANTUM ELECT, V25, P2562, DOI 10.1109/3.40643; Ju YS, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1931827; Jund P, 1999, PHYS REV B, V59, P13707, DOI 10.1103/PhysRevB.59.13707; LIN HN, 1991, J APPL PHYS, V69, P3816, DOI 10.1063/1.348958; Maiti A, 1997, SOLID STATE COMMUN, V102, P517, DOI 10.1016/S0038-1098(97)00049-5; Medwick PA, 1997, J SOLID STATE CHEM, V133, P44, DOI 10.1006/jssc.1997.7314; MONCTON DE, 1977, PHYS REV B, V16, P801, DOI 10.1103/PhysRevB.16.801; Moss S, 1996, CHEM MATER, V8, P1853, DOI 10.1021/cm960109z; O'Hara KE, 2001, J APPL PHYS, V90, P4852, DOI 10.1063/1.1406543; PADDOCK CA, 1986, J APPL PHYS, V60, P285, DOI 10.1063/1.337642; Schelling PK, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144306; SCHUTTE WJ, 1987, J SOLID STATE CHEM, V70, P207, DOI 10.1016/0022-4596(87)90057-0; STONER RJ, 1993, PHYS REV B, V48, P16373, DOI 10.1103/PhysRevB.48.16373; WILSON JA, 1969, ADV PHYS, V18, P193, DOI 10.1080/00018736900101307	20	646	671	21	525	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					351	353		10.1126/science.1136494	http://dx.doi.org/10.1126/science.1136494			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17170252				2022-12-28	WOS:000243535400033
J	Ridgway, J; Zhang, G; Wu, Y; Stawicki, S; Liang, WC; Chanthery, Y; Kowalski, J; Watts, RJ; Callahan, C; Kasman, I; Singh, M; Chien, M; Tan, C; Hongo, JAS; de Sauvage, F; Plowman, G; Yan, MH				Ridgway, John; Zhang, Gu; Wu, Yan; Stawicki, Scott; Liang, Wei-Ching; Chanthery, Yvan; Kowalski, Joe; Watts, Ryan J.; Callahan, Christopher; Kasman, Ian; Singh, Mallika; Chien, May; Tan, Christine; Hongo, Jo-Anne S.; de Sauvage, Fred; Plowman, Greg; Yan, Minhong			Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis	NATURE			English	Article							ENDOTHELIAL-CELL FUNCTION; VASCULAR DEVELOPMENT; UP-REGULATION; VEGF; DIFFERENTIATION; EXPRESSION; ANTIBODIES; LETHALITY; ARTERIAL; PATHWAY	Haploinsufficiency of DII4, a vascular-specific Notch ligand, has shown that it is essential for embryonic vascular development and arteriogenesis(1-3). Mechanistically, it is unclear how the DII4-mediated Notch pathway contributes to complex vascular processes that demand meticulous coordination of multiple signalling pathways. Here we show that DII4-mediated Notch signalling has a unique role in regulating endothelial cell proliferation and differentiation. Neutralizing DII4 with a DII4-selective antibody rendered endothelial cells hyperproliferative, and caused defective cell fate specification or differentiation both in vitro and in vivo. In addition, blocking DII4 inhibited tumour growth in several tumour models. Remarkably, antibodies against DII4 and antibodies against vascular endothelial growth factor (VEGF) had paradoxically distinct effects on tumour vasculature. Our data also indicate that DII4-mediated Notch signalling is crucial during active vascularization, but less important for normal vessel maintenance. Furthermore, unlike blocking Notch signalling globally, neutralizing DII4 had no discernable impact on intestinal goblet cell differentiation(4,5), supporting the idea that DII4-mediated Notch signalling is largely restricted to the vascular compartment. Therefore, targeting DII4 might represent a broadly efficacious and well-tolerated approach for the treatment of solid tumours.	Genentech Inc, Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; Genentech Inc, Antibody Engn, San Francisco, CA 94080 USA; Genentech Inc, Pathol, San Francisco, CA 94080 USA; Genentech Inc, Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Yan, MH (corresponding author), Genentech Inc, Tumor Biol & Angiogenesis, 1 DNA Way, San Francisco, CA 94080 USA.	minhong@gene.com	Plowman, Greg/O-8032-2019; PLOWMAN, Greg D/E-2012-2011	Plowman, Gregory D/0000-0002-6465-309X				Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ferrara N, 2005, EXP SUPPL, V94, P209; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	22	762	875	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1083	1087		10.1038/nature05313	http://dx.doi.org/10.1038/nature05313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183323				2022-12-28	WOS:000242971100059
J	Ware, JH				Ware, James H.			Statistics and medicine - The limitations of risk factors as prognostic tools	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Ware, JH (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							ANDERSON TW, 2003, INTR MULT STAT AN; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562	4	340	346	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2615	2617		10.1056/NEJMp068249	http://dx.doi.org/10.1056/NEJMp068249			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	118QG	17182986				2022-12-28	WOS:000242956200002
J	Davis, TC; Wolf, MS; Bass, PF; Thompson, JA; Tilson, HH; Neuberger, M; Parker, RM				Davis, Terry C.; Wolf, Michael S.; Bass, Pat F., III; Thompson, Jason A.; Tilson, Hugh H.; Neuberger, Marolee; Parker, Ruth M.			Literacy and misunderstanding prescription drug labels	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTIONAL HEALTH LITERACY; ADVERSE EVENTS; OLDER-ADULTS; PRESCRIBED MEDICATION; PATIENT SAFETY; COMPREHENSION; CARE; NONCOMPLIANCE; READABILITY; INFORMATION	Background: Health literacy has increasingly been viewed as a patient safety issue and may contribute to medication errors. Objective: To examine patients' abilities to understand and demonstrate instructions found on container labels of common prescription medications. Design: Cross-sectional study using in-person, structured interviews. Setting: 3 primary care clinics serving mostly indigent populations in Shreveport, Louisiana; Jackson, Michigan; and Chicago, Illinois. Patients: 395 English-speaking adults waiting to see their providers. Measurement: Correct understanding of instructions on 5 container labels; demonstration of 1 label's dosage instructions. Results: Correct understanding of the 5 labels ranged from 67.1 % to 91.1%. Patients reading at or below the sixth-grade level (low literacy) were less able to understand all 5 label instructions. Although 70.7% of patients with low literacy correctly stated the instructions, "Take two tablets by mouth twice daily," only 34.7% could demonstrate the number of pills to be taken daily. After potential confounding variables were controlled for, low (adjusted relative risk, 2.32 [95% Cl, 1.26 to 4.281) and marginal (adjusted relative risk, 1.94 [Cl, 1.14 to 3.27]) literacy were significantly associated with misunderstanding. Taking a greater number of prescription medications was also statistically significantly associated with misunderstanding (adjusted relative risk, 2.98 [Cl, 1.40 to 6.34] for >= 5 medications). Limitations: The study sample was at high risk for poor health literacy and outcomes. Most participants were women, and all spoke English. The authors did not examine the association between misunderstanding and medication error or evaluate patients' actual prescription drug-taking behaviors. Conclusions: Lower literacy and a greater number of prescription medications were independently associated with misunderstanding the instructions on prescription medication labels.	Louisiana State Univ, Hlth Sci Ctr, Dept Med Pediat, Shreveport, LA 71104 USA; Northwestern Univ, Chicago, IL 60611 USA; Univ N Carolina, Chapel Hill, NC USA; Western Michigan Area Hlth Educ Ctr, Jackson, MI USA; Emory Univ, Atlanta, GA 30322 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Northwestern University; University of North Carolina; University of North Carolina Chapel Hill; Emory University	Davis, TC (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Med Pediat, 1501 Kings Highway, Shreveport, LA 71104 USA.	TDAVIS1@lsuhsc.edu	Parker, Ruth M/S-4583-2017; Wolf, Michael/V-3351-2018	Parker, Ruth M/0000-0001-9685-6396; Wolf, Michael/0000-0002-4342-6517	NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [K01EH000067] Funding Source: NIH RePORTER; NCEH CDC HHS [1 K01 EH000067-01] Funding Source: Medline	NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NCEH CDC HHS		Altman DE, 2004, NEW ENGL J MED, V351, P2041, DOI 10.1056/NEJMp048243; *AM PHARM ASS AM P, 2003, PHARM YOU; American Association for Public Opinion Research, 2004, STAND DEF FIN DISP C; [Anonymous], HLTH PEOPL 2010 UND; Aspden P, 2006, PREVENTING MED ERROR; Blendon RJ, 2002, NEW ENGL J MED, V347, P1933, DOI 10.1056/NEJMsa022151; Cline CMJ, 1999, EUR J HEART FAIL, V1, P145, DOI 10.1016/S1388-9842(99)00014-8; Davis T C, 1993, Fam Med, V25, P391; Davis TC, 1998, HEALTH EDUC BEHAV, V25, P613, DOI 10.1177/109019819802500508; DAVIS TC, 2004, UNDERSTANDING HLTH L, P157; Davis TC, 2006, J GEN INTERN MED, V21, P847, DOI 10.1111/j.1525-1497.2006.00529.x; *DEP HLTH HUM SERV, 2006, MED EXP PAN SURV; Dowse R, 2001, PATIENT EDUC COUNS, V45, P87, DOI 10.1016/S0738-3991(00)00197-X; Elder NC, 2002, J FAM PRACTICE, V51, P927; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Kutner M., 2005, 1 LOOK LITERACY AM A; Leape LL, 2002, NEW ENGL J MED, V347, P1633, DOI 10.1056/NEJMNEJMhpr011493; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mansoor LE, 2003, ANN PHARMACOTHER, V37, P1003, DOI 10.1345/aph.1C449; Metlay JP, 2005, J AM GERIATR SOC, V53, P976, DOI 10.1111/j.1532-5415.2005.53308.x; Moisan J, 2002, GERONTOLOGY, V48, P44, DOI 10.1159/000048924; MORRELL RW, 1990, J GERONTOL, V45, pP166, DOI 10.1093/geronj/45.4.P166; MORRELL RW, 1989, GERONTOLOGIST, V29, P345, DOI 10.1093/geront/29.3.345; Morris LA, 1997, MED CARE, V35, P996, DOI 10.1097/00005650-199710000-00002; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Phillips DP, 1998, LANCET, V351, P643, DOI 10.1016/S0140-6736(98)24009-8; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; Vincent C, 2003, NEW ENGL J MED, V348, P1051, DOI 10.1056/NEJMhpr020760; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; Wogalter MS, 2003, ERGONOMICS, V46, P327, DOI 10.1080/0014013021000048006; Wolf MS, 2005, ARCH INTERN MED, V165, P1946, DOI 10.1001/archinte.165.17.1946; Wolf MS, 2004, INT J STD AIDS, V15, P747, DOI 10.1258/0956462042395131	36	405	414	0	57	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2006	145	12					887	894		10.7326/0003-4819-145-12-200612190-00144	http://dx.doi.org/10.7326/0003-4819-145-12-200612190-00144			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120BB	17135578				2022-12-28	WOS:000243057400003
J	Newton, KM; Reed, SD; LaCroix, AZ; Grothaus, LC; Ehrlich, K; Guiltinan, J				Newton, Katherine M.; Reed, Susan D.; LaCroix, Andrea Z.; Grothaus, Louis C.; Ehrlich, Kelly; Guiltinan, Jane			Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							ESTROGEN PLUS PROGESTIN; QUALITY-OF-LIFE; CONTROLLED CLINICAL-TRIAL; HEALTH INITIATIVE MEMORY; POPULATION-BASED SURVEY; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; HOT FLUSHES; BREAST-CANCER; PERIMENOPAUSAL WOMEN	Background: Herbal supplements are widely used for vasomotor Symptoms. Objective: To test the efficacy of 3 herbal regimens and hormone therapy for relief of vasomotor symptoms compared with placebo. Design: 1-year randomized, double-blind, placebo-controlled trial conducted from May 2001 to September 2004. Setting: Group Health, Washington State. Participants: 351 women age 45 to 55 years with 2 or more vasomotor symptoms per day; 52% of the women were in menopausal transition and 48% were postmenopausal. Measurements: Rate and intensity of vasomotor symptoms (1 mild to 3 = severe), and Wiklund Vasomotor Symptom Subscale. Interventions: 1) Black cohosh, 160 mg daily; 2) multibotanical with black cohosh, 200 mg daily, and 9 other ingredients; 3) multibotanical plus dietary soy counseling; 4) conjugated equine estrogen, 0.625 mg daily, with or without medroxyprogesterone acetate, 2.5 mg daily; or 5) placebo. Results: Vasomotor symptoms per day, symptom intensity, Wiklund Vasomotor Symptom Subscale score did not differ between the herbal interventions and placebo at 3, 6, or 12 months or for the average over all the follow-up time points (P > 0.05 for all comparisons) with 1 exception: At 12 months, symptom intensity was significantly worse with the multibotanical plus soy intervention than with placebo (P = 0.016). The difference in vasomotor symptoms per day between placebo and any of the herbal treatments at any time point was less than 1 symptom per day; for the average over all the follow-up time points, the difference was less than 0.55 symptom per day. The difference for hormone therapy versus placebo was - 4.06 vasomotor symptoms per day for the average over all the follow-up time points (95% Cl, -5.93 to - 2.19 symptoms per day; P < 0.001). Limitations: The trial did not simulate the whole-person approach used by naturopathic physicians. Differences between treatment groups smaller than 1.5 Vasomotor symptoms per day cannot be ruled out. Conclusion: Black cohosh used in isolation, or as part of a multibotanical regimen, shows little potential as an important therapy for relief of vasomotor symptoms.	Univ Washington, Ctr Hlth Studies, Grp Hlth, Seattle, WA 98101 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Bastyr Univ, Kenmore, WA USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Newton, KM (corresponding author), Univ Washington, Ctr Hlth Studies, Grp Hlth, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	newton.k@ghc.org		Reed, Susan/0000-0001-7532-3785	NIA NIH HHS [R01AG17057] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG017057] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albertazzi P, 1998, OBSTET GYNECOL, V91, P6, DOI 10.1016/S0029-7844(97)00597-8; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; BAIRD DD, 1995, J CLIN ENDOCR METAB, V80, P1685, DOI 10.1210/jc.80.5.1685; Beresford SAA, 2001, PREV MED, V32, P230, DOI 10.1006/pmed.2000.0806; Brzezinski A, 1997, MENOPAUSE, V4, P89; Burke GL, 2003, MENOPAUSE, V10, P147, DOI 10.1097/00042192-200310020-00006; Center for Drug Evaluation and Research, 2003, GUID IND ESTR ESTR P; Crisafulli A, 2004, MENOPAUSE, V11, P400, DOI 10.1097/01.GME.0000109314.11228.E5; Dalais F S, 1998, Climacteric, V1, P124, DOI 10.3109/13697139809085527; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Faure ED, 2002, MENOPAUSE, V9, P329, DOI 10.1097/00042192-200209000-00005; Frankenfeld CL, 2003, AM J CLIN NUTR, V77, P674, DOI 10.1093/ajcn/77.3.674; Frei-Kleiner S, 2005, MATURITAS, V51, P397, DOI 10.1016/j.maturitas.2004.10.003; Han KK, 2002, OBSTET GYNECOL, V99, P389, DOI 10.1016/S0029-7844(01)01744-6; Hirata JD, 1997, FERTIL STERIL, V68, P981, DOI 10.1016/S0015-0282(97)00397-X; Jacobson JS, 2001, J CLIN ONCOL, V19, P2739, DOI 10.1200/JCO.2001.19.10.2739; Keenan NL, 2003, MENOPAUSE, V10, P507, DOI 10.1097/01.GME.0000064865.58809.3E; MURKIES AL, 1995, MATURITAS, V21, P189, DOI 10.1016/0378-5122(95)00899-V; Newton KM, 2002, OBSTET GYNECOL, V100, P18, DOI 10.1016/S0029-7844(02)02005-7; Newton KM, 2005, MATURITAS, V52, P134, DOI 10.1016/j.maturitas.2005.01.007; Oldendick R, 2000, SOUTH MED J, V93, P375; Osmers R, 2005, OBSTET GYNECOL, V105, P1074, DOI 10.1097/01.AOG.0000158865.98070.89; Penotti M, 2003, FERTIL STERIL, V79, P1112, DOI 10.1016/S0015-0282(03)00158-4; Pockaj BA, 2006, J CLIN ONCOL, V24, P2836, DOI 10.1200/JCO.2005.05.4296; Quella SK, 2000, J CLIN ONCOL, V18, P1068, DOI 10.1200/JCO.2000.18.5.1068; Rapp SR, 2003, JAMA-J AM MED ASSOC, V289, P2663, DOI 10.1001/jama.289.20.2663; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Scambia G, 2000, MENOPAUSE, V7, P105, DOI 10.1097/00042192-200007020-00006; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; St Germain A, 2001, MENOPAUSE, V8, P17, DOI 10.1097/00042192-200101000-00005; Stoll W., 1987, THERAPEUTIKON, V1, P23; U.S Food and Drug Administration (FDA) National Adverse Drug Reaction Directory, 1970, COSTART; Upmalis DH, 2000, MENOPAUSE, V7, P236, DOI 10.1097/00042192-200007040-00005; Van Patten CL, 2002, J CLIN ONCOL, V20, P1449, DOI 10.1200/JCO.20.6.1449; Verhoeven MO, 2005, MENOPAUSE, V12, P412, DOI 10.1097/01.gme.0000170603.63022.62; Washburn S, 1999, MENOPAUSE, V6, P7; WIKLUND I, 1991, CONTROL CLIN TRIALS, V12, pS204, DOI 10.1016/S0197-2456(05)80024-8; WIKLUND I, 1992, MATURITAS, V14, P211, DOI 10.1016/0378-5122(92)90116-L; Wiklund IK, 1999, INT J CLIN PHARM RES, V19, P89; Wuttke W, 2003, MATURITAS, V44, pS67, DOI 10.1016/S0378-5122(02)00350-X	40	198	208	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2006	145	12					869	879		10.7326/0003-4819-145-12-200612190-00003	http://dx.doi.org/10.7326/0003-4819-145-12-200612190-00003			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120BB	17179056	Green Published			2022-12-28	WOS:000243057400001
J	A'Hearn, MF				A'Hearn, Michael F.			Whence comets?	SCIENCE			English	Editorial Material							DEEP IMPACT		Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	A'Hearn, MF (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	ma@astro.umd.edu						A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; AHEARN MF, 2005, SCIENCE         0908, DOI DOI 10.1126/SCIENCE.1118923; BELTON MJS, 2006, ICARUS          1107, DOI DOI 10.1016/J.ICARUS.2006.09.05; Duncan M, 2004, SPACE SCI S, P193; FEAGA LM, UNPUB; Fernandez JA, 2004, ICARUS, V172, P372, DOI 10.1016/j.icarus.2004.07.023; Kirk RL, 2004, ICARUS, V167, P54, DOI 10.1016/j.icarus.2003.07.009; KIRK RL, 2005, LUNAR PLANET SCI, V36, P2244; Lisse CM, 2006, SCIENCE, V313, P635, DOI 10.1126/science.1124694; LISSE CM, 2006, SCIENCE         0712, DOI DOI 10.1126/SCIENCE.1124694; Oberst J, 2004, ICARUS, V167, P70, DOI 10.1016/j.icarus.2003.05.001; THOMAS P, UNPUB	12	19	19	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1708	1709		10.1126/science.1137083	http://dx.doi.org/10.1126/science.1137083			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170287				2022-12-28	WOS:000242833600039
J	Burnett, DS				Burnett, Don S.			Perspective - NASA returns rocks from a comet	SCIENCE			English	Editorial Material									CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Burnett, DS (corresponding author), CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA.	burnett@gps.caltech.edu						Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Keller LP, 2006, SCIENCE, V314, P1728, DOI 10.1126/science.1135796; KISSEL J, 1986, NATURE, V321, P280, DOI 10.1038/321280a0; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	7	20	20	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1709	1710		10.1126/science.1137084	http://dx.doi.org/10.1126/science.1137084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	116WD	17170288				2022-12-28	WOS:000242833600040
J	Barclay, RL; Vicari, JJ; Doughty, AS; Johanson, JF; Greenlaw, RL				Barclay, Robert L.; Vicari, Joseph J.; Doughty, Andrea S.; Johanson, John F.; Greenlaw, Roger L.			Colonoscopic withdrawal times and adenoma detection during screening colonoscopy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLORECTAL-CANCER INCIDENCE; FLEXIBLE SIGMOIDOSCOPY; MISS RATES; POLYPECTOMY; PREVENTION; EFFICACY; RECOMMENDATIONS; SURVEILLANCE; VARIABILITY; PERFORMANCE	BACKGROUND: Colonoscopy is commonly used to screen for neoplasia. To assess the performance of screening colonoscopy in everyday practice, we conducted a study of the rates of detection of adenomas and the amount of time taken to withdraw the colonoscope among endoscopists in a large community-based practice. METHODS: During a 15-month period, 12 experienced gastroenterologists performed 7882 colonoscopies, of which 2053 were screening examinations in subjects who had not previously undergone colonoscopy. We recorded the numbers, sizes, and histologic features of the neoplastic lesions detected during screening, as well as the duration of insertion and of withdrawal of the colonoscope during the procedure. We compared rates of detection of neoplastic lesions among gastroenterologists who had mean colonoscopic withdrawal times of less than 6 minutes with the rates of those who had mean withdrawal times of 6 minutes or more. According to experts, 6 minutes is the minimum length of time to allow adequate inspection during instrument withdrawal. RESULTS: Neoplastic lesions (mostly adenomatous polyps) were detected in 23.5% of screened subjects. There were large differences among gastroenterologists in the rates of detection of adenomas (range of the mean number of lesions per subject screened, 0.10 to 1.05; range of the percentage of subjects with adenomas, 9.4 to 32.7%) and in their times of withdrawal of the colonoscope from the cecum to the anus (range, 3.1 to 16.8 minutes for procedures during which no polyps were removed). As compared with colonoscopists with mean withdrawal times of less than 6 minutes, those with mean withdrawal times of 6 minutes or more had higher rates of detection of any neoplasia (28.3% vs. 11.8%, P<0.001) and of advanced neoplasia (6.4% vs. 2.6%, P=0.005). CONCLUSIONS: In this large community-based gastroenterology practice, we observed greater rates of detection of adenomas among endoscopists who had longer mean times for withdrawal of the colonoscope. The effect of variation in withdrawal times on lesion detection and the prevention of colorectal cancer in the context of widespread colonoscopic screening is not known. Ours was a preliminary study, so the generalizability and implications for clinical practice need to be determined by future studies.	Rockford Gastroenterol Associates, Rockford, IL 61107 USA; Univ Illinois, Coll Med, Rockford, IL 61107 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford	Barclay, RL (corresponding author), Rockford Gastroenterol Associates, 401 Roxbury Rd, Rockford, IL 61107 USA.	drbarclay@rockfordgi.com	Wilkins, Thad/G-2541-2010					Atkin W, 2004, GASTROENTEROLOGY, V126, P1247, DOI 10.1053/j.gastro.2004.01.023; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; Barclay RL, 2004, GASTROINTEST ENDOSC, V60, P527, DOI 10.1016/S0016-5107(04)01857-7; Beam CA, 2003, J NATL CANCER I, V95, P282, DOI 10.1093/jnci/95.4.282; Bresalier R, 2002, SLEISENGER FORDTRANS, P2215; Citarda F, 2001, GUT, V48, P812, DOI 10.1136/gut.48.6.812; Gupta DK, 2001, ACTA CYTOL, V45, P697, DOI 10.1159/000328290; Halligan S, 2003, CLIN RADIOL, V58, P948, DOI 10.1016/S0009-9260(03)00317-9; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; Itzkowitz SH, 2002, SLEISENGER FORDTRANS, P2175; LEE YS, 1988, DIS COLON RECTUM, V31, P291, DOI 10.1007/BF02554363; Lieberman D, 2004, ANN INTERN MED, V141, P401, DOI 10.7326/0003-4819-141-5-200409070-00018; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Pinsky PF, 2005, CLIN GASTROENTEROL H, V3, P792, DOI 10.1053/S1542-3565(05)00286-7; Prajapati DN, 2003, AM J GASTROENTEROL, V98, P194; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rex DK, 2000, GASTROINTEST ENDOSC, V51, P33, DOI 10.1016/S0016-5107(00)70383-X; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Sanchez W, 2004, AM J GASTROENTEROL, V99, P1941, DOI 10.1111/j.1572-0241.2004.40569.x; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	25	987	1021	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2533	2541		10.1056/NEJMoa055498	http://dx.doi.org/10.1056/NEJMoa055498			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116BZ	17167136				2022-12-28	WOS:000242778800005
J	Strebhardt, K; Ullrich, A				Strebhardt, Klaus; Ullrich, Axel			Another look at imatinib mesylate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Goethe Univ Frankfurt, Sch Med, Dept Obstet & Gynecol, D-6000 Frankfurt, Germany; Proteos, Inst Mol & Cell Biol, Ctr Mol Med, Singapore Oncogenome Lab, Singapore, Singapore; Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany	Goethe University Frankfurt; Agency for Science Technology & Research (ASTAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Max Planck Society	Strebhardt, K (corresponding author), Goethe Univ Frankfurt, Sch Med, Dept Obstet & Gynecol, D-6000 Frankfurt, Germany.		Strebhardt, Klaus/E-8765-2011	Strebhardt, Klaus/0000-0003-2173-9763				Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664	4	15	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2481	2482		10.1056/NEJMcibr065325	http://dx.doi.org/10.1056/NEJMcibr065325			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113EO	17151370				2022-12-28	WOS:000242581400014
J	Cummings, SR; Reynolds				Cummings, Steven R.; Reynolds			A 55-year-old woman with osteopenia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; VITAMIN-D SUPPLEMENTATION; HIP FRACTURE; POSTMENOPAUSAL WOMEN; RISK-FACTORS; VERTEBRAL FRACTURES; ALENDRONATE THERAPY; RANDOMIZED-TRIAL; ALCOHOL INTAKE; OSTEOPOROTIC FRACTURE	About half of postmenopausal women have a bone density T score at the femoral neck between -1.0 and -2.5. Bone density in this range was termed "osteopenia" by a World Health Organization working group. Osteopenia is not a disease and the label can cause unnecessary anxiety. Osteopenia encompasses a wide range of fracture risks; an individual patient's risk can be estimated from her age, bone mineral density, and clinical risk factors. Regardless of bone mineral density, regular exercise and adherence with vitamin D and calcium intake may reduce the risk of hip fracture. Osteopenia by itself is not an indication for treatment. Decisions about pharmacological treatment to prevent fractures should be based on the patient's risk of fractures, evidence about the efficacy and nonskeletal effects of the specific treatment, and the patient's preferences.	San Francisco Coordinating Ctr, San Francisco, CA 94107 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute	Cummings, SR (corresponding author), San Francisco Coordinating Ctr, 185 Berry St,Lobby 4,Suite 5700, San Francisco, CA 94107 USA.	scummings@sfcc-cpmc.net						Ahmed LA, 2006, OSTEOPOROSIS INT, V17, P495, DOI 10.1007/s00198-005-0013-x; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Baron JA, 2001, ARCH INTERN MED, V161, P983, DOI 10.1001/archinte.161.7.983; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Bates DW, 2002, JAMA-J AM MED ASSOC, V288, P1898, DOI 10.1001/jama.288.15.1898; Berg AO, 2002, ANN INTERN MED, V137, P526, DOI 10.7326/0003-4819-137-6-200209170-00014; Binkley N, 2006, J CLIN DENSITOM, V9, P4, DOI 10.1016/j.jocd.2006.05.002; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Black D, 2004, J BONE MINER RES, V19, pS45; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Black DM, 2000, J CLIN ENDOCR METAB, V85, P4118, DOI 10.1210/jc.85.11.4118; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Brown JP., 2002, CMAJ S10, V167, P1; Campbell MK, 1998, OSTEOPOROSIS INT, V8, P584, DOI 10.1007/s001980050103; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; CHRISTIANSEN C, 1981, LANCET, V1, P459; Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P1318, DOI 10.1001/jama.283.10.1318; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; CUMMINGS SR, 2000, JAMA-J AM MED ASSOC, V288, P1889; Cummings SR, 2006, J BONE MINER RES, V21, P1550, DOI 10.1359/JBMR.060708; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; DAWSONHUGHES B, 1990, NEW ENGL J MED, V323, P878, DOI 10.1056/NEJM199009273231305; de Boer MR, 2004, J BONE MINER RES, V19, P1539, DOI 10.1359/JBMR.040504; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; De Laet CEDH, 1998, J BONE MINER RES, V13, P1587, DOI 10.1359/jbmr.1998.13.10.1587; Dennis MS, 2002, STROKE, V33, P728, DOI 10.1161/hs0302.103621; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; Ettinger B, 2005, J WOMENS HEALTH, V14, P159, DOI 10.1089/jwh.2005.14.159; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Faulkner KG, 1999, J CLIN DENSITOM, V2, P343, DOI 10.1385/JCD:2:3:343; Faulkner KG, 2005, OSTEOPOROSIS INT, V16, P347, DOI 10.1007/s00198-004-1779-y; Feskanich D, 2002, JAMA-J AM MED ASSOC, V288, P2300, DOI 10.1001/jama.288.18.2300; Feskanich D, 1999, J WOMENS HEALTH, V8, P65, DOI 10.1089/jwh.1999.8.65; Fink H, 2005, J BONE MINER RES, V20, pS88; Fink HA, 2003, OSTEOPOROSIS INT, V14, P69, DOI 10.1007/s00198-002-1314-y; Gage BF, 2006, ARCH INTERN MED, V166, P241, DOI 10.1001/archinte.166.2.241; Ganry O, 2000, AM J EPIDEMIOL, V151, P773, DOI 10.1093/oxfordjournals.aje.a010277; Greendale GA, 2002, ARCH INTERN MED, V162, P665, DOI 10.1001/archinte.162.6.665; Greenspan SL, 2002, ANN INTERN MED, V137, P875, DOI 10.7326/0003-4819-137-11-200212030-00008; Gregg EW, 2003, JAMA-J AM MED ASSOC, V289, P2379, DOI 10.1001/jama.289.18.2379; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; Hodgson Stephen F, 2003, Endocr Pract, V9, P544; Hoidrup S, 1999, AM J EPIDEMIOL, V149, P993; Holmberg AH, 2005, OSTEOPOROSIS INT, V16, P2185, DOI 10.1007/s00198-005-2006-1; Ivers RQ, 2003, J AM GERIATR SOC, V51, P356, DOI 10.1046/j.1532-5415.2003.51109.x; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jamal SA, 1998, ANN INTERN MED, V128, P829, DOI 10.7326/0003-4819-128-10-199805150-00006; Jorgensen L, 2001, BONE, V28, P655, DOI 10.1016/S8756-3282(01)00434-3; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Kanis JA, 2006, OSTEOPOROSIS INT, V17, P527, DOI 10.1007/s00198-005-0014-9; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2004, BONE, V35, P1029, DOI 10.1016/j.bone.2004.06.017; Kanis JA, 2004, J BONE MINER RES, V19, P893, DOI 10.1359/JBMR.040134; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kelley GA, 2006, AM J OBSTET GYNECOL, V194, P760, DOI 10.1016/j.ajog.2005.09.006; Kelley GA, 2002, J GERONTOL A-BIOL, V57, pM599, DOI 10.1093/gerona/57.9.M599; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; Mamdani M, 2003, PHARMACOTHERAPY, V23, P1, DOI 10.1592/phco.23.1.1.31922; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; McClung M, 2005, ANN INTERN MED, V142, P796, DOI 10.7326/0003-4819-142-9-200505030-00018; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Miller PD, 2004, ARCH INTERN MED, V164, P1113, DOI 10.1001/archinte.164.10.1113; National Osteoporosis Foundation, 1998, PHYS GUID PREV TREAT; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nevitt MC, 2005, J BONE MINER RES, V20, P131, DOI 10.1359/JBMR.041003; Orwoll ES, 1996, ANN INTERN MED, V124, P187, DOI 10.7326/0003-4819-124-2-199601150-00001; Ott SM, 2005, J CLIN ENDOCR METAB, V90, P1897, DOI 10.1210/jc.2005-0057; Ramnemark A, 1998, OSTEOPOROSIS INT, V8, P92, DOI 10.1007/s001980050053; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Rimes KA, 2002, BEHAV RES THER, V40, P359, DOI 10.1016/S0005-7967(01)00015-8; Rodan G, 2004, CURR MED RES OPIN, V20, P1291, DOI 10.1185/030079904125004475; Roy DK, 2003, OSTEOPOROSIS INT, V14, P19, DOI 10.1007/s00198-002-1317-8; *ROYAL COLL PHYS L, 1999, OST CLIN GUID PREV T; RUBIN SM, 1992, ANN INTERN MED, V116, P990, DOI 10.7326/0003-4819-116-12-990; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Sato Y, 2005, JAMA-J AM MED ASSOC, V293, P1082, DOI 10.1001/jama.293.9.1082; Schousboe JT, 2006, J CLIN DENSITOM, V9, P133, DOI 10.1016/j.jocd.2005.11.004; Schousboe JT, 2005, J AM GERIATR SOC, V53, P1697, DOI 10.1111/j.1532-5415.2005.53504.x; Schousboe JT, 2005, ANN INTERN MED, V142, P734, DOI 10.7326/0003-4819-142-9-200505030-00008; Sellmeyer DE, 2001, AM J CLIN NUTR, V73, P118; Sornay-Rendu E, 2005, J BONE MINER RES, V20, P1813, DOI 10.1359/JBMR.050609; STEIGER P, 1992, J BONE MINER RES, V7, P625; Stone K, 1998, J BONE MINER RES, V13, P1167, DOI 10.1359/jbmr.1998.13.7.1167; Taylor BC, 2004, J AM GERIATR SOC, V52, P1479, DOI 10.1111/j.1532-5415.2004.52410.x; van der Klift M, 2004, J BONE MINER RES, V19, P1172, DOI 10.1359/JBMR.040215; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; van Staa TP, 2006, ARTHRITIS RHEUM-US, V54, P3104, DOI 10.1002/art.22117; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P777, DOI 10.1007/s001980200108; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; Woodhouse A, 2000, J BONE MINER RES, V15, pS549	99	26	28	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2006	296	21					2601	2610		10.1001/jama.296.21.2601	http://dx.doi.org/10.1001/jama.296.21.2601			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112ND	17148725				2022-12-28	WOS:000242532000022
J	Gornall, J				Gornall, Jonathan			Was message of sudden infant death study misleading?	BRITISH MEDICAL JOURNAL			English	Editorial Material												Jgornall@mac.com						Bacon C, 2005, LANCET, V365, P1137, DOI 10.1016/S0140-6736(05)71872-9; Carpenter RG, 2005, LANCET, V365, P29, DOI 10.1016/S0140-6736(04)17662-9; Emery JL, 2000, BRIT MED J, V320, P310, DOI 10.1136/bmj.320.7230.310; *GMC FITN PRACT PA, 2005, CAS MEAD DAY 10 6 JU; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; MEADOW R, 1997, ABC CHILD ABUSE, P27; WAITE A, 1996, P 4 SUDD INF DEATH S; WAITE A, 1998, REPORT 5000 BABIES U; WOLKIND S, 1993, ACTA PAEDIATR, V82, P873, DOI 10.1111/j.1651-2227.1993.tb12583.x; 2004, INDEPENDENT     1231	10	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 2	2006	333	7579					1165	1168		10.1136/bmj.39031.590914.68	http://dx.doi.org/10.1136/bmj.39031.590914.68			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114LG	17138999	Green Published			2022-12-28	WOS:000242667100020
J	Galavotti, C; Green, DC				Galavotti, Christine; Green, Diane C.			England's national teenage pregnancy strategy	LANCET			English	Editorial Material							ADOLESCENT PREGNANCY; DEVELOPED-COUNTRIES; BEHAVIORS; RATES; MEDIA		Ctr Dis Control & Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Galavotti, C (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30341 USA.	cxg2@cdc.gov						ADAM G, 1999, RADIO HIV AIDS MAKIN; *BBC WORLD SERV TR, JAS VIJ HITS REC AUD; Brooke P., 1995, COMMUNICATING STORY; Darroch JE, 2001, FAM PLANN PERSPECT, V33, P244, DOI 10.2307/3030191; Escobar-Chaves SL, 2005, PEDIATRICS, V116, P303, DOI 10.1542/peds.2005-0355D; Galavotti C., 2005, STORYTELLING SELF SO, V1, P26, DOI 10.1080/15505340509490264; L'Engle KL, 2006, J ADOLESCENT HEALTH, V38, P186, DOI 10.1016/j.jadohealth.2005.03.020; *MED SUPP SOL LTD, MED SUPP; Narring F, 1996, FAM PLANN PERSPECT, V28, P232, DOI 10.2307/2135843; Santelli JS, 2004, J ADOLESCENT HEALTH, V35, P80, DOI 10.1016/j.jadohealth.2004.05.001; Singh S, 2000, FAM PLANN PERSPECT, V32, P14, DOI 10.2307/2648144; SINGHAL A, 1999, ENTERTAINMENT ED COM; *UNICEF INN RES CT, 2001, 3 UNICEF INN RES CTR; VUTTANONT U, IN PRESS LANCET; Wilkinson P, 2006, LANCET, V368, P1879, DOI 10.1016/S0140-6736(06)69777-8	15	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2006	368	9550					1846	1848		10.1016/S0140-6736(06)69751-1	http://dx.doi.org/10.1016/S0140-6736(06)69751-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126699				2022-12-28	WOS:000242345900005
J	Gale, CR; Deary, IJ; Batty, GD; Schoon, I				Gale, Catharine R.; Deary, Ian J.; Batty, G. David; Schoon, Ingrid			IQ in childhood and vegetarianism in adulthood: 1970 British cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MENTAL SURVEY 1932; MORTALITY; INTELLIGENCE; MIDSPAN; ABILITY; LINKING; HEALTH; DIETS; RISK; LIFE	Objective To examine the relation between IQ in childhood and vegetarianism in adulthood. Design Prospective cohort study in which IQ was assessed by tests of mental ability at age 10 years and vegetarianism by self-report at age 30 years. Setting Great Britain. Participants 8170 men and women aged 30 years participating in the 1970 British cohort study, a national birth cohort. Main outcome measures Self-reported vegetarianism and type of diet followed. Results 366 (4.5%) participants said they were vegetarian, although 123 (33.6%) admitted eating fish or chicken. Vegetarians were more likely to be female, to be of higher social class (both in childhood and currently), and to have attained higher academic or vocational qualifications, although these socioeconomic advantages were not reflected in their income. Higher IQ at age 10 years was associated with an increased likelihood of being vegetarian at age 30 (odds ratio for one standard deviation increase in childhood IQ score 1.38, 95% confidence interval 1.24 to 1.53). IQ remained a statistically significant predictor of being vegetarian as an adult after adjustment for social class (both in childhood and currently), academic or vocational qualifications, and sex (1.20, 1.06 to 1.36). Exclusion of those who said they were vegetarian but ate fish or chicken had little effect on the strength of this association. Conclusion Higher scores for IQ in childhood are associated with an increased likelihood of being a vegetarian as an adult.	Univ Southampton, Med Res Council, Epidemiol Resource Ctr, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; Univ Glasgow, Med Res Council, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; City Univ London, Dept Psychol, London, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton; University of Edinburgh; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Glasgow; City University London	Gale, CR (corresponding author), Univ Southampton, Med Res Council, Epidemiol Resource Ctr, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England.	crg@mrc.soton.ac.uk	Batty, GD/Y-4401-2018; Schoon, Ingrid/AAC-5715-2019; Deary, Ian J/C-6297-2009; Gale, Catharine R/B-1653-2012; Schoon, Ingrid/E-7430-2010	Batty, GD/0000-0003-1822-5753; Schoon, Ingrid/0000-0002-4262-3711; Deary, Ian J/0000-0002-1733-263X; Gale, Catharine/0000-0002-3361-8638	Economic and Social Research Council [RES-225-25-2001] Funding Source: researchfish; Medical Research Council [U1475000002] Funding Source: researchfish; Medical Research Council [MC_U130059821] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U130059821] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Batty GD, 2005, PAEDIATR PERINAT EP, V19, P452, DOI 10.1111/j.1365-3016.2005.00671.x; Batty GD, 2004, BMJ-BRIT MED J, V329, P585, DOI 10.1136/bmj.329.7466.585; BATTY GD, 2006, IN PRESS J EPIDEMIOL; CARROLL J, 2006, HUMAN COGNITIVE ABIL; DEARY I, 2006, IN PRESS INTELLIGENC; Elliott C., 1978, BRIT ABILITY SCALES; FRANKLIN B, 1962, AUTOBIOGRAPHY B FRAN; Fu CH, 2006, AM J CARDIOL, V97, P380, DOI 10.1016/j.amjcard.2005.08.057; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P665, DOI 10.1093/ije/dyi321; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s; Martin LT, 2004, J EPIDEMIOL COMMUN H, V58, P674, DOI 10.1136/jech.2003.016444; Schoon I., 2003, CHANGING BRITAIN CHA; Taylor MD, 2003, J EPIDEMIOL COMMUN H, V57, P464, DOI 10.1136/jech.57.6.464	15	52	52	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2007	334	7587					245	248B		10.1136/bmj.39030.675069.55	http://dx.doi.org/10.1136/bmj.39030.675069.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135SD	17175567	Green Published, Bronze			2022-12-28	WOS:000244172400030
J	Tanaka, S; Umemori, T; Hirai, K; Muramatsu, S; Kamimura, Y; Araki, H				Tanaka, Seiji; Umemori, Toshiko; Hirai, Kazuyuki; Muramatsu, Sachiko; Kamimura, Yoichiro; Araki, Hiroyuki			CDK-dependent phosphorylation of Sld2 and Sld3 initiates DNA replication in budding yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL DNA; RE-REPLICATION; PROTEIN-KINASE; CELL-CYCLE; COMPLEX; GINS; PROGRESSION; INTERACTS; DPB11	In eukaryotic cells, cyclin-dependent kinases (CDKs) have an important involvement at various points in the cell cycle. At the onset of S phase, active CDK is essential for chromosomal DNA replication(1), although its precise role is unknown. In budding yeast ( Saccharomyces cerevisiae), the replication protein Sld2 (ref. 2) is an essential CDK substrate(3), but its phospho-mimetic form (Sld2-11D) alone neither affects cell growth(4) nor promotes DNA replication in the absence of CDK activity(4), suggesting that other essential CDK substrates promote DNA replication. Here we show that both an allele of CDC45 (JET1) and high-copy DPB11, in combination with Sld2-11D, separately confer CDK-independent DNA replication. Although Cdc45 is not an essential CDK substrate, CDK-dependent phosphorylation of Sld3, which associates with Cdc45 ( ref. 5), is essential and generates a binding site for Dpb11. Both the JET1 mutation and high-copy DPB11 by-pass the requirement for Sld3 phosphorylation in DNA replication. Because phosphorylated Sld2 binds to the carboxy-terminal pair of BRCT domains in Dpb11 ( ref. 4), we propose that Dpb11 connects phosphorylated Sld2 and Sld3 to facilitate interactions between replication proteins, such as Cdc45 and GINS. Our results demonstrate that CDKs regulate interactions between BRCT-domain-containing replication proteins and other phosphorylated proteins for the initiation of chromosomal DNA replication; similar regulation may take place in higher eukaryotes.	Res Org Informat & Syst, Natl Inst Genet, Div Microbial Genet, Shizuoka 4118540, Japan; SOKENDAI, Dept Genet, Shizuoka 4118540, Japan; CREST, Kawaguchi, Saitama 3320012, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Araki, H (corresponding author), Res Org Informat & Syst, Natl Inst Genet, Div Microbial Genet, Yata 1111 Mishima, Shizuoka 4118540, Japan.	hiaraki@lab.nig.ac.jp	Kamimura, Yoichiro/M-2585-2017; Tanaka, Seiji/Q-8601-2019	Tanaka, Seiji/0000-0003-3882-3494; Hirai, Kazuyuki/0000-0003-1640-3667				ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Edwards S, 2003, MOL CELL BIOL, V23, P2733, DOI 10.1128/MCB.23.8.2733-2748.2003; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kearsey SE, 2003, MOL CELL, V12, P1067, DOI 10.1016/S1097-2765(03)00441-6; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Schwob Etienne, 2006, V47, P295; Sivaprasad Umasundari, 2006, V47, P63; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Walter Johannes C., 2006, V47, P89; ZEGERMAN P, 2006, NATURE          1213, DOI DOI 10.1038/NATURE05432	29	337	339	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					328	332		10.1038/nature05465	http://dx.doi.org/10.1038/nature05465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17167415				2022-12-28	WOS:000243504700048
J	Wetzel, C; Hu, J; Riethmacher, D; Benckendorff, A; Harder, L; Eilers, A; Moshourab, R; Kozlenkov, A; Labuz, D; Caspani, O; Erdmann, B; Machelska, H; Heppenstall, PA; Lewin, GR				Wetzel, Christiane; Hu, Jing; Riethmacher, Dieter; Benckendorff, Anne; Harder, Lena; Eilers, Andreas; Moshourab, Rabih; Kozlenkov, Alexey; Labuz, Dominika; Caspani, Ombretta; Erdmann, Bettina; Machelska, Halina; Heppenstall, Paul A.; Lewin, Gary R.			A stomatin-domain protein essential for touch sensation in the mouse	NATURE			English	Article							SENSING ION CHANNELS; SENSORY NEURONS; C-ELEGANS; MEMBRANE-PROTEIN; RECEPTOR NEURONS; MECHANOSENSATION; PAIN; RAT; MECHANORECEPTOR; LOCALIZATION	Touch and mechanical pain are first detected at our largest sensory surface, the skin. The cell bodies of sensory neurons that detect such stimuli are located in the dorsal root ganglia, and subtypes of these neurons are specialized to detect specific modalities of mechanical stimuli. Molecules have been identified that are necessary for mechanosensation in invertebrates but so far not in mammals. In Caenorhabditis elegans, mec-2 is one of several genes identified in a screen for touch insensitivity and encodes an integral membrane protein with a stomatin homology domain(1). Here we show that about 35% of skin mechanoreceptors do not respond to mechanical stimuli in mice with a mutation in stomatin-like protein 3 (SLP3, also called Stoml3), a mammalian mec-2 homologue that is expressed in sensory neurons. In addition, mechanosensitive ion channels found in many sensory neurons do not function without SLP3. Tactile-driven behaviours are also impaired in SLP3 mutant mice, including touch-evoked pain caused by neuropathic injury. SLP3 is therefore indispensable for the function of a subset of cutaneous mechanoreceptors, and our data support the idea that this protein is an essential subunit of a mammalian mechanotransducer.	Max Delbruck Ctr Mol Med, Dept Neurosci, D-13125 Berlin, Germany; Charite Univ Med Berlin, D-13125 Berlin, Germany; Univ Hamburg, Zentrum Mol Neurobiol, D-20251 Hamburg, Germany; Charite Univ Med Berlin, Klin Anaesthesiol & Operat Med, D-12200 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lewin, GR (corresponding author), Max Delbruck Ctr Mol Med, Dept Neurosci, Robert Rossle Str 10, D-13125 Berlin, Germany.	glewin@mdc-berlin.de	Lewin, Gary R/B-8028-2011; Riethmacher, Dieter/AAB-8690-2022; Riethmacher, Dieter/AAP-2227-2021; Hu, Jing/G-2092-2011; Riethmacher, Dieter/A-6242-2010	Riethmacher, Dieter/0000-0002-4206-5529; Machelska, Halina/0000-0001-6315-2958; Caspani, Ombretta/0000-0002-9700-3149; Lewin, Gary/0000-0002-2890-6352; Wetzel, Christiane/0000-0003-0587-8018; moshourab, rabih/0000-0002-9180-8472				Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Fricke B, 2003, ANAT EMBRYOL, V207, P1, DOI 10.1007/s00429-003-0324-7; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Goldstein BJ, 2003, JARO-J ASSOC RES OTO, V4, P74, DOI 10.1007/s10162-002-2039-5; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P123, DOI 10.1016/0167-4781(91)90047-P; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; LEWIN GR, 1991, J NEUROPHYSIOL, V66, P1205, DOI 10.1152/jn.1991.66.4.1205; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Manni A, 2004, SOIL SEDIMENT CONTAM, V13, P391, DOI 10.1080/10588330490466003; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Page AJ, 2004, GASTROENTEROLOGY, V127, P1739, DOI 10.1053/j.gastro.2004.08.061; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Shin JB, 2003, NAT NEUROSCI, V6, P724, DOI 10.1038/nn1076; STEWART GW, 1992, BLOOD, V79, P1593, DOI 10.1182/blood.V79.6.1593.bloodjournal7961593; TAL M, 1994, PAIN, V57, P375, DOI 10.1016/0304-3959(94)90013-2	29	175	184	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					206	209		10.1038/nature05394	http://dx.doi.org/10.1038/nature05394			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17167420				2022-12-28	WOS:000243384300051
J	Rouault, TA				Rouault, Tracey A.			If the RNA fits, use it	SCIENCE			English	Editorial Material							IRON REGULATORY PROTEINS; ACONITASE; DIVERSITY		NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rouault, TA (corresponding author), NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA.	trou@helix.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001602] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001602] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; Dupuy J, 2006, STRUCTURE, V14, P129, DOI 10.1016/j.str.2005.09.009; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gruer MJ, 1997, TRENDS BIOCHEM SCI, V22, P3, DOI 10.1016/S0968-0004(96)10069-4; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Wachtershauser G, 2006, PHILOS T R SOC B, V361, P1787, DOI 10.1098/rstb.2006.1904; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116	9	5	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1886	1887		10.1126/science.1137174	http://dx.doi.org/10.1126/science.1137174			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185590				2022-12-28	WOS:000242996800034
J	Yeates, TO; Beeby, M				Yeates, Todd O.; Beeby, Morgan			Proteins in a small world	SCIENCE			English	Editorial Material							INTERACTION NETWORK; BIOLOGY; EVOLUTION		Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA.	yeates@mbi.ucla.edu	Beeby, Morgan/G-2768-2013	Beeby, Morgan/0000-0001-6413-9835; Yeates, Todd/0000-0001-5709-9839				Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Karev GP, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-32; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Levin SA, 2006, PLOS BIOL, V4, P1471, DOI 10.1371/journal.pbio.0040300; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Smith RD, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/02/P02006; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004	15	8	8	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1882	1883		10.1126/science.1137400	http://dx.doi.org/10.1126/science.1137400			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185587				2022-12-28	WOS:000242996800031
J	Gehrels, N; Norris, JP; Barthelmy, SD; Granot, J; Kaneko, Y; Kouveliotou, C; Markwardt, CB; Meszaros, P; Nakar, E; Nousek, JA; O'Brien, PT; Page, M; Palmer, DM; Parsons, AM; Roming, PWA; Sakamoto, T; Sarazin, CL; Schady, P; Stamatikos, M; Woosley, SE				Gehrels, N.; Norris, J. P.; Barthelmy, S. D.; Granot, J.; Kaneko, Y.; Kouveliotou, C.; Markwardt, C. B.; Meszaros, P.; Nakar, E.; Nousek, J. A.; O'Brien, P. T.; Page, M.; Palmer, D. M.; Parsons, A. M.; Roming, P. W. A.; Sakamoto, T.; Sarazin, C. L.; Schady, P.; Stamatikos, M.; Woosley, S. E.			A new gamma-ray burst classification scheme from GRB 060614	NATURE			English	Article							HOST GALAXY; GRB-050709; AFTERGLOW	Gamma-ray bursts (GRBs) are known to come in two duration classes(1), separated at similar to 2 s. Long-duration bursts originate from star-forming regions in galaxies(2), have accompanying supernovae when these are near enough to observe and are probably caused by massive-star collapsars(3). Recent observations(4-10) show that short-duration bursts originate in regions within their host galaxies that have lower star-formation rates, consistent with binary neutron star or neutron star - black hole mergers(11,12). Moreover, although their hosts are predominantly nearby galaxies, no supernovae have been so far associated with short-duration GRBs. Here we report that the bright, nearby GRB 060614 does not fit into either class. Its similar to 102-s duration groups it with long-duration GRBs, while its temporal lag and peak luminosity fall entirely within the short-duration GRB subclass. Moreover, very deep optical observations exclude an accompanying supernova(13-15), similar to short-duration GRBs. This combination of a long-duration event without an accompanying supernova poses a challenge to both the collapsar and the merging-neutron-star interpretations and opens the door to a new GRB classification scheme that straddles both long- and short-duration bursts.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Stanford Univ, KIPAC, Stanford, CA 94309 USA; NASA, George C Marshall Space Flight Ctr, NSSTC, Huntsville, AL 35805 USA; NSSTC, USRA, Huntsville, AL 35805 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Penn State Univ, Dept Phys, University Pk, PA 16802 USA; CALTECH, Pasadena, CA 91125 USA; Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Oak Ridge Associated Univ, Oak Ridge, TN 37831 USA; Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Stanford University; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University System of Maryland; University of Maryland College Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; California Institute of Technology; University of Leicester; University of London; University College London; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Virginia; University of California System; University of California Santa Cruz	Gehrels, N (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	gehrels@milkyway.gsfc.nasa.gov	Gehrels, Neil/D-2971-2012; Barthelmy, Scott D/D-2943-2012; Kaneko, Yuki/V-2908-2019; Parsons, Ann/I-6604-2012	Kaneko, Yuki/0000-0002-1861-5703; Schady, Patricia/0000-0002-1214-770X; Nakar, Ehud/0000-0002-4534-7089				Barthelmy SD, 2005, NATURE, V438, P994, DOI 10.1038/nature04392; Berger E, 2005, NATURE, V438, P988, DOI 10.1038/nature04238; Bloom JS, 2006, ASTROPHYS J, V638, P354, DOI 10.1086/498107; Cobb BE, 2006, ASTROPHYS J, V651, pL85, DOI 10.1086/509724; DONAGHY TQ, 2006, HETE2 LOCALIZATIONS; EICHLER D, 1989, NATURE, V340, P126, DOI 10.1038/340126a0; Faber JA, 2006, ASTROPHYS J, V641, pL93, DOI 10.1086/504111; Fox DB, 2005, NATURE, V437, P845, DOI 10.1038/nature04189; Fruchter AS, 2006, NATURE, V441, P463, DOI 10.1038/nature04787; Gehrels N, 2005, NATURE, V437, P851, DOI 10.1038/nature04142; GOLENETSKII SV, 2006, 5264 GCN; Hjorth J, 2005, NATURE, V437, P859, DOI 10.1038/nature04174; KANEKO Y, IN PRESS ASTROPHYS J; Kouveliotou C., 1993, APJ, V413, P101; Mazets E. P., 2002, KONUS CATALOG SHORT; Narayan R, 2001, ASTROPHYS J, V557, P949, DOI 10.1086/322267; Norris JP, 2006, ASTROPHYS J, V643, P266, DOI 10.1086/502796; Norris JP, 2002, ASTROPHYS J, V579, P386, DOI 10.1086/342747; PACZYNSKI B, 1986, APJ, V308, P43; PRICE PA, 2006, 5275 GCN; SCHAEFER BE, 2006, GRB060614 IS HIGH RE; Vanderspek R, 2004, ASTROPHYS J, V617, P1251, DOI 10.1086/423923; Villasenor JS, 2005, NATURE, V437, P855, DOI 10.1038/nature04213; Woosley SE, 2006, ANNU REV ASTRON ASTR, V44, P507, DOI 10.1146/annurev.astro.43.072103.150558; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359; Zhang WQ, 2003, ASTROPHYS J, V586, P356, DOI 10.1086/367609	27	392	399	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1044	1046		10.1038/nature05376	http://dx.doi.org/10.1038/nature05376			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183315	Green Submitted			2022-12-28	WOS:000242971100048
J	Gudmundsson, GH				Gudmundsson, G. Hilmar			Fortnightly variations in the flow velocity of Rutford Ice Stream, West Antarctica	NATURE			English	Article							RADAR INTERFEROMETRY; SHEET; SEISMICITY; MOTION	Most of the ice lost from the Antarctic ice sheet passes through a few fast-flowing and highly dynamic ice streams(1). Quantifying temporal variations in flow in these ice streams, and understanding their causes, is a prerequisite for estimating the potential contribution of the Antarctic ice sheet to global sea-level change(2,3). Here I show that surface velocities on a major West Antarctic Ice Stream, Rutford Ice Stream, vary periodically by about 20 per cent every two weeks as a result of tidal forcing. Tidally induced motion on ice streams has previously been thought to be limited to diurnal or even shorter-term variations(4-9). The existence of strong fortnightly variations in flow demonstrates the potential pitfalls of using repeated velocity measurements over intervals of days to infer long-term change.	British Antarctic Survey, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Gudmundsson, GH (corresponding author), British Antarctic Survey, High Cross,Madingley Rd, Cambridge CB3 0ET, England.	ghg@bas.ac.uk	Gudmundsson, Gudmundur Hilmar/F-6499-2012; Gudmundsson, Gudmundur Hilmar/AAU-5987-2020	Gudmundsson, Gudmundur Hilmar/0000-0003-4236-5369; Gudmundsson, Gudmundur Hilmar/0000-0003-4236-5369	Natural Environment Research Council [bas010018] Funding Source: researchfish; NERC [bas010018] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; ANANDAKRISHNAN S, 1993, J GLACIOL, V39, P455, DOI 10.3189/S0022143000016348; Anandakrishnan S, 1997, J GEOPHYS RES-SOL EA, V102, P15183, DOI 10.1029/97JB01073; ANANDAKRISHNAN S, 2003, J GEOPHYS RES, V30, DOI DOI 10.1029/2002GL016329; Bentley CR, 1997, SCIENCE, V275, P1077, DOI 10.1126/science.275.5303.1077; Bindschadler RA, 2003, SCIENCE, V301, P1087, DOI 10.1126/science.1087231; Bindschadler RA, 2003, ANN GLACIOL, V36, P263, DOI 10.3189/172756403781816284; Frolich RM, 1998, J GLACIOL, V44, P77, DOI 10.3189/S0022143000002379; GOLDSTEIN RM, 1993, SCIENCE, V262, P1525, DOI 10.1126/science.262.5139.1525; HARRISON WD, 1993, J GLACIOL, V39, P463, DOI 10.3189/S002214300001635X; HUGENTOBLER U, 2005, BERNESE GPS SOFTWARE; Joughin I, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001029; King M, 2004, J GLACIOL, V50, P601, DOI 10.3189/172756504781829747; Pawlowicz R, 2002, COMPUT GEOSCI-UK, V28, P929, DOI 10.1016/S0098-3004(02)00013-4; Vaughan DG, 2005, SCIENCE, V308, P1877, DOI 10.1126/science.1114670	15	84	86	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1063	1064		10.1038/nature05430	http://dx.doi.org/10.1038/nature05430			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183321				2022-12-28	WOS:000242971100054
J	Nico, JS; Dewey, MS; Gentile, TR; Mumm, HP; Thompson, AK; Fisher, BM; Kremsky, I; Wietfeldt, FE; Chupp, TE; Cooper, RL; Beise, EJ; Kiriluk, KG; Byrne, J; Coakley, KJ				Nico, Jeffrey S.; Dewey, Maynard S.; Gentile, Thomas R.; Mumm, H. Pieter; Thompson, Alan K.; Fisher, Brian M.; Kremsky, Isaac; Wietfeldt, Fred E.; Chupp, Timothy E.; Cooper, Robert L.; Beise, Elizabeth J.; Kiriluk, Kristin G.; Byrne, James; Coakley, Kevin J.			Observation of the radiative decay mode of the free neutron	NATURE			English	Article							BETA-DECAY; LOW-TEMPERATURE	The theory of quantum electrodynamics (QED) predicts that beta decay of the neutron into a proton, electron and antineutrino should be accompanied by a continuous spectrum of soft photons. While this inner bremsstrahlung branch has been previously measured in nuclear beta and electron capture decay, it has never been observed in free neutron decay. Recently, the photon energy spectrum and branching ratio for neutron radiative decay have been calculated using two approaches: a standard QED framework(1-3) and heavy baryon chiral perturbation theory(4) (an effective theory of hadrons based on the symmetries of quantum chromodynamics). The QED calculation treats the nucleons as point-like, whereas the latter approach includes the effect of nucleon structure in a systematic way. Here we observe the radiative decay mode of free neutrons, measuring photons in coincidence with both the emitted electron and proton. We determined a branching ratio of (3.13 +/- 0.34) x 10(-3) (68 per cent level of confidence) in the energy region between 15 and 340 keV, where the uncertainty is dominated by systematic effects. The value is consistent with the predictions of both theoretical approaches; the characteristic energy spectrum of the radiated photons, which differs from the uncorrelated background spectrum, is also consistent with the calculated spectrum. This result may provide opportunities for more detailed investigations of the weak interaction processes involved in neutron beta decay.	Natl Inst Stand & Technol, Phys Lab, Gaithersburg, MD 20899 USA; Tulane Univ, Dept Phys, New Orleans, LA 70118 USA; Univ Michigan, FOCUS, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Sussex, Dept Phys & Astron, Brighton BN1 9QH, E Sussex, England; Natl Inst Stand & Technol, Informat Technol Lab, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA; Tulane University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland College Park; University of Sussex; National Institute of Standards & Technology (NIST) - USA	Nico, JS (corresponding author), Natl Inst Stand & Technol, Phys Lab, Gaithersburg, MD 20899 USA.	jnico@nist.gov	Mumm, Pieter/AAT-3908-2020	Mumm, Pieter/0000-0003-4204-9817; Nico, Jeffrey/0000-0002-8372-6426				Beck M, 2002, JETP LETT+, V76, P332, DOI 10.1134/1.1525031; Bernard W, 2004, PHYS LETT B, V599, P348, DOI 10.1016/j.physletb.2004.08.041; Bernard W, 2004, PHYS LETT B, V593, P105, DOI [10.1016/j.physletb.2004.04.064, 10.1016/j.physletb.2004.(A.064]; BROWN FB, 2003, LANL PUBLICATION; Byrne J, 2002, J PHYS G NUCL PARTIC, V28, P1325, DOI 10.1088/0954-3899/28/6/314; Dewey MS, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.152302; Fisher BM, 2005, J RES NATL INST STAN, V110, P421, DOI 10.6028/jres.110.064; Gaponov YV, 1996, PHYS ATOM NUCL+, V59, P1213; Gaponov YV, 1996, PHYS LETT B, V379, P7, DOI 10.1016/0370-2693(96)00398-X; Gaponov YV, 2000, NUCL INSTRUM METH A, V440, P557, DOI 10.1016/S0168-9002(99)01036-0; GENTILE TR, IN PRESS NUCL INST A; Jauch J. M., 1955, THEORY PHOTONS ELECT; Khafizov RU, 2006, JETP LETT+, V83, P5, DOI 10.1134/S0021364006010024; KINOSHITA T, 1962, J MATH PHYS, V3, P650, DOI 10.1063/1.1724268; LEE TD, 1964, PHYS REV B, V133, P1549, DOI 10.1103/PhysRev.133.B1549; Mumm HP, 2004, REV SCI INSTRUM, V75, P5343, DOI 10.1063/1.1821628; Nico JS, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.055502; PILTINGSRUD HV, 1979, J NUCL MED, V20, P1279; Severijns N, 2006, JETP LETT+, V84, P231, DOI 10.1134/S0021364006160144; Yang L, 2003, NUCL INSTRUM METH A, V508, P388, DOI 10.1016/S0168-9002(03)01665-6	20	29	30	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1059	1062		10.1038/nature05390	http://dx.doi.org/10.1038/nature05390			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183320	Green Published			2022-12-28	WOS:000242971100053
J	Grossmann, M; Topliss, DJ				Grossmann, Mathis; Topliss, Duncan J.			A cool case: hypothermia and adrenal failure	LANCET			English	Editorial Material							HEMORRHAGE		Austin Hosp, Dept Med, Heidelberg, Vic 3084, Australia; Alfred Hosp, Dept Endocrinol & Diabet, Melbourne, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health	Grossmann, M (corresponding author), Austin Hosp, Dept Med, Heidelberg, Vic 3084, Australia.	mathisg@unimelb.edu.au	Topliss, Duncan/AAK-7082-2020	Topliss, Duncan/0000-0003-4763-3385				Caron P, 1998, J CLIN ENDOCR METAB, V83, P1437, DOI 10.1210/jc.83.5.1437; Kovacs KA, 2001, MEDICINE, V80, P45, DOI 10.1097/00005792-200101000-00005; RAO RH, 1995, MED CLIN N AM, V79, P107, DOI 10.1016/S0025-7125(16)30087-6; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; RuDusky BM, 2004, AM J CARDIOL, V93, P671, DOI 10.1016/j.amjcard.2003.10.065	5	1	1	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 16	2006	368	9553					2184	2184		10.1016/S0140-6736(06)69866-8	http://dx.doi.org/10.1016/S0140-6736(06)69866-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174711				2022-12-28	WOS:000242856900027
J	Sandall, S; Severin, F; McLeod, IX; Yates, JR; Oegema, K; Hyman, A; Desai, A				Sandall, Sharsti; Severin, Fedor; McLeod, Ian X.; Yates, John R., III; Oegema, Karen; Hyman, Anthony; Desai, Arshad			A Bir1-Sli15 complex connects centromeres to microtubules and is required to sense kinetochore tension	CELL			English	Article							CHROMOSOME SEGREGATION; BUDDING YEAST; AURORA-B; PROTEIN-KINASE; SPINDLE CHECKPOINT; CELL-DIVISION; SACCHAROMYCES-CEREVISIAE; APOPTOSIS FAMILY; CLEAVAGE FURROW; INCENP BINDS	Proper connections between centromeres and spindle microtubules are of critical importance in ensuring accurate segregation of the genome during cell division. Using an in vitro approach based on the sequence-specific budding yeast centromere, we identified a complex of the chromosomal passenger proteins Bir1 and Sli15 (Survivin and INCENP) that links centromeres to microtubules. This linkage does not require Ipl1/Aurora B kinase, whose targeting and activation are controlled by Bir1 and Sli15. Ipl1 is the tension-dependent regulator of centromere-microtubule interactions that ensures chromosome biorientation on the spindle. Elimination of the linkage between centromeres and microtubules mediated by Bir1-Sli15 phenocopies mutations that selectively cripple Ipl1 kinase activation. These findings lead us to propose that the Bir1-Sli15-mediated linkage, which bridges centromeres and microtubules and includes the Aurora kinase-activating domain of INCENP family proteins, is the tension sensor that relays the mechanical state of centromere-microtubule attachments into local control of Ipl1 kinase activity.	Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society; Scripps Research Institute	Desai, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, CMM E Room 3052,9500 Gilman Dr, La Jolla, CA 92093 USA.	abdesai@ucsd.edu	Hyman, Tony/F-1923-2011; Severin, Fedor/AAD-5444-2019	Severin, Fedor/0000-0001-6703-1256	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR11823, P41 RR011823] Funding Source: Medline; NIGMS NIH HHS [R01 GM074215-01, R01 GM074215-02, R01 GM074215] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Biggins S, 2003, CURR BIOL, V13, pR449, DOI 10.1016/S0960-9822(03)00369-5; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bouck DC, 2005, P NATL ACAD SCI USA, V102, P5408, DOI 10.1073/pnas.0405925102; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Clarke L, 1998, CURR OPIN GENET DEV, V8, P212, DOI 10.1016/S0959-437X(98)80143-3; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Gillis AN, 2005, J CELL BIOL, V171, P773, DOI 10.1083/jcb.200507017; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HYMAN AA, 1992, NATURE, V359, P533, DOI 10.1038/359533a0; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; KINGSBURY J, 1991, CELL, V66, P483, DOI 10.1016/0092-8674(81)90012-X; Kline-Smith SL, 2005, CURR OPIN CELL BIOL, V17, P35, DOI 10.1016/j.ceb.2004.12.009; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; Li FZ, 2000, J BIOL CHEM, V275, P6707, DOI 10.1074/jbc.275.10.6707; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; NICKLAS RB, 1969, J CELL BIOL, V43, P40, DOI 10.1083/jcb.43.1.40; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Severin F, 1999, METHOD CELL BIOL, V61, P145; Severin FF, 1997, NATURE, V388, P888, DOI 10.1038/42270; SORGER PK, 1994, J CELL BIOL, V127, P995, DOI 10.1083/jcb.127.4.995; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Stoepel J, 2005, MOL BIOL CELL, V16, P5465, DOI 10.1091/mbc.E05-04-0337; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Uren AG, 1999, P NATL ACAD SCI USA, V96, P10170, DOI 10.1073/pnas.96.18.10170; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; Widlund PO, 2006, MOL BIOL CELL, V17, P1065, DOI 10.1091/mbc.E05-07-0640; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208	56	100	108	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1179	1191		10.1016/j.cell.2006.09.049	http://dx.doi.org/10.1016/j.cell.2006.09.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174893	Green Accepted, Bronze			2022-12-28	WOS:000242991000016
J	Sandford, SA; Aleon, J; Alexander, CMO; Araki, T; Bajt, S; Baratta, GA; Borg, J; Bradley, JP; Brownlee, DE; Brucato, JR; Burchell, MJ; Busemann, H; Butterworth, A; Clemett, SJ; Cody, G; Colangeli, L; Cooper, G; D'Hendecourt, L; Djouadi, Z; Dworkin, JP; Ferrini, G; Fleckenstein, H; Flynn, GJ; Franchi, IA; Fries, M; Gilles, MK; Glavin, DP; Gounelle, M; Grossemy, F; Jacobsen, C; Keller, LP; Kilcoyne, ALD; Leitner, J; Matrajt, G; Meibom, A; Mennella, V; Mostefaoui, S; Nittler, LR; Palumbo, ME; Papanastassiou, DA; Robert, F; Rotundi, A; Snead, CJ; Spencer, MK; Stadermann, FJ; Steele, A; Stephan, T; Tsou, P; Tyliszczak, T; Westphal, AJ; Wirick, S; Wopenka, B; Yabuta, H; Zare, RN; Zolensky, ME				Sandford, Scott A.; Aleon, Jerome; Alexander, Conel M. O'D.; Araki, Tohru; Bajt, Sasa; Baratta, Giuseppe A.; Borg, Janet; Bradley, John P.; Brownlee, Donald E.; Brucato, John R.; Burchell, Mark J.; Busemann, Henner; Butterworth, Anna; Clemett, Simon J.; Cody, George; Colangeli, Luigi; Cooper, George; D'Hendecourt, Louis; Djouadi, Zahia; Dworkin, Jason P.; Ferrini, Gianluca; Fleckenstein, Holger; Flynn, George J.; Franchi, Ian A.; Fries, Marc; Gilles, Mary K.; Glavin, Daniel P.; Gounelle, Matthieu; Grossemy, Faustine; Jacobsen, Chris; Keller, Lindsay P.; Kilcoyne, A. L. David; Leitner, Jan; Matrajt, Graciela; Meibom, Anders; Mennella, Vito; Mostefaoui, Smail; Nittler, Larry R.; Palumbo, Maria E.; Papanastassiou, Dimitri A.; Robert, Francois; Rotundi, Alessandra; Snead, Christopher J.; Spencer, Maegan K.; Stadermann, Frank J.; Steele, Andrew; Stephan, Thomas; Tsou, Peter; Tyliszczak, Tolek; Westphal, Andrew J.; Wirick, Sue; Wopenka, Brigitte; Yabuta, Hikaru; Zare, Richard N.; Zolensky, Michael E.			Organics captured from comet 81P/Wild 2 by the Stardust spacecraft	SCIENCE			English	Article							RAMAN-SPECTROSCOPY; INTERSTELLAR; DUST; IDENTIFICATION; MOLECULES; MATTER; IDPS	Organics found in comet 81P/ Wild 2 samples show a heterogeneous and unequilibrated distribution in abundance and composition. Some organics are similar, but not identical, to those in interplanetary dust particles and carbonaceous meteorites. A class of aromatic-poor organic material is also present. The organics are rich in oxygen and nitrogen compared with meteoritic organics. Aromatic compounds are present, but the samples tend to be relatively poorer in aromatics than are meteorites and interplanetary dust particles. The presence of deuterium and nitrogen-15 excesses suggest that some organics have an interstellar/ protostellar heritage. Although the variable extent of modification of these materials by impact capture is not yet fully constrained, a diverse suite of organic compounds is present and identifiable within the returned samples.	NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA; Lawrence Livermore Natl Lab, Glenn I Seaborg Inst, Livermore, CA 94550 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Inst Astrophys Spatiale, F-91405 Orsay, France; Osserv Astrofis Catania, Ist Nazl Astrofis, I-95123 Catania, Italy; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; Univ Kent, Sch Phys Sci, Canterbury CT2 7NH, Kent, England; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; NASA, Lyndon B Johnson Space Ctr, Expense Reduct Consulting Inc, Houston, TX 77058 USA; Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; NASA, Ames Res Ctr, Exobiol Branch, Moffett Field, CA 94035 USA; NASA, Goddard Space Flight Ctr, Goddard Ctr Astrobiol, Greenbelt, MD 20771 USA; SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; SUNY Coll Plattsburgh, Dept Phys, Plattsburgh, NY 12901 USA; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; Univ Calif Berkeley, Div Chem Sci, Berkeley, CA 94720 USA; Museum Natl Hist Nat, Lab Etud Mat Extraterr, Paris, France; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Univ Munster, Inst Planetol, D-48149 Munster, Germany; CALTECH, Jet Prop Lab, Div Sci, Pasadena, CA 91109 USA; Univ Naples Parthenope, Dipartimento Sci Applicate, I-80133 Naples, Italy; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Washington Univ, Dept Phys, St Louis, MO 63130 USA; Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Carnegie Institution for Science; Universite de Lorraine; University of North Carolina; North Carolina State University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Istituto Nazionale Astrofisica (INAF); University of Washington; University of Washington Seattle; Istituto Nazionale Astrofisica (INAF); University of Kent; University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Plattsburgh; Open University - UK; University of California System; University of California Berkeley; Museum National d'Histoire Naturelle (MNHN); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Munster; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Parthenope University Naples; Stanford University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Sandford, SA (corresponding author), NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA.	ssandford@mail.arc.nasa.gov	Leitner, Jan/A-7391-2015; Stephan, Thomas/C-1023-2008; Yabuta, Hikaru/S-2662-2018; Steele, Andrew/A-3573-2013; Araki, Tohru/K-9301-2015; Bajt, Sasa/O-4695-2019; Jacobsen, Chris Johnson/E-2827-2015; Zare, Richard N./A-8410-2009; Alexander, Conel M. O'D./N-7533-2013; Yabuta, Hikaru/M-9041-2014; Bajt, Sasa/G-2228-2010; Matrajt, Graciela/A-4812-2017; 1.4, ALS Beamline/I-1886-2014; Appourchaux, Thierry/F-4692-2010; Kilcoyne, Arthur A L/I-1465-2013; Baratta, Giuseppe/AAY-6188-2021; Dworkin, Jason P./C-9417-2012; Glavin, Daniel P/D-6194-2012	Leitner, Jan/0000-0003-3655-6273; Stephan, Thomas/0000-0001-6377-8731; Steele, Andrew/0000-0001-9643-2841; Araki, Tohru/0000-0002-2689-4642; Bajt, Sasa/0000-0002-7163-7602; Jacobsen, Chris Johnson/0000-0001-8562-0353; Alexander, Conel M. O'D./0000-0002-8558-1427; Yabuta, Hikaru/0000-0002-4625-5362; Kilcoyne, Arthur A L/0000-0002-8805-8690; Dworkin, Jason P./0000-0002-3961-8997; Glavin, Daniel P/0000-0001-7779-7765; Palumbo, MariaElisabetta/0000-0002-9122-491X; Butterworth, Anna/0000-0002-6439-1472; Baratta, Giuseppe/0000-0002-3688-160X; Meibom, Anders/0000-0002-4542-2819; Burchell, Mark/0000-0002-2680-8943; Zare, Richard/0000-0001-5266-4253; Busemann, Henner/0000-0002-0867-6908; Zolensky, Michael/0000-0002-3181-1303; Mennella, Vito/0000-0001-9525-895X; Brucato, John Robert/0000-0002-4738-5521; Rotundi, Alessandra/0000-0001-5467-157X; Colangeli, Luigi/0000-0001-6801-9152				Aleon J, 2004, ICARUS, V167, P424, DOI 10.1016/j.icarus.2003.10.012; Baratta GA, 2004, J RAMAN SPECTROSC, V35, P487, DOI 10.1002/jrs.1169; BERNSTEIN MP, 1995, ASTROPHYS J, V454, P327, DOI 10.1086/176485; Bonal L, 2006, GEOCHIM COSMOCHIM AC, V70, P1849, DOI 10.1016/j.gca.2005.12.004; Brownlee DE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002087; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; CLEMETT SJ, 1993, SCIENCE, V262, P721, DOI 10.1126/science.262.5134.721; DELSEMME AH, 1992, ADV SPACE RES-SERIES, V12, P5, DOI 10.1016/0273-1177(92)90147-P; Festou C.M., 2004, COMETS 2; FLYNN GJ, 2006, IPAP C SERIES, V7, P315; Glavin DP, 2006, METEORIT PLANET SCI, V41, P889, DOI 10.1111/j.1945-5100.2006.tb00493.x; Keller LP, 2006, SCIENCE, V314, P1728, DOI 10.1126/science.1135796; KISSEL J, 1987, NATURE, V326, P755, DOI 10.1038/326755a0; Kissel J, 2004, SCIENCE, V304, P1774, DOI 10.1126/science.1098836; Matrajt G, 2005, ASTRON ASTROPHYS, V433, P979, DOI 10.1051/0004-6361:20041605; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; MUMMA MJ, 1993, PROTOSTARS PLANETS, V3, P1171; Pendleton YJ, 2002, ASTROPHYS J SUPPL S, V138, P75, DOI 10.1086/322999; Quirico E, 2005, PLANET SPACE SCI, V53, P1443, DOI 10.1016/j.pss.2005.07.009; SCHUTTE WA, 1993, ICARUS, V104, P118, DOI 10.1006/icar.1993.1087; Strazzulla G, 2001, SPECTROCHIM ACTA A, V57, P825, DOI 10.1016/S1386-1425(00)00447-9; Strazzulla G, 1999, SPACE SCI REV, V90, P269, DOI 10.1023/A:1005270703284; WOPENKA B, 1993, AM MINERAL, V78, P533; WOPENKA B, 1988, EARTH PLANET SC LETT, V88, P221, DOI 10.1016/0012-821X(88)90079-9; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	29	458	465	0	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1720	1724		10.1126/science.1135841	http://dx.doi.org/10.1126/science.1135841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170291				2022-12-28	WOS:000242833600043
J	Biondi, EG; Reisinger, SJ; Skerker, JM; Arif, M; Perchuk, BS; Ryan, KR; Laub, MT				Biondi, Emanuele G.; Reisinger, Sarah J.; Skerker, Jeffrey M.; Arif, Muhammad; Perchuk, Barrett S.; Ryan, Kathleen R.; Laub, Michael T.			Regulation of the bacterial cell cycle by an integrated genetic circuit	NATURE			English	Article							DNA-REPLICATION; HISTIDINE KINASE; POLAR LOCALIZATION; PROTEIN; PROGRESSION; DIVISION; CTRA	How bacteria regulate cell cycle progression at a molecular level is a fundamental but poorly understood problem. In Caulobacter crescentus, two-component signal transduction proteins are crucial for cell cycle regulation, but the connectivity of regulators involved has remained elusive and key factors are unidentified. Here we identify ChpT, an essential histidine phosphotransferase that controls the activity of CtrA, the master cell cycle regulator. We show that the essential histidine kinase CckA initiates two phosphorelays, each requiring ChpT, which lead to the phosphorylation and stabilization of CtrA. Downregulation of CckA activity therefore results in the dephosphorylation and degradation of CtrA, which in turn allow the initiation of DNA replication. Furthermore, we show that CtrA triggers its own destruction by promoting cell division and inducing synthesis of the essential regulator DivK, which feeds back to downregulate CckA immediately before S phase. Our results define a single integrated circuit whose components and connectivity can account for the cell cycle oscillations of CtrA in Caulobacter.	Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Harvard University; University of California System; University of California Berkeley	Laub, MT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	laub@mit.edu		Laub, Michael/0000-0002-8288-7607				Biondi EG, 2006, MOL MICROBIOL, V59, P386, DOI 10.1111/j.1365-2958.2005.04970.x; Collier J, 2006, EMBO J, V25, P346, DOI 10.1038/sj.emboj.7600927; Cross FR, 2003, DEV CELL, V4, P741, DOI 10.1016/S1534-5807(03)00119-9; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x; Holtzendorff J, 2006, BIOESSAYS, V28, P355, DOI 10.1002/bies.20384; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Jacobs C, 2003, MOL MICROBIOL, V47, P1279, DOI 10.1046/j.1365-2958.2003.03379.x; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; Ohta N, 2000, PROKARYOTIC DEVELOPMENT, P341; Pierce DL, 2006, J BACTERIOL, V188, P2473, DOI 10.1128/JB.188.7.2473-2482.2006; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Sciochetti SA, 2002, J BACTERIOL, V184, P6037, DOI 10.1128/JB.184.21.6037-6049.2002; Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Wang Y, 2001, MOL MICROBIOL, V40, P347, DOI 10.1046/j.1365-2958.2001.02395.x; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wortinger M, 2000, EMBO J, V19, P4503, DOI 10.1093/emboj/19.17.4503; Wu JG, 1998, P NATL ACAD SCI USA, V95, P1443, DOI 10.1073/pnas.95.4.1443	34	197	199	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					899	904		10.1038/nature05321	http://dx.doi.org/10.1038/nature05321			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17136100				2022-12-28	WOS:000242805400049
J	Hoffer, LJ				Hoffer, L. John			Controversy - Tube feeding in advanced dementia: the metabolic perspective	BRITISH MEDICAL JOURNAL			English	Article							NUTRITION; HYDRATION; CARE		McGill Univ, Fac Med, Montreal, PQ, Canada	McGill University	Hoffer, LJ (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	l.hoffer@mcgill.ca						Casarett D, 2005, NEW ENGL J MED, V353, P2607, DOI 10.1056/NEJMsb052907; Chernoff Ronni, 2006, Nutr Clin Pract, V21, P142, DOI 10.1177/0115426506021002142; Fine Robert L, 2006, Nutr Clin Pract, V21, P118, DOI 10.1177/0115426506021002118; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; GALANOS AN, 1994, J AM GERIATR SOC, V42, P368, DOI 10.1111/j.1532-5415.1994.tb07483.x; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; Harris D, 2005, J ROY SOC MED, V98, P411, DOI 10.1258/jrsm.98.9.411; Hoffer LJ, 2006, MODERN NUTR HLTH DIS, P730; Jotkowitz AB, 2005, J AM GERIATR SOC, V53, P881, DOI 10.1111/j.1532-5415.2005.53271.x; McCann R, 1999, JAMA-J AM MED ASSOC, V282, P1380, DOI 10.1001/jama.282.14.1380; McNamara EP, 2001, P NUTR SOC, V60, P179, DOI 10.1079/PNS200083; Monteleoni C, 2004, BMJ-BRIT MED J, V329, P491, DOI 10.1136/bmj.329.7464.491; QUILL TE, 1989, ARCH INTERN MED, V149, P1937, DOI 10.1001/archinte.149.9.1937; Roberts SB, 2006, PHYSIOL REV, V86, P651, DOI 10.1152/physrev.00019.2005; Skelly RH, 2002, CURR OPIN CLIN NUTR, V5, P35, DOI 10.1097/00075197-200201000-00007; Truog RD, 2005, ARCH INTERN MED, V165, P2574, DOI 10.1001/archinte.165.22.2574; Wang SY, 1997, J AM GERIATR SOC, V45, P1189, DOI 10.1111/j.1532-5415.1997.tb03768.x; Wilson MMG, 2003, J APPL PHYSIOL, V95, P1728, DOI 10.1152/japplphysiol.00313.2003	18	29	30	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 9	2006	333	7580					1214	1215		10.1136/bmj.39021.785197.47	http://dx.doi.org/10.1136/bmj.39021.785197.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	119JW	17158389	Green Published			2022-12-28	WOS:000243009600019
J	Colgrove, J				Colgrove, James			The ethics and politics of compulsory HPV vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10012 USA	Columbia University	Colgrove, J (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10012 USA.							COLGROVE JK, 2006, STATE IMMUNITY PLITI; Lo B, 2006, BMJ-BRIT MED J, V332, P1106, DOI 10.1136/bmj.332.7550.1106; Salmon DA, 2006, LANCET, V367, P436, DOI 10.1016/S0140-6736(06)68144-0; Temte JL, 2006, BMJ-BRIT MED J, V332, P715, DOI 10.1136/bmj.332.7543.715; Zimmerman RK, 2006, VACCINE, V24, P4812, DOI 10.1016/j.vaccine.2006.03.019	5	116	122	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2389	2391		10.1056/NEJMp068248	http://dx.doi.org/10.1056/NEJMp068248			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113EO	17151362	Green Submitted, Bronze			2022-12-28	WOS:000242581400001
J							Global Hlth Diagnostics Forum	The right tools can save lives	NATURE			English	Editorial Material																		BURGESS DC, 2006, NATURE S, pS1; Lon CT, 2005, T ROY SOC TROP MED H, V99, P493, DOI 10.1016/j.trstmh.2005.01.001; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; *WHO, 2004, WHO GLOB TUB CONTR	5	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					681	681		10.1038/444681a	http://dx.doi.org/10.1038/444681a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113EL	17151639	Bronze			2022-12-28	WOS:000242581100027
J	Amazigo, U; Boatin, B				Amazigo, Uche; Boatin, Boakye			The future of onchocerciasis control in Africa	LANCET			English	Editorial Material									WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland; WHO African Programme Onchocerciasis Control, Ouagadougou, Burkina Faso	World Health Organization	Amazigo, U (corresponding author), WHO African Programme Onchocerciasis Control, Ouagadougou, Burkina Faso.	amazigouv@oncho.oms.bf						Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; *WHO, 2002, SUCC AFR ONCH CONTR; *WHO AFR PROGR ONC, 2006, STRAT OV FUT ONCH CO; *WHO AFR PROGR ONC, 2006, PARTN M FUT ONCH CON; *WHO AFR PROGR ONC, 2001, PROGR DOC PHAS 2 200	5	19	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					1946	1947		10.1016/S0140-6736(06)69786-9	http://dx.doi.org/10.1016/S0140-6736(06)69786-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141687				2022-12-28	WOS:000242593300008
J	Thomas, G				Thomas, Gareth			Sex, politics, and money	LANCET			English	Editorial Material									Parliamentary Secretary State, Dept Int Dev, London SW1E 5HE, England		Thomas, G (corresponding author), Parliamentary Secretary State, Dept Int Dev, London SW1E 5HE, England.	rch@dfid.gov.uk						Druce N., 2006, REPROD HLTH COMMODIT; Druce N, 2006, STRENGTHENING LINKAG; *IPPF, 2006, DEATH DEN UNS AB POV, P2; Jewkes R, 2005, SAMJ S AFR MED J, V95, P250; MWANAMKE U, 2003, FACES DIGNITY 7 STOR; SCHOTT W, 2005, EFFECTS GLOBAL FUND; SINGH S, 2003, ADDING IT BENEFITS I, P9; *UN PROGR ACT, 1994, INT C POP DEV CAIR S; *UNAIDS WHO, 2005, AIDS EP UPD, P11; *UNAIDS WHO, 2005, AIDS EP UPD, P1; *UNFPA, 2003, FIN RES FLOWS POP AC; WHO, 2006, PREV CONTR SEX TRANS; 2005, G8 GLEANEAGLES COMMU	13	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					1943	1946		10.1016/S0140-6736(06)69488-9	http://dx.doi.org/10.1016/S0140-6736(06)69488-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141686				2022-12-28	WOS:000242593300007
J	Morel, FMM; Groves, JT				Morel, Francois M. M.; Groves, John T.			Edward I. Stiefel (1942-2006)	SCIENCE			English	Biographical-Item									Princeton Univ, Dept Geosci & Chem, Princeton, NJ 08544 USA	Princeton University	Morel, FMM (corresponding author), Princeton Univ, Dept Geosci & Chem, Princeton, NJ 08544 USA.	morel@princeton.edu; jtgroves@princeton.edu	Morel, Francois M M/A-8107-2008; Groves, John T./GPP-7588-2022	Groves, John T./0000-0002-9944-5899				Bertini I., 2006, BIOL INORGANIC CHEM; CASTRUITA M, UNPUB; MUKUND S, 1990, J BIOL CHEM, V265, P11508; STIEFEL EI, 1979, NATURE, V279, P81, DOI 10.1038/279081a0; STIEFEL EI, PUBLICATION LIST	5	1	1	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1406	1406		10.1126/science.1136957	http://dx.doi.org/10.1126/science.1136957			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138889				2022-12-28	WOS:000242406100025
J	von Bubnoff, A				von Bubnoff, Andreas			Seeking new antibiotics in nature's backyard	CELL			English	Editorial Material																			0	12	12	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 1	2006	127	5					867	869		10.1016/j.cell.2006.11.021	http://dx.doi.org/10.1016/j.cell.2006.11.021			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129770	Bronze			2022-12-28	WOS:000242613800001
J	Sijen, T; Steiner, FA; Thijssen, KL; Plasterk, RHA				Sijen, Titia; Steiner, Florian A.; Thijssen, Karen L.; Plasterk, Ronald H. A.			RETRACTED: Secondary siRNAs result from unprimed RNA synthesis and form a distinct class (Retracted article. See vol. 370, pg. 921, 2020)	SCIENCE			English	Article; Retracted Publication							C-ELEGANS; GENE; POLYMERASE; MICRORNA; TRANSCRIPTION; DEGRADATION; ARGONAUTE; HELICASE; RDE-1; DICER	In Caenorhabditis elegans, an effective RNA interference (RNAi) response requires the production of secondary short interfering RNAs (siRNAs) by RNA-directed RNA polymerases (RdRPs). We cloned secondary siRNAs from transgenic C. elegans lines expressing a single 22-nucleotide primary siRNA. Several secondary siRNAs start a few nucleotides downstream of the primary siRNA, indicating that non-RISC (RNA-induced silencing complex)-cleaved mRNAs are substrates for secondary siRNA production. In lines expressing primary siRNAs with single-nucleotide mismatches, secondary siRNAs do not carry the mismatch but contain the nucleotide complementary to the mRNA. We infer that RdRPs perform unprimed RNA synthesis. Secondary siRNAs are only of antisense polarity, carry 5' di- or triphosphates, and are only in the minority associated with RDE-1, the RNAi-specific Argonaute protein. Therefore, secondary siRNAs represent a distinct class of small RNAs. Their biogenesis depends on RdRPs, and we propose that each secondary siRNA is an individual RdRP product.	Hubrecht Lab, NIOB KNAW, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Plasterk, RHA (corresponding author), Hubrecht Lab, NIOB KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl						Alder MN, 2003, RNA, V9, P25, DOI 10.1261/rna.2650903; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Petersen BO, 2005, PLANT MOL BIOL, V58, P575, DOI 10.1007/s11103-005-7307-4; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	23	312	338	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2007	315	5809					244	247		10.1126/science.1136699	http://dx.doi.org/10.1126/science.1136699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17158288				2022-12-28	WOS:000243407400048
J	Koh, THHG; Butow, PN; Coory, M; Budge, D; Collie, LA; Whitehall, J; Tattersall, MH				Koh, Tieh Hee Hai Guan; Butow, Phyllis N.; Coory, Michael; Budge, Donna; Collie, Li-An; Whitehall, John; Tattersall, Martin H.			Provision of taped conversations with neonatologists to mothers of babies in intensive care: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CANCER-PATIENTS; POSTNATAL DEPRESSION; CONSULTATION; INFORMATION; AUDIOTAPES	Objective To determine whether providing mothers of babies in neonatal intensive care units with audiotapes of their conversations with a neonatologist improves recall of information and psychological wellbeing. Design Randomised, single blinded trial. Setting Neonatal intensive care unit, north Queensland, Australia. Participants 200 mothers of babies in a neonatal intensive care unit. Interventions Mothers given (n=102) or not given (n=98) audiotapes of their conversations with a neonatologist. Main outcome measures Recall of information, attitudes to and use of the tape, satisfaction with conversations, postnatal depression, anxiety, general health, and stress about parenting, at 10 days and four and 12 months. Results 91% 0=93) of mothers in the tape group listened to the tape (once by day 10, twice by four months, and three times by 12 months; range 1-10). At 10 days and four months, mothers in the tape group recalled significantly more information about diagnosis, treatment, and outcome than mothers in the control group. At four months mothers in the tape group were 75% more likely to recall all of the information about treatment than mothers in the control group (59% v 34%; risk ratio 1.75, 95% confidence interval 1.27 to 2.4). Six mothers, all in the control group, could not recall their conversations. No statistically significant differences were found between the groups in satisfaction with conversations (10 days), postnatal depression and anxiety scores (10 days, four and 12 months), and stress about parenting (12 months). Conclusion Providing the mothers of babies in neonatal intensive care units with audiotapes of conversations with a neonatologist enhanced their recall of information (up to four months). The taped conversations did not affect the mothers' wellbeing or satisfaction with the neonatologist.	Townsville Hosp, Inst Womens & Childrens Hlth, Douglas, Qld 4814, Australia; James Cook Univ N Queensland, Sch Med, Douglas, Qld, Australia; Univ Sydney, Med Psychol Res Unit, Sydney, NSW 2006, Australia; Queensland Hlth, Sch Populat Hlth, Brisbane, Qld, Australia; Univ Sydney, Fac Med, Sydney, NSW 2006, Australia	James Cook University; University of Sydney; Queensland Health; University of Queensland; University of Sydney	Koh, THHG (corresponding author), Townsville Hosp, Inst Womens & Childrens Hlth, Douglas, Qld 4814, Australia.	guan_koh@health.qld.gov.au						Abidin RR., 1990, PARENTING STRESS IND, DOI [10.4236/psych.2018.97104, DOI 10.4236/PSYCH.2018.97104]; ALROOMI L, 1995, LANCET, V345, P1020; Brown R, 1997, ANN ONCOL, V8, P877, DOI 10.1023/A:1008213630112; BUTT HR, 1977, ANN INTERN MED, V86, P478, DOI 10.7326/0003-4819-86-4-478; Buunk B.P., 1990, HDB FAMILY MEASUREME, P106; CASSILETH BR, 1980, ANN INTERN MED, V92, P832, DOI 10.7326/0003-4819-92-6-832; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Hagan R, 2004, BJOG-INT J OBSTET GY, V111, P641, DOI 10.1111/j.1471-0528.2004.00165.x; Hogbin B, 1992, PSYCHO-ONCOLOGY, V1, P147; Koh THHG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004502.pub2; MCHUGH P, 1995, BRIT J CANCER, V71, P388, DOI 10.1038/bjc.1995.79; Ong LML, 2000, J CLIN ONCOL, V18, P3052, DOI 10.1200/JCO.2000.18.16.3052; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; SCOTT JT, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001539; Snowdon C, 1997, SOC SCI MED, V45, P1337, DOI 10.1016/S0277-9536(97)00063-4; Spielberger CD, 1970, MANUAL STATE TRAIT A; Tattersall MH, 2002, LANCET ONCOL, V3, P431, DOI 10.1016/S1470-2045(02)00790-8; TATTERSALL MHN, 1994, J CLIN ONCOL, V12, P1305, DOI 10.1200/JCO.1994.12.6.1305; 1987, BR J PSYCHIAT, V150, P782	19	35	35	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2007	334	7583					28	31		10.1136/bmj.39017.675648.BE	http://dx.doi.org/10.1136/bmj.39017.675648.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125CH	17142256	Bronze, Green Published			2022-12-28	WOS:000243418600036
J	Finkelberg, DL; Sahani, D; Deshpande, V; Brugge, WR				Finkelberg, Dnitry L.; Sahani, Dushyant; Deshpande, Vikrarn; Brugge, William R.			Current concepts - Autoimmune pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IDIOPATHIC CHRONIC-PANCREATITIS; LYMPHOPLASMACYTIC SCLEROSING PANCREATITIS; CARBONIC-ANHYDRASE-II; DUCT; AUTOANTIBODIES; INVOLVEMENT; CHOLANGITIS; RELEVANCE; DIAGNOSIS; FEATURES		Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Brugge, WR (corresponding author), Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Blake 452C,55 Fruit St, Boston, MA 02114 USA.	wbrugge@partners.org						Aoki S, 2005, HISTOPATHOLOGY, V47, P147, DOI 10.1111/j.1365-2559.2005.02204.x; Aparisi L, 2005, GUT, V54, P703, DOI 10.1136/gut.2004.047142; Chari ST, 2006, CLIN GASTROENTEROL H, V4, P1010, DOI 10.1016/j.cgh.2006.05.017; Davidson TS, 2005, AM J PATHOL, V166, P729, DOI 10.1016/S0002-9440(10)62294-8; Deshpande V, 2005, ARCH PATHOL LAB MED, V129, P1148; Ectors N, 1997, GUT, V41, P263, DOI 10.1136/gut.41.2.263; Farrell JJ, 2004, GASTROINTEST ENDOSC, V60, P927, DOI 10.1016/S0016-5107(04)02230-8; Fernandez-del Castillo CF, 2003, NEW ENGL J MED, V349, P893, DOI 10.1056/NEJMcpc030022; Frulloni L, 1999, PANCREAS, V19, P33, DOI 10.1097/00006676-199907000-00005; Fukumori K, 2005, INTERNAL MED, V44, P886, DOI 10.2169/internalmedicine.44.886; Hardacre JM, 2003, ANN SURG, V237, P853, DOI 10.1097/00000658-200306000-00014; Hirano K, 2003, CLIN GASTROENTEROL H, V1, P453, DOI 10.1016/S1542-3565(03)00221-0; Ito T, 1997, DIGEST DIS SCI, V42, P1458, DOI 10.1023/A:1018862626221; Kamisawa T, 2005, PANCREATOLOGY, V5, P234, DOI 10.1159/000085277; Kamisawa T, 2003, GUT, V52, P683, DOI 10.1136/gut.52.5.683; Kawa S, 2002, GASTROENTEROLOGY, V122, P1264, DOI 10.1053/gast.2002.33022; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; Kim KP, 2004, AM J GASTROENTEROL, V99, P1605, DOI 10.1111/j.1572-0241.2004.30336.x; Kodama T, 2003, J GASTROEN HEPATOL, V18, P108, DOI 10.1046/j.1440-1746.2003.02788.x; Kojima E, 2003, J GASTROENTEROL, V38, P603, DOI 10.1007/s00535-002-1108-1; Levy MJ, 2005, GASTROINTEST ENDOSC, V61, P467, DOI 10.1016/S0016-5107(04)02802-0; Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society, 2002, J JPN PANCREAS SOC, V17, P585; Nakazawa T, 2004, GASTROINTEST ENDOSC, V60, P937, DOI 10.1016/S0016-5107(04)02229-1; Notohara K, 2003, AM J SURG PATHOL, V27, P1119, DOI 10.1097/00000478-200308000-00009; Numata K, 2004, J ULTRAS MED, V23, P199, DOI 10.7863/jum.2004.23.2.199; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Ozden I, 2005, PANCREATOLOGY, V5, P300, DOI 10.1159/000085287; Pearson RK, 2003, PANCREAS, V27, P1, DOI 10.1097/00006676-200307000-00001; Sahani DV, 2004, RADIOLOGY, V233, P345, DOI 10.1148/radiol.2332031436; Saito T, 2002, PANCREATOLOGY, V2, P550, DOI 10.1159/000066092; Shinji A, 2004, GASTROINTEST ENDOSC, V59, P506, DOI 10.1016/S0016-5107(03)02874-8; SOOD S, 1995, PANCREAS, V10, P419, DOI 10.1097/00006676-199505000-00018; Takeda S, 2004, NEPHROL DIAL TRANSPL, V19, P474, DOI 10.1093/ndt/gfg477; Taniguchi T, 2003, PANCREAS, V27, P26, DOI 10.1097/00006676-200307000-00004; Uchida K, 2002, LAB INVEST, V82, P411, DOI 10.1038/labinvest.3780435; Uchiyama-Tanaka Y, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2003.12.006; Uzan KN, 2005, CLIN GASTROENTEROL H, V3, P903, DOI 10.1053/S1542-3565(05)00540-9; Wakabayashi T, 2002, PANCREAS, V25, P283, DOI 10.1097/00006676-200210000-00011; Wakabayashi T, 2005, PANCREAS, V30, P31; Weber SM, 2003, J GASTROINTEST SURG, V7, P129, DOI 10.1016/S1091-255X(02)00148-8; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; Zamboni G, 2004, VIRCHOWS ARCH, V445, P552, DOI 10.1007/s00428-004-1140-z	42	310	354	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2670	2676		10.1056/NEJMra061200	http://dx.doi.org/10.1056/NEJMra061200			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182992				2022-12-28	WOS:000242956200008
J	Aronson, JK; Hauben, M				Aronson, Jeffrey K.; Hauben, Manfred			Drug safety - Anecdotes that provide definitive evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FOLLOW; INJECTION	When a criminal is caught in the act, other evidence is unnecessary. Should the same be true for adverse drug reactions?	Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England; Pfizer Inc, Risk Management Strategy, New York, NY USA	Radcliffe Infirmary; University of Oxford; Pfizer	Aronson, JK (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England.	jeffrey.aronson@clinpharm.ox.ac.uk						Barclay TS, 2002, ANN PHARMACOTHER, V36, P1558; Cherasse A, 2003, JOINT BONE SPINE, V70, P390, DOI 10.1016/S1297-319X(03)00137-4; Culora GA, 1996, J CLIN PATHOL, V49, P844, DOI 10.1136/jcp.49.10.844; Daudon M, 2004, DRUGS, V64, P245, DOI 10.2165/00003495-200464030-00003; Diaz M, 2005, QUAL SAF HEALTH CARE, V14, P140, DOI 10.1136/qshc.2005.013763; Eiferman RA, 2001, J CATARACT REFR SURG, V27, P1701, DOI 10.1016/S0886-3350(01)00893-8; Kashiwagi Y, 1997, J MED VIROL, V52, P195, DOI 10.1002/(SICI)1096-9071(199706)52:2<195::AID-JMV13>3.0.CO;2-K; Korantzopoulos P, 2005, INT J CARDIOL, V98, P355, DOI 10.1016/j.ijcard.2004.01.001; Loke YK, 2006, BMJ-BRIT MED J, V332, P335, DOI 10.1136/bmj.38701.399942.63; McGee AM, 2002, BRIT J ANAESTH, V88, P139, DOI 10.1093/bja/88.1.139; Meyboom RHB, 2002, DRUG SAFETY, V25, P459, DOI 10.2165/00002018-200225060-00011; O'Neill JL, 2003, ANN PHARMACOTHER, V37, P1675, DOI 10.1345/aph.1D056; Shojaei Ali R, 2002, J Can Dent Assoc, V68, P622; SMYTH JA, 1986, NEW ENGL J MED, V315, P767; Tramer MR, 2000, PAIN, V85, P169, DOI 10.1016/S0304-3959(99)00267-5; Trevenzoli M, 2004, J INFECTION, V48, P363, DOI 10.1016/j.jinf.2004.01.013; Vandenbroucke JP, 2001, ANN INTERN MED, V134, P330, DOI 10.7326/0003-4819-134-4-200102200-00017; Wald NJ, 2003, BRIT MED J, V327, P616, DOI 10.1136/bmj.327.7415.616	18	110	112	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2006	333	7581					1267	1269		10.1136/bmj.39036.666389.94	http://dx.doi.org/10.1136/bmj.39036.666389.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122AB	17170419	Green Published, Green Submitted			2022-12-28	WOS:000243197000024
J	Keller, LP; Bajt, S; Baratta, GA; Borg, J; Bradley, JP; Brownlee, DE; Busemann, H; Brucato, JR; Burchell, M; Colangeli, L; d'Hendecourt, L; Djouadi, Z; Ferrini, G; Flynn, G; Franchi, IA; Fries, M; Grady, MM; Graham, GA; Grossemy, F; Kearsley, A; Matrajt, G; Nakamura-Messenger, K; Mennella, V; Nittler, L; Palumbo, ME; Stadermann, FJ; Tsou, P; Rotundi, A; Sandford, SA; Snead, C; Steele, A; Wooden, D; Zolensky, M				Keller, Lindsay P.; Bajt, Sasa; Baratta, Giuseppe A.; Borg, Janet; Bradley, John P.; Brownlee, Don E.; Busemann, Henner; Brucato, John R.; Burchell, Mark; Colangeli, Luigi; d'Hendecourt, Louis; Djouadi, Zahia; Ferrini, Gianluca; Flynn, George; Franchi, Ian A.; Fries, Marc; Grady, Monica M.; Graham, Giles A.; Grossemy, Faustine; Kearsley, Anton; Matrajt, Graciela; Nakamura-Messenger, Keiko; Mennella, Vito; Nittler, Larry; Palumbo, Maria E.; Stadermann, Frank J.; Tsou, Peter; Rotundi, Alessandra; Sandford, Scott A.; Snead, Christopher; Steele, Andrew; Wooden, Diane; Zolensky, Mike			Infrared spectroscopy of comet 81P/Wild 2 samples returned by Stardust	SCIENCE			English	Article							DIFFUSE INTERSTELLAR-MEDIUM; ORGANIC-MATTER; DUST; SPECTROPHOTOMETRY; MINERALOGY	Infrared spectra of material captured from comet 81P/Wild 2 by the Stardust spacecraft reveal indigenous aliphatic hydrocarbons similar to those in interplanetary dust particles thought to be derived from comets, but with longer chain lengths than those observed in the diffuse interstellar medium. Similarly, the Stardust samples contain abundant amorphous silicates in addition to crystalline silicates such as olivine and pyroxene. The presence of crystalline silicates in Wild 2 is consistent with mixing of solar system and interstellar matter. No hydrous silicates or carbonate minerals were detected, which suggests a lack of aqueous processing of Wild 2 dust.	NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Osserv Astrofis Catania, INAF, I-95123 Catania, Italy; Inst Astrophys Spatiale, F-91405 Orsay, France; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; Univ Kent, Sch Phys Sci, Canterbury CT2 7NR, Kent, England; Novaetech SRL, I-80125 Naples, Italy; SUNY Coll Plattsburgh, Dept Phys, Plattsburgh, NY 12901 USA; Open Univ, Milton Keynes MK7 6AA, Bucks, England; Nat Hist Museum, Dept Mineral, London SW7 5BD, England; NASA, Lyndon B Johnson Space Ctr, Engn Sci Contract Grp, Houston, TX 77058 USA; Washington Univ, Space Sci Lab, St Louis, MO 63160 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Napoli Parthenope, Dipartimento Sci Applicate, I-80133 Naples, Italy; NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Washington; University of Washington Seattle; Carnegie Institution for Science; Istituto Nazionale Astrofisica (INAF); University of Kent; State University of New York (SUNY) System; SUNY Plattsburgh; Open University - UK; Natural History Museum London; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Parthenope University Naples; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Berkeley	Keller, LP (corresponding author), NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Mail Code KR, Houston, TX 77058 USA.	lindsay.p.keller@nasa.gov	Baratta, Giuseppe/AAY-6188-2021; Steele, Andrew/A-3573-2013; Bajt, Sasa/G-2228-2010; Matrajt, Graciela/A-4812-2017; Bajt, Sasa/O-4695-2019; 1.4, ALS Beamline/I-1886-2014; Appourchaux, Thierry/F-4692-2010	Steele, Andrew/0000-0001-9643-2841; Bajt, Sasa/0000-0002-7163-7602; Zolensky, Michael/0000-0002-3181-1303; Colangeli, Luigi/0000-0001-6801-9152; Brucato, John Robert/0000-0002-4738-5521; Baratta, Giuseppe/0000-0002-3688-160X; Mennella, Vito/0000-0001-9525-895X; Grady, Monica/0000-0002-4055-533X; Burchell, Mark/0000-0002-2680-8943; Palumbo, MariaElisabetta/0000-0002-9122-491X; Rotundi, Alessandra/0000-0001-5467-157X; Busemann, Henner/0000-0002-0867-6908				Bradley JP, 1999, SCIENCE, V285, P1716, DOI 10.1126/science.285.5434.1716; BRADLEY JP, 2004, TREATISE GEOCHEMISTR, V1, P1121; BREGMAN JD, 1988, ASTROPHYS J, V334, P1044, DOI 10.1086/166896; BREGMAN JD, 1987, ASTRON ASTROPHYS, V187, P616; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; CAMPINS H, 1989, ASTROPHYS J, V341, P1059, DOI 10.1086/167563; Chiar JE, 2000, ASTROPHYS J, V537, P749, DOI 10.1086/309047; Crovisier J, 1997, SCIENCE, V275, P1904, DOI 10.1126/science.275.5308.1904; Dartois E, 2004, ASTRON ASTROPHYS, V423, P549, DOI 10.1051/0004-6361:20047067; DISANTI MA, 1995, ICARUS, V116, P1, DOI 10.1006/icar.1995.1110; Dorschner J, 1995, ASTRON ASTROPHYS REV, V6, P271, DOI 10.1007/BF00873686; EHRENFREUND P, 1991, ASTRON ASTROPHYS, V252, P712; Flynn GJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4791, DOI 10.1016/j.gca.2003.09.001; FLYNN GJ, 2003, WORKSH COM DUST ASTR; Gardinier A, 2000, EARTH PLANET SC LETT, V184, P9, DOI 10.1016/S0012-821X(00)00300-9; Harker DE, 2002, ASTROPHYS J, V580, P579, DOI 10.1086/343091; Keller LP, 2004, GEOCHIM COSMOCHIM AC, V68, P2577, DOI 10.1016/j.gca.2003.10.044; KELLER LP, 2004, LUNAR PLANET SCI, V35, P1985; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; Kemper F, 2005, ASTROPHYS J, V633, P534, DOI 10.1086/447764; Lisse CM, 2006, SCIENCE, V313, P635, DOI 10.1126/science.1124694; Matrajt G, 2005, ASTRON ASTROPHYS, V433, P979, DOI 10.1051/0004-6361:20041605; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Molster FJ, 2003, LECT NOTES PHYS, V609, P121; MUMMA MJ, 1993, PROTOSTARS PLANETS, V3, P1172; PENDLETON YJ, 1994, ASTROPHYS J, V437, P683, DOI 10.1086/175031; Pendleton YJ, 2002, ASTROPHYS J SUPPL S, V138, P75, DOI 10.1086/322999; Rietmeijer F.J.M., 1998, PLANETARY MAT, V36; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Whittet DCB, 1997, ASTROPHYS J, V490, P729, DOI 10.1086/304914; Wooden DH, 1999, ASTROPHYS J, V517, P1034, DOI 10.1086/307206; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	33	145	146	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1728	1731		10.1126/science.1135796	http://dx.doi.org/10.1126/science.1135796			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170293				2022-12-28	WOS:000242833600045
J	Azaele, S; Pigolotti, S; Banavar, JR; Maritan, A				Azaele, Sandro; Pigolotti, Simone; Banavar, Jayanth R.; Maritan, Amos			Dynamical evolution of ecosystems	NATURE			English	Article							NEUTRAL THEORY; VEGETATION DYNAMICS; SPECIES ABUNDANCE; BETA-DIVERSITY; FOREST; COMMUNITIES; MODEL	The assembly of an ecosystem such as a tropical forest depends crucially on the species interaction network, and the deduction of its rules is a formidably complex problem(1). In spite of this, many recent studies(2-16) using Hubbell's neutral theory of biodiversity and biogeography(2) have demonstrated that the resulting emergent macroscopic behaviour of the ecosystem at or near a stationary state shows a surprising simplicity reminiscent of many physical systems(17). Indeed the symmetry postulate(2), that the effective birth and death rates are species-independent within a single trophic level, allows one to make analytical predictions for various static distributions such as the relative species abundance(3-12), beta-diversity(13-15) and the species - area relationship(16). In contrast, there have only been a few studies of the dynamics and stability of tropical rain forests(18-20). Here we consider the dynamical behaviour of a community, and benchmark it against the exact predictions of a neutral model near or at stationarity. In addition to providing a description of the relative species abundance, our analysis leads to a quantitative understanding of the species turnover distribution and extinction times, and a measure of the temporal scales of neutral evolution. Our model gives a very good description of the large quantity of data collected in Barro Colorado Island in Panama in the period 1990 - 2000 with just three ecologically relevant parameters and predicts the dynamics of extinction of the existing species.	Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA; Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; Niels Bohr Inst, DK-2100 Copenhagen, Denmark	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Padua; University of Copenhagen; Niels Bohr Institute	Banavar, JR (corresponding author), Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA.	banavar@psu.edu; maritan@pd.infn.it	Azaele, Sandro/N-1137-2013; Azaele, Sandro/AAN-8986-2020; Pigolotti, Simone/AAU-2395-2021; Azaele, Sandro/B-2444-2008	Azaele, Sandro/0000-0002-5153-4833; Azaele, Sandro/0000-0002-5153-4833; Pigolotti, Simone/0000-0002-6157-6906; Maritan, Amos/0000-0002-3535-7873				Abramowitz M, 1970, HDB MATH FUNCTIONS F, V9th ed; Adler PB, 2004, ECOLOGY, V85, P1265, DOI 10.1890/03-0602; Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; Durrett R, 1996, J THEOR BIOL, V179, P119, DOI 10.1006/jtbi.1996.0053; Etienne RS, 2005, ECOL LETT, V8, P1147, DOI 10.1111/j.1461-0248.2005.00817.x; FOSTER DR, 1993, ECOLOGY, V74, P982, DOI 10.2307/1940468; Gilbert B, 2006, AM NAT, V168, P304, DOI 10.1086/506969; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Harte J, 2003, NATURE, V424, P1006, DOI 10.1038/4241006a; Hilborn Ray, 1997, V28; Hubbell Stephen P., 2001, V32, pi; McKane A, 2000, PHYS REV E, V62, P8466, DOI 10.1103/PhysRevE.62.8466; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Pigolotti S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011916; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Sheil D, 2000, J TROP ECOL, V16, P765, DOI 10.1017/S0266467400001723; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Zillio T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098101	29	85	87	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					926	928		10.1038/nature05320	http://dx.doi.org/10.1038/nature05320			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167485				2022-12-28	WOS:000242805400055
J	Hafner, M; Schmitz, A; Grune, I; Srivatsan, SG; Paul, B; Kolanus, W; Quast, T; Kremmer, E; Bauer, I; Famulok, M				Hafner, Markus; Schmitz, Anton; Gruene, Imke; Srivatsan, Seergazhi G.; Paul, Bianca; Kolanus, Waldemar; Quast, Thomas; Kremmer, Elisabeth; Bauer, Inga; Famulok, Michael			Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; NUCLEOTIDE-EXCHANGE FACTOR; GTP-BINDING PROTEINS; GUANINE-NUCLEOTIDE; BREFELDIN-A; ARF; MICE; DISRUPTION; ACTIVATION; MECHANISM	G proteins are an important class of regulatory switches in all living systems. They are activated by guanine nucleotide exchange factors (GEFs), which facilitate the exchange of GDP for GTP(1,2). This activity makes GEFs attractive targets for modulating disease-relevant G-protein-controlled signalling networks(3-5). GEF inhibitors are therefore of interest as tools for elucidating the function of these proteins and for therapeutic intervention; however, only one small molecule GEF inhibitor, brefeldin A (BFA), is currently available(6-9). Here we used an aptamer displacement screen to identify SecinH3, a small molecule antagonist of cytohesins. The cytohesins are a class of BFA-resistant small GEFs for ADP-ribosylation factors (ARFs), which regulate cytoskeletal organization(10), integrin activation(11) or integrin signalling(12). The application of SecinH3 in human liver cells showed that insulin-receptor-complex-associated cytohesins are required for insulin signalling. SecinH3-treated mice show increased expression of gluconeogenic genes, reduced expression of glycolytic, fatty acid and ketone body metabolism genes in the liver, reduced liver glycogen stores, and a compensatory increase in plasma insulin. Thus, cytohesin inhibition results in hepatic insulin resistance. Because insulin resistance is among the earliest pathological changes in type 2 diabetes, our results show the potential of chemical biology for dissecting the molecular pathogenesis of this disease.	Univ Bonn, Kekule Inst Organ Chem & Biochem, LIMES Program Unit Chem Biol & Med Chem, D-53121 Bonn, Germany; Univ Bonn, Lab Mol Immunol, LIMES Program Unit Mol Immune & Cell Biol, D-53115 Bonn, Germany; GSF Forschungszentrum Umwelt & Gesundheit, Inst Mol Immunol, D-81377 Munich, Germany	University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Famulok, M (corresponding author), Univ Bonn, Kekule Inst Organ Chem & Biochem, LIMES Program Unit Chem Biol & Med Chem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	m.famulok@uni-bonn.de	Hafner, Markus/O-7100-2018	Hafner, Markus/0000-0002-4336-6518				Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kruljac-Letunic A, 2003, J BIOL CHEM, V278, P29560, DOI 10.1074/jbc.M302278200; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Malecki MT, 2005, DIABETES RES CLIN PR, V68, pS10, DOI 10.1016/j.diabres.2005.03.003; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mayer G, 2001, P NATL ACAD SCI USA, V98, P4961, DOI 10.1073/pnas.091100698; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Mora A, 2005, BIOCHEM J, V385, P639, DOI 10.1042/BJ20041782; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	30	195	205	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					941	944		10.1038/nature05415	http://dx.doi.org/10.1038/nature05415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167487				2022-12-28	WOS:000242805400059
J	Watters, TR; Leuschen, CJ; Plaut, JJ; Picardi, G; Safaeinili, A; Clifford, SM; Farrell, WM; Ivanov, AB; Phillips, RJ; Stofan, ER				Watters, Thomas R.; Leuschen, Carl J.; Plaut, Jeffrey J.; Picardi, Giovanni; Safaeinili, Ali; Clifford, Stephen M.; Farrell, William M.; Ivanov, Anton B.; Phillips, Roger J.; Stofan, Ellen R.			MARSIS radar sounder evidence of buried basins in the northern lowlands of Mars	NATURE			English	Article							CRUSTAL DICHOTOMY; GIANT IMPACT; MANTLE; ORIGIN	A hemispheric dichotomy on Mars is marked by the sharp contrast between the sparsely cratered northern lowland plains and the heavily cratered southern highlands. Mechanisms proposed to remove ancient crust or form younger lowland crust include one or more giant impacts, subcrustal transport by mantle convection, the generation of thinner crust by plate tectonics, and mantle overturn following solidification of an early magma ocean(1-7). The age of the northern lowland crust is a significant constraint on these models. The Mars Advanced Radar for Subsurface and Ionospheric Sounding (MARSIS) instrument on the European Space Agency's Mars Express spacecraft is providing new constraints on the martian subsurface(8). Here we show evidence of buried impact basins ranging in diameter from about 130 km to 470 km found over 14 per cent of the northern lowlands. The number of detected buried basins >200 km in diameter indicates that the lowland crust is ancient, dating back to the Early Noachian epoch. This crater density is a lower limit because of the likelihood that not all buried basins in the area surveyed by MARSIS have been detected. An Early Noachian age for the lowland crust has been previously suggested on the basis of a large number of quasi-circular topographic depressions interpreted to be evidence of buried basins(9-11). Only a few of these depressions in the area surveyed by MARSIS, however, correlate with the detected subsurface echoes. On the basis of the MARSIS data, we conclude that the northern lowland crust is at least as old as the oldest exposed highland crust. This suggests that the crustal dichotomy formed early in the geologic evolution of Mars.	Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; Univ Kansas, Ctr Remote Sensing Ice Sheets, Lawrence, KS 66045 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Roma La Sapienza, Infocom Dept, I-00184 Rome, Italy; Lunar & Planetary Inst, Houston, TX 77058 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Proxemy Res, Laytonville, MD 20882 USA	Smithsonian Institution; University of Kansas; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Sapienza University Rome; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Washington University (WUSTL)	Watters, TR (corresponding author), Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA.	watterst@si.edu	Farrell, William/I-4865-2013; Ivanov, Anton B/C-8944-2014	Ivanov, Anton B/0000-0001-8376-8581				Elkins-Tanton LT, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002480; FREY H, 1988, GEOPHYS RES LETT, V15, P229, DOI 10.1029/GL015i003p00229; Frey HV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002449; Frey HV, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024484; Frey HV, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013832; Head JW, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001445; Kreslavsky MA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001831; Lenardic A, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002172; MCGILL GE, 1989, J GEOPHYS RES-SOLID, V94, P2753, DOI 10.1029/JB094iB03p02753; MCGILL GE, 1990, J GEOPHYS RES-SOLID, V95, P12595, DOI 10.1029/JB095iB08p12595; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Roberts JH, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002668; SLEEP NH, 1994, J GEOPHYS RES-PLANET, V99, P5639, DOI 10.1029/94JE00216; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; Tanaka KL, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001908; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; WILHELMS DE, 1984, NATURE, V309, P138, DOI 10.1038/309138a0; WISE DU, 1979, ICARUS, V38, P456, DOI 10.1016/0019-1035(79)90200-8; Zhong SJ, 2001, EARTH PLANET SC LETT, V189, P75, DOI 10.1016/S0012-821X(01)00345-4; Zuber MT, 2001, NATURE, V412, P220, DOI 10.1038/35084163	22	41	42	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					905	908		10.1038/nature05356	http://dx.doi.org/10.1038/nature05356			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167480				2022-12-28	WOS:000242805400050
J	Kirschner, MW				Kirschner, Marc W.			Reinhart Heinrich (1946-2006) - Obituary	NATURE			English	Biographical-Item									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	marc@hms.harvard.edu						HEINRICH R, PUBLICATION LIST	1	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2006	444	7120					700	700		10.1038/444700a	http://dx.doi.org/10.1038/444700a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151654	Bronze			2022-12-28	WOS:000242581100041
J	Peel, MC; McMahon, TA				Peel, Murray C.; McMahon, Thomas A.			Continental runoff - A quality-controlled global runoff data set	NATURE			English	Letter							ET-AL		Univ Melbourne, Dept Civil & Environm Engn, Melbourne, Vic 3010, Australia	University of Melbourne	Peel, MC (corresponding author), Univ Melbourne, Dept Civil & Environm Engn, Melbourne, Vic 3010, Australia.	mpeel@unimelb.edu.au	Peel, Murray C/F-4621-2014; McMahon, Thomas/AAD-9845-2020	Peel, Murray C/0000-0002-3255-3692; 				Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Labat D, 2005, ADV WATER RESOUR, V28, P1316, DOI 10.1016/j.advwatres.2005.04.007; Labat D, 2004, ADV WATER RESOUR, V27, P631, DOI 10.1016/j.advwatres.2004.02.020; Legates DR, 2005, ADV WATER RESOUR, V28, P1310, DOI 10.1016/j.advwatres.2005.04.006	4	40	40	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2006	444	7120					E14	E14		10.1038/nature05480	http://dx.doi.org/10.1038/nature05480			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151608	Bronze			2022-12-28	WOS:000242581100046
J	Puhan, MA; Busching, G; Schunemann, HJ; vanOort, E; Zaugg, C; Frey, M				Puhan, Milo A.; Buesching, Gilbert; Schuenemann, Holger J.; vanOort, Evelien; Zaugg, Christian; Frey, Martin			Interval versus continuous high-intensity exercise in chronic obstructive pulmonary disease - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; CHRONIC RESPIRATORY QUESTIONNAIRE; CHRONIC HEART-FAILURE; AIR-FLOW OBSTRUCTION; CLINICAL-TRIAL; EQUIVALENCE TRIALS; COPD PATIENTS; REHABILITATION; EXACERBATION; READMISSION	Background: Guidelines recommend high-intensity continuous exercise to reduce peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease but acknowledge that interval exercise might be an equally effective alternative that is better tolerated by patients. Objective: To assess whether interval exercise is no less effective than high-intensity continuous exercise and whether it is tolerated better by patients with severe chronic obstructive pulmonary disease. Design: Randomized, noninferiority trial. Setting: Publicly funded rehabilitation hospital in Switzerland. Patients: 98 patients with severe chronic obstructive pulmonary disease, with or without recent exacerbations. Intervention: 12 to 15 supervised interval or high-intensity continuous exercise sessions (over 3 weeks) followed by exercise at home. Measurements: Health-related quality of life determined by using the Chronic Respiratory Questionnaire (CRQ) (scores from 1 [most severe impairment] to 7 [no impairment]) after 5 weeks and number of unintended breaks during supervised exercise. Results: Both groups experienced large improvements in health-related quality of life (increase of CRQ total scores of 1.00 [SD, 0.98] for the interval exercise group and 1.02 [SD, 1.05] for the continuous exercise group). Adjusted between-group differences between the interval exercise group and the continuous exercise group (-0.05 [95% CI, -0.42 to -0.32] for CRQ and 1.1 meters [CI, -25.4 to 27.6 meters] for 6-minute walking distance) were within the a priori defined boundaries of noninferiority (0.5 for CRQ and 45 meters for 6-minute walking distance). Twenty-one (47.9%) patients using interval exercise and 11 (24.0%) patients using continuous exercise were able to adhere to the protocol (difference, 23.9 percentage points [CI, 5.0 to 42.8 percentage points]; P = 0.014). The median number of unintended breaks lasting 1 minute or more was 2 (interquartile range, 0 to 16) for patients in the interval exercise group and 11 interquartile range, 2 to 26) for patients in the continuous exercise group (P = 0.023). Limitations: The study focused on initiation of exercise and not on outpatient or home-based maintenance of exercise. Conclusions: Clinicians and patients can choose either of the 2 exercise plans to initiate physical exercise.	Univ Zurich, Zurich, Switzerland; Klin Barmelweid, Barmelweid, Switzerland; McMaster Univ, Hamilton, ON, Canada; Univ Buffalo, Buffalo, NY USA; Italian Natl Canc Inst Regina Elena, Rome, Italy; Univ Basel, Basel, Switzerland	University of Zurich; McMaster University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Basel	Puhan, MA (corresponding author), Univ Zurich Hosp, Horten Ctr, Postfach Nord, CH-8091 Zurich, Switzerland.	milo.puhan@usz.ch	Puhan, Milo/ABE-6298-2020	Puhan, Milo/0000-0003-4721-1879; Schunemann, Holger/0000-0003-3211-8479				*AM THOR SOC EUR R, 2004, MAN STAB COPD PULM R; American Thoracic Society, 1999, AM J RESP CRIT CARE, V159, P1666; BENNETT KJ, 1996, QUALITY LIFE PHARMAC, P253; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cambach W, 1997, EUR RESPIR J, V10, P104, DOI 10.1183/09031936.97.10010104; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Coppoolse R, 1999, EUR RESPIR J, V14, P258, DOI 10.1034/j.1399-3003.1999.14b04.x; Cote CG, 2005, EUR RESPIR J, V26, P630, DOI 10.1183/09031936.05.00045505; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Decramer M, 1997, EUR RESPIR J, V10, P417, DOI 10.1183/09031936.97.10020417; Fleming TR, 2000, AM HEART J, V139, pS171, DOI 10.1016/S0002-8703(00)90067-X; Garcia-Aymerich J, 2003, THORAX, V58, P100, DOI 10.1136/thorax.58.2.100; GOTZSCHE PC, 1996, BMJ-BRIT MED J, V313, P36; Greene WL, 2000, ANN INTERN MED, V132, P715, DOI 10.7326/0003-4819-132-9-200005020-00006; Griffiths TL, 2000, LANCET, V355, P362, DOI 10.1016/S0140-6736(99)07042-7; Hinz A, 2001, PSYCHOTHER PSYCH MED, V51, P193, DOI 10.1055/s-2001-13279; KAELIN ME, 1999, AM SOC EX PHYS 2 ANN; Lacasse Y, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003793.PUB2; Maltais F, 1997, AM J RESP CRIT CARE, V155, P555, DOI 10.1164/ajrccm.155.2.9032194; McAlister FA, 2001, AM J MED, V111, P553, DOI 10.1016/S0002-9343(01)00900-7; Meyer K, 1996, EUR HEART J, V17, P1040; Meyer K, 1997, MED SCI SPORT EXER, V29, P306, DOI 10.1097/00005768-199703000-00004; Moody A, 2004, THORAX, V59, P1; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Puhan MA, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-54; Puhan MA, 2005, THORAX, V60, P367, DOI 10.1136/thx.2004.033274; Puhan MA, 2004, RESP MED, V98, P1195, DOI 10.1016/j.rmed.2004.04.011; Puhan MA, 2004, RESP MED, V98, P342, DOI 10.1016/j.rmed.2003.10.013; Puhan Milo A, 2004, BMC Pulm Med, V4, P5, DOI 10.1186/1471-2466-4-5; Puhan Milo A, 2004, Health Qual Life Outcomes, V2, P1; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278, DOI 10.1164/ajrccm.155.4.9105067; Sabapathy S, 2004, THORAX, V59, P1026, DOI 10.1136/thx.2004.026617; Schunemann H, 2004, THORAX, V59, P81; Schunemann HJ, 2005, EUR RESPIR J, V25, P31, DOI 10.1183/09031936.04.00029704; Schunemann HJ, 2003, J CLIN EPIDEMIOL, V56, P1170, DOI 10.1016/S0895-4356(03)00115-X; Schunemann HJ, 2003, MED DECIS MAKING, V23, P140, DOI 10.1177/0272989X03251243; Troosters T, 2001, J Cardiopulm Rehabil, V21, P10, DOI 10.1097/00008483-200101000-00004; Troosters T, 2000, AM J MED, V109, P207, DOI 10.1016/S0002-9343(00)00472-1; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Vogiatzis I, 2002, EUR RESPIR J, V20, P12, DOI 10.1183/09031936.02.01152001; WIJKSTRA PJ, 1994, EUR RESPIR J, V7, P269, DOI 10.1183/09031936.94.07020269	43	86	97	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2006	145	11					816	825		10.7326/0003-4819-145-11-200612050-00006	http://dx.doi.org/10.7326/0003-4819-145-11-200612050-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114PE	17146066				2022-12-28	WOS:000242677300003
J	Belfort, R; Harrison, SA; Brown, K; Darland, C; Finch, J; Hardies, J; Balas, B; Gastaldelli, A; Tio, F; Pulcini, J; Berria, R; Ma, JZ; Dwivedi, S; Havranek, R; Fincke, C; DeFronzo, R; Bannayan, GA; Schenker, S; Cusi, K				Belfort, Renata; Harrison, Stephen A.; Brown, Kenneth; Darland, Celia; Finch, Joan; Hardies, Jean; Balas, Bogdan; Gastaldelli, Amalia; Tio, Fermin; Pulcini, Joseph; Berria, Rachele; Ma, Jennie Z.; Dwivedi, Sunil; Havranek, Russell; Fincke, Chris; DeFronzo, Ralph; Bannayan, George A.; Schenker, Steven; Cusi, Kenneth			A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FATTY LIVER-DISEASE; HEPATIC INSULIN-RESISTANCE; ACTIVATED PROTEIN-KINASE; TYPE-2 DIABETIC-PATIENTS; WEIGHT-LOSS; PLASMA ADIPONECTIN; ADIPOSE-TISSUE; OBESE SUBJECTS; RAT-LIVER; VITAMIN-E	BACKGROUND: No pharmacologic therapy has conclusively proved to be effective for the treatment of nonalcoholic steatohepatitis, which is characterized by insulin resistance, steatosis, and necroinflammation with or without centrilobular fibrosis. Pioglitazone is a thiazolidinedione that ameliorates insulin resistance and improves glucose and lipid metabolism in type 2 diabetes mellitus. METHODS: We randomly assigned 55 patients with impaired glucose tolerance or type 2 diabetes and liver biopsy-confirmed nonalcoholic steatohepatitis to 6 months of treatment with a hypocaloric diet (a reduction of 500 kcal per day in relation to the calculated daily intake required to maintain body weight) plus pioglitazone (45 mg daily) or a hypocaloric diet plus placebo. Before and after treatment, we assessed hepatic histologic features, hepatic fat content by means of magnetic resonance spectroscopy, and glucose turnover during an oral glucose tolerance test ([(C-14]glucose given with the oral glucose load and [H-3]glucose given by intravenous infusion). RESULTS: Diet plus pioglitazone, as compared with diet plus placebo, improved glycemic control and glucose tolerance (P<0.001), normalized liver aminotransferase levels as it decreased plasma aspartate aminotransferase levels (by 40% vs. 21%, P=0.04), decreased alanine aminotransferase levels (by 58% vs. 34%, P<0.001), decreased hepatic fat content (by 54% vs. 0%, P<0.001), and increased hepatic insulin sensitivity (by 48% vs. 14%, P=0.008). Administration of pioglitazone, as compared with placebo, was associated with improvement in histologic findings with regard to steatosis (P=0.003), ballooning necrosis (P=0.02), and inflammation (P=0.008). Subjects in the pioglitazone group had a greater reduction in necroinflammation (85% vs. 38%, P=0.001), but the reduction in fibrosis did not differ significantly from that in the placebo group (P=0.08). Fatigue and mild lower-extremity edema developed in one subject who received pioglitazone; no other adverse events were observed. CONCLUSIONS: In this proof-of-concept study, the administration of pioglitazone led to metabolic and histologic improvement in subjects with nonalcoholic steatohepatitis. Larger controlled trials of longer duration are warranted to assess the long-term clinical benefit of pioglitazone.	Univ Texas, Hlth Sci Ctr, Diabet Div, San Antonio, TX 78229 USA; Brooke Army Med Ctr, San Antonio, TX USA; S Texas Vet Hlth Care Syst, Audie L Murphy Div, San Antonio, TX USA; CNR, Inst Clin Physiol, Pisa, Italy	University of Texas System; University of Texas Health San Antonio; San Antonio Military Medical Center; United States Department of Defense; United States Army; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Cusi, K (corresponding author), Univ Texas, Hlth Sci Ctr, Diabet Div, Rm 3-3805,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	cusi@uthscsa.edu	Gastaldelli, Amalia/H-3319-2014	Gastaldelli, Amalia/0000-0003-2594-1651	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001346] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR-01346] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abbasi F, 2006, AM J PHYSIOL-REG I, V290, pR139, DOI 10.1152/ajpregu.00287.2005; Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Adams LA, 2004, AM J GASTROENTEROL, V99, P2365, DOI 10.1111/j.1572-0241.2004.40064.x; ANDERSEN T, 1991, J HEPATOL, V12, P224, DOI 10.1016/0168-8278(91)90942-5; Anderwald C, 2002, DIABETES, V51, P3025, DOI 10.2337/diabetes.51.10.3025; Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P200, DOI 10.1210/jc.2003-031315; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Bugianesi E, 2005, AM J GASTROENTEROL, V100, P1082, DOI 10.1111/j.1572-0241.2005.41583.x; Caldwell SH, 2001, AM J GASTROENTEROL, V96, P519; FERRANNINI E, 1988, METABOLISM, V37, P79, DOI 10.1016/0026-0495(88)90033-9; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Harrison SA, 2004, ALIMENT PHARM THERAP, V20, P623, DOI 10.1111/j.1365-2036.2004.02153.x; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1111/j.1572-0241.2003.08699.x; Hickman IJ, 2004, GUT, V53, P413, DOI 10.1136/gut.2003.027581; Kaser S, 2005, GUT, V54, P117, DOI 10.1136/gut.2003.037010; Kawaguchi K, 2004, BIOCHEM BIOPH RES CO, V315, P187, DOI 10.1016/J.BBRC.2004.01.038; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lindor KD, 2004, HEPATOLOGY, V39, P770, DOI 10.1002/hep.20092; Luyckx FH, 1998, INT J OBESITY, V22, P222, DOI 10.1038/sj.ijo.0800571; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Merat S, 2003, J CLIN GASTROENTEROL, V36, P266, DOI 10.1097/00004836-200303000-00015; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V38, P1008, DOI 10.1053/jhep.2003.50420; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Promrat K, 2004, HEPATOLOGY, V39, P188, DOI 10.1002/hep.20012; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sanyal AJ, 2004, CLIN GASTROENTEROL H, V2, P1107, DOI 10.1016/S1542-3565(04)00457-4; Tiikkainen M, 2004, DIABETES, V53, P2169, DOI 10.2337/diabetes.53.8.2169; Wang RT, 2003, AM J MED, V115, P554, DOI 10.1016/S0002-9343(03)00449-2; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	38	1233	1288	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2297	2307		10.1056/NEJMoa060326	http://dx.doi.org/10.1056/NEJMoa060326			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110CG	17135584				2022-12-28	WOS:000242355300005
J	Willis, KJ; Birks, HJB				Willis, K. J.; Birks, H. J. B.			What is natural? The need for a long-term perspective in biodiversity conservation	SCIENCE			English	Review							CLIMATE-CHANGE; POLLEN ANALYSIS; FIRE; VARIABILITY; ECOLOGY; FOREST; COLONIZATION; EXTINCTION; MANAGEMENT; EVOLUTION	Ecosystems change in response to factors such as climate variability, invasions, and wildfires. Most records used to assess such change are based on short-term ecological data or satellite imagery spanning only a few decades. In many instances it is impossible to disentangle natural variability from other, potentially significant trends in these records, partly because of their short time scale. We summarize recent studies that show how paleoecological records can be used to provide a longer temporal perspective to address specific conservation issues relating to biological invasions, wildfires, climate change, and determination of natural variability. The use of such records can reduce much of the uncertainty surrounding the question of what is "natural" and thereby start to provide important guidance for long-term management and conservation.	Univ Oxford, Ctr Environm, Long Term Ecol Lab, Oxford OX1 3QY, England; Univ Bergen, Dept Biol, Ecol & Environm Change Res Grp, N-5007 Bergen, Norway; Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; UCL, Environm Change Res Ctr, London WC1E 6BT, England	University of Oxford; University of Bergen; Bjerknes Centre for Climate Research; University of Bergen; University of London; University College London	Willis, KJ (corresponding author), Univ Oxford, Ctr Environm, Long Term Ecol Lab, South Parks Rd, Oxford OX1 3QY, England.	kathy.willis@ouce.ox.ac.uk	Birks, John B/C-3103-2008	Birks, John B/0000-0002-5891-9859; Willis, Katherine/0000-0002-6763-2489	Natural Environment Research Council [NE/C510667/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Birks HJB, 2005, GRANA, V44, P1, DOI 10.1080/00173130510010477; Birks HJB, 1996, J VEG SCI, V7, P89, DOI 10.2307/3236420; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bradshaw RHW, 2005, ECOLOGY, V86, P1679, DOI 10.1890/03-0785; Brown KJ, 2005, P NATL ACAD SCI USA, V102, P8865, DOI 10.1073/pnas.0503621102; Callicott JB, 2002, J BIOSCIENCES, V27, P409, DOI 10.1007/BF02704969; Clapham A. R., 1952, FLORA BRIT ISLES; Clark JS, 2001, ECOLOGY, V82, P620; Clark JS, 1996, ECOLOGY, V77, P2148, DOI 10.2307/2265709; Douglas ME, 2006, MOL ECOL, V15, P3353, DOI 10.1111/j.1365-294X.2006.03007.x; DUNN S.T., 1905, ALIEN FLORA BRITAIN; DURIEZ O, IN PRESS CONSERV GEN; *FAUNMAP WORK GROU, 1994, 25 FAUNMAP WORK GROU; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Fule PZ, 1997, ECOL APPL, V7, P895, DOI 10.1890/1051-0761(1997)007[0895:DRCFEM]2.0.CO;2; Gillson L, 2004, ECOL LETT, V7, P990, DOI 10.1111/j.1461-0248.2004.00658.x; GILLSON L, IN PRESS PHILOS T B; Graumlich LJ, 2005, ECOLOGY, V86, P1667, DOI 10.1890/03-0783; Gray ST, 2006, ECOLOGY, V87, P1124, DOI 10.1890/0012-9658(2006)87[1124:ROMCVI]2.0.CO;2; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hannah L, 2002, CONSERV BIOL, V16, P264, DOI 10.1046/j.1523-1739.2002.00465.x; Hannah L, 2002, GLOBAL ECOL BIOGEOGR, V11, P485, DOI 10.1046/j.1466-822X.2002.00306.x; Henderson S, 2006, PROG PHYS GEOG, V30, P25, DOI 10.1191/0309133306pp468ra; Jablonski D, 2004, NATURE, V427, P589, DOI 10.1038/427589a; Jackson ST, 1997, ASSESSMENT MANAGEMEN, P37; Johnson VS, 2006, FOREST ECOL MANAG, V228, P124, DOI 10.1016/j.foreco.2006.02.033; Kowalewski M, 2000, GEOLOGY, V28, P1059, DOI 10.1130/0091-7613(2000)28<1059:DDFPTT>2.0.CO;2; Landres PB, 1999, ECOL APPL, V9, P1179, DOI 10.2307/2641389; Lindbladh M, 2003, BIOL CONSERV, V114, P231, DOI 10.1016/S0006-3207(03)00043-0; Lyford ME, 2003, ECOL MONOGR, V73, P567, DOI 10.1890/03-4011; Lynch EA, 2002, WETLANDS, V22, P637, DOI 10.1672/0277-5212(2002)022[0637:PAGAPE]2.0.CO;2; Lynch JA, 2004, J ECOL, V92, P477, DOI 10.1111/j.0022-0477.2004.00879.x; MACDONALD GM, 1993, ADV ECOL RES, V24, P67, DOI 10.1016/S0065-2504(08)60041-0; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Maxwell AL, 2004, J BIOGEOGR, V31, P225, DOI 10.1046/j.0305-0270.2003.01015.x; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; Millar CI, 1999, ECOL APPL, V9, P1207, DOI 10.1890/1051-0761(1999)009[1207:TROCCI]2.0.CO;2; NRC, 2005, GEOL REC EC DYN UND; Preston CD, 2004, BOT J LINN SOC, V145, P257, DOI 10.1111/j.1095-8339.2004.00284.x; Reid MA, 2006, RIVER RES APPL, V22, P167, DOI 10.1002/rra.903; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Smol J. P., 2002, POLLUTION LAKES RIVE; Stace C.A., 1991, NEW FLORA BRIT ISLES; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tzedakis PC, 2002, SCIENCE, V297, P2044, DOI 10.1126/science.1073083; van Leeuwen JFN, 2005, NEOBIOTA, P27; Von Holle B, 2003, J VEG SCI, V14, P425, DOI 10.1111/j.1654-1103.2003.tb02168.x; Whitlock C, 2004, NATURE, V432, P28, DOI 10.1038/432028a; Willis K. J., 2002, EVOLUTION PLANTS; Willis KJ, 2005, TRENDS ECOL EVOL, V20, P107, DOI 10.1016/j.tree.2004.12.003	56	457	476	9	262	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1261	1265		10.1126/science.1122667	http://dx.doi.org/10.1126/science.1122667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124315	Green Submitted, Green Accepted			2022-12-28	WOS:000242215800032
J	Perel, P; Roberts, I; Sena, E; Wheble, P; Briscoe, C; Sandercock, P; Macleod, M; Mignini, LE; Jayaram, P; Khan, KS				Perel, Pablo; Roberts, Ian; Sena, Emily; Wheble, Philipa; Briscoe, Catherine; Sandercock, Peter; Macleod, Malcolm; Mignini, Luciano E.; Jayaram, Pradeep; Khan, Khalid S.			Comparison of treatment effects between animal experiments and clinical trials: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							METAANALYSIS	Objective To examine concordance between treatment effects in animal experiments and clinical trials. Study design Systematic review. Data sources Medline, Embase, SIGLE, NTIS, Science Citation Index, CAB, BIOSIS. Study selection Animal studies for interventions with unambiguous evidence of a treatment effect (benefit or harm) in clinical. trials: head injury, antifibrinolytics in haemorrhage, thrombolysis in acute ischaemic stroke, tirilazad in acute ischaemic stroke, antenatal corticosteroids to prevent neonatal respiratory distress syndrome, and bisphosphonates in the prevention and treatment of osteoporosis. Review methods Data were extracted on study design, allocation concealment, number of randomised animals, type of model, intervention, and outcome. Results Corticosteroids did not show any benefit in clinical trials of treatment for head injury but did show a benefit in animal models (pooled odds ratio for adverse functional outcome 0.58, 95% confidence interval 0.41 to 0.83). Antifibrinolytics reduced bleeding in clinical trials but the data were inconclusive in animal models. Thrombolysis improved outcome in patients with ischaemic stroke. In animal models, tissue plasminogen activator reduced infarct volume by 24% (95% confidence interval 20% to 28%) and improved neurobehavioural scores by 23% (17% to 29%). Tirilazad was associated with a worse outcome in patients with ischaemic stroke. In animal models, tirilazad reduced infarct volume by 29% (21% to 37%) and improved neurobehavioural scores by 48% (29% to 67%). Antenatal corticosteroids reduced respiratory distress and mortality in neonates whereas in animal models respiratory distress was reduced but the effect on mortality was inconclusive (odds ratio 4.2, 95% confidence interval 0.85 to 20.9). Bisphosphonates increased bone mineral density in patients with osteoporosis. In animal models the bisphosphonate alendronate increased bone mineral density compared with placebo by 11.0% (95% confidence interval 9.2% to 12.9%) in the combined results for the hip region. The corresponding treatment effect in the lumbar spine was 8.5% (5.8% to 11.2%) and in the combined results for the forearms (baboons only) was 1.7% (-1.4% to 4.7%). Conclusions Discordance between animal and human studies may be due to bias or to the failure of animal models to mimic clinical disease adequately.	Univ London London Sch Hyg & Trop Med, Crash Trials Coordinating Ctr, London WC1E 7HT, England; Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; WHO, Ctr Rosarino Estudios Perinatales, Collaborat Ctr Maternal & Child Hlth, RA-2000 Rosario, Santa Fe, Argentina; Univ Birmingham, Birmingham Womens Hosp, Div Reprod & Child Hlth, Birmingham B15 2TT, W Midlands, England	University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh; World Health Organization; Birmingham Women's Hospital; University of Birmingham	Perel, P (corresponding author), Univ London London Sch Hyg & Trop Med, Crash Trials Coordinating Ctr, Keppel St, London WC1E 7HT, England.	pablo.perel@lshtm.ac.uk	Khan, Khalid S/AAT-8824-2020; Macleod, Malcolm Robert/B-2052-2010; Jayaram, Pradeep/AAC-3466-2020	Khan, Khalid S/0000-0001-5084-7312; Macleod, Malcolm Robert/0000-0001-9187-9839; /0000-0002-2342-301X; Sena, Emily S/0000-0002-3282-8502; Wheble, Philippa/0000-0003-1860-1106				Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cranney A, 2002, ENDOCR REV, V23, P508, DOI 10.1210/er.2001-2002; Croce P., 1999, VIVISECTION SCI INVE; Edwards P, 2005, LANCET, V365, P1957; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Hacke W, 2004, LANCET, V363, P768; HENRY DA, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001886; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; MIELKE O, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000514.PUB2; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Pound P, 2002, BRIT MED J, V325, P1038; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Roberts I, 2002, BRIT MED J, V324, P474, DOI 10.1136/bmj.324.7335.474; Sibbald WJ, 2000, CRIT CARE, V4, pS8, DOI 10.1186/cc970; *TIR INT STEER COM, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002087	19	508	521	2	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2007	334	7586					197	200		10.1136/bmj.39048.407928.BE	http://dx.doi.org/10.1136/bmj.39048.407928.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17175568	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000244027600036
J	Gompert, Z; Fordyce, JA; Forister, ML; Shapiro, AM; Nice, CC				Gompert, Zachariah; Fordyce, James A.; Forister, Matthew L.; Shapiro, Arthur M.; Nice, Chris C.			Homoploid hybrid speciation in an extreme habitat	SCIENCE			English	Article							HYBRIDIZATION; DIVERSIFICATION; BUTTERFLIES; LYCAENIDAE; LYCAEIDES; ORIGINS	According to theory, homoploid hybrid speciation, which is hybrid speciation without a change in chromosome number, is facilitated by adaptation to a novel or extreme habitat. Using molecular and ecological data, we found that the alpine-adapted butterflies in the genus Lycaeides are the product of hybrid speciation. The alpine populations possess a mosaic genome derived from both L. melissa and L. idas and are differentiated from and younger than their putative parental species. As predicted, adaptive traits may allow for persistence in the environmentally extreme alpine habitat and reproductively isolate these populations from their parental species.	Texas State Univ, Dept Biol, Populat & Conservat Biol Program, San Marcos, TX 78666 USA; Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89512 USA; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA	Texas State University System; Texas State University San Marcos; University of Tennessee System; University of Tennessee Knoxville; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California Davis	Nice, CC (corresponding author), Texas State Univ, Dept Biol, Populat & Conservat Biol Program, San Marcos, TX 78666 USA.	ccnice@txstate.edu		Gompert, Zachariah/0000-0003-2248-2488; Fordyce, James/0000-0002-2731-0418				Anderson EC, 2002, GENETICS, V160, P1217; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Coyne J.A., 2004, SPECIATION; DEMARAIS BD, 1992, COPEIA, P697; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Fordyce JA, 2003, ECOL LETT, V6, P23, DOI 10.1046/j.1461-0248.2003.00389.x; Fordyce JA, 2002, J EVOLUTION BIOL, V15, P871, DOI 10.1046/j.1420-9101.2002.00432.x; Forister ML, 2006, ANN ENTOMOL SOC AM, V99, P933, DOI 10.1603/0013-8746(2006)99[933:EMVAPA]2.0.CO;2; GRANT V, 1981, PLANT SPECIATION; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Lomolino M. V., 2006, BIOGEOGRAPHY; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Nabokov V., 1949, Bulletin of the Museum of Comparative Zoology Harvard, V101, P479; Nice CC, 2005, MOL ECOL, V14, P1741, DOI 10.1111/j.1365-294X.2005.02527.x; Nice CC, 2002, ECOL ENTOMOL, V27, P702, DOI 10.1046/j.1365-2311.2002.00458.x; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Schelly R, 2006, MOL PHYLOGENET EVOL, V38, P426, DOI 10.1016/j.ympev.2005.04.023; Schwarz D, 2005, NATURE, V436, P546, DOI 10.1038/nature03800; Scott J. A., 1986, BUTTERFLIES N AM NAT; Scriber JM, 2005, ENTOMOL EXP APPL, V115, P247, DOI 10.1111/j.1570-7458.2005.00285.x; STANFORD RE, 1996, ATLAS W US BUTTERFLI	24	227	234	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1923	1925		10.1126/science.1135875	http://dx.doi.org/10.1126/science.1135875			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17138866				2022-12-28	WOS:000242996800047
J	Cha, JHJ; Furie, K; Kay, J; Walensky, RP; Mullins, ME; Hedley-Whyte, ET; Chou, S				Cha, Jang-Ho J.; Furie, Karen; Kay, Jonathan; Walensky, Rochelle P.; Mullins, Mark E.; Hedley-Whyte, E. Tessa; Chou, Sherry			Case 39-2006: A 24-year-old woman with systemic lupus erythematosus, seizures, and right arm weakness - Granulomatous amebic encephalitis due to acanthamoeba species	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CENTRAL-NERVOUS-SYSTEM; CLINICAL SYNDROMES; PATIENT; INFECTIONS; NEUROCYSTICERCOSIS; TOXOPLASMOSIS; ANTIBODIES; DISEASE		Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Rheumatol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med & Infect Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Cha, JHJ (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Kay, Jonathan/HGE-1248-2022; Hedley-Whyte, E Tessa/AAJ-9975-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905; Walensky, Rochelle P./0000-0002-8795-379X; Kay, Jonathan/0000-0002-8970-4260				Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; ALFETRA A, 2003, NEUROLOGY, V61, P108; Bloch KC, 2005, J CLIN MICROBIOL, V43, P3003, DOI 10.1128/JCM.43.6.3003-3006.2005; BOONTON GC, 2005, J CLIN MICROBIOL, V43, P1689; Deetz TR, 2003, CLIN INFECT DIS, V37, P1304, DOI 10.1086/379020; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; DUBIN HV, 1971, ARCH DERMATOL, V104, P547, DOI 10.1001/archderm.104.5.547; Ehlers S, 2005, J RHEUMATOL, V32, P35; GRUNNET ML, 1981, NEUROLOGY, V31, P174, DOI 10.1212/WNL.31.2.174; Hanly JG, 1997, ANN NY ACAD SCI, V823, P60, DOI 10.1111/j.1749-6632.1997.tb48379.x; Hanly JG, 1997, ARTHRITIS RHEUM, V40, P1542, DOI 10.1002/art.1780400825; HELLMANN DB, 1987, MEDICINE, V66, P341, DOI 10.1097/00005792-198709000-00002; Huang ZH, 1999, J INFECT DIS, V179, P1305, DOI 10.1086/314731; Hung JJ, 2005, J RHEUMATOL, V32, P40; Iliopoulos AG, 1996, SEMIN ARTHRITIS RHEU, V25, P318, DOI 10.1016/S0049-0172(96)80018-7; Jennekens FGI, 2002, RHEUMATOLOGY, V41, P605, DOI 10.1093/rheumatology/41.6.605; Jennekens FGI, 2002, RHEUMATOLOGY, V41, P619, DOI 10.1093/rheumatology/41.6.619; Jonsen A, 2002, RHEUMATOLOGY, V41, P1308, DOI 10.1093/rheumatology/41.11.1308; Koide J, 1998, CLIN RHEUMATOL, V17, P329, DOI 10.1007/BF01451015; Lee BY, 2004, CLIN NUCL MED, V29, P620, DOI 10.1097/00003072-200410000-00004; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; *MASS GEN HOSP, 1993, NEW ENGL J MED, V328, P566; *MASS GEN HOSP, 2006, NEW ENGL J MED, V354, P1178; Nash TE, 2004, NEUROLOGY, V62, P1934, DOI 10.1212/01.WNL.0000129481.12067.06; Petri M, 1998, RHEUM DIS CLIN N AM, V24, P423, DOI 10.1016/S0889-857X(05)70016-8; Petri Michelle, 1994, Current Opinion in Rheumatology, V6, P481, DOI 10.1097/00002281-199409000-00005; Pisani F, 2003, J NEUROL NEUROSUR PS, V74, P1445, DOI 10.1136/jnnp.74.10.1445-a; RUBIN LA, 1985, Q J MED, V55, P87; Senecal JL, 2004, J RHEUMATOL, V31, P2093; Shirwadkar CG, 2006, EMERG INFECT DIS, V12, P984, DOI 10.3201/eid1206.060087; STAHL NI, 1979, AM J MED, V67, P935, DOI 10.1016/0002-9343(79)90633-8; Uschuplich Vedran, 2004, Arch Pathol Lab Med, V128, pe109; Wallin MT, 2004, NEUROLOGY, V63, P1559, DOI 10.1212/01.WNL.0000142979.98182.FF; WILCOX MH, 1990, ANN RHEUM DIS, V49, P254, DOI 10.1136/ard.49.4.254	35	16	18	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2678	2689		10.1056/NEJMcpc069030	http://dx.doi.org/10.1056/NEJMcpc069030			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182994				2022-12-28	WOS:000242956200011
J	Wong, YN; Mitra, N; Hudes, G; Localio, R; Schwartz, JS; Wan, F; Montagnet, C; Armstrong, K				Wong, Yu-Ning; Mitra, Nandita; Hudes, Gary; Localio, Russell; Schwartz, J. Sanford; Wan, Fei; Montagnet, Chantal; Armstrong, Katrina			Survival associated with treatment vs observation of localized prostate cancer in elderly men (Reprinted from JAMA, vol 296, 2006)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPARING RADICAL PROSTATECTOMY; QUALITY-OF-LIFE; CONSERVATIVE MANAGEMENT; OUTCOMES; COMORBIDITY; POPULATION; BIAS; SUBCLASSIFICATION; INTERVENTION; CARCINOMA	Context Prostate-specific antigen screening has led to an increase in the diagnosis and treatment of localized prostate cancer. However, the role of active treatment of low- and intermediate-risk disease in elderly men is controversial. Objective To estimate the association between treatment ( with radiation therapy or radical prostatectomy) compared with observation and overall survival in men with low- and intermediate-risk prostate cancer. Design and Setting Observational US cohort from Surveillance, Epidemiology, and End Results Medicare data. Patients At total of 44 630 men aged 65 to 80 years who were diagnosed between 1991 and 1999 with organ-confined, well-or moderately differentiated prostate cancer and who had survived more than a year past diagnosis. Patients were followed up until death or study end ( December 31, 2002). Patients were classified as having received treatment ( n= 32 022) if they had claims for radical prostatectomy or radiation therapy during the first 6 months after diagnosis. They were classified as having received observation ( n= 12 608) if they did not have claims for radical prostatectomy, radiation, or hormonal therapy. Patients who received only hormonal therapy were excluded. Main Outcome Measure Overall survival. Results At the end of the 12-year study period, 4663 men ( 37%) in the observational group and 7639 men ( 23.8%) in the treatment group had died. The treatment group had longer 5- and 10-year survival than the observation group. After using propensity scores to adjust for potential confounders ( tumor characteristics, demographics, and comorbidities), there was a statistically significant survival advantage associated with treatment ( hazard ratio, 0.69; 95% confidence interval, 0.66-0.72). A benefit associated with treatment was seen in all subgroups examined, including older men ( aged 75-80 years at diagnosis), black men, and men with low- risk disease. Conclusions This study suggests a survival advantage is associated with active treatment for low- and intermediate-risk prostate cancer in elderly men aged 65 to 80 years. Because observational data cannot completely adjust for potential selection bias and confounding, these results must be validated in randomized controlled trials of alternative management strategies in elderly men with localized prostate cancer.	Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA; Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA; Univ Penn, Dept Biostat & Epidemiol, Div Gen Internal Med, Philadelphia, PA 19104 USA; Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Wong, YN (corresponding author), Fox Chase Canc Ctr, Div Populat Sci, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Y_Wong@fccc.edu			NATIONAL CANCER INSTITUTE [R25CA057708, P50CA105641] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K30RR022255] Funding Source: NIH RePORTER; NCI NIH HHS [P50-CA105641, R25 CA057708] Funding Source: Medline; NCRR NIH HHS [K30 RR022255] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975; Alibhai SMH, 2005, JNCI-J NATL CANCER I, V97, P1525, DOI 10.1093/jnci/dji313; Beissner RS, 2002, UROLOGY, V59, P721, DOI 10.1016/S0090-4295(02)01531-5; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; BRIGANTI A, 2006, EUR UROL, V175, P721; Chang KP, 2004, J BONE MINER RES, V19, P532, DOI 10.1359/JBMR.040109; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; Chodak GW, 2002, UROLOGY, V60, P201, DOI 10.1016/S0090-4295(02)01677-1; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; Donovan J, 2003, Health Technol Assess, V7, P1; Etzioni R, 2002, J NATL CANCER I, V94, P981; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Harlan SR, 2003, J UROLOGY, V170, P1804, DOI 10.1097/01.ju.0000091641.34674.11; Hoffman RM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-27; Hoffman RM, 2003, CANCER, V97, P1653, DOI 10.1002/cncr.11233; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Houterman S, 2006, CRIT REV ONCOL HEMAT, V58, P60, DOI 10.1016/j.critrevonc.2005.08.003; Kim-Sing C, 2004, INT J RADIAT ONCOL, V60, P463, DOI 10.1016/j.ijrobp.2004.03.004; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; LuYao GL, 1997, LANCET, V349, P906, DOI 10.1016/S0140-6736(96)09380-4; MITRA N, 2005, U PENNSYLVANIA BIOST; *NAT COMPR CANC NE, 2006, PROST CANC CLIN PRAC; Potosky AL, 1999, JNCI-J NATL CANCER I, V91, P1719, DOI 10.1093/jnci/91.20.1719; Potters L, 2005, J UROLOGY, V173, P1562, DOI 10.1097/01.ju.0000154633.73092.8e; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Silber JH, 2001, MED CARE, V39, P1048, DOI 10.1097/00005650-200110000-00003; Spillman BC, 2004, MILBANK Q, V82, P157, DOI 10.1111/j.0887-378X.2004.00305.x; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; WILT TJ, 1994, J UROLOGY, V152, P1910, DOI 10.1016/S0022-5347(17)32413-8; WONG YN, 2006, 4A7A, V296	36	225	226	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2683	2693		10.1001/jama.296.22.2683	http://dx.doi.org/10.1001/jama.296.22.2683			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164454	Bronze			2022-12-28	WOS:000242765700023
J	Fried, M; Farthing, M; Krabshuis, J; Quigley, E				Fried, Michael; Farthing, Michael; Krabshuis, Justus; Quigley, Eamonn		WGO-OMGE Global Guidelines Task Fo	Global guidelines: is gastroenterology leading the way?	LANCET			English	Editorial Material							AMERICAN-COLLEGE		Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; Univ London St Georges Hosp, London, England; Highland Data, Tourtoirac, France; Univ Hosp Cork, Dept Gastroenterol, Cork, Ireland	University of Zurich; University Zurich Hospital; St Georges University London; University College Cork	Fried, M (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	michael.fried@usz.ch						Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; HORTON R, 2005, S WCOG 2005 MONTR CA; Irwin RS, 2006, LANCET, V367, P981, DOI 10.1016/S0140-6736(06)68414-6; *WGO OMGE SPEC IN, 2005, OMGE GLOB GUID S WCO; 2006, LANCET, V367, P276	6	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 9	2006	368	9552					2041	2042		10.1016/S0140-6736(06)69819-X	http://dx.doi.org/10.1016/S0140-6736(06)69819-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114JY	17161716				2022-12-28	WOS:000242663700007
J	Hoofnagle, JH; Seeff, LB				Hoofnagle, Jay H.; Seeff, Leonard B.			Peginterferon and ribavirin for chronic hepatitis C	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALPHA-2B PLUS RIBAVIRIN; VIRUS-INFECTION; PEGYLATED INTERFERON-ALPHA-2B; COMBINATION THERAPY; INITIAL TREATMENT; GENOTYPE-2; EFFICACY; MONOTHERAPY; MANAGEMENT; MECHANISM		NIDDKD, Liver Dis Res Branch, Div Digest Dis & Nutr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hoofnagle, JH (corresponding author), NIDDKD, Liver Dis Res Branch, Div Digest Dis & Nutr, NIH, Bldg 31,Rm 9A27,31 Ctr Dr, Bethesda, MD 20892 USA.	hoofnaglej@extra.niddk.nih.gov						[Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bacon BR, 2002, HEPATOLOGY, V36, pS179, DOI 10.1053/jhep.2002.36386; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Brok J, 2006, AM J GASTROENTEROL, V101, P842, DOI 10.1111/j.1572-0241.2006.00505.x; Chevaliez Stephane, 2005, Clin Liver Dis, V9, P371, DOI 10.1016/j.cld.2005.05.009; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Crotty S, 2001, NAT MED, V7, P255; Dalgard O, 2004, HEPATOLOGY, V40, P1260, DOI 10.1002/hep.20467; Davis GL, 2002, HEPATOLOGY, V36, pS145, DOI 10.1053/jhep.2002.36798; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P231, DOI 10.1053/j.gastro.2005.11.010; El-Zayadi AR, 2005, AM J GASTROENTEROL, V100, P2447, DOI 10.1111/j.1572-0241.2005.00253.x; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fried MW, 2002, HEPATOLOGY, V36, pS237, DOI 10.1053/jhep.2002.36810; Glue P, 2000, CLIN PHARMACOL THER, V68, P556, DOI 10.1067/mcp.2000.110973; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Kleiner DE, 2005, SEMIN LIVER DIS, V25, P52, DOI 10.1055/s-2005-864781; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2006, J HEPATOL, V44, P411, DOI 10.1016/j.jhep.2005.12.001; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; Myers RP, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000370; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Strader DB, 2004, HEPATOLOGY, V40, P269, DOI 10.1002/hep.20316; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Thomas DL, 2002, HEPATOLOGY, V36, pS201, DOI 10.1053/jhep.2002.36380; Tilg H, 1997, GASTROENTEROLOGY, V112, P1017, DOI 10.1053/gast.1997.v112.pm9041265; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Wiegand J, 2006, HEPATOLOGY, V43, P250, DOI 10.1002/hep.21043; Wirth S, 2005, HEPATOLOGY, V41, P1013, DOI 10.1002/hep.20661; Zeuzem S, 2006, J HEPATOL, V44, P97, DOI 10.1016/j.jhep.2005.10.003	51	363	386	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2444	2451		10.1056/NEJMct061675	http://dx.doi.org/10.1056/NEJMct061675			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113EO	17151366				2022-12-28	WOS:000242581400008
J	Prasad, M; Buller, GK; Mena, CI; Sofair, AN				Prasad, Meeta; Buller, Gregory K.; Mena, Carlos I.; Sofair, Andre N.			Sum of the parts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-C VIRUS; INTERFERON; THERAPY; CRYOGLOBULINEMIA; VASCULITIS; RIBAVIRIN		Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; St Marys Hosp, Dept Internal Med, Waterbury, CT USA	Yale University	Prasad, M (corresponding author), 1500 Locust St,Apt 2518, Philadelphia, PA 19102 USA.	meeta@alumni.princeton.edu						Alric L, 2004, AM J KIDNEY DIS, V43, P617, DOI 10.1053/j.ajkd.2003.11.020; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bosch X, 1999, LUPUS, V8, P258, DOI 10.1191/096120399678847740; Bruchfeld A, 2003, NEPHROL DIAL TRANSPL, V18, P1573, DOI 10.1093/ndt/gfg209; Cacoub P, 1999, ARTHRITIS RHEUM-US, V42, P2204, DOI 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D; Cacoub P, 2002, CURR OPIN RHEUMATOL, V14, P29, DOI 10.1097/00002281-200201000-00006; Calleja JL, 1996, J HEPATOL, V24, P308, DOI 10.1016/S0168-8278(96)80009-2; Gomez-Tello V, 1999, INTENS CARE MED, V25, P319, DOI 10.1007/s001340050843; *HCV, 1998, MMWR RECOMM REP, V47; Mathurin P, 1999, HEPATOLOGY, V29, P257, DOI 10.1002/hep.510290123; MISIANI R, 1994, NEW ENGL J MED, V330, P751, DOI 10.1056/NEJM199403173301104; MUSSET L, 1992, CLIN CHEM, V38, P798; ROITHINGER FX, 1995, AM J GASTROENTEROL, V90, P1006; Sabry AA, 2002, NEPHROL DIAL TRANSPL, V17, P1924, DOI 10.1093/ndt/17.11.1924; Vassilopoulos D, 2002, ARTHRITIS RHEUM-US, V46, P585, DOI 10.1002/art.10107	15	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2468	2473		10.1056/NEJMcps060364	http://dx.doi.org/10.1056/NEJMcps060364			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113EO	17151369				2022-12-28	WOS:000242581400011
J	Veit-Haibach, P; Kuehle, CA; Beyer, T; Stergar, H; Kuehl, H; Schmidt, J; Borsch, G; Dahmen, G; Barkhausen, J; Bockisch, A; Antoch, G				Veit-Haibach, Patrick; Kuehle, Christiane A.; Beyer, Thomas; Stergar, Hrvoje; Kuehl, Hilmar; Schmidt, Johannes; Boersch, Gereon; Dahmen, Gerlinde; Barkhausen, Joerg; Bockisch, Andreas; Antoch, Gerald			Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ROW CT COLONOGRAPHY; F-18-FDG PET; LYMPH-NODES; FDG-PET/CT; METAANALYSIS; IMPACT; VALIDATION; MANAGEMENT; ARTIFACTS	Context Staging of patients with colorectal cancer often requires a multimodality, multistep imaging approach. Colonography composed of a combined modality of positron emission tomography (PET) and computed tomography (CT) provides whole-body tumor staging in a single session. Objectives To determine the staging accuracy of whole-body PET/CT colonography compared with the staging accuracies of CT followed by PET (CT + PET) and CT alone and to evaluate the effect of PET/CT colonography on therapy planning compared with conventional staging (CT of the abdomen and thorax and optical colonoscopy). Design, Setting, and Patients Prospective study of 47 patients enrolled between May 2004 and June 2006 with clinical findings and optical colonoscopy that suggested primary colorectal cancer (mean [SD] age, 71 [11] years; range, 47-92 years). Patients underwent whole-body PET/CT colonography 1 day after colonoscopy. The study was conducted at a university hospital with a mean (SD) follow-up of 447 (140) days (range, 232-653 days). Main Outcome Measures Correct classification of overall TNM stage using PET/CT colonography compared with CT + PET and CT alone. Secondary outcome measures were the accurate assessment of T-stage, N-stage, and M-stage by PET/CT colonography compared with CT + PET and CT alone and the effect of PET/CT colonography on therapy planning. Results Of the 47 patients with a total of 50 lesions, the overall TNM stage was correctly determined for 37 lesions with PET/CT colonography (74%; 95% confidence interval [CI], 60%-85%), 32 lesions with CT + PET (64%; 95% CI, 49%-77%), and 26 lesions with CT alone with a 0.7-cm node threshold (52%; 95% CI, 37%-66%). Compared with optimized abdominal CT staging alone, PET/CT colonography was significantly more accurate in defining TNM stage (difference, 22%; 95% CI, 9%- 36%; P=.003), which was mainly based on a more accurate definition of the T-stage. Differences were not detected for defining N-stage between PET/CT colonography and CT alone with a threshold of 0.7 cm for malignant nodes but were detected with a threshold of 1 cm. Differences were not detected in defining M-stage separately or when comparing the accuracies of PET/CT colonography with CT + PET. PET/CT colonography affected consecutive therapy decisions in 4 patients (9%; 95% CI, 2.4%-20.4%) compared with conventional staging (CT alone and colonoscopy). Conclusions In this preliminary study, PET/CT colonography is at least equivalent to CT + PET for tumor staging in patients with colorectal cancer. Thus, PET/CT colonography in conjunction with optical colonoscopy may be a suitable concept of tumor staging for patients with colorectal cancer.	Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, D-45122 Essen, Germany; Univ Duisburg Essen, Univ Hosp Essen, Dept Nucl Med, D-45122 Essen, Germany; Lutheran Hosp Essen, Dept Gen & Vasc Surg, Essen, Germany; Elisabeth Hosp Essen, Dept Internal Med, Essen, Germany; Univ Lubeck, Inst Med Biometry & Stat, Lubeck, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Lubeck	Antoch, G (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Hufelandstr 55, D-45122 Essen, Germany.	gerald.antoch@uni-duisburg-essen.de	Barkhausen, Joerg/E-3921-2010; beyer, thomas/AAN-1789-2020					Abdel-Nabi H, 1998, RADIOLOGY, V206, P755, DOI 10.1148/radiology.206.3.9494497; Antoch G, 2004, J CLIN ONCOL, V22, P4357, DOI 10.1200/JCO.2004.08.120; Antoch G, 2004, RADIOLOGY, V230, P879, DOI 10.1148/radiol.2303021287; Bar-Shalom R, 2003, J NUCL MED, V44, P1200; Beyer T, 2003, EUR J NUCL MED MOL I, V30, P588, DOI 10.1007/s00259-002-1097-6; Bipat S, 2004, RADIOLOGY, V232, P773, DOI 10.1148/radiol.2323031368; Cohade C, 2003, J NUCL MED, V44, P1797; Delbeke D, 1998, ARCH SURG-CHICAGO, V133, P510, DOI 10.1001/archsurg.133.5.510; DISARIO JA, 1991, AM J GASTROENTEROL, V86, P941; DORFMAN RE, 1991, RADIOLOGY, V180, P319, DOI 10.1148/radiology.180.2.2068292; Drenth JPH, 2001, EUR J NUCL MED, V28, P1766, DOI 10.1007/s002590100645; Filippone A, 2004, RADIOLOGY, V231, P83, DOI 10.1148/radiol.2311021152; Friedland S, 2005, GASTROINTEST ENDOSC, V61, P395, DOI 10.1016/S0016-5107(04)02775-0; Gutman F, 2005, AM J ROENTGENOL, V185, P495, DOI 10.2214/ajr.185.2.01850495; Hara AK, 2001, RADIOLOGY, V219, P461, DOI 10.1148/radiology.219.2.r01ma28461; Huebner RH, 2000, J NUCL MED, V41, P1177; Israel O, 2005, J NUCL MED, V46, P758; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Kalff V, 2002, J NUCL MED, V43, P492; Kamel IR, 2004, ABDOM IMAGING, V29, P663, DOI 10.1007/s00261-003-0163-2; Kantorova I, 2003, J NUCL MED, V44, P1784; Kim JH, 2005, J NUCL MED, V46, P587; Laforest R, 2005, EUR J NUCL MED MOL I, V32, P764, DOI 10.1007/s00259-004-1756-x; Mahy P, 2004, EUR J NUCL MED MOL I, V31, P1263, DOI 10.1007/s00259-004-1573-2; Mulhall BP, 2005, ANN INTERN MED, V142, P635, DOI 10.7326/0003-4819-142-8-200504190-00013; Nakamoto Y, 2004, NUCL MED COMMUN, V25, P221, DOI 10.1097/00006231-200403000-00002; Piert M, 2005, J NUCL MED, V46, P106; Rockey DC, 2005, LANCET, V365, P305; Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; Saunders TH, 2002, BRIT MED BULL, V64, P81, DOI 10.1093/bmb/64.1.81; Selzner MK, 2004, ANN SURG, V240, P1027, DOI 10.1097/01.sla.0000146145.69835.c5; Sosna J, 2005, ABDOM IMAGING, V30, P709, DOI 10.1007/s00261-005-0333-5; Sosna J, 2003, RADIOLOGY, V228, P152, DOI 10.1148/radiol.2281020950; Stevenson GW, 2000, RADIOLOGY, V214, P615, DOI 10.1148/radiology.214.3.r00mr46615; Tango T, 1998, STAT MED, V17, P891, DOI 10.1002/(SICI)1097-0258(19980430)17:8<891::AID-SIM780>3.0.CO;2-B; Taylor SA, 2003, RADIOLOGY, V229, P99, DOI 10.1148/radiol.2291021151; Valk PE, 1999, ARCH SURG-CHICAGO, V134, P503, DOI 10.1001/archsurg.134.5.503; VELT P, 2006, GUT, V55, P68; VINNICOMBE SJ, 1995, RADIOLOGY, V194, P349, DOI 10.1148/radiology.194.2.7824709; Wyss MT, 2006, EUR J NUCL MED MOL I, V33, P311, DOI 10.1007/s00259-005-1951-4; Yamamoto M, 2004, HEPATO-GASTROENTEROL, V51, P121; Yasuda S, 2001, J NUCL MED, V42, P989; Zhou XH, 2002, STAT METHODS DIAGNOS, P165	43	89	93	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2006	296	21					2590	2600		10.1001/jama.296.21.2590	http://dx.doi.org/10.1001/jama.296.21.2590			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112ND	17148724	Bronze			2022-12-28	WOS:000242532000021
J	Ramsay, JE; Greer, I; Sattar, N				Ramsay, Jane E.; Greer, Ian; Sattar, Naveed			ABC of obesity - Obesity and reproduction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Ayrshire Matern Unit, Kilmarnock, Scotland; Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Ramsay, JE (corresponding author), Ayrshire Matern Unit, Kilmarnock, Scotland.	nsattar@clinmed.gla.ac.uk						*AM COLL OBST GYN, 2005, AM COLL OBST GYN GUI; Callaway LK, 2006, MED J AUSTRALIA, V184, P56, DOI 10.5694/j.1326-5377.2006.tb00115.x; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Galtier-Dereure F, 2000, AM J CLIN NUTR, V71, p1242S, DOI 10.1093/ajcn/71.5.1242s; Kanagalingam MG, 2005, BJOG-INT J OBSTET GY, V112, P1431, DOI 10.1111/j.1471-0528.2005.00685.x; Ramsay J. E., 2004, FETAL MATERN MED REV, V15, P109, DOI DOI 10.1017/S0965539504001263; Wong SF, 2002, ULTRASOUND OBST GYN, V19, P171, DOI 10.1046/j.0960-7692.2001.00560.x	7	77	78	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2006	333	7579					1159	1162		10.1136/bmj.39049.439444.DE1	http://dx.doi.org/10.1136/bmj.39049.439444.DE1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114LG	17138998	Green Published			2022-12-28	WOS:000242667100019
J	Ehebauer, M; Hayward, P; Arias, AM				Ehebauer, Matthias; Hayward, Penelope; Arias, Alfonso Martinez			Notch, a universal arbiter of cell fate decisions	SCIENCE			English	Editorial Material							SEGMENTATION; ENDOCYTOSIS; INHIBITION; DROSOPHILA; PATHWAY; GENES		Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge; University of Cambridge	Arias, AM (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	ama11@hermes.cam.ac.uk	Martinez Arias, Alfonso/F-1966-2010	Ehebauer, Matthias/0000-0002-3148-8390	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Bray S, 1998, SEMIN CELL DEV BIOL, V9, P591, DOI 10.1006/scdb.1998.0262; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; EHEBAUER M, 2006, SCI STKE         AUG; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Kopan R, 2002, J CELL SCI, V115, P1095; Lai EC, 2002, EMBO REP, V3, P840, DOI 10.1093/embo-reports/kvf170; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; SIMPSON P, 1990, DEVELOPMENT, V109, P509; Stollewerk A, 2003, NATURE, V423, P863, DOI 10.1038/nature01682; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	19	149	167	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1414	1415		10.1126/science.1134042	http://dx.doi.org/10.1126/science.1134042			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138893				2022-12-28	WOS:000242406100029
J	Geiger, B				Geiger, Benjamin			A role for p130Cas in mechanotransduction	CELL			English	Editorial Material							SUBSTRATE		Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Geiger, B (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	benny.geiger@weizmann.ac.il			NIGMS NIH HHS [U54 GM64346] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Zamir E, 2001, J CELL SCI, V114, P3577	7	31	32	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 1	2006	127	5					879	881		10.1016/j.cell.2006.11.020	http://dx.doi.org/10.1016/j.cell.2006.11.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129774	Bronze			2022-12-28	WOS:000242613800005
J	Bilezikian, JP				Bilezikian, John P.			Osteonecrosis of the jaw - Do biphosphonates pose a risk?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Bilezikian, JP (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA.							Cabanillas ME, 2005, J BONE MINER RES, V20, pS211; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Polizzotto MN, 2006, BRIT J HAEMATOL, V132, P114, DOI 10.1111/j.1365-2141.2005.05833.x; Shane E, 2006, J BONE MINER RES, V21, P1503, DOI 10.1359/JBMR.060712; Woo SB, 2006, ANN INTERN MED, V145, P235, DOI 10.7326/0003-4819-145-10-200611210-00023; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009	6	199	214	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2278	2281		10.1056/NEJMp068157	http://dx.doi.org/10.1056/NEJMp068157			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110CG	17135582				2022-12-28	WOS:000242355300003
J	Corder, R; Mullen, W; Khan, NQ; Marks, SC; Wood, EG; Carrier, MJ; Crozier, A				Corder, R.; Mullen, W.; Khan, N. Q.; Marks, S. C.; Wood, E. G.; Carrier, M. J.; Crozier, A.			Red wine procyanidins and vascular health	NATURE			English	Article							BEER		Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; Univ Glasgow, Inst Biomed & Life Sci, Plant Prod & Human Nutr Grp, Glasgow G12 8QQ, Lanark, Scotland	University of London; Queen Mary University London; University of Glasgow	Corder, R (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England.	r.corder@qmul.ac.uk	Crozier, Alan/H-6642-2017; Mullen, William/GWC-8078-2022; Corder, Roger/H-2588-2012; Marks, Serena/F-2867-2010	Crozier, Alan/0000-0001-7581-6782; Corder, Roger/0000-0003-1712-6841; Mullen, William/0000-0002-5685-1563				Auger C, 2004, J AGR FOOD CHEM, V52, P5297, DOI 10.1021/jf040125d; Corder R, 2001, NATURE, V414, P863, DOI 10.1038/414863a; Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01; FITZPATRICK DF, 1993, AM J PHYSIOL, V265, pH774; Hashimoto M, 2001, AM J CARDIOL, V88, P1457, DOI 10.1016/S0002-9149(01)02137-3; Kris-Etherton PM, 2002, CURR OPIN LIPIDOL, V13, P41, DOI 10.1097/00041433-200202000-00007; Poulain M, 2004, EXP GERONTOL, V39, P1423, DOI 10.1016/j.exger.2004.06.016; Renaud SC, 1999, ARCH INTERN MED, V159, P1865, DOI 10.1001/archinte.159.16.1865; Shoji T, 2006, J AGR FOOD CHEM, V54, P884, DOI 10.1021/jf052260b; Waterhouse AL, 2002, ANN NY ACAD SCI, V957, P21, DOI 10.1111/j.1749-6632.2002.tb02903.x	10	258	277	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					566	566		10.1038/444566a	http://dx.doi.org/10.1038/444566a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136085	Bronze			2022-12-28	WOS:000242377600033
J	Hennerici, MG; Kay, R; Bogousslavsky, J; Lenzi, GL; Verstraete, M; Orgogozo, JM				Hennerici, Michael G.; Kay, Richard; Bogousslavsky, Julien; Lenzi, Gian Luigi; Verstraete, Marc; Orgogozo, Jean Marc		ESTAT Investigators	Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial	LANCET			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; COOPERATIVE ACUTE STROKE; THROMBOLYTIC THERAPY; VEIN-THROMBOSIS; CLINICAL-TRIALS; ECASS; DEFIBRINATION; INFARCTION	Background Intravenous tissue plasminogen activator is the only approved specific treatment for acute ischaemic stroke. Ancrod, a natural defibrinogenating agent from snake venom, has proved to have a favourable effect when given within 3 h after an acute ischaemic stroke. The European Stroke Treatment with Ancrod Trial was undertaken to assess the effects of ancrod when given within 6 h. Methods 1222 patients with an acute ischaemic stroke were included in this randomised double-blind placebo-controlled trial. Brain CT scans were done to exclude intracranial haemorrhages and large evolving ischaemic infarctions. Patients were randomly assigned ancrod (n=604) or placebo (n=618). The primary outcome was functional success at 3 months (survival, Barthel Index of 95 or 100, or return to prestroke level). The analysis was by intention-to-treat. This trial is registered with ClinicalTrials.gov, trial number NCT00343174. Findings Functional success at 3 months did not differ between patients given ancrod (42%) and those given placebo (42%) (p=0.94, OR=0.99, 95% CI, 0.76-1.29). Interpretation On the basis of our findings, ancrod should not be recommended for use in acute ischaemic stroke beyond 3 h.	Univ Heidelberg, Univ Klinikum Mannheim, Dept Neurol, D-68135 Mannheim, Germany; Great Longstone, Bakewell, England; Clin Valmont Genolier, Swiss Med Network, Glion, Switzerland; Univ Roma La Sapienza, Dept Neurol Sci, I-00185 Rome, Italy; Ctr Mol & Vasc Biol, Louvain, Belgium; Grp Hosp Pellegrin, Serv Univ Neurol, Bordeaux, France	Ruprecht Karls University Heidelberg; Sapienza University Rome; CHU Bordeaux	Hennerici, MG (corresponding author), Univ Heidelberg, Univ Klinikum Mannheim, Dept Neurol, D-68135 Mannheim, Germany.	Hennerici@neuro.ma.uni-heidelberg.de						ASPLUND K, 1985, STROKE, V16, P885; BELL W, 1968, LANCET, V291, P490; Blom G., 1958, STAT ESTIMATES TRANS; Bolland K, 2000, STAT MED, V19, P2899, DOI 10.1002/1097-0258(20001115)19:21<2899::AID-SIM597>3.0.CO;2-O; DAVIES JA, 1972, LANCET, V1, P113; DORMANDY JA, 1978, ANGIOLOGY, V29, P80, DOI 10.1177/000331977802900112; EHRLY A M, 1973, Biorheology, V10, P453; GENT A, 1979, THROMB RES, V14, P61, DOI 10.1016/0049-3848(79)90024-0; Hacke W, 2005, STROKE, V36, P66, DOI 10.1161/01.STR.0000149938.08731.2c; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2004, LANCET, V363, P768; HENNERICI MG, 2001, J NEUROL SCI, V187, pS436; HOSSMANN V, 1983, ARCH NEUROL-CHICAGO, V40, P803, DOI 10.1001/archneur.1983.04050120053007; LAN KKG, 1988, BIOMETRICS, V44, P579, DOI 10.2307/2531870; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Larrue V, 1997, STROKE, V28, P957, DOI 10.1161/01.STR.28.5.957; LINDENSTROM E, 1991, CEREBROVASC DIS, V1, P103, DOI 10.1159/000108825; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; OLINGER CP, 1988, ANN EMERG MED, V17, P1208, DOI 10.1016/S0196-0644(88)80071-4; Orgogozo JM, 2000, JAMA-J AM MED ASSOC, V284, P1926; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; POLLAK VE, 1990, AM J MED SCI, V299, P319, DOI 10.1097/00000441-199005000-00006; REID H, 1963, LANCET, V281, P621; Sherman DG, 2000, JAMA-J AM MED ASSOC, V283, P2395, DOI 10.1001/jama.283.18.2395; SHERMAN DG, 1994, STROKE, V25, P1755; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611; Wardlaw JM, 2003, STROKE, V34, P1437, DOI 10.1161/01.STR.0000072513.72262.7E	28	85	93	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1871	1878		10.1016/S0140-6736(06)69776-6	http://dx.doi.org/10.1016/S0140-6736(06)69776-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	109YQ	17126719				2022-12-28	WOS:000242345900028
J	Lein, ES; Hawrylycz, MJ; Ao, N; Ayres, M; Bensinger, A; Bernard, A; Boe, AF; Boguski, MS; Brockway, KS; Byrnes, EJ; Chen, L; Chen, L; Chen, TM; Chin, MC; Chong, J; Crook, BE; Czaplinska, A; Dang, CN; Datta, S; Dee, NR; Desaki, AL; Desta, T; Diep, E; Dolbeare, TA; Donelan, MJ; Dong, HW; Dougherty, JG; Duncan, BJ; Ebbert, AJ; Eichele, G; Estin, LK; Faber, C; Facer, BA; Fields, R; Fischer, SR; Fliss, TP; Frensley, C; Gates, SN; Glattfelder, KJ; Halverson, KR; Hart, MR; Hohmann, JG; Howell, MP; Jeung, DP; Johnson, RA; Karr, PT; Kawal, R; Kidney, JM; Knapik, RH; Kuan, CL; Lake, JH; Laramee, AR; Larsen, KD; Lau, C; Lemon, TA; Liang, AJ; Liu, Y; Luong, LT; Michaels, J; Morgan, JJ; Morgan, RJ; Mortrud, MT; Mosqueda, NF; Ng, LL; Ng, R; Orta, GJ; Overly, CC; Pak, TH; Parry, SE; Pathak, SD; Pearson, OC; Puchalski, RB; Riley, ZL; Rockett, HR; Rowland, SA; Royall, JJ; Ruiz, MJ; Sarno, NR; Schaffnit, K; Shapovalova, NV; Sivisay, T; Slaughterbeck, CR; Smith, SC; Smith, KA; Smith, BI; Sodt, AJ; Stewart, NN; Stumpf, KR; Sunkin, SM; Sutram, M; Tam, A; Teemer, CD; Thaller, C; Thompson, CL; Varnam, LR; Visel, A; Whitlock, RM; Wohnoutka, PE; Wolkey, CK; Wong, VY; Wood, M; Yaylaoglu, MB; Young, RC; Youngstrom, BL; Yuan, XF; Zhang, B; Zwingman, TA; Jones, AR				Lein, Ed S.; Hawrylycz, Michael J.; Ao, Nancy; Ayres, Mikael; Bensinger, Amy; Bernard, Amy; Boe, Andrew F.; Boguski, Mark S.; Brockway, Kevin S.; Byrnes, Emi J.; Chen, Lin; Chen, Li; Chen, Tsuey-Ming; Chin, Mei Chi; Chong, Jimmy; Crook, Brian E.; Czaplinska, Aneta; Dang, Chinh N.; Datta, Suvro; Dee, Nick R.; Desaki, Aimee L.; Desta, Tsega; Diep, Ellen; Dolbeare, Tim A.; Donelan, Matthew J.; Dong, Hong-Wei; Dougherty, Jennifer G.; Duncan, Ben J.; Ebbert, Amanda J.; Eichele, Gregor; Estin, Lili K.; Faber, Casey; Facer, Benjamin A.; Fields, Rick; Fischer, Shanna R.; Fliss, Tim P.; Frensley, Cliff; Gates, Sabrina N.; Glattfelder, Katie J.; Halverson, Kevin R.; Hart, Matthew R.; Hohmann, John G.; Howell, Maureen P.; Jeung, Darren P.; Johnson, Rebecca A.; Karr, Patrick T.; Kawal, Reena; Kidney, Jolene M.; Knapik, Rachel H.; Kuan, Chihchau L.; Lake, James H.; Laramee, Annabel R.; Larsen, Kirk D.; Lau, Christopher; Lemon, Tracy A.; Liang, Agnes J.; Liu, Ying; Luong, Lon T.; Michaels, Jesse; Morgan, Judith J.; Morgan, Rebecca J.; Mortrud, Marty T.; Mosqueda, Nerick F.; Ng, Lydia L.; Ng, Randy; Orta, Geralyn J.; Overly, Caroline C.; Pak, Tu H.; Parry, Sheana E.; Pathak, Sayan D.; Pearson, Owen C.; Puchalski, Ralph B.; Riley, Zackery L.; Rockett, Hannah R.; Rowland, Stephen A.; Royall, Joshua J.; Ruiz, Marcos J.; Sarno, Nadia R.; Schaffnit, Katherine; Shapovalova, Nadiya V.; Sivisay, Taz; Slaughterbeck, Clifford R.; Smith, Simon C.; Smith, Kimberly A.; Smith, Bryan I.; Sodt, Andy J.; Stewart, Nick N.; Stumpf, Kenda-Ruth; Sunkin, Susan M.; Sutram, Madhavi; Tam, Angelene; Teemer, Carey D.; Thaller, Christina; Thompson, Carol L.; Varnam, Lee R.; Visel, Axel; Whitlock, Ray M.; Wohnoutka, Paul E.; Wolkey, Crissa K.; Wong, Victoria Y.; Wood, Matthew; Yaylaoglu, Murat B.; Young, Rob C.; Youngstrom, Brian L.; Yuan, Xu Feng; Zhang, Bin; Zwingman, Theresa A.; Jones, Allan R.			Genome-wide atlas of gene expression in the adult mouse brain	NATURE			English	Article							IN-SITU HYBRIDIZATION; HIPPOCAMPAL-FORMATION; PROTEIN-SYNTHESIS; RAT; ORGANIZATION; NEURONS; PATTERNS; MEMORY; PROFILES; DATABASE	Molecular approaches to understanding the functional circuitry of the nervous system promise new insights into the relationship between genes, brain and behaviour. The cellular diversity of the brain necessitates a cellular resolution approach towards understanding the functional genomics of the nervous system. We describe here an anatomically comprehensive digital atlas containing the expression patterns of,20,000 genes in the adult mouse brain. Data were generated using automated high-throughput procedures for in situ hybridization and data acquisition, and are publicly accessible online. Newly developed image-based informatics tools allow global genome-scale structural analysis and cross-correlation, as well as identification of regionally enriched genes. Unbiased fine-resolution analysis has identified highly specific cellular markers as well as extensive evidence of cellular heterogeneity not evident in classical neuroanatomical atlases. This highly standardized atlas provides an open, primary data resource for a wide variety of further studies concerning brain organization and function.	Allen Inst Brain Sci, Seattle, WA 98103 USA; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Max Planck Inst Biophys Chem, Dept Genes & Behav, D-37077 Gottingen, Germany	Allen Institute for Brain Science; Baylor College of Medicine; Max Planck Society	Lein, ES (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	edl@alleninstitute.org; allanj@alleninstitute.org	Morgan, James/N-8104-2018; Visel, Axel/A-9398-2009; Morgan, James/GRO-2905-2022; Wood, Matthew/HDN-1469-2022; Martinez, Octavio/B-7375-2009	Visel, Axel/0000-0002-4130-7784; Morgan, James/0000-0002-8920-1065; Pathak, Shankar D/0000-0001-9689-7577; Bernard, Amy/0000-0003-2540-1153; Dee, Nick/0000-0002-2831-9254; Thompson, Carol/0000-0003-1528-3237; Wood, Matthew/0000-0002-5436-6011; Karr, Paul/0000-0003-3560-2178; Larsen, Kirk/0000-0002-7809-2916				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Boguski MS, 2004, NAT NEUROSCI, V7, P429, DOI 10.1038/nn1232; Brecht M, 2004, J NEUROSCI, V24, P9223, DOI 10.1523/JNEUROSCI.3344-04.2004; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chan TF, 2005, IMAGE PROCESSING AND ANALYSIS, P1, DOI 10.1137/1.9780898717877; Christiansen JH, 2006, NUCLEIC ACIDS RES, V34, pD637, DOI 10.1093/nar/gkj006; Datson NA, 2001, HIPPOCAMPUS, V11, P430, DOI 10.1002/hipo.1058; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GRAVEL C, 1990, J COMP NEUROL, V291, P79, DOI 10.1002/cne.902910107; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hawkes R, 1995, J MOL NEUROSCI, V6, P147, DOI 10.1007/BF02736761; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Heuer H, 2003, NEUROSCIENCE, V119, P43, DOI 10.1016/S0306-4522(03)00100-3; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Kamme F, 2003, J NEUROSCI, V23, P3607; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Lein ES, 2005, J COMP NEUROL, V485, P1, DOI 10.1002/cne.20426; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; NG L, IN PRESS IEEE T COMP; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Siddiqui AS, 2005, P NATL ACAD SCI USA, V102, P18485, DOI 10.1073/pnas.0509455102; Small SA, 2002, REV NEUROSCIENCE, V13, P183; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; THOMPSON PM, 2000, HDB MED IMAGING PROC; Tole S, 1997, DEVELOPMENT, V124, P4959; Toledo-Rodriguez M, 2005, J PHYSIOL-LONDON, V567, P401, DOI 10.1113/jphysiol.2005.089250; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; Vavouri T, 2005, CURR OPIN GENET DEV, V15, P395, DOI 10.1016/j.gde.2005.05.002; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; VOOGD J, 1987, PARASAGITTAL ZONATIO; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	55	3467	3505	11	251	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					168	176		10.1038/nature05453	http://dx.doi.org/10.1038/nature05453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17151600				2022-12-28	WOS:000243384300043
J	Canfield, DE; Poulton, SW; Narbonne, GM				Canfield, Don E.; Poulton, Simon W.; Narbonne, Guy M.			Late-Neoproterozoic deep-ocean oxygenation and the rise of animal life	SCIENCE			English	Article							MISTAKEN POINT; SNOWBALL; IRON; PRESERVATION; ORIGIN	Because animals require oxygen, an increase in late-Neoproterozoic oxygen concentrations has been suggested as a stimulus for their evolution. The iron content of deep-sea sediments shows that the deep ocean was anoxic and ferruginous before and during the Gaskiers glaciation 580 million years ago and that it became oxic afterward. The first known members of the Ediacara biota arose shortly after the Gaskiers glaciation, suggesting a causal link between their evolution and this oxygenation event. A prolonged stable oxic environment may have permitted the emergence of bilateral motile animals some 25 million years later.	Univ So Denmark, Nord Ctr Earth Evolut, DK-5230 Odense M, Denmark; Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark; Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON K7L 3N6, Canada	University of Southern Denmark; University of Southern Denmark; Newcastle University - UK; Queens University - Canada	Canfield, DE (corresponding author), Univ So Denmark, Nord Ctr Earth Evolut, Campusvej 55, DK-5230 Odense M, Denmark.	dec@biology.sdu.dk	Narbonne, Guy M/I-7518-2012; Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366; Poulton, Simon/0000-0001-7621-189X	Natural Environment Research Council [NE/C518465/2] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Benus AP., 1988, GEOLOGICAL SURVEY B, P8; BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; BOWRING SA, 2003, ASTROBIOLOGY, V2, P112; Broecker W.S., 1982, TRACERS SEA; CANFIELD DE, 1989, GEOCHIM COSMOCHIM AC, V53, P619, DOI 10.1016/0016-7037(89)90005-7; CANFIELD DE, 1994, CHEM GEOL, V114, P315, DOI 10.1016/0009-2541(94)90061-2; Clapham ME, 2003, PALEOBIOLOGY, V29, P527, DOI 10.1666/0094-8373(2003)029<0527:POTOKA>2.0.CO;2; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; GARDINER S, 1988, CAN J EARTH SCI, V25, P1579, DOI 10.1139/e88-151; Gorjan P, 2000, PRECAMBRIAN RES, V100, P151, DOI 10.1016/S0301-9268(99)00073-X; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Halverson Galen P., 2006, V27, P231; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hurtgen MT, 2006, EARTH PLANET SC LETT, V245, P551, DOI 10.1016/j.epsl.2006.03.026; Knoll AH, 2006, LETHAIA, V39, P13, DOI 10.1080/00241160500409223; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Knoll AH, 2003, LIFE YOUNG PLANET 1; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; MISRA SB, 1971, GEOL SOC AM BULL, V82, P979, DOI 10.1130/0016-7606(1971)82[979:SADHOL]2.0.CO;2; Narbonne G., 2005, N AM PAL CONV FIELD; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; NARBONNE GM, 2001, B5 GEOL ASS CAN; Olcott AN, 2006, GEOCHIM COSMOCHIM AC, V70, pA456, DOI 10.1016/j.gca.2006.06.918; Olcott AN, 2005, SCIENCE, V310, P471, DOI 10.1126/science.1115769; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Poulton SW, 2002, AM J SCI, V302, P774, DOI 10.2475/ajs.302.9.774; Premuzic E.T., 1982, ORG GEOCHEM, V4, P63, DOI [10.1016/0146-6380(82)90009-2., DOI 10.1016/0146-6380(82)90009-2]; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; RUNNEGAR B, 1991, GLOBAL PLANET CHANGE, V97, P97; SCOTESE CR, 2001, PALEOMAP PROJECT, V51; Shen YN, 2002, AM J SCI, V302, P81, DOI 10.2475/ajs.302.2.81; WILLIAMS H, 1979, GEOL SURV CAN MEM, V389; Wood DA, 2003, CAN J EARTH SCI, V40, P1375, DOI 10.1139/E03-048; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318	37	661	734	9	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					92	95		10.1126/science.1135013	http://dx.doi.org/10.1126/science.1135013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17158290				2022-12-28	WOS:000243259100042
J	Evans, AR; Wilson, GP; Fortelius, M; Jernvall, J				Evans, Alistair R.; Wilson, Gregory P.; Fortelius, Mikael; Jernvall, Jukka			High-level similarity of dentitions in carnivorans and rodents	NATURE			English	Article							TOOTH; MORPHOLOGY; DIET	The study of mammalian evolution depends greatly on understanding the evolution of teeth and the relationship of tooth shape to diet. Links between gross tooth shape, function and diet have been proposed since antiquity, stretching from Aristotle(1) to Cuvier(2), Owen(3) and Osborn(4). So far, however, the possibilities for exhaustive, quantitative comparisons between greatly different tooth shapes have been limited. Cat teeth and mouse teeth, for example, are fundamentally distinct in shape and structure as a result of independent evolutionary change over tens of millions of years(5). There is difficulty in establishing homology between their tooth components or in summarizing their tooth shapes, yet both carnivorans and rodents possess a comparable spectrum of dietary specializations from animals to plants. Here we introduce homology-free techniques(6-8) to measure the phenotypic complexity of the three-dimensional shape of tooth crowns. In our geographic information systems (GIS) analysis of 441 teeth from 81 species of carnivorans and rodents, we show that the surface complexity of tooth crowns directly reflects the foods they consume. Moreover, the absolute values of dental complexity for individual dietary classes correspond between carnivorans and rodents, illustrating a high-level similarity between overall tooth shapes despite a lack of low-level similarity of specific tooth components. These results suggest that scale-independent forces have determined the high-level dental shape in lineages that are widely divergent in size, ecology and life history. This link between diet and phenotype will be useful for inferring the ecology of extinct species and illustrates the potential of fast-throughput, high-level analysis of the phenotype.	Inst Biotechnol, Evolut & Dev Unit, FIN-00014 Helsinki, Finland; Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO 80205 USA; Univ Helsinki, Dept Geol, FIN-00014 Helsinki, Finland	University of Helsinki	Evans, AR (corresponding author), Inst Biotechnol, Evolut & Dev Unit, POB 56 Viikinkaari 9, FIN-00014 Helsinki, Finland.	arevans@fastmail.fm	Wilson, Gregory P/A-2363-2009; Self, Casey J/B-6871-2011; Evans, Alistair R/D-4239-2011	Evans, Alistair R/0000-0002-4078-4693; Wilson Mantilla, Gregory/0000-0003-3604-5473; Fortelius, Mikael/0000-0002-4851-783X				ARISTOTLE, 1983, PARTS ANIMALS; Birdsey GM, 2005, P ROY SOC B-BIOL SCI, V272, P833, DOI 10.1098/rspb.2004.3011; Cover TM., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; Cuvier Georges, 1825, DISCOURS REVOLUTIONS; Eterovick PC, 1997, BIOL J LINN SOC, V61, P485, DOI 10.1111/j.1095-8312.1997.tb01803.x; Evans AR, 2005, BIOL J LINN SOC, V85, P81, DOI 10.1111/j.1095-8312.2005.00474.x; Evans AR, 2003, BIOL J LINN SOC, V78, P173, DOI 10.1046/j.1095-8312.2003.00146.x; FORTELIUS M, 1988, TEETH REVISITED, P459; Hillson S., 2005, TEETH; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; King SJ, 2005, P NATL ACAD SCI USA, V102, P16579, DOI 10.1073/pnas.0508377102; Kurten B., 1964, Acta Zoologica Fennica, V108, P1; Kurten B., 1968, PLEISTOCENE MAMMALS; Lucas P., 2004, DENT FUNCTIONAL MORP; NOWAK R, 1999, WALKERS MAMNMALS WOR; Osborn, 1907, EVOLUTION MAMMALIAN, P48; Owen R., 1840, ODONTOGRAPHY; Peyer B, 1968, COMP ODONTOLOGY; Phillips CJ, 1998, EUR J MORPHOL, V36, P19; Polly P. David, 2005, Journal of Mammalian Evolution, V12, P283, DOI 10.1007/s10914-005-4866-8; Polly PD, 2001, GENETICA, V112, P339, DOI 10.1023/A:1013395907225; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Stevens CE., 1995, COMP PHYSL VERTEBRAT, DOI 10.1086/416640; STRAIT SG, 1993, J HUM EVOL, V25, P471, DOI 10.1006/jhev.1993.1062; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; Ungar PS, 2003, P NATL ACAD SCI USA, V100, P3874, DOI 10.1073/pnas.0637016100; Wible John R., 2005, P15	30	280	284	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					78	81		10.1038/nature05433	http://dx.doi.org/10.1038/nature05433			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17167416				2022-12-28	WOS:000243225100039
J	Castro, G; Martinez, R				Castro, Gleusa; Martinez, Roberto			Disseminated paracoccidioidomycosis and coinfection with HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Sao Paulo, BR-14048900 Ribeirao Preto, Brazil	Universidade de Sao Paulo	Castro, G (corresponding author), Univ Sao Paulo, BR-14048900 Ribeirao Preto, Brazil.	gcastro@hcrp.fmrp.usp.br							0	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2677	2677		10.1056/NEJMicm053465	http://dx.doi.org/10.1056/NEJMicm053465			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182993				2022-12-28	WOS:000242956200009
J	Lehmann, S; Jackson, AD; Lautrup, BE				Lehmann, Sune; Jackson, Andrew D.; Lautrup, Benny E.			Measures for measures	NATURE			English	Editorial Material							INDEX		Tech Univ Denmark, Dept Informat & Math Modeling, DK-2800 Lyngby, Denmark; Niels Bohr Inst, DK-2100 Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen; Niels Bohr Institute	Lehmann, S (corresponding author), Tech Univ Denmark, Dept Informat & Math Modeling, DK-2800 Lyngby, Denmark.			Lehmann, Sune/0000-0001-6099-2345; Jackson, Andrew D./0000-0002-4005-0171				Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Lehmann S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026113; LEHMANN S, 2003, THESIS N BOHR I; SEGLEN PO, 1994, J AM SOC INFORM SCI, V45, P1, DOI 10.1002/(SICI)1097-4571(199401)45:1<1::AID-ASI1>3.0.CO;2-Y; van Raan AFJ, 2006, J AM SOC INF SCI TEC, V57, P408, DOI 10.1002/asi.20284; Van Raan AFJ, 2006, SCIENTOMETRICS, V67, P491, DOI 10.1556/Scient.67.2006.3.10	6	209	219	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1003	1004		10.1038/4441003a	http://dx.doi.org/10.1038/4441003a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183295				2022-12-28	WOS:000242971100029
J	Levin, TR; Zhao, W; Conell, C; Seeff, LC; Manninen, DL; Shapiro, JA; Schulman, J				Levin, Theodore R.; Zhao, Wei; Conell, Carol; Seeff, Laura C.; Manninen, Diane L.; Shapiro, Jean A.; Schulman, Jane			Complications of colonoscopy in an integrated health care delivery system	ANNALS OF INTERNAL MEDICINE			English	Article							LONGITUDINAL DATA-ANALYSIS; COLORECTAL-CANCER; COLONIC POLYPS; AVERAGE-RISK; TASK-FORCE; PERFORATIONS; MANAGEMENT; RECOMMENDATIONS; SIGMOIDOSCOPY; GUIDELINES	Background: Information about colonoscopy complications, particularly postpolypectomy bleeding, is limited. Objective: To quantify the magnitude and severity of colonoscopy complications. Design: Retrospective cohort. Setting: Kaiser Permanente of Northern California. Patients: 16 318 members 40 years of age or older undergoing colonoscopy between January 1994 and July 2002. Measurements: Electronic records reviewed for serious complications, including hospital admission within 30 days of colonoscopy for colonic perforation, colonic bleeding, diverticulitis, the postpolypectomy syndrome, or other serious illnesses directly related to colonoscopy. Results: 82 serious complications occurred (5.0 per 1000 colonescopies [95% Cl, 4.0 to 6.2 per 1000 colonoscopies]). Serious complications occurred in 0.8 per 1000 colonoscopies without biopsy or polypectomy and in 7.0 per 1000 colonoscopies with biopsy or polypectomy. Perforations occurred in 0.9 per 1000 colonoscopies (Cl, 0.5 to 1.5 per 1000 colonoscopies) (0.6 per 1000 without biopsy or polypectomy and 1.1 per 1000 with biopsy or polypectomy). Postbiopsy or postpolypectomy bleeding occurred in 4.8 per 1000 colonoscopies with biopsy (Cl, 3.6 to 6.2 per 1000 colonescopies). Biopsy or polypectomy was associated with an increased risk for any serious complication (rate ratio, 9.2 [Cl, 2.9 to 29.01 vs. colonoscopy without biopsy). Ten deaths (1 attributable to colonoscopy) occurred within 30 days of the colonoscopy. Limitations: 99.3% (16 204) of colonoscopies were nonscreening examinations. The rate of complications may be lower in a primary screening sample. The small number of observed adverse events limited power to detect risk factors for complications. Conclusions: Colonoscopy with biopsy or polypectomy is associated with increased risk for complications. Perforation may also occur during colonoscopies without biopsies.	Kaiser Permanente, Med Care Program, Oakland, CA 94612 USA; Battelle Mem Inst, Seattle, WA USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Kaiser Permanente; Battelle Memorial Institute; Centers for Disease Control & Prevention - USA	Levin, TR (corresponding author), Kaiser Permanente, Med Care Program, 2000 Broadway, Oakland, CA 94612 USA.	Theodore.Levin@kp.org						Anderson ML, 2000, AM J GASTROENTEROL, V95, P3418, DOI 10.1111/j.1572-0241.2000.03356.x; Araghizadeh FY, 2001, DIS COLON RECTUM, V44, P713, DOI 10.1007/BF02234572; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Cobb WS, 2004, AM SURGEON, V70, P750; Eisen GM, 2002, GASTROINTEST ENDOSC, V55, P687, DOI 10.1067/mge.2002.123619; Farley DR, 1997, MAYO CLIN PROC, V72, P729, DOI 10.1016/S0025-6196(11)63592-1; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; Korman LY, 2003, GASTROINTEST ENDOSC, V58, P554, DOI 10.1067/S0016-5107(03)01890-X; Levin TR, 2002, GASTROENTEROLOGY, V123, P1786, DOI 10.1053/gast.2002.37064; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; LO AY, 1994, J AM COLL SURGEONS, V179, P333; Moore RA, 2004, AM SURGEON, V70, P757; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Sakashita M, 2003, ENDOSCOPY, V35, P1033, DOI 10.1055/s-2003-44595; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Waye J D, 1997, Gastrointest Endosc Clin N Am, V7, P413; Waye J D, 1996, Gastrointest Endosc Clin N Am, V6, P343; WAYE JD, 1988, AM J GASTROENTEROL, V83, P120; WAYE JD, 1992, J CLIN GASTROENTEROL, V15, P347, DOI 10.1097/00004836-199212000-00018; WESTON AP, 1995, AM J GASTROENTEROL, V90, P24; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Woolf SH, 2000, NEW ENGL J MED, V343, P1641, DOI 10.1056/NEJM200011303432211; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zubarik R, 1999, GASTROINTEST ENDOSC, V50, P322, DOI 10.1053/ge.1999.v50.97111	30	387	397	1	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2006	145	12					880	886		10.7326/0003-4819-145-12-200612190-00004	http://dx.doi.org/10.7326/0003-4819-145-12-200612190-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120BB	17179057				2022-12-28	WOS:000243057400002
J	Linden, J				Linden, Joel			Purinergic chemotaxis	SCIENCE			English	Editorial Material							ATP RELEASE		Univ Virginia, Dept Med, Charlottesville, VA 22908 USA	University of Virginia	Linden, J (corresponding author), Univ Virginia, Dept Med, Charlottesville, VA 22908 USA.	jlinden@virginia.edu	Linden, Joel/AAH-5690-2020					Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Goepfert C, 2001, CIRCULATION, V104, P3109, DOI 10.1161/hc5001.100663; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Nandigama R, 2006, J BIOL CHEM, V281, P5686, DOI 10.1074/jbc.M510452200; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Wu JJ, 2005, MOL BIOL CELL, V16, P1661, DOI 10.1091/mbc.e04-10-0886	7	44	48	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1689	1690		10.1126/science.1137190	http://dx.doi.org/10.1126/science.1137190			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170280				2022-12-28	WOS:000242833600031
J	Stoerig, P				Stoerig, Petra			The impact of invisible stimuli	SCIENCE			English	Editorial Material									Univ Dusseldorf, Inst Expt Psychol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Stoerig, P (corresponding author), Univ Dusseldorf, Inst Expt Psychol, D-40225 Dusseldorf, Germany.	stoerig@uni-duesseldorf.de						Claparede E, 1911, ARCH PSYCHOLOGIE, V11, P79; de Gelder B, 2001, OUT MIND VARIETIES U; Johansson P, 2005, SCIENCE, V310, P116, DOI 10.1126/science.1111709; Libet B, 2004, MIND TIME TEMPORAL F; Mack A., 1998, INATTENTIONAL BLINDN; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; Tsushima Y, 2006, SCIENCE, V314, P1786, DOI 10.1126/science.1133197; Wegner DM, 2002, BRADFORD BOOKS, P1; [No title captured]	13	6	6	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1694	1695		10.1126/science.1136956	http://dx.doi.org/10.1126/science.1136956			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170285				2022-12-28	WOS:000242833600036
J	Abu-Raddad, LJ; Patnaik, P; Kublin, JG				Abu-Raddad, Laith J.; Patnaik, Padmaja; Kublin, James G.			Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CLINICAL EPISODES; ADULTS; TRANSMISSION; REPLICATION; UGANDA; TUBERCULOSIS; ACTIVATION; INDUCTION; COHORT	Mounting evidence has revealed pathological interactions between HIV and malaria in dually infected patients, but the public health implications of the interplay have remained unclear. A transient almost one-log elevation in HIV viral load occurs during febrile malaria episodes; in addition, susceptibility to malaria is enhanced in HIV-infected patients. A mathematical model applied to a setting in Kenya with an adult population of roughly 200,000 estimated that, since 1980, the disease interaction may have been responsible for 8,500 excess HIV infections and 980,000 excess malaria episodes. Co-infection might also have facilitated the geographic expansion of malaria in areas where HIV prevalence is high. Hence, transient and repeated increases in HIV viral load resulting from recurrent co-infection with malaria may be an important factor in promoting the spread of HIV in sub-Saharan Africa.	Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA; Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA; Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27599 USA; Univ Washington, Int Hlth Program, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Abu-Raddad, LJ (corresponding author), Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA.	laith@scharp.org; jkublin@fhcrc.org	Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506; Kublin, James/0000-0003-1279-3741	NIAID NIH HHS [P30 AI 27757] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2004, MAL HIV INT THEIR IM; BRUCE-CHWATT L. J., 1963, W AFRICAN MED JOUR, V12, P199; Cohen C, 2005, CLIN INFECT DIS, V41, P1631, DOI 10.1086/498023; Cohen MS, 2005, J INFECT DIS, V191, P1391, DOI 10.1086/429414; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Froebel K, 2004, PARASITE IMMUNOL, V26, P213, DOI 10.1111/j.0141-9838.2004.00701.x; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/00002030-200402200-00023; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; *JOINT UN PROGR HI, AIDS EP UP 2005; Kamya MR, 2006, J INFECT DIS, V193, P9, DOI 10.1086/498577; Kirungi WL, 2006, SEX TRANSM INFECT, V82, pI36, DOI 10.1136/sti.2005.017111; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Maher D, 2005, TROP MED INT HEALTH, V10, P734, DOI 10.1111/j.1365-3156.2005.01456.x; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Patnaik P, 2005, J INFECT DIS, V192, P984, DOI 10.1086/432730; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pisell TL, 2002, AIDS, V16, P1503, DOI 10.1097/00002030-200207260-00007; Quigley MA, 2005, TROP MED INT HEALTH, V10, P894, DOI 10.1111/j.1365-3156.2005.01461.x; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; Whitworth JAG, 2005, LANCET, V365, P196; Xiao LH, 1998, J INFECT DIS, V177, P437, DOI 10.1086/514212	28	309	321	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1603	1606		10.1126/science.1132338	http://dx.doi.org/10.1126/science.1132338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158329				2022-12-28	WOS:000242624600044
J	Fike, DA; Grotzinger, JP; Pratt, LM; Summons, RE				Fike, D. A.; Grotzinger, J. P.; Pratt, L. M.; Summons, R. E.			Oxidation of the Ediacaran Ocean	NATURE			English	Article							EARLY ANIMAL EVOLUTION; ATMOSPHERIC OXYGEN; SULFUR-ISOTOPE; CARBON-CYCLE; SULFATE; OMAN; EXCURSION; RISE; AGES	Oxygenation of the Earth's surface is increasingly thought to have occurred in two steps. The first step, which occurred similar to 2,300 million years (Myr) ago, involved a significant increase in atmospheric oxygen concentrations and oxygenation of the surface ocean(1,2). A further increase in atmospheric oxygen appears to have taken place during the late Neoproterozoic period(3,4) (similar to 800-542 Myr ago). This increase may have stimulated the evolution of macroscopic multicellular animals and the subsequent radiation of calcified invertebrates(4,5), and may have led to oxygenation of the deep ocean(6). However, the nature and timing of Neoproterozoic oxidation remain uncertain. Here we present high-resolution carbon isotope and sulphur isotope records from the Huqf Supergroup, Sultanate of Oman, that cover most of the Ediacaran period (similar to 635 to similar to 548 Myr ago). These records indicate that the ocean became increasingly oxygenated after the end of the Marinoan glaciation, and they allow us to identify three distinct stages of oxidation. When considered in the context of other records from this period(7-15), our data indicate that certain groups of eukaryotic organisms appeared and diversified during the second and third stages of oxygenation. The second stage corresponds with the Shuram excursion in the carbon isotope record(16) and seems to have involved the oxidation of a large reservoir of organic carbon suspended in the deep ocean(6), indicating that this event may have had a key role in the evolution of eukaryotic organisms. Our data thus provide new insights into the oxygenation of the Ediacaran ocean and the stepwise restructuring of the carbon(6,16,17) and sulphur cycles(3,18,19) that occurred during this significant period of Earth's history.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA	Massachusetts Institute of Technology (MIT); Indiana University System; Indiana University Bloomington	Fike, DA (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	dfike@mit.edu	Fike, David A/D-3634-2011; Summons, Roger Everett/AAL-3789-2020	Fike, David A/0000-0003-2848-0328; 				Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; BOWRING SA, 2003, ASTROBIOLOGY, V2, P112; BOWRING SA, IN PRESS AM J SCI; BURNS SJ, 1993, ECLOGAE GEOL HELV, V86, P595; Calver CR, 2000, PRECAMBRIAN RES, V100, P121, DOI 10.1016/S0301-9268(99)00072-8; Canfield DE, 2004, AM J SCI, V304, P839, DOI 10.2475/ajs.304.10.839; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Corsetti FA, 2003, GEOL SOC AM BULL, V115, P916, DOI 10.1130/B25066.1; Detmers J, 2001, APPL ENVIRON MICROB, V67, P888, DOI 10.1128/AEM.67.2.888-894.2001; GREY K, 2005, EDIACARAN PALYNOLOGY, V31; GROTZINGER JP, 1995, SCIENCE, V270, P598, DOI 10.1126/science.270.5236.598; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Holland HD., 1984, CHEM EVOLUTION ATMOS; Hurtgen MT, 2006, EARTH PLANET SC LETT, V245, P551, DOI 10.1016/j.epsl.2006.03.026; Hurtgen MT, 2005, GEOLOGY, V33, P41, DOI 10.1130/G20923.1; Johnston DT, 2005, SCIENCE, V310, P1477, DOI 10.1126/science.1117824; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; Le Guerroue E, 2006, PRECAMBRIAN RES, V146, P68, DOI 10.1016/j.precamres.2006.01.007; Le Guerroue E, 2006, TERRA NOVA, V18, P147, DOI 10.1111/j.1365-3121.2006.00674.x; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; MCCARRON GME, 2000, THESIS U OXFORD; Melezhik VA, 2005, PRECAMBRIAN RES, V137, P131, DOI 10.1016/j.precamres.2005.03.010; NARBONNE G, 2005, ANN REV EARTH PLANET, V33, P1; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; Workman RK, 2002, GEOCHIM COSMOCHIM AC, V66, pA847	30	684	760	7	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					744	747		10.1038/nature05345	http://dx.doi.org/10.1038/nature05345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151665				2022-12-28	WOS:000242581100057
J	Kahn, SE; Haffner, SM; Heise, MA; Herman, WH; Holman, RR; Jones, NP; Kravitz, BG; Lachin, JM; O'Neill, MC; Zinman, B; Viberti, G				Kahn, Steven E.; Haffner, Steven M.; Heise, Mark A.; Herman, William H.; Holman, Rury R.; Jones, Nigel P.; Kravitz, Barbara G.; Lachin, John M.; O'Neill, M. Colleen; Zinman, Bernard; Viberti, Giancarlo		ADOPT Study Grp	Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-CELL FUNCTION; TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; CONSENSUS STATEMENT; SULFONYLUREA; ASSOCIATION; PROGRESSION; PREVENTION; THERAPY; TRIAL	BACKGROUND: The efficacy of thiazolidinediones, as compared with other oral glucose-lowering medications, in maintaining long-term glycemic control in type 2 diabetes is not known. METHODS: We evaluated rosiglitazone, metformin, and glyburide as initial treatment for recently diagnosed type 2 diabetes in a double-blind, randomized, controlled clinical trial involving 4360 patients. The patients were treated for a median of 4.0 years. The primary outcome was the time to monotherapy failure, which was defined as a confirmed level of fasting plasma glucose of more than 180 mg per deciliter (10.0 mmol per liter), for rosiglitazone, as compared with metformin or glyburide. Prespecified secondary outcomes were levels of fasting plasma glucose and glycated hemoglobin, insulin sensitivity, and (beta)-cell function. RESULTS: Kaplan-Meier analysis showed a cumulative incidence of monotherapy failure at 5 years of 15% with rosiglitazone, 21% with metformin, and 34% with glyburide. This represents a risk reduction of 32% for rosiglitazone, as compared with metformin, and 63%, as compared with glyburide (P<0.001 for both comparisons). The difference in the durability of the treatment effect was greater between rosiglitazone and glyburide than between rosiglitazone and metformin. Glyburide was associated with a lower risk of cardiovascular events (including congestive heart failure) than was rosiglitazone (P<0.05), and the risk associated with metformin was similar to that with rosiglitazone. Rosiglitazone was associated with more weight gain and edema than either metformin or glyburide but with fewer gastrointestinal events than metformin and with less hypoglycemia than glyburide (P<0.001 for all comparisons). CONCLUSIONS: The potential risks and benefits, the profile of adverse events, and the costs of these three drugs should all be considered to help inform the choice of pharmacotherapy for patients with type 2 diabetes.	Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; Univ Washington, Seattle, WA 98195 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; GlaxoSmithKline, King Of Prussia, PA USA; GlaxoSmithKline, Harlow, Essex, England; Univ Michigan, Ann Arbor, MI 48109 USA; Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; George Washington Univ, Ctr Biostat, Rockville, MD USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Toronto, ON, Canada; Univ London, Kings Coll London Sch Med, London WC1E 7HU, England	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health San Antonio; GlaxoSmithKline; GlaxoSmithKline; University of Michigan System; University of Michigan; University of Oxford; George Washington University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of London; King's College London	Kahn, SE (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, 1660 S Columbian Way, Seattle, WA 98108 USA.	skahn@u.washington.edu	Zinman, Bernard/E-7266-2013; Hramiak, Irene/G-3305-2011	Kahn, Steven/0000-0001-7307-9002; Lachin, John/0000-0001-9838-2841				American Diabetes Association, 1998, DIABETES CARE, V21, pS23, DOI [10.2337/diacare.21.1.S23, DOI 10.2337/DIACARE.21.1.S23]; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Carey DG, 2002, OBES RES, V10, P1008, DOI 10.1038/oby.2002.137; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Ehrmann DA, 1997, J CLIN ENDOCR METAB, V82, P2108, DOI 10.1210/jc.82.7.2108; Festa A, 2006, DIABETES, V55, P1114, DOI 10.2337/diabetes.55.04.06.db05-1100; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Harris SB, 2004, CAN FAM PHYSICIAN, V50, P425; Jensen CC, 2002, DIABETES, V51, P2170, DOI 10.2337/diabetes.51.7.2170; Johnsen S P, 2006, Am J Ther, V13, P134, DOI 10.1097/00045391-200603000-00009; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; Lachin J. M., 2000, WILEY SER PROB STAT; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Samaha FF, 2006, ARTERIOSCL THROM VAS, V26, P624, DOI 10.1161/01.ATV.0000200136.56716.30; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Simpson SH, 2006, CAN MED ASSOC J, V174, P169, DOI 10.1503/cmaj.050748; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UKPDS GROUP, 1995, LANCET, V44, P1249; *UKPDS GROUP, 1996, LANCET, V45, P1655; Viberti G, 2006, DIABETIC MED, V23, P1289, DOI 10.1111/j.1464-5491.2006.02022.x; Viberti G, 2002, DIABETES CARE, V25, P1737, DOI 10.2337/diacare.25.10.1737; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wright A, 2002, DIABETES CARE, V25, P330, DOI 10.2337/diacare.25.2.330; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	33	2217	2336	5	109	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2427	2443		10.1056/NEJMoa066224	http://dx.doi.org/10.1056/NEJMoa066224			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113EO	17145742	Bronze			2022-12-28	WOS:000242581400007
J	Kindig, DA				Kindig, David A.			A pay-for-population health performance system	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY; CARE		Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53726 USA	University of Wisconsin System; University of Wisconsin Madison	Kindig, DA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, 610 Walnut Room,760 WARF, Madison, WI 53726 USA.	dakindig@wisc.edu						*AG HLTH CAR POL R, 1997, PUBL AG HLTH CAR POL; [Anonymous], 1997, PURCHASING POPULATIO; *ASS COMM HLTH IMP, HLTH COMM TOOLS ORG; Birkmeyer NJO, 2006, NEW ENGL J MED, V354, P864, DOI 10.1056/NEJMsb053364; *BRIDG EXC WEB SIT, REW QUAL HEALTHC SYS; DUDLEY RA, 2004, PUBLICATION AG HEALT; EVANS R, 1990, SOC SCI MED, V33, P1347; Fox DM, 2006, HEALTH ECON POLICY L, V1, P395, DOI 10.1017/S1744133106006037; Grossbart SR, 2006, MED CARE RES REV, V63, p29S, DOI 10.1177/1077558705283643; Kindig D, 2003, HEALTH SERV RES, V38, P1923, DOI 10.1111/j.1475-6773.2003.00209.x; *LEAPFR GROUP WEB, AL INC HIGH QUAL HLT; Marmot M., 2004, STATUS SYNDROME, DOI 10.1111/J.1740-9713.2004.00058.X; McGinnis JM, 2006, HEALTH AFFAIR, V25, P1044, DOI 10.1377/hlthaff.25.4.1044; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; *NAT AC PRESS WEB, 2006, REW PROV PERF AL INC; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Size T, 2006, J RURAL HEALTH, V22, P93, DOI 10.1111/j.1748-0361.2006.00015.x; Smith P., 1995, INT J PUBLIC ADMIN, V18, P277, DOI DOI 10.1080/01900699508525011; Starr P, 1982, SOCIAL TRANSFORMATIO; STODDART GL, 2006, HLTH SOC; *US DEP HHS, 2005, 76641496 US DEP HLTH; WENNBERG JE, HLTH AFFAIRS; Williams A, 1997, BRIT MED J, V314, P820, DOI 10.1136/bmj.314.7083.820; Woolf SH, 2004, ANN INTERN MED, V140, P33, DOI 10.7326/0003-4819-140-1-200401060-00009	24	36	36	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2006	296	21					2611	2613		10.1001/jama.296.21.2611	http://dx.doi.org/10.1001/jama.296.21.2611			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	112ND	17148726				2022-12-28	WOS:000242532000023
J	Horton, R				Horton, Richard			A new discipline is born: comparative health-systems studies	LANCET			English	Editorial Material							MEXICO; REFORM; POLICY		Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.							[Anonymous], 2004, LANCET, V364, P1911; [Anonymous], 2004, MEXICO STATEMENT HLT; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Frenk J, 2006, LANCET, V368, P3, DOI 10.1016/S0140-6736(06)68942-3; Hamid M, 2005, LANCET, V366, P1758, DOI 10.1016/S0140-6736(05)67709-4; Knaul FM, 2005, HEALTH AFFAIR, V24, P1467, DOI 10.1377/hlthaff.24.6.1467; MDEL CRM, 2006, SCIENCE, V319, P1610; Pang T, 2003, B WORLD HEALTH ORGAN, V81, P815; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0	11	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 2	2006	368	9551					1949	1950		10.1016/S0140-6736(06)69788-2	http://dx.doi.org/10.1016/S0140-6736(06)69788-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141689				2022-12-28	WOS:000242593300010
J	Anderson, ARA; Weaver, AM; Cummings, PT; Quaranta, V				Anderson, Alexander R. A.; Weaver, Alissa M.; Cummings, Peter T.; Quaranta, Vito			Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment	CELL			English	Article							GROWTH; MODEL; METASTASIS; PROGRESSION	Emergence of invasive behavior in cancer is life-threatening, yet ill-defined due to its multifactorial nature. We present a multiscale mathematical model of cancer invasion, which considers cellular and microenvironmental factors simultaneously and interactively. Unexpectedly, the model simulations predict that harsh tumor microenvironment conditions (e.g., hypoxia, heterogenous extracellular matrix) exert a dramatic selective force on the tumor, which grows as an invasive mass with fingering margins, dominated by a few clones with aggressive traits. In contrast, mild microenvironment conditions (e.g., normoxia, homogeneous matrix) allow clones with similar aggressive traits to coexist with less aggressive phenotypes in a heterogeneous tumor mass with smooth, noninvasive margins. Thus, the genetic make-up of a cancer cell may realize its invasive potential through a clonal evolution process driven by definable microenvironmental selective forces. Our mathematical model provides a theoretical/ experimental framework to quantitatively characterize this selective pressure for invasion and test ways to eliminate it.	Univ Dundee, Div Math, Dundee DD1 4HN, Scotland; Vanderbilt Univ, Dept Chem Engn, Nashville, TN 37235 USA; Oak Ridge Natl Lab, Nanomat Theory Inst, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA	University of Dundee; Vanderbilt University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; Vanderbilt University	Anderson, ARA (corresponding author), Univ Dundee, Div Math, Dundee DD1 4HN, Scotland.	anderson@maths.dundee.ac.uk; vito.quaranta@vanderbilt.edu	Anderson, Alexander R.A./A-2713-2011; Cummings, Peter T/B-8762-2013; Quaranta, Vito/G-6512-2016	Anderson, Alexander R.A./0000-0002-2536-4383; Cummings, Peter T/0000-0002-9766-2216; Quaranta, Vito/0000-0001-7491-8672	NCI NIH HHS [U54 CA113007, K22 CA109590] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA109590, U54CA113007] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Anderson ARA, 1997, FUND APPL NEMATOL, V20, P165; AndersonAR ChaplainMA, 2000, J THEORETICAL MED, V2, P129, DOI DOI 10.1080/10273660008833042; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chaplain MAJ, 1996, MATH COMPUT MODEL, V23, P47, DOI 10.1016/0895-7177(96)00019-2; EIGEN M, 1993, GENE, V135, P37, DOI 10.1016/0378-1119(93)90047-7; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Kerbel R S, 1990, Adv Cancer Res, V55, P87, DOI 10.1016/S0065-230X(08)60469-8; KORCZAK B, 1988, MOL CELL BIOL, V8, P3143, DOI 10.1128/MCB.8.8.3143; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liotta LA, 2003, NAT GENET, V33, P10, DOI 10.1038/ng0103-10; Maley CC, 2005, SEMIN CANCER BIOL, V15, P474, DOI 10.1016/j.semcancer.2005.06.004; Matrisian LM, 2001, CANCER RES, V61, P3844; Michor F, 2005, SEMIN CANCER BIOL, V15, P484, DOI 10.1016/j.semcancer.2005.06.005; Michor F, 2004, CELL CYCLE, V3, P358; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; RAK JW, 1993, IN VITRO CELL DEV-AN, V29A, P742; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rubin H, 2003, ADV CANCER RES, V90, P1, DOI 10.1016/S0065-230X(03)90001-7; Weiss L, 1990, Adv Cancer Res, V54, P159, DOI 10.1016/S0065-230X(08)60811-8; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327	33	515	527	1	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					905	915		10.1016/j.cell.2006.09.042	http://dx.doi.org/10.1016/j.cell.2006.09.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129778	Bronze			2022-12-28	WOS:000242613800009
J	Cheeseman, IM; Chappie, JS; Wilson-Kubalek, EM; Desai, A				Cheeseman, Iain M.; Chappie, Joshua S.; Wilson-Kubalek, Elizabeth M.; Desai, Arshad			The conserved KMN network constitutes the core microtubule-binding site of the kinetochore	CELL			English	Article							OUTER KINETOCHORE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; SPINDLE CHECKPOINT; NDC80 COMPLEX; ATTACHMENT; ARCHITECTURE; COMPONENTS; INTERFACE; DYNAMICS	The microtubule-binding interface of the kinetochore is of central importance in chromosome segregation. Although kinetochore components that stabilize, translocate on, and affect the polymerization state of microtubules have been identified, none have proven essential for kinetochore-microtubule interactions. Here, we examined the conserved KNL-1 /Mis12 complex/Ndc80 complex (KMN) network, which is essential for kinetochore-microtubule interactions in vivo. We identified two distinct microtubule-binding activities within the KMN network: one associated with the Ndc80/Nuf2 subunits of the Ndc80 complex, and a second in KNL-1. Formation of the complete KMN network, which additionally requires the Mis12 complex and the Spc24/Spc25 subunits of the Ndc80 complex, synergistically enhances microtubule-binding activity. Phosphorylation by Aurora B, which corrects improper kinetochore-microtubule connections in vivo, reduces the affinity of the Ndc80 complex for microtubules in vitro. Based on these findings, we propose that the conserved KMN network constitutes the core microtubule-binding site of the kinetochore.	Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, Ctr Integrat Mol Biosci, La Jolla, CA 92037 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute	Cheeseman, IM (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, CMM E,Room 3052, La Jolla, CA 92093 USA.	icheeseman@ucsd.edu; abdesai@ucsd.edu	Chappie, Joshua S./AAV-6076-2021	Chappie, Joshua S./0000-0002-5733-7275; Cheeseman, Iain/0000-0002-3829-5612	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061938, R01GM074215, R01GM052468] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52468, R01 GM074215, GM61938] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Emanuele MJ, 2005, MOL BIOL CELL, V16, P4882, DOI 10.1091/mbc.E05-03-0239; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Kline-Smith SL, 2005, CURR OPIN CELL BIOL, V17, P35, DOI 10.1016/j.ceb.2004.12.009; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Schrader, 1953, MITOSIS MOVEMENT CHR; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349	32	714	729	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					983	997		10.1016/j.cell.2006.09.039	http://dx.doi.org/10.1016/j.cell.2006.09.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129783	Bronze			2022-12-28	WOS:000242613800015
J	Swanton, E; High, S				Swanton, Eileithyia; High, Stephen			ER targeting signals: More than meets the eye?	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM; SEQUENCES; PEPTIDE		Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Swanton, E (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	lisa.swanton@manchester.ac.uk; stephen.high@manchester.ac.uk		Swanton, Eileithyia/0000-0002-3299-4228; High, Stephen/0000-0002-4532-8152	Biotechnology and Biological Sciences Research Council [SF16973] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; KAISER CA, 1987, SCIENCE, V235, P312, DOI 10.1126/science.3541205; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; York J, 2004, J VIROL, V78, P10783, DOI 10.1128/JVI.78.19.10783-10792.2004	9	11	11	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 1	2006	127	5					877	879		10.1016/j.cell.2006.11.018	http://dx.doi.org/10.1016/j.cell.2006.11.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129773	Bronze			2022-12-28	WOS:000242613800004
J	Rubegni, P; Fimiani, M				Rubegni, Pietro; Fimiani, MicrIete			Bisphosphonate-associated contact stomatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Siena, I-53100 Siena, Italy	University of Siena	Rubegni, P (corresponding author), Univ Siena, Via Laterina 8, I-53100 Siena, Italy.	rubegni@unisi.it	Rubegni, Pietro/J-8734-2016	Rubegni, Pietro/0000-0002-4128-3145					0	26	26	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					E25	E25		10.1056/NEJMicm054413	http://dx.doi.org/10.1056/NEJMicm054413			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110CG	17135579				2022-12-28	WOS:000242355300011
J	Sidibe, M; Ramiah, I; Buse, K				Sidibe, Michel; Ramiah, Ilavenil; Buse, Kent			Alignment, harmonisation, and accountability in HIV/AIDS	LANCET			English	Editorial Material									UNAIDS, Country & Reg Support, Geneva, Switzerland; Overseas Dev Inst, London SE1 7JD, England	UNAIDS	Buse, K (corresponding author), UNAIDS, Country & Reg Support, Geneva, Switzerland.	k.buse@odi.org.uk	Buse, Kent/AAK-6688-2020	Buse, Kent/0000-0002-5485-0110				Sidibe M, 2006, J ROY SOC MED, V99, P497, DOI 10.1258/jrsm.99.10.497; *UNAIDS, UN ACC UNAIDS ASS SC; *UNAIDS, 2006, EFF MULT ACT AIDS HA; UNAIDS, 2005, GLOB TASK TEAM IMPR; 2005, JOINT PROGR ENHANCED	5	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1853	1854		10.1016/S0140-6736(06)69755-9	http://dx.doi.org/10.1016/S0140-6736(06)69755-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126703				2022-12-28	WOS:000242345900009
J	MacAlister, CA; Ohashi-Ito, K; Bergmann, DC				MacAlister, Cora A.; Ohashi-Ito, Kyoko; Bergmann, Dominique C.			Transcription factor control of asymmetric cell divisions that establish the stomatal lineage	NATURE			English	Article							ARABIDOPSIS; MOUTHS; TOO; MUTANTS; PATTERN	The establishment of new cell lineages during development often requires a symmetry-breaking event. An asymmetric division in the epidermis of plants initiates a lineage that ultimately produces stomatal guard cells. Stomata are pores in the epidermis that serve as the main conduits for gas exchange between plants and the atmosphere; they are critical for photosynthesis and exert a major influence on global carbon and water cycles(1). Recent studies implicated intercellular signalling in preventing the inappropriate production of stomatal complexes(2-4). Genes required to make stomata, however, remained elusive. Here we report the identification of a gene, SPEECHLESS (SPCH), encoding a basic helix - loop helix ( bHLH) transcription factor that is necessary and sufficient for the asymmetric divisions that establish the stomatal lineage in Arabidopsis thaliana. We demonstrate that SPCH and two paralogues are successively required for the initiation, proliferation and terminal differentiation of cells in the stomatal lineage. The stomatal bHLHs define a molecular pathway sufficient to create one of the key cell types in plants. Similar molecules and regulatory mechanisms are used during muscle and neural development(5,6), highlighting a conserved use of closely related bHLHs for cell fate specification and differentiation.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Bergmann, DC (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	dbergmann@stanford.edu		Bergmann, Dominique/0000-0003-0873-3543; MacAlister, Cora/0000-0003-1470-0596				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Geisler M, 1998, PLANTA, V205, P522, DOI 10.1007/s004250050351; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; Lucas JR, 2006, J EXP BOT, V57, P71, DOI 10.1093/jxb/erj017; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau Jeanette A, 2002, Arabidopsis Book, V1, pe0066, DOI 10.1199/tab.0066; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227	20	361	399	6	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					537	540		10.1038/nature05491	http://dx.doi.org/10.1038/nature05491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17183265				2022-12-28	WOS:000243867300043
J	Ito, Y; Obara, K; Shiomi, K; Sekine, S; Hirose, H				Ito, Yoshihiro; Obara, Kazushige; Shiomi, Katsuhiko; Sekine, Shutaro; Hirose, Hitoshi			Slow earthquakes coincident with episodic tremors and slow slip events	SCIENCE			English	Article							LOW-FREQUENCY EARTHQUAKES; MOMENT TENSOR; JAPAN; SUBDUCTION; INVERSION	We report on the very-low-frequency earthquakes occurring in the transition zone of the subducting plate interface along the Nankai subduction zone in southwest Japan. Seismic waves generated by very-low-frequency earthquakes with seismic moment magnitudes of 3.1 to 3.5 predominantly show a long period of about 20 seconds. The seismicity of very-low-frequency earthquakes accompanies and migrates with the activity of deep low-frequency tremors and slow slip events. The coincidence of these three phenomena improves the detection and characterization of slow earthquakes, which are thought to increase the stress on updip megathrust earthquake rupture zones.	Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan	National Research Institute for Earth Science & Disaster Resilience	Ito, Y (corresponding author), Natl Res Inst Earth Sci & Disaster Prevent, 3-1 Tennodai, Tsukuba, Ibaraki 3050006, Japan.	yito@bosai.go.jp	汐見, 勝彦/V-4649-2019; Hirose, Hitoshi/AAF-8903-2020; Ito, Yoshihiro/M-2319-2017	Hirose, Hitoshi/0000-0001-5527-3733; Ito, Yoshihiro/0000-0001-9484-9539; SHIOMI, Katsuhiko/0000-0003-3566-0749				ANDO M, 1975, TECTONOPHYSICS, V25, P69, DOI 10.1016/0040-1951(75)90011-6; Hirose H, 2005, EARTH PLANETS SPACE, V57, P961, DOI 10.1186/BF03351875; HYNDMAN RD, 1995, J GEOPHYS RES-SOL EA, V100, P15373, DOI 10.1029/95JB00153; Ito Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025270; Ito Y, 2006, GEOPHYS J INT, V167, P1317, DOI 10.1111/j.1365-246X.2006.03109.x; Kao H, 2005, NATURE, V436, P841, DOI 10.1038/nature03903; Kawakatsu H., 1998, B EARTHQ RES I TOKYO, V73, P267; Kodaira S, 2004, SCIENCE, V304, P1295, DOI 10.1126/science.1096535; Lay T., 1981, Earthquake Prediction. An International Review. Symposium on Earthquake Prediction, P579, DOI 10.1029/ME004p0579; Obara K, 2006, TECTONOPHYSICS, V417, P33, DOI 10.1016/j.tecto.2005.04.013; Obara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020848; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Obara K, 2005, EARTH PLANETS SPACE, V57, P321, DOI 10.1186/BF03352570; OBARA K, 2005, REV SCI INSTRUM, V76, DOI DOI 10.1036/1.1854197; Okada Y, 2004, EARTH PLANETS SPACE, V56, pXV, DOI 10.1186/BF03353076; OKAL EA, 1982, EARTH PLANET SC LETT, V57, P75, DOI 10.1016/0012-821X(82)90174-1; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; ROGERS G, 2003, SCIENCE         0508, DOI DOI 10.1126/SCIENCE.1084783; SEKINE S, 2006, JAP GEOSC UN M 2006; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Shiomi K, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002774; Shiomi K, 2006, TECTONOPHYSICS, V420, P205, DOI 10.1016/j.tecto.2006.01.017; Tajima F, 2002, B SEISMOL SOC AM, V92, P739, DOI 10.1785/0120000294; WESSON RL, 1973, J GEOPHYS RES, V78, P8527, DOI 10.1029/JB078i035p08527	24	336	345	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					503	506		10.1126/science.1134454	http://dx.doi.org/10.1126/science.1134454			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17138867				2022-12-28	WOS:000243726600043
J	Banikazemi, M; Bultas, J; Waldek, S; Wilcox, WR; Whitley, CB; McDonald, M; Finkel, R; Packman, S; Bichet, DG; Warnock, DG; Desnick, RJ				Banikazemi, Maryam; Bultas, Jan; Waldek, Stephen; Wilcox, William R.; Whitley, Chester B.; McDonald, Marie; Finkel, Richard; Packman, Seymour; Bichet, Daniel G.; Warnock, David G.; Desnick, Robert J.		Fabry Dis Clin Trial Study Grp	Agalsidase-beta therapy for advanced Fabry disease - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							ENZYME-REPLACEMENT THERAPY; CLINICAL MANIFESTATIONS; ALPHA-GALACTOSIDASE; ATYPICAL VARIANT; EFFICACY; KIDNEY; SAFETY; NEPHROPATHY; INVOLVEMENT; MANAGEMENT	Background: Fabry disease (alpha-galactosidase A deficiency) is a rare, X-linked lysosomal storage disorder that can cause early death from renal, cardiac, and cerebrovascular involvement. Objective: To see whether agalsidase beta delays the onset of a composite clinical outcome of renal, cardiovascular, and cerebrovascular events and death in patients with advanced Fabry disease. Design: Randomized (2:1 treatment-to-placebo randomization), double-blind, placebo-controlled trial. Setting: 41 referral centers in 9 countries Patients: 82 adults with mild to moderate kidney disease; 74 of whom were protocol-adherent. Intervention: Intravenous infusion of agalsiclase beta (1 mg per kg of body weight) or placebo every 2 weeks for up to 35 months (median, 18.5 months). Measurements: The primary end point was the time to first clinical event (renal, cardiac, or cerebrovascular event or death). Six patients withdrew before reaching an end point: 3 to receive commercial therapy and 3 due to positive or inconclusive serum IgE or skin test results. Three patients assigned to agalsidase beta elected to transition to open-label treatment before reaching an end point. Results: Thirteen (42%) of the 31 patients in the placebo group and 14 (27%) of the 51 patients in the agalsidase-beta group experienced clinical events. Primary intention-to-treat analysis that adjusted for an imbalance in baseline proteinuria showed that, compared with placebo, agalsiclase beta delayed the time to first clinical event (hazard ratio, 0.47 [95% CI, 0.21 to 1.03]; P = 0.06). Secondary analyses of protocol-adherent patients showed similar results (hazard ratio, 0.39 [CI, 0.16 to 0.93]; P = 0.034). Ancillary subgroup analyses found larger treatment effects in patients with baseline estimated glomerular filtration rates greater than 55 mL/min per 1.73 m(2) (hazard ratio, 0.19 [CI, 0.05 to 0.82]; P = 0.025) compared with 55 mL/min per 1.73 m(2) or less (hazard ratio, 0.85 [CI, 0.32 to 2.3]; P = 0.75) (formal test for interaction, P = 0.09). Most treatment-related adverse events were mild or moderate infusion-associated reactions, reported by 55% of patients in the agalsidase-beta. group and 23% of patients in the placebo group. Limitations: The study sample was small. Only one third of the patients experienced clinical events, and some patients withdrew before experiencing any event. Conclusions: Agalsidase-beta therapy slowed progression to the composite clinical outcome of renal, cardiac, and cerebrovascular complications and death compared with placebo in patients with advanced Fabry disease. Therapeutic intervention before irreversible organ damage may provide greater clinical benefit.	NYU, Dept Human Genet, Mt Sinai Sch Med, New York, NY 10029 USA; Univ Hosp, Prague, Czech Republic; Hope Hosp, Manchester, Lancs, England; Salford Royal Hosp, Natl Hlth Serv Trust, Manchester, Lancs, England; Inst Med Genet, Los Angeles, CA USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Univ Minnesota, Minneapolis, MN USA; Duke Univ, Med Ctr, Durham, NC USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Montreal, Montreal, PQ, Canada; Univ Alabama Birmingham, Birmingham, AL USA	Icahn School of Medicine at Mount Sinai; New York University; General University Hospital Prague; Salford Royal NHS Foundation Trust; Salford Royal Hospital; Cedars Sinai Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Duke University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California San Francisco; Universite de Montreal; University of Alabama System; University of Alabama Birmingham	Desnick, RJ (corresponding author), NYU, Dept Human Genet, Mt Sinai Sch Med, 5th Ave 100th St,Box 1498, New York, NY 10029 USA.	admin.desnick@mssm.edu		Tylki-Szymanska, Anna/0000-0002-8935-1768; BICHET, DANIEL-G/0000-0003-2856-6850; west, michael/0000-0003-4897-1378	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000032, M01RR000071, M01RR001271, M01RR000400, M01RR000240, M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034045] Funding Source: NIH RePORTER; NCRR NIH HHS [5 M01 RR00240, 5 M01 RR00400, 5 M01 RR00425, 5 M01 RR01271, 5 M01 RR00032, 5 M01 RR00071] Funding Source: Medline; NIDDK NIH HHS [5 R37 DK34045] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2014, METABOLIC MOL BASES; Banikazemi M, 2005, MOL GENET METAB, V85, P255, DOI 10.1016/j.ymgme.2005.04.009; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Breunig F, 2006, KIDNEY INT, V69, P1216, DOI 10.1038/sj.ki.5000208; COLOMBI A, 1967, HELV MED ACTA, V34, P67; De Schoenmakere G, 2003, NEPHROL DIAL TRANSPL, V18, P33, DOI 10.1093/ndt/18.1.33; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; *EUR MED AG COMM M, 2006, GUID CLIN TRIALS SMA; Fisher LD., 1997, BIOMETRICS, V53, P1182; Fleiss JL., 2003, STAT METHODS RATES P; Gould AL, 1998, STAT MED, V17, P89, DOI 10.1002/(SICI)1097-0258(19980115)17:1<89::AID-SIM730>3.3.CO;2-4; Grimm RH, 1997, KIDNEY INT, pS10; Guffon N, 2004, J INHERIT METAB DIS, V27, P221, DOI 10.1023/B:BOLI.0000028726.11177.8b; Hilz MJ, 2004, NEUROLOGY, V62, P1066, DOI 10.1212/01.WNL.0000118207.84514.40; Hosmer DW, 1999, WILEY PS TX; KALBFLEISCH JD, 2002, STAT ANAL FAILURE TI, P95, DOI DOI 10.1002/9781118032985; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Mignani R, 2004, KIDNEY INT, V65, P1381, DOI 10.1111/j.1523-1755.2004.00514.x; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Nakao S, 2003, KIDNEY INT, V64, P801, DOI 10.1046/j.1523-1755.2003.00160.x; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pisani A, 2005, AM J KIDNEY DIS, V46, P120, DOI 10.1053/j.ajkd.2005.03.016; ROTHMAN KJ, 1999, APPL SURVIVAL ANAL R, P256; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P256; SCHIFFMANN R, 2000, AM SOC HUM GEN ANN M; Segura J, 2004, KIDNEY INT, V66, pS45, DOI 10.1111/j.1523-1755.2004.09212.x; Segura Julian, 2002, Curr Cardiol Rep, V4, P458, DOI 10.1007/s11886-002-0106-5; Shahinfar S, 2005, KIDNEY INT, V67, pS48, DOI 10.1111/j.1523-1755.2005.09311.x; Spinelli L, 2004, CLIN GENET, V66, P158, DOI 10.1111/j.1399-0004.2004.00284.x; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Thadhani R, 2002, KIDNEY INT, V61, P249, DOI 10.1046/j.1523-1755.2002.00097.x; Thurberg BL, 2004, J INVEST DERMATOL, V122, P900, DOI 10.1111/j.0022-202X.2004.22425.x; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Tsakiris D, 1996, NEPHROL DIAL TRANSPL, V11, P4; VONSCHEIDT W, 1991, NEW ENGL J MED, V324, P395, DOI 10.1056/NEJM199102073240607; Waldek S, 2003, NEW ENGL J MED, V348, P1186, DOI 10.1056/NEJM200303203481224; Weidemann F, 2003, CIRCULATION, V108, P1299, DOI 10.1161/01.CIR.0000091253.71282.04; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366	45	438	467	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2007	146	2					77	86		10.7326/0003-4819-146-2-200701160-00148	http://dx.doi.org/10.7326/0003-4819-146-2-200701160-00148			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131WF	17179052				2022-12-28	WOS:000243901000001
J	Bocquet, N; de Carvalho, LP; Cartaud, J; Neyton, J; Le Poupon, C; Taly, A; Grutter, T; Changeux, JP; Corringer, PJ				Bocquet, Nicolas; de Carvalho, Lia Prado; Cartaud, Jean; Neyton, Jacques; Le Poupon, Chantal; Taly, Antoine; Grutter, Thomas; Changeux, Jean-Pierre; Corringer, Pierre-Jean			A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family	NATURE			English	Article							BINDING-PROTEIN; GATING MECHANISM; DOMAIN; MODULATION; SUBUNIT; DESENSITIZATION; MUTATIONS; REVEALS; FORM; LOOP	Ligand-gated ion channels (LGICs) mediate excitatory and inhibitory transmission in the nervous system. Among them, the pentameric or 'Cys-loop' receptors (pLGICs) compose a family that until recently was found in only eukaryotes. Yet a recent genome search identified putative homologues of these proteins in several bacterial species(1). Here we report the cloning, expression and functional identification of one of these putative homologues from the cyanobacterium Gloeobacter violaceus. It was expressed as a homo-oligomer in HEK 293 cells and Xenopus oocytes, generating a transmembrane cationic channel that is opened by extracellular protons and shows slow kinetics of activation, no desensitization and a single channel conductance of 8 pS. Electron microscopy and cross-linking experiments of the protein fused to the maltose-binding protein and expressed in Escherichia coli are consistent with a homo-pentameric organization. Sequence comparison shows that it possesses a compact structure, with the absence of the amino-terminal helix, the canonical disulphide bridge and the large cytoplasmic domain found in eukaryotic pLGICs. Therefore it embodies a minimal structure required for signal transduction. These data establish the prokaryotic origin of the family. Because Gloeobacter violaceus carries out photosynthesis and proton transport at the cytoplasmic membrane(2), this new proton-gated ion channel might contribute to adaptation to pH change.	Inst Pasteur, CNRS, URA D2182, Unit Receptor & Cognit, F-75015 Paris, France; Univ Paris 06 & 7, Inst Jacques Monod, CNRS, UMR 7590, F-75005 Paris, France; Ecole Normale Super, CNRS, UMR 8544, Neurobiol Lab, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Corringer, PJ (corresponding author), Inst Pasteur, CNRS, URA D2182, Unit Receptor & Cognit, F-75015 Paris, France.	pjcorrin@pasteur.fr	Taly, Antoine/B-3339-2008	Taly, Antoine/0000-0001-5109-0091; Grutter, Thomas/0000-0002-4351-9203				BELKIN S, 1987, PLANT PHYSIOL, V84, P25, DOI 10.1104/pp.84.1.25; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CARTAUD J, 1978, J CELL SCI, V29, P313; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; Fischer M, 2001, P NATL ACAD SCI USA, V98, P3567, DOI 10.1073/pnas.041594798; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; Grutter T, 2005, CR BIOL, V328, P223, DOI 10.1016/j.crvi.2004.11.004; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Paoletti P, 1997, J NEUROSCI, V17, P5711; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Schofield CM, 2004, BIOCHEMISTRY-US, V43, P10058, DOI 10.1021/bi036159g; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wilkins ME, 2005, J PHYSIOL-LONDON, V567, P365, DOI 10.1113/jphysiol.2005.088823; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030	30	242	281	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					116	119		10.1038/nature05371	http://dx.doi.org/10.1038/nature05371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17167423				2022-12-28	WOS:000243225100047
J	Horz, F; Bastien, R; Borg, J; Bradley, JP; Bridges, JC; Brownlee, DE; Burchell, MJ; Chi, MF; Cintala, MJ; Dai, ZR; Djouadi, Z; Dominguez, G; Economou, TE; Fairey, SAJ; Floss, C; Franchi, IA; Graham, GA; Green, SF; Heck, P; Hoppe, P; Huth, J; Ishii, H; Kearsley, AT; Kissel, J; Leitner, J; Leroux, H; Marhas, K; Messenger, K; Schwandt, CS; See, TH; Snead, C; Stadermann, FJ; Stephan, T; Stroud, R; Teslich, N; Trigo-Rodriguez, JM; Tuzzolino, AJ; Troadec, D; Tsou, P; Warren, J; Westphal, A; Wozniakiewicz, P; Wright, I; Zinner, E				Hoerz, Friedrich; Bastien, Ron; Borg, Janet; Bradley, John P.; Bridges, John C.; Brownlee, Donald E.; Burchell, Mark J.; Chi, Miaofang; Cintala, Mark J.; Dai, Zu Rong; Djouadi, Zahia; Dominguez, Gerardo; Economou, Thanasis E.; Fairey, Sam A. J.; Floss, Christine; Franchi, Ian A.; Graham, Giles A.; Green, Simon F.; Heck, Philipp; Hoppe, Peter; Huth, Joachim; Ishii, Hope; Kearsley, Anton T.; Kissel, Jochen; Leitner, Jan; Leroux, Hugues; Marhas, Kuljeet; Messenger, Keiko; Schwandt, Craig S.; See, Thomas H.; Snead, Christopher; Stadermann, Frank J.; Stephan, Thomas; Stroud, Rhonda; Teslich, Nick; Trigo-Rodriguez, Josep M.; Tuzzolino, A. J.; Troadec, David; Tsou, Peter; Warren, Jack; Westphal, Andrew; Wozniakiewicz, Penelope; Wright, Ian; Zinner, Ernst			Impact features on Stardust: Implications for comet 81P/Wild 2 dust	SCIENCE			English	Article								Particles emanating from comet 81P/ Wild 2 collided with the Stardust spacecraft at 6.1 kilometers per second, producing hypervelocity impact features on the collector surfaces that were returned to Earth. The morphologies of these surprisingly diverse features were created by particles varying from dense mineral grains to loosely bound, polymineralic aggregates ranging from tens of nanometers to hundreds of micrometers in size. The cumulative size distribution of Wild 2 dust is shallower than that of comet Halley, yet steeper than that of comet Grigg-Skjellerup.	NASA, Lyndon B Johnson Space Ctr, Engn Sci Contract Grp, Houston, TX 77058 USA; Inst Astrophys Spatiale, F-91405 Orsay, France; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Univ Kent, Ctr Astrophys & Planetary Sci, Canterbury CT2 7NH, Kent, England; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Chicago, Enrico Fermi Inst, Lab Astrophys & Space Res, Chicago, IL 60637 USA; Washington Univ, Space Sci Lab, St Louis, MO 63160 USA; Max Planck Inst Chem, Particle Chem Dept, D-55020 Mainz, Germany; Nat Hist Museum, Dept Mineral, London SW7 5BD, England; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; Univ Munster, Inst Planetol, D-48149 Munster, Germany; Univ Lille, Lab Struct & Proprietes Etat Solide, F-59655 Villeneuve Dascq, France; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; USN, Res Lab, Washington, DC 20375 USA; CSIC, Inst Estudis Espacials Catalunya, Inst Space Sci, Barcelona 08193, Spain; Inst Estudis Espacials Catalunya, Barcelona 08034, Spain; Univ Lille, Inst Electron Microelectron & Nanotechnol, F-59655 Villeneuve Dascq, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Open University - UK; University of Washington; University of Washington Seattle; University of Kent; University of California System; University of California San Diego; University of Chicago; Washington University (WUSTL); Max Planck Society; Natural History Museum London; Max Planck Society; University of Munster; Universite de Lille - ISITE; Universite de Lille; University of California System; University of California Berkeley; United States Department of Defense; United States Navy; Naval Research Laboratory; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Institut d'Estudis Espacials de Catalunya (IEEC); Universite de Lille - ISITE; Universite de Lille; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Horz, F (corresponding author), NASA, Lyndon B Johnson Space Ctr, Engn Sci Contract Grp, Houston, TX 77058 USA.	friedrich.p.horz@jsc.nasa.gov	Stephan, Thomas/C-1023-2008; Hoppe, Peter/B-3032-2015; Stroud, Rhonda M./C-5503-2008; Stroud, Rhonda M/S-4584-2018; Trigo-Rodriguez, Josep M./ABF-5444-2020; Heck, Philipp R/AAU-1433-2021; Chi, Miaofang/Y-3603-2019; Leitner, Jan/A-7391-2015; Stroud, Rhonda/GQZ-0151-2022; Leroux, Hugues/S-4570-2017; Green, Simon F/C-7408-2009; Dai, Zurong/E-6732-2010; Trigo-Rodríguez, Josep M./L-3870-2014; Heck, Philipp/C-6092-2012	Stephan, Thomas/0000-0001-6377-8731; Hoppe, Peter/0000-0003-3681-050X; Stroud, Rhonda M./0000-0001-5242-8015; Stroud, Rhonda M/0000-0001-5242-8015; Heck, Philipp R/0000-0002-6319-2594; Chi, Miaofang/0000-0003-0764-1567; Leitner, Jan/0000-0003-3655-6273; Stroud, Rhonda/0000-0001-5242-8015; Leroux, Hugues/0000-0002-8806-8434; Green, Simon F/0000-0002-9153-9786; Trigo-Rodríguez, Josep M./0000-0001-8417-702X; Dai, Zurong/0000-0002-4209-8718; Burchell, Mark/0000-0002-2680-8943; Marhas, Kuljeet/0000-0002-3375-3047; Ishii, Hope/0000-0002-7976-5078				Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; Burchell MJ, 2006, ANNU REV EARTH PL SC, V34, P385, DOI 10.1146/annurev.earth.34.031405.124939; BURCHELL MJ, COMMUNICATION; CLARK SC, 2004, J GEOPHYS RES, V109, DOI DOI 10.1029/2004JE002319; EDENHOFER P, 1987, ASTRON ASTROPHYS, V187, P712; Flynn GJ, 2006, SCIENCE, V314, P1731, DOI 10.1126/science.1136141; Green SF, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002318; Greenberg JM, 1999, SPACE SCI REV, V90, P149, DOI 10.1023/A:1005298014670; Horz F, 2000, ICARUS, V147, P559, DOI 10.1006/icar.2000.6450; Kearsley AT, 2006, METEORIT PLANET SCI, V41, P167, DOI 10.1111/j.1945-5100.2006.tb00201.x; KEARSLEY AT, IN PRESS METEORIT PL; Lasue J, 2006, J QUANT SPECTROSC RA, V100, P220, DOI 10.1016/j.jqsrt.2005.11.040; LEVINE AS, 1993, NASA C PUBLICATION, V3275; MCDONNELL JAM, 1993, NATURE, V362, P732, DOI 10.1038/362732a0; MCDONNELL JAM, 1991, COMETS POST HALLEY E, V2, P1043; RIETMEIJER FJM, 1998, PLANETARY MAT, V36; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Tuzzolino AJ, 2004, SCIENCE, V304, P1776, DOI 10.1126/science.1098759; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	19	266	267	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1716	1719		10.1126/science.1135705	http://dx.doi.org/10.1126/science.1135705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170290				2022-12-28	WOS:000242833600042
J	Venken, KJT; He, YC; Hoskins, RA; Bellen, HJ				Venken, Koen J. T.; He, Yuchun; Hoskins, Roger A.; Bellen, Hugo J.			P[acman]: A BAC transgenic platform for targeted insertion of large DNA fragments in D-melanogaster	SCIENCE			English	Article							PHYSICAL MAP; GENOME; SYSTEM; TRANSFORMATION; CHROMOSOME; PIGGYBAC; SEQUENCE; VECTORS; CLONING; GENES	We describe a transgenesis platform for Drosophila melanogaster that integrates three recently developed technologies: a conditionally amplifiable bacterial artificial chromosome (BAC), recombineering, and bacteriophage phi C31-mediated transgenesis. The BAC is maintained at low copy number, facilitating plasmid maintenance and recombineering, but is induced to high copy number for plasmid isolation. Recombineering allows gap repair and mutagenesis in bacteria. Gap repair efficiently retrieves DNA fragments up to 133 kilobases long from P1 or BAC clones. phi C31-mediated transgenesis integrates these large DNA fragments at specific sites in the genome, allowing the rescue of lethal mutations in the corresponding genes. This transgenesis platform should greatly facilitate structure/function analyses of most Drosophila genes.	Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Biol, Berkeley, CA 94720 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hbellen@bcm.edu	Venken, Koen/B-9909-2013	Venken, Koen/0000-0003-0741-4698; Bellen, Hugo/0000-0001-5992-5989	NIGMS NIH HHS [GM067858-05] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067858] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; CELNIKER SE, 2002, GENOME BIOL, V6, pH79; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Court DL, 2003, GENE, V315, P63, DOI 10.1016/S0378-1119(03)00728-5; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; Jafar-Nejad H, 2004, MOL CELL BIOL, V24, P8803, DOI 10.1128/MCB.24.20.8803-8812.2004; Kimmerly W, 1996, GENOME RES, V6, P414, DOI 10.1101/gr.6.5.414; Kotzamanis G, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-1; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li X, 2001, MOL GENET GENOMICS, V266, P190, DOI 10.1007/s004380100525; Matthews KA, 2005, NAT REV GENET, V6, P179, DOI 10.1038/nrg1554; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryder Edward, 2003, Briefings in Functional Genomics & Proteomics, V2, P57, DOI 10.1093/bfgp/2.1.57; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Sorrell DA, 2005, BIOTECHNOL ADV, V23, P431, DOI 10.1016/j.biotechadv.2005.03.003; STERNBERG N, 1990, P NATL ACAD SCI USA, V87, P103, DOI 10.1073/pnas.87.1.103; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Xu HF, 2006, MOL GENET GENOMICS, V276, P31, DOI 10.1007/s00438-006-0124-x	25	551	587	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1747	1751		10.1126/science.1134426	http://dx.doi.org/10.1126/science.1134426			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17138868				2022-12-28	WOS:000242833600050
J	Yamamoto, Y; Fukushima, T; Suna, Y; Ishii, N; Saeki, A; Seki, S; Tagawa, S; Taniguchi, M; Kawai, T; Aida, T				Yamamoto, Yohei; Fukushima, Takanori; Suna, Yuki; Ishii, Noriyuki; Saeki, Akinori; Seki, Shu; Tagawa, Seiichi; Taniguchi, Masateru; Kawai, Tomoji; Aida, Takuzo			Photoconductive coaxial nanotubes of molecularly connected electron donor and acceptor layers	SCIENCE			English	Article							CHARGE-TRANSFER; GRAPHITIC NANOTUBES; SELF-ORGANIZATION; LIQUID-CRYSTALS; ENERGY-TRANSFER; ARRAYS; HEXABENZOCORONENE; HETEROJUNCTIONS; FABRICATION; CHEMISTRY	Controlled self-assembly of a trinitrofluorenone-appended gemini-shaped amphiphilic hexabenzocoronene selectively formed nanotubes or microfibers with different photochemical properties. In these nanotubes, which are 16 nanometers in diameter and several micrometers long, a molecular layer of electron-accepting trinitrofluorenone laminates an electron-donating graphitic layer of pi-stacked hexabenzocoronene. The coaxial nanotubular structure allows photochemical generation of spatially separated charge carriers and a quick photoconductive response with a large on/off ratio greater than 10(4). In sharp contrast, the microfibers consist of a charge-transfer complex between the hexabenzocoronene and trinitrofluorenone parts and exhibit almost no photocurrent generation.	Natl Museum Emerging Sci & Innovat, Aida Nanospace Project, ERATO SORST, Japan Sci & Technol Agcy,Koto Ku, Tokyo 1350064, Japan; Univ Tokyo, Dept Chem & Biotechnol, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Ctr Nanobio Integrat, Bunkyo Ku, Tokyo 1138656, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba, Ibaraki 3058566, Japan; Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Osaka University	Fukushima, T (corresponding author), Natl Museum Emerging Sci & Innovat, Aida Nanospace Project, ERATO SORST, Japan Sci & Technol Agcy,Koto Ku, 2-41 Aomi, Tokyo 1350064, Japan.	fukushima@nanospace.miraikan.jst.go.jp; aida@macro.t.u-tokyo.ac.jp	Aida, Takuzo/I-9117-2012; Ishii, Noriyuki/E-5661-2011; Taniguchi, Masateru/G-3185-2017; Saeki, Akinori/B-7756-2011; 修平, 関/E-5346-2010; Fukushima, Takanori/D-2474-2015; Tagawa, Seiichi/B-8078-2010; 洋平, 山本/C-8919-2011	Ishii, Noriyuki/0000-0002-4120-6203; Saeki, Akinori/0000-0001-7429-2200; 修平, 関/0000-0001-7851-4405; Fukushima, Takanori/0000-0001-5586-9238; 洋平, 山本/0000-0002-2166-3730				Acharya A, 2005, J PHYS CHEM B, V109, P20174, DOI 10.1021/jp053300h; Beckers EHA, 2006, J AM CHEM SOC, V128, P649, DOI 10.1021/ja0568042; Bredas JL, 2004, CHEM REV, V104, P4971, DOI 10.1021/cr040084k; Freitag M, 2003, NANO LETT, V3, P1067, DOI 10.1021/nl034313e; Granstrom M, 1998, NATURE, V395, P257, DOI 10.1038/26183; Grimsdale AC, 2005, ANGEW CHEM INT EDIT, V44, P5592, DOI 10.1002/anie.200500805; Hill JP, 2004, SCIENCE, V304, P1481, DOI 10.1126/science.1097789; Itkis ME, 2006, SCIENCE, V312, P413, DOI 10.1126/science.1125695; Jin W, 2005, P NATL ACAD SCI USA, V102, P10801, DOI 10.1073/pnas.0500852102; Li WS, 2006, J AM CHEM SOC, V128, P10527, DOI 10.1021/ja063081t; LOUTFY RO, 1984, CAN J CHEM, V62, P1877, DOI 10.1139/v84-322; MARKOVITSI D, 1992, J CHEM SOC FARADAY T, V88, P1275, DOI 10.1039/ft9928801275; Percec V, 2002, NATURE, V419, P384, DOI 10.1038/nature01072; Pisula W, 2006, ANGEW CHEM INT EDIT, V45, P819, DOI 10.1002/anie.200500669; Roger C, 2006, J AM CHEM SOC, V128, P6542, DOI 10.1021/ja0584469; Samori P, 2004, J AM CHEM SOC, V126, P3567, DOI 10.1021/ja038648+; Schmidt-Mende L, 2001, SCIENCE, V293, P1119, DOI 10.1126/science.293.5532.1119; Schwab AD, 2004, NANO LETT, V4, P1261, DOI 10.1021/nl049421v; Simpson CD, 2004, J MATER CHEM, V14, P494, DOI 10.1039/b312789c; SULZBERG T, 1970, J ORG CHEM, V35, P2762, DOI 10.1021/jo00833a064; TANG CW, 1986, APPL PHYS LETT, V48, P183, DOI 10.1063/1.96937; van de Craats AM, 1999, ADV MATER, V11, P1469, DOI 10.1002/(SICI)1521-4095(199912)11:17<1469::AID-ADMA1469>3.0.CO;2-K; van de Craats AM, 2003, ADV MATER, V15, P495, DOI 10.1002/adma.200390114; Watson MD, 2001, CHEM REV, V101, P1267, DOI 10.1021/cr990322p; Wurthner F, 2004, J AM CHEM SOC, V126, P10611, DOI 10.1021/ja0475353; Xing YJ, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2159103; Yamamoto Y, 2006, ADV MATER, V18, P1297, DOI 10.1002/adma.200502116; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789	28	595	604	11	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1761	1764		10.1126/science.1134441	http://dx.doi.org/10.1126/science.1134441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170300				2022-12-28	WOS:000242833600054
J	Das, CJ; Pangtey, GS				Das, Chandan Jyoti; Pangtey, Ghan Shyam			Arterial microaneurysms in polyarteritis nodosa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									All India Inst Med Sci, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Das, CJ (corresponding author), All India Inst Med Sci, New Delhi 110029, India.	dascj@yahoo.com							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2574	2574		10.1056/NEJMicm050820	http://dx.doi.org/10.1056/NEJMicm050820			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116BZ	17167140				2022-12-28	WOS:000242778800009
J	Murphy, KG; Bloom, SR				Murphy, Kevin G.; Bloom, Stephen R.			Gut hormones and the regulation of energy homeostasis	NATURE			English	Article							INHIBITS FOOD-INTAKE; PLACEBO-CONTROLLED TRIAL; GLUCAGON-LIKE PEPTIDE-1; GASTRIC BYPASS-SURGERY; BODY-WEIGHT GAIN; PANCREATIC-POLYPEPTIDE; EXENATIDE EXENDIN-4; GLYCEMIC CONTROL; OBESE SUBJECTS; SHORT-TERM	Food intake, energy expenditure and body adiposity are homeostatically regulated. Central and peripheral signals communicate information about the current state of energy balance to key brain regions, including the hypothalamus and brainstem. Hunger and satiety represent coordinated responses to these signals, which include neural and hormonal messages from the gut. In recent years our understanding of how neural and hormonal brain - gut signalling regulates energy homeostasis has advanced considerably. Gut hormones have various physiological functions that include specifically targeting the brain to regulate appetite. New research suggests that gut hormones can be used to specifically regulate energy homeostasis in humans, and offer a target for anti-obesity drugs.	Imperial Coll Fac Med, Dept Metab Med, London W12 0NN, England	Imperial College London	Bloom, SR (corresponding author), Imperial Coll Fac Med, Dept Metab Med, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.	s.bloom@imperial.ac.uk		Murphy, Kevin/0000-0002-3417-0310				Abbott CR, 2006, INT J OBESITY, V30, P288, DOI 10.1038/sj.ijo.0803137; Abbott CR, 2005, BRAIN RES, V1043, P139, DOI 10.1016/j.brainres.2005.02.065; Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Acuna-Goycolea C, 2005, J NEUROSCI, V25, P10510, DOI 10.1523/JNEUROSCI.2552-05.2005; Adams SH, 2004, ENDOCRINOLOGY, V145, P4967, DOI 10.1210/en.2004-0518; ADRIAN TE, 1986, GASTROENTEROLOGY, V90, P379, DOI 10.1016/0016-5085(86)90936-4; ALLEN JM, 1983, DIGESTION, V28, P191, DOI 10.1159/000198985; Arafat AM, 2006, J CLIN ENDOCR METAB, V91, P3528, DOI 10.1210/jc.2006-0225; Asakawa A, 2003, GASTROENTEROLOGY, V124, P1325, DOI 10.1016/S0016-5085(03)00216-6; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Baggio LL, 2004, GASTROENTEROLOGY, V127, P546, DOI 10.1053/j.gastro.2004.04.063; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Batterham RL, 2003, J CLIN ENDOCR METAB, V88, P3989, DOI 10.1210/jc.2003-030630; BESTERMAN HS, 1983, SCAND J GASTROENTERO, V18, P845, DOI 10.3109/00365528309182104; BESTERMAN HS, 1979, BMJ-BRIT MED J, V2, P1252, DOI 10.1136/bmj.2.6200.1252; Bi S, 2002, NEUROPEPTIDES, V36, P171, DOI 10.1054/npep.2002.0895; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; Borg CM, 2006, BRIT J SURG, V93, P210, DOI 10.1002/bjs.5227; Browning KN, 2003, J PHYSIOL-LONDON, V549, P775, DOI 10.1113/jphysiol.2003.042036; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Chan JL, 2006, OBESITY, V14, P194, DOI 10.1038/oby.2006.25; Chelikani PK, 2006, AM J PHYSIOL-REG I, V290, pR298, DOI 10.1152/ajpregu.00674.2005; Chelikani PK, 2005, ENDOCRINOLOGY, V146, P879, DOI 10.1210/en.2004-1138; CHELIKANI PK, 2006, PEPTIDES        0906, DOI DOI 10.1016/J.PEPTIDES.2006.08.001; Chen CC, 1997, ABSTR PAP AM CHEM S, V213, P218; Cohen MA, 2003, J CLIN ENDOCR METAB, V88, P4696, DOI 10.1210/jc.2003-030421; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cox JE, 2004, PEPTIDES, V25, P985, DOI 10.1016/j.peptides.2004.03.003; CRAWLEY JN, 1983, NATURE, V302, P703, DOI 10.1038/302703a0; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Dakin CL, 2004, ENDOCRINOLOGY, V145, P2687, DOI 10.1210/en.2003-1338; Dakin CL, 2002, AM J PHYSIOL-ENDOC M, V283, pE1173, DOI 10.1152/ajpendo.00233.2002; Dakin CL, 2001, ENDOCRINOLOGY, V142, P4244, DOI 10.1210/en.142.10.4244; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Degen L, 2005, GASTROENTEROLOGY, V129, P1430, DOI 10.1053/j.gastro.2005.09.001; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Dong J, 2006, ENDOCRINOLOGY, V147, P2634, DOI 10.1210/en.2005-1335; Drucker DJ, 2005, NAT CLIN PRACT ENDOC, V1, P22, DOI 10.1038/ncpendmet0017; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Flanagan DE, 2003, AM J PHYSIOL-ENDOC M, V284, pE313, DOI 10.1152/ajpendo.00569.2001; Gelfand EV, 2006, J AM COLL CARDIOL, V47, P1919, DOI 10.1016/j.jacc.2005.12.067; Gourcerol G, 2006, PEPTIDES, V27, P2811, DOI 10.1016/j.peptides.2006.07.012; Greenough A, 1998, PHYSIOL BEHAV, V65, P303, DOI 10.1016/S0031-9384(98)00169-3; Halatchev IG, 2004, ENDOCRINOLOGY, V145, P2585, DOI 10.1210/en.2003-1754; Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003; Halford JCG, 2006, APPETITE, V46, P6, DOI 10.1016/j.appet.2005.07.010; HOLST B, 2003, ENDOCRINOLOGY   0907, DOI DOI 10.1210/EN.2006-0933; James WPT, 2000, LANCET, V356, P2119, DOI 10.1016/S0140-6736(00)03491-7; Katsuura G, 2002, PEPTIDES, V23, P323, DOI 10.1016/S0196-9781(01)00604-0; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Kim BJ, 2005, J CLIN ENDOCR METAB, V90, P6665, DOI 10.1210/jc.2005-0409; Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Korner J, 2005, J CLIN ENDOCR METAB, V90, P359, DOI 10.1210/jc.2004-1076; KUVSHINOFF BW, 1991, J SURG RES, V50, P425, DOI 10.1016/0022-4804(91)90019-I; le Roux CW, 2005, J CLIN ENDOCR METAB, V90, P4521, DOI 10.1210/jc.2004-2537; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Martin NM, 2004, INT J OBESITY, V28, P886, DOI 10.1038/sj.ijo.0802646; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; Moran TH, 2005, AM J PHYSIOL-REG I, V288, pR384, DOI 10.1152/ajpregu.00535.2004; Murray CDR, 2005, GUT, V54, P1693, DOI 10.1136/gut.2005.069088; Neary NM, 2005, ENDOCRINOLOGY, V146, P5120, DOI 10.1210/en.2005-0237; Neary NM, 2004, J CLIN ENDOCR METAB, V89, P2832, DOI 10.1210/jc.2003-031768; Nogueiras R., 2006, CNS & Neurological Disorders-Drug Targets, V5, P335, DOI 10.2174/187152706777452227; NOGUEIRAS R, 2006, ENDOCRINOLOGY   0928, DOI DOI 10.1210/EN.2006-0915; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Pittner RA, 2004, INT J OBESITY, V28, P963, DOI 10.1038/sj.ijo.0802696; Ratner R, 2005, EXP CLIN ENDOCR DIAB, V113, P199, DOI 10.1055/s-2005-837662; Schmidt PT, 2005, J CLIN ENDOCR METAB, V90, P5241, DOI 10.1210/jc.2004-2089; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Scott V, 2005, J NEUROENDOCRINOL, V17, P452, DOI 10.1111/j.1365-2826.2005.01330.x; Stock S, 2005, J CLIN ENDOCR METAB, V90, P2161, DOI 10.1210/jc.2004-1251; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Tschop M, 2004, NATURE, V430, DOI 10.1038/nature02665; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Ueno M, 2006, DIABETOLOGIA, V49, P2449, DOI 10.1007/s00125-006-0371-8; Wang J, 2006, CHAOS SOLITON FRACT, V27, P427, DOI 10.1016/j.chaos.2005.04.024; WEST DB, 1987, PHYSIOL BEHAV, V39, P111, DOI 10.1016/0031-9384(87)90407-0; WEST DB, 1984, AM J PHYSIOL, V246, pR776, DOI 10.1152/ajpregu.1984.246.5.R776; Whitehouse F, 2002, DIABETES CARE, V25, P724, DOI 10.2337/diacare.25.4.724; Wynne K, 2006, INT J OBESITY, V30, P1729, DOI 10.1038/sj.ijo.0803344; Wynne K, 2005, J AM SOC NEPHROL, V16, P2111, DOI 10.1681/ASN.2005010039; Wynne K, 2005, DIABETES, V54, P2390, DOI 10.2337/diabetes.54.8.2390; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; ZORRILLA EP, 2006, P NATL ACAD SCI US	95	515	539	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					854	859		10.1038/nature05484	http://dx.doi.org/10.1038/nature05484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167473				2022-12-28	WOS:000242805400042
J	Postma, E; Griffith, SC; Brooks, R				Postma, Erik; Griffith, Simon C.; Brooks, Robert			Evolutionary genetics - Evolution of mate choice in the wild	NATURE			English	Letter							PREFERENCE; SELECTION; ORNAMENT		Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Postma, E (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia.	e.postma@unsw.edu.au	Brooks, Robert/A-1251-2008; Postma, Erik/B-7258-2008; Griffith, Simon/A-1996-2010; Griffith, Simon/AAH-3706-2021	Brooks, Robert/0000-0001-6926-0781; Postma, Erik/0000-0003-0856-1294; Griffith, Simon/0000-0001-7612-4999; Griffith, Simon/0000-0001-7612-4999				Andersson Malte, 1994; BAKKER TCM, 1993, NATURE, V363, P255, DOI 10.1038/363255a0; Charmantier A, 2006, TRENDS ECOL EVOL, V21, P417, DOI 10.1016/j.tree.2006.06.001; Iyengar VK, 2002, NATURE, V419, P830, DOI 10.1038/nature01027; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; Sheldon BC, 1999, ANIM BEHAV, V57, P285, DOI 10.1006/anbe.1998.0968	10	14	14	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					E16	E16		10.1038/nature05501	http://dx.doi.org/10.1038/nature05501			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167425				2022-12-28	WOS:000242805400035
J	Banthin, JS; Bernard, DM				Banthin, Jessica S.; Bernard, Didem M.			Changes in financial burdens for health care - National estimates for the population younger than 65 years, 1996 to 2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXPENDITURE BURDENS; COVERAGE; ADULTS	Context Policymakers as well as physicians need to understand how rapidly rising health care costs are affecting specific groups of patients. Objective To estimate the number and characteristics of individuals in the United States faced with very high financial burdens for health care. Design, Setting, and Population Data from a nationally representative sample of civilian, noninstitutionalized US individuals younger than 65 years from the Medical Expenditure Panel Surveys were used to calculate 2 measures of financial burden as a function of tax-adjusted family income. Total burden included all out-of-pocket expenditures for health care services, including premiums. Health care services burden excluded premiums and, when applied to the insured population, was used to identify the underinsured. We defined the underinsured as insured persons with health care service burdens in excess of 10% of tax-adjusted family income. Main Outcome Measures Total and health care services burdens exceeding 10% and 20% of family income in 1996 and 2003. Results In 2003, there were 48.8 million individuals (19.2%) living in families spending more than 10% of family income on health care, an increase of 11.7 million persons since 1996. Of these individuals, about 18.7 million (7.3%) were spending more than 20% of family income. In 2003, individuals with higher-than-average risk of incurring high total burdens included poor and low-income persons and those with non-group coverage, aged 55 to 64 years, living in a non - metropolitan statistical area, in fair or poor health, having any type of limitation, or having a chronic medical condition. Applying our definition of underinsured to the insured population, an estimated 17.1 million persons younger than 65 years were underinsured in 2003, including 9.3 million persons with private employment-related insurance, 1.3 million persons with private nongroup policies, and 6.6 million persons with public coverage. Conclusions Our analysis identifies patients at greatest risk of health-related financial burdens that may adversely affect their access and adherence to recommended treatments. Our study also highlights the high costs associated with nongroup health insurance policies.	US Dept HHS, Div Modeling & Simulat, Ctr Financing Access & Cost Trends, Agcy Healthcare Res & Qual, Rockville, MD 20850 USA	Agency for Healthcare Research & Quality	Banthin, JS (corresponding author), US Dept HHS, Div Modeling & Simulat, Ctr Financing Access & Cost Trends, Agcy Healthcare Res & Qual, 540 Gaither Rd, Rockville, MD 20850 USA.	Jessica.Banthin@ahrq.hhs.gov						Alecxih L, 2001, HEALTH SERV RES, V35, P1365; Alexander GC, 2003, JAMA-J AM MED ASSOC, V290, P953, DOI 10.1001/jama.290.7.953; Banthin JS, 2003, INQUIRY-J HEALTH CAR, V40, P133, DOI 10.5034/inquiryjrnl_40.2.133; Banthin JS., 2006, 06005 AG HLTH RES QU; Bernard DM, 2006, MED CARE, V44, P210, DOI 10.1097/01.mlr.0000199729.25503.60; Buntin MB, 2004, HEALTH AFFAIR, V23, P79, DOI 10.1377/hlthaff.23.6.79; Cohen JW, 2003, HEALTH AFFAIR, V22, P129, DOI 10.1377/hlthaff.22.2.129; ELIXHAUSER A, 1998, PUBLICATION AGENCY H; Goldman DP, 2001, HEALTH SERV RES, V35, P1357; Gross DJ, 1999, HEALTH SERV RES, V34, P241; *NAT BUR EC RES, INT TAXSIM VERS 5 0; SCHOEN C, 2005, HLTH AFF MILLWOOD S, V14; Selden TM, 2003, MED CARE, V41, P13; SHORT PF, 1995, JAMA-J AM MED ASSOC, V274, P1302; Smith C, 2006, HEALTH AFFAIR, V25, P186, DOI 10.1377/hlthaff.25.1.186; Zillier EC, 2004, HEALTH AFFAIR, V23, P210, DOI 10.1377/hlthaff.23.6.210	16	148	148	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2712	2719		10.1001/jama.296.22.2712	http://dx.doi.org/10.1001/jama.296.22.2712			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	115WY	17164457	Bronze			2022-12-28	WOS:000242765700026
J	Ding, B; Seeman, NC				Ding, Baoquan; Seeman, Nadrian C.			Operation of a DNA robot arm inserted into a 2D DNA crystalline substrate	SCIENCE			English	Article							NANOSCALE; DESIGN	The success of nanorobotics requires the precise placement and subsequent operation of specific nanomechanical devices at particular locations. The structural programmability of DNA makes it a particularly attractive system for nanorobotics. We have developed a cassette that enables the placement of a robust, sequence-dependent DNA robot arm within a two-dimensional (2D) crystalline DNA array. The cassette contains the device, an attachment site, and a reporter of state. We used atomic force microscopy to demonstrate that the rotary device is fully functional after insertion. Thus, a nanomechanical device can operate within a fixed frame of reference.	NYU, Dept Chem, New York, NY 10003 USA	New York University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	ned.seeman@nyu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029554] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM029554] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birac JJ, 2006, J MOL GRAPH MODEL, V25, P470, DOI 10.1016/j.jmgm.2006.03.005; Carbone A, 2002, P NATL ACAD SCI USA, V99, P12577, DOI 10.1073/pnas.202418299; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e; Liao SP, 2004, SCIENCE, V306, P2072, DOI 10.1126/science.1104299; Qiu HX, 1997, J MOL BIOL, V267, P881, DOI 10.1006/jmbi.1997.0918; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seeman NC, 2005, REP PROG PHYS, V68, P237, DOI 10.1088/0034-4885/68/1/R05; Shen ZY, 2004, J AM CHEM SOC, V126, P1666, DOI 10.1021/ja038381e; Sherman WB, 2006, BIOPHYS J, V90, P4546, DOI 10.1529/biophysj.105.080390; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a	12	182	184	4	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1583	1585		10.1126/science.1131372	http://dx.doi.org/10.1126/science.1131372			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158323	Green Accepted			2022-12-28	WOS:000242624600037
J	Malin, MC; Edgett, KS; Posiolova, LV; McColley, SM; Dobrea, EZN				Malin, Michael C.; Edgett, Kenneth S.; Posiolova, Liliya V.; McColley, Shawn M.; Dobrea, Eldar Z. Noe			Present-day impact cratering rate and contemporary gully activity on Mars	SCIENCE			English	Article							MARTIAN GULLIES; ORBITER CAMERA; GLOBAL SURVEYOR; CARBON-DIOXIDE; SURFACE RUNOFF; LIQUID WATER; CONSTRAINTS; METEOROIDS; CHRONOLOGY; ATMOSPHERE	The Mars Global Surveyor Mars Orbiter Camera has acquired data that establish the present-day impact cratering rate and document new deposits formed by downslope movement of material in mid-latitude gullies on Mars. Twenty impacts created craters 2 to 150 meters in diameter within an area of 21.5 x 10(6) square kilometers between May 1999 and March 2006. The values predicted by models that scale the lunar cratering rate to Mars are close to the observed rate, implying that surfaces devoid of craters are truly young and that as yet unrecognized processes of denudation must be operating. The new gully deposits, formed since August 1999, are light toned and exhibit attributes expected from emplacement aided by a fluid with the properties of liquid water: relatively long, extended, digitate distal and marginal branches, diversion around obstacles, and low relief. The observations suggest that liquid water flowed on the surface of Mars during the past decade.	Malin Space Sci Syst, San Diego, CA 92191 USA		Malin, MC (corresponding author), Malin Space Sci Syst, POB 910148, San Diego, CA 92191 USA.			Edgett, Kenneth/0000-0001-7197-5751				Caplinger MA, 2001, J GEOPHYS RES-PLANET, V106, P23595, DOI 10.1029/2000JE001341; CEPLECHA Z, 1993, ASTRON ASTROPHYS, V279, P615; Ceplecha Z, 1995, EARTH MOON PLANETS, V68, P107, DOI 10.1007/BF00671501; Christensen PR, 2003, NATURE, V422, P45, DOI 10.1038/nature01436; Costard F, 2002, SCIENCE, V295, P110, DOI 10.1126/science.1064419; Gaidos EJ, 2001, ICARUS, V153, P218, DOI 10.1006/icar.2001.6649; GAULT DE, 1970, RADIO SCI, V5, P273, DOI 10.1029/RS005i002p00273; Gilmore MS, 2002, GEOLOGY, V30, P1107, DOI 10.1130/0091-7613(2002)030<1107:ROAIFO>2.0.CO;2; Hartmann WK, 1999, METEORIT PLANET SCI, V34, P167, DOI 10.1111/j.1945-5100.1999.tb01743.x; Hartmann WK, 2005, ICARUS, V174, P294, DOI 10.1016/j.icarus.2004.11.023; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; HEIDMANN JL, 2004, ICARUS, V168, P285; HEIDMANN JL, 2005, J GEOPHYS RES, V110, DOI DOI 10.1029/2004JE002261; Hoffman N, 2002, ASTROBIOLOGY, V2, P313, DOI 10.1089/153110702762027899; Horz F, 1999, SCIENCE, V285, P2105, DOI 10.1126/science.285.5436.2105; HORZ F, 2004, LUNAR PLANET SCI, V35, P1116; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; McEwen AS, 2006, ANNU REV EARTH PL SC, V34, P535, DOI 10.1146/annurev.earth.34.031405.125018; McEwen AS, 2005, ICARUS, V176, P351, DOI 10.1016/j.icarus.2005.02.009; Mellon MT, 2001, J GEOPHYS RES-PLANET, V106, P23165, DOI 10.1029/2000JE001424; MELOSH HJ, 1981, MULTIRING BASINS, P29; Musselwhite DS, 2001, GEOPHYS RES LETT, V28, P1283, DOI 10.1029/2000GL012496; PASSEY QR, 1980, ICARUS, V42, P211, DOI 10.1016/0019-1035(80)90072-X; Popova O, 2003, METEORIT PLANET SCI, V38, P905, DOI 10.1111/j.1945-5100.2003.tb00287.x; Shoemaker E. M., 1965, 32700 JET PROP LAB, P75; Stewart ST, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001465; Sullivan R, 2001, J GEOPHYS RES-PLANET, V106, P23607, DOI 10.1029/2000JE001296; Treiman AH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001900; [No title captured]	32	323	327	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1573	1577		10.1126/science.1135156	http://dx.doi.org/10.1126/science.1135156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158321				2022-12-28	WOS:000242624600034
J	Bondy, C; Bakalov, VK; Lange, ED; Ceniceros, I				Bondy, Carolyn; Bakalov, Vladimir K.; Lange, Eileen Dunn; Ceniceros, Irene			Deficient medical care for adults with the Turner syndrome	ANNALS OF INTERNAL MEDICINE			English	Letter									NICHHD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bondy, C (corresponding author), NICHHD, NIH, Bethesda, MD 20892 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000628] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bakalov VK, 2003, AM J MED, V115, P259, DOI 10.1016/S0002-9343(03)00364-4; Lin AE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e12; Nielsen J, 1990, Birth Defects Orig Artic Ser, V26, P209; Ostberg JE, 2004, J CLIN ENDOCR METAB, V89, P5966, DOI 10.1210/jc.2004-1090; Saenger P, 2001, J CLIN ENDOCR METAB, V86, P3061, DOI 10.1210/jc.86.7.3061	5	27	27	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2006	145	11					866	867		10.7326/0003-4819-145-11-200612050-00020	http://dx.doi.org/10.7326/0003-4819-145-11-200612050-00020			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114PE	17146077				2022-12-28	WOS:000242677300016
J	Andrews, L; Paradise, J; Holbrook, T; Bochneak, D				Andrews, Lori; Paradise, Jordan; Holbrook, Timothy; Bochneak, Danielle			When patents threaten science	SCIENCE			English	Editorial Material									Chicago Kent Coll Law, Inst Sci Law & Technol, Chicago, IL 60661 USA; Univ Minnesota, Sch Law, Consortium Law & Values Hlth Environm & Life Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Andrews, L (corresponding author), Chicago Kent Coll Law, Inst Sci Law & Technol, Chicago, IL 60661 USA.	landrews@kentlaw.edu						Andrews Lori B, 2006, CHRON HIGHER EDUC, V52, pB20; [Anonymous], 1999, U.S. Patent, Patent No. [5,966,712, 5966712]; Eisenberg RS, 2006, NAT BIOTECHNOL, V24, P317, DOI 10.1038/nbt0306-317; Klemens B, 2006, MATH YOU CAN'T USE: PATENTS, COPYRIGHT, AND SOFTWARE, P44; MERRILL S, 2004, PATENT SYSTEM 21 CEN, P25; Paradise J, 2005, SCIENCE, V307, P1566, DOI 10.1126/science.1105162; 2006, WALL STREET J   0301, pA14; 2006, FED REG, V70, P75451; 2006, NY TIMES        0322, pA24; 1999, Patent No. 6660476; 2005, Patent No. 6904421; 2006, FED REG, V71, P34307; 1993, Patent No. 5190458	13	19	19	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1395	1396		10.1126/science.1135872	http://dx.doi.org/10.1126/science.1135872			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138884				2022-12-28	WOS:000242406100019
J	Peter, T; Marcolli, C; Spichtinger, P; Corti, T; Baker, MB; Koop, T				Peter, Thomas; Marcolli, Claudia; Spichtinger, Peter; Corti, Thierry; Baker, Marcia B.; Koop, Thomas			When dry air is too humid	SCIENCE			English	Editorial Material							SUPERCOOLED WATER; RELATIVE-HUMIDITY; CIRRUS FORMATION; ICE NUCLEATION; CLOUDS; NUCLEI		ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Washington; University of Washington Seattle; University of Bielefeld	Peter, T (corresponding author), ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland.	thomas.peter@ethz.ch	Corti, Thierry/C-6332-2008; Spichtinger, Peter/F-5587-2014; Peter, Thomas/B-2529-2018; Koop, Thomas/B-7861-2008; Marcolli, Claudia/E-8078-2017	Spichtinger, Peter/0000-0003-4008-4977; Peter, Thomas/0000-0002-7218-7156; Koop, Thomas/0000-0002-7571-3684; Marcolli, Claudia/0000-0002-9125-8722				Abbatt JPD, 2006, SCIENCE, V313, P1770, DOI 10.1126/science.1129726; DeMott PJ, 2003, P NATL ACAD SCI USA, V100, P14655, DOI 10.1073/pnas.2532677100; Gao RS, 2004, SCIENCE, V303, P516, DOI 10.1126/science.1091255; Jensen EJ, 2005, ATMOS CHEM PHYS, V5, P851, DOI 10.5194/acp-5-851-2005; KLEY D, SPARC ASSESSMENT UPP; Koop T, 2000, NATURE, V406, P611, DOI 10.1038/35020537; Korolev A, 2006, J ATMOS SCI, V63, P2865, DOI 10.1175/JAS3784.1; Lee SH, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD005033; Magee N, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026665; Mohler O, 2005, METEOROL Z, V14, P477, DOI 10.1127/0941-2948/2005/0055; Murphy DM, 2005, Q J ROY METEOR SOC, V131, P1539, DOI 10.1256/qj.04.94; Murray BJ, 2005, NATURE, V434, P202, DOI 10.1038/nature03403; Pratte P, 2006, J PHYS CHEM A, V110, P3042, DOI 10.1021/jp053974s; Shilling JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026671; Tabazadeh A, 2002, P NATL ACAD SCI USA, V99, P15873, DOI 10.1073/pnas.252640699; Vomel H, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000707; VOMEL H, 2006, NDACC M ATM WAT VAP	17	113	113	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1399	+		10.1126/science.1135199	http://dx.doi.org/10.1126/science.1135199			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138887				2022-12-28	WOS:000242406100022
J	El-Sadr, WM; Lundgren, JD; Neaton, JD; Gordin, F; Abrams, D; Arduino, RC; Babiker, A; Burman, W; Clumeck, N; Cohen, CJ; Cohn, D; Cooper, D; Darbyshire, J; Emery, S; Fatkenheuer, G; Gazzard, B; Grund, B; Hoy, J; Klingman, K; Losso, M; Mejia, JMR; Markowitz, N; Neuhaus, J; Phillips, A; Rappoport, C				El-Sadr, W. M.; Lundgren, J. D.; Neaton, J. D.; Gordin, F.; Abrams, D.; Arduino, R. C.; Babiker, A.; Burman, W.; Clumeck, N.; Cohen, C. J.; Cohn, D.; Cooper, D.; Darbyshire, J.; Emery, S.; Faetkenheuer, G.; Gazzard, B.; Grund, B.; Hoy, J.; Klingman, K.; Losso, M.; Mejia, J. M. Ramos; Markowitz, N.; Neuhaus, J.; Phillips, A.; Rappoport, C.		Strategies Management Antiretrovir	CD4+count-guided interruption of antiretroviral treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; RANDOMIZED-TRIAL; COMBINATION THERAPY; AIDS EVENTS; T-CELLS; HIV; MORTALITY; INFECTION; VIRUS; DEATH	BACKGROUND: Despite declines in morbidity and mortality with the use of combination antiretroviral therapy, its effectiveness is limited by adverse events, problems with adherence, and resistance of the human immunodeficiency virus (HIV). METHODS: We randomly assigned persons infected with HIV who had a CD4+ cell count of more than 350 per cubic millimeter to the continuous use of antiretroviral therapy (the viral suppression group) or the episodic use of antiretroviral therapy (the drug conservation group). Episodic use involved the deferral of therapy until the CD4+ count decreased to less than 250 per cubic millimeter and then the use of therapy until the CD4+ count increased to more than 350 per cubic millimeter. The primary end point was the development of an opportunistic disease or death from any cause. An important secondary end point was major cardiovascular, renal, or hepatic disease. RESULTS: A total of 5472 participants (2720 assigned to drug conservation and 2752 to viral suppression) were followed for an average of 16 months before the protocol was modified for the drug conservation group. At baseline, the median and nadir CD4+ counts were 597 per cubic millimeter and 250 per cubic millimeter, respectively, and 71.7% of participants had plasma HIV RNA levels of 400 copies or less per milliliter. Opportunistic disease or death from any cause occurred in 120 participants (3.3 events per 100 person-years) in the drug conservation group and 47 participants (1.3 per 100 person-years) in the viral suppression group (hazard ratio for the drug conservation group vs. the viral suppression group, 2.6; 95% confidence interval [CI], 1.9 to 3.7; P<0.001). Hazard ratios for death from any cause and for major cardiovascular, renal, and hepatic disease were 1.8 (95% CI, 1.2 to 2.9; P=0.007) and 1.7 (95% CI, 1.1 to 2.5; P=0.009), respectively. Adjustment for the latest CD4+ count and HIV RNA level (as time-updated covariates) reduced the hazard ratio for the primary end point from 2.6 to 1.5 (95% CI, 1.0 to 2.1). CONCLUSIONS: Episodic antiretroviral therapy guided by the CD4+ count, as used in our study, significantly increased the risk of opportunistic disease or death from any cause, as compared with continuous antiretroviral therapy, largely as a consequence of lowering the CD4+ cell count and increasing the viral load. Episodic antiretroviral therapy does not reduce the risk of adverse events that have been associated with antiretroviral therapy.	Harlem Hosp Med Ctr, Div Infect Dis, New York, NY 10037 USA; Columbia Univ, New York, NY USA; Hvidovre Univ Hosp, DK-2650 Hvidovre, Denmark; Univ Minnesota, Minneapolis, MN USA; Washington Vet Affairs Med Ctr, Washington, DC USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Texas, Sch Med, Houston, TX USA; MRC, London, England; Denver Publ Hlth Dept, Denver, CO USA; Ctr Hosp Univ St Pierre, Brussels, Belgium; Community Res Initiat New England, Boston, MA USA; Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; Univ Hosp, Cologne, Germany; Natl Ctr HIV Epidemiol & Clin Res, Melbourne, Vic, Australia; NIAID, Bethesda, MD 20892 USA; Hosp Gen de Agudos JM Ramos Mejia, Buenos Aires, DF, Argentina; Henry Ford Hosp, Detroit, MI 48202 USA; Royal Free Hosp, Sch Med, London NW3 2QG, England	Columbia University; University of Copenhagen; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of Texas System; Denver Health Medical Center; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of New South Wales Sydney; Kirby Institute; University of Cologne; University of New South Wales Sydney; Kirby Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Hospital Ramos Mejia; Henry Ford Health System; Henry Ford Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	El-Sadr, WM (corresponding author), Harlem Hosp Med Ctr, Div Infect Dis, Rm 3107,506 Lenox Ave, New York, NY 10037 USA.	wme1@columbia.edu	Hoy, Jennifer/AAK-7968-2020; Lundgren, Jens/AAE-6876-2019; Phillips, Andrew N/B-4427-2008; Emery, Sean/J-3825-2017	Phillips, Andrew N/0000-0003-2384-4807; Lundgren, Jens/0000-0001-8901-7850; Emery, Sean/0000-0001-6072-8309; Hoy, Jennifer/0000-0002-6948-7086; REUTER, TANIA/0000-0003-2176-5603	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046362, U01AI042170] Funding Source: NIH RePORTER; Medical Research Council [MC_U122886352] Funding Source: Medline; NIAID NIH HHS [U01AI042170, U01AI46362] Funding Source: Medline; MRC [MC_U122886352] Funding Source: UKRI	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ananworanich J, 2005, JAIDS-J ACQ IMM DEF, V39, P523; Ananworanich J, 2006, LANCET, V368, P459, DOI 10.1016/S0140-6736(06)69153-8; [Anonymous], 1992, MMWR RECOMM REP, V41; Cardiello PG, 2005, CLIN INFECT DIS, V40, P594, DOI 10.1086/427695; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; CROW RS, 1989, AM J CARDIOL, V64, P454, DOI 10.1016/0002-9149(89)90420-7; Crow RS, 1997, AM J CARDIOL, V80, P138, DOI 10.1016/S0002-9149(97)00307-X; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Danel C, 2006, LANCET, V367, P1981, DOI 10.1016/S0140-6736(06)68887-9; de Requena DG, 2002, AIDS, V16, P290, DOI 10.1097/00002030-200201250-00020; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; FriisMoller N, 2004, NEW ENGL J MED, V350, P955; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Hogg RS, 2002, AIDS, V16, P787, DOI 10.1097/00002030-200203290-00015; *JOINT UN PROGR HI, 2006, UNAIDS UN BUDG WORKP; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Lori F, 2001, JAMA-J AM MED ASSOC, V286, P2981, DOI 10.1001/jama.286.23.2981; Maggiolo F, 2004, AIDS, V18, P439, DOI 10.1097/00002030-200402200-00010; Mocroft A, 2005, AIDS, V19, P2117, DOI 10.1097/01.aids.0000194799.43799.ea; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 2000, LANCET, V356, P291, DOI 10.1016/S0140-6736(00)02504-6; Monforte AD, 2004, AIDS, V18, P1811, DOI 10.1097/00002030-200409030-00010; Monforte AD, 2005, ARCH INTERN MED, V165, P1200; Monforte AD, 2005, ARCH INTERN MED, V165, P416; NEATON JD, 1994, STAT MED, V13, P2107, DOI 10.1002/sim.4780131919; *NIH, STRAT MAN ANT THER S; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Panel on Clinical Practices for Treatment of HIV Infection, 2003, GUID US ANT AG HIV 1; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Phair JP, 2002, AIDS, V16, P2455, DOI 10.1097/00002030-200212060-00011; Prineas R., 1982, MINNESOTA CODE MANUA; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Reisler RB, 2003, JAIDS-J ACQ IMM DEF, V34, P379, DOI 10.1097/00126334-200312010-00004; Selik RM, 2002, J ACQ IMMUN DEF SYND, V29, P378, DOI 10.1097/00126334-200204010-00009; Shih JH, 1995, CONTROL CLIN TRIALS, V16, P395, DOI 10.1016/S0197-2456(95)00132-8	41	1691	1722	1	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2283	2296						14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110CG	17135583	Green Published, Green Accepted			2022-12-28	WOS:000242355300004
J	Treister, N; Woo, S				Treister, Nathaniel; Woo, Sook-Bin			Bisphosphonate-associated osteonecrosis of the jaw	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Treister, N (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	ntreister@partners.org		Treister, Nathaniel/0000-0002-5596-7222					0	21	21	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2348	2348		10.1056/NEJMicm055784	http://dx.doi.org/10.1056/NEJMicm055784			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110CG	17135588				2022-12-28	WOS:000242355300010
J	Bell, P; Binagwaho, A				Bell, Peter; Binagwaho, Agnes			The Joint Learning Initiative on Children and HIV/AIDS	LANCET			English	Editorial Material									Emory Univ, Carter Ctr, Atlanta, GA 30307 USA; Commiss Natl Lutte SIDA, Kigali, Rwanda	Emory University	Bell, P (corresponding author), Emory Univ, Carter Ctr, Atlanta, GA 30307 USA.	peter.bell@emory.edu						Horton R, 2006, LANCET, V368, P716, DOI 10.1016/S0140-6736(06)69266-0; *UNICEF, 2005, CHILDR MISS FAC AIDS; UNICEF, 2004, FRAM PROT CAR SUPP O; UNICEF, 2006, AFR ORPH VULN GEN CH; 2006, LANCET, V368, P424; JOINT LEARNING INITI	6	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1850	1851		10.1016/S0140-6736(06)69753-5	http://dx.doi.org/10.1016/S0140-6736(06)69753-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126701				2022-12-28	WOS:000242345900007
J	Komar, AA				Komar, Anton A.			SNPs, silent but not invisible	SCIENCE			English	Editorial Material							MOLECULAR CHAPERONES; TRANSLATION; PROTEINS		Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University	Komar, AA (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA.	a.komar@csuohio.edu		Komar, Anton/0000-0003-4188-0633				ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; PURVIS IJ, 1987, J MOL BIOL, V193, P413, DOI 10.1016/0022-2836(87)90230-0; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3	9	155	168	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					466	467		10.1126/science.1138239	http://dx.doi.org/10.1126/science.1138239			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17185559				2022-12-28	WOS:000243726600030
J	Baker, BJ; Tyson, GW; Webb, RI; Flanagan, J; Hugenholtz, P; Allen, EE; Banfield, JF				Baker, Brett J.; Tyson, Gene W.; Webb, Richard I.; Flanagan, Judith; Hugenholtz, Philip; Allen, Eric E.; Banfield, Jillian F.			Lineages of acidophilic archaea revealed by community genomic analysis	SCIENCE			English	Article							MICROORGANISMS; ASSEMBLAGES; DIVERSITY; BACTERIA; PHYLUM	Novel, low-abundance microbial species can be easily overlooked in standard polymerase chain reaction (PCR)-based surveys. We used community genomic data obtained without PCR or cultivation to reconstruct DNA fragments bearing unusual 16S ribosomal RNA ( rRNA) and protein-coding genes from organisms belonging to novel archaeal lineages. The organisms are minor components of all biofilms growing in pH 0.5 to 1.5 solutions within the Richmond Mine, California. Probes specific for 16S rRNA showed that the fraction less than 0.45 micrometers in diameter is dominated by these organisms. Transmission electron microscope images revealed that the cells are pleomorphic with unusual folded membrane protrusions and have apparent volumes of < 0.006 cubic micrometer.	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; Univ Queensland, Dept Microbiol & Parasitol, Brisbane, Qld 4072, Australia	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Queensland; University of Queensland	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jill@eps.berkeley.edu	Baker, Brett/P-1783-2014; Hugenholtz, Philip/AAD-9138-2019; Tyson, Gene W/C-6558-2013	Baker, Brett/0000-0002-5971-1021; Hugenholtz, Philip/0000-0001-5386-7925; Tyson, Gene W/0000-0001-8559-9427; Banfield, Jill/0000-0001-8203-8771; Flanagan, Judith/0000-0002-4053-3288				Baker BJ, 2003, ENVIRON MICROBIOL, V5, P267, DOI 10.1046/j.1462-2920.2003.00408.x; Baker BJ, 2003, APPL ENVIRON MICROB, V69, P5512, DOI 10.1128/AEM.69.9.5512-5518.2003; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Druschel GK, 2004, GEOCHEM T, V5, P13, DOI 10.1186/1467-4866-5-13; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; Huber H, 2003, RES MICROBIOL, V154, P165, DOI 10.1016/S0923-2508(03)00035-4; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Miteva VI, 2005, APPL ENVIRON MICROB, V71, P7806, DOI 10.1128/AEM.71.12.7806-7818.2005; Nomura N, 1998, J BACTERIOL, V180, P3635, DOI 10.1128/JB.180.14.3635-3643.1998; RIEGER G, 1995, J STRUCT BIOL, V115, P78, DOI 10.1006/jsbi.1995.1032; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; *STEER GROUP WORKS, 1999, SIZ LIM VER SMALL MI; Sunna A, 2003, EXTREMOPHILES, V7, P63, DOI 10.1007/s00792-002-0296-1; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100	24	154	163	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1933	1935		10.1126/science.1132690	http://dx.doi.org/10.1126/science.1132690			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185602				2022-12-28	WOS:000242996800051
J	Ibrahim, F; Rohr, J; Jeong, WJ; Hesson, J; Cerutti, H				Ibrahim, Fadia; Rohr, Jennifer; Jeong, Won-Joong; Hesson, Jennifer; Cerutti, Heriberto			Untemplated oligoadenylation promotes degradation of RISC-cleaved transcripts	SCIENCE			English	Article							RNAS; EXOSOME; COMPLEX		Univ Nebraska, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Cerutti, H (corresponding author), Univ Nebraska, Lincoln, NE 68588 USA.	hcerutti@unl.edu		Ibrahim, Fadia/0000-0002-4344-765X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062915] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062915-06, GM62915] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	7	72	79	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1893	1893		10.1126/science.1135268	http://dx.doi.org/10.1126/science.1135268			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185594	Green Submitted			2022-12-28	WOS:000242996800038
J	Koo, SH; Montminy, M				Koo, Seung-Hoi; Montminy, Marc			In vino veritas: A tale of two Sirt1s?	CELL			English	Editorial Material							FAMILY; MICE	Resveratrol increases life span in lower organisms by activating the NAD+-dependent histone deacetylase Sirt1. Studies by Lagouge et al. (2006) and Baur et al. (2006) now show that resveratrol promotes longevity and improves glucose homeostasis in mice by stimulating the Sirt1-mediated deacetylation of the transcriptional coactivator PGC-1 alpha.	Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Gyeonggi Do, South Korea; Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA	Sungkyunkwan University (SKKU); Salk Institute	Montminy, M (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, 300 Chunchon Dong, Suwon 440746, Gyeonggi Do, South Korea.	montminy@salk.edu	Koo, Seung-Hoi/E-2763-2015	Koo, Seung-Hoi/0000-0001-8769-2879				Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Gescher AJ, 2003, CANCER EPIDEM BIOMAR, V12, P953; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; McDonald RB, 1999, J BIOENERG BIOMEMBR, V31, P507, DOI 10.1023/A:1005404708710; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188	10	45	48	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1091	1093		10.1016/j.cell.2006.11.034	http://dx.doi.org/10.1016/j.cell.2006.11.034			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174885	Bronze			2022-12-28	WOS:000242991000005
J	Zaiss, DM; Yang, L; Shah, PR; Kobie, JJ; Urban, JF; Mosmann, TR				Zaiss, Dietmar M.; Yang, Li; Shah, Pranav R.; Kobie, James J.; Urban, Joseph F.; Mosmann, Tim R.			Amphiregulin, a T(H)2 cytokine enhancing resistance to nematodes	SCIENCE			English	Article							PARASITE; MOUSE		Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14642 USA; ARS, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD 20705 USA	University of Rochester; University of Rochester; United States Department of Agriculture (USDA)	Mosmann, TR (corresponding author), Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Tim_Mosmann@urmc.rochester.edu		Zaiss, Dietmar M.W./0000-0003-3596-7062; Urban, Joseph/0000-0002-1590-8869	NIAID NIH HHS [AI48604] Funding Source: Medline; PHS HHS [DFG/ZA280] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048604] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; POTTEN CS, 1995, GUT, V36, P864, DOI 10.1136/gut.36.6.864; Shea-Donohue T, 2004, CURR OPIN GASTROEN, V20, P3, DOI 10.1097/00001574-200401000-00003; Yang L, 2004, EUR J IMMUNOL, V34, P1617, DOI 10.1002/eji.200424939	7	135	140	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1746	1746		10.1126/science.1133715	http://dx.doi.org/10.1126/science.1133715			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170297				2022-12-28	WOS:000242833600049
J	Fuss, B; Becker, T; Zinke, I; Hoch, M				Fuss, Bernhard; Becker, Thomas; Zinke, Ingo; Hoch, Michael			The cytohesin Steppke is essential for insulin signalling in Drosophila	NATURE			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHOINOSITIDE 3-KINASE; CELL-GROWTH; RECEPTOR; ARF; NUMBER; MECHANISMS; AKT/PKB; PATHWAY; BINDING	In metazoans, the insulin signalling pathway has a key function in regulating energy metabolism and organismal growth(1). Its activation stimulates a highly conserved downstream kinase cascade that includes phosphatidylinositol-3-OH kinase ( PI( 3) K) and the serine - threonine protein kinase Akt. This study identifies a new component of insulin signalling in Drosophila, the steppke gene ( step). step encodes a member of the cytohesin family of guanine nucleotide exchange factors ( GEFs), which have been characterized as activators for ADP-ribosylation factor (ARF) GTPases(2-4). In step mutant animals both cell size and cell number are reduced, resulting in decreased body size and body weight in larvae, pupae and adults. step acts upstream of PI( 3) K and is required for the proper regulation of Akt and the transcription factor FOXO. Temporally controlled interference with the GEF activity of the Step protein by feeding the chemical inhibitor SecinH3 causes a block of insulin signalling and a phenocopy of the step mutant growth defect. Step represses its own expression and the synthesis of growth inhibitors such as the translational repressor 4E-BP. Our findings indicate a crucial role of an ARF - GEF in insulin signalling that has implications for understanding insulin-related disorders, such as diabetes and obesity.	Univ Bonn, Lab Mol Dev Biol, LIMES Inst, Program Unit Dev & Genet, D-53115 Bonn, Germany	University of Bonn	Hoch, M (corresponding author), Univ Bonn, Lab Mol Dev Biol, LIMES Inst, Program Unit Dev & Genet, Meckenheimer Allee 169, D-53115 Bonn, Germany.	m.hoch@uni-bonn.de	Gimenez, Luis E Diaz/D-9291-2011					Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Hafen E, 2004, SWISS MED WKLY, V134, P711; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Randazzo PA, 2001, TRENDS BIOCHEM SCI, V26, P220, DOI 10.1016/S0968-0004(01)01806-0; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Xuan ZY, 2005, MECH AGEING DEV, V126, P209, DOI 10.1016/j.mad.2004.09.021; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	27	108	109	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					945	948		10.1038/nature05412	http://dx.doi.org/10.1038/nature05412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167488				2022-12-28	WOS:000242805400060
J	Meng, J; Hu, YM; Wang, YQ; Wang, XL; Li, CK				Meng, Jin; Hu, Yaoming; Wang, Yuanqing; Wang, Xiaolin; Li, Chuankui			A mesozoic gliding mammal from northeastern china	NATURE			English	Article							FLYING SQUIRRELS; EVOLUTION; BEHAVIOR; ADAPTATIONS; AGE	Gliding flight has independently evolved many times in vertebrates. Direct evidence of gliding is rare in fossil records and is unknown in mammals from the Mesozoic era. Here we report a new Mesozoic mammal from Inner Mongolia, China, that represents a previously unknown group characterized by a highly specialized insectivorous dentition and a sizable patagium ( flying membrane) for gliding flight. The patagium is covered with dense hair and supported by an elongated tail and limbs; the latter also bear many features adapted for arboreal life. This discovery extends the earliest record of gliding flight for mammals to at least 70 million years earlier in geological history, and demonstrates that early mammals were diverse in their locomotor strategies and lifestyles; they had experimented with an aerial habit at about the same time as, if not earlier than, when birds endeavoured to exploit the sky.	Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	American Museum of Natural History (AMNH); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Meng, J (corresponding author), Amer Museum Nat Hist, Div Paleontol, Cent Pk W & 79th St, New York, NY 10024 USA.	jmeng@amnh.org; huyaoming@ivpp.ac.cn						[Anonymous], 1999, WALKERS MAMMALS WORL; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Beard K. C., 1993, PRIMATES THEIR RELAT, P63, DOI DOI 10.1007/978-1-4899-2388-2; BEARD KC, 1990, NATURE, V345, P340, DOI 10.1038/345340a0; Bloch JI, 2002, SCIENCE, V298, P1606, DOI 10.1126/science.1078249; CAPLE G, 1983, AM NAT, V121, P455, DOI 10.1086/284076; Chen BS, 2004, J SHELLFISH RES, V23, P1169; Cifelli RL, 1998, J VERTEBR PALEONTOL, V18, P237, DOI 10.1080/02724634.1998.10011048; FENTON MB, 1995, PALEOBIOLOGY, V21, P229, DOI 10.1017/S0094837300013221; Gunnell Gregg F., 2005, Journal of Mammalian Evolution, V12, P209, DOI 10.1007/s10914-005-6945-2; Hamrick MW, 1999, AM J PHYS ANTHROPOL, V109, P397; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020792; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Jackson SM, 2000, MAMMAL REV, V30, P9, DOI 10.1046/j.1365-2907.2000.00056.x; JENKINS FA, 1976, PHILOS T ROY SOC B, V273, P387, DOI 10.1098/rstb.1976.0022; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Q, 1999, NATURE, V398, P326; JOHNSONMURRAY JL, 1977, J MAMMAL, V58, P374, DOI 10.2307/1379336; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Lillegraven JA, 1979, MESOZOIC MAMMALS 1 2; Lindenmayer D, 2002, GLIDERS AUSTR NATURA; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Maddison WP, 2005, MACCLADE ANAL PHYLOG; MADDISON WP, 2005, MESQUITE MODULAR SYS; Norberg U.M., 1989, P197; Norberg U.M., 1985, P129; NORBERG UM, 1985, AM NAT, V126, P303, DOI 10.1086/284419; NORBERG UM, 1990, ZOOPHYSIOLOGY, V27, P1; Rayner JM, 1981, S ZOOL SOC LONDON, V48, P137; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; RUNESTAD JA, 1995, AM J PHYS ANTHROPOL, V98, P101, DOI 10.1002/ajpa.1330980202; Shen Yan-bin, 2003, Journal of Stratigraphy, V27, P311; Sigogneau-Russell Denise, 1995, Acta Palaeontologica Polonica, V40, P149; Simmons NB, 1998, B AM MUS NAT HIST, P1; Stafford BJ, 2003, J MAMMAL, V84, P263, DOI 10.1644/1545-1542(2003)084<0263:PBOJGF>2.0.CO;2; Storch G, 1996, NATURE, V379, P439, DOI 10.1038/379439a0; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Szalay Frederick S., 1993, P187; THORINGTON RW, 1984, SCIENCE, V225, P1048, DOI 10.1126/science.225.4666.1048; THORINGTON RW, 1981, J MAMMAL, V62, P101, DOI 10.2307/1380481; Wang XL, 2005, CHINESE SCI BULL, V50, P2369, DOI 10.1360/982005-581; Zhang Jun-feng, 2002, Journal of Stratigraphy, V26, P173	45	141	164	3	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					889	893		10.1038/nature05234	http://dx.doi.org/10.1038/nature05234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167478				2022-12-28	WOS:000242805400047
J	Thursby, J; Thursby, M				Thursby, Jerry; Thursby, Marie			Research and development - Where is the new science in corporate R& D?	SCIENCE			English	Editorial Material									Emory Univ, Atlanta, GA 30322 USA; Georgia Inst Technol, Atlanta, GA 30308 USA	Emory University; University System of Georgia; Georgia Institute of Technology	Thursby, M (corresponding author), Georgia Inst Technol, Atlanta, GA 30308 USA.	marie.thursby@mgt.gatech.edu						Aho Group, 2006, CREAT INN EUR; Branstetter LG, 2006, Q J ECON, V121, P321; Committee on Prospering in the Global Economy of the 21stCentury: An Agenda for American Science and Technology, 2006, RIS GATH STORM EN EM; Economist Intelligence Unit, 2004, SCATT SEEDS INV GLOB; Freeman R. B, 2005, 11457 NBER; Jaffe A.B., 2004, INNOVATION ITS DISCO; LANDEFIELD J, 2004, 200406 US BUR EC AN; Marburger JH, 2005, SCIENCE, V308, P1087, DOI 10.1126/science.1114801; National Science Foundation Division of Science Resources Statistics, 2006, SCI ENG IND; Nelson RR, 1996, SOURCES EC GROWTH; Thursby J., 2006, HERE THERE SURVEY FA; VALENTIN F, EFFECTS ACAD IND COL; ZAMISKA N, 2006, WALL STREET J   1106, pA3	13	20	21	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1547	1548		10.1126/science.1134257	http://dx.doi.org/10.1126/science.1134257			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158307				2022-12-28	WOS:000242624600021
J	Ledford, H				Ledford, Heidi			Making it up as you go along	NATURE			English	News Item																		WILLIAMS RH, 2006, 8 INT C GREENH GAS C	1	9	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2006	444	7120					677	678		10.1038/444677a	http://dx.doi.org/10.1038/444677a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151629				2022-12-28	WOS:000242581100017
J	Rockenbach, B; Milinski, M				Rockenbach, Bettina; Milinski, Manfred			The efficient interaction of indirect reciprocity and costly punishment	NATURE			English	Article							COOPERATION; EVOLUTION; REPUTATION; CUES	Human cooperation in social dilemmas challenges researchers from various disciplines. Here we combine advances in experimental economics and evolutionary biology that separately have shown that costly punishment and reputation formation, respectively, induce cooperation in social dilemmas. The mechanisms of punishment and reputation, however, substantially differ in their means for 'disciplining' non-cooperators. Direct punishment incurs salient costs for both the punisher and the punished, whereas reputation mechanisms discipline by withholding action, immediately saving costs for the 'punisher'. Consequently, costly punishment may become extinct in environments in which effective reputation building - for example, through indirect reciprocity - provides a cheaper and powerful way to sustain cooperation. Unexpectedly, as we show here, punishment is maintained when a combination with reputation building is available, however, at a low level. Costly punishment acts are markedly reduced although not simply substituted by appreciating reputation. Indeed, the remaining punishment acts are concentrated on free-riders, who are most severely punished in the combination. When given a choice, subjects even prefer a combination of reputation building with costly punishment. The interaction between punishment and reputation building boosts cooperative efficiency. Because punishment and reputation building are omnipresent interacting forces in human societies, costly punishing should appear less destructive without losing its deterring force.	Univ Erfurt, Dept Econ, D-99089 Erfurt, Germany; Max Planck Inst Limnol, Dept Evolut Ecol, D-24306 Plon, Germany	University of Erfurt; Max Planck Society	Rockenbach, B (corresponding author), Univ Erfurt, Dept Econ, Nordhauser Str 63, D-99089 Erfurt, Germany.	bettina.rockenbach@uni-erfurt.de; milinski@mpil-ploen.mpg.de	Rockenbach, Bettina/B-5447-2016; Rockenbach, Bettina/AAI-8072-2021	Rockenbach, Bettina/0000-0003-2624-1964; Rockenbach, Bettina/0000-0003-2624-1964				Alexander R., 1987, BIOL MORAL SYSTEMS; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bolton GE, 2005, J PUBLIC ECON, V89, P1457, DOI 10.1016/j.jpubeco.2004.03.008; Botelho Anabela, 2005, 30 NIMA U MINH; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, NATURE, V432, P449, DOI 10.1038/432449a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2004, CURR OPIN NEUROBIOL, V14, P784, DOI 10.1016/j.conb.2004.10.007; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; FISCHBACHER, 1999, 21 U ZUR I EMP RES E; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Milinski M, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P265, DOI 10.1007/3-540-28277-7_14; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; SEFTON M, 2002, 200202 CEDEX; Seinen I, 2006, EUR ECON REV, V50, P581, DOI 10.1016/j.euroecorev.2004.10.005; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Sutter M., 2006, 5497 CEPR; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	33	326	334	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					718	723		10.1038/nature05229	http://dx.doi.org/10.1038/nature05229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113EL	17151660				2022-12-28	WOS:000242581100051
J	Kelen, GD; Kraus, CK; McCarthy, ML; Bass, E; Hsu, EB; Li, GH; Scheulen, JJ; Shahan, JB; Brill, JD; Green, GB				Kelen, Gabor D.; Kraus, Chadd K.; McCarthy, Melissa L.; Bass, Eric; Hsu, Edbert B.; Li, Guohua; Scheulen, James J.; Shahan, Judy B.; Brill, Justin D.; Green, Gary B.			Inpatient disposition classification for the creation of hospital surge capacity: a multiphase study	LANCET			English	Article							ADVERSE EVENTS; EMERGENCY; WORKERS; PREDICTION; EVACUATION; MANAGEMENT; DISCHARGE; SEVERITY; SYSTEM; IMPACT	Background The ability to provide medical care during sudden increases in patient volume during a disaster or other high-consequence event is a serious concern for health-care systems. Identification of inpatients for safe early discharge (ie, reverse triage) could create additional hospital surge capacity. We sought to develop a disposition classification system that categorises inpatients according to suitability for immediate discharge on the basis of risk tolerance for a subsequent consequential medical event. Methods We did a warfare analysis laboratory exercise using evidence-based techniques, combined with a consensus process of 39 expert panellists. These panellists were asked to define the categories of a disposition classification system, assign risk tolerance of a consequential medical event to each category, identify critical interventions, and rank each (using a scale of 1-10) according to the likelihood of a resultant consequential medical event if a critical intervention is withdrawn or withheld because of discharge. Findings The panellists unanimously agreed on a five-category disposition classification system. The upper limit of risk tolerance for a consequential medical event in the lowest risk group if discharged early was less than 4%. The next categories had upper limits of risk tolerance of about 12% (IQR 8-15%), 33% (25-50%), 60% (45-80%) and 100% (95-100%), respectively. The expert panellists identified 28 critical interventions with a likelihood of association with a consequential medical event if withdrawn, ranging from 3 to 10 on the 10-point scale. Interpretation The disposition classification system allows conceptual classification of patients for suitable disposition, including those deemed safe for early discharge home during surges in demand. Clinical criteria allowing real-time categorisation of patients are awaited.	Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Johns Hopkins Off Crit Event Preparedness & Respo, Baltimore, MD 21287 USA; Johns Hopkins Univ, Evidence Based Practice Ctr, Baltimore, MD 21287 USA; Johns Hopkins Univ, Dept Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kelen, GD (corresponding author), Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD 21287 USA.	gkelen@jhmi.edu		Kelen, Gabor/0000-0002-3236-8286; Bass, Eric/0000-0001-9106-527X	AHRQ HHS [U01 HS14353-01, U01 HS014353] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U01HS014353] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Almogy G, 2005, ARCH SURG-CHICAGO, V140, P390, DOI 10.1001/archsurg.140.4.390; American College of Emergency Physicians, 2005, Ann Emerg Med, V45, P239; Anderson RJ, 2004, ACAD MED, V79, P1162, DOI 10.1097/00001888-200412000-00008; [Anonymous], 1972, JAMA, V220, P717; Avendano M, 2003, CAN MED ASSOC J, V168, P1649; Booth Christopher M, 2005, Crit Care Med, V33, pS53, DOI 10.1097/01.CCM.0000150954.88817.6; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; CARAFANO JJ, 2006, LEARNING DISASTER RO; Challen K, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-108; Cocanour CS, 2002, ARCH SURG-CHICAGO, V137, P1141, DOI 10.1001/archsurg.137.10.1141; Cushman JG, 2003, J TRAUMA, V54, P147, DOI 10.1097/00005373-200301000-00018; Davis DP, 2005, PREHOSPITAL DISASTER, V20, P169, DOI 10.1017/S1049023X00002405; Department of Homeland Security, 2004, NAT INC MAN SYST; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Greenwald PW, 2004, ACAD EMERG MED, V11, P786, DOI 10.1197/j.aem.2003.12.032; Gutierrez de Ceballos J Peral, 2005, Crit Care Med, V33, pS107, DOI 10.1097/01.CCM.0000151072.17826.72; Hick JL, 2006, ACAD EMERG MED, V13, P223, DOI [10.1111/j.1553-2712.2006.tb01677.x, 10.1197/j.aem.2005.07.037]; Hick JL, 2004, ANN EMERG MED, V44, P253, DOI 10.1016/j.annemergmed.2004.04.011; Ho AS, 2003, ANN INTERN MED, V139, P564, DOI 10.7326/0003-4819-139-7-200310070-00008; Hogan DE, 1999, ANN EMERG MED, V34, P160, DOI 10.1016/S0196-0644(99)70224-6; *I MED COMM QUAL H, 2000, ERR IS HUM BUILD SAF; Joint Commission on Accreditation of Healthcare Organizations, 2003, HLTH CAR CROSSR STRA; KELEN GD, 2005, ACAD EMERG MED S1, V12, P23; Keller W.K., 1971, JAMA-J AM MED ASSOC, V215, P277, DOI [10.1001/jama.1971.03180150059012, DOI 10.1001/JAMA.1971.03180150059012]; Kirschenbaum Linda, 2005, Crit Care Med, V33, pS48, DOI 10.1097/01.CCM.0000151067.76074.21; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Lau JTF, 2004, EMERG INFECT DIS, V10, P1399, DOI 10.3201/eid1008.040041; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1994, JAMA-J AM MED ASSOC, V272, P1049, DOI 10.1001/jama.272.13.1049; Mahoney EJ, 2005, J TRAUMA, V58, P487, DOI 10.1097/01.TA.0000153939.17932.E7; May AK, 2000, J TRAUMA, V48, P666, DOI 10.1097/00005373-200004000-00014; McDonald CJ, 2000, JAMA-J AM MED ASSOC, V284, P93, DOI 10.1001/jama.284.1.93; Nolen JM, 2000, J HOPKINS APL TECH D, V21, P225; NORCROSS ED, 1993, AM SURGEON, V59, P28; RHODES JD, 2006, STATE REGIONAL RESPO; Rodoplu Ulkumen, 2004, Prehosp Disaster Med, V19, P133; Schafermeyer Robert W, 2003, Emerg Med (Fremantle), V15, P22, DOI 10.1046/j.1442-2026.2003.00403.x; Schull MJ, 2001, ACAD EMERG MED, V8, P1037, DOI 10.1111/j.1553-2712.2001.tb01112.x; Schultz CH, 2002, EMERG MED CLIN N AM, V20, P437, DOI 10.1016/S0733-8627(02)00003-2; Schultz CH, 2003, NEW ENGL J MED, V348, P1349, DOI 10.1056/NEJMsa021807; US Centers for Disease Control and Prevention, FISC YEAR 2006 JUST; *US GOV ACC OFF, 2003, HOSP PREP MOST URB H	45	72	74	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					1984	1990		10.1016/S0140-6736(06)69808-5	http://dx.doi.org/10.1016/S0140-6736(06)69808-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113JD	17141705	Bronze, Green Published			2022-12-28	WOS:000242593300030
J	Mirzayan, MJ; Koenig, K; Bastuerk, M; Krauss, JK				Mirzayan, M. Javad; Koenig, Kathrin; Bastuerk, Murat; Krauss, Joachim K.			Coma due to meteorism and increased intra-abdominal pressure subsequent to ventriculoperitoneal shunt dysfunction	LANCET			English	Editorial Material							MALFUNCTION; PREGNANCY		Hannover Med Sch, Dept Neurosurg, D-30625 Hannover, Germany; Hannover Med Sch, Dept Gastroenterol, D-30625 Hannover, Germany	Hannover Medical School; Hannover Medical School	Mirzayan, MJ (corresponding author), Hannover Med Sch, Dept Neurosurg, Carl Neuberg Str 1, D-30625 Hannover, Germany.	mirzayan@hotmail.com						CUSIMANO MD, 1992, PEDIATR NEUROSURG, V17, P10, DOI 10.1159/000120558; HANAKITA J, 1985, J NEUROSURG, V63, P459, DOI 10.3171/jns.1985.63.3.0459; KLEINMAN G, 1983, OBSTET GYNECOL, V61, P753; Miele VJ., 2004, NEUROSURGERY, V55, P434, DOI [10.1227/01.neu.0000130038.49240.6f, DOI 10.1227/01.NEU.0000130038.49240.6F]; RICHARDS WO, 1983, ANN SURG, V197, P183, DOI 10.1097/00000658-198302000-00010	5	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					2032	2032		10.1016/S0140-6736(06)69811-5	http://dx.doi.org/10.1016/S0140-6736(06)69811-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141711				2022-12-28	WOS:000242593300036
J	Banu, SH; Jahan, M; Koli, UK; Ferdousi, S; Khan, NZ; Neville, B				Banu, Selina H.; Jahan, Moshrat; Koli, Umme Kulsum; Ferdousi, Saadia; Khan, Naila Z.; Neville, Brian			Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANTIEPILEPTIC DRUG-TREATMENT; BEHAVIOR; CHILDREN	Objective To compare the behavioural side effects associated with two commonly used antiepilepsy drugs-phenobarbital and carbamazepine-in children in Bangladesh. Design Prospective randomised controlled single Centre trial. Setting Specialist children's hospital in Dhaka, Bangladesh. Participants 108 children aged 2-15 with generalised tonic-clonic (n=51) or partial and secondarily generalised seizures (n=57). Main outcome measures Seizure control and behavioural side effects. Results 91 children were followed up for 12 months. Six required a change of antiepilepsy drug. Side effects were compared in 85 children. In the last quarter of the 12 month follow-up 71 children were seizure free after one year's treatment. Thirty two in the phenobarbital group and 39 in the carbamazepine group had no seizures for 74 and 102 days after randomisation, respectively. Ten children had increased behavioural problems, which were unacceptable in four (one in the phenobarbital group and three in the carbamazepine group). Independent t tests, however, showed no difference between the two trial drugs. Conclusion There was no excess in behavioural side effects with phenobarbital in children with epilepsy in a country with limited resources.	UCL, Inst Child Hlth, Wolfson Ctr, Neurosci Unit, London WC1N 2AP, England; Dhaka Shishu Childrens Hosp, Bangladesh Inst Child Hlth, Child Dev & Neurol Unit, Dhaka 1207, Bangladesh	University of London; University College London	Neville, B (corresponding author), UCL, Inst Child Hlth, Wolfson Ctr, Neurosci Unit, London WC1N 2AP, England.	bneville@ncype.org.uk						[Anonymous], 1993, EPILEPSIA, V34, P592; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Banu SH, 2003, DEV MED CHILD NEUROL, V45, P477, DOI 10.1017/S0012162203000884; BANU SH, 2003, THESIS U COLL LONDON; Conners CK., 1997, MANUAL CONNERS RATIN; deSilva M, 1996, LANCET, V347, P709, DOI 10.1016/S0140-6736(96)90074-4; DURKIN MS, 1993, AM J PUBLIC HEALTH, V83, P1549, DOI 10.2105/AJPH.83.11.1549; Egan D.F., 1990, DEV EXAMINATION INFA; FARWELL JR, 1990, NEW ENGL J MED, V322, P364, DOI 10.1056/NEJM199002083220604; FEKSI AT, 1991, LANCET, V337, P406, DOI 10.1016/0140-6736(91)91176-U; GASTAUT H, 1976, EPILEPSIA, V17, P355, DOI 10.1111/j.1528-1157.1976.tb04445.x; Huq S, 1994, SCI STUDIES DEV DISA, P183; Kale R, 2004, BMJ-BRIT MED J, V329, P1199, DOI 10.1136/bmj.329.7476.1199; Kwan P, 2004, EPILEPSIA, V45, P1141, DOI 10.1111/j.0013-9580.2004.12704.x; MACHIN D, 1997, SAMPLE SIZE TABLES C, P13; Munir SZ, 1999, J APPL RES INTELLECT, V12, P241, DOI 10.1111/j.1468-3148.1999.tb00080.x; Pal DK, 1998, LANCET, V351, P19, DOI 10.1016/S0140-6736(97)06250-8; PLACENCIA M, 1993, EPILEPSY RES, V14, P237, DOI 10.1016/0920-1211(93)90048-C; Richman N, 1982, PRESCHOOL SCH BEHAV; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Rutter M, 1970, NEUROPSYCHIATRIC STU; SHORVON SD, 1988, EPILEPSIA, V29, pS36, DOI 10.1111/j.1528-1157.1988.tb05790.x; VINING EPG, 1987, PEDIATRICS, V80, P165; WENDY G, 1987, EPILEPSIA, V28, P56; *WHO, 1990, MND903 WHOMHH; *WISC R, 1971, MAN WECHSL INT SCAL; WOLF SM, 1978, PEDIATRICS, V61, P728; WOLF SM, 1981, PEDIATRICS, V68, P820; Yi S.H., 1993, MANUAL BAYLEY SCALES	29	37	37	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2007	334	7605					1207	1210A		10.1136/bmj.39022.436389.BE	http://dx.doi.org/10.1136/bmj.39022.436389.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17145735	Green Published, Bronze			2022-12-28	WOS:000247277000036
J	Pillitteri, LJ; Sloan, DB; Bogenschutz, NL; Torii, KU				Pillitteri, Lynn Jo; Sloan, Daniel B.; Bogenschutz, Naomi L.; Torii, Keiko U.			Termination of asymmetric cell division and differentiation of stomata	NATURE			English	Article							MYOD FAMILY; SELAGINELLA; POLARITY	Stomata consist of a pair of guard cells that mediate gas and water-vapour exchange between plants and the atmosphere. Stomatal precursor cells - meristemoids - possess a transient stem-cell-like property and undergo several rounds of asymmetric divisions before further differentiation. Here we report that the Arabidopsis thaliana basic helix - loop - helix ( bHLH) protein MUTE is a key switch for meristemoid fate transition. In the absence of MUTE, meristemoids abort after excessive asymmetric divisions and fail to differentiate stomata. Constitutive overexpression of MUTE directs the entire epidermis to adopt guard cell identity. MUTE has two paralogues: FAMA, a regulator of guard cell morphogenesis, and SPEECHLESS (SPCH). We show that SPCH directs the first asymmetric division that initiates stomatal lineage. Together, SPCH, MUTE and FAMA bHLH proteins control stomatal development at three consecutive steps: initiation, meristemoid differentiation and guard cell morphogenesis. Our findings highlight the roles of closely related bHLHs in cell type differentiation in plants and animals.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Japan Science & Technology Agency (JST)	Torii, KU (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	ktorii@u.washington.edu	Sloan, Daniel/D-4152-2011; TORII, KEIKO U./A-6041-2013	TORII, KEIKO U./0000-0002-6168-427X; Sloan, Daniel/0000-0002-3618-0897				Bailey PC, 2003, PLANT CELL, V15, P2497, DOI 10.1105/tpc.151140; Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; BROWN RC, 1985, AM J BOT, V72, P1914, DOI 10.2307/2443608; Buck MJ, 2003, J MOL EVOL, V56, P742, DOI 10.1007/s00239-002-2449-3; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; DENGLER NG, 1983, AM J BOT, V70, P193, DOI 10.2307/2443263; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Geisler MJ, 2003, PLANTA, V216, P571; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau Jeanette A, 2002, Arabidopsis Book, V1, pe0066, DOI 10.1199/tab.0066; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; POETHIG RS, 2006, ENHANCER TRAPS; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3	24	323	360	5	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					501	505		10.1038/nature05467	http://dx.doi.org/10.1038/nature05467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17183267				2022-12-28	WOS:000243867300035
J	Oliver, D; Connelly, JB; Victor, CR; Shaw, FE; Whitehead, A; Genc, Y; Vanoli, A; Martin, FC; Gosney, MA				Oliver, David; Connelly, James B.; Victor, Christina R.; Shaw, Fiona E.; Whitehead, Anne; Genc, Yasemin; Vanoli, Alessandra; Martin, Finbarr C.; Gosney, Margot A.			Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses	BRITISH MEDICAL JOURNAL			English	Article							COMPLEX INTERVENTIONS; RANDOMIZED-TRIAL; VITAMIN-D; HEALTH; QUALITY; PEOPLE	Objectives To evaluate the evidence for strategies to prevent falls or fractures in residents in care homes and hospital inpatients and to investigate the effect of dementia and cognitive impairment. Design Systematic review and meta-analyses of studies grouped by intervention and setting (hospital or care home). Meta-regression to investigate the effects of dementia and of study quality and design. Data sources Medline, CINAHL, Embase, PsychInfo, Cochrane Database, Clinical Trials Register, and hand searching of references from reviews and guidelines to January 2005. Results 1207 references were identified, including 115 systematic reviews, expert reviews, or guidelines. Of the 92 full papers inspected, 43 were included. Meta-analysis for multifaceted interventions in hospital (13 studies) showed a rate ratio of 0.82 (95% confidence interval 0.68 to 0.997) for falls but no significant effect on the number of falters or fractures. For hip protectors in care homes (11 studies) the rate ratio for hip fractures was 0.67 (0.46 to 0.98), but there was no significant effect on falls and not enough studies on falters. For all other interventions (multifaceted interventions in care homes; removal of physical restraints in either setting; fall alarm devices in either setting; exercise in care homes; calcium/vitamin D in care homes; changes in the physical environment in either setting; medication review in hospital) meta-analysis was either unsuitable because of insufficient studies or showed no significant effect on fails, falters, or fractures, despite strongly positive results in some individual studies. Meta-regression showed no significant association between effect size and prevalence of dementia or cognitive impairment. Conclusion There is some evidence that multifaceted interventions in hospital reduce the number of falls and that use of hip protectors in care homes prevents hip fractures. There is insufficient evidence, however, for the effectiveness of other single interventions in hospitals or care homes or multifaceted interventions in care homes.	Univ Reading, Inst Hlth Sci, Reading RG1 5AG, Berks, England; Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Reading, Med & Pharmaceut Stat Res Unit, Reading RG6 6FN, Berks, England; Ankara Univ, Fac Med, Dept Biostat, TR-06100 Ankara, Turkey; Newcastle Univ, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Guys & St Thomas NHS Fdn Trust, Dept Ageing & Hlth, London SE1 7EH, England	University of Reading; Newcastle University - UK; University of Reading; Ankara University; Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust	Oliver, D (corresponding author), Univ Reading, Inst Hlth Sci, Reading RG1 5AG, Berks, England.	d.oliver@reading.ac.uk		Victor, Christina/0000-0002-4213-3974				BATES DW, 1995, AM J MED, V99, P137, DOI 10.1016/S0002-9343(99)80133-8; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Connelly J, 2001, HEALTH EDUC RES, V16, P115, DOI 10.1093/her/16.2.115; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Flicker L, 2005, J AM GERIATR SOC, V53, P1881, DOI 10.1111/j.1532-5415.2005.00468.x; GILLESPIE LD, 2006, COCHRANE DB SYST REV; Healey F, 1994, Nurs Times, V90, P40; Healey F, 2006, HEALTHCARE RISK  JUN, P12; Herbert RD, 2005, BMJ-BRIT MED J, V331, P507, DOI 10.1136/bmj.331.7515.507; Law M, 2006, AGE AGEING, V35, P482, DOI 10.1093/ageing/afj080; Liddle J, 1994, AGE AGEING S4, V23, P17; Mahoney JE, 1998, CLIN GERIATR MED, V14, P699; MURPHY J, 1982, GERONTOLOGY, V28, P265, DOI 10.1159/000212543; National Ageing Research Institute, 2004, AN RES PREV FALLS FA; National Institute for Health and Clinical Excellence, 2004, FALLS ASS PREV FALLS; Oakley A, 2006, BRIT MED J, V332, P413, DOI 10.1136/bmj.332.7538.413; Oliver D, 2002, AGE AGEING, V31, P415, DOI 10.1093/ageing/31.5.415; Rubenstein LZ, 1996, CLIN GERIATR MED, V12, P881; Simpson AHRW, 2004, AGE AGEING, V33, P242, DOI 10.1093/ageing/afh071; Vetter N, 1989, INT J GERIATR PSYCH, V4, P168	20	346	352	2	43	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 13	2007	334	7584					82	85		10.1136/bmj.39049.706493.55	http://dx.doi.org/10.1136/bmj.39049.706493.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	127DZ	17158580	Green Published, Bronze			2022-12-28	WOS:000243566800031
J	Millis, AJ				Millis, A. J.			Gaps and our understanding	SCIENCE			English	Editorial Material							STATE; SUPERCONDUCTORS		Columbia Univ, Dept Phys, New York, NY 10027 USA	Columbia University	Millis, AJ (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.	millis@phys.columbia.edu						ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Doiron-Leyraud N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.207001; Le Tacon M, 2006, NAT PHYS, V2, P537, DOI 10.1038/nphys362; Tanaka K, 2006, SCIENCE, V314, P1910, DOI 10.1126/science.1133411; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Valla T, 2006, SCIENCE, V314, P1914, DOI 10.1126/science.1134742	6	45	45	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1888	1889		10.1126/science.1137173	http://dx.doi.org/10.1126/science.1137173			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185592				2022-12-28	WOS:000242996800036
J	Chen, JY; Li, YH				Chen, Ju-Yi; Li, Yi-Heng			Multiple pulmonary bacterial abscesses	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Natl Cheng Kung Univ, Med Ctr, Tainan 70428, Taiwan	National Cheng Kung University	Chen, JY (corresponding author), Natl Cheng Kung Univ, Med Ctr, Tainan 70428, Taiwan.	t025215@ms17.hinet.net							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					E27	E27		10.1056/NEJMicm055451	http://dx.doi.org/10.1056/NEJMicm055451			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182984				2022-12-28	WOS:000242956200010
J	Bour-Jordan, H; Bluestone, JA				Bour-Jordan, Helene; Bluestone, Jeffrey A.			Sensory neurons link the nervous system and autoimmune diabetes	CELL			English	Editorial Material							NOD MICE; TYPE-1; CELLS	The initial factors that trigger the autoimmune response against pancreatic islets in the nonobese diabetic (NOD) mouse are still unknown. In this issue of Cell, Razavi et al. (2006) propose that a defect in a subset of sensory neurons innervating the pancreas plays a major role in initiating the chain of events that will lead to local inflammation, islet destruction, and autoimmune diabetes.	Univ Calif San Francisco, Dept Med, UCSF Diabet Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bluestone, JA (corresponding author), Univ Calif San Francisco, Dept Med, UCSF Diabet Ctr, 513 Parnassus Ave,Box 0540, San Francisco, CA 94143 USA.	jbluest@diabetes.ucsf.edu						Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Chaparro RJ, 2006, P NATL ACAD SCI USA, V103, P12475, DOI 10.1073/pnas.0604317103; HORNODELARCHE F, 2004, ILAR J, V45, P237; Khachatryan A, 1997, J IMMUNOL, V158, P1409; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Winer S, 2001, J IMMUNOL, V166, P2831, DOI 10.4049/jimmunol.166.4.2831; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818	9	11	13	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1097	1099		10.1016/j.cell.2006.11.030	http://dx.doi.org/10.1016/j.cell.2006.11.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174888	Bronze			2022-12-28	WOS:000242991000008
J	Kuo, CT; Mirzadeh, Z; Soriano-Navarro, M; Rasin, M; Wang, D; Shen, J; Sestan, N; Garcia-Verdugo, J; Alvarez-Buylla, A; Jan, LY; Jan, YN				Kuo, Chay T.; Mirzadeh, Zaman; Soriano-Navarro, Mario; Rasin, Mladen; Wang, Denan; Shen, Jie; Sestan, Nenad; Garcia-Verdugo, Jose; Alvarez-Buylla, Arturo; Jan, Lily Y.; Jan, Yuh-Nung			Postnatal deletion of numb/numblike reveals repair and remodeling capacity in the subventricular neurogenic niche	CELL			English	Article							PROGENITOR-CELL MAINTENANCE; RADIAL GLIAL-CELLS; NEURAL STEM-CELLS; ADULT BRAIN; CORTICAL NEUROGENESIS; NEURONAL MIGRATION; SONIC HEDGEHOG; NUMB; MOUSE; ZONE	Neural stem cells are retained in the postnatal subventricular zone (SVZ), a specialized neurogenic niche with unique cytoarchitecture and cell-cell contacts. Although the SVZ stem cells continuously regenerate, how they and the niche respond to local changes is unclear. Here we generated nestin-creER(tm) transgenic mice with inducible Cre recombinase in the SVZ and removed Numb/Numblike, key regulators of embryonic neurogenesis from postnatal SVZ progenitors and ependymal cells. This resulted in severe damage to brain lateral ventricle integrity and identified roles for Numb/Numblike in regulating ependymal wall integrity and SVZ neuroblast survival. Surprisingly, the ventricular damage was eventually repaired: SVZ reconstitution and ventricular wall remodeling were mediated by progenitors that escaped Numb deletion. Our results show a self-repair mechanism in the mammalian brain and may have implications for both niche plasticity in other areas of stem cell biology and the therapeutic use of neural stem cells in neurodegenerative diseases.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol Surg, Program Dev & Stem Cell Biol, San Francisco, CA 94143 USA; Univ Valencia, Unidad Asociada Ctr Invest Principe Felipe, Lab Morfol Celular, Valencia 46013, Spain; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Prince Felipe Research Center; University of Valencia; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu	García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Soriano Navarro, Mario/0000-0002-7245-2095	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047200, R37NS040929, R01NS028478, R29NS028478, R37NS028478] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD045481] Funding Source: Medline; NIMH NIH HHS [R01 MH084234] Funding Source: Medline; NINDS NIH HHS [R01 NS047200, 5 R01 NS047200, R37 NS040929, NS28478] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Campbell K, 2005, NEURON, V46, P373, DOI 10.1016/j.neuron.2005.04.014; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Chambers CB, 2001, DEVELOPMENT, V128, P689; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lindvall O, 2004, STROKE, V35, P2691, DOI 10.1161/01.STR.0000143323.84008.f4; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Morhenn VB, 2004, EXP DERMATOL, V13, P505, DOI 10.1111/j.0906-6705.2004.00186.x; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Sharp CD, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-28; Shen Q, 2002, DEVELOPMENT, V129, P4843; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	41	168	182	2	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1253	1264		10.1016/j.cell.2006.10.041	http://dx.doi.org/10.1016/j.cell.2006.10.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174898	Green Accepted, Bronze			2022-12-28	WOS:000242991000021
J	Reilly, JJ; Wilson, D				Reilly, John J.; Wilson, David			ABC of obesity - Childhood obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		Yorkhill Hosp, Univ Div Dev Med, Glasgow, Lanark, Scotland; Univ Edinburgh, Royal Hosp Sick Children, Div Child Life & Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh	Reilly, JJ (corresponding author), Yorkhill Hosp, Univ Div Dev Med, Glasgow, Lanark, Scotland.							[Anonymous], CLIN PRACTICE GUIDEL, DOI DOI 10.1002/hlca.19480310102; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Gibson Penny, 2002, J Fam Health Care, V12, P108; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Kopelman P. G., 2005, CLIN OBESITY ADULTS; NEOVIUS M, 2004, OBES REV, V52, P105; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Rudolf MCJ., 2004, ARCH DIS CHILDHOOD-E, V89, pep57; *SIGN, 2003, MAN OB CHILDR YOUNG; Stewart L, 2005, J AM DIET ASSOC, V105, P1810, DOI 10.1016/j.jada.2005.08.006; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Viner R, 2005, ARCH DIS CHILD, V90, P385, DOI 10.1136/adc.2004.062224; Whitaker RC, 2003, ARCH PEDIAT ADOL MED, V157, P725, DOI 10.1001/archpedi.157.8.725	13	49	51	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2006	333	7580					1207	1210		10.1136/bmj.39048.503750.BE	http://dx.doi.org/10.1136/bmj.39048.503750.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	119JW	17158388	Green Published, Green Submitted			2022-12-28	WOS:000243009600018
J	Schliewen, UK; Kocher, TD; McKaye, KR; Seehausen, O; Tautz, D				Schliewen, U. K.; Kocher, T. D.; McKaye, K. R.; Seehausen, O.; Tautz, D.			Evolutionary biology - Evidence for sympatric speciation?	NATURE			English	Letter									Bavarian State Collect Zool, D-81247 Munich, Germany; Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA; UMCES, Appalachian Lab, Frostburg, MD 21532 USA; Univ Bern, Inst Zool, CH-3012 Bern, Switzerland; EAWAG Ecol Ctr, CH-6047 Kastanienbaum, Switzerland; Univ Cologne, Inst Genet, Dept Evolutionary Genet, D-5000 Cologne, Germany	University System Of New Hampshire; University of New Hampshire; University System of Maryland; University of Maryland Center for Environmental Science; University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Cologne	Schliewen, UK (corresponding author), Bavarian State Collect Zool, D-81247 Munich, Germany.	schliewen@zsm.mwn.de	Tautz, Diethard/D-4304-2011; Tautz, Diethard/H-8436-2014; Seehausen, Ole/C-8272-2011; Kocher, Thomas D/B-3089-2013	Tautz, Diethard/0000-0002-0460-5344; Seehausen, Ole/0000-0001-6598-1434; Kocher, Thomas/0000-0002-7547-0133				Barluenga M, 2004, MOL ECOL, V13, P2061, DOI 10.1111/j.1365-294X.2004.02211.x; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; BERNATCHEZ L, 1995, CAN J FISH AQUAT SCI, V52, P179, DOI 10.1139/f95-018; Dieckmann U., 2004, ADAPTIVE SPECIATION; GAVRILETS S, 2004, MONOGRAPHS POPULATIO, V41; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; McKaye K.R., 2002, CUADERNOS INVESTIGAC, V12, P19; Schliewen Ulrich K., 2004, Frontiers in Zoology, V1, P1; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Stauffer J.R.Jr., 2002, CUADERNOS INVESTIGAC, V12, P1; Taylor EB, 2000, P ROY SOC B-BIOL SCI, V267, P2375, DOI 10.1098/rspb.2000.1294	11	40	42	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2006	444	7120					E12	E13		10.1038/nature05419	http://dx.doi.org/10.1038/nature05419			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151605				2022-12-28	WOS:000242581100044
J	Sawada, Y; Tamada, M; Dubin-Thaler, BJ; Cherniavskaya, O; Sakai, R; Tanaka, S; Sheetz, MP				Sawada, Yasuhiro; Tamada, Masako; Dubin-Thaler, Benjamin J.; Cherniavskaya, Oksana; Sakai, Ryuichi; Tanaka, Sakae; Sheetz, Michael P.			Force sensing by mechanical extension of the Src family kinase substrate p130Cas	CELL			English	Article							CRK-ASSOCIATED SUBSTRATE; FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; CELL-MIGRATION; IN-VIVO; V-SRC; PROTEIN; DOMAIN; ACTIVATION; P130(CAS)	How physical force is sensed by cells and transduced into cellular signaling pathways is poorly understood. Previously, we showed that tyrosine phosphorylation of p130Cas (Cas) in a cytoskeletal complex is involved in force-dependent activation of the small GTPase Rap1. Here, we mechanically extended bacterially expressed Cas substrate domain protein (CasSD) in vitro and found a remarkable enhancement of phosphorylation by Src family kinases with no apparent change in kinase activity. Using an antibody that recognized extended CasSD in vitro, we observed Cas extension in intact cells in the peripheral regions of spreading cells, where higher traction forces are expected and where phosphorylated Cas was detected, suggesting that the in vitro extension and phosphorylation of CasSD are relevant to physiological force transduction. Thus, we propose that Cas acts as a primary force sensor, transducing force into mechanical extension and thereby priming phosphorylation and activation of downstream signaling.	Columbia Univ, Dept Sci Biol, New York, NY 10027 USA; Natl Canc Ctr, Res Inst, Growth Factor Div, Chuo Ku, Tokyo 1040045, Japan; Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1130033, Japan	Columbia University; National Cancer Center - Japan; University of Tokyo	Sawada, Y (corresponding author), Columbia Univ, Dept Sci Biol, Sherman Fairchild Ctr Room 715,MC 2416,1212 Amste, New York, NY 10027 USA.	ys454-ind@umin.ac.jp	Tanaka, Sakae/Y-3061-2019; Sakai, Ryuichi/R-7741-2017; Sawada, Yasuhiro/H-8044-2012	Tanaka, Sakae/0000-0001-9210-9414; Sawada, Yasuhiro/0000-0003-0625-3335; Sakai, Ryuichi/0000-0001-6833-1103	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001480] Funding Source: NIH RePORTER; NIBIB NIH HHS [R01 EB001480-03, R01 EB001480] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 2006, J CELL SCI, V119, P866, DOI 10.1242/jcs.02794; BOUGERET C, 1993, ONCOGENE, V8, P1241; Briknarova K, 2005, J BIOL CHEM, V280, P21908, DOI 10.1074/jbc.M501258200; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Chien S, 2005, FRONT BIOSCI-LANDMRK, V10, P1985, DOI 10.2741/1673; COOPER JA, 1984, J BIOL CHEM, V259, P7835; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Fisher TE, 1999, TRENDS BIOCHEM SCI, V24, P379, DOI 10.1016/S0968-0004(99)01453-X; Fonseca PM, 2004, CELL SIGNAL, V16, P621, DOI 10.1016/j.cellsig.2003.10.004; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Isakov N, 1996, J BIOL CHEM, V271, P15753, DOI 10.1074/jbc.271.26.15753; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; Missbach M, 1999, BONE, V24, P437, DOI 10.1016/S8756-3282(99)00020-4; Miyake I, 2005, ONCOGENE, V24, P3206, DOI 10.1038/sj.onc.1208523; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sakakibara A, 2002, J CELL SCI, V115, P4915, DOI 10.1242/jcs.00207; Sawada Y, 2001, J CELL SCI, V114, P1221; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Tang DD, 2003, HYPERTENSION, V42, P858, DOI 10.1161/01.HYP.0000085333.76141.33; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Wisniewska M, 2005, J MOL BIOL, V347, P1005, DOI 10.1016/j.jmb.2005.02.017; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	44	693	706	0	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					1015	1026		10.1016/j.cell.2006.09.044	http://dx.doi.org/10.1016/j.cell.2006.09.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129785	Green Accepted, Bronze			2022-12-28	WOS:000242613800017
J	Lund, DC; Lynch-Stieglitz, J; Curry, WB				Lund, David C.; Lynch-Stieglitz, Jean; Curry, William B.			Gulf Stream density structure and transport during the past millennium	NATURE			English	Article							FLORIDA CURRENT; PLANKTONIC-FORAMINIFERA; VARIABILITY; TEMPERATURE; STRAITS; PERIOD	The Gulf Stream transports approximately 31 Sv ( 1 Sv = 10(6) m(3) s(-1)) of water(1,2) and 1.3 x 10(15) W of heat(3) into the North Atlantic ocean. The possibility of abrupt changes in Gulf Stream heat transport is one of the key uncertainties in predictions of climate change for the coming centuries. Given the limited length of the instrumental record, our knowledge of Gulf Stream behaviour on long timescales must rely heavily on information from geologic archives. Here we use foraminifera from a suite of high-resolution sediment cores in the Florida Straits to show that the cross-current density gradient and vertical current shear of the Gulf Stream were systematically lower during the Little Ice Age ( AD 1200 to 1850). We also estimate that Little Ice Age volume transport was ten per cent weaker than today's. The timing of reduced flow is consistent with temperature minima in several palaeoclimate records(4-9), implying that diminished oceanic heat transport may have contributed to Little Ice Age cooling in the North Atlantic. The interval of low flow also coincides with anomalously high Gulf Stream surface salinity(10), suggesting a tight linkage between the Atlantic Ocean circulation and hydrologic cycle during the past millennium.	MIT Woods Hole Oceanog Inst Joint Program Oceanog, Woods Hole, MA 02543 USA; Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); University System of Georgia; Georgia Institute of Technology; Woods Hole Oceanographic Institution	Lund, DC (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	dlund@gps.caltech.edu	Lynch-Stieglitz, Jean/J-2277-2018	Lynch-Stieglitz, Jean/0000-0002-9353-1972				Anand P, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000846; Baringer MO, 2001, GEOPHYS RES LETT, V28, P3179, DOI 10.1029/2001GL013246; CARTON JA, 2005, UNPUB J GEOPHYS RES; Chiang JCH, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000307; DahlJensen D, 1998, SCIENCE, V282, P268, DOI 10.1126/science.282.5387.268; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; DEUSER WG, 1987, J FORAMIN RES, V17, P14, DOI 10.2113/gsjfr.17.1.14; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Hamilton P, 2005, J PHYS OCEANOGR, V35, P308, DOI 10.1175/JPO-2688.1; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hodell DA, 2005, QUATERNARY RES, V63, P109, DOI 10.1016/j.yqres.2004.11.004; Keigwin LD, 1996, SCIENCE, V274, P1504, DOI 10.1126/science.274.5292.1504; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; Lamb H.H., 1995, CLIMATE HIST MODERN, P211; LARSEN JC, 1992, PHILOS T R SOC A, V338, P169, DOI 10.1098/rsta.1992.0007; LEAMAN KD, 1995, J GEOPHYS RES-OCEANS, V100, P8561, DOI 10.1029/94JC01436; Lund DC, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001218; Lund DC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001008; Lynch-Stieglitz J, 1999, NATURE, V402, P644, DOI 10.1038/45204; Lynch-Stieglitz J, 1999, PALEOCEANOGRAPHY, V14, P360, DOI 10.1029/1999PA900001; Marchitto TM, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000598; Montgomery RB, 1941, J MAR RES, V4, P198; NIILER PP, 1973, J MAR RES, V31, P144; Pillsbury J. E, 1890, REPORT SUPERINTENDEN, P173; SCHMITZ WJ, 1993, B MAR SCI, V53, P1048; SCHMITZ WJ, 1991, DEEP-SEA RES, V38, pS379, DOI 10.1016/S0198-0149(12)80018-5; SCHMITZ WJ, 1968, DEEP-SEA RES, V15, P679, DOI 10.1016/0011-7471(68)90081-8; SCHOTT FA, 1988, J PHYS OCEANOGR, V18, P1209, DOI 10.1175/1520-0485(1988)018<1209:VOSATO>2.0.CO;2; Vellinga M, 2004, J CLIMATE, V17, P4498, DOI 10.1175/3219.1; WERTHEIM GK, 1954, T AM GEOPHYS UNION, V35, P872	30	154	157	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					601	604		10.1038/nature05277	http://dx.doi.org/10.1038/nature05277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136090				2022-12-28	WOS:000242377600044
J	Roumagnac, P; Weill, FX; Dolecek, C; Baker, S; Brisse, S; Chinh, NT; Le, TAH; Acosta, CJ; Farrar, J; Dougan, G; Achtman, M				Roumagnac, Philippe; Weill, Francois-Xavier; Dolecek, Christiane; Baker, Stephen; Brisse, Sylvain; Chinh, Nguyen Tran; Le, Thi Anh Hong; Acosta, Camilo J.; Farrar, Jeremy; Dougan, Gordon; Achtman, Mark			Evolutionary history of Salmonella Typhi	SCIENCE			English	Article							ESCHERICHIA-COLI; FEVER; POLYMORPHISMS; RESISTANCE; DYNAMICS; BACILLUS; STRAINS	For microbial pathogens, phylogeographic differentiation seems to be relatively common. However, the neutral population structure of Salmonella enterica serovar Typhi reflects the continued existence of ubiquitous haplotypes over millennia. In contrast, clinical use of fluoroquinolones has yielded at least 15 independent gyrA mutations within a decade and stimulated clonal expansion of haplotype H58 in Asia and Africa. Yet, antibiotic-sensitive strains and haplotypes other than H58 still persist despite selection for antibiotic resistance. Neutral evolution in Typhi appears to reflect the asymptomatic carrier state, and adaptive evolution depends on the rapid transmission of phenotypic changes through acute infections.	Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany; Inst Pasteur, Unite Biodivers Bacteries Pathogenes Emergentes, F-75724 Paris 15, France; Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Inst Natl Hyg & Epidemiol, Hanoi 1000, Vietnam; Int Vaccine Inst, Seoul 151600, South Korea	Max Planck Society; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford; Wellcome Trust Sanger Institute; International Vaccine Institute	Achtman, M (corresponding author), Max Planck Inst Infekt Biol, Dept Mol Biol, Charitepl 1, D-10117 Berlin, Germany.	achtman@mpiib-berlin.mpg.de	Farrar, Jeremy J./HGA-7610-2022; Brisse, Sylvain/M-8723-2013	Brisse, Sylvain/0000-0002-2516-2108; Farrar, Jeremy/0000-0002-2700-623X; Achtman, Mark/0000-0001-6815-0070; Weill, Francois-Xavier/0000-0001-9941-5799; Baker, Stephen/0000-0003-1308-5755	Wellcome Trust [076962] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; FRANKEL G, 1989, EMBO J, V8, P3149, DOI 10.1002/j.1460-2075.1989.tb08468.x; Fraser C, 2005, P NATL ACAD SCI USA, V102, P1968, DOI 10.1073/pnas.0406993102; Funk DJ, 2001, GENETICS, V157, P477; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Mortimer PP, 1999, LANCET, V353, P1354, DOI 10.1016/S0140-6736(98)11315-6; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Rodrigues C, 2002, CLIN INFECT DIS, V34, P126, DOI 10.1086/323019; Threlfall EJ, 2001, EMERG INFECT DIS, V7, P448, DOI 10.3201/eid0703.017315; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Young D, 2002, NAT IMMUNOL, V3, P1026, DOI 10.1038/ni1102-1026; Zhu PX, 2001, P NATL ACAD SCI USA, V98, P5234, DOI 10.1073/pnas.061386098	25	254	265	5	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1301	1304		10.1126/science.1134933	http://dx.doi.org/10.1126/science.1134933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124322	Green Accepted			2022-12-28	WOS:000242215800044
J	Rubino, A; Roskell, N; Tennis, P; Mines, D; Weich, S; Andrews, E				Rubino, Annalisa; Roskell, Neil; Tennis, Pat; Mines, Daniel; Weich, Scott; Andrews, Elizabeth			Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; ANTIDEPRESSANTS; PLACEBO; DEPRESSION; TRIALS; SSRIS	Objective To compare the risk of suicide in adults using the antidepressant venlafaxine with the risk of suicide in adult using citalopram, fluoxetine, and dothiepin. Design Retrospective cohort study. Setting UK General Practice Research Database. Participants 219088 patients, aged 18-89 years, who were prescribed venlafaxine, citalopram, fluoxetine, or dothiepin from 1995 to 2005. Main outcome measures Completed suicide and attempted suicide. Results Venlafaxine users had a higher burden of risk factors for suicide, including previous suicide attempts and proxies for severe depression or depression that was difficult to treat. In the analysis for completed suicides, unadjusted and adjusted hazard ratios for venlafaxine compared with citalopram were 2.44 (95% confidence interval 1.12 to 5.31) and 1.70 (0.76 to 3.80), for venlafaxine compared with fluoxetine were 2.85 (1.37 to 5.94) and 1.63 (0.74 to 3.59), and for venlafaxine compared with dothiepin were 2.54 (1.07 to 6.02) and 1.31 (0.53 to 3.25). Compared with other study drugs, venlafaxine was also associated with an increased risk of attempted suicide, but adjustment for measured confounders substantially reduced the hazard ratios. Conclusions Venlafaxine use was consistently associated with higher risk of suicide compared with citalopram, fluoxetine, and dothiepin. Venlafaxine users had a higher burden of suicide risk factors, however, and adjustment for measured confounders substantially reduced the excess risks. Since the secondary data used in this analysis allowed only indirect and partial measurements of potential confounders, it is possible that residual confounding explains much, if not all, of the observed excess risk.	RTI Hlth Solut, Manchester M15 6SE, Lancs, England; RTI Hlth Solut, Pharmacoepidemiol & Risk Management, Res Triangle Pk, NC USA; Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	Research Triangle Institute; Research Triangle Institute; University of Warwick	Rubino, A (corresponding author), RTI Hlth Solut, Manchester Sci Pk, Manchester M15 6SE, Lancs, England.	arubino@rti.org		Mines, Daniel/0000-0002-9134-2836; Andrews, Elizabeth B./0000-0003-1131-5983				Collins MH, 2001, PEDIATR TRANSPLANT, V5, P250, DOI 10.1034/j.1399-3046.2001.005004250.x; De Hert M, 2001, SCHIZOPHR RES, V47, P127, DOI 10.1016/S0920-9964(00)00003-7; Didham RC, 2005, BRIT J CLIN PHARMACO, V60, P519, DOI 10.1111/j.1365-2125.2005.02480.x; Egberts ACG, 1997, J CLIN PSYCHOPHARM, V17, P149, DOI 10.1097/00004714-199706000-00002; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; JICK H, 1992, PHARMACOTHERAPY, V12, P451; JICK SS, 1995, BRIT MED J, V310, P215, DOI 10.1136/bmj.310.6974.215; Juurlink DN, 2006, AM J PSYCHIAT, V163, P813, DOI 10.1176/appi.ajp.163.5.813; Khan A, 2003, AM J PSYCHIAT, V160, P790, DOI 10.1176/appi.ajp.160.4.790; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Mines D, 2005, PHARMACOEPIDEM DR S, V14, P367, DOI 10.1002/pds.1095; Plunkett A, 2001, AMBUL PEDIATR, V1, P262, DOI 10.1367/1539-4409(2001)001<0262:SRFCSA>2.0.CO;2; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rothman KJ, 2003, EPIDEMIOLOGY, V14, P55, DOI 10.1097/00001648-200301000-00014; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; SAVITZ DA, 1989, AM J EPIDEMIOL, V129, P1062, DOI 10.1093/oxfordjournals.aje.a115210; Simon TR, 2002, SUICIDE LIFE-THREAT, V32, P42, DOI 10.1521/suli.32.1.42.22181; Stahl SM, 2005, CNS SPECTRUMS, V10, P732, DOI 10.1017/S1092852900019726; Storosum JG, 2001, AM J PSYCHIAT, V158, P1271, DOI 10.1176/appi.ajp.158.8.1271; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	23	77	85	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2007	334	7587					242	245		10.1136/bmj.39041.445104.BE	http://dx.doi.org/10.1136/bmj.39041.445104.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135SD	17164297	Bronze, Green Published			2022-12-28	WOS:000244172400029
J	Ives, A; Saunders, C; Bulsara, M; Semmens, J				Ives, Angela; Saunders, Christobel; Bulsara, Max; Semmens, James			Pregnancy after breast cancer: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WESTERN-AUSTRALIA; CARCINOMA; PROGNOSIS; SURVIVAL; OUTCOMES; WOMEN	Objectives To identify women who survived breast cancer and subsequently conceived and to determine the rate of pregnancy (proportion), management, outcome of the cancer, and outcome of the first subsequent pregnancy. Design Population based descriptive study with cases identified from the Western Australian data linkage system and validated by review of medical charts. Supplementary data obtained from hospital and clinician records. Setting Western Australia, 1982-2003. Participants Women aged <45 with a diagnosis of breast cancer who subsequently conceived. Main outcome measures Pregnancy outcome and rate, survival, time from diagnosis to pregnancy. Results Sixty two (54%) women with a diagnosis of breast cancer who subsequently conceived did so less than two years after their diagnosis: 29 of them had an abortion, 27 had a live birth, and six miscarried. Within a proportional hazards regression model subsequent pregnancy was associated with improved overall survival (hazard ratio 0.59, 95% confidence interval 0.37 to 0.95). When the model was stratified by time from diagnosis subsequent pregnancy was associated with improved overall survival in women who waited at least 24 months to conceive (0.48, 0.27 to 0.83) and a non-significant protective effect was seen for women who waited at least six months to become pregnant. Conclusions Our study does not support the current medical advice given to premenopausal women with a diagnosis of breast cancer to wait two years before attempting to conceive. This recommendation may be valid for women who are receiving treatment or have systemic disease at diagnosis, but for women with localised disease early conception, six months after completing treatment, is unlikely to reduce survival.	Univ Western Australia, Sch Surg & Pathol, Crawley, WA, Australia; Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; Curtin Univ Technol, Sch Publ Hlth, Bentley, WA 6845, Australia	University of Western Australia; University of Western Australia; Curtin University	Ives, A (corresponding author), Univ Western Australia, Sch Surg & Pathol, M507, Crawley, WA, Australia.	angela.ives@uwa.edu.au	Ives, Angela D/H-5113-2014; Bulsara, Max/A-5966-2008; Saunders, Christobel M/H-5779-2014	Bulsara, Max/0000-0002-8033-6123; Saunders, Christobel M/0000-0003-2281-9829; Ives, Angela Denise/0000-0001-5734-0821				Blakely LJ, 2004, CANCER-AM CANCER SOC, V100, P465, DOI 10.1002/cncr.11929; Clark R M, 1989, Clin Oncol (R Coll Radiol), V1, P11, DOI 10.1016/S0936-6555(89)80004-4; CLARK RM, 1978, INT J RADIAT ONCOL, V4, P693, DOI 10.1016/0360-3016(78)90196-7; GUINEE VF, 1994, LANCET, V343, P1587; Gwyn K, 2001, ONCOLOGY-NY, V15, P39; HARVEY JC, 1981, SURG GYNECOL OBSTET, V153, P723; HOLLEB AI, 1962, SURG GYNECOL OBSTET, V115, P65; Ives Angela, 2002, Aust Fam Physician, V31, P929; Kroman N, 1997, LANCET, V350, P319, DOI 10.1016/S0140-6736(97)03052-3; McEvoy SP, 2004, MED J AUSTRALIA, V181, P305, DOI 10.5694/j.1326-5377.2004.tb06294.x; *NAT CTR CLASS, 2000, INT STAT CLASS DIS R; National Coding Centre, 1995, AUSTR VERS INT CLASS; NUGENT P, 1985, ARCH SURG-CHICAGO, V120, P1221; Peters MV, 1968, PROGNOSTIC FACTORS B, P65; PETREK JA, 1994, CANCER-AM CANCER SOC, V74, P528, DOI 10.1002/cncr.2820741342; Reichman B S, 1994, J Natl Cancer Inst Monogr, P125; RIBEIRO G, 1986, BRIT J SURG, V73, P607, DOI 10.1002/bjs.1800730805; RIBEIRO GG, 1977, BRIT MED J, V2, P1524, DOI 10.1136/bmj.2.6101.1524; SANKILA R, 1994, AM J OBSTET GYNECOL, V170, P818, DOI 10.1016/S0002-9378(94)70290-X; Semmens JB, 1998, AUST NZ J SURG, V68, P397, DOI 10.1111/j.1445-2197.1998.tb04786.x; Singh KL, 2005, HUM REPROD UPDATE, V11, P69, DOI 10.1093/humupd/dmh052; SUTTON R, 1990, CANCER, V65, P847, DOI 10.1002/1097-0142(19900215)65:4<847::AID-CNCR2820650402>3.0.CO;2-A; Velentgas P, 1999, CANCER, V85, P2424, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2424::AID-CNCR17>3.0.CO;2-4	23	164	174	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2007	334	7586					194	196B		10.1136/bmj.39035.667176.55	http://dx.doi.org/10.1136/bmj.39035.667176.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17158581	Green Published			2022-12-28	WOS:000244027600035
J	Saeij, JPJ; Coller, S; Boyle, JP; Jerome, ME; White, MW; Boothroyd, JC				Saeij, J. P. J.; Coller, S.; Boyle, J. P.; Jerome, M. E.; White, M. W.; Boothroyd, J. C.			Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue	NATURE			English	Article							GONDII STRAINS; PARASITOPHOROUS VACUOLE; PARASITE GENOTYPE; MACROPHAGES; MICROARRAYS; MEMBRANE; LINEAGES; INVASION; REVEALS; IL-12	Toxoplasma gondii, an obligate intracellular parasite of the phylum Apicomplexa, can cause severe disease in humans with an immature or suppressed immune system. The outcome of Toxoplasma infection is highly dependent on the strain type, as are many of its in vitro growth properties(1). Here we use genetic crosses between type II and III lines to show that strain-specific differences in the modulation of host cell transcription are mediated by a putative protein kinase, ROP16. Upon invasion by the parasite, this polymorphic protein is released from the apical organelles known as rhoptries and injected into the host cell, where it ultimately affects the activation of signal transducer and activator of transcription ( STAT) signalling pathways and consequent downstream effects on a key host cytokine, interleukin (IL)-12. Our findings provide a new mechanism for how an intracellular eukaryotic pathogen can interact with its host and reveal important differences in how different Toxoplasma lineages have evolved to exploit this interaction.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Montana State Univ, Coll Agr, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Stanford University; Montana State University System; Montana State University Bozeman	Boothroyd, JC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Fairchild Bldg D305,300 Pasteur Dr, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu	White, Michael/A-4978-2012	Saeij, Jeroen/0000-0003-0289-7109; Boothroyd, John C./0000-0001-9719-745X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021423] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI021423, R01 AI021423-20] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BURG JL, 1988, J IMMUNOL, V141, P3584; Butcher BA, 2005, J IMMUNOL, V174, P3148, DOI 10.4049/jimmunol.174.6.3148; Carme B, 2002, J CLIN MICROBIOL, V40, P4037, DOI 10.1128/JCM.40.11.4037-4044.2002; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Darde ML, 1998, J CLIN MICROBIOL, V36, P324; DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305; Fuentes I, 2001, J CLIN MICROBIOL, V39, P1566, DOI 10.1128/JCM.39.4.1566-1570.2001; GILBERT LA, 2006, EUKARYOT CELL   1103, DOI DOI 10.1128/EC/00309-06; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Khan A, 2005, J CLIN MICROBIOL, V43, P5881, DOI 10.1128/JCM.43.12.5881-5887.2005; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Limnander A, 2004, MOL CELL, V15, P329, DOI 10.1016/j.molcel.2004.06.041; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	24	406	439	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					324	327		10.1038/nature05395	http://dx.doi.org/10.1038/nature05395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17183270	Green Accepted			2022-12-28	WOS:000243504700047
J	Hayward, AC; Harling, R; Wetten, S; Johnson, AM; Munro, S; Smedley, J; Murad, S; Watson, JM				Hayward, Andrew C.; Harling, Richard; Wetten, Sally; Johnson, Anne M.; Munro, Susan; Smedley, Julia; Murad, Shahed; Watson, John M.			Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM-CARE; A H3N2 EPIDEMIC; NURSING-HOME; ELDERLY-PATIENTS; WORKERS; HOSPITALS; MORTALITY; EFFICACY; OUTBREAK; PEOPLE	Objective To determine whether vaccination of care home staff against influenza indirectly protects residents. Design Pair matched cluster randomised controlled trial. Setting Large private chain of UK care homes during the winters of 2003-4 and 2004-5. Participants Nursing home staff (n = 1703) and residents (n = 2604) in 44 care homes (22 intervention homes and 22 matched control homes). Interventions Vaccination offered to staff in intervention homes but not in control homes. Main outcome measures The primary outcome was all cause mortality of residents. Secondary outcomes were influenza-like illness and health service use in residents. Results In 2003-4 vaccine coverage in full time staff was 48.2% (407/884) in intervention homes and 5.9% (51/859) in control homes. In 2004-5 uptake rates were 43.2% (365/844) and 3.5% (28/800). National influenza rates were substaritially below average in 2004-5. In the 2003-4 period of influenza activity significant decreases were found in mortality of residents in intervention homes compared with control homes (rate difference - 5.0 per 100 residents, 95% confidence interval - 7.0 to - 2.0) and in influenza-like illness (P = 0.004), consultations with general practitioners for influenza-like illness (P = 0.008), and admissions to hospital with influenza-like illness (P = 0.009). No significant differences were found in 2004-5 or during periods of no influenza activity in 2003-4. Conclusions Vaccinating care home staff against influenza can prevent deaths, health service use, and influenza-like illness in residents during periods of moderate influenza activity.	UCL, Ctr Infect Dis Epidemiol, Dept Primary Care & Populat Sci, London NW3 2PF, England; Westminster Healthcare, Leatherhead, Surrey, England; Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton, Hants, England; Hlth Protect Agcy, Ctr Infect Dis, London, England	University of London; University College London; University of Southampton; Health Protection Agency	Hayward, AC (corresponding author), UCL, Ctr Infect Dis Epidemiol, Dept Primary Care & Populat Sci, London NW3 2PF, England.	a.hayward@pcps.ucl.ac.uk	Hayward, Andrew C/C-3268-2013	Hayward, Andrew C/0000-0002-3549-6232; Johnson, Anne/0000-0003-1330-7100				BEYER WEP, 1989, VACCINE, V7, P385, DOI 10.1016/0264-410X(89)90150-3; Bradley SF, 1999, INFECT CONT HOSP EP, V20, P629, DOI 10.1086/501687; Burls A, 2006, VACCINE, V24, P4212, DOI 10.1016/j.vaccine.2005.12.043; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; *CDCP, 1983, MMWR-MORBID MORTAL W, V32, P32; COLES FB, 1992, J AM GERIATR SOC, V40, P589, DOI 10.1111/j.1532-5415.1992.tb02108.x; Department of Health, PLCMO20052 DEP HLTH; ELGOHARI S, 2004, 5 NAT HLTH PROT C; *HLTH PROT AG, EP DAT INFL; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Kerry SM, 1998, FAM PRACT, V15, P84, DOI 10.1093/fampra/15.1.84; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; McBean AM, 2004, INT J INFECT DIS, V8, P227, DOI 10.1016/j.ijid.2004.04.013; Monto AS, 2001, AM J EPIDEMIOL, V154, P155, DOI 10.1093/aje/154.2.155; MORENS DM, 1995, INFECT CONT HOSP EP, V16, P275; Nicholson KG, 2000, LANCET, V355, P83, DOI 10.1016/S0140-6736(99)00310-4; Ohmit SE, 1999, J AM GERIATR SOC, V47, P165, DOI 10.1111/j.1532-5415.1999.tb04574.x; OLUMNI SE, 1999, J AM GERIATR SOC, V47, P165; PATRIARCA PA, 1985, JAMA-J AM MED ASSOC, V253, P1136, DOI 10.1001/jama.253.8.1136; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; Remarque EJ, 1996, BRIT MED J, V312, P1015; Saito R, 2002, INFECT CONT HOSP EP, V23, P82, DOI 10.1086/502011; Salgado CD, 2004, INFECT CONT HOSP EP, V25, P923, DOI 10.1086/502321; Staynor K, 1994, Can J Infect Control, V9, P109; Steiner M, 2002, INFECT CONT HOSP EP, V23, P625, DOI 10.1086/501984; Thompson SG, 1997, STAT MED, V16, P2063, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2063::AID-SIM642>3.0.CO;2-8; van Essen GA, 2003, VACCINE, V21, P1780, DOI 10.1016/S0264-410X(03)00072-0; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908; 1995, CAN COMM DIS REPORT, V21, P61	30	298	311	0	22	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 16	2006	333	7581					1241	1244B		10.1136/bmj.39010.581354.55	http://dx.doi.org/10.1136/bmj.39010.581354.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122AB	17142257	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000243197000015
J	McCoy, D; Narayan, R; Baum, F; Sanders, D; Serag, H; Salvage, J; Rawson, M; Schrecker, T; Woodward, D; Labonte, R; Sengupta, A; Qizphe, A; Schuftan, C				McCoy, David; Narayan, Ravi; Baum, Fran; Sanders, David; Serag, Hani; Salvage, Jane; Rawson, Mike; Schrecker, Ted; Woodward, David; Labonte, Ron; Sengupta, Amit; Qizphe, Arturo; Schuftan, Claudio		Movement, PH	A new Director General for WHO - an opportunity for bold and inspirational leadership	LANCET			English	Editorial Material							HEALTH		UCL, Dept Publ Hlth & Epidemiol, London WC1E 6BT, England; Soc Community Hlth Awareness Res & Act, Bangalore, Karnataka, India; Flinders Univ S Australia, Dept Publ Hlth, Adelaide, SA, Australia; Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa; Peoples Hlth Movement, Global Secretariat, Cairo, Egypt; Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada; New Econ Fdn, New Global Econ Programme, London, England; Univ Cuenca, Dept Pediat, Fac Med Sci, Azuay, Ecuador; Peoples Hlth Movement Vietnam, Hanoi, Vietnam	University of London; University College London; Flinders University South Australia; University of the Western Cape; University of Ottawa; Universidad de Cuenca	McCoy, D (corresponding author), UCL, Dept Publ Hlth & Epidemiol, Mortimer St, London WC1E 6BT, England.	d.mccoy@ucl.ac.uk	Baum, Fran/AAJ-1896-2021; Labonte, Ronald/G-4229-2011; Baum, Fran/AGN-4014-2022	Baum, Fran/0000-0002-2294-1368; Serag, Hani/0000-0003-0014-2685				BAKER D, 2002, PROMOTING GOOD IDEAS; BENKIMOUN P, LANCET, V367, P1806; Buse Kent, 2004, DEVELOPMENT, V47, P43; Cannon G, 2004, PUBLIC HEALTH NUTR, V7, P369, DOI 10.1079/PHN2004625; Chen SH, 2004, WORLD BANK RES OBSER, V19, P141, DOI 10.1093/wbro/lkh020; *DEP INT DEV, 2002, WORK PARTN WHO; Drahos P, 2004, BMJ-BRIT MED J, V328, P1271, DOI 10.1136/bmj.328.7451.1271; Drahos P., 2004, WHO OWNS KNOWLEDGE E; HORTON R, 2006, LANCET, V367, P1993; JAWARA F, 2004, SCENES WTO REAL WORL, P211; *MIN EC FIN IND MI, INN DEV FIN MECH BUI; MURPHY R, 2005, TAX US IF YOU CAN TR; People's Health Movement, 2005, GLOB HLTH WATCH 2005; Reddy S. G., NOT COUNT POOR; *UN, 2005, E200551REV1 UN DEP E; *UN DEP PROGR, 2005, HUM DEV REP 2005, P4; Woodward David, 2006, GROWTH ISNT WORKING; World Commission on the Social Dimension of Globalization, 2004, FAIR GLOB CREAT OPP; World Health Organisation, 2006, PROP PROGR BUDG 2006; 2004, LANCET, V364, P475; 2006, LANCET, V367, P1704	21	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 16	2006	368	9553					2179	2183		10.1016/S0140-6736(06)69570-6	http://dx.doi.org/10.1016/S0140-6736(06)69570-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174710	Bronze, Green Published			2022-12-28	WOS:000242856900026
J	Bernevig, BA; Hughes, TL; Zhang, SC				Bernevig, B. Andrei; Hughes, Taylor L.; Zhang, Shou-Cheng			Quantum spin Hall effect and topological phase transition in HgTe quantum wells	SCIENCE			English	Article							SEMICONDUCTORS; LATTICE	We show that the quantum spin Hall (QSH) effect, a state of matter with topological properties distinct from those of conventional insulators, can be realized in mercury telluride-cadmium telluride semiconductor quantum wells. When the thickness of the quantum well is varied, the electronic state changes from a normal to an "inverted" type at a critical thickness d(c). We show that this transition is a topological quantum phase transition between a conventional insulating phase and a phase exhibiting the QSH effect with a single pair of helical edge states. We also discuss methods for experimental detection of the QSH effect.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	Stanford University; University of California System; University of California Santa Barbara	Zhang, SC (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	sczhang@stanford.edu	Zhang, Shou-Cheng/B-2794-2010	Hughes, Taylor/0000-0002-1523-389X				Becker CR, 2000, PHYS REV B, V62, P10353, DOI 10.1103/PhysRevB.62.10353; Bernevig BA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106802; DYAKONOV MI, 1971, PHYS LETT A, VA 35, P459, DOI 10.1016/0375-9601(71)90196-4; GOLTERMAN MFL, 1993, PHYS LETT B, V301, P219, DOI 10.1016/0370-2693(93)90692-B; HALDANE FDM, 1988, PHYS REV LETT, V60, P635, DOI 10.1103/PhysRevLett.60.635; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; KANE EO, 1957, PHYS CHEM SOLIDS, V1, P249; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Min H, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165310; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Murakami S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156804; MURAKAMI S, HTTPARXIVORGABSCONDM; NIELSEN HB, 1981, NUCL PHYS B, V185, P20, DOI 10.1016/0550-3213(81)90361-8; Novik EG, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035321; ONODA M, HTTPARXIVORGABSCONDM; Ortner K, 2001, APPL PHYS LETT, V79, P3980, DOI 10.1063/1.1425465; PFEUFFLERJESCHK.A, 2003, THESIS U WURZBURG; Qi XL, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045125; Qi XL, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.085308; SHENG L, 2005, PHYS REV LETT, V95; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Wu CJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106401; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204; Xu CK, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045322; YAO Y, HTTPARXIVORGABSCONDM	27	4843	4940	66	1755	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1757	1761		10.1126/science.1133734	http://dx.doi.org/10.1126/science.1133734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170299	Green Submitted			2022-12-28	WOS:000242833600053
J	Gibbs, SJ; Bown, PR; Sessa, JA; Bralower, TJ; Wilson, PA				Gibbs, Samantha J.; Bown, Paul R.; Sessa, Jocelyn A.; Bralower, Timothy J.; Wilson, Paul A.			Nannoplankton extinction and origination across the Paleocene-Eocene Thermal Maximum	SCIENCE			English	Article							OCEAN; CARBON; SEA; ACIDIFICATION; METHANE; RISE; END	The Paleocene-Eocene Thermal Maximum (PETM, similar to 55 million years ago) was an interval of global warming and ocean acidification attributed to rapid release and oxidation of buried carbon. We show that the onset of the PETM coincided with a prominent increase in the origination and extinction of calcareous phytoplankton. Yet major perturbation of the surface-water saturation state across the PETM was not detrimental to the survival of most calcareous nannoplankton taxa and did not impart a calcification or ecological bias to the pattern of evolutionary turnover. Instead, the rate of environmental change appears to have driven turnover, preferentially affecting rare taxa living close to their viable limits.	Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; UCL, Dept Earth Sci, London WC1E 6BT, England; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	NERC National Oceanography Centre; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gibbs, SJ (corresponding author), Natl Oceanog Ctr, Sch Ocean & Earth Sci, European Way, Southampton SO14 3ZH, Hants, England.	sxg@noc.soton.ac.uk	Bown, Paul/C-5235-2011	Bown, Paul/0000-0001-6777-4463; Sessa, Jocelyn A./0000-0003-1509-5519; Wilson, Paul/0000-0001-6425-8906	Natural Environment Research Council [NE/C002407/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Bralower TJ, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000662; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; COLOSIMO AB, 2006, P OC DRILL PROGR SCI, V0198; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Farley KA, 2003, EARTH PLANET SC LETT, V208, P135, DOI 10.1016/S0012-821X(03)00017-7; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Gibbs SJ, 2006, GEOLOGY, V34, P233, DOI 10.1130/G22381.1; Gingerich P.D., 2003, CAUSES CONSEQUENCES, V369, P463; Houghton J. T., 2001, CLIMATE CHANGE 2001; Katz ME, 1999, SCIENCE, V286, P1531, DOI 10.1126/science.286.5444.1531; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; NORRIS RD, 2000, DEEP TIME PALEOBIOLO, P236; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas E, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P214; Wilson E. O., 1994, DIVERSITY LIFE; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110	24	141	148	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1770	1773		10.1126/science.1133902	http://dx.doi.org/10.1126/science.1133902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170303				2022-12-28	WOS:000242833600057
J	Despres, JP; Lemieux, I				Despres, Jean-Pierre; Lemieux, Isabelle			Abdominal obesity and metabolic syndrome	NATURE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; AMERICAN-DIABETES-ASSOCIATION; VISCERAL ADIPOSE-TISSUE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; WAIST CIRCUMFERENCE; GLUCOSE-TOLERANCE; BODY-FAT	Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.	Hop Laval, Res Ctr, Quebec Heart Inst, Ste Foy, PQ G1V 4G5, Canada; Univ Laval, Dept Social & Prevent Med, Div Kinesiol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Despres, JP (corresponding author), Hop Laval, Res Ctr, Quebec Heart Inst, 2725 Chemin St Foy,Pavil Marguerite DYouville,4t, Ste Foy, PQ G1V 4G5, Canada.	jean-pierre.despres@crhl.ulaval.ca						Abbasi F, 2002, J AM COLL CARDIOL, V40, P937, DOI 10.1016/S0735-1097(02)02051-X; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Albu JB, 1997, DIABETES, V46, P456, DOI 10.2337/diabetes.46.3.456; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; BECKLEY ET, 2006, DOC NEWS, V3, P1; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bergeman CS, 2006, N D SER QUANT METHOD, V1, P19; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conway JM, 1997, AM J CLIN NUTR, V66, P1345, DOI 10.1093/ajcn/66.6.1345; Cote M, 2005, J CLIN ENDOCR METAB, V90, P1434, DOI 10.1210/jc.2004-1711; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Despres JP, 2000, ARTERIOSCL THROM VAS, V20, P1932, DOI 10.1161/01.ATV.20.8.1932; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Despres JP, 2001, BMJ-BRIT MED J, V322, P716, DOI 10.1136/bmj.322.7288.716; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; DESPRES JP, 2006, 14 INT S ATH ROM 18; DESPRES JP, 2006, 66 SCI SESS AM DIAB; Dumont M, 2001, INT J OBESITY, V25, P1136, DOI 10.1038/sj.ijo.0801665; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Eckel RH, 2006, CIRCULATION, V113, P2943, DOI 10.1161/CIRCULATIONAHA.106.176583; Ferrannini E, 2006, ANN MED, V38, P42, DOI 10.1080/07853890500415358; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gale EAM, 2005, DIABETOLOGIA, V48, P1679, DOI 10.1007/s00125-005-1873-5; Garg A, 2004, ENDOCRIN METAB CLIN, V33, P305, DOI 10.1016/j.ecl.2004.03.003; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Girman CJ, 2004, AM J CARDIOL, V93, P136, DOI 10.1016/j.amjcard.2003.09.028; Golden SH, 2002, DIABETES, V51, P3069, DOI 10.2337/diabetes.51.10.3069; Grundy SM, 2006, AM J CLIN NUTR, V83, P1248, DOI 10.1093/ajcn/83.6.1248; Grundy SM, 2006, NAT REV DRUG DISCOV, V5, P294, DOI 10.1038/nrd2005; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Hegele R A, 2000, Curr Atheroscler Rep, V2, P397, DOI 10.1007/s11883-000-0078-0; Hotamisligil GS, 2000, INT J OBESITY, V24, pS23, DOI 10.1038/sj.ijo.0801497; Jensen MD, 2006, OBESITY, V14, p20S, DOI 10.1038/oby.2006.278; Jorgensen ME, 2003, INT J OBESITY, V27, P1507, DOI 10.1038/sj.ijo.0802434; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Kahn HS, 2003, AM J CLIN NUTR, V78, P928, DOI 10.1093/ajcn/78.5.928; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Katzmarzyk PT, 2003, MED SCI SPORT EXER, V35, P1703, DOI 10.1249/01.MSS.0000089337.73244.9B; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; Klein BEK, 2002, DIABETES CARE, V25, P1790, DOI 10.2337/diacare.25.10.1790; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; Laaksonen DE, 2002, AM J EPIDEMIOL, V156, P1070, DOI 10.1093/aje/kwf145; Lamarche B, 1998, JAMA-J AM MED ASSOC, V279, P1955, DOI 10.1001/jama.279.24.1955; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lebovitz HE, 2005, DIABETES CARE, V28, P2322, DOI 10.2337/diacare.28.9.2322; Lemieux I, 2004, ARTERIOSCL THROM VAS, V24, P795, DOI 10.1161/01.ATV.0000126485.80373.33; Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961; Lemieux I, 2001, OBES RES, V9, p66S; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Lemieux I, 2006, DIABETES CARE, V29, P1417, DOI 10.2337/dc06-0441; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Libby P, 2002, CIRCULATION, V106, P2760, DOI 10.1161/01.CIR.0000037282.92395.AE; Lovejoy JC, 1996, METABOLISM, V45, P1119, DOI 10.1016/S0026-0495(96)90011-6; Macchia A, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.023; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; MAURIEGE P, 1995, J LIPID RES, V36, P672; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Mittelman SD, 2002, DIABETES, V51, P755, DOI 10.2337/diabetes.51.3.755; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Orchard TJ, 2005, ANN INTERN MED, V142, P611, DOI 10.7326/0003-4819-142-8-200504190-00009; Pincock S, 2006, LANCET, V368, P1643, DOI 10.1016/S0140-6736(06)69682-7; POULIOT MC, 1992, DIABETES, V41, P826, DOI 10.2337/diabetes.41.7.826; Reaven G, 2003, J AM COLL CARDIOL, V41, P1044, DOI 10.1016/S0735-1097(02)02982-0; Reaven GM, 2006, AM J CLIN NUTR, V83, P1237, DOI 10.1093/ajcn/83.6.1237; Reaven GM, 2005, CLIN CHEM, V51, P931, DOI 10.1373/clinchem.2005.048611; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Sattar N, 2006, CURR OPIN LIPIDOL, V17, P404, DOI 10.1097/01.mol.0000236366.48593.07; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shafrir E, 1996, DIABETES METAB, V22, P122; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Tsimikas S, 2006, J AM COLL CARDIOL, V47, pC19, DOI 10.1016/j.jacc.2005.10.066; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Underwood PM, 2004, CURR OPIN LIPIDOL, V15, P495, DOI 10.1097/01.mol.0000137237.97341.fd; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WHO, 2004, LANCET, V363, P902; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	94	2907	3005	7	334	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					881	887		10.1038/nature05488	http://dx.doi.org/10.1038/nature05488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167477				2022-12-28	WOS:000242805400046
J	Gauld, R; Mays, N				Gauld, Robin; Mays, Nicholas			Reforming primary care - Are New Zealand's new primary health organisations fit for purpose?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, London WC1E 7HT, England	University of Otago; University of London; London School of Hygiene & Tropical Medicine	Gauld, R (corresponding author), Univ Otago, Dept Prevent & Social Med, POB 913, Dunedin, New Zealand.	robin.gauld@otago.ac.nz						Bell DW, 1997, NEW ZEAL MED J, V110, P440; *CAP STRAT LTD, 2004, REV PRIM HLTH ORG MA; *CONS I, 2005, CONSUMER         MAY; Crampton P, 2005, INT J HEALTH SERV, V35, P465, DOI 10.2190/K6KV-K8EL-C7N9-J2AU; CRAMPTON P., 2001, HLTH PUBLIC POLICY N; Cumming J., 2005, EVALUATION IMPLEMENT; Durie M., 1998, WHAIORA MAORI HLTH D; GAULD R, 2001, REVOLVING DOORS NZ H; *GP LEAD FOR, 2006, SCOOP           0515; Greenhalgh S, 2005, J GEOPHYS ENG, V2, P8, DOI 10.1088/1742-2132/2/1/002; Hefford M, 2005, HEALTH POLICY, V72, P9, DOI 10.1016/j.healthpol.2004.06.005; *HLTH WORKF ADV CO, 2002, NZ HLTH WORKF STOCKT; *IPA COUNC NZ, 2002, OPT INTR NEW PRIM HL; King A, 2001, PRIMARY HLTH CARE ST; King A., 2001, MINIMUM REQUIREMENTS; Majeed A, 1999, BRIT MED J, V318, P772, DOI 10.1136/bmj.318.7186.772; Malcolm L, 1999, NEW ZEAL MED J, V112, P162; Malcolm L, 1999, BRIT MED J, V319, P1340, DOI 10.1136/bmj.319.7221.1340; Malcolm L, 1999, DEV PRIMARY CARE ORG; Marshall M, 2005, BMJ-BRIT MED J, V331, P1196, DOI 10.1136/bmj.331.7526.1196; *PRIM HLTH STRAT P, 2005, PICT PRIM HLTH CAR 2; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; TOPHAMKINDLEY L, 2002, NZ DOCTOR       0313; TOPHAMKINDLEY L, 2005, NZ DOCTOR       0518; *WAVE ADV BOARD, 2001, STRAT REAL WAVE WORK; 2005, OTAGO DAILY TIM 0316, P1	27	20	22	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 9	2006	333	7580					1216	1218		10.1136/bmj.39029.493542.94	http://dx.doi.org/10.1136/bmj.39029.493542.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	119JW	17158390	Green Published, Green Submitted			2022-12-28	WOS:000243009600020
J	Valenzuela, SO; Oliver, WD; Berns, DM; Berggren, KK; Levitov, LS; Orlando, TP				Valenzuela, Sergio O.; Oliver, William D.; Berns, David M.; Berggren, Karl K.; Levitov, Leonid S.; Orlando, Terry P.			Microwave-induced cooling of a superconducting qubit	SCIENCE			English	Article							MACROSCOPIC QUANTUM STATES; ATOMS; SUPERPOSITION; DYNAMICS; CESIUM	We demonstrated microwave-induced cooling in a superconducting flux qubit. The thermal population in the first-excited state of the qubit is driven to a higher-excited state by way of a sideband transition. Subsequent relaxation into the ground state results in cooling. Effective temperatures as low as approximate to 3 millikelvin are achieved for bath temperatures of 30 to 400 millikelvin, a cooling factor between 10 and 100. This demonstration provides an analog to optical cooling of trapped ions and atoms and is generalizable to other solid-state quantum systems. Active cooling of qubits, applied to quantum information science, provides a means for qubit-state preparation with improved fidelity and for suppressing decoherence in multi-qubit systems.	MIT, Francis Bitter Natl Magnet Lab, Cambridge, MA 02139 USA; MIT, Lincoln Lab, Lexington, MA 02420 USA; MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Lincoln Laboratory; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Valenzuela, SO (corresponding author), MIT, Francis Bitter Natl Magnet Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sov@mit.edu	Valenzuela, Sergio/A-1169-2007	Valenzuela, Sergio/0000-0002-4632-8891; Levitov, Leonid/0000-0002-4268-731X				Berns DM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.150502; Chiorescu I, 2004, NATURE, V431, P159, DOI 10.1038/nature02831; Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; Chu S, 1998, REV MOD PHYS, V70, P685, DOI 10.1103/RevModPhys.70.685; CLARKE J, 1988, SCIENCE, V239, P992, DOI 10.1126/science.239.4843.992; Cohen-Tannoudji CN, 1998, REV MOD PHYS, V70, P707, DOI 10.1103/RevModPhys.70.707; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; Johansson J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127006; Kerman AJ, 2000, PHYS REV LETT, V84, P439, DOI 10.1103/PhysRevLett.84.439; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; MARZOLI I, 1994, PHYS REV A, V49, P2771, DOI 10.1103/PhysRevA.49.2771; MONROE C, 1995, PHYS REV LETT, V75, P4011, DOI 10.1103/PhysRevLett.75.4011; Morigi G, 2000, PHYS REV LETT, V85, P4458, DOI 10.1103/PhysRevLett.85.4458; Nakamura Y, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.246601; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; NEUHAUSER W, 1978, PHYS REV LETT, V41, P233, DOI 10.1103/PhysRevLett.41.233; Oliver WD, 2005, SCIENCE, V310, P1653, DOI 10.1126/science.1119678; Orlando TP, 1999, PHYS REV B, V60, P15398, DOI 10.1103/PhysRevB.60.15398; Perrin H, 1998, EUROPHYS LETT, V42, P395, DOI 10.1209/epl/i1998-00261-y; Phillips WD, 1998, REV MOD PHYS, V70, P721, DOI 10.1103/RevModPhys.70.721; Saito S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107001; Sillanpaa M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.187002; van der Wal CH, 2000, SCIENCE, V290, P773, DOI 10.1126/science.290.5492.773; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Vuletic V, 1998, PHYS REV LETT, V81, P5768, DOI 10.1103/PhysRevLett.81.5768; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wieman CE, 1999, REV MOD PHYS, V71, pS253, DOI 10.1103/RevModPhys.71.S253; WINELAND DJ, 1978, PHYS REV LETT, V40, P1639, DOI 10.1103/PhysRevLett.40.1639; Yu Y, 2002, SCIENCE, V296, P889, DOI 10.1126/science.1069452	31	114	118	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1589	1592		10.1126/science.1134008	http://dx.doi.org/10.1126/science.1134008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158325	Green Submitted			2022-12-28	WOS:000242624600039
J	De Wilde, Y; Formanek, F; Carminati, R; Gralak, B; Lemoine, PA; Joulain, K; Mulet, JP; Chen, Y; Greffet, JJ				De Wilde, Yannick; Formanek, Florian; Carminati, Remi; Gralak, Boris; Lemoine, Paul-Arthur; Joulain, Karl; Mulet, Jean-Philippe; Chen, Yong; Greffet, Jean-Jacques			Thermal radiation scanning tunnelling microscopy	NATURE			English	Article							FIELD; EMISSION; LIGHT; RESOLUTION; CONTRAST	In standard near-field scanning optical microscopy (NSOM), a subwavelength probe acts as an optical 'stethoscope' to map the near field produced at the sample surface by external illumination(1). This technique has been applied using visible(1,2), infrared(3), terahertz(4) and gigahertz(5,6) radiation to illuminate the sample, providing a resolution well beyond the diffraction limit. NSOM is well suited to study surface waves such as surface plasmons(7) or surface-phonon polaritons(8). Using an aperture NSOM with visible laser illumination, a near-field interference pattern around a corral structure has been observed(9), whose features were similar to the scanning tunnelling microscope image of the electronic waves in a quantum corral(10). Here we describe an infrared NSOM that operates without any external illumination: it is a near-field analogue of a night-vision camera, making use of the thermal infrared evanescent fields emitted by the surface, and behaves as an optical scanning tunnelling microscope(11,12). We therefore term this instrument a 'thermal radiation scanning tunnelling microscope' (TRSTM). We show the first TRSTM images of thermally excited surface plasmons, and demonstrate spatial coherence effects in near-field thermal emission.	CNRS, UPR A0005, Ecole Super Phys & Chim Ind, Lab Opt Phys, F-75005 Paris, France; Ecole Cent Paris, CNRS, Lab EM2C, F-92295 Chatenay Malabry, France; Fac Sci & Tech St Jerome, CNRS, Inst Fresnel, F-13397 Marseille 20, France; Ecol NAtl Super Mecan & Aerotech, Lab Etud Therm, F-86960 Futuroscope, France; CNRS, Lab Photon & Nanostruct, F-91460 Marcoussis, France; Ecole Normale Super, Dept Chim, F-75231 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Superieure de Mecanique et d'Aerotechnique (ISAE-ENSMA); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	De Wilde, Y (corresponding author), CNRS, UPR A0005, Ecole Super Phys & Chim Ind, Lab Opt Phys, F-75005 Paris, France.	dewilde@optique.espci.fr	Greffet, Jean-Jacques/S-3495-2019; Carminati, Remi/H-6882-2014; Greffet, Jean-Jacques/Q-2427-2015; Chen, Yong/A-1700-2009; Joulain, Karl/F-2808-2017	Greffet, Jean-Jacques/0000-0002-4048-2150; Carminati, Remi/0000-0002-5839-1820; Greffet, Jean-Jacques/0000-0002-4048-2150; Chen, Yong/0000-0002-2903-8753; Joulain, Karl/0000-0001-6968-8390; De Wilde, Yannick/0000-0002-5973-1460				AGARWAL GS, 1975, PHYS REV A, V12, P1475, DOI 10.1103/PhysRevA.12.1475; ASH EA, 1972, NATURE, V237, P510, DOI 10.1038/237510a0; Carminati R, 2000, PHYS REV LETT, V84, P5156, DOI 10.1103/PhysRevLett.84.5156; Carminati R, 1999, PHYS REV LETT, V82, P1660, DOI 10.1103/PhysRevLett.82.1660; Chen HT, 2003, APPL PHYS LETT, V83, P3009, DOI 10.1063/1.1616668; Chicanne C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097402; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; De Wilde Y, 2003, REV SCI INSTRUM, V74, P3889, DOI 10.1063/1.1593785; Gralak B, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066601; Greffet JJ, 2002, NATURE, V416, P61, DOI 10.1038/416061a; Hecht B, 1997, J APPL PHYS, V81, P2492, DOI 10.1063/1.363956; Hillenbrand R, 2002, NATURE, V418, P159, DOI 10.1038/nature00899; Joulain K, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.245405; Knoll B, 1997, APPL PHYS LETT, V70, P2667, DOI 10.1063/1.119255; Knoll B, 2000, OPT COMMUN, V182, P321, DOI 10.1016/S0030-4018(00)00826-9; Kreiter M, 1999, OPT COMMUN, V168, P117, DOI 10.1016/S0030-4018(99)00328-4; Lahrech A, 1996, OPT LETT, V21, P1315, DOI 10.1364/OL.21.001315; MARTI O, 1993, OPT COMMUN, V96, P225, DOI 10.1016/0030-4018(93)90265-7; POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865; Porto JA, 2000, J APPL PHYS, V88, P4845, DOI 10.1063/1.1311811; Shchegrov AV, 2000, PHYS REV LETT, V85, P1548, DOI 10.1103/PhysRevLett.85.1548; TERSOFF J, 1985, PHYS REV B, V31, P805, DOI 10.1103/PhysRevB.31.805; ZENHAUSERN F, 1995, SCIENCE, V269, P1083, DOI 10.1126/science.269.5227.1083	23	399	400	6	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					740	743		10.1038/nature05265	http://dx.doi.org/10.1038/nature05265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151664				2022-12-28	WOS:000242581100056
J	Warriner, IK; Meirik, O; Hoffman, M; Morroni, C; Harries, J; Huong, NTM; Vy, ND; Seuc, AH				Warriner, I. K.; Meirik, O.; Hoffman, M.; Morroni, C.; Harries, J.; Huong, N. T. My; Vy, N. D.; Seuc, A. H.			Rates of complication in first-trimester manual vacuum aspiration abortion done by doctors and mid-level providers in South Africa and Vietnam: a randomised controlled equivalence trial	LANCET			English	Article							PHYSICIAN ASSISTANTS	Background We assessed whether the safety of first-trimester manual vacuum aspiration abortion done by health-care providers who are not doctors (mid-level providers) is equivalent to that of procedures done by doctors in South Africa and Vietnam, where mid-level providers are government trained and accredited to do first-trimester abortions. Methods We did a randomised, two-sided controlled equivalence trial to compare rates of complication in abortions done by the two groups of providers. An a-priori margin of equivalence of 4.5% with 80% power and 95% CI (alpha=0.05) was used. 1160 women participated in South Africa and 1734 in Vietnam. Women presenting for an induced abortion at up to 12 weeks' gestation were randomly assigned to a doctor or a mid-level provider for manual vacuum aspiration and followed-up 10-14 days later. The primary outcome was complication of abortion. Complications were recorded during the abortion procedure, before discharge from the clinic, and at follow-up. Per-protocol and intention-to-treat analyses were done. This trial is registered at Clinicaltrials.gov with the identifier NCT00370487. Findings In both countries, rates of complication satisfied the predetermined statistical criteria for equivalence: rates per 100 patients in South Africa were 1.4 (eight of 576) for mid-level providers and 0 for doctors (difference 1.4, 95% Cl 0.4 to 2.7); in Vietnam, rates were 1.2 (ten of 824) for mid-level providers and 1.2 (ten of 812) for doctors (difference 0.0, 95% CI -1.2 to 1.1). There was one immediate complication related to analgesics. Delayed Complications were caused by retained products and infection. Interpretation With appropriate government training, mid-level health-care providers can provide first trimester manual vacuum aspiration abortions as safely as doctors can.	WHO, UNDP UNFPA WHO World Bank Special Programme Res D, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, ZA-7700 Rondebosch, South Africa; Natl Hosp Obstet & Gynecol, Hanoi, Vietnam; Inst Nacl Angiol & Cirugia Vasc, Havana 12000, Cuba	United Nations Population Fund; World Health Organization; University of Cape Town	Warriner, IK (corresponding author), WHO, UNDP UNFPA WHO World Bank Special Programme Res D, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland.	warrineri@who.int	Harries, Jane/R-6504-2019	Harries, Jane/0000-0001-7359-8419; Morroni, Chelsea/0000-0002-2026-6039				Choudhary N, 2005, INT J GYNECOL OBSTET, V91, P81, DOI 10.1016/j.ijgo.2005.06.012; FREEDMAN MA, 1986, AM J PUBLIC HEALTH, V76, P550, DOI 10.2105/AJPH.76.5.550; GANATRA BR, 2000, WHAT WE KNOW WHAT WE; GARCIA LL, 2001, REV CUB OBSTET GINEC, V27, P205; Goldman MB, 2004, AM J PUBLIC HEALTH, V94, P1352, DOI 10.2105/AJPH.94.8.1352; HAKIMELAHI E, 1990, OBSTET GYNECOL, V76, P129; Henshaw SK, 1999, INT FAM PLAN PERSPEC, V25, pS30, DOI 10.2307/2991869; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Machin D, 1997, SAMPLE SIZE TABLES C; *NAT AB FED, 2001, CLIN POL GUID; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1172; Singh S, 1997, INT FAM PLAN PERSPEC, V23, P59, DOI 10.2307/2950825; Thonneau P, 1998, EUR J OBSTET GYN R B, V81, P59, DOI 10.1016/S0301-2115(98)00147-X; Westfall JM, 1998, ARCH FAM MED, V7, P559, DOI 10.1001/archfami.7.6.559; *WHO, 1997, MED METH TERM PREGN; World Health Organization, 2004, GLOB REG EST INC UNS	16	104	104	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					1965	1972		10.1016/S0140-6736(06)69742-0	http://dx.doi.org/10.1016/S0140-6736(06)69742-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141703				2022-12-28	WOS:000242593300028
J	Poole, AJ; Li, Y; Kim, Y; Lin, SCJ; Lee, WH; Lee, EYHP				Poole, Aleksandra Jovanovic; Li, Ying; Kim, Yoon; Lin, Suh-Chin J.; Lee, Wen-Hwa; Lee, Eva Y. -H. P.			Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist	SCIENCE			English	Article							ESTROGEN-RECEPTOR-ALPHA; SUSCEPTIBILITY GENE BRCA1; BREAST-CANCER; GLAND DEVELOPMENT; EPITHELIAL-CELLS; EXPRESSION; PROLIFERATION; MORPHOGENESIS; MUTATION; LACKING	Women with mutations in the breast cancer susceptibility gene BRCA1 are predisposed to breast and ovarian cancers. Why the BRCA1 protein suppresses tumor development specifically in ovarian hormone - sensitive tissues remains unclear. We demonstrate that mammary glands of nulliparous Brca1/p53-deficient mice accumulate lateral branches and undergo extensive alveologenesis, a phenotype that occurs only during pregnancy in wild-type mice. Progesterone receptors, but not estrogen receptors, are overexpressed in the mutant mammary epithelial cells because of a defect in their degradation by the proteasome pathway. Treatment of Brca1/p53-deficient mice with the progesterone antagonist mifepristone (RU 486) prevented mammary tumorigenesis. These findings reveal a tissue-specific function for the BRCA1 protein and raise the possibility that antiprogesterone treatment may be useful for breast cancer prevention in individuals with BRCA1 mutations.	Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Lee, EYHP (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	elee@uci.edu	Lee, Wen-Hwa/C-2519-2014		NATIONAL CANCER INSTITUTE [R01CA049649, R29CA049649, R37CA049649] Funding Source: NIH RePORTER; NCI NIH HHS [CA049649] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aupperlee MD, 2005, ENDOCRINOLOGY, V146, P3577, DOI 10.1210/en.2005-0346; Beral V, 2002, LANCET, V360, P942, DOI 10.1016/S0140-6736(02)11032-4; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; BRESCIANI F, 1964, SCIENCE, V146, P653, DOI 10.1126/science.146.3644.653; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Jones LP, 2005, ONCOGENE, V24, P3554, DOI 10.1038/sj.onc.1208426; King TA, 2004, CANCER RES, V64, P5051, DOI 10.1158/0008-5472.CAN-04-1283; KORACH KS, 1994, SCIENCE, V266, P1524, DOI 10.1126/science.7985022; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Lee S, 2006, INT J CANCER, V118, P1285, DOI 10.1002/ijc.21481; Li XT, 2004, MECH AGEING DEV, V125, P669, DOI 10.1016/j.mad.2004.04.007; Lin SCJ, 2004, CANCER RES, V64, P3525, DOI 10.1158/0008-5472.CAN-03-3524; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Ma YX, 2006, MOL ENDOCRINOL, V20, P14, DOI 10.1210/me.2004-0488; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; NANDI S, 1958, J NATL CANCER I, V21, P1039; Razandi M, 2004, MOL CELL BIOL, V24, P5900, DOI 10.1128/MCB.24.13.5900-5913.2004; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shyamala G, 1998, P NATL ACAD SCI USA, V95, P696, DOI 10.1073/pnas.95.2.696; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Ting NSY, 2004, DNA REPAIR, V3, P935, DOI 10.1016/j.dnarep.2004.03.026; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7	32	240	250	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1467	1470		10.1126/science.1130471	http://dx.doi.org/10.1126/science.1130471			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138902				2022-12-28	WOS:000242406100046
J	Rowland, BD; Bernards, R				Rowland, Benjamin D.; Bernards, Rene			Re-evaluating cell-cycle regulation by E2Fs	CELL			English	Editorial Material							S-PHASE; FAMILY; GROWTH; EXPRESSION; PROLIFERATION; SUPPRESSION; REPRESSION; APOPTOSIS; ARREST; E2F/DP		Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl		Bernards, Rene/0000-0001-8677-3423				Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bargou RC, 1996, J EXP MED, V183, P1205, DOI 10.1084/jem.183.3.1205; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Humbert PO, 2000, GENE DEV, V14, P690; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Krek W, 1995, CELL, V83, P1149, DOI 10.1016/0092-8674(95)90141-8; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Maehara K, 2005, J CELL BIOL, V168, P553, DOI 10.1083/jcb.200411093; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; Wu CL, 1996, MOL CELL BIOL, V16, P3698; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Zhang L, 1999, NEW DIAM FRONT C TEC, V9, P53	20	67	69	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 1	2006	127	5					871	874		10.1016/j.cell.2006.11.019	http://dx.doi.org/10.1016/j.cell.2006.11.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129771	Bronze, Green Published			2022-12-28	WOS:000242613800002
J	Seydoux, G; Braun, RE				Seydoux, Geraldine; Braun, Robert E.			Pathway to totipotency: Lessons from germ cells	CELL			English	Review							EMBRYONIC STEM-CELLS; C-ELEGANS EMBRYOGENESIS; CAENORHABDITIS-ELEGANS; MICRORNA PATHWAY; SELF-RENEWAL; SM PROTEINS; P-GRANULES; INTERCELLULAR BRIDGES; DNA METHYLATION; CHROMATOID BODY		Johns Hopkins Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Washington; University of Washington Seattle	Seydoux, G (corresponding author), Johns Hopkins Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, 725 N Wolfe St, Baltimore, MD 21205 USA.	gseydoux@jhmi.edu; braun@u.washington.edu	SEYDOUX, Geraldine/AAA-2005-2020	Seydoux, Geraldine/0000-0001-8257-0493				Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anne J, 2005, DEVELOPMENT, V132, P2167, DOI 10.1242/dev.01809; Arkov AL, 2006, DEVELOPMENT, V133, P4053, DOI 10.1242/dev.02572; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Barbee SA, 2006, DEV BIOL, V291, P132, DOI 10.1016/j.ydbio.2005.12.011; Barbee SA, 2002, CURR BIOL, V12, P1502, DOI 10.1016/S0960-9822(02)01111-9; Bilinski SM, 2004, EXP CELL RES, V299, P171, DOI 10.1016/j.yexcr.2004.05.016; Blackwell TK, 2004, CURR BIOL, V14, pR229, DOI 10.1016/j.cub.2004.02.052; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; Bowerman B, 2006, DEVELOPMENT, V133, P773, DOI 10.1242/dev.02276; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Chang CC, 2006, INT J DEV BIOL, V50, P413, DOI 10.1387/ijdb.052100cc; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Chuma S, 2003, MECH DEVELOP, V120, P979, DOI 10.1016/S0925-4773(03)00181-3; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; Costa Y, 2006, HUM MOL GENET, V15, P2324, DOI 10.1093/hmg/ddl158; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; DeJong J, 2006, GENE, V366, P39, DOI 10.1016/j.gene.2005.10.012; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; EDDY EM, 1975, INT REV CYTOL, V43, P229; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Fiering S, 2000, BIOESSAYS, V22, P381, DOI 10.1002/(SICI)1521-1878(200004)22:4<381::AID-BIES8>3.0.CO;2-E; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Fitch KR, 1998, CURR TOP DEV BIOL, V38, P1; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Guo GQ, 2004, J THEOR BIOL, V229, P139, DOI 10.1016/j.jtbi.2004.03.010; Harris AN, 2001, DEVELOPMENT, V128, P2823; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hayashi Y, 2004, P NATL ACAD SCI USA, V101, P10338, DOI 10.1073/pnas.0401647101; John L, 2004, HIV MED, V5, P131, DOI 10.1111/j.1468-1293.2004.00199.x; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; KIMBLE J, 2005, GERMLINE PROLIFERATI, DOI DOI 10.1895/WORMBOOK.A.13.1; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; Kobayashi S, 2005, ZOOL SCI, V22, P943, DOI 10.2108/zsj.22.943; Koprunner M, 2001, GENE DEV, V15, P2877; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Lall S, 2005, MOL BIOL CELL, V16, P5880, DOI 10.1091/mbc.E05-07-0622; Leatherman JL, 2003, BIOESSAYS, V25, P326, DOI 10.1002/bies.10247; Lin MD, 2006, DEV CELL, V10, P601, DOI 10.1016/j.devcel.2006.02.021; Linder P, 2006, CELL, V125, P219, DOI 10.1016/j.cell.2006.03.030; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; MAHOWALD AP, 1968, J EXP ZOOL, V167, P237, DOI 10.1002/jez.1401670211; Matsui Y, 2005, BIOESSAYS, V27, P136, DOI 10.1002/bies.20178; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Miller D, 2005, TRENDS MOL MED, V11, P156, DOI 10.1016/j.molmed.2005.02.006; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; MOSQUERA L, 1993, DEVELOPMENT, V117, P377; MOUSSA F, 1994, CELL TISSUE RES, V278, P363, DOI 10.1007/BF00414179; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Ohinata Y, 2006, E SCHERING RES FDN W, V60, P143; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; Payne C, 2006, DEV BIOL, V293, P461, DOI 10.1016/j.ydbio.2006.02.013; Pepling ME, 1999, TRENDS CELL BIOL, V9, P257, DOI 10.1016/S0962-8924(99)01594-9; Pitt JN, 2000, DEV BIOL, V219, P315, DOI 10.1006/dbio.2000.9607; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Reunov A, 2000, DEV GROWTH DIFFER, V42, P139; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Schaner CE, 2006, GERMLINE CHROMATIN, P1, DOI [10.1895/wormbook.1.73.1, DOI 10.1895/WORMBOOK.1.73.1]; Schisa JA, 2001, DEVELOPMENT, V128, P1287; Schultz RM, 2005, REPRODUCTION, V130, P825, DOI 10.1530/rep.1.00902; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Shibata N, 1999, DEV BIOL, V206, P73, DOI 10.1006/dbio.1998.9130; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Snee MJ, 2004, J CELL SCI, V117, P2109, DOI 10.1242/jcs.01059; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; STEVENS LC, 1974, DEV BIOL, V37, P369, DOI 10.1016/0012-1606(74)90155-9; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Thomson T, 2005, CELL RES, V15, P281, DOI 10.1038/sj.cr.7290297; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Vasudevan S, 2006, GENE DEV, V20, P138, DOI 10.1101/gad.1398906; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Ward WS, 2000, ZYGOTE, V8, P51, DOI 10.1017/S0967199400000824; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015; Wolpert L., 1991, TRIUMPH EMBRYO; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Xi RW, 2005, DEVELOPMENT, V132, P5365, DOI 10.1242/dev.02151; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	101	294	302	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					891	904		10.1016/j.cell.2006.11.016	http://dx.doi.org/10.1016/j.cell.2006.11.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129777	Bronze			2022-12-28	WOS:000242613800008
J	Summerfield, C; Egner, T; Greene, M; Koechlin, E; Mangels, J; Hirsch, J				Summerfield, Christopher; Egner, Tobias; Greene, Matthew; Koechlin, Etienne; Mangels, Jennifer; Hirsch, Joy			Predictive codes for forthcoming perception in the frontal cortex	SCIENCE			English	Article							FACE PERCEPTION; BRAIN; DECISION; OBJECTS; MEMORY	Incoming sensory information is often ambiguous, and the brain has to make decisions during perception. "Predictive coding" proposes that the brain resolves perceptual ambiguity by anticipating the forthcoming sensory environment, generating a template against which to match observed sensory evidence. We observed a neural representation of predicted perception in the medial frontal cortex, while human subjects decided whether visual objects were faces or not. Moreover, perceptual decisions about faces were associated with an increase in top-down connectivity from the frontal cortex to face-sensitive visual areas, consistent with the matching of predicted and observed evidence for the presence of faces.	Columbia Univ, Dept Psychol, New York, NY 10027 USA; Ecole Normale Super, INSERM, U742, Dept Etud Cognit, F-75005 Paris, France; Columbia Univ, Neurol Inst, Funct MRI Res Ctr, New York, NY 10032 USA; Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA; Columbia Univ, Neurol Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Columbia University; Northwestern University; Feinberg School of Medicine; Columbia University	Summerfield, C (corresponding author), Columbia Univ, Dept Psychol, 1190 Amsterdam Ave, New York, NY 10027 USA.	summerfd@paradox.columbia.edu	Egner, Tobias/AAD-5864-2022; Koechlin, Etienne/E-5061-2016; Koechlin, Etienne/AAF-5717-2021; Egner, Tobias/A-5237-2009	Egner, Tobias/0000-0001-7956-3241; Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311; Egner, Tobias/0000-0001-7956-3241; Hirsch, Joy/0000-0002-1418-6489	PHS HHS [R21066129] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Barbas H, 2000, ADV NEUROL, V84, P87; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Friston KJ, 2003, NEURAL NETWORKS, V16, P1325, DOI 10.1016/j.neunet.2003.06.005; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Sharma J, 2003, SCIENCE, V300, P1758, DOI 10.1126/science.1081721; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Summerfield C, 2006, CEREB CORTEX, V16, P500, DOI 10.1093/cercor/bhi129; Swets J. A., 1964, SIGNAL DETECT RECOG, P164; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; TODOROV A, 2006, NEUROPSYCHOLOGIA; WALD A, 1949, P NATL ACAD SCI USA, V35, P99, DOI 10.1073/pnas.35.2.99	28	369	372	7	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1311	1314		10.1126/science.1132028	http://dx.doi.org/10.1126/science.1132028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124325				2022-12-28	WOS:000242215800047
J	Kim, K; Lerou, P; Yabuuchi, A; Lengerke, C; Ng, K; West, J; Kirby, A; Daly, MJ; Daley, GQ				Kim, Kitai; Lerou, Paul; Yabuuchi, Akiko; Lengerke, Claudia; Ng, Kitwa; West, Jason; Kirby, Andrew; Daly, Mark J.; Daley, George Q.			Histocompatible embryonic stem cells by parthenogenesis	SCIENCE			English	Article							MOUSE; GENOME; INSTABILITY; MICE	Genetically matched pluripotent embryonic stem (ES) cells generated via nuclear transfer or parthenogenesis (pES cells) are a potential source of histocompatible cells and tissues for transplantation. After parthenogenetic activation of murine oocytes and interruption of meiosis I or II, we isolated and genotyped pES cells and characterized those that carried the full complement of major histocompatibility complex (MHC) antigens of the oocyte donor. Differentiated tissues from these pES cells engrafted in immunocompetent MHC-matched mouse recipients, demonstrating that selected pES cells can serve as a source of histocompatible tissues for transplantation.	Harvard Univ, Childrens Hosp, Sch Med, Div Pediat Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Newborn Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Daley, GQ (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Daly, Mark J/B-2453-2017; West, Jason/I-4445-2014; Lengerke, Claudia/AAV-8745-2021	Daly, Mark J/0000-0002-0949-8752; West, Jason/0000-0002-7252-8651; Lengerke, Claudia/0000-0001-5442-2805	NICHD NIH HHS [T32: HD07466] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN ND, 1994, DEVELOPMENT, V120, P1473; BALAKIER H, 1976, J EMBRYOL EXP MORPH, V35, P25; Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; Hernandez L, 2003, P NATL ACAD SCI USA, V100, P13344, DOI 10.1073/pnas.2234026100; Hoglund P, 1997, IMMUNOL REV, V155, P11, DOI 10.1111/j.1600-065X.1997.tb00936.x; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Klebs SHG, 2003, J IMMUNOL METHODS, V276, P197, DOI 10.1016/S0022-1759(03)00063-2; KUBIAK J, 1991, DEVELOPMENT, V111, P763; Lin H, 2003, STEM CELLS, V21, P152, DOI 10.1634/stemcells.21-2-152; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Opelz G, 1999, Rev Immunogenet, V1, P334; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; ROBERTSON EJ, 1983, J EMBRYOL EXP MORPH, V74, P297; STRAIN L, 1995, NAT GENET, V11, P164, DOI 10.1038/ng1095-164; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; VANDEWATER J, 1989, NEW ENGL J MED, V320, P1377, DOI 10.1056/NEJM198905253202104; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	21	166	186	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					482	486		10.1126/science.1133542	http://dx.doi.org/10.1126/science.1133542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17170255				2022-12-28	WOS:000243726600037
J	Cookson, MR; Hardy, J				Cookson, Mark R.; Hardy, John			Clinical implications of basic research: The persistence of memory	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UBIQUITIN		NIA, Neurogenet Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cookson, MR (corresponding author), NIA, Neurogenet Lab, Bethesda, MD 20892 USA.		Cookson, Mark/AAW-2516-2021; Hardy, John/C-2451-2009	Cookson, Mark/0000-0002-1058-3831; Hardy, John/0000-0002-3122-0423	Medical Research Council [G0701075] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000953, ZIAAG000953] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Selkoe DJ, 2002, SCIENCE, V298, P963; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008	4	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2697	2698		10.1056/NEJMcibr065999	http://dx.doi.org/10.1056/NEJMcibr065999			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182998				2022-12-28	WOS:000242956200015
J	Chen, Y; Corriden, R; Inoue, Y; Yip, L; Hashiguchi, N; Zinkernagel, A; Nizet, V; Insel, PA; Junger, WG				Chen, Yu; Corriden, Ross; Inoue, Yoshiaki; Yip, Linda; Hashiguchi, Naoyuki; Zinkernagel, Annelies; Nizet, Victor; Insel, Paul A.; Junger, Wolfgang G.			ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors	SCIENCE			English	Article							ADENOSINE; MIGRATION; CHEMOATTRACTANT; NUCLEOTIDES; STIMULATION; EOSINOPHILS; LEUKOCYTES; SYSTEM; CELLS	Cells must amplify external signals to orient and migrate in chemotactic gradient fields. We find that human neutrophils release adenosine triphosphate (ATP) from the leading edge of the cell surface to amplify chemotactic signals and direct cell orientation by feedback through P2Y2 nucleotide receptors. Neutrophils rapidly hydrolyze released ATP to adenosine that then acts via A3-type adenosine receptors, which are recruited to the leading edge, to promote cell migration. Thus, ATP release and autocrine feedback through P2Y2 and A3 receptors provide signal amplification, controlling gradient sensing and migration of neutrophils.	Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Junger, WG (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	wjunger@ucsd.edu	Nizet, Victor/AAF-3190-2019; Junger, Wolfgang G/I-1932-2013; Zinkernagel, Annelies S/F-1780-2017	Junger, Wolfgang G/0000-0003-3350-8452; Zinkernagel, Annelies S/0000-0003-4700-1118; Nizet, Victor/0000-0003-3847-0422	NIDDK NIH HHS [T32 DK007202] Funding Source: Medline; NIGMS NIH HHS [GM-66232, R01 GM-51477, GM-60475] Funding Source: Medline; OCPHP CDC HHS [PR043034] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232, R01GM051477, R01GM060475] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OCPHP CDC HHS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; DOWNEY GP, 1994, CURR OPIN IMMUNOL, V6, P113, DOI 10.1016/0952-7915(94)90042-6; Fredholm BB, 1997, GEN PHARMACOL-VASC S, V28, P345, DOI 10.1016/S0306-3623(96)00169-3; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Kimmel AR, 2004, CURR OPIN GENET DEV, V14, P540, DOI 10.1016/j.gde.2004.08.001; Knight D, 1997, J LEUKOCYTE BIOL, V62, P465, DOI 10.1002/jlb.62.4.465; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Seo JK, 1997, J IMMUNOL, V158, P1895; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Walker BAM, 1997, AM J RESP CELL MOL, V16, P531, DOI 10.1165/ajrcmb.16.5.9160835; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Yegutkin G, 2000, BRIT J PHARMACOL, V129, P921, DOI 10.1038/sj.bjp.0703136; Zhang Y, 1996, BIOCHEM PHARMACOL, V51, P957, DOI 10.1016/0006-2952(95)02403-4; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	21	637	654	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1792	1795		10.1126/science.1132559	http://dx.doi.org/10.1126/science.1132559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170310				2022-12-28	WOS:000242833600064
J	Mandel, CR; Kaneko, S; Zhang, HL; Gebauer, D; Vethantham, V; Manley, JL; Tong, L				Mandel, Corey R.; Kaneko, Syuzo; Zhang, Hailong; Gebauer, Damara; Vethantham, Vasupradha; Manley, James L.; Tong, Liang			Polyadenylation factor CPSF-73 is the pre-mRNA 3 '-end-processing endonuclease	NATURE			English	Article							METALLO-BETA-LACTAMASE; CRYSTAL-STRUCTURE; PROTEIN; CLEAVAGE; FOLD; RECOMBINATION; TRANSCRIPTION; EUKARYOTES; POLYMERASE; MECHANISM	Most eukaryotic messenger RNA precursors (pre-mRNAs) undergo extensive maturational processing, including cleavage and polyadenylation at the 3'-end(1-8). Despite the characterization of many proteins that are required for the cleavage reaction, the identity of the endonuclease is not known(4,9,10). Recent analyses indicated that the 73-kDa subunit of cleavage and polyadenylation specificity factor (CPSF-73) might be the endonuclease for this and related reactions(10-15), although no direct data confirmed this. Here we report the crystal structures of human CPSF-73 at 2.1 angstrom resolution, complexed with zinc ions and a sulphate that might mimic the phosphate group of the substrate, and the related yeast protein CPSF-100 (Ydh1) at 2.5 angstrom resolution. Both CPSF-73 and CPSF-100 contain two domains, a metallo-beta-lactamase domain and a novel beta-CASP ( named for metallo-beta-lactamase, CPSF, Artemis, Snm1, Pso2) domain(12). The active site of CPSF-73, with two zinc ions, is located at the interface of the two domains. Purified recombinant CPSF-73 possesses RNA endonuclease activity, and mutations that disrupt zinc binding in the active site abolish this activity. Our studies provide the first direct experimental evidence that CPSF-73 is the pre-mRNA 3'-end-processing endonuclease.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Kaneko, Syuzo/GPP-3257-2022	Kaneko, Syuzo/0000-0003-4558-9800; Manley, James/0000-0002-8341-1459; Tong, Liang/0000-0002-0563-6468	NIGMS NIH HHS [R01 GM077175-01A2, R01 GM077175] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077175] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002; Dominski Z, 2005, MOL CELL BIOL, V25, P1489, DOI 10.1128/MCB.25.4.1489-1500.2005; Garrity JD, 2005, BIOCHEMISTRY-US, V44, P1078, DOI 10.1021/bi048385b; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hirose Y, 1997, J BIOL CHEM, V272, P29636, DOI 10.1074/jbc.272.47.29636; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ishii R, 2005, J BIOL CHEM, V280, P14138, DOI 10.1074/jbc.M500355200; Kolev NG, 2005, GENE DEV, V19, P2583, DOI 10.1101/gad.1371105; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mandel CR, 2006, ACTA CRYSTALLOGR F, V62, P1041, DOI 10.1107/S1744309106038152; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; TAKAGAKI Y, 1988, CELL, V52, P731, DOI 10.1016/0092-8674(88)90411-4; Ullah JH, 1998, J MOL BIOL, V284, P125, DOI 10.1006/jmbi.1998.2148; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wickens M, 2004, SCIENCE, V306, P1299, DOI 10.1126/science.1100137; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	30	311	319	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					953	956		10.1038/nature05363	http://dx.doi.org/10.1038/nature05363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17128255	Green Accepted			2022-12-28	WOS:000242805400062
J	Werner, RM; Bradlow, ET				Werner, Rachel M.; Bradlow, Eric T.			Relationship between medicare's hospital compare performance measures and mortality rates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; COMORBIDITY MEASURES; US HOSPITALS; GUIDELINES; MANAGEMENT; SEVERITY; SURVIVAL; OUTCOMES; THERAPY; ADULTS	Context In response to concerns about the quality of care in US hospitals, the Centers for Medicare & Medicaid Services began measuring hospital performance and reporting this performance on their Web site, Hospital Compare. It is unknown whether these process performance measures are related to hospital-level outcomes. Objective To determine whether quality measured with the process measures used in Hospital Compare are correlated with and predictive of hospitals' risk-adjusted mortality rates. Design, Setting, and Participants Cross-sectional study of hospital care between January 1 and December 31, 2004, for acute myocardial infarction, heart failure, and pneumonia at acute care hospitals in the United States included on the Hospital Compare Web site. Ten process performance measures included in Hospital Compare were compared with hospital risk-adjusted mortality rates, which were measured using Medicare Part A claims data. Main Outcome Measures Condition-specific inpatient, 30-day, and 1-year risk-adjusted mortality rates. Results A total of 3657 acute care hospitals were included in the study based on their performance as reported in Hospital Compare. Across all acute myocardial infarction performance measures, the absolute reduction in risk-adjusted mortality rates between hospitals performing in the 25th percentile vs those performing in the 75th percentile was 0.005 for inpatient mortality, 0.006 for 30-day mortality, and 0.012 for 1-year mortality ( P <. 001 for each comparison). For the heart failure performance measures, the absolute mortality reduction was smaller, ranging from 0.001 for inpatient mortality ( P=. 03) to 0.002 for 1-year mortality ( P=. 08). For the pneumonia performance measures, the absolute reduction in mortality ranged from 0.001 for 30-day mortality ( P=. 05) to 0.005 for inpatient mortality ( P <. 001). Differences in mortality rates for hospitals performing in the 75th percentile on all measures within a condition vs those performing lower than the 25th percentile on all reported measures for acute myocardial infarction ranged between 0.008 ( P=. 06) and 0.018 ( P=. 008). For pneumonia, the effects ranged between 0.003 ( P=. 09) and 0.014 ( P <. 001); for heart failure, the effects ranged between - 0.013 ( P=. 06) and - 0.038 ( P=. 45). Conclusions Hospital performance measures predict small differences in hospital risk-adjusted mortality rates. Efforts should be made to develop performance measures that are tightly linked to patient outcomes.	Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equit Res & Promot, Philadelphia, PA USA; Univ Penn, Dept Mkt, Philadelphia, PA 19104 USA; Univ Penn, Dept Stat, Philadelphia, PA 19104 USA; Univ Penn, Dept Educ, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Werner, RM (corresponding author), 1230 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	rwerner@mail.med.upenn.edu		Werner, Rachel/0000-0003-3435-4221				*AG HLTH CAR RES Q, 2003, HCUP 3 NAT INP SAMPL; AIKEN LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI [DOI 10.1001/JAMA.288.16.1987, 10.1001/jama.288.16.1987]; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; *AM HOSP ASS, HOSP QUAL ALL; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, Lancet, V2, P57; ANTMAN EM, 2004, ACC AHA GUIDELINES M; Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; Austin PC, 2005, MED CARE, V43, P801, DOI 10.1097/01.mlr.0000170414.55821.27; Ayanian JZ, 1998, HEALTH AFFAIR, V17, P194, DOI 10.1377/hlthaff.17.6.194; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; *CA CABG MORT REP, CAL REP COR ART BYP; Centers for Medicare & Medicaid, HOSP COMP; Christiansen CL, 1997, ANN INTERN MED, V127, P764, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00065; *COMM FUND WEB SIT, CMS REP JUMP HOSP RE; *CTR MED MED, 1 HOSP QUAL INC DEM; *CTR MED MED, NURS HOM COMP; *CTR MED MED, MED PHYS GROUP PRACT; *CTR MED MED, HOM HLTH COMP; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Ferguson TB, 2003, JAMA-J AM MED ASSOC, V290, P49, DOI 10.1001/jama.290.1.49; Glied S, 2000, HANDB ECON, V17, P707; HARTZ AJ, 1989, NEW ENGL J MED, V321, P1720, DOI 10.1056/NEJM198912213212506; Higashi T, 2005, ANN INTERN MED, V143, P274, DOI 10.7326/0003-4819-143-4-200508160-00008; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; HUNT SA, 2005, ACC AHA 2005 GUIDELI; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; *JOINT COMM ACCR H, QUAL REP US GUID; KOLATA G, 2005, NY TIMES        0415, pC1; *LEAPFR GROUP, 2004, LEAPFR GROUP HOSP PA; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; McCormick D, 2002, JAMA-J AM MED ASSOC, V288, P1484, DOI 10.1001/jama.288.12.1484; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; National Committee for Quality Assurance, STAT HLTH CAR QUAL 2; Needleman J, 2003, HEALTH SERV RES, V38, P1487, DOI 10.1111/j.1475-6773.2003.00189.x; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; *NJ DEP HLTH SEN S, CARD SURG NEW JERS C; Nolan T, 2006, JAMA-J AM MED ASSOC, V295, P1168, DOI 10.1001/jama.295.10.1168; *NY STAT DEP HLTH, PERC COR INT PCI NEW; *NY STAT DEP HLTH, COR ART BYP SURG NEW; *PA HLTH CAR COST, 2005, HOSP PERF REP; *PA HLTH CAR COST, PENNS GUID COR ART B; Palmer RH, 1997, ANN INTERN MED, V127, P733, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00059; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; STEIN CM, 1981, ANN STAT, V9, P1135, DOI 10.1214/aos/1176345632; Stukenborg GJ, 2001, MED CARE, V39, P727, DOI 10.1097/00005650-200107000-00009; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; *US GOV ACC OFF, 2006, PUBL US GOV ACC OFF; *US NEWS WORLD REP, AM BEST HOSP; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	62	385	387	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2694	2702		10.1001/jama.296.22.2694	http://dx.doi.org/10.1001/jama.296.22.2694			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164455	Bronze			2022-12-28	WOS:000242765700024
J	Hogenauer, C; Langner, C; Beubler, E; Lippe, IT; Schicho, R; Gorkiewicz, G; Krause, R; Gerstgrasser, N; Krejs, GJ; Hinterleitner, TA				Hoegenauer, Christoph; Langner, Cord; Beubler, Eckhard; Lippe, Irmgard T.; Schicho, Rudolf; Gorkiewicz, Gregor; Krause, Robert; Gerstgrasser, Nikolas; Krejs, Guenter J.; Hinterleitner, Thomas A.			Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DIARRHEA; TOXIN; CYTOTOXIN; CELLS	BACKGROUND: Antibiotic-associated hemorrhagic colitis is a distinct form of antibiotic-associated colitis in which Clostridium difficile is absent. Although the cause is not known, previous reports have suggested a role of Klebsiella oxytoca. METHODS: We studied 22 consecutive patients who had suspected antibiotic-associated colitis and who were negative for C. difficile. Patients underwent diagnostic colonoscopy, and among those who received a diagnosis of antibiotic-associated hemorrhagic colitis, stool samples were cultured for K. oxytoca. We isolated K. oxytoca strains and tested them for cytotoxin production using a tissue-culture assay. In addition, we also cultured stool samples obtained from 385 healthy subjects for K. oxytoca. An in vivo animal model for antibiotic-associated hemorrhagic colitis was established with the use of Sprague-Dawley rats. RESULTS: Of the 22 patients, 6 had findings on colonoscopy that were consistent with the diagnosis of antibiotic-associated hemorrhagic colitis, and 5 of these 6 patients had positive cultures for K. oxytoca. No other common enteric pathogens were found in the five patients. Before the onset of colitis, all five were receiving penicillins, and two were also taking nonsteroidal antiinflammatory drugs (NSAIDs). All isolated K. oxytoca strains produced cytotoxin. K. oxytoca was found in 1.6% of the healthy subjects. In the animal model, K. oxytoca was found only in the colon of rats that received amoxicillin-clavulanate in addition to being inoculated with K. oxytoca. In these rats, infection with K. oxytoca induced a right-sided hemorrhagic colitis that was not observed in uninfected animals that received amoxicillin-clavulanate, indomethacin (an NSAID), or both. CONCLUSIONS: Our fulfillment of Koch's postulates for cytotoxin-producing K. oxytoca suggests that it is the causative organism in at least some cases of antibiotic-associated hemorrhagic colitis. Infection with K. oxytoca should be considered in patients with antibiotic-associated colitis who are negative for C. difficile.	Med Univ Graz, Dept Internal Med, A-8036 Graz, Austria; Med Univ Graz, Inst Pathol, A-8036 Graz, Austria; Med Univ Graz, Inst Expt & Clin Pharmacol, A-8036 Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Hogenauer, C (corresponding author), Med Univ Graz, Dept Internal Med, Auenbruggerpl 15, A-8036 Graz, Austria.	christoph.hoegenauer@meduni-graz.at	Gorkiewicz, Gregor/ABF-1602-2021	Gorkiewicz, Gregor/0000-0003-1149-4782; Schicho, Rudolf/0000-0002-5726-4731; Hogenauer, Christoph/0000-0003-4566-0806				BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Beaugerie L, 2003, CLIN GASTROENTEROL H, V1, P370, DOI 10.1053/S1542-3565(03)00183-6; Bellaiche G, 1997, GASTROEN CLIN BIOL, V21, P764; BENOIT R, 1992, GASTROEN CLIN BIOL, V16, P860; BRUMFITT W, 1986, ANTIMICROB AGENTS CH, V30, P335, DOI 10.1128/AAC.30.2.335; Chen J, 2004, GASTROINTEST ENDOSC, V60, P142, DOI 10.1016/S0016-5107(04)01537-8; Etienney I, 2003, GUT, V52, P260, DOI 10.1136/gut.52.2.260; Evans JMM, 1997, GUT, V40, P619, DOI 10.1136/gut.40.5.619; Gleeson MH, 2003, ALIMENT PHARM THER, V17, P817, DOI 10.1046/j.1365-2036.2003.01519.x; GRIFFIN PM, 1990, GASTROENTEROLOGY, V99, P142, DOI 10.1016/0016-5085(90)91241-W; HEER M, 1989, SCHWEIZ MED WSCHR, V119, P733; HIGAKI M, 1990, MICROBIOL IMMUNOL, V34, P147, DOI 10.1111/j.1348-0421.1990.tb00999.x; Koga H, 1999, DIS COLON RECTUM, V42, P1502, DOI 10.1007/BF02235056; Lode H, 2001, SCAND J INFECT DIS, V33, P899, DOI 10.1080/00365540110076714; MINAMI J, 1992, J GEN MICROBIOL, V138, P1921, DOI 10.1099/00221287-138-9-1921; MINAMI J, 1994, INFECT IMMUN, V62, P172, DOI 10.1128/IAI.62.1.172-177.1994; MINAMI J, 1989, MICROB PATHOGENESIS, V7, P203, DOI 10.1016/0882-4010(89)90056-9; O'Loughlin EV, 2001, MICROBES INFECT, V3, P493, DOI 10.1016/S1286-4579(01)01405-8; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; SAKURAI Y, 1979, DIGEST DIS SCI, V24, P910, DOI 10.1007/BF01311944; Soussi F, 2001, GASTROEN CLIN BIOL, V25, P814; TOFFLER RB, 1978, LANCET, V2, P707; Yonei Y, 1996, J GASTROEN HEPATOL, V11, P681, DOI 10.1111/j.1440-1746.1996.tb00314.x	24	169	187	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2418	2426		10.1056/NEJMoa054765	http://dx.doi.org/10.1056/NEJMoa054765			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113EO	17151365				2022-12-28	WOS:000242581400006
J	Spitzer, NC				Spitzer, Nicholas C.			Electrical activity in early neuronal development	NATURE			English	Review							SPONTANEOUS CALCIUM TRANSIENTS; NERVE GROWTH CONES; POSTNATAL SUBVENTRICULAR ZONE; SPONTANEOUS CA2+ TRANSIENTS; DEVELOPING CORTICAL-NEURONS; DEVELOPING SPINAL-CORD; ADULT-RAT HIPPOCAMPUS; IN-VIVO; RECEPTOR ACTIVATION; PROGENITOR CELLS	The construction of the brain during embryonic development was thought to be largely independent of its electrical activity. In this view, proliferation, migration and differentiation of neurons are driven entirely by genetic programs and activity is important only at later stages in refinement of connections. However, recent findings demonstrate that activity plays essential roles in early development of the nervous system. Activity has similar roles in the incorporation of newly born neurons in the adult nervous system, suggesting that there are general rules underlying activity-dependent development. The extensive involvement of activity makes it likely that it is required at all developmental stages as a necessary partner with genetic programs.	Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Kavli Inst Brain & Mind, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Spitzer, NC (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	nspitzer@ucsd.edu		Spitzer, Nicholas/0000-0002-3523-1103				Adelsberger H, 2005, NAT NEUROSCI, V8, P988, DOI 10.1038/nn1502; AHMED Z, 1983, J NEUROSCI, V3, P2448; Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Ashworth R, 2002, DEV BRAIN RES, V139, P131, DOI 10.1016/S0165-3806(02)00538-2; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BLANTON MG, 1990, P NATL ACAD SCI USA, V87, P8027, DOI 10.1073/pnas.87.20.8027; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; BORODINSKY LN, IN PRESS P NATL ACAD; Brosenitsch TA, 2002, MOL CELL NEUROSCI, V20, P447, DOI 10.1006/mcne.2002.1135; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; Brunelli G, 2005, P NATL ACAD SCI USA, V102, P8752, DOI 10.1073/pnas.0500530102; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Carey MB, 1999, DEV BIOL, V215, P298, DOI 10.1006/dbio.1999.9433; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Conklin MW, 2005, DEV BIOL, V287, P201, DOI 10.1016/j.ydbio.2005.09.006; Corlew R, 2004, J PHYSIOL-LONDON, V560, P377, DOI 10.1113/jphysiol.2004.071621; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Dallman JE, 1998, J PHYSIOL-LONDON, V511, P683, DOI 10.1111/j.1469-7793.1998.683bg.x; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; DESARMENIEN MG, 1991, NEURON, V7, P797, DOI 10.1016/0896-6273(91)90282-5; Erhardt NM, 2004, MOL CELL ENDOCRINOL, V221, P121, DOI 10.1016/j.mce.2004.01.013; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fiszman ML, 1999, DEV BRAIN RES, V115, P1, DOI 10.1016/S0165-3806(99)00035-8; Flint AC, 1999, P NATL ACAD SCI USA, V96, P12144, DOI 10.1073/pnas.96.21.12144; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gibbs SM, 2003, MOL NEUROBIOL, V27, P107, DOI 10.1385/MN:27:2:107; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; GOMEZ TM, 1995, NEURON, V14, P1233, DOI 10.1016/0896-6273(95)90270-8; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; GU XN, 1994, J NEUROSCI, V14, P6325; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Haase A, 2003, DEVELOPMENT, V130, P3977, DOI 10.1242/dev.00612; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Hunt PN, 2005, J PHYSIOL-LONDON, V566, P807, DOI 10.1113/jphysiol.2005.089581; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; Jiang SJA, 2005, J NEUROPHYSIOL, V94, P491, DOI 10.1152/jn.00096.2005; Kasyanov AM, 2004, P NATL ACAD SCI USA, V101, P3967, DOI 10.1073/pnas.0305974101; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lohmann C, 2005, NAT NEUROSCI, V8, P305, DOI 10.1038/nn1406; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manent JB, 2005, J NEUROSCI, V25, P4755, DOI 10.1523/JNEUROSCI.0553-05.2005; MCCOBB DP, 1990, J NEUROSCI, V10, P2974; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; Mercer AR, 2002, J NEUROPHYSIOL, V87, P2650, DOI 10.1152/jn.2002.87.6.2650; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Momose-Sato Y, 1999, NEUROSCIENCE, V90, P1293, DOI 10.1016/S0306-4522(98)00517-X; Momose-Sato Y, 2003, NEUROSCIENCE, V116, P407, DOI 10.1016/S0306-4522(02)00585-7; NERBONNE JM, 1989, J NEUROSCI, V9, P3272; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; O'Donovan MJ, 2005, CELL CALCIUM, V37, P443, DOI 10.1016/j.ceca.2005.01.012; OLEARY DDM, 1991, DEVELOPMENT, P123; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Parent JM, 1997, J NEUROSCI, V17, P3727; Rajan I, 1998, J NEUROSCI, V18, P7836; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Tang FJ, 2005, J NEUROSCI, V25, P6702, DOI 10.1523/JNEUROSCI.0871-05.2005; Tang FJ, 2003, J NEUROSCI, V23, P927; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Watt SD, 2000, MOL CELL NEUROSCI, V16, P376, DOI 10.1006/mcne.2000.0871; Webb SE, 2005, CELL CALCIUM, V37, P375, DOI 10.1016/j.ceca.2005.01.005; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Wong WT, 2000, J NEUROSCI, V20, P5024; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yacubova E, 2002, NATURE, V415, P77, DOI 10.1038/415077a; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	96	512	522	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					707	712		10.1038/nature05300	http://dx.doi.org/10.1038/nature05300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151658				2022-12-28	WOS:000242581100049
J	Boyd, MM; Zelevinsky, T; Ludlow, AD; Foreman, SM; Blatt, S; Ido, T; Ye, J				Boyd, Martin M.; Zelevinsky, Tanya; Ludlow, Andrew D.; Foreman, Seth M.; Blatt, Sebastian; Ido, Tetsuya; Ye, Jun			Optical atomic coherence at the 1-second time scale	SCIENCE			English	Article							FREQUENCY STANDARDS; SPECTROSCOPY	Highest-resolution laser spectroscopy has generally been limited to single trapped ion systems because of the rapid decoherence that plagues neutral atom ensembles. Precision spectroscopy of ultracold neutral atoms confined in a trapping potential now shows superior optical coherence without any deleterious effects from motional degrees of freedom, revealing optical resonance linewidths at the hertz level with a good signal-to-noise ratio. The resonance quality factor of 2.4 x 10(14) is the highest ever recovered in any form of coherent spectroscopy. The spectral resolution permits direct observation of the breaking of nuclear spin degeneracy for the S-1(0) and P-3(0) optical clock states of Sr-87 under a small magnetic bias field. This optical approach for excitation of nuclear spin states allows an accurate measurement of the differential Lande g factor between S-1(0) and P-3(0). The optical atomic coherence demonstrated for collective excitation of a large number of atoms will have a strong impact on quantum measurement and precision frequency metrology.	Univ Colorado, Natl Inst Stand & Technol, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Ye, J (corresponding author), Univ Colorado, Natl Inst Stand & Technol, Joint Inst Lab Astrophys, Boulder, CO 80309 USA.	Ye@jila.colorado.edu	Ye, Jun/C-3312-2011; Blatt, Sebastian/F-8986-2012; Ido, Tetsuya/AAJ-5181-2020	Ye, Jun/0000-0003-0076-2112; Blatt, Sebastian/0000-0003-2466-9967; 				Barber ZW, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.083002; Bize S, 2005, J PHYS B-AT MOL OPT, V38, pS449, DOI 10.1088/0953-4075/38/9/002; Black AT, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.203001; Bloch I, 2005, ADV ATOM MOL OPT PHY, V52, P1, DOI 10.1016/S1049-250X(05)52001-9; BOYD MM, PREPRINT; Brusch A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.103003; Courtillot I, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.030501; Dube P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033001; Ferrari G, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.243002; Haffner H, 2005, NATURE, V438, P643, DOI 10.1038/nature04279; Haffner H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.143602; Haycock DL, 2000, PHYS REV LETT, V85, P3365, DOI 10.1103/PhysRevLett.85.3365; Heavner TP, 2005, METROLOGIA, V42, P411, DOI 10.1088/0026-1394/42/5/012; Hong T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.050801; Ido T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.153001; Katori H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.173005; KLUGE HJ, 1974, Z PHYS, V270, P295, DOI 10.1007/BF01677766; Le Targat R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.130801; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Loftus TH, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.063413; Loftus TH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.073003; Ludlow AD, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.033003; LUDLOW AD, PREPRINT; LURIO A, 1962, PHYS REV, V126, P1758, DOI 10.1103/PhysRev.126.1758; Margolis HS, 2004, SCIENCE, V306, P1355, DOI 10.1126/science.1105497; Mukaiyama T, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.113002; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; OLSCHEWSKI L, 1972, Z PHYS, V249, P205, DOI 10.1007/BF01400226; PROSEV SG, 2004, PHYS REV A, V69; Rafac RJ, 2000, PHYS REV LETT, V85, P2462, DOI 10.1103/PhysRevLett.85.2462; Ruschewitz F, 1998, PHYS REV LETT, V80, P3173, DOI 10.1103/PhysRevLett.80.3173; Santra R, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042510; Santra R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.173002; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schneider T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230801; Sterr U, 2004, CR PHYS, V5, P845, DOI 10.1016/j.crhy.2004.08.005; Takamoto M, 2005, NATURE, V435, P321, DOI 10.1038/nature03541; Ye J, 1999, PHYS REV LETT, V83, P4987, DOI 10.1103/PhysRevLett.83.4987; Ye J, 2003, J OPT SOC AM B, V20, P1459, DOI 10.1364/JOSAB.20.001459; Zelevinsky T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.203201	40	127	133	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1430	1433		10.1126/science.1133732	http://dx.doi.org/10.1126/science.1133732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138896	Green Submitted			2022-12-28	WOS:000242406100034
J	Cang, Y; Zhang, JX; Nicholas, SA; Bastien, J; Li, BJ; Zhou, PB; Goff, SP				Cang, Yong; Zhang, Jianxuan; Nicholas, Sally A.; Bastien, Jayson; Li, Baojie; Zhou, Pengbo; Goff, Stephen P.			Deletion of DDB1 in mouse brain and lens leads to p53-dependent elimination of proliferating cells	CELL			English	Article							UBIQUITIN LIGASE; DNA-DAMAGE; XERODERMA-PIGMENTOSUM; GENOME STABILITY; COP9 SIGNALOSOME; V PROTEIN; PROTEOLYSIS; CDT1; REPLICATION; MICE	DDB1, a component of the Cul4 ubiquitin ligase complex, promotes protein ubiquitination in diverse cellular functions, including nuclear excision repair, regulation of the cell cycle, and DNA replication. To investigate its physiological significance, we generated mice with null and floxed alleles of the DDB1 gene. Here we report that null mutation of DDB1 caused early embryonic lethality, while conditional inactivation of the gene in brain and lens led to neuronal and lens degeneration, brain hemorrhages, and neonatal death. These defects stemmed from a selective elimination of nearly all proliferating neuronal progenitor cells and lens epithelial cells by apoptosis. The cell death was preceded by aberrant accumulation of cell cycle regulators and increased genomic instability and could be partially rescued by removal of the tumor suppressor protein p53. Our results indicate that DDB1 plays an essential role in maintaining viability and genomic integrity of dividing cells.	Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 138673, Singapore	Columbia University; Howard Hughes Medical Institute; Cornell University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Goff, SP (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	goff@cancercenter.columbia.edu	Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547; Cang, Yong/0000-0002-1148-7008	NATIONAL CANCER INSTITUTE [R01CA098210, R56CA098210, R01CA118085, R37CA030488, P01CA023767] Funding Source: NIH RePORTER; NCI NIH HHS [CA 23767, CA098210, CA118085, R37 CA 30488] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Bhat SP, 2001, BIOSCIENCE REP, V21, P537, DOI 10.1023/A:1017952128502; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; Bootsma D., 2002, GENETIC BASIS HUMAN, P211; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Holmberg C, 2005, GENE DEV, V19, P853, DOI 10.1101/gad.329905; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Takata K, 2004, GENETICS, V168, P855, DOI 10.1534/genetics.103.025965; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Watanabe T, 1999, J NEUROCHEM, V72, P549, DOI 10.1046/j.1471-4159.1999.0720549.x; Wen PH, 2005, DEVELOPMENT, V132, P3873, DOI 10.1242/dev.01946; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yang J, 2000, MECH DEVELOP, V94, P287, DOI 10.1016/S0925-4773(00)00301-4; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	36	112	115	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					929	940		10.1016/j.cell.2006.09.045	http://dx.doi.org/10.1016/j.cell.2006.09.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129780	Bronze			2022-12-28	WOS:000242613800011
J	DeLuca, JG; Gall, WE; Ciferri, C; Cimini, D; Musacchio, A; Salmon, ED				DeLuca, Jennifer G.; Gall, Walter E.; Ciferri, Claudio; Cimini, Daniela; Musacchio, Andrea; Salmon, E. D.			Kinetochore microtubule dynamics and attachment stability are regulated by Hec1	CELL			English	Article							SMALL-MOLECULE INHIBITOR; MITOTIC SPINDLE; AURORA-B; CENTROMERIC MCAK; NDC80 COMPLEX; XENOPUS EGGS; PROTEIN; METAPHASE; SEGREGATION; ORIENTATION	Mitotic cells face the challenging tasks of linking kinetochores to growing and, shortening microtubules and actively regulating these dynamic attachments to produce accurate chromosome segregation. We report here that Ndc80/Hec1 functions in regulating kinetochore microtubule plus-end dynamics and attachment stability. Microinjection of an antibody to the N terminus of Hec1 suppresses both microtubule detachment and microtubule plus-end polymerization and depolymerization at kinetochores of PtK1 cells. Centromeres become hyperstretched, kinetochore fibers shorten from spindle poles, kinetochore microtubule attachment errors increase, and chromosomes severely mis-segregate. The N terminus of Hec1 is phosphorylated by Aurora B kinase in vitro, and cells expressing N-terminal nonphosphorylatable mutants of Hec1 exhibit an increase in merotelic attachments, hyperstretching of centromeres, and errors in chromosome segregation. These findings reveal a key role for the Hec1 N terminus in controlling dynamic behavior of kinetochore microtubules.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy	University of North Carolina; University of North Carolina Chapel Hill; Virginia Polytechnic Institute & State University; IRCCS European Institute of Oncology (IEO)	DeLuca, JG (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	jgdeluca@email.unc.edu	, Proteomics Core UNC/AFQ-7201-2022; Cimini, Daniela/A-3039-2016	Cimini, Daniela/0000-0002-4082-4894; Musacchio, Andrea/0000-0003-2362-8784	NIGMS NIH HHS [GM67370, GM66588, GM24364, R37 GM024364] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024364, F32GM066588, R37GM024364, F32GM067370] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Cameron LA, 2006, J CELL BIOL, V173, P173, DOI 10.1083/jcb.200601075; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; CASSIMERIS L, 1990, J CELL SCI, V96, P9; Charrasse S, 1998, J CELL SCI, V111, P1371; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Le Blanc JCY, 2003, PROTEOMICS, V3, P859, DOI 10.1002/pmic.200300415; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; MITCHISON TJ, 1992, J CELL BIOL, V119, P569, DOI 10.1083/jcb.119.3.569; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Moore A, 2004, TRENDS CELL BIOL, V14, P537, DOI 10.1016/j.tcb.2004.09.001; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tien AC, 2004, MOL CELL PROTEOMICS, V3, P93, DOI 10.1074/mcp.M300072-MCP200; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.e02-04-0236; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; WEISENBERG RC, 1981, BIOCHEM BIOPH RES CO, V102, P924, DOI 10.1016/0006-291X(81)91626-0; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	54	527	537	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					969	982		10.1016/j.cell.2006.09.047	http://dx.doi.org/10.1016/j.cell.2006.09.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129782	Bronze, Green Submitted			2022-12-28	WOS:000242613800014
J	Serizawa, S; Miyamichi, K; Takeuchi, H; Yamagishi, Y; Suzuki, M; Sakano, H				Serizawa, Shou; Miyamichi, Kazunari; Takeuchi, Haruki; Yamagishi, Yuya; Suzuki, Misao; Sakano, Hitoshi			A neuronal identity code for the odorant receptor-specific and activity-dependent axon sorting	CELL			English	Article							OLFACTORY SENSORY NEURONS; GENE-EXPRESSION; MOLECULAR-BASIS; EPH RECEPTORS; BULB; MAP; PROJECTIONS; SYSTEM; MOUSE; GLOMERULI	In the mouse, olfactory sensory neurons (OSNs) expressing the same odorant receptor (OR) converge their axons to a specific set of glomeruli in the olfactory bulb. To study how OR-instructed axonal fasciculation is controlled, we searched for genes whose expression profiles are correlated with the expressed ORs. Using the transgenic mouse in which the majority of OSNs express a particular OR, we identified such genes coding for the homophilic adhesive molecules Kirrel2/Kirrel3 and repulsive molecules ephrin-A5/EphA5. In the CNGA2 knockout mouse, where the odor-evoked cation influx is disrupted, Kirrel2 and EphA5 were downregulated, while Kirrel3 and ephrin-A5 were upregulated, indicating that these genes are transcribed in an activity-dependent manner. Mosaic analysis demonstrated that gain of function of these genes generates duplicated glomeruli. We propose that a specific set of adhesive/repulsive molecules, whose expression levels are determined by OR molecules, regulate the axonal fasciculation of OSNs during the process of glomerular map formation.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; Japan Sci & Technol Agcy, CREST Program, Kawaguchi, Saitama 3320012, Japan; Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8620976, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kumamoto University	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Miyamichi, Kazunari/AAO-3705-2021	Takeuchi, Haruki/0000-0003-4911-4060				Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Cramer Karina S., 1995, Current Opinion in Neurobiology, V5, P106, DOI 10.1016/0959-4388(95)80094-8; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Gerke P, 2005, J AM SOC NEPHROL, V16, P1693, DOI 10.1681/ASN.2004060439; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Minaki Y, 2005, NEUROSCI RES, V52, P250, DOI 10.1016/j.neures.2005.03.014; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; SAUCIER D, 1986, BRAIN RES BULL, V16, P455, DOI 10.1016/0361-9230(86)90173-5; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; St John JA, 2002, DEV BRAIN RES, V138, P1, DOI 10.1016/S0165-3806(02)00454-6; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Ueno H, 2003, NAT IMMUNOL, V4, P457, DOI 10.1038/ni916; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Yu TT, 2005, J COMP NEUROL, V483, P251, DOI 10.1002/cne.20429; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	46	244	248	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					1057	1069		10.1016/j.cell.2006.10.031	http://dx.doi.org/10.1016/j.cell.2006.10.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129788	Bronze			2022-12-28	WOS:000242613800020
J	Slessareva, JE; Dohlman, HG				Slessareva, Janna E.; Dohlman, Henrik G.			G protein signaling in yeast: New components, new connections, new compartments	SCIENCE			English	Editorial Material							ALPHA-SUBUNIT; ACTIVATION		Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu		Dohlman, Henrik/0000-0003-2443-0729	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM065533] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01-GM065533] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Elion EA, 2001, J CELL SCI, V114, P3967; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Guo M, 2003, MOL CELL, V12, P517, DOI 10.1016/S1097-2765(03)00307-1; HELMS JB, 1995, FEBS LETT, V369, P84, DOI 10.1016/0014-5793(95)00620-O; Lyons DM, 1996, MOL CELL BIOL, V16, P4095; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Misra S, 2001, CELL, V107, P559, DOI 10.1016/S0092-8674(01)00594-3; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Roman DL, 2007, MOL PHARMACOL, V71, P169, DOI 10.1124/mol.106.028670; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6	19	37	39	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1412	1413		10.1126/science.1134041	http://dx.doi.org/10.1126/science.1134041			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138892				2022-12-28	WOS:000242406100028
J	Grimes, DA; Benson, J; Singh, S; Romero, M; Ganatra, B; Okonofua, FE; Shah, IH				Grimes, David A.; Benson, Janie; Singh, Susheela; Romero, Mariana; Ganatra, Bela; Okonofua, Friday E.; Shah, Iqbal H.			Sexual and reproductive health 4 - Unsafe abortion: the preventable pandemic	LANCET			English	Review							INCOMPLETE ABORTION; POSTABORTION CARE; ILLEGAL ABORTION; EARLY-PREGNANCY; SOUTH-AFRICA; POLICY; MISOPROSTOL; SERVICES; COMPLICATIONS; CONTRACEPTION	Ending the silent pandemic of unsafe abortion is an urgent public-health and human-rights imperative. As with other more visible global-health issues, this scourge threatens women throughout the developing world. Every year, about 19-20 million abortions are done by individuals without the requisite skills, or in environments below minimum medical standards, or both. Nearly all unsafe abortions (97%) are in developing countries. An estimated 68 000 women die as a result, and millions more have complications, many permanent. Important causes of death include haemorrhage, infection, and poisoning. Legalisation of abortion on request is a necessary but insufficient step toward improving women's health; in some countries, such as India, where abortion has been legal for decades, access to competent care remains restricted because of other barriers. Access to safe abortion improves women's health, and vice versa, as documented in Romania during the regime of President Nicolae Ceausescu. The availability of modem contraception can reduce but never eliminate the need for abortion. Direct costs of treating abortion complications burden impoverished health care systems, and indirect costs also drain struggling economies. The development of manual vacuum aspiration to empty the uterus, and the use of misoprostol, an oxytocic agent, have improved the care of women. Access to safe, legal abortion is a fundamental right of women, irrespective of where they live. The underlying causes of morbidity and mortality from unsafe abortion today are not blood loss and infection but, rather, apathy and disdain toward women.	Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA; Ipas, Chapel Hill, NC USA; Alan Guttmacher Inst, New York, NY 10005 USA; Consejo Nacl Invest Cient & Tecn, Ctr Estudios Estado & Soc, RA-1033 Buenos Aires, DF, Argentina; Ipas, Pune, Maharashtra, India; Univ Benin, Coll Med Sci, Benin, Nigeria; Int Federat Obstetricians & Gynaecologists, Benin, Nigeria; World Hlth Org, Geneva, Switzerland	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Benin; World Health Organization	Grimes, DA (corresponding author), Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA.	dagrimes@mindspring.com	Okonofua, Friday/AAB-9703-2021	Ganatra, Bela/0000-0002-4812-4577; Romero, Mariana/0000-0003-4272-3138				*A GUTTM I, 1994, AB CLAND REAL LAT; *A GUTTM I, 1999, SHAR RESP WOM SOC AB; Adewole I F, 2002, J Obstet Gynaecol, V22, P436, DOI 10.1080/01443610220141461; [Anonymous], 2003, ADDING IT BENEFITS I; Bankole A, 1998, INT FAM PLAN PERSPEC, V24, P117, DOI 10.2307/3038208; Benson J, 2005, STUD FAMILY PLANN, V36, P189, DOI 10.1111/j.1728-4465.2005.00061.x; Berer M, 2004, REPROD HEALTH MATTER, V12, P1, DOI 10.1016/S0968-8080(04)24024-1; Berer M, 2000, B WORLD HEALTH ORGAN, V78, P580; Billings DL, 2005, HEALTH POLICY PLANN, V20, P158, DOI 10.1093/heapol/czi020; Billings DL, 2003, INT FAM PLAN PERSPEC, V29, P112, DOI 10.2307/3181076; Blanchard K, 1999, CONTRACEPTION, V59, P209, DOI 10.1016/S0010-7824(99)00029-3; BOONSTRA H, ABORTION WOMENS LIVE; *BRAZ MIN SAUD, SIST INF HOSP SUS SI; Briozzo L, 2004, INT J GYNECOL OBSTET, V85, P70, DOI 10.1016/j.ijgo.2003.09.014; BURNHILL MS, 1985, J REPROD MED, V30, P610; CATES W, 1982, SCIENCE, V215, P1586, DOI 10.1126/science.7071579; COELHO HLL, 1993, LANCET, V341, P1261, DOI 10.1016/0140-6736(93)91157-H; Costa SH, 1998, INT J GYNECOL OBSTET, V63, pS131, DOI 10.1016/S0020-7292(98)00195-7; Crane BB, 2004, REPROD HEALTH MATTER, V12, P128, DOI 10.1016/S0968-8080(04)24140-4; *CTR REPR RIGHTS, MEX ADM RESP DEN CHI; *CTR REPR RIGHTS, WORLDS AB LAWS 2005; *CTR REPR RIGHTS, PROT RIGHTS WOM AFR; *CTR REPR RIGHTS, AB LAW 10 YEARS REF; *CTR REPR RIGHTS, 14 NEP WOM FREED AB; DAVID HP, 1992, STUD FAMILY PLANN, V23, P1, DOI 10.2307/1966824; Fathalla MF, 2006, BEST PRACT RES CL OB, V20, P409, DOI 10.1016/j.bpobgyn.2005.11.004; Faundes A, 1996, ADV CONTRACEPT, V12, P1, DOI 10.1007/BF01849540; FAUVEAU V, 1989, SOC SCI MED, V29, P1121, DOI 10.1016/0277-9536(89)90025-7; Ferrando D, 2002, ABORTO CLANDESTINO P; FORNA F, 2001, COCHRANE DB SYST REV; Fu HS, 1998, FAM PLANN PERSPECT, V30, P128, DOI 10.2307/2991627; Gallo MF, 2004, REPROD HEALTH MATTER, V12, P218, DOI 10.1016/S0968-8080(04)24027-7; Ganatra B, 2002, REPROD HEALTH MATTER, V10, P76, DOI 10.1016/S0968-8080(02)00016-2; GANATRA B, 2006, PREVENTING UNSAFE AB, P151; Garcia SG, 2004, REPROD HEALTH MATTER, V12, P65, DOI 10.1016/S0968-8080(04)24003-4; Gebreselassie H, 2005, BJOG-INT J OBSTET GY, V112, P1229, DOI 10.1111/j.1471-0528.2004.00503.x; Glenc F, 1974, Pol Tyg Lek, V29, P1957; Grimes DA, 2003, BRIT MED BULL, V67, P99, DOI 10.1093/bmb/ldg002; Grimes DA, 2006, PREVENTING UNSAFE AB, P73; Henshaw SK, 1999, INT FAM PLAN PERSPEC, V25, pS30, DOI 10.2307/2991869; Hessini L, 2005, REPROD HEALTH MATTER, V13, P88, DOI 10.1016/S0968-8080(05)25168-6; Hirve SS, 2004, REPROD HEALTH MATTER, V12, P114, DOI 10.1016/S0968-8080(04)24017-4; HITT J, PROLIFE NATION; HOGBERG U, 1985, GYNECOL OBSTET INVES, V20, P169; Huntington D, 1998, INT FAM PLAN PERSPEC, V24, P25, DOI 10.2307/2991916; Iyengar K, 2002, REPROD HEALTH MATTER, V10, P54, DOI 10.1016/S0968-8080(02)00002-2; Jewkes R, 2005, BJOG-INT J OBSTET GY, V112, P355, DOI 10.1111/j.1471-0528.2004.00422.x; JOHNSON BR, 1993, SOC SCI MED, V36, P1443, DOI 10.1016/0277-9536(93)90386-I; Johnson BR, 2004, REPROD HEALTH MATTER, V12, P184, DOI 10.1016/S0968-8080(04)24023-X; Johnson BR, 2002, STUD FAMILY PLANN, V33, P195, DOI 10.1111/j.1728-4465.2002.00195.x; Jowett M, 2000, HEALTH POLICY, V53, P201, DOI 10.1016/S0168-8510(00)00089-0; Juarez F, 2005, INT FAM PLAN PERSPEC, V31, P140, DOI 10.1363/3114005; Kay BJ, 1997, S AFR MED J, V87, P442; Kestler E, 2006, REPROD HEALTH MATTER, V14, P138, DOI 10.1016/S0968-8080(06)27235-5; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Koster-Oyekan W, 1998, SOC SCI MED, V46, P1303, DOI 10.1016/S0277-9536(97)10058-2; Kulier R, 2011, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002855.PUB3; KWAST BE, 1986, STUD FAMILY PLANN, V17, P288, DOI 10.2307/1966906; Lafaurie MM, 2005, REPROD HEALTH MATTER, V13, P75, DOI 10.1016/S0968-8080(05)26199-2; LANGER A, 1999, POSTABORTION CARE LE; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; LISKIN LS, 1980, POPULATION REPORTS F, pF105; Marston C, 2003, INT FAM PLAN PERSPEC, V29, P6, DOI 10.2307/3180995; MPANGILE GS, 1999, ABORTION DEV WORLD, P387; Nations MK, 1997, SOC SCI MED, V44, P1833, DOI 10.1016/S0277-9536(96)00293-6; NUNES FE, 1997, REPROD HEALTH MATTER, V9, P66; ODONNELL RP, 1954, OBSTET GYNECOL, V4, P122; Okonofua F E, 1994, Afr J Med Med Sci, V23, P165; Okonofua FE, 2005, ACTA OBSTET GYN SCAN, V84, P270, DOI 10.1111/j.0001-6349.2005.00405.x; Okonofua FE, 1999, STUD FAMILY PLANN, V30, P67, DOI 10.1111/j.1728-4465.1999.00067.x; Oye-Adeniran BA, 2002, REPROD HEALTH MATTER, V10, P18, DOI 10.1016/S0968-8080(02)00024-1; POLGAR S, 1976, FAM PLANN PERSPECT, V8, P125, DOI 10.2307/2133634; Pollack A E, 2000, J Am Med Womens Assoc (1972), V55, P186; RALISATA LR, 2001, J GYNECOL OBST BIO R, V30, P282; Rogo K, 2004, INT J GYNECOL OBSTET, V85, pS73, DOI 10.1016/j.ijgo.2004.02.010; Ross JA, 2002, INT FAM PLAN PERSPEC, V28, P138, DOI 10.2307/3088256; *SAF MOTH INT GROU, MAT HLTH VIT SOC EC; Shah Iqbal H., 1994, World Health Statistics Quarterly, V47, P9; Shah L, 2004, REPROD HEALTH MATTER, V12, P9, DOI 10.1016/S0968-8080(04)24002-2; Sibuyi Mafanato Constance, 2004, Afr J Reprod Health, V8, P75, DOI 10.2307/3583309; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Singh S, 2006, INT FAM PLAN PERSPEC, V32, P136, DOI 10.1363/3213606; Solo J, 1999, STUD FAMILY PLANN, V30, P17, DOI 10.1111/j.1728-4465.1999.00017.x; STEPHENSON P, 1992, AM J PUBLIC HEALTH, V82, P1328, DOI 10.2105/AJPH.82.10.1328; TESFAYE S, 2006, EXPANDING OUR REACH; Ugboma H A A, 2004, Niger J Med, V13, P259; *UN, 2002, AB POL GLOB REV, V3; UN, 1995, 4 WORLD C WOM BEIJ 4; *UN COMM EL DISCR, GEN REC 24 WOM HLTH; *UN DEP EC SOC AFF, WORLD CONTR US 2003; *UN HUM RIGHTS COM, 2005, VIEW HUM RIGHTS COMM; UNFPA, PROGR ACT INT C POP; *UNFPA, 1999, INT C POP DEV AD 21; Varkey P, 2000, REPROD HEALTH MATTER, V8, P83, DOI 10.1016/S0968-8080(00)90190-3; VERKUYL DAA, 1993, S AFR MED J, V83, P13; VLASSOFF M, 2004, 11 A GUTTM I; *WHO, PREV MAN UNS AB REP; *WHO, 1967, 20 WORLD HLTH ASS RE; *WHO, COMPL AB; WILCOX AJ, 1984, AM J EPIDEMIOL, V120, P727, DOI 10.1093/oxfordjournals.aje.a113940; *WOM LINK WORLDW, COL HIGH COURT RUL F; World Health Organization, 2004, UNS AB GLOB REG EST; World Health Organization, 2003, SAF AB TECHN POL GUI; Zhang J, 2005, NEW ENGL J MED, V353, P761, DOI 10.1056/NEJMoa044064; CATHOLIC ONLINE COLO; 2003, POPUL REP M, V17, P1	106	460	477	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2006	368	9550					1908	1919		10.1016/S0140-6736(06)69481-6	http://dx.doi.org/10.1016/S0140-6736(06)69481-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126724				2022-12-28	WOS:000242345900033
J	Sazawal, S; Dhingra, U; Hiremath, G; Kumar, J; Dhingra, P; Sarkar, A; Menon, VP; Black, RE				Sazawal, Sunil; Dhingra, Usha; Hiremath, Girish; Kumar, Jitendra; Dhingra, Pratibha; Sarkar, Archana; Menon, Venugopal P.; Black, Robert E.			Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ZINC SUPPLEMENTATION; DOUBLE-BLIND; INFANTS; GROWTH; DIARRHEA	Objective To evaluate the efficacy of milk fortified with specific multiple micronutrients on morbidity in children compared with the same milk without fortification. Design Community based, double masked, individually randomised trial. Setting Peri-urban settlement in north India. Participants Children (n=633) aged 1-3 randomly allocated to receive fortified milk (n=316) or control milk (n=317). Intervention One year of fortified milk providing additional 7.8 mg zinc, 9.6 mg iron, 4.2 mu g selenium, 0.27 mg copper, 156 mu g vitamin A, 40.2 mg vitamin C, 7.5 mg vitamin E per day (three feeds). Main outcome measures Days with severe illnesses, incidence and prevalence of diarrhoea, and acute tower respiratory illness. Results Study groups were comparable at baseline; compliance in the groups was similar. Mean number of episodes of diarrhoea per child was 4.46 (SD 3.8) in the intervention (fortified milk) group and 5.36 (SD 4.1) in the control group. Mean number of episodes of acute lower respiratory illness was 0.62 (SD 1.1) and 0.83 (SD 1.4), respectively. The fortified milk reduced the odds for days with severe illnesses by 15% (95% confidence interval 5% to 24%), the incidence of diarrhoea by 18% (7% to 27%), and the incidence of acute lower respiratory illness by 26% (3% to 43%). Consistently greater beneficial effects were observed in children aged <= 24 months than in older children. Conclusion Milk is well accepted as a means of delivery of micronutrients. Consumption of milk fortified with specific micronutrients can significantly reduce the burden of common morbidities among preschool children, especially in the first two years of life.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Annamalai Univ, Dept Biochem, Ctr Micronutrient Res, Chidambaram, India	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Annamalai University	Sazawal, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	ssazawal@jhsph.edu		Menon, Venugopal Padmanabhan/0000-0002-1283-3822; Black, Robert/0000-0001-9926-7984				ADAMSON P, 2004, VITAMINS MINERAL DEF; Allen LH, 2002, J NUTR, V132, p813S, DOI 10.1093/jn/132.4.813S; Bhandari N, 2004, J NUTR, V134, P2342; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Black MM, 2004, PEDIATRICS, V113, P1297, DOI 10.1542/peds.113.5.1297; Cunningham-Rundles S, 2005, J ALLERGY CLIN IMMUN, V115, P1119, DOI 10.1016/j.jaci.2005.04.036; DAVIDSSON L, 1994, AM J CLIN NUTR, V60, P231, DOI 10.1093/ajcn/60.2.231; Penny ME, 2004, AM J CLIN NUTR, V79, P457; Rivera JA, 2003, J NUTR, V133, p4010S, DOI 10.1093/jn/133.11.4010S; Rosado JL, 1997, AM J CLIN NUTR, V65, P13, DOI 10.1093/ajcn/65.1.13; Sazawal S, 1998, PEDIATRICS, V102, P1, DOI 10.1542/peds.102.1.1; Sazawal S, 1997, AM J CLIN NUTR, V66, P413, DOI 10.1093/ajcn/66.2.413; Sazawal S, 2001, PEDIATRICS, V108, P1280, DOI 10.1542/peds.108.6.1280; SOLOMONS NW, 1979, J NUTR, V109, P1519, DOI 10.1093/jn/109.9.1519; *WHO, 2001, WHONID013; *WHO, 2003, 120 WS WHO; *WHO, 2003, WS120 WHO; WHO, 1998, WHONUT981	18	54	56	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2007	334	7585					140	142		10.1136/bmj.39035.482396.55	http://dx.doi.org/10.1136/bmj.39035.482396.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130LP	17132678	Green Published, Bronze			2022-12-28	WOS:000243801400034
J	Reznick, RK; MacRae, H				Reznick, Richard K.; MacRae, Helen			Medical education - Teaching surgical skills - Changes in the wind	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BENCH MODEL FIDELITY; VIRTUAL-REALITY; TECHNICAL-SKILLS; OPERATING-ROOM; PERFORMANCE; ACQUISITION; COMPETENCE; SIMULATION; SURGERY; TRIAL		Univ Toronto, Dept Surg, Univ Hlth Network, Toronto, ON M5G 1L5, Canada; Univ Toronto, Mt Sinai Hosp, Surg Skills Ctr, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Reznick, RK (corresponding author), Univ Toronto, Dept Surg, Univ Hlth Network, Suite 311,100 Coll St, Toronto, ON M5G 1L5, Canada.	richard.reznick@utoronto.ca						Anastakis DJ, 1999, AM J SURG, V177, P167, DOI 10.1016/S0002-9610(98)00327-4; CARTER BN, 1952, SURGERY, V32, P518; Cauraugh JH, 1999, AM J SURG, V177, P331, DOI 10.1016/S0002-9610(99)00057-4; Cotin S, 2000, Stud Health Technol Inform, V70, P59; Darzi A, 2001, QUAL HEALTH CARE, V10, P64; Datta V, 2001, J AM COLL SURGEONS, V193, P479, DOI 10.1016/S1072-7515(01)01041-9; DeVita MA, 2005, QUAL SAF HEALTH CARE, V14, P326, DOI 10.1136/qshc.2004.011148; Ericsson KA, 1996, ROAD TO EXCELLENCE, P1; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Fried GM, 2004, ANN SURG, V240, P518, DOI 10.1097/01.sla.0000136941.46529.56; Gallagher AG, 2004, JAMA-J AM MED ASSOC, V292, P3024, DOI 10.1001/jama.292.24.3024; Grantcharov TP, 2004, BRIT J SURG, V91, P146, DOI 10.1002/bjs.4407; Grober ED, 2004, ANN SURG, V240, P374, DOI 10.1097/01.sla.0000133346.07434.30; Grober ED, 2004, J UROLOGY, V172, P378, DOI 10.1097/01.ju.0000123824.74075.9c; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Haluck RS, 2000, ARCH SURG-CHICAGO, V135, P786, DOI 10.1001/archsurg.135.7.786; Helmreich RL, 1997, SCI AM, V276, P62, DOI 10.1038/scientificamerican0597-62; HEPPELL J, 1995, CAN J SURG, V38, P27; Holcomb JB, 2002, J TRAUMA, V52, P1078, DOI 10.1097/00005373-200206000-00009; HUTCHISON C, 1998, FOCUS SURG ED, V16, P22; JANSEN JJM, 1995, MED EDUC, V29, P247, DOI 10.1111/j.1365-2923.1995.tb02839.x; Kopta J A, 1971, Clin Orthop Relat Res, V75, P80, DOI 10.1097/00003086-197103000-00011; Leach DC, 2004, MED EDUC, V38, P12, DOI 10.1111/j.1365-2923.2004.01732.x; LEEDOM DK, 1995, MIL PSYCHOL, V7, P109, DOI 10.1207/s15327876mp0702_5; LOSSING AG, 1992, CAN J SURG, V35, P536; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1046/j.1365-2168.1997.02502.x; Matsumoto ED, 2002, J UROLOGY, V167, P1243, DOI 10.1016/S0022-5347(05)65274-3; Moorthy K, 2005, ANN SURG, V242, P631, DOI 10.1097/01.sla.0000186298.79308.a8; PITTS PM, 1967, HUMAN PERFORMANCE; Regehr G, 1998, ACAD MED, V73, P993, DOI 10.1097/00001888-199809000-00020; Reznick R, 1997, AM J SURG, V173, P226, DOI 10.1016/S0002-9610(97)89597-9; REZNICK RK, 1993, AM J SURG, V165, P358, DOI 10.1016/S0002-9610(05)80843-8; Risucci D, 2001, Curr Surg, V58, P230, DOI 10.1016/S0149-7944(00)00425-6; SCALLON SE, 1992, CAN J SURG, V35, P173; Scott DJ, 2000, J AM COLL SURGEONS, V191, P272, DOI 10.1016/S1072-7515(00)00339-2; Sedlack RE, 2004, AM J GASTROENTEROL, V99, P33, DOI 10.1111/j.1572-0241.2004.04007.x; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/00000658-200210000-00008; Szalay D, 2000, AM J SURG, V180, P234, DOI 10.1016/S0002-9610(00)00470-0; Taffinder N, 1998, ST HEAL T, V50, P124; WINCKEL CP, 1994, AM J SURG, V167, P423, DOI 10.1016/0002-9610(94)90128-7; Wong AK, 2004, CAN J ANAESTH, V51, P455, DOI 10.1007/BF03018308; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127	42	1122	1147	4	181	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2664	2669		10.1056/NEJMra054785	http://dx.doi.org/10.1056/NEJMra054785			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182991				2022-12-28	WOS:000242956200007
J	Eyer, P; Buckley, N				Eyer, Peter; Buckley, Nicholas			Pralidoxime for organophosphate poisoning	LANCET			English	Editorial Material							TRIALS		Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany; Canberra Hosp, Canberra, ACT, Australia	University of Munich; Australian National University; Canberra Hospital	Eyer, P (corresponding author), Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany.	peter.eyer@lrz.uni-muenchen.de	Buckley, Nicholas A/D-4030-2012	Buckley, Nicholas A/0000-0002-6326-4711	Wellcome Trust [071669] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Buckley NA, 2004, BMJ-BRIT MED J, V329, P1231, DOI 10.1136/bmj.329.7476.1231; Eddleston M, 2000, QJM-INT J MED, V93, P715, DOI 10.1093/qjmed/93.11.715; Eddleston M, 2006, QJM-INT J MED, V99, P513, DOI 10.1093/qjmed/hcl065; Eddleston M, 2005, LANCET, V366, P1452, DOI 10.1016/S0140-6736(05)67598-8; Eyer Peter, 2003, Toxicological Reviews, V22, P165, DOI 10.2165/00139709-200322030-00004; Johnson MK., 2000, EMERGEN MED, V12, P22, DOI [DOI 10.1046/J.1442-2026.2000.00087.X, 10.1046/j.1442-2026.2000.00087.x]; Pawar KS, 2006, LANCET, V368, P2136, DOI 10.1016/S0140-6736(06)69862-0; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 2002, LANCET, V359, P515, DOI 10.1016/S0140-6736(02)07683-3; Seger D, 2004, J TOXICOL-CLIN TOXIC, V42, P133, DOI 10.1081/CLT-120037421; Shivakumar S, 2006, J Assoc Physicians India, V54, P250	11	17	18	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 16	2006	368	9553					2110	2111		10.1016/S0140-6736(06)69843-7	http://dx.doi.org/10.1016/S0140-6736(06)69843-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174692	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000242856900005
J	McPhaden, MJ; Zebiak, SE; Glantz, MH				McPhaden, Michael J.; Zebiak, Stephen E.; Glantz, Michael H.			ENSO as an integrating concept in Earth science	SCIENCE			English	Review							1997-98 EL-NINO; SEA-SURFACE TEMPERATURES; SOUTHERN-OSCILLATION; LA-NINA; MULTIMODEL ENSEMBLES; CLIMATE FORECASTS; TROPICAL PACIFIC; UNITED-STATES; OCEAN; EVOLUTION	The El Nino-Southern Oscillation (ENSO) cycle of alternating warm El Nino and cold La Nina events is the dominant year-to-year climate signal on Earth. ENSO originates in the tropical Pacific through interactions between the ocean and the atmosphere, but its environmental and socioeconomic impacts are felt worldwide. Spurred on by the powerful 1997-1998 El Nino, efforts to understand the causes and consequences of ENSO have greatly expanded in the past few years. These efforts reveal the breadth of ENSO's influence on the Earth system and the potential to exploit its predictability for societal benefit. However, many intertwined issues regarding ENSO dynamics, impacts, forecasting, and applications remain unresolved. Research to address these issues will not only lead to progress across a broad range of scientific disciplines but also provide an opportunity to educate the public and policy makers about the importance of climate variability and change in the modern world.	NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Int Res Inst Climate & Soc, Palisades, NY USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Center Atmospheric Research (NCAR) - USA	McPhaden, MJ (corresponding author), NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way NE, Seattle, WA 98115 USA.	michael.j.mcphaden@noaa.gov	McPhaden, Michael J/D-9799-2016	McPhaden, Michael J/0000-0002-8423-5805				AchutaRao K, 2006, CLIM DYNAM, V27, P1, DOI 10.1007/s00382-006-0119-7; ALLAN J, 2003, J COASTAL RES S1, V38, P83; An SI, 2004, J CLIMATE, V17, P2399, DOI 10.1175/1520-0442(2004)017<2399:NAAOE>2.0.CO;2; Barnston AG, 1999, B AM METEOROL SOC, V80, P217, DOI 10.1175/1520-0477(1999)080<0217:PSOSAD>2.0.CO;2; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; BJERKNES J, 1966, TELLUS, V18, P820, DOI 10.1111/j.2153-3490.1966.tb00303.x; Broad K, 2002, CLIMATIC CHANGE, V54, P415, DOI 10.1023/A:1016164706290; Cane MA, 2005, EARTH PLANET SC LETT, V230, P227, DOI 10.1016/j.epsl.2004.12.003; Changnon SA, 1999, B AM METEOROL SOC, V80, P1819, DOI 10.1175/1520-0477(1999)080<1819:IOENOG>2.0.CO;2; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Chen D, 2004, NATURE, V428, P733, DOI 10.1038/nature02439; Davis Mike., 2001, LATE VICTORIAN HOLOC; Diaz HF, 2001, INT J CLIMATOL, V21, P1845, DOI 10.1002/joc.631; Doblas-Reyes FJ, 2005, TELLUS A, V57, P234, DOI 10.1111/j.1600-0870.2005.00104.x; Eisenman I, 2005, J CLIMATE, V18, P5224, DOI 10.1175/JCLI3588.1; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Feely RA, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003129; FILHO FAS, 2003, WATER RESOUR RES, V39, P1307, DOI DOI 10.1029/2002WR001373; GLANTZ M, 2000, ONCE BURNED TWICE SH; Glantz M., 2001, CURRENT CHANGE IMPAC; Glantz M., 2002, LA NINA ITS IMPACTS; Goddard L, 2001, INT J CLIMATOL, V21, P1111, DOI 10.1002/joc.636; GODDARD L, 2005, J CLIMATOL, V18, P661; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Guilyardi E, 2006, CLIM DYNAM, V26, P329, DOI 10.1007/s00382-005-0084-6; Harrison RD, 2000, P ROY SOC B-BIOL SCI, V267, P911, DOI 10.1098/rspb.2000.1089; Hoerling MP, 2001, J CLIMATE, V14, P1277, DOI 10.1175/1520-0442(2001)014<1277:ROTNCR>2.0.CO;2; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Huber M, 2003, SCIENCE, V299, P877, DOI 10.1126/science.1078766; Kessler WS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015924; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Kumar KK, 2006, SCIENCE, V314, P115, DOI 10.1126/science.1131152; Larkin NK, 2002, J CLIMATE, V15, P1118, DOI 10.1175/1520-0442(2002)015<1118:EWENOA>2.0.CO;2; Latif M, 1998, J GEOPHYS RES-OCEANS, V103, P14375, DOI 10.1029/97JC03413; Levin L, 2002, PROG OCEANOGR, V53, P1, DOI 10.1016/S0079-6611(02)00022-8; Lloyd-Hughes B, 2002, INT J CLIMATOL, V22, P1, DOI 10.1002/joc.723; Lyon B., 2005, US CLIVAR VARIATIONS, V3, P1; Mann ME, 2005, J CLIMATE, V18, P447, DOI 10.1175/JCLI-3276.1; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; McPhaden MJ, 1998, J GEOPHYS RES-OCEANS, V103, P14169, DOI 10.1029/97JC02906; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Naylor R, 2002, B INDONES ECON STUD, V38, P75, DOI 10.1080/000749102753620293; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; *NOAA NAT WEATH SE, ENSO DIAGN DISC ARCH; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Palmer TN, 2004, B AM METEOROL SOC, V85, P853, DOI 10.1175/BAMS-85-6-853; Patt A, 2002, GLOBAL ENVIRON CHANG, V12, P185, DOI 10.1016/S0959-3780(02)00013-4; Pielke RA, 1999, B AM METEOROL SOC, V80, P2027, DOI 10.1175/1520-0477(1999)080<2027:LNAENO>2.0.CO;2; Quetin LB, 2003, MAR ECOL PROG SER, V259, P185, DOI 10.3354/meps259185; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; Rodgers KB, 2004, J CLIMATE, V17, P3761, DOI 10.1175/1520-0442(2004)017<3761:TPDVAI>2.0.CO;2; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Sponberg K., 1999, COMPENDIUM CLIMATOLO, V1; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Taguchi M, 2006, J CLIMATE, V19, P324, DOI 10.1175/JCLI3655.1; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; Trenberth KE, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000298; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Turner J, 2004, INT J CLIMATOL, V24, P1, DOI 10.1002/joc.965; van Oldenborgh GJ, 2005, OCEAN SCI, V1, P81, DOI 10.5194/os-1-81-2005; Van Oldenborgh GJ, 2005, J CLIMATE, V18, P3240, DOI 10.1175/JCLI3420.1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Witze A, 2006, NATURE, V441, P564, DOI 10.1038/441564a; WRIGHT SJ, 2005, RAIN FORESTS PRESENT, P295; Wunsch C, 1999, B AM METEOROL SOC, V80, P245, DOI 10.1175/1520-0477(1999)080<0245:TIOSCR>2.0.CO;2	68	1046	1087	13	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1740	1745		10.1126/science.1132588	http://dx.doi.org/10.1126/science.1132588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170296				2022-12-28	WOS:000242833600048
J	Mehta, MP; Baross, JA				Mehta, Mausmi P.; Baross, John A.			Nitrogen fixation at 92 degrees C by a hydrothermal vent archaeon	SCIENCE			English	Article							MIDOCEAN RIDGE SUBSEAFLOOR; METHANOSARCINA-BARKERI 227; FUNCTIONAL-ORGANIZATION; STRUCTURAL GENES; EVOLUTION; SEA; DIVERSITY; PROTEINS; HABITAT; CLONING	A methanogenic archaeon isolated from deep-sea hydrothermal vent fluid was found to reduce N-2 to NH3 at up to 92 degrees C, which is 28 degrees C higher than the current upper temperature limit of biological nitrogen fixation. The 16S ribosomal RNA gene of the hyperthermophilic nitrogen fixer, designated FS406-22, was 99% similar to that of non-nitrogen fixing Methanocaldococcus jannaschii DSM 2661. At its optimal growth temperature of 90 degrees C, FS406-22 incorporated N-15(2) and expressed nifH messenger RNA. This increase in the temperature limit of nitrogen fixation could reveal a broader range of conditions for life in the subseafloor biosphere and other nitrogen-limited ecosystems than previously estimated.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Mehta, MP (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	mausmi@alum.mit.edu						Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; BELAY N, 1984, NATURE, V312, P286, DOI 10.1038/312286a0; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; Butterfield DA, 2004, GEOPH MONOG SERIES, V144, P269, DOI 10.1029/144GM17; Charlou JL, 2000, CHEM GEOL, V171, P49, DOI 10.1016/S0009-2541(00)00244-8; CHIEN YT, 1994, J BACTERIOL, V176, P6590, DOI 10.1128/JB.176.21.6590-6598.1994; Chien YT, 1996, J BACTERIOL, V178, P143, DOI 10.1128/jb.178.1.143-148.1996; Chien YT, 2000, J BACTERIOL, V182, P3247, DOI 10.1128/JB.182.11.3247-3253.2000; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dodsworth JA, 2006, P NATL ACAD SCI USA, V103, P9779, DOI 10.1073/pnas.0602278103; GILBERT LA, 2004, THESIS U WASHINGTON; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; JONES WJ, 1983, ARCH MICROBIOL, V136, P254, DOI 10.1007/BF00425213; Kasting JF, 2002, SCIENCE, V296, P1066, DOI 10.1126/science.1071184; KENNICUTT MC, 1995, MICR EXTREM UNUSUAL, P275; Leigh JA, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P7; Leigh JA, 2000, PROKARYOTIC NITROGEN FIXATION, P657; Mehta MP, 2003, APPL ENVIRON MICROB, V69, P960, DOI 10.1128/AEM.69.2.960-970.2003; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Pruis MJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013977; RAU GH, 1981, NATURE, V289, P484, DOI 10.1038/289484a0; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; SOUILLARD N, 1989, MOL MICROBIOL, V3, P541, DOI 10.1111/j.1365-2958.1989.tb00200.x; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Summit M, 2001, P NATL ACAD SCI USA, V98, P2158, DOI 10.1073/pnas.051516098; Young J. P. W., 1992, BIOL NITROGEN FIXATI, V1544, P43; [No title captured]	28	151	160	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1783	1786		10.1126/science.1134772	http://dx.doi.org/10.1126/science.1134772			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170307				2022-12-28	WOS:000242833600061
J	Lewis, RF; Carey, JP				Lewis, Richard F.; Carey, John P.			Abnormal eye movements associated with unilateral loss of vestibular function	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Lewis, RF (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.	richard_lewis@meei.harvard.edu							0	6	6	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					E26	E26		10.1056/NEJMicm031134	http://dx.doi.org/10.1056/NEJMicm031134			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116BZ	17167131				2022-12-28	WOS:000242778800010
J	Pallansch, MA; Sandhu, HS				Pallansch, Mark A.; Sandhu, Hardeep S.			The eradication of polio - Progress and challenges	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Pallansch, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.							[Anonymous], 2006, MMWR MORB MORTAL WKL, V55, P145; Heymann DL, 2004, NEW ENGL J MED, V351, P1275, DOI 10.1056/NEJMp048204; Samba E, 2004, NEW ENGL J MED, V350, P645, DOI 10.1056/NEJMp038210	3	49	52	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2508	2511		10.1056/NEJMp068200	http://dx.doi.org/10.1056/NEJMp068200			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116BZ	17167133	Bronze			2022-12-28	WOS:000242778800002
J	Liu, ZP; Neff, RA; Berg, DK				Liu, Zhaoping; Neff, Robert A.; Berg, Darwin K.			Sequential interplay of nicotinic and GABAergic signaling guides neuronal development	SCIENCE			English	Article							CILIARY GANGLION NEURONS; ACETYLCHOLINE-RECEPTOR; GABA; INTERNEURONS; HIPPOCAMPUS; CIRCUITS; CULTURE; MICE; DIFFERENTIATION; EXPRESSION	GABA (gamma-aminobutyric acid), the major inhibitory transmitter in the brain, goes through a transitory phase of excitation during development. The excitatory phase promotes neuronal growth and integration into circuits. We show here that spontaneous nicotinic cholinergic activity is responsible for terminating GABAergic excitation and initiating inhibition. It does so by changing chloride transporter levels, shifting the driving force on GABA-induced currents. The timing of the transition is critical, because the two phases of GABAergic signaling provide contrasting developmental instructions. Synergistic with nicotinic excitation, GABAergic inhibition constrains neuronal morphology and innervation. The results reveal a multitiered activity-dependent strategy controlling neuronal development.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Berg, DK (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dberg@ucsd.edu	liu, zhao/GXV-6141-2022	Neff, Robert/0000-0002-7550-4348	NINDS NIH HHS [NS035469, NS012601] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035469, R01NS012601] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams CE, 2002, DEV BRAIN RES, V139, P175, DOI 10.1016/S0165-3806(02)00547-3; Alkondon M, 1999, J NEUROSCI, V19, P2693; Bansal A, 2000, J NEUROSCI, V20, P7672; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Chen M, 2001, J NEUROBIOL, V47, P265, DOI 10.1002/neu.1034; DRYER SE, 1994, PROG NEUROBIOL, V43, P281, DOI 10.1016/0301-0082(94)90003-5; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; Kasyanov AM, 2004, P NATL ACAD SCI USA, V101, P3967, DOI 10.1073/pnas.0305974101; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Le Magueresse C, 2006, J PHYSIOL-LONDON, V576, P533, DOI 10.1113/jphysiol.2006.117572; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MCEACHERN AE, 1985, J NEUROSCI, V5, P2690; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015	28	171	177	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1610	1613		10.1126/science.1134246	http://dx.doi.org/10.1126/science.1134246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158331				2022-12-28	WOS:000242624600046
J	Tajima, K; Kurabayashi, M				Tajima, Kumiko; Kurabayashi, Masahiko			Medical mystery: Medical mystery - Abnormal abdominal radiograph	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Gunma Univ, Grad Sch Med, Gunma 3718511, Japan	Gunma University	Tajima, K (corresponding author), Gunma Univ, Grad Sch Med, Gunma 3718511, Japan.	mkuraba@med.gunma-u.ac.jp							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2467	2467		10.1056/NEJMicm050317	http://dx.doi.org/10.1056/NEJMicm050317			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113EO	17151368				2022-12-28	WOS:000242581400010
J	Pearson, H				Pearson, Helen			The bitterest pill	NATURE			English	News Item																		Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980	1	28	28	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2006	444	7119					532	533		10.1038/444532a	http://dx.doi.org/10.1038/444532a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136064				2022-12-28	WOS:000242377600012
